https://www.pharmaradar360.com hourly 1 https://www.pharmaradar360.com/news hourly 0.95 https://www.pharmaradar360.com/regulators daily 0.9 https://www.pharmaradar360.com/trials daily 0.85 https://www.pharmaradar360.com/pipeline daily 0.9 https://www.pharmaradar360.com/drug-approvals daily 0.9 https://www.pharmaradar360.com/journals weekly 0.8 https://www.pharmaradar360.com/pharma-companies weekly 0.8 https://www.pharmaradar360.com/specialties weekly 0.8 https://www.pharmaradar360.com/sources weekly 0.8 https://www.pharmaradar360.com/newsrooms weekly 0.8 https://www.pharmaradar360.com/pharma-tools weekly 0.8 https://www.pharmaradar360.com/pharma-communities weekly 0.75 https://www.pharmaradar360.com/pro weekly 0.75 https://www.pharmaradar360.com/tools weekly 0.7 https://www.pharmaradar360.com/about monthly 0.5 https://www.pharmaradar360.com/privacy yearly 0.35 https://www.pharmaradar360.com/support monthly 0.35 https://www.pharmaradar360.com/disclaimer yearly 0.35 https://www.pharmaradar360.com/drug/pembrolizumab daily 0.9 https://www.pharmaradar360.com/drug/semaglutide daily 0.9 https://www.pharmaradar360.com/drug/tirzepatide daily 0.9 https://www.pharmaradar360.com/drug/trastuzumab-deruxtecan daily 0.9 https://www.pharmaradar360.com/drug/osimertinib daily 0.9 https://www.pharmaradar360.com/drug/nivolumab daily 0.9 https://www.pharmaradar360.com/drug/dupilumab daily 0.9 https://www.pharmaradar360.com/drug/risankizumab daily 0.9 https://www.pharmaradar360.com/drug/lecanemab daily 0.9 https://www.pharmaradar360.com/drug/atezolizumab daily 0.9 https://www.pharmaradar360.com/article/ai-drug-discovery-on-the-eve-of-full-value-realization-in-modern-pharmaceutical-06757b6282d027ab 2026-09-26T10:52:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-data-harmonization-is-the-bottleneck-for-life-sciences-ai-6523456644754b15 2026-09-26T10:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/commentary-the-prescription-drug-affordability-board-is-working-it-s-time-to-pre-c716bb20e31d28e8 2026-09-26T10:18:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/results-are-due-monday-from-a-study-of-two-potential-treatments-for-an-age-relat-87cd3e491349b862 2026-09-26T10:05:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drug-industry-s-care-gap-novo-aims-to-diversify-and-more-94fb54d839beca63 2026-09-26T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-hits-kyiv-pharmaceutical-plant-second-time-in-a-week-f81a10d67ee2ab91 2026-09-26T09:31:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-forces-strike-darnytsia-pharmaceutical-plant-in-kyiv-again-14945dbed4fb36a5 2026-09-26T08:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-inc-nasdaq-rare-stock-has-consensus-price-target-of-34-cc9516ac59c30051 2026-09-26T08:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-002-7p-phase-2-data-selected-for-esmo-2026-oral-presentation-51bca2865302a680 2026-09-26T06:43:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-struck-the-pharmaceutical-company-darnitsa-for-the-second-time-in-four-da-e1a4757d3eb9349f 2026-09-26T06:32:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-assets-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-r-0ebd88a86d57b92b 2026-09-26T05:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/greenland-mines-nasdaq-grml-sets-q4-biotech-spin-off-as-company-sharpens-critica-827b8cea89bf7fcc 2026-09-26T03:52:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-liabilities-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-in-2ba17615a74ef7da 2026-09-26T03:12:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-pharmaceuticals-announces-phase-3-enabling-topline-results-from-phase-2-r-bfc2d18115b8e3c4 2026-09-26T02:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-ltd-bnr-shares-surge-3-3-what-gf-scor-5e0b4dd39ed88219 2026-09-26T02:35:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-files-resale-prospectus-for-751-879-shares-994c1b7db293f72a 2026-09-26T02:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-makes-another-biotech-bet-ahead-of-retatrutide-data-lly-stock-surges-t-f277b743c44c8524 2026-09-26T01:53:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-natural-medicine-biotech-enveda-raises-311m-series-e-9ab31ef431554506 2026-09-26T01:50:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ag-fitch-urges-nsc-to-protect-glp-1-drugs-cda4d5edfcdcd63c 2026-09-26T01:05:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-chinese-biotech-is-graduating-from-licensing-deals-to-broader-partnerships-183cd687d9726f33 2026-09-26T01:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-biotech-startup-at-stanford-is-run-by-thousands-of-ai-agents-475453ac2c308eef 2026-09-26T00:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-biotech-is-moving-behind-the-label-0f6be4fba0036f13 2026-09-26T00:41:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-debt-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-4e3da3a19b763c2a 2026-09-26T00:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-pharmaceutical-and-2-japanese-ai-healthcare-stocks-to-own-dad20d1ebc13d0ef 2026-09-26T00:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-6d6db8d53ff59d8c 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9794-4-crore-consolidated-revenue-and-e2-82-b9206-5-crore-o-5f007ead935d5468 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-33e8b6b6ad98b572 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-olaparib-tablets-from-the-united-states-fo-d811b52390b0afd8 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-7c46eedf80fd409f 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-gets-approval-from-its-board-of-directors-for-increasing-it-72b59d7174a3b9a3 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-completes-acquisition-of-additional-13-25-stake-in-adcock-i-14e9196c217b943d 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-3fd550483f66794a 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-limited-announces-conclusion-of-us-fda-inspection-at-visakhapatnam-563c93e91fa18339 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-d0e1b50f11e06745 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-2089d34b685056eb 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-c77eeaad812063d0 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investment-of-us-14-million-in-egenesis-inc-by-natco-pharma-canada-inc-and-natco-a5efdea1fa732b7e 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-page-e05c95cbe49665be 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-clinical-use-of-cefoperazone-sulbactam-and-post-discharge-antibio-de43bf2af77c554d 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polycystic-ovary-syndrome-pcos-associated-infertility-clinical-insights-and-emer-83c6bc6c8507db43 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-dose-silodosin-for-premature-ejaculation-a-clinical-evaluation-45c0c2795e660c9f 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sociodemographic-and-clinical-characteristics-of-tuberculosispositivity-and-rifa-4ce74de0c5bbbec3 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/african-hla-diversity-and-its-implications-for-transfusion-transplantation-infec-97b857cf9a314545 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-coordinated-cd4-and-cd8-t-cell-immunity-for-virus-specific-adoptive-i-1b602c6ec922594c 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/induced-pluripotent-stem-cell-derived-chimeric-antigen-receptor-natural-killer-c-d1be5f82d021a8a7 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-oral-paracetamol-versus-intravenous-paracetamol-in-preter-1aeadb35921e3545 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p4ha3-promotes-gastric-cancer-cell-proliferation-and-invasion-via-the-pi3k-akt-m-33a6b1c82ca3a9d0 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-medication-adherence-and-health-related-quality-of-lif-ee8db90c935c5ed5 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/terapia-hormonal-de-la-menopausia-reevaluacion-del-balance-riesgo-beneficio-dos-dd70098654c62292 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-twin-of-drug-induced-liver-injury-and-systemic-adverse-drug-reactions-in-0551ae2a8f18f7f0 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-intersection-of-artificial-intelligence-and-intellectual-property-the-impact-66b51a1456a6de5b 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iron-accumulation-in-non-transfusion-dependent-thalassemia-from-molecular-mechan-d1c333f0838c0072 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-sauna-and-waon-therapy-on-cardiovascular-function-and-clinical-outcom-2d7175966a24da73 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-case-of-atypical-occult-hepatitis-b-infection-obi-with-hbsag-negativity-and-hi-d4a1743a51e55130 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-multi-modal-training-in-patients-with-mild-cognitive-impairment-a-rand-423debf0992ec711 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-differences-in-sentiment-scored-vocabulary-patterns-in-vaers-free-text-narra-3d06f6c8aa9c3a7b 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-skin-penetration-of-a-hydrophilic-large-molecular-weight-compound-usin-f56a6a4d8e2bb9a3 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-salivary-cortisol-cortisone-and-dexamethasone-with-serum-measureme-d76f10631ca18dd3 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fluid-intolerance-signals-as-bedside-safety-limits-during-early-septic-shock-res-f4a9bdb767151ed4 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-the-system-fails-the-community-leads-field-insights-from-the-self-efficacy-93ebbf8aed800074 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-biochemical-and-genetic-spectra-of-carnosinemia-a-systematic-review-of-e2c70be37f41686e 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/postprandial-lipopolysaccharide-after-a-saturated-compared-to-monounsaturated-fa-d14b5d2d6417c0fb 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-nudges-are-not-enough-an-ethics-of-escalating-behavioural-interventions-in-93e891b830e4c076 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceptions-of-micro-learning-modules-on-knowledge-retention-and-clinical-decisi-0a8cffb9f2848e80 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/platinum-based-chemotherapy-and-nephrotoxicity-frequency-clinical-characteristic-d4cca52e1258bb58 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-models-combining-multimodal-ultrasound-and-clinical-factors-for-0587d6eee90880e1 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idiopathic-granulomatous-inflammation-of-the-periocular-structures-in-four-dogs-8d673f367bc771fe 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparation-and-i-in-vitro-i-evaluation-of-amphotericin-b-chondroitin-sulfate-po-67ac2740a793f501 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-virtual-reality-based-aerobic-exercise-versus-traditional-aerobic-exe-0726fa7784af4fbd 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinician-curated-chatgpt-4o-and-deepseek-r1-assisted-exercise-programmes-added-1854cdd7da17f8a5 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benchmarking-model-based-design-of-experiment-approaches-with-a-pharmaceutical-c-39b3209501f13f07 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/semaglutide-and-tirzepatide-in-cardiovascular-and-cardiometabolic-risk-managemen-3a1c317d994a2f39 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relationship-between-breast-arterial-calcification-detected-on-mammography-and-c-b61df578ae71bdd2 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-literacy-primary-healthcare-accessibility-and-hypertension-self-care-mana-161c74695fc7a346 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinicians-perspectives-on-the-design-of-multi-output-ai-based-early-warning-sys-96c5ad937ea54cfd 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-the-5-item-modified-frailty-index-and-chronological-age-with-post-cbf14f8eb36fce46 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/internalized-weight-stigma-and-associated-clinical-features-in-treatment-seeking-83ea0ad14fda1f23 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/automated-reporting-for-serum-immunofixation-electrophoresis-using-a-two-stage-d-43c8f7d90ebbeb81 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blockchain-based-pharmaceutical-supply-chain-a-scalable-and-transparent-model-fo-7c8d96259f0a09b5 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-clinical-translation-of-a-stepwise-simulation-based-curriculum-f-f94eb722ad3070c8 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-of-thermoresponsive-pnipam-coated-hollow-bimetallic-nanocomposites-for-ph-7d6337f875827942 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-kpaq-improvement-reassessing-the-clinical-meaning-of-cilostazol-rosuvasta-6a232b0f64ce470d 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/splice-site-variants-in-neurology-from-molecular-mechanisms-to-clinical-interpre-47616a2bbc486454 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dietary-inflammatory-potential-and-oral-periodontal-health-in-children-a-cross-s-c6073d301f8193af 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-surface-treatment-protocols-and-thermocycling-on-the-optical-surface-a-c467701c4ba52a3b 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/influence-of-cold-plasma-activation-on-fluoride-uptake-and-demineralization-of-e-eb9109194738a3a2 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-cannabis-use-disorder-with-clinical-outcomes-following-lumbar-spi-856f9a813f88bb67 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoliposomal-silymarin-as-a-multi-mechanistic-therapy-for-nafld-dose-dependent-cc068a3b9bcdbfcb 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-handgrip-strength-in-advanced-cancer-associated-factors-and-clinical-implica-7269a0855ff7e4c1 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novel-semi-automated-system-for-multi-dimensional-analysis-of-macular-neovascula-7bebf046e75cd0e0 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-covid-19-on-refractive-amblyopia-risk-factors-in-5-years-old-children-b5d42cfabe22f6ff 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-spiz-study-rationale-and-protocol-of-a-randomized-controlled-trial-to-optimi-ba23ab4a9346904b 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-laboratory-characteristics-distinguishing-node-first-kawasaki-disea-4e3f1b106d63d0ff 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-innovation-in-advanced-nanomedicine-for-the-treatment-of-hypervir-18f8abae5a555e61 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/child-human-in-the-loop-ood-detection-for-safe-clinical-deployment-63f5fa2dc79454b0 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biogait-vlm-a-tri-modal-vision-language-biomechanics-framework-for-interpretable-1233b179f74e6545 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atomimed-hierarchical-atomic-fact-checking-for-universal-clinical-aware-medical-3d7e99bd2b99d254 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomass-derived-carbon-dots-based-frap-analog-for-sensitive-evaluation-of-antiox-7fc4c245e4935099 2026-09-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edsa-stock-rallied-over-50-today-what-s-ahead-for-the-small-cap-biotech-ad8c8a2cd49d9062 2026-09-25T23:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/murkowski-concerned-fda-pick-may-limit-chemical-abortion-killing-of-preborn-alas-a423c9902e1ff283 2026-09-25T23:16:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-street-spdr-s-p-biotech-etf-xbi-stock-price-news-quote-and-history-c439df664c2384a2 2026-09-25T22:54:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/budd-blunt-rochester-introduce-bill-to-establish-biometrology-laboratory-program-35bcca7365f58ae5 2026-09-25T22:47:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/zeria-pharmaceutical-co-ltd-tse-4559-looks-like-a-good-stock-and-it-s-going-ex-d-6fb6c2f2205f1cfb 2026-09-25T22:07:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/consideration-of-the-political-declaration-on-pandemic-prevention-preparedness-a-a6e8e4bc3b7ddcd2 2026-09-25T22:00:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-confirmation-hearing-gives-update-on-abortion-pill-study-under-new-leadershi-25744d59fca613e4 2026-09-25T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/community-pharmacist-prescribing-service-planned-for-october-2026-start-20a197d64ffbf786 2026-09-25T21:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacy-at-the-heart-of-welsh-government-s-healthcare-priorities-3e55daddcdec949f 2026-09-25T21:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/supporting-patients-who-are-clinically-vulnerable-to-covid-19-330ca89993016f45 2026-09-25T21:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-commissioner-nominee-affirms-mmr-vaccine-safety-despite-trump-s-claims-e1569d4826e14760 2026-09-25T21:31:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/here-s-how-much-1000-invested-in-krystal-biotech-5-years-ago-would-be-worth-toda-33624fb55441f011 2026-09-25T21:30:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-stock-looks-stretched-against-current-earnings-power-41a3057190af1eb4 2026-09-25T21:27:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-s-30-plunge-hides-an-epilepsy-moat-says-biotech-hangout-s-paul-matteis-fb5cf78ea2e8552b 2026-09-25T21:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuevas-convocatorias-de-la-revista-cientifica-anmat-inteligencia-artificial-en-c-00ed4f21feb981cc 2026-09-25T21:06:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nominee-faces-pressure-on-independence-vaccine-safety-31e39264518030ba 2026-09-25T20:50:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulefnersen-slows-disease-progression-in-phase-3-als-trial-7764ca56678d1f84 2026-09-25T20:41:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/egypt-implements-new-economic-framework-for-pharmaceutical-pricing-e9fb11da9de11118 2026-09-25T20:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-c-supplements-tied-to-fewer-deaths-in-blood-disorder-trial-ce51979419b24198 2026-09-25T20:32:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/ifinatamab-deruxtecan-biologics-license-application-for-certain-patients-with-pr-fdd32384f0449deb 2026-09-25T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-etf-xbi-hits-an-interest-rate-wall-as-40-catalysts-approach-6892588234ed9157 2026-09-25T20:19:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/gene-silencing-biotech-adarx-makes-some-noise-with-535m-stock-market-debut-3f23777dd63f10de 2026-09-25T19:39:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanbio-fy2026-q2-earnings-call-25-years-since-founding-first-product-revenue-of-467e21310849ea46 2026-09-25T19:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sitc-2026-pre-conference-program-explores-biotech-funding-pitching-and-partnersh-2830973c41044f8e 2026-09-25T19:32:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-early-development-decisions-shape-commercial-readiness-for-biologics-c1e5c43319558596 2026-09-25T19:20:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/axios-live-sen-todd-young-says-china-s-out-front-on-biomanufacturing-b49284f426081da4 2026-09-25T19:15:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/selected-major-pharmaceutical-policy-events-0ee8a0811c339cde 2026-09-25T19:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-pharmaceutical-inc-ttnp-net-income-2024-4-7m-net-loss-up-15-5-691d0ee54d871172 2026-09-25T18:53:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-pharmaceutical-inc-ttnp-total-assets-2024-2-9m-down-63-9-a782b2e61d657e20 2026-09-25T18:52:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-welireg-plus-lenvima-pharmexec-8c55391006ed9467 2026-09-25T18:30:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-expands-its-manufacturing-role-for-biopharma-s-new-drugs-061c904da3b0dd6d 2026-09-25T18:23:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-life-groups-urge-fda-to-restore-abortion-pill-safeguards-e2426af77046aa39 2026-09-25T17:54:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambridge-biotech-co-founded-by-alnylam-founder-maraganore-files-for-ipo-d9376a06cfff0ac8 2026-09-25T17:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-next-generation-of-chinese-biotech-ready-to-go-global-alone-16f3874a1f435179 2026-09-25T16:51:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-transaction-in-own-shares-26d78d02c383c40c 2026-09-25T16:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-research-september-25th-e5e9193f41a03d33 2026-09-25T16:26:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/spdr-s-p-biotech-etf-xbi-stock-price-news-quote-and-history-c496072a78141080 2026-09-25T16:17:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/vicapsys-life-sciences-forms-advisory-board-following-stateline-merger-56f7f08bb6f5a3b6 2026-09-25T16:02:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/newron-provides-update-on-phase-3-enigma-trs-2-study-fff1b0c9b4486667 2026-09-25T15:52:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovation-is-driving-a-new-bull-market-in-biotech-16-ways-to-play-it-from-our-r-f1f9afd0dfc1e9ed 2026-09-25T15:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/faq-what-comes-next-for-the-340b-rebate-pilot-f6900c9fa2358bd2 2026-09-25T15:38:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-commission-approves-nezglyal-for-rare-brain-disease-c2623348facae534 2026-09-25T15:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-wins-approval-for-once-weekly-insulin-shot-7c44bd319c61a23f 2026-09-25T15:29:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-high-level-meeting-on-pandemic-prevention-preparedness-and-response-b2a1545f834e1570 2026-09-25T15:26:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-caused-by-bundibugyo-virus-democratic-republic-of-the-congo-50e21450deb19fcd 2026-09-25T15:16:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmtech-s-weekly-roundup-september-25-2026-b5fc39bb00930c54 2026-09-25T15:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/b-riley-s-top-biotech-picks-ahead-of-3q26-earnings-season-21f4b57a11c16fa9 2026-09-25T15:14:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-meso-lly-anip-win-fda-nod-kala-hcti-sign-loi-imvt-halts-lupus-study-83b52857014b8cdb 2026-09-25T14:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mfn-drug-pricing-won-t-help-but-competition-will-8f6bd219b441a807 2026-09-25T14:45:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-commissioner-nominee-heidi-overton-is-ignoring-the-science-on-abortion-drug-1a056e8e92e3362e 2026-09-25T14:45:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pneumococcal-vaccination-programmes-for-infants-adults-and-individuals-at-increa-8050db2fd0e7d296 2026-09-25T14:39:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/easy-read-guide-to-the-pneumococcal-vaccine-8c98aa2e7ccf2022 2026-09-25T14:39:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiv-action-plan-monitoring-and-evaluation-framework-9cb704956fd8cbf0 2026-09-25T14:35:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-presents-first-data-from-phase-3-excaliber-rrmm-trial-evalu-a5174cf8f58830c5 2026-09-25T14:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/movianto-opens-major-pharmaceutical-cold-storage-facility-in-germany-1aeea997cdab52fa 2026-09-25T14:24:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-commissioner-pick-pledges-to-follow-statutory-requirements-in-fda-hearing-6bf2c47d70768346 2026-09-25T14:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanexa-shares-soar-on-1-17-billion-novo-nordisk-deal-for-injection-technology-ca4540a23314bb08 2026-09-25T14:14:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-pharmaceuticals-raises-446-million-in-upsized-ipo-e629ef97252c4630 2026-09-25T14:07:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/vicapsys-life-sciences-announces-advisory-board-following-completion-of-statelin-ab434b9c25697d61 2026-09-25T14:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebitda-per-share-of-teva-pharmaceutical-industries-limited-bsesof-teva-bb0623bc9221f62c 2026-09-25T14:04:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/kali-therapeutics-named-to-the-2026-endpoints-11-recognizing-biotech-s-most-prom-74a7f7f08c42a90b 2026-09-25T14:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-s-most-exciting-startups-of-2026-meet-this-year-s-endpoints-11-1f64947210f404ce 2026-09-25T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endpoints-news-announces-the-2026-winners-of-the-endpoints-11-awards-showcasing-fc3bb47616ec9a7b 2026-09-25T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-first-presentation-of-results-for-zenbexustm-iber-207c719acf715ab6 2026-09-25T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convergesouth-draws-its-largest-crowd-yet-to-winston-salem-with-north-carolina-b-a0deefed0c501d10 2026-09-25T13:57:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/longevity-biotech-s-617billion-opportunity-longevity-news-roundup-week-39-2026-a4efa343bee041fc 2026-09-25T13:52:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecoceres-supports-astrazeneca-s-net-zero-journey-with-first-hvo-application-in-c-54be299a0feb5edd 2026-09-25T13:41:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-raises-446m-in-biotech-s-third-largest-ipo-of-2026-city-files-to-go-public-1ed124e1049c5e15 2026-09-25T13:39:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-pharma-asia-lilly-s-3-35b-innocare-deal-korea-s-breakthrough-china-s-5-ye-044c28fe098dc5e6 2026-09-25T13:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/kobayashi-in-500-billion-buyout-talks-after-red-yeast-case-415a1d65abcc4062 2026-09-25T13:37:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-retail-pharmacy-s-trust-challenge-is-also-its-path-forward-e2b0702c8d08029b 2026-09-25T13:28:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-aiff-jagx-surge-cdt-gctk-slide-d30c867d6ba2929e 2026-09-25T13:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-milan-usp-benchmarks-reshape-procurement-incentives-1d09ef64bee6e38b 2026-09-25T13:15:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/movianto-opens-one-of-europe-s-largest-pharmaceutical-logistics-hub-e13951088a73e86f 2026-09-25T13:13:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-graft-versus-host-disease-treatments-what-s-in-the-biotech-pipeline-in-2026-916b9bd374d9f453 2026-09-25T13:01:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/italy-s-reported-first-psychedelic-trial-for-hard-to-treat-depression-will-inclu-52166ac52bd4d21f 2026-09-25T12:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-welireg-and-lenvima-combo-for-advanced-kidney-cancer-004774cf23718913 2026-09-25T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-aventis-canada-inc-recalling-certain-insulin-pens-and-cartridges-57d08a4b5c103889 2026-09-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perma-handtm-silk-suture-bcb56fa36b10c35f 2026-09-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/limited-number-of-sarclisa-single-use-vials-may-have-been-frozen-during-shipment-7434ecaa767510a3 2026-09-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amplatzertm-amulettm-left-atrial-appendage-occluder-4548369052f42f94 2026-09-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endpoints-news-hires-reuters-correspondent-maggie-fick-to-cover-u-s-pharma-ac4ed419dd313f6c 2026-09-25T11:57:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-robotic-endovascular-access-for-critical-treatment-ec96d2bc8d2fff8f 2026-09-25T11:46:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-biological-permeation-enhancers-for-transbuccal-drug-delivery-f903b39bcb8a3170 2026-09-25T11:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-the-first-personalized-precision-digital-intervention-in-a-video-b11922c4cc6a045a 2026-09-25T11:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-directed-evolution-to-understand-and-engineer-bioactive-long-nonc-267f4cef2ae7db76 2026-09-25T11:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-reports-5-year-carvykti-data-in-myeloma-patients-df8b969fbedfd4ab 2026-09-25T11:28:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-reports-five-year-cartitude-2-data-showing-durable-treatment-free-2cdf62d76e1caf6e 2026-09-25T11:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-presents-carvykti-data-showing-half-of-patients-with-rrmm-remaine-ff4a6ffb89197ecb 2026-09-25T11:07:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurion-biotech-completes-enrollment-in-phase-3-astra-study-of-aurn001-for-cornea-793eaa6eb89c9b72 2026-09-25T11:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-next-alnylam-rnai-biotech-city-therapeutics-files-for-ipo-48715f4874cf4d45 2026-09-25T11:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-and-earendil-forge-1-5bn-bispecific-discovery-deal-63a03f3822c118f0 2026-09-25T11:01:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/half-of-20-blood-cancer-patients-were-alive-with-no-cancer-progression-or-furthe-93634d310aa07310 2026-09-25T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-electronic-prescribing-systems-as-safe-as-we-think-12bd8c34773b70f3 2026-09-25T10:59:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-welireg-belzutifan-plus-lenvima-lenvatinib-for-certain-previous-83acca6a2792462a 2026-09-25T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jusvinza-demonstrates-efficacy-against-chikungunya-6d6d32c7c91d7f05 2026-09-25T10:43:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/find-product-information-about-medicines-985a650e836aba64 2026-09-25T10:32:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-does-another-small-deal-this-time-with-drug-delivery-biotech-nanexa-7af623e602aaf0f3 2026-09-25T10:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safer-radiotherapy-triannual-event-analysis-and-learning-e491d544e5e562ba 2026-09-25T10:20:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-legend-biotech-legn-turn-cell-therapy-scale-into-compounding-wealth-9cd9384b41318f65 2026-09-25T10:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nominee-faces-bipartisan-scrutiny-over-vaccines-and-abortion-drug-981d4c9267bd431f 2026-09-25T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dispatches-from-cgt-international-big-pharma-m-a-is-the-new-biotech-ipo-c9b1d472ba4b94cf 2026-09-25T09:59:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/phoenix-quad-c-thoma-bravo-target-occupational-health-pharmaceutical-growth-driv-2a771b66ec7f2301 2026-09-25T09:38:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-biotech-is-becoming-essential-to-the-future-of-food-and-how-ai-is-accelerati-cd444053f8da00cd 2026-09-25T08:58:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-inks-1-3b-nanexa-deal-to-unlock-long-acting-obesity-injectables-a881a2e28ecbc524 2026-09-25T08:53:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/wnt-drug-gives-msd-first-eye-disease-win-after-eyebio-deal-c83e09dee95e6dcf 2026-09-25T08:48:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/auburn-native-s-biotech-company-goes-public-it-s-incredibly-rewarding-d118005799e1566d 2026-09-25T08:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-cdna-13-gral-15-twst-16-adpt-rvty-41820e80afb11d18 2026-09-25T08:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-pick-to-lead-fda-questioned-by-us-senate-da9afb42dd1ba14b 2026-09-25T08:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/msd-s-eye-drug-meets-primary-endpoint-in-trial-de38639efd712b58 2026-09-25T08:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/confirmatory-trials-and-the-new-realities-of-fda-expedited-approval-6cd33a2239afedcc 2026-09-25T07:57:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/teclistamab-plus-daratumumab-shows-18-point-survival-gain-at-3-years-in-multiple-5f53bbf58e19036b 2026-09-25T07:48:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-reaches-fda-protocol-agreement-for-efzofitimod-phase-3-trial-ff90d06e40159c37 2026-09-25T07:48:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-prices-446-3m-nasdaq-debut-continuing-industry-s-ipo-momentum-bf62d46d4f4c34c2 2026-09-25T07:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-hits-over-3-year-high-as-aml-drug-trial-nears-final-readout-wall-stree-d690b1c596b74875 2026-09-25T07:41:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-pays-atavistik-bio-usd-70m-upfront-in-research-partnership-3aae3741cae97a47 2026-09-25T07:36:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/kobayashi-in-3-2-billion-buyout-talks-after-red-yeast-case-915308a75717f883 2026-09-25T07:34:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cd47-signal-that-oncology-trial-designers-are-misreading-e7b943df4346729d 2026-09-25T07:33:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryoport-strong-pipeline-of-cell-and-gene-therapy-approvals-nasdaq-cyrx-61f64e59e3b25d5a 2026-09-25T07:26:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-it-smart-to-buy-aska-pharmaceutical-holdings-co-ltd-tse-4886-before-it-goes-e-3f677d584b0cf63b 2026-09-25T07:17:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pre-cision-platform-wins-research-and-development-achievement-award-from-pha-32dde6afcca1bf48 2026-09-25T07:09:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/black-hawk-locks-in-meteora-financing-for-vesicor-biotech-merger-59ec0fc485d3bbaa 2026-09-25T07:04:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-scores-upsized-446m-ipo-while-city-maps-out-nasdaq-plans-27b8fac812a355c8 2026-09-25T06:46:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-reports-phase-2-results-for-remlifanserin-in-alzheimer-s-disease-psychosi-c74361f0213b1564 2026-09-25T06:43:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyverna-reports-one-year-miv-cel-data-in-stiff-person-syndrome-gmg-624d0813a544aea2 2026-09-25T06:43:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/sefaxersen-meets-primary-endpoint-in-phase-3-iga-nephropathy-trial-517888a3e70e4a9c 2026-09-25T06:43:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-us-house-and-senate-propose-2-bills-for-cisa-to-step-up-the-protection-o-75a015ecbb7d07ec 2026-09-25T06:23:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/big-read-big-pharma-bets-billions-on-china-biotech-will-washington-pull-the-plug-0756239395352f22 2026-09-25T06:19:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/big-read-big-pharma-bets-billions-on-china-biotech-will-washington-pull-the-plug-3511dc5fb4bbb15a 2026-09-25T06:19:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-focus-01-clinical-trial-design-and-preclinical-data-further-demonstrate-the-0802ba0230a00153 2026-09-25T06:01:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-pharmaceutical-tse-4536-could-be-a-buy-for-its-upcoming-dividend-211ec25c526845c1 2026-09-25T05:59:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-it-might-not-make-sense-to-buy-kyorin-pharmaceutical-co-ltd-tse-4569-for-its-b0042c5cef02d226 2026-09-25T05:50:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-begins-phase-1-clinical-trial-of-ebola-vaccine-against-strain-behind-drc-0f15edae8af6e558 2026-09-25T04:42:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-brief-the-tightrope-faced-by-trump-s-fda-pick-5298af1eb3d49489 2026-09-25T04:34:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/movianto-opens-30-000-sqm-pharmaceutical-logistics-hub-in-germany-06c67aeac3bd7d82 2026-09-25T04:00:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/angiographic-catheter-recall-boston-scientific-removes-imager-ii-angiographic-ca-7806189c7e5eea8c 2026-09-25T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-on-track-to-be-september-s-no-2-s-p-500-stock-but-these-5-smaller-health-ca-aae5b19ae2ba20e5 2026-09-25T03:23:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-on-track-to-be-september-s-no-2-s-p-500-stock-but-these-5-smaller-health-ca-c11e7e5386621baa 2026-09-25T03:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sunhawk-vision-biotech-inc-cash-flow-tpex-7759-7c6d9d5bf85008f9 2026-09-25T02:21:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-discusses-american-biotech-leadership-at-axios-live-event-7d6d523c5d4a26a9 2026-09-25T01:26:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/adrx-ipo-news-sirna-biotech-adarx-pharmaceuticals-prices-upsized-ipo-at-17-the-h-b33fc17edd8dc0b6 2026-09-25T00:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-advances-oncology-pipeline-as-xlife-sciences-reports-first-h-4e1dcb90c50a16ab 2026-09-25T00:40:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/rnai-drug-specialist-adarx-raises-446m-ipo-bbfd6fd6937188fb 2026-09-25T00:37:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-foods-to-revise-prices-of-some-products-new-prices-to-take-effect-with-de-dae178c5cb3b056c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicaid-and-children-s-health-insurance-program-chip-generic-information-collec-a517ce386e9bcc9a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/draft-nih-policy-on-sharing-summary-level-study-results-with-clinical-research-p-91eacb94fe96ce62 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/robotically-assisted-surgical-devices-premarket-submissions-draft-guidance-for-i-f617f9d98de05341 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dermatologic-and-ophthalmic-drugs-advisory-committee-notice-of-meeting-establish-e70cef7ecba8973b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reauthorization-of-the-biosimilar-user-fee-act-public-meeting-request-for-commen-e1de7e5e0a4360e9 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/filing-of-color-additive-petition-from-doehler-gmbh-request-to-amend-the-color-a-fa83a20668624e42 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-additives-permitted-for-direct-addition-to-food-for-human-consumption-vitam-4f95d0d5dc7d090e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeffrey-thies-final-debarment-order-3892b6ffea2019a7 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/naveed-aslam-final-debarment-order-93b24598baec685e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/privacy-act-of-1974-matching-program-77516d93d671562e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-cleveland-clinic-hospitals-recognized-as-top-performers-by-vizient-0f6d6d965abc6e20 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scaling-back-screen-time-during-school-year-40c09147c29d6937 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-and-value-implications-of-veligrotug-versus-teprotumumab-for-7ece3f4eda8bff11 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/retained-root-fragments-following-exodontia-a-narrative-review-of-clinical-outco-9379bf909d7708cd 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/debriefing-characteristics-associated-with-the-development-of-clinical-judgment-52584a8e15933521 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-periodontology-promise-practicality-and-clinical-reality-1e0dfc4f5dbe38f0 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictive-factors-for-hemoglobin-decrease-after-simple-open-prostatectomy-singl-5786a2682345ae91 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-gender-dysphoria-through-diverse-clinical-presentations-6af452b0df960475 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-ultrasound-guided-quadratus-lumborum-block-combined-31384ddc215f7dd5 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-social-architecture-of-participation-7b1cd5b917b0f0da 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-a-moving-threshold-antigen-density-as-a-design-constraint-for-particul-fe54455bb8a0b1f9 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-challenge-of-treating-syringomyelia-associated-with-extensive-arachnoiditis-74de3063e7988678 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nod2-variants-and-duration-of-hospitalization-after-endoscopic-treatment-of-bili-fff75a7aa65897eb 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dynamic-changes-in-serum-neutrophil-gelatinase-associated-lipocalin-for-discrimi-82b06f23ed85e2ef 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/retrospective-assessment-of-llm-decision-making-for-iol-power-selection-in-catar-8e2149ab35ed73e5 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodality-imaging-of-mitral-regurgitation-2f6766a1086173c4 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bullying-and-cyberbullying-in-childhood-and-adolescence-a-narrative-review-and-p-76e3cd8ef6e55b2e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/validation-of-the-hungarian-fad-gf-and-baffs-in-a-multi-informant-clinical-sampl-3fe5b25c797bd30d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vermicomposting-reshapes-microbial-communities-and-functional-potential-in-sewag-ae6e64b6b8199af4 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/choriocapillaris-dysfunction-in-retinal-diseases-multimodal-imaging-biomarkers-p-4b51271ff5f4702b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotypic-divergence-among-genomically-closely-related-klebsiella-pneumoniae-cl-d785ff96c21dac46 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feasibility-of-a-teacher-supervised-chatgpt-assisted-workflow-for-individualized-3e57e1bd3fbefb65 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-clinical-relevance-of-loneliness-in-the-treatment-of-depression-study-488121acc67451a2 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/added-effects-of-dual-task-water-based-exercise-on-global-cognition-and-physical-d78831b4678fef85 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cannabinoids-in-hematologic-malignancies-mechanisms-and-therapeutic-potential-fo-455ec19e5f96dc3d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-clinical-outcomes-and-safety-of-anlotinib-containing-regimens-in-pedi-730b69bf7352220b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcutaneous-auricular-vagus-nerve-stimulation-tavns-a-comprehensive-review-of-3a56ae80f15917b1 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-12-week-24-form-tai-chi-on-cognitive-function-cerebral-perfusion-and-3074684e688c186c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delayed-diagnosis-of-selected-thoracic-and-mediastinal-conditions-in-young-adult-8b5dc28ca3ef2176 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-new-concepts-advances-and-future-trends-in-clinical-research-on-eye-di-a57c8623c59995e7 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-manifestations-and-proportions-of-severe-outcomes-in-pediatric-acute-po-554128e88e8ff456 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deproteinized-calf-blood-extract-with-or-without-punctal-plugs-versus-preservati-8d74bf281ef03d4b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/omentin-1-and-cardiovascular-disease-a-comprehensive-review-from-molecular-mecha-8982c91fdb3fc976 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-genotype-phenotype-correlation-analysis-in-279-pati-32e62f97fa08d151 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-pre-market-open-label-single-arm-study-to-evaluate-b-bone-for-posterolateral-f-fd21f5760f204dba 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-s-response-to-the-comments-on-long-term-clinical-and-functional-outcomes-344b23c04227b021 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/protein-drug-interaction-in-psoriasis-therapy-using-molecular-docking-and-molecu-8ace86625ddb7a15 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-nurse-led-care-plan-and-parents-education-on-sleep-quality-and-behavi-c248428cdfe9a25a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/explainable-deep-learning-based-integration-of-multi-omics-data-rna-seq-dna-meth-4cf7874d8e5b91af 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characterization-of-human-mesenchymal-stem-cell-according-to-delivery-route-and-966a5a72762014a4 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-relationship-between-systemic-inflammation-response-index-and-clinical-and-h-cc45a3ab13df34bf 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicted-but-powerless-rethinking-clinical-predictors-against-patient-reported-77f69db8b6c5683d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantifying-data-leakage-in-multimodal-clinical-augmentation-a-decomposition-fra-8482fc036ca2b068 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/demographic-and-clinical-profile-of-visits-to-the-pediatric-emergency-department-07b84b023040b184 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/renal-denervation-for-hypertension-mechanisms-evidence-and-clinical-integration-89333ab93d31de1b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-lt-i-gt-in-vivo-lt-i-gt-factor-connecting-sustained-reactive-oxygen-species-c-19516830e05a44b5 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-impact-of-recipe-boxes-on-dietary-quality-and-food-agency-a-pilot-e1f30ebf291262ad 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-older-age-and-lower-body-mass-index-with-initial-teicoplanin-trou-8d0a8a8bd7f44a2e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/methods-for-assessing-the-acquisition-of-pharmaceutical-care-skills-among-studen-593bf59c0bc1f1d8 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-value-of-targeted-next-generation-sequencing-and-metagenomic-next-gener-0874c5f449175572 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fully-automated-deep-learning-based-lenke-classification-for-adolescent-idiopath-daf8de2070c9d732 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-clozapine-discontinuation-in-clinical-practice-an-updated-framework-7488313ea3f6a362 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/socio-behavioral-research-experiences-and-acceptability-of-serial-lymph-node-and-5062a19f2f415ef6 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ketamine-enhanced-psychotherapy-for-smoking-cessation-a-pilot-study-of-feasibili-018ff76e8825fb30 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-2-from-shiva02-trial-using-patients-as-their-own-controls-to-assess-effic-6668e28e9218790e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-3-from-shiva02-trial-using-patients-as-their-own-controls-to-assess-effic-364f83e96d41bc6c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-1-from-shiva02-trial-using-patients-as-their-own-controls-to-assess-effica-74b4363d0bc703b3 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-major-pathologic-response-in-lung-cancer-biomarkers-predict-outcomes-2c644ad99e830c5e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/galleri-cancer-test-fails-to-meet-main-aim-in-nhs-trial-but-fda-still-endorses-i-a4607d427d15019c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-preoperative-intravenous-crystalloid-bolus-on-postinduction-blood-pres-0ab3a25007a12a6c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-exercise-effective-at-reducing-pain-catastrophizing-in-people-with-chronic-no-9f4e6c1fe9682df4 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-a-3-day-benzodiazepine-detoxification-protocol-with-continu-7896503f860a0cbc 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remnant-cholesterol-and-cardiovascular-risk-in-maintenance-haemodialysis-55c8fd1757e06d30 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hyperhomocysteine-a-key-mediator-linking-chronic-kidney-disease-to-parkinson-s-d-4a4fda6ba17b205b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-scintigraphic-improvement-of-mandibular-involvement-associated-with-863d1e03d48f7f8d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agreement-between-lunar-densitometers-in-the-capital-region-of-denmark-a-phantom-55a77cdddb8ea4ff 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-asymmetric-hearing-loss-in-children-from-a-large-ped-af05d1ae7aef697d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combined-ethanol-and-lauromacrogol-sclerotherapy-for-ovarian-endometriotic-cysts-9cd9b1be8d8f1ac3 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mass-test-and-treat-mtat-for-malaria-prevalence-in-a-moderate-transmission-setti-0795b638aa2a9426 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-expansion-of-clinical-trial-capacity-improve-healthcare-access-ae0f4d61286726a6 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-n-of-1-therapy-to-health-system-implementation-270f1daf4b4e659c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-discovery-in-india-9d724a6f7997a1e5 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-comprehensive-review-of-the-multifaceted-contributions-of-nanoparticles-and-th-91393b62f456a422 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polypharmacy-and-multimorbidity-in-hospitalized-patients-clinical-consequences-a-98df5e6edbb17c16 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ramadan-fasting-and-thyroid-function-a-narrative-review-of-physiological-adaptat-7b51ac2a6f4820a9 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-muscle-activation-after-transtibial-amputation-clinical-and-rehabi-93679889148d9a2e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-delivery-of-methotrexate-and-curcumin-in-hyaluronic-acid-coated-solid-lipid-n-bdb4a64c1b090f5b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-traumatic-nfectious-keratitis-clinical-microbiological-and-visual-outcomes-6f786fc8dff3064f 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-stress-processes-induced-by-the-negative-impact-of-lead-on-rats-on-bod-96874046ebd865ba 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-single-cell-and-spatial-transcriptomic-analysis-characterizes-a-tnbc-79a171f6ebab31ae 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spherical-clinical-embedding-with-adaptive-multi-expert-fusion-for-aaa-rupture-c-008c5241b71d2d7f 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-modality-aware-mixture-of-experts-framework-for-clinical-multimodal-breast-ult-11349169e872d62c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skeletal-muscle-transcriptomic-responses-to-concurrent-training-with-polyphenols-095aa02436316a77 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-of-laser-interstitial-thermal-therapy-vs-anterior-temporal-lo-2cd784718f89ad89 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcriptomics-driven-identification-and-engineering-of-a-novel-lactone-esteras-11778ba041bbd5ca 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ofatumumab-therapy-and-long-term-seizure-outcomes-of-patients-with-relapsing-ant-67d4ec84ce91b614 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07843173-peri-implantation-abstinence-and-placental-health-8df54d912a3bd404 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07842939-pre-cannulation-ultrasound-vascular-mapping-combined-with-handgrip-e-ea6a46a39948ef03 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07842926-acute-effects-of-capacitive-resistive-radiofrequency-therapy-in-peop-3d7db39f70958919 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07842692-serum-endocan-levels-in-colorectal-cancer-3c97efba7b080f97 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07842536-efficacy-of-lycium-barbarum-polysaccharide-in-dry-eye-disease-manage-22032a9cb14508aa 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07842133-the-effect-of-progressive-muscle-relaxation-exercises-on-fatigue-dys-6511c6386c58830e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07841730-tibial-nerve-mobilization-versus-multisensory-exercises-in-patients-79bd105296f64cb3 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07841496-alt001-in-patients-with-ischemic-stroke-in-the-sequelae-stage-0b40791cdc142754 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840859-clinical-effectiveness-of-oxygen-releasing-oral-gel-as-an-adjunct-to-70cccd112dfa932a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840573-feasibility-and-performance-of-a-structured-video-telemedicine-progr-bcf0538a8e0b6dbb 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840547-teleneurology-assessment-program-for-creutzfeldt-jakob-disease-bf9a3961e81bf61c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840508-velocity-loss-training-and-parkinson-s-disease-240b3f93fd0ca415 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840495-the-efficacy-of-low-level-laser-therapy-lllt-as-an-adjunct-treatment-74ff0760ee9eac49 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07840430-home-based-exercise-for-improving-health-related-quality-of-life-in-a26947c447105390 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07834021-body-scan-meditations-to-support-well-being-in-patients-at-antwerp-u-41375b929642b76a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831317-multi-strain-probiotic-supplement-for-digestive-comfort-and-well-bei-7ca83f8b737254ba 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07817875-efficacy-safety-and-pharmacokinetics-of-tirzepatide-ly3298176-once-w-d01e4e31aeceef19 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07769437-non-nutritive-sweeteners-in-inflammatory-bowel-disease-4a0a5f1029895664 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07768345-a-study-to-learn-about-revaccination-with-a-vaccine-called-rsvpref-i-454efe6eed63ee46 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07735104-the-first-in-human-study-of-qls2319-in-healthy-subjects-and-cancer-c-f83f611dd4c57f4f 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07670312-evaluation-of-xya02-in-patients-with-advanced-solid-tumors-440162864358cbef 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07626606-how-gut-health-affects-immune-responses-to-the-oral-rotavirus-vaccin-31b1b7f3e75e973f 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07624396-association-between-circulating-bdnf-levels-and-cardioembolic-stroke-333f5aba151f8344 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07525206-a-study-to-access-intravenous-iv-telisotuzumab-adizutecan-in-combina-0879403a59c0aa87 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07524530-stem-cell-transplantation-for-participants-with-germline-runx1-assoc-f7c7537ec91ee762 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07519772-a-clinical-study-of-mk-1045-in-people-with-non-hodgkin-lymphoma-mk-1-a50ac56f09684b1d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07377006-decision-support-tool-to-enhance-germline-genetic-testing-for-patien-5285daa9f071f049 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07367100-a-pivotal-study-evaluating-safety-and-effectiveness-of-adaptative-ti-92afb94a8c357747 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07270666-ctdna-testing-to-inform-standard-of-care-treatment-decisions-in-peop-297379c3cf7b9251 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07216027-a-study-to-learn-about-study-medicine-called-pf-08049820-in-people-w-6d025df09f63a144 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07196748-a-protocol-of-icotrokinra-therapy-in-adult-and-adolescent-participan-43d2c33926f40196 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07194070-a-study-on-hemolytic-disease-of-the-fetus-and-newborn-hdfn-through-g-9d04807a7dac3c6d 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07164443-a-study-of-pasritamig-with-or-without-jnj-87189401-versus-placebo-fo-5035cb4415c3afeb 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07106593-treatment-for-ptsd-and-tinnitus-303bc2b13d57d85a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06981091-a-multicenter-randomized-double-blind-placebo-controlled-parallel-gr-b76857e2f5e5b8ab 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06956118-electrical-vestibular-nerve-stimulation-vens-as-a-treatment-for-impr-dddc94e9572bd87f 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06801236-phase-1-study-of-ace-232-to-treat-patients-with-metastatic-castratio-95936c80f9b52ea2 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06667908-a-study-of-jnj-90301900-in-combination-with-chemoradiation-followed-82f1d5b6ab760f0c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06642337-nutritional-educational-program-on-therapy-in-iron-deficiency-anemia-330e71da13c23231 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06624163-evaluation-of-patient-coach-support-for-older-adults-with-obesity-577cdaa75b5e11be 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06607003-induced-blood-stage-malaria-in-healthy-malaria-naive-adults-to-asses-7e071e53d6f06a4c 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06595940-genetic-analysis-of-uncommon-disease-presentations-in-non-us-populat-9a7defcdd77feca2 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06459648-study-for-prevent-chronification-migraine-through-prediction-of-resp-751f651224054abf 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06383988-a-web-based-program-to-help-caregivers-of-lung-patients-learn-about-62002d70191a65fd 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06349408-ibi3001-in-participants-with-unresectable-locally-advanced-or-metast-561bb4909064d74a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06302257-pain-selective-anesthesia-for-labor-mobility-psalm-study-a-randomize-0e4dbd290ac0e7fa 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06272747-study-of-xh-s003-in-healthy-volunteers-366ccf33e5652b3e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06236841-a-phase-i-study-of-xh-s004-in-healthy-volunteers-bd38dbc6419120a2 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06211764-a-study-of-tar-200-versus-intravesical-chemotherapy-in-participants-70fb428c8c501859 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06149559-a-study-of-rozanolixizumab-in-pediatric-study-participants-with-mode-37bfb1fcb56a93c9 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06091865-a-study-to-compare-how-well-odronextamab-combined-with-chemotherapy-6660dc234a37eda6 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05828069-a-study-with-tovorafenib-day101-as-a-treatment-option-for-progressiv-62c1d830acc793ea 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05621291-a-multicenter-study-to-evaluate-next-generation-sequencing-ngs-testi-b35317055f480c6e 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05132075-study-of-jdq443-in-comparison-with-docetaxel-in-participants-with-lo-5398a6b6916ab47a 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04923893-a-study-of-bortezomib-lenalidomide-and-dexamethasone-vrd-followed-by-44e427687aa6d817 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04606381-a-study-of-amivantamab-subcutaneous-sc-administration-for-the-treatm-2dd0ceee06690bd9 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03759717-molecular-and-cellular-characterization-of-skull-base-tumors-28fe734c106cbfe0 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03599245-this-is-an-extension-study-of-the-roche-p-trials-to-investigate-safe-de31de7344570942 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03498261-a-prospective-randomized-double-blind-trial-to-assess-the-effect-of-94f75079d93aaff5 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01900132-electrical-impedance-myography-natural-history-studies-inneuromuscul-4e262bdc8f5dcc6b 2026-09-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kobayashi-pharmaceutical-co-ltd-notice-regarding-certain-media-reports-622d9a7eca7e2127 2026-09-24T23:31:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-ownership-in-life-sciences-transactions-why-it-matters-more-than-ever-in-th-888286bf4bf04710 2026-09-24T23:05:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-might-not-be-a-great-idea-to-buy-towa-pharmaceutical-co-ltd-tse-4553-for-its-6320b287911428d7 2026-09-24T22:55:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/city-therapeutics-files-for-us-ipo-as-biotech-listings-surge-5daeb04034b53a20 2026-09-24T22:25:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/richmond-biotech-company-feels-pressure-over-nih-grant-uncertainty-3d6ef6ed6b223974 2026-09-24T22:18:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-plastic-pots-market-to-2035-demand-accelerates-on-chronic-disease-f4a3a5c86f34ff5c 2026-09-24T22:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/candidaturas-presidenciais-aprensentam-suas-prioridades-para-a-industria-da-saud-38c2c47a921cf22f 2026-09-24T21:39:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cty-ipo-news-rna-interference-biotech-city-therapeutics-files-for-a-100-million-f57f26022f990fc3 2026-09-24T21:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/house-and-senate-members-propose-legislation-for-cisa-to-step-up-cyber-defenses-e612a03d10136345 2026-09-24T21:28:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/australia-starts-investigation-into-openai-medicare-breach-a86a3687e693513c 2026-09-24T21:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-fda-s-new-rule-could-accelerate-non-animal-testing-in-beauty-3c553e6eaaa6ba66 2026-09-24T21:18:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-fda-pick-dodges-vaccine-abortion-questions-at-senate-confirmation-hearing-8c24e92bad0a3cce 2026-09-24T21:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezolute-inc-rzlt-faces-valuation-challenges-amid-cash-burn-an-ecae3de68ba09b45 2026-09-24T21:01:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-the-party-s-over-the-top-is-in-nysearca-xbi-ccd380813c56ca50 2026-09-24T20:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/richmond-biotech-company-feels-pressure-over-nih-grant-uncertainty-a16a33d04af6ae48 2026-09-24T20:47:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/voyager-technologies-exobiosphere-team-for-biotech-research-67960ecbc1248c01 2026-09-24T20:35:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nominee-evasive-on-abortion-pill-but-firm-on-vaccine-safety-8abce6ebccf2a425 2026-09-24T20:31:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/50-pro-life-leaders-call-on-fda-nominee-dr-heidi-overton-to-restore-minimal-safe-b4a6cb899b86a77e 2026-09-24T19:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-s-overton-era-and-dispatches-from-shanghai-51acf1b2992e66e0 2026-09-24T19:35:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/aria-cybersecurity-announces-a-leading-pharmaceutical-manufacturer-deploys-azt-p-edd8e9566658b5e3 2026-09-24T19:15:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-life-groups-ask-fda-to-restore-abortion-pill-safeguards-704a0ff085fc32d2 2026-09-24T19:11:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-participo-de-la-30a-reunion-del-foro-internacional-de-reguladores-de-dispo-9a67a011afc45e36 2026-09-24T19:06:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-sen-hawley-says-fda-commissioner-nominee-denied-dangers-of-chemical-ab-1161e11edbe13322 2026-09-24T19:06:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-slams-glp-1-compounder-over-risk-of-contaminating-drugs-with-filth-8bcdf3d618446ae8 2026-09-24T18:58:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-chinese-drug-extends-stroke-treatment-window-from-hours-to-2-days-study-find-318b2f8f8cdf8426 2026-09-24T18:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/governor-hochul-celebrates-completion-of-ima-life-north-america-s-30-million-exp-0ef7bfd615ba30f2 2026-09-24T18:54:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-heidi-overton-appears-before-senate-committee-for-confirmation-hearing-as-nex-927f5ad766e1ef04 2026-09-24T18:34:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-fda-pick-heidi-overton-calls-vaccines-mifepristone-safe-and-effective-in-7432ec419d7fa40e 2026-09-24T18:32:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/copeland-closes-dickson-deal-to-expand-cold-chain-monitoring-9e5f8bef77b45a28 2026-09-24T18:29:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nominee-overton-says-all-us-vaccines-safe-as-senators-press-on-shots-abortio-9d53ed4780db055e 2026-09-24T18:23:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-jumps-5-after-fda-signs-off-on-phase-3-trial-design-for-lung-disease-1845acd19bbdd17a 2026-09-24T18:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeted-therapy-may-improve-function-survival-in-fus-als-7f66b0be01dbe142 2026-09-24T18:13:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-onswik-pharmexec-a912f4b5c9411f64 2026-09-24T17:57:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-acadia-pharmaceuticals-stock-tumbling-today-acadia-pharmaceuticals-nasdaq-cdfa7fc397f2f998 2026-09-24T17:43:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyverna-s-cell-therapy-shows-lasting-autoimmune-benefit-2450aa478dccce91 2026-09-24T17:35:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-fda-alignment-boosts-atyr-pharma-s-rare-lung-disease-09bca1f5840f8f0d 2026-09-24T17:31:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nominee-pressed-on-vaccines-abortion-pill-e773458488d78778 2026-09-24T17:31:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-research-in-microgravity-experiment-campaigns-outlined-af4aefe3125628aa 2026-09-24T16:56:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-health-in-prisons-and-secure-settings-e3554700b1659c8c 2026-09-24T16:48:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-heidi-overton-appears-before-senate-committee-for-confirmation-hearing-as-nex-0664b41dc4c24382 2026-09-24T16:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/xlv-vs-ibb-how-healthcare-diversification-compares-to-biotech-concentration-365380469bcb2def 2026-09-24T16:03:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-vicapsys-stateline-merger-and-veritiv-s-tempsafe-rxshield-741f22ac71864ee7 2026-09-24T15:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/xlv-vs-ibb-how-healthcare-diversification-compares-to-biotech-concentration-4b45fd335a5f66c4 2026-09-24T15:57:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/erlc-calls-for-stronger-fda-protections-on-mifepristone-58d8b71863d1edc6 2026-09-24T15:57:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/innocare-signs-research-deal-with-lilly-worth-up-to-3-35-billion-a4ef898820ec5e0f 2026-09-24T15:52:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/taro-pharmaceutical-industries-stock-faces-a-legal-settlement-b82bcea56e890817 2026-09-24T15:47:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-orphan-registered-medicinal-products-99fb5dd11a1ac4aa 2026-09-24T15:45:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-eli-lilly-s-psychedelic-investment-could-mean-for-the-emerging-field-1631e12377162d46 2026-09-24T15:37:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/kobayashi-pharmaceutical-receives-take-private-proposal-from-japan-uk-fund-conso-cf4425fbc6c8fdc0 2026-09-24T15:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-aligns-with-fda-on-phase-3-trial-design-for-sarcoidosis-drug-efzofit-7e1f399d800d3373 2026-09-24T15:29:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-expands-china-biotech-strategy-with-usd-3-25b-innocare-discovery-collabora-69046fa55deceef8 2026-09-24T15:25:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-s-alzheimer-s-psychosis-drug-remlifanserin-posts-phase-3-enabling-phase-2-2d19fc0bc1643851 2026-09-24T15:25:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-launches-festival-food-safety-drive-9-76-crore-suspected-stock-s-7b3bb672c3ca1ccb 2026-09-24T15:21:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidelity-healthcare-etf-fhlc-vs-vaneck-biotech-etf-bbh-which-fund-is-the-better-36084fc467c759f7 2026-09-24T15:10:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/marinomed-biotech-ag-mari-operations-ordered-closed-f5cdc1e3765a0c59 2026-09-24T15:08:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/sourcing-the-next-blockbuster-big-pharma-banks-on-chinese-biotech-1b18adbe7944c5f1 2026-09-24T15:06:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/sourcing-the-next-blockbuster-big-pharma-uses-chinese-biotech-7b142b8c9f28e67b 2026-09-24T15:06:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-upgrades-thyroid-drug-recall-to-its-riskiest-level-fc4b286a0c33caeb 2026-09-24T15:03:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-says-phase-iii-trial-of-becotatug-achieves-positive-topline-45ba1ec5b8d7169f 2026-09-24T15:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-senior-officials-business-expenses-hospitality-and-meetings-april-to-june-2-7d9da5047a679d1e 2026-09-24T15:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-senior-officials-business-expenses-hospitality-and-meetings-a328912eb87631b3 2026-09-24T15:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-special-advisers-gifts-hospitality-and-meetings-april-to-june-2026-3dd02564ad41de97 2026-09-24T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-special-advisers-gifts-hospitality-and-meetings-52d34624ad3609c5 2026-09-24T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-ministerial-gifts-hospitality-overseas-travel-and-meetings-2332d5d2f3822f2e 2026-09-24T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-ministerial-travel-and-meetings-april-to-june-2026-99b9b0a66353fa3e 2026-09-24T15:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-business-appointment-rules-advice-april-to-june-2026-6e8c1aef13dcf8a5 2026-09-24T15:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-business-appointment-rules-advice-3b5125a476d37863 2026-09-24T15:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/live-trump-s-nominee-to-lead-the-fda-testifies-in-front-of-the-senate-602ce242ed0ee6ec 2026-09-24T14:59:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-nominee-to-lead-fda-questioned-on-vaccines-abortion-in-senate-hearing-42adf24ae85ddedf 2026-09-24T14:52:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-antibiotics-lakewood-amedex-advances-diabetic-foot-ulcer-trial-dcd9b419ec422d7d 2026-09-24T14:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fidelity-healthcare-etf-fhlc-vs-vaneck-biotech-etf-bbh-which-fund-is-the-better-79716d464d0ab893 2026-09-24T14:45:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-policy-in-motion-continued-the-trump-administration-s-second-wave-9ef8298908d47403 2026-09-24T14:36:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-consequence-infectious-disease-country-specific-risk-11ed7e663ad962ce 2026-09-24T14:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-and-marburg-haemorrhagic-fevers-outbreaks-and-case-locations-16b29cdb0bb31831 2026-09-24T14:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/outbreaks-under-monitoring-in-2026-eb6ae222898106b1 2026-09-24T14:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/7-breast-cancer-clinical-trials-currently-enrolling-in-the-us-3d754367ca23279a 2026-09-24T14:28:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-update-30d4e36f5ec7eb5a 2026-09-24T14:26:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/senators-question-fda-nominee-overton-about-her-views-on-abortion-pill-and-vacci-c943ab22658c95ed 2026-09-24T14:21:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ai-agents-need-regulatory-guardrails-5c84bf499aa76f81 2026-09-24T14:17:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-out-of-distribution-aware-reasoning-agents-for-clinical-learning-26668a9652a31e99 2026-09-24T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-senators-question-heidi-overton-in-confirmation-hearing-for-fda-commission-1cdb413fdff776b1 2026-09-24T14:06:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-market-europe-september-2026-4bdbac2b14a27119 2026-09-24T14:05:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-henlius-carves-out-440m-t-cell-engager-deal-with-amberstone-228b047b6c3cadb1 2026-09-24T14:02:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/enveda-nabs-311m-to-progress-nature-derived-drug-pipeline-55af799b19cd9116 2026-09-24T14:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-nbmea-niobium-multi-electrode-arrays-for-next-generation-ofelectr-ccd296ec42d9a0f8 2026-09-24T13:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-toward-pd-free-pharma-iron-catalysis-in-cross-coupling-reactions-b999d7ac32c5efa3 2026-09-24T13:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-nasdaq-atyr-initiates-phase-3-efzofitimod-trial-with-5-0-mg-kg-dosin-9e1f6d23d606c8b8 2026-09-24T13:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-misses-mark-in-alzheimer-s-but-concludes-phase-3-absolutely-worth-pursuin-182796a9f2f9775e 2026-09-24T13:46:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyverna-steps-closer-to-fda-first-car-t-for-an-autoimmune-condition-with-durabil-aec309193e41be1e 2026-09-24T13:43:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/panel-will-weigh-overton-s-fda-public-health-direction-e565fb64fbc05ab4 2026-09-24T13:42:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-jv-recalls-one-lot-of-sodium-chloride-over-labeling-issue-efc8c0c36d286f61 2026-09-24T13:41:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-things-to-know-in-life-sciences-week-of-sept-21-2026-06f05da46e262ef6 2026-09-24T13:32:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-biotech-has-a-lot-riding-on-trump-s-fda-pick-7b6780f9008f70f9 2026-09-24T13:32:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-animal-safety-tests-gain-a-new-place-in-fda-drug-rules-but-animal-studies-ar-30132ac08a5c623a 2026-09-24T13:31:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/students-take-first-steps-toward-biotech-careers-5ccf576365171d58 2026-09-24T13:25:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/organisation-testing-registration-record-of-combo-rapid-lfd-test-users-b084323e6e76370d 2026-09-24T13:17:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/combined-covid-19-and-flu-tests-use-in-ari-outbreaks-in-adult-social-care-homes-81119bdf4cea369a 2026-09-24T13:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-life-leaders-call-on-fda-to-restore-abortion-drug-safeguards-d8f96c48f0333a28 2026-09-24T13:12:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/students-take-first-steps-toward-biotech-careers-db6cd5e1b4a0bddd 2026-09-24T13:09:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-27-september-2026-c943810d2c68d2ca 2026-09-24T13:05:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-2026-to-2027-46b78a2386536090 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-reports-2026-to-2027-season-32f74fa23fd23c69 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/syndromic-surveillance-weekly-summaries-for-2026-45747e3878253def 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/remote-health-advice-weekly-bulletins-for-2026-0b8fbceac342c05c 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-ambulance-syndromic-surveillance-weekly-bulletins-2026-6dee157afd1fba75 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/gp-out-of-hours-syndromic-surveillance-weekly-bulletins-for-2026-f212a5a75078c06e 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/gp-in-hours-weekly-bulletins-for-2026-dfebf391f225843d 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergency-department-weekly-bulletins-for-2026-08abcdde2881ef86 2026-09-24T13:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-you-need-new-experts-for-ai-validation-canva-01eb9bca8a13d35c 2026-09-24T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-fellow-advocates-for-workforce-support-recognition-of-the-human-element-at-adb76937931c263c 2026-09-24T12:59:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-chain-signal-how-policy-pressures-are-converging-on-pharma-657d9fba122364cb 2026-09-24T12:59:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/gmp-inspections-timelines-a-critical-regulatory-challenge-for-russian-pharmaceut-e7dc698ef5110745 2026-09-24T12:53:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-upgrades-vitruvias-thyroid-drug-recall-to-highest-risk-level-628ccd913b0388b6 2026-09-24T12:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-equity-strategies-reports-and-tools-c0ffe1b40e5cb25d 2026-09-24T12:43:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/bionation-2026-makes-the-case-for-canadian-biotech-as-a-national-priority-ad639bc356d65e3d 2026-09-24T12:32:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/bionation-2026-makes-the-case-for-canadian-biotech-as-a-national-priority-associ-a2e87b82d11840dd 2026-09-24T12:32:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/bionation-2026-makes-the-case-for-canadian-biotech-as-a-national-priority-b9989c6df729a5ef 2026-09-24T12:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/complete-routine-immunisation-schedule-f183272f6e9e9379 2026-09-24T12:27:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-patient-dosed-in-phase-2a-trial-of-nu-3-a-53d1f94ef30eddf0 2026-09-24T12:17:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-sees-pivotal-victory-for-3b-eye-disease-prospect-c531284e9416942c 2026-09-24T12:15:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-makes-the-frontline-case-for-phase-3-imnn-001-study-14-7-month-os-signal-868d8772ba1a6b61 2026-09-24T12:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicinova-completes-lplv-in-phase-2b-3-clinical-trial-evaluating-mn-166-3a4ea04bcd5ee983 2026-09-24T12:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-makes-the-frontline-case-for-phase-3-imnn-001-study-6ccc720fedebca3a 2026-09-24T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-patient-in-an-ovarian-cancer-trial-reports-no-recurrence-nearly-10-years-after-8f16a726488b52b3 2026-09-24T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-first-patient-has-received-a-germ-fighting-gel-being-tested-for-infected-dia-5fb89581d66b5d03 2026-09-24T12:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-biotherapeutics-announces-first-patient-dosed-in-phase-2a-clinic-b4d7c458a487039e 2026-09-24T12:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/likoralltm-patient-lift-systems-d7a7892377661e3e 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inzone-detachment-system-84fd5fe3a11f8c81 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interstimtm-systems-8f983b571970ef4c 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-8-million-people-have-an-eye-disease-that-can-cause-blindness-annexon-079bcae73e5453e0 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-canadian-patient-joins-a-trial-of-a-self-administered-nasal-spray-for-sudden-f-d8711bed16991723 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-presents-baseline-characteristics-of-104-patients-in-glo-8ddd06580f20c1fe 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-a-us-senator-wants-a-biotech-leader-in-the-white-house-who-has-the-president-b6e7dabb5e589933 2026-09-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-atyr-gains-5-after-securing-fda-protocol-approval-for-phase-3-sarcoi-16bd40c5d8cb33ae 2026-09-24T11:50:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-protection-report-volume-20-2026-f9e0b8a49f9df3c3 2026-09-24T11:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/prac-september-2026-veiligheidsonderzoek-naar-injecteerbare-ijzerhoudende-genees-d3df9ebf3c2363ce 2026-09-24T11:27:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/arwr-stock-goldman-sachs-resumes-coverage-with-74-target-as-clinical-catalysts-n-54f6027f066b31dc 2026-09-24T11:20:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-workforce-management-information-62f452371af74327 2026-09-24T11:12:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-workforce-management-information-august-2026-291cf16d23181a61 2026-09-24T11:11:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-second-measure-favored-the-higher-dose-the-alzheimer-s-drug-narrowly-missed-it-3c1bb4ef41c89852 2026-09-24T11:03:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/flsc-ipo-news-biotech-spac-frazier-life-sciences-acquisition-ii-files-for-a-75-m-d5eab25a2dd31e90 2026-09-24T11:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-pharmaceutical-co-ophlf-soars-13-9-is-further-upside-left-in-the-stock-0950027dcda4a100 2026-09-24T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acadia-pharmaceuticals-announces-phase-3-enabling-topline-results-from-phase-2-r-c918ae34422e8020 2026-09-24T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthy-start-extension-application-guidance-84d59c59b495a9a2 2026-09-24T10:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/podcast-how-sandoz-plans-to-harness-its-golden-decade-68b53bc08b1c1d6f 2026-09-24T10:55:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctt-pharmaceutical-adds-karen-larson-to-board-e7cff323c616d17f 2026-09-24T10:49:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-s-remigromig-a-tri-specific-agonist-of-the-wingless-related-integration-si-564f990f527f019d 2026-09-24T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-fda-approved-weekly-insulin-could-mean-over-300-fewer-shots-a-year-than-a8e09cc6f5e4003a 2026-09-24T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schorr-family-foundation-scholarships-help-two-pharmacy-students-c82a687b573f5292 2026-09-24T10:40:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/gohub-ventures-invests-in-swiss-biotech-startup-prevision-medicine-5b7fe1d6af0950f2 2026-09-24T10:36:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-gilead-can-t-stop-talking-about-its-ambitions-in-immunology-4e9a973d5ffa33b5 2026-09-24T10:34:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-for-dhsc-7fde6c0568507ce7 2026-09-24T10:31:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-stock-initiated-at-buy-by-goldman-sachs-06ed5dbd214c1bc0 2026-09-24T10:26:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-direct-final-rule-clarifying-that-non-animal-methods-may-be-used-in-p-f33c5d985998b2fe 2026-09-24T10:13:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-actually-went-wrong-when-a-phase-3-trial-fails-q-a-with-dr-remo-moomiaie-qa-c88ca5967f76fd20 2026-09-24T10:06:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-announces-alignment-with-fda-on-phase-3-study-of-efzofitimod-in-pulm-631edf73e98b701e 2026-09-24T10:06:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicinova-announces-completion-of-last-patient-last-visit-in-the-double-blind-p-cfde8abb806f2672 2026-09-24T10:06:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-is-excelling-in-health-tech-that-s-good-news-for-the-world-30d79eb43ed47a25 2026-09-24T10:05:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/0a2b89983de35c79 2026-09-24T10:02:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-and-atyr-align-on-a-planned-lung-disease-drug-trial-for-up-to-about-372-pati-f7ff287b591c8a1e 2026-09-24T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-909-27-2026-c0fc667f86e8537c 2026-09-24T09:56:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/caliway-reports-phase-ii-success-for-dercum-s-disease-therapy-d74330c3d4bd909c 2026-09-24T09:49:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/anti-vax-ally-of-rfk-jr-faces-senate-showdown-in-bid-to-run-fda-c94a6418d0603cf5 2026-09-24T09:33:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-visual-guide-to-vaccines-9bd59f2f55e933f2 2026-09-24T09:26:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-tkno-mrna-atrc-ilmn-db25e51232f70ef0 2026-09-24T09:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/basecamp-research-secures-140m-for-ai-driven-therapies-1fb496172a1d55e7 2026-09-24T09:15:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/saudi-arabia-s-1-3-billion-biotech-push-following-riyadh-summit-1a760444b9610383 2026-09-24T09:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-initiates-phase-iii-trial-of-hb1801-for-advanced-breast-canc-722961134acadef9 2026-09-24T09:04:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-pills-vaccines-and-food-safety-f-d-a-nominee-heidi-overton-faces-senate-8657d6ea819eb9f9 2026-09-24T09:02:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/japan-s-kobayashi-pharmaceutical-considering-going-private-under-japan-uk-invest-b7d7019e91da6c88 2026-09-24T09:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-monitoring-following-the-grenfell-tower-fire-85d5cc3f2b36adbc 2026-09-24T09:01:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisory-panel-endorses-grail-blood-test-for-cancer-saying-benefits-outweigh-839e5eff0a011929 2026-09-24T09:00:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-phd-to-biotech-series-clarifying-your-direction-before-you-leave-academia-32528df980be6fab 2026-09-24T08:58:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-presents-baseline-characteristics-of-104-patients-in-glo-9e2412cd0063c035 2026-09-24T08:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-release-access-lists-cover-programme-quarterly-data-428cef6b96303d41 2026-09-24T08:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/pseudomonas-aeruginosa-bacteraemia-annual-data-1d797b39720d627d 2026-09-24T08:30:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/mssa-bacteraemia-annual-data-f528c463d0bdaf78 2026-09-24T08:30:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/klebsiella-species-bacteraemia-annual-data-503a503e52f5c85b 2026-09-24T08:30:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/clostridioides-difficile-c-difficile-infection-cdi-annual-data-8aca3e044b7619f2 2026-09-24T08:30:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/escherichia-coli-bacteraemia-annual-data-3f475f96b5a9b5cb 2026-09-24T08:30:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-of-adult-carers-in-england-d418d708ba824a58 2026-09-24T08:30:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-surveillance-reports-2026-to-2027-season-1cc078fa257f8153 2026-09-24T08:30:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/group-a-streptococcal-infections-seasonal-activity-in-england-2025-to-2026-ce123cc7682acde2 2026-09-24T08:30:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/salmonella-statistical-releases-5659a2d745797007 2026-09-24T08:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/gastrointestinal-infections-and-outbreak-statistics-for-england-05961f6c3dda1ec2 2026-09-24T08:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/childhood-vaccine-coverage-provisional-monthly-data-england-2026-29f210faf64d1d4d 2026-09-24T08:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/staphylococcus-aureus-guidance-data-and-analysis-a8912dd7bdb60a2d 2026-09-24T08:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pertussis-guidance-data-and-analysis-03c0c3d9c5f593d2 2026-09-24T08:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/rubella-confirmed-cases-and-notifications-926536a7ab5f7350 2026-09-24T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pertussis-laboratory-confirmed-cases-reported-in-england-2026-db4e82e10f96250a 2026-09-24T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-and-mssa-bacteraemia-and-c-difficile-infections-annual-epidem-f5bcd757f0f31131 2026-09-24T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-2026-to-2027-quarterly-da-c123be05410e88f7 2026-09-24T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-2025-to-2026-quarterly-da-ec5c68eb5b9089f9 2026-09-24T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumps-confirmed-cases-and-notifications-c7fa17868bb576d7 2026-09-24T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-statistics-ba0b6fc132b9bc62 2026-09-24T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-associated-infections-hcai-statistics-b7d400e2cae94ffc 2026-09-24T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-priorities-in-2026-to-2027-1952003048c98805 2026-09-24T08:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-annual-remit-letters-951394235efaad03 2026-09-24T08:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-associated-infections-hcai-qmi-report-3d3a05bef1af6387 2026-09-24T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-of-adult-carers-in-england-2025-to-2026-report-dd94c8c57d1015b9 2026-09-24T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-and-mssa-bacteraemia-and-c-difficile-infections-annual-epidem-0349e3e77f352fa2 2026-09-24T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrsa-bacteraemia-annual-data-41045b47b36919ad 2026-09-24T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-and-mssa-bacteraemia-and-c-difficile-infections-annual-epidem-15eaf59b1e073a25 2026-09-24T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zawya-jordan-innovation-to-boost-pharmaceutical-industry-expansion-competitivene-176d20ac670397c0 2026-09-24T08:06:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-265-additional-job-cuts-9a849e8b43466d86 2026-09-24T07:56:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/five-reputable-food-safety-pharmaceutical-analysis-testing-comp-8d1fad0593c07239 2026-09-24T07:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/sweden-sees-rise-in-reported-adverse-reactions-to-semaglutide-c726e3240e922ecd 2026-09-24T07:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-klinische-forschung-unter-druck-die-schweiz-verliert-den-anschl-f10a4dd63d4b7ad6 2026-09-24T07:12:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-raids-41-food-establishments-seizes-suspected-adulterated-stock-banned-51ac538ccadea7b8 2026-09-24T06:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-starts-phase-3-trial-of-setidegrasib-vs-docetaxel-in-kras-g12d-lung-can-04158db7875be88d 2026-09-24T06:43:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurion-biotech-completes-enrolment-in-pivotal-phase-3-astra-trial-of-aurn001-054fc721ae97f0f7 2026-09-24T06:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-1816dbb998f2b4ff 2026-09-24T06:39:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-puts-up-100m-plus-billions-on-the-backend-to-form-5-target-deal-with-china-6c61ef54a1649f1c 2026-09-24T06:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/8ebee4139de8b40a 2026-09-24T06:36:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-opportunity-to-capture-the-value-in-china-biotech-mcdermott-will-schult-085f959c32a8b182 2026-09-24T06:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iii-imagination-a496c4076e536916 2026-09-24T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-announcement-regarding-sefaxersen-announcement-of-interim-analysis-resul-2b62b1533500f4e4 2026-09-24T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/senators-to-question-fda-nominee-about-her-views-on-abortion-pill-and-vaccines-7927482d11e62167 2026-09-24T06:10:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/amylyx-pharmaceuticals-inc-amlx-stock-price-news-quote-and-history-60c744dabbcc341a 2026-09-24T06:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-mrna-player-arcturus-buys-belgian-biotech-myneo-d16ed4fa7c90683b 2026-09-24T05:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-scientific-excellence-to-industrial-implementation-7d269cad5f6bcd35 2026-09-24T05:31:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/scancell-completes-up-to-us-25-million-in-debt-financing-providing-optionality-a-bf9b9582e6d48052 2026-09-24T05:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-open-innovation-how-to-make-pharma-biotech-collab-work-at-scale-56c6678157e4dce8 2026-09-24T05:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-biotech-can-outsource-the-work-but-not-the-thinking-62440c8a0f80ffa8 2026-09-24T04:48:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-ibrx-eye-green-month-as-biotech-etf-gains-steam-analyst-sees-continued-oppor-6a1aa66cf3396998 2026-09-24T04:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/14-new-weight-loss-drugs-8f97f67645d6c678 2026-09-24T04:23:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncolytics-biotech-nasdaq-oncy-trading-down-5-2-time-to-sell-0ef78dc82ada9778 2026-09-24T04:23:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licence-of-big-basket-outlet-2-others-in-pune-983a0d3619458216 2026-09-24T04:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-pump-controller-recall-abiomed-removes-automated-impella-controllers-47fbe907b89dde32 2026-09-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenience-kit-correction-becton-dickinson-issues-correction-for-kits-and-proce-3ead510ad9a3f821 2026-09-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/forge-nano-and-nanexa-enter-joint-development-agreement-to-advance-manufacturing-ba5c9042fb0dd3d3 2026-09-24T03:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relay-therapeutics-stock-in-focus-as-phase-3-trial-begins-ae162c061bbbe4de 2026-09-24T03:40:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-gravity-what-happens-when-biotech-leaves-earth-f07a29aa63bed1c2 2026-09-24T03:19:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-fine-chemicals-market-research-by-the-business-research-company-h-d995cc154853c988 2026-09-24T02:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-india-speaks-up-after-karnataka-fda-crackdown-says-patient-safety-is-top-1dec1b1061b8c217 2026-09-24T01:37:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/denmark-s-novo-nordisk-drives-pharmaceutical-growth-amid-economi-614c7030a4d75324 2026-09-24T01:30:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-nasdaq-vrxa-appoints-raju-willener-as-chief-financial-officer-f28b533ec19df462 2026-09-24T01:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-limited-teva-stock-price-news-quote-and-history-fc990b185865c912 2026-09-24T01:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-presents-new-phase-3b-results-for-simtriyo-centanafadine-highlighting-con-1a29f0f899bb75bd 2026-09-24T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-s-cellid-sells-control-to-huniverse-global-bluemtec-goes-to-kolmar-g-3f9c640f1bbe8a4b 2026-09-24T00:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-wins-fda-nod-for-fgfr2-cholangiocarcinoma-drug-targets-q4-us-launch-chosunbi-1f8b2d48bd4073d8 2026-09-24T00:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kringle-pharma-seeks-u-s-phase-3-trial-for-spinal-cord-injury-drug-14edbc70749803b0 2026-09-24T00:33:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-ad72045ab683f604 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-center-program-performance-period-extensions-0f0cd04cdb1c8a07 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-deafness-and-other-communication-disorders-notice-of-close-ba042779be6415ec 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-the-intent-to-award-a-single-source-cooperative-agreement-to-int-196740f909292d40 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-patient-access-to-deceased-donor-islet-cells-and-cell-products-request-7c8bf0c1fd2bd478 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-cayman-chemical-company-83551c67b2dddf3e 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-eli-elsohly-laboratories-7b874ac6769188b4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-fisher-clinical-services-inc-i-22f4ec8f816e8d51 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-cambridge-isotope-laboratories-inc-339a6737685ac403 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-cambridge-isotope-laborat-5e9cedccc508e97d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/request-for-information-medicare-part-d-reasonable-and-relevant-pharmacy-contrac-a32ed7dcd8d4274e 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-academy-of-pediatrics-expands-newborn-screening-guidelines-49e8dc43210bf960 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-levels-of-vitamin-d-and-cementum-thickness-and-clinica-56654c30b5b58af4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-risks-associated-with-traumatic-exposures-among-flood-disaster-victims-in-5b55d48739ec2191 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-medicine-in-diffuse-large-b-cell-lymphoma-integrating-molecular-biomar-e12408836930ea28 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-transcatheter-arterial-embolization-plus-targeted-chemotherapy-for-a-dfcd1446063adacc 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tubulocystic-renal-cell-carcinoma-with-aggressive-behavior-insights-from-molecul-d6bf7b15a82a28e4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlations-of-the-expression-of-akap95-cx43-cpsf5-6-scffbxl2-and-scffbxo31-in-457d4f522a00c9ed 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-effects-of-transcutaneous-electrical-stimulation-on-perip-083d3f36c265066e 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/snake-antivenom-therapy-for-improving-outcome-in-russell-s-viper-envenomation-sa-8b0d24c073b55439 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-nca-outcomes-665cec7eddea2887 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/topical-and-systemic-nca-interventions-b325eeec46041d2f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/disrupting-hierarchies-of-knowledge-and-strengthening-collective-wisdom-e4b32b559b1fa8d2 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/physical-activity-and-exercise-in-pediatric-oncology-conceptual-distinctions-and-0aa355a994cf5c81 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-vestibular-electrical-stimulation-combined-with-vestibular-reha-eaef322f5700f043 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiological-outcomes-of-percutaneous-k-wire-fixation-versus-open-r-083f8f81779d12e2 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-neck-imaging-reporting-and-data-system-in-post-treatment-sur-4b6e85ce06f08615 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/41-metabolic-dysregulation-and-immune-activation-in-vitiligo-unveiling-the-mitoc-a1301e9a89728dbf 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-associated-factors-and-mortality-related-factors-of-pne-f48946eb2b5492dd 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidemiology-genetics-clinical-characteristics-and-dietary-risk-factors-of-famil-51e317c6f6c3535b 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/areszt-elektroniczny-a-ograniczenie-skali-stosowania-tymczasowego-aresztowania-e7128e91325fe374 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/critical-care-ultrasound-guided-targeted-volume-management-as-precision-medicine-e319763ba39afdc9 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotic-prophylaxis-of-infective-endocarditis-in-dentistry-an-update-on-the-e-9e0a810bc5198dd3 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-outcomes-of-multivessel-minimally-invasive-coronary-revascularizat-9a13b25dc7aea994 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-choledocholithiasis-in-rare-congenital-hepatobiliary-anomalies-a-report-acb1ff9b5c98f97c 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/handgrip-strength-relative-to-estimated-skeletal-muscle-mass-and-threshold-defin-7cbe553532899c08 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-changes-to-the-payment-restrictions-of-the-national-reimbursement-2a6860a059aca4d9 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-molecular-landscape-and-clinical-subtype-of-hpv-positive-esophageal-squ-f21f3f790fac31eb 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psoriasis-and-bullous-pemphigoid-an-updated-review-of-clinical-association-targe-419f7c5d8d17be8a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/role-of-the-gut-microbiome-in-natural-and-synthetic-drug-efficacy-and-safety-a-n-a0533936020f92e9 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-electrophysiological-and-payload-release-assessment-of-neuronal-respo-f1dfbb664f726b56 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-hearing-loss-in-the-universal-newborn-hearing-screening-era-etiologies-f07e99478d594e3d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidence-burden-and-associated-factors-of-severe-potential-drug-drug-interactio-000263b0d1b1ca97 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-safety-evaluation-of-dexmedetomidine-hydrochloride-nasal-s-cffd6c1dca84e355 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-the-interpretation-of-longitudinal-eqa-data-through-the-sporadic-i-b9fb7e0dd74e7ef1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-pregnancy-outcomes-of-doxycycline-plus-medroxyprogesterone-67f55084828f7378 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-digital-and-clinical-approaches-for-detection-of-podoc-e46d474d49be2259 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/periodic-fever-aphthous-stomatitis-pharyngitis-adenitis-clinical-manifestations-300bd22349cb7d3a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-contribution-of-mngs-in-the-diagnosis-and-management-of-imported-falcip-f7d332a21c9659e8 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-on-3d-bioprinted-scaffolds-for-lower-extremity-vascular-diabetic-c3b698dce392e375 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/surface-marker-defined-functional-subpopulations-of-mesenchymal-stromal-cells-me-7c9f34b112f5444f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nonresponse-to-intravitreal-anti-vegf-therapy-for-retinopathy-of-prematurity-cli-2ab291d4acdae5d7 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investigation-of-potential-drug-drug-interactions-due-to-linezolid-use-in-anesth-9387ce60364a4bc5 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-effects-of-lentinan-in-gastrointestinal-inflammation-and-carcinogene-6b0c8444a3b58127 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-an-oral-amino-acid-containing-formulation-on-clinical-and-functional-o-1593243086615193 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dna-methylation-biomarkers-from-precancerous-lesions-to-adenocarcinoma-in-the-st-a86ae7786dc25552 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vespula-spp-venom-immunotherapy-basophil-excitability-and-fc-ri-fc-riib-expressi-9fb9de0999d796fe 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-pea-protein-enriched-snacks-and-vitamin-d-supplementation-on-the-progr-90b2d33384ecf18c 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emotional-disclosure-for-alleviating-depression-anxiety-and-stress-in-women-afte-386ec9a3a7de9df0 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-infiltration-versus-intramuscular-esketamine-for-procedural-pain-and-posto-2318a0d193c092bf 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comprehensive-evaluation-of-plasma-proteomics-platforms-toward-practical-applica-e7db85d32b44d1b4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-outcomes-of-hypertrophic-cardiomyopathy-associated-e0f6f3c7bfda81eb 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multi-criteria-decision-analysis-of-dendrimer-applications-in-drug-delivery-syst-041e66390a001be0 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heterogeneity-of-breast-and-nodal-response-to-neoadjuvant-pembrolizumab-based-ch-f56993f250266eb1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/triage-administration-of-ondansetron-for-gastroenteritis-in-children-8cc45fd4d1f1be8d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-an-acceptance-based-healthy-lifestyle-programme-for-communi-9e8b88965342ff19 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-molecular-metabolic-and-clinical-aspects-of-human-selenoproteins-a-narrative-9fed693ac9ae7fc1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishing-the-value-of-call-handling-metrics-in-a-united-kingdom-poisons-info-96d501ba8dbd4d6c 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/surgical-telementoring-platforms-for-clinical-care-and-training-a-systematic-rev-417edb1bfd1a54b1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychosocial-and-clinical-factors-associated-with-diabetes-self-management-in-ty-ff48bf860447a18b 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sustained-intravitreal-delivery-of-triamcinolone-acetonide-via-in-situ-forming-l-5c18ed713309c5c3 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-exosome-conjugated-with-cardiac-homing-peptide-alleviates-myocardial-i-da0e401a6a4a33e0 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-repeal-of-the-ntap-alternative-pathway-will-impact-u-s-clinical-ai-innovatio-73bf9e1dbd1e638f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-technical-performance-to-clinical-readiness-a-phase-based-framework-for-evi-2073a706a466abd2 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-approach-methodologies-drug-screening-platform-to-identify-antifibrotic-comp-bc05f6f071d85d54 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/waterless-mof-des-eutectogels-with-adaptive-viscoelasticity-for-dual-hydrophilic-d2680ba1651e875d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analyzing-and-redesigning-deployment-pathways-for-internally-developed-artificia-af509b768608b3f5 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-to-correspondence-pharmacogenomics-and-digital-adherence-tools-a-commen-ec0f525822d42de2 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supramolecular-salicylic-acid-chemical-peeling-combined-with-supramolecular-acti-b0f0423ae96908dd 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effects-of-coenzyme-q10-supplementation-on-exercise-induced-oxidative-stress-93afc53a8c0ba492 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-q-rung-picture-fuzzy-hypersoft-sets-with-aczel-alsina-operators-for-5f96258fcdd82d41 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/staged-radiotherapy-for-symptomatic-unresectable-giant-hepatic-hemangiomas-with-748970dca67acc07 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishing-antidiabetic-potential-of-navayasa-churnam-phyto-metabolomics-syste-c0392b5a87139d5d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-neuroangiostrongyliasis-caused-by-angiostrongylus-cantonensis-in-northern-e5359583bc4dbfd4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-predictors-of-at-risk-mental-states-in-general-adolescent-population-a-ca29d77470e7ce30 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subsequent-depression-in-patients-with-lip-and-head-and-neck-cancer-a-population-d779f0bbe3d24fa6 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-age-specific-patterns-of-lymph-node-involvement-in-elderly-patient-0db7585dd0d8bb83 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gnal-associated-dystonia-clinical-spectrum-genetic-features-and-genotype-phenoty-89faae5b45271657 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-on-clinical-and-logistical-determinants-of-operative-timing-ec647449118c39c7 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-an-excitation-customized-ict-type-turn-on-probe-for-visualization-e2c8a53da25d0c12 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-estimates-of-agreement-between-dispensed-medications-and-forensic-toxico-518bf5af11781f67 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-management-and-outcomes-of-neonatal-rhinitis-nasal-obstruction-a-scopin-8975fc8cab937599 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-duration-and-clinical-response-patterns-of-laryngopharyngeal-reflux-di-94bf8b18875eb65b 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scp-expression-of-concern-scp-randomized-controlled-trial-comparing-ondansetron-aa25d492a6d17cf4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-reality-for-anxiety-and-pain-management-in-lower-limb-orthopedic-surgery-8580b8bb44e53af4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laparoscopic-splenectomy-for-a-completely-infarcted-wandering-spleen-after-prolo-e4accf4b5864dd95 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scp-igg4-scp-to-scp-igg-scp-ratio-and-orbital-involvement-predict-clinical-respo-4f3b8f715383dd93 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07839767-treatment-selection-by-3d-bioprinting-liver-model-to-prevent-liver-c-73ca2158e5a1d5d9 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07839676-a-prospective-study-of-concurrent-hyperthermia-chemotherapy-and-radi-bcfddab6e768c51e 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07839429-effect-of-mhealth-intervention-on-oral-health-related-quality-of-lif-03ae595228cb3fbf 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07839390-determination-of-the-best-therapeutic-strategy-interventional-with-b-7c88aba6b78c8f50 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07839143-a-prospective-multicenter-randomized-parallel-controlled-superiority-835dc5046489ff3d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07838792-theory-guided-socratic-ai-scaffolding-for-clinical-reasoning-in-nurs-46fa6ed30d0194ee 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07838519-personalizing-veterans-lung-cancer-screening-and-diagnosis-b91b2ffab0a2d9e2 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07838415-multimodalomics-based-construction-of-spatiotemporal-characteristics-5670e10fd7be4982 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07838389-evaluation-of-donor-derived-b-cell-infusions-in-patients-with-amyotr-6d8c441a36cb372a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07837960-exploration-of-diagnosis-etiology-and-prognosis-prediction-of-cracke-9986ebb45114f2e6 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07837921-post-market-clinical-follow-up-to-assess-the-portable-nitric-oxide-g-9f2721f8484594f7 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07835100-probiotics-for-sustained-health-0bd133d29e3e07c1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07829224-effects-of-green-tea-mouthwash-on-halitosis-periodontal-health-and-s-93034438aa1638bb 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804719-possible-sarcopenia-sarcopenia-and-functional-status-in-patients-wit-c03b1338aa2a5c39 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792148-adapting-the-esteem-intervention-to-improve-mental-health-and-prep-u-99a67792a1ad2864 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07758985-safety-tolerability-pharmacokinetics-and-mosquitocidal-activity-of-l-dae09b2c2f32117f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07748585-effect-of-titanium-prepared-platelet-rich-fibrin-and-low-level-laser-9905f16d40902696 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07743151-a-clinical-trial-of-mk-1406-in-healthy-participants-mk-1406-008-e8eaa30f431ccd48 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07718724-impact-of-gdmt-in-uncontrolled-asthma-patients-receiving-mhd-inhaled-e94a608d12789aa8 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07715903-hepatic-artery-infusion-of-carfilzomib-in-participants-with-liver-me-c34d97c9f5173517 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07659938-frontal-gamma-coherence-neurofeedback-for-patients-with-schizophreni-81705dac9dc518ed 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07559929-a-study-of-dxc006-with-immune-checkpoint-inhibitors-or-platinum-for-1f8a9402a0540504 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07468695-feasibility-study-comparing-use-of-one-or-two-probes-for-thermal-abl-2ba43ec1db3fe996 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07262983-evaluating-the-safety-and-tolerability-of-baricitinib-in-patients-wi-834c49c5b61fdd2a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07176390-a-clinical-study-of-tulisokibart-mk-7240-to-treat-rheumatoid-arthrit-dbaf95e2920ec211 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06911008-mti-301-for-the-treatment-of-metastatic-or-unresectable-and-refracto-17b496678483e328 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06891781-investigating-adaptive-deep-brain-stimulation-in-parkinson-s-disease-d76735e44e3d5b8f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06799286-a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pre-9ba7328ab5818a5a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06714591-evaluate-the-safety-tolerability-pharmacokinetic-profile-efficacy-of-d8a0669bb7483b51 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06664814-an-open-label-phase-2-study-of-n-acetyl-d-mannosamine-mannac-in-subj-9877c6064cd79368 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06649812-testing-the-effectiveness-of-a-combination-targeted-therapy-vipor-fo-e14d4ad232d4bf26 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06605404-pan-tumor-mrd-study-7899044323ff4d92 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06559891-thrive-therapeutic-intravascular-ultrasound-tivustm-renal-denervatio-7e5a898f7c07c279 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06496178-a-phase-3-study-to-evaluate-petosemtamab-compared-with-investigator-f242ef17ac83768d 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06299319-feasibility-clinical-effects-and-safety-of-psilocybin-assisted-psych-50ae9f844280d2a4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06270316-safety-pk-pd-and-exploratory-efficacy-study-of-amt-191-in-classic-fa-6a684f5b33f662b4 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06177691-hybrid-closed-loop-therapy-and-verapamil-for-beta-cell-preservation-87ea3be44bd5d67e 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06172296-dinutuximab-with-chemotherapy-surgery-and-stem-cell-transplantation-1b596c853203ca11 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06131372-a-research-study-to-see-if-kidney-damage-in-people-with-chronic-kidn-578e512f0482adb1 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06081010-fchv-htn-implementation-trial-in-nepal-194420f26967ba3c 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06000748-neph-rosis-nephrology-in-cirrhosis-pilot-trial-a-trial-to-treat-acut-c0cc788849a22b44 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05946629-selution-4-de-novo-small-vessel-ide-trial-d7f4a6e4c6a16aed 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05773274-comparing-retreatment-of-177lu-dotatate-prrt-versus-the-usual-treatm-bea045017e16a062 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05757687-evaluation-of-the-safety-tolerability-and-efficacy-of-the-omega-syst-03e122565f0adf8a 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05669222-the-favor-v-ami-trial-1037b870a700016f 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05215340-study-of-dato-dxd-plus-pembrolizumab-vs-pembrolizumab-alone-in-the-f-be0102e5a66bd1fd 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04339270-chronic-airway-disease-mucus-rheology-and-exacerbations-9e70b71c37f34208 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00924196-natural-history-study-of-patients-with-neurofibromatosis-type-i-e33d6a0d6b3f308c 2026-09-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellid-bluemtec-rally-on-change-of-control-deals-inventera-gains-279029e5eedb31ac 2026-09-23T23:54:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellid-bluemtec-rally-on-change-of-control-deals-inventera-gains-k-bio-pulse-ddd3aa5d40251ec1 2026-09-23T23:37:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-doses-first-patient-in-phase-3-study-of-setidegrasib-in-previously-trea-935385bd343d9a9d 2026-09-23T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-i-wst-stock-forecasts-398c8f9315345cfa 2026-09-23T23:22:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/moleculin-biotech-inc-mbrx-stock-price-news-quote-history-d7c26e9dfccad274 2026-09-23T23:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-this-biotech-innovation-halt-the-destructive-march-of-a-cereal-killer-3d54d3360d238eac 2026-09-23T23:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-teva-pharmaceutical-industries-teva-undervalued-following-new-phase-3-schizop-d925da119001e5c1 2026-09-23T22:33:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-data-could-make-roche-drug-a-contender-to-treat-rare-kidney-disease-373f4e947a97b2b4 2026-09-23T22:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/stealth-tactic-makes-chemotherapy-smarter-f5c2518014bb4ff0 2026-09-23T21:27:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-ltd-to-report-third-quarter-2026-financial-result-36a5a6e45481d27b 2026-09-23T20:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-court-enters-consent-decree-against-gold-star-distribution-inc-following-512ca83e8b0ada73 2026-09-23T20:40:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-lirafugratinib-for-advanced-fgfr2-cholangiocarcinoma-577ff202acb6b4ef 2026-09-23T20:17:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-share-grant-led-to-a-tax-related-sale-legend-biotech-legn-cfo-received-19-676-63772b78d4a2cd05 2026-09-23T20:16:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-widely-dive-here-are-the-hardest-hit-6f022ab383ea840c 2026-09-23T20:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-completes-acquisition-of-theravance-biopharma-e7abdc6fed51279d 2026-09-23T20:02:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/statement-on-fda-s-warning-letter-to-empower-pharmacy-for-producing-drug-product-808db959903e7461 2026-09-23T19:48:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-street-spdr-s-p-biotech-etf-xbi-stock-price-news-quote-history-d4dae5114aa6fc80 2026-09-23T19:31:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-commits-to-lowering-select-medicaid-drug-costs-in-us-deal-989bbca238192ff9 2026-09-23T19:17:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-update-for-winrevair-based-on-phase-3-hyperion-trial-data-1de1c592cb071425 2026-09-23T18:29:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-food-safety-and-drugs-administration-seeks-price-cap-on-essential-medi-5cbb84318e38421d 2026-09-23T18:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-health-active-responsive-materials-development-stability-safety-a-bf4ed37261c96c41 2026-09-23T18:06:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-from-molecules-to-brain-health-a-framework-for-european-excellenc-4c2ddfe2c9c5c79d 2026-09-23T18:05:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-colour-and-patterns-as-fundamental-and-applied-training-playgroun-9a1ed4c01f204816 2026-09-23T18:05:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-drug-discovery-s-new-frontier-competing-for-data-assets-virtual-cells-and-org-2cc9bf94b788c23e 2026-09-23T18:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-european-clinical-research-infrastructure-network-2030-122633066644981b 2026-09-23T18:04:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-pediatric-clinical-research-infrastructure-service-model-7ce354e83b800a93 2026-09-23T18:04:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugmaker-astellas-looks-to-sell-u-s-headquarters-in-northbrook-a5e6a86dc138ed43 2026-09-23T18:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-seizure-cluster-relief-through-smart-therapeutic-management-65b7869edefb7046 2026-09-23T18:02:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-this-biotech-innovation-halt-the-destructive-march-of-a-cereal-killer-21dcbc1414047dd9 2026-09-23T18:01:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-cardio-oncology-multidisciplinary-patient-assistance-solution-0fae8f4b4eab75ca 2026-09-23T18:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-pharma-s-operating-model-being-rewritten-1bd526557033e831 2026-09-23T17:56:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunovant-stock-slides-after-biotech-scraps-autoimmune-drug-program-a060f5478bcaac74 2026-09-23T17:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mike-doustdar-open-to-direct-listing-for-novo-shares-pharmexec-fdbd724d0a2d9419 2026-09-23T17:29:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-orleans-biotech-informuta-wins-1-25m-nsf-grant-b1d18ceb24c761cb 2026-09-23T17:15:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-strong-buy-on-injectable-vk2735-maintenance-data-and-treatme-2e88ffec779c1167 2026-09-23T17:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/september-highlights-a-defined-path-from-enrollment-to-data-to-regulatory-submis-546ba70def50c57b 2026-09-23T16:54:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-ionis-rna-drug-scores-in-kidney-disease-study-4f1c7b194b826b87 2026-09-23T16:26:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/africa-needs-more-medicines-can-its-pharmaceutical-industry-keep-up-9a8de728ab5d07fe 2026-09-23T16:20:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-ai-2026-fall-update-preview-agentic-ai-takes-the-wheel-of-pharmaceutical-eec65fbc2b19e4c5 2026-09-23T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-issues-new-guidelines-on-fentanyl-related-crimes-clarifies-sentencing-stan-d40ab24fc3aaf703 2026-09-23T15:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmap-2027-addresses-the-future-of-pharmaceutical-manufacturing-and-packaging-a24f87902f85969a 2026-09-23T15:47:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-dazodalibep-meets-primary-endpoint-in-phase-3-sjogren-s-trial-86c74bc3b8f5dcad 2026-09-23T15:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-packaging-materials-and-drug-compatibility-2f30272ed752ddb3 2026-09-23T15:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-immunotherapy-stop-the-clock-on-type-1-diabetes-01c89bbc9df567f0 2026-09-23T15:42:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/37-000-ai-agents-are-running-a-virtual-biotech-at-stanford-aa00bf1f361ce5fe 2026-09-23T15:41:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-vs-pfizer-in-2027-one-is-a-much-better-place-to-park-your-pharmaceutic-4de0a023ca1e4643 2026-09-23T15:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-pharma-leaders-sound-alarm-bells-on-biotech-s-decline-in-europe-8cae6dd44987e769 2026-09-23T15:31:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-okanagan-boosts-biotech-growth-jobs-in-kelowna-b5445b438b22e3df 2026-09-23T15:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-vaccine-product-information-2f002a54e328b7a9 2026-09-23T15:24:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/sweden-a-powerhouse-for-early-stage-innovation-32336554ff8d853f 2026-09-23T15:19:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/jaguar-health-plunges-59-and-viking-therapeuti-db83db73d7dc3b68 2026-09-23T15:14:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/petroliferos-lobo-and-oz-studio-expand-trace-from-petroleum-into-pharmaceutical-d8b3b5494ab74d32 2026-09-23T15:06:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/jefferies-raises-amgen-stock-price-target-on-drug-trial-success-by-investing-com-4967b24b3c63a739 2026-09-23T15:04:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-safety-module-in-the-clinical-trials-information-system-ctis-50e683a4919aefce 2026-09-23T15:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-pharma-chiefs-warn-bloc-is-losing-innovation-race-dd74789b50fb2c08 2026-09-23T14:56:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/students-fill-high-paying-biotech-jobs-7b177440d9c34a4e 2026-09-23T14:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-holding-ab-exprs2-secures-sek-19-3m-to-13-exercise-1-1-b1ec93da641bbb8d 2026-09-23T14:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-big-pharma-unites-amid-ringing-alarm-bells-of-continents-dominance-42c06e624a767769 2026-09-23T13:54:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-asset-from-27-8b-horizon-buy-scores-in-phase-3-sjogren-s-study-c6347dd93b97ff66 2026-09-23T13:52:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/bit-bio-partners-with-miriamed-to-bring-human-cardiomyocytes-to-its-drug-discove-6dfc3ef16dd20840 2026-09-23T13:47:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/enveda-reaps-311m-series-e-to-feed-ambition-to-become-a-household-name-f72260477437e222 2026-09-23T13:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/flagship-gets-a-pentagon-contract-fcb7bac7859a0771 2026-09-23T13:38:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-expands-pivotal-phase-3-thio-104-non-small-cell-lung-cancer-t-410cbc55b527a9d2 2026-09-23T13:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/jedco-innovation-to-boost-jordan-s-pharmaceutical-industry-expansion-competitive-60088197bf5af4b5 2026-09-23T13:29:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-mental-health-autumn-webinar-school-based-mental-health-interventions-9698cdb22343e0dc 2026-09-23T13:28:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-why-ndc-12-readiness-has-to-happen-before-day-one-b1cd27b1952015f8 2026-09-23T13:26:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/penny-stock-vistagen-analyst-highlights-caution-after-anxiety-data-608d73e82bd1b1da 2026-09-23T13:25:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-30-000-new-lung-cancer-cases-occur-yearly-in-spain-and-portugal-a-trial-ha-0bd639da70000348 2026-09-23T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-expands-pivotal-phase-3-thio-104-non-small-cell-lung-cancer-t-b15e8246fc57d89c 2026-09-23T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concord-biotech-announces-1-1-bonus-share-issue-shareholders-to-get-one-free-sha-e452dcfda4d71e2b 2026-09-23T13:15:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/rbc-says-ai-weakness-appears-to-be-fueling-biotech-rally-f7ddd140c25173b3 2026-09-23T13:13:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/amylyx-pharmaceuticals-inc-amlx-stock-price-news-quote-and-history-881f9021c1f02419 2026-09-23T13:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurion-biotech-completes-enrollment-in-phase-3-astra-trial-of-aurn001-for-cornea-d5b3dd232e1b81b4 2026-09-23T13:09:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/enveda-raises-311-million-from-leading-ai-and-biotech-investors-to-bring-pharma-d2d89fe7cfa4c511 2026-09-23T13:08:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-chief-tukaram-mundhe-welcomes-bollywood-actors-support-for-food-eaabf07195793f3a 2026-09-23T13:06:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-chief-tukaram-mundhe-welcomes-bollywood-actors-support-for-food-7704108b6ff5afbe 2026-09-23T13:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-yorkers-prescribed-generic-drugs-could-be-entitled-to-share-of-96m-settlemen-079f2f04be6ccf19 2026-09-23T13:05:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-4-medicines-defect-notification-b-braun-melsungen-ag-meropenem-1000-mg-pow-c017a279be305219 2026-09-23T13:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-men-joined-forces-at-a-biotech-firm-one-is-being-hailed-for-his-work-to-cure-b32648efcb588026 2026-09-23T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/main-sequence-backs-dementia-biotech-kinoxis-in-a-9-25m-round-1e029c7e02718a39 2026-09-23T12:53:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-tukaram-mundhe-led-fda-expands-food-safety-drive-to-schools-festival-ff43b1c3c042f5f4 2026-09-23T12:52:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-alerta-sobre-solicitudes-de-datos-en-nombre-del-organismo-920bc6d837759649 2026-09-23T12:44:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-dispuso-la-cancelacion-de-certificados-de-especialidades-medicinales-que-n-878404cca01dfa0e 2026-09-23T12:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-milan-2026-preview-key-themes-and-emerging-trends-64ad898e4b3525ce 2026-09-23T12:33:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/dcoy-stock-whipsaws-as-traders-game-biotech-volatility-f2eafaf137ceaf88 2026-09-23T12:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-drug-formulation-designed-to-reach-lung-tumors-has-mexican-patent-protection-t-9a6226bbb164d9be 2026-09-23T12:29:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-moonshot-biotech-stocks-that-offer-big-risks-bigger-rewards-2ec5afb22e0bf892 2026-09-23T12:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oppenheimer-initiates-coverage-on-teva-pharmaceutical-industries-nyse-teva-d07bac4ace81e494 2026-09-23T12:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/moleculin-nasdaq-mbrx-lowers-warrant-price-while-stating-it-needs-trial-funding-37feb91e0c967f74 2026-09-23T12:25:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/moleculin-biotech-secures-mexican-patent-protecting-lung-targeted-liposomal-anna-72c1ed32316517e8 2026-09-23T12:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurion-biotech-completes-enrollment-in-pivotal-astra-phase-3-study-advancing-aur-900b781ebb8e9b5b 2026-09-23T12:19:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-pharmaceutical-sector-faces-decline-amid-global-competition-87e90953660cdc78 2026-09-23T12:06:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/enveda-raises-311-million-from-leading-ai-and-biotech-investors-to-bring-pharma-dc35a2b891936318 2026-09-23T12:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/williams-cystoscopic-injection-needle-6c20102f9f238606 2026-09-23T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/omniasecuretm-mri-surescantm-2d8833077cd38fa9 2026-09-23T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dcoy-stock-whipsaws-as-traders-target-biotech-volatility-4c2712f525e7e336 2026-09-23T11:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-1d5604d4a504007c 2026-09-23T11:39:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-why-biotech-s-recovery-could-still-have-further-to-310d1862d2e9b283 2026-09-23T11:27:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-s-vk2735-shows-durable-weight-loss-with-less-frequent-maintenance-dosing-03f08420126a796f 2026-09-23T11:23:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/oppenheimer-initiates-collegium-pharmaceutical-stock-at-outperform-c9f41444cb0d0522 2026-09-23T11:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/bollywood-actors-back-tukaram-mundhe-s-food-safety-drive-fda-chief-says-grateful-d2aaf98462181b67 2026-09-23T11:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/americans-should-not-be-experimenting-with-peptides-that-is-the-fda-s-job-1e92ac73cc966e7d 2026-09-23T11:01:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-are-testing-an-unexpected-new-weapon-against-screwworm-7d6cd17f448fee72 2026-09-23T11:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-expands-wastewater-surveillance-to-strengthen-early-warning-system-for-dan-cebf5a4b17395e76 2026-09-23T11:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurion-biotech-completes-enrollment-in-pivotal-astra-phase-3-study-advancing-aur-b6711b307932a822 2026-09-23T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henlius-looks-to-us-biotech-for-global-tce-rights-in-amberstone-deal-61b48e357cb64d42 2026-09-23T10:35:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/jefferies-raises-amgen-stock-price-target-on-drug-trial-success-cc7e529ee5fe6e74 2026-09-23T10:21:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-proposes-former-takeda-ceo-christoph-weber-for-board-seat-eb5e783eba6901a0 2026-09-23T10:11:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-inc-and-amberstone-biosciences-inc-enter-collaboration-fc21a4575dc1493d 2026-09-23T10:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-biotech-startup-enveda-doubles-in-value-to-2-billion-wsj-2a17d33df3769840 2026-09-23T10:03:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-statistics-user-engagement-plan-65fe5013a86b6246 2026-09-23T10:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-statistics-in-england-and-wales-62845a4d19ed888c 2026-09-23T10:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-ai-biotech-enveda-doubles-in-value-to-2-billion-a869218d6b806c02 2026-09-23T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jimmy-kimmel-trolls-trump-s-allies-with-parody-pharmaceutical-ad-b474764485d9f9c8 2026-09-23T09:59:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyurethane-tubing-for-biotech-market-to-2035-biopharma-capacity-expansion-driv-2c9779b6fa8fae8d 2026-09-23T09:46:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-companies-push-trump-administration-to-protect-china-deals-40671ca1388c0776 2026-09-23T09:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-suspends-licences-of-rangla-punjab-manisha-dosa-center-over-safety-viol-27217126f6acd7c7 2026-09-23T09:40:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/nine-european-pharma-chairs-warn-of-slow-agony-as-investment-slips-1254cc631db64b03 2026-09-23T09:22:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-and-ionis-report-positive-phase-iii-readout-for-ulefnersen-36ca2d60798ce8df 2026-09-23T09:22:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugmakers-biotech-vcs-show-reinvigorated-interest-in-osteoporosis-treatments-ed6a223fc4d8d0a9 2026-09-23T09:15:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/doustdar-on-plunging-share-price-reflects-level-of-confidence-in-the-company-and-73e26491eface571 2026-09-23T09:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/field-safety-notices-14-to-18-september-2026-e1fc284848d2c91c 2026-09-23T09:03:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/transparency-data-mhra-performance-data-d981698b76b6bbf6 2026-09-23T09:00:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-britain-working-20e801e2a2496745 2026-09-23T08:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-pharmaceuticals-phase-3-kidney-trial-meets-proteinuria-endpoint-a1f79eed08f46dc9 2026-09-23T08:58:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/excipient-selection-strategies-to-mitigate-nitrosamine-risks-812ded3585d60c32 2026-09-23T08:56:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fullgoal-fund-management-co-ltd-fullgoal-hang-seng-biotech-index-etf-159132-sz-i-566836e7c8e4c8f8 2026-09-23T08:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovation-must-remain-at-the-heart-of-pandemic-prevention-preparedness-and-resp-3432662b985a1270 2026-09-23T08:22:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-update-issue-376-september-2026-d78aba8959192ee6 2026-09-23T08:19:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-10-pharmaceutical-manufacturing-leaders-bfa3f2c240dbd84f 2026-09-23T08:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/testo-at-cphi-2026-in-milan-digital-monitoring-for-the-pharmaceutical-industry-51206cd2f0198a2f 2026-09-23T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/redweiler-480g-red-punch-redweiler-480g-orange-redweiler-480g-cola-tcm-120-mega-f98b8409bad1dcce 2026-09-23T07:53:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-phase-3-win-tees-up-fight-with-novartis-for-blockbuster-kidney-disease-m-bcdf360813c716a3 2026-09-23T07:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-flu-programme-8d7750db1c23f662 2026-09-23T07:48:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-die-bevolkerung-erwartet-einen-besseren-zugang-zu-innovativen-m-f83c269f70b8021f 2026-09-23T07:14:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-otsuka-s-phase-3-win-in-als-subtype-boehringer-s-up-to-1b-cancer-deal-c9153ce71a34dadf 2026-09-23T07:01:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/anaconda-biomed-snares-56m-in-funding-for-endovascular-tech-ec4619246ad794d9 2026-09-23T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-lifts-clinical-hold-on-simufilam-for-tsc-related-epilepsy-study-eca3143a8c42883f 2026-09-23T06:54:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/barzolvolimab-meets-all-primary-and-key-secondary-endpoints-in-phase-3-csu-trial-aaa1c6a5ed41a8da 2026-09-23T06:53:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/cbl-514-meets-primary-endpoint-in-phase-2-dercum-s-disease-trial-4aa1315c77b554dc 2026-09-23T06:53:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-sefaxersen-meets-primary-endpoint-in-phase-3-igan-study-8446d6133f8aa4ca 2026-09-23T06:53:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/denmark-s-central-bank-sees-4-gdp-growth-in-2026-boosted-by-pharmaceutical-indus-ae01f315cf303771 2026-09-23T06:44:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/wednesday-newspaper-round-up-state-pension-pharmaceutical-companies-bmw-22f669ea94e5958f 2026-09-23T06:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-kidney-disease-can-progress-to-kidney-failure-in-up-to-half-of-patients-within-b504c1b48ca0f4bd 2026-09-23T05:53:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenx-arrowhead-incyte-and-other-moonshot-biotech-stocks-to-watch-6bcfcd137294b001 2026-09-23T05:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-stained-ice-found-at-gallops-in-mumbai-restaurant-deepika-padukone-hosted-d7c8d4be6fe7ad46 2026-09-23T05:41:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-unveils-new-initiatives-to-reduce-animal-testing-in-drug-development-dcfb867919371bdd 2026-09-23T05:18:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-interim-data-shows-roche-s-sefaxersen-significantly-reduces-proteinuria-18f5014a922c38ad 2026-09-23T05:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-proposes-former-takeda-ceo-for-board-seat-904ade392ec97c62 2026-09-23T05:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-india-speaks-up-after-karnataka-fda-crackdown-says-patient-safety-is-top-2d42ea33dec63e93 2026-09-23T05:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/change-in-roche-s-board-of-directors-3f66dadd4f0ce683 2026-09-23T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-is-incyte-s-stock-performance-compared-to-other-biotech-stocks-217f74a05b95f6c6 2026-09-23T04:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-is-incyte-s-stock-performance-compared-to-other-biotech-stocks-31a60ba7548325a7 2026-09-23T04:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/varda-space-industries-signs-steve-layne-as-chief-revenue-officer-and-aaron-hube-c7f0826d164cee9b 2026-09-23T04:37:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-surging-biotech-sector-represents-both-competition-and-lifeline-for-the-3c127d71cc0c9a1e 2026-09-23T04:23:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-clinical-trials-give-biotech-edge-us-concerns-grow-news-and-statistics-0f3c5f350061d556 2026-09-23T04:03:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-is-one-area-where-the-us-can-afford-to-let-china-flourish-804a8a8a2ecb3155 2026-09-23T04:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-ventilator-issue-from-react-health-4555c2f71c7babb4 2026-09-23T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-heart-pump-controller-issue-from-abiomed-58b5f7dbc0aead0f 2026-09-23T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guggenheim-names-top-stock-pick-in-biotech-sector-b71fce6a39b3f0f4 2026-09-23T03:49:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/pca-girls-varsity-volleyball-vs-biotech-senior-32c8f64109110091 2026-09-23T03:45:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-share-market-update-pharmaceutical-stocks-surge-broadly-cansino-biologics-rise-8cc39d37a45eb156 2026-09-23T03:40:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailwind-biotech-wins-dkk-0-7m-innobooster-grant-9b2a13b8bb0fe6d2 2026-09-23T03:11:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fake-drug-case-pfizer-issues-statement-after-fda-revokes-licenses-of-1-21bf72b4a7e780a2 2026-09-23T03:05:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/better-healthcare-etf-invesco-s-biotech-focused-ibbq-vs-ishares-broad-iyh-cf62d79b13533fb7 2026-09-23T03:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dementia-biotech-kinoxis-raises-6-75-million-with-a-2-5m-grant-as-cherry-on-top-75874c1badfd9fdd 2026-09-23T02:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeil-pharmaceutical-s-onconic-begins-phase-3-trial-in-china-for-jaqubo-injectabl-fc3a04ac114cee7e 2026-09-23T02:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-4359a68ab4882f23 2026-09-23T02:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-fda-suspends-five-food-licences-after-finding-fake-ghee-cockroaches-blood-89c6ba90f7452325 2026-09-23T02:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-clinical-trials-about-to-become-a-new-front-in-the-us-china-biotech-race-4d06a653e66fe2bd 2026-09-23T02:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-opens-recruitment-for-new-community-and-patient-advisory-committee-2a31f0e2b8d9a966 2026-09-23T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onconic-s-zastaprazan-enters-phase-3-injectable-trial-in-china-c9376c3ab0540be3 2026-09-23T01:53:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-says-patient-safety-top-priority-amid-karnataka-fake-drug-probe-6fdf8d6d60f6d15c 2026-09-23T01:52:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-discusses-national-security-threats-at-fdd-5b739c7bae264418 2026-09-23T00:35:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/onconic-therapeutics-launches-phase-3-clinical-trial-for-zaqubo-injectable-in-ch-5441eaf5cd51f86a 2026-09-23T00:14:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/onconic-advances-ja-q-bo-in-china-as-phase-3-injection-starts-royalties-rise-cho-b856b83f3cc2b983 2026-09-23T00:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/information-zum-swissmedic-portal-release-23-09-2026-0aa465ff8cc2bb82 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-16511f0f2ac5ad4f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-protection-and-affordable-care-act-temporary-moratoria-on-certain-agent-5d843f42db06f8b8 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-9d0893d801a68de3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-neurological-disorders-and-stroke-notice-of-closed-meeting-1fac41b8e10220fb 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-owned-inventions-availability-for-licensing-bc642d60aa107458 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanjay-kumar-final-debarment-order-b205422749fd0e88 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedules-of-controlled-substances-placement-of-4-hydroxy-n-n-diisopropyltryptam-4e3caa3036ced2d5 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importance-of-eating-dinner-as-a-family-92246a91af7931c3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carson-valley-health-becomes-cleveland-clinic-connected-member-174093ab24c60298 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-dose-sulfadoxine-pyrimethamine-plus-artesunate-pyronaridine-for-malaria-a-36b9f53f0faf04c6 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distribution-and-target-engagement-of-peripherally-administered-fremanezumab-in-3c33676614931eb7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-co-medication-quality-in-older-patients-with-polypharmacy-a-large-randomi-5b8638bd9e2ba1d1 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-year-follow-up-of-the-randomized-trial-comparing-open-versus-laparoscopic-95fac763305e58a2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-biochemical-responses-to-sglt2-sodium-glucose-cotransporter-2-inhib-7adc369689ad7377 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-blueprint-to-traditional-craftsmanship-rehabilitation-of-atraumatic-maxi-b15c1c90f65e1e61 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coping-strategies-among-early-phase-cancer-clinical-trial-participants-6d40b1b740992c12 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-impact-of-pharmacist-involvement-in-antimicrobial-steward-b6da4337dc8c16fc 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-transplantation-in-patients-over-80-years-of-age-clinical-opportunity-eth-609ac733fe0515e3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trefoil-technique-in-cryoballoon-isolation-of-the-left-common-pulmonary-vein-tru-9ab9b4bb159c12bf 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-a-fortified-date-bar-on-perceived-stress-and-morning-salivary-cort-795cb59bd9f91736 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neck-disability-associated-factors-and-quality-of-life-among-physiotherapists-in-49a201e66e78e7eb 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/postoperative-c-reactive-protein-as-a-marker-of-the-early-inflammatory-response-875ae85d2ce71266 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-safety-of-gastric-endoscopic-submucosal-dissection-in-patients-aged-8-4db1fa7ffa8f382b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multidimensional-assessment-of-cardiometabolic-risk-in-asian-americans-with-ch-03ad6b21bec4495c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/general-hiv-related-knowledge-and-attitudes-among-nurses-and-nursing-students-a-c6efa7106a99e37c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cannabinoids-in-diabetes-integrating-scientometric-trends-with-mechanistic-pharm-39278e405c2b26f7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrative-analysis-of-atp2b4-expression-and-its-clinical-and-molecular-associa-930117645916a86d 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-acquisition-quantifying-the-annual-carrying-cost-of-long-term-biospecimen-b9123924b47e7a6c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paraprobiotics-and-postbiotics-from-mechanistic-evidence-to-food-applications-an-8f9399cd6bdd47cc 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-explainable-artificial-intelligence-for-trustworthy-and-human-centric-ac82feba19738eaa 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-role-stress-and-job-burnout-among-clinical-research-nurses-a-b5aa08fccae4bfd4 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapist-self-report-reliability-and-accuracy-in-individual-vs-conjoint-systemi-e555b020dd335edd 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimal-prophylaxis-for-perioperative-drug-induced-delayed-neurocognitive-recove-5ca2615ca4e7f295 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-clinical-outcomes-associated-with-a-standardized-multicomponent-facia-e1801e946690bdbb 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-anticoagulation-therapy-in-elderly-patients-with-clinically-diagnose-de416e1a65baf3d8 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multimodal-machine-learning-diagnostic-model-for-alzheimer-s-disease-integrati-226cd8e46b6e3b46 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biological-characterization-of-a-clinical-human-adenovirus-type-3-isolate-with-o-cdfc8156c517f734 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-retrospective-cohort-study-predictive-nomogram-for-clinical-pregnancy-outcomes-3525205333fa2902 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-early-enteral-nutrition-support-on-gastrointestinal-function-abe6b8b27c7ff208 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-cellular-metabolism-the-immune-system-and-oncogenesis-opportunities-fo-f6f882b45b14e4b6 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-epidemiological-profile-of-hospitalized-patients-with-leptospirosis-b7104dcb13cec58b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metabolic-and-anthropometric-predictors-of-paediatric-metabolic-steatotic-liver-c04828fdbc62dda2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-whole-body-chlorhexidine-gluconate-cleansingwith-or-witho-bf1520c4fa2ebd4f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uptake-barriers-and-facilitators-of-open-science-in-clinical-psychology-findings-e79006e53d98c6de 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-care-contributes-to-tuberculosis-treatment-adherence-and-drug-saf-c97458518d1fd4b2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-review-of-nanostructured-lipid-carriers-nlcs-and-their-applications-in-pharmac-4190dcc03c58cab9 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-optimization-of-an-rt-qpcr-assay-for-determining-mirna-1202-expr-f465d5014a63c6eb 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/addictive-escapism-in-the-context-of-fragmentation-of-value-semantic-space-drug-39c30a45b7c82bb5 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-effect-of-a-community-based-intervention-for-cardiovascul-bffd3e087f4f828c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-timing-of-presentation-and-laparoscopic-findings-on-clinical-outcomes-99b32a220658c2ef 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-aimsi-protocol-study-protocol-of-a-randomized-double-blind-non-inferiority-c-0d2f973c86632267 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-four-tier-anti-hcv-hcv-rna-interpretation-grid-for-risk-selected-clinical-popu-0462e6238c73bb27 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immediate-analgesic-effect-of-cheek-acupuncture-vs-etoricoxib-for-patients-with-1f433045c616e8d5 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recombinase-polymerase-amplification-coupled-with-crispr-cas12a-for-rapid-detect-9088f98caabcd613 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polygenic-risk-score-enhances-comprehensive-breast-cancer-risk-assessment-and-mo-f105e2006792438e 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-status-influences-circulating-microrna-expression-and-their-clinical-a-330230b34efa50ae 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-clinical-characteristics-species-composition-and-antimicrobial-res-ad48db0c75ecfcad 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-free-therapies-emerging-applications-of-extracellular-vesicles-and-secretom-0eb0c307fb10fd9d 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legal-organizational-and-financial-mechanisms-for-providing-medicines-not-includ-adcb8486b171831b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leveraging-long-read-sequencing-to-bridge-the-diagnostic-and-equity-gaps-in-diff-e2cbefef207ca413 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-from-y-lmaz-et-al-the-free-t3-free-t4-ratio-predicts-relaps-73b9efa36fc223a3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dna-methylation-dysregulation-in-ebv-associated-lymphoproliferative-disorders-mo-5a356c91440576fd 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-note-on-patient-follow-up-time-distribution-in-clinical-trial-simulations-with-d0133161e4e00572 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-treatments-and-outcomes-of-patients-with-ornithine-tran-a1c88d6d32ef3a51 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adherence-to-treat-to-target-recommendations-in-juvenile-idiopathic-arthritis-in-84176e3cd58018ed 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precise-repair-of-extremity-soft-tissue-defects-using-anterolateral-thigh-flaps-ec30ab4fc6df8f00 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-clinical-need-socioeconomic-inequalities-in-access-to-hospital-at-home-am-7c521189ed269087 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-invited-commentary-on-i-kandathil-et-al-s-postoperative-pain-management-in-rhi-658daec99b991957 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenolic-mannich-bases-review-on-synthetic-aspects-and-biological-activity-profi-61a6f71ecb860f68 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/red-blood-cell-aggregation-and-atherosclerosis-curvilinear-clinical-implications-ef768b300cdbacbe 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-eating-disorders-in-relation-to-premenstrual-syndrome-in-adolescen-c0244b80e5002d85 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/defining-near-term-treatment-goals-for-benzodiazepine-use-in-clinical-practice-04a3e19325e3d4f7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-next-frontier-in-quantitative-co-clinical-imaging-to-advance-functional-prec-ee218ea96855a1a9 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-whole-genome-sequencing-in-identifying-a-rare-i-mycobacteriu-94f0e27ffb6f1678 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-mechanisms-of-scp-ziyushuang-scp-an-anti-skin-aging-formul-dcb5b530a46d9958 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-ambient-digital-scribe-systems-in-clinical-documentati-7e52ee06c03a15d9 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reduced-antibiotic-exposure-is-not-equivalent-to-reduced-antibiotic-overuse-afte-befc1cf0c44de4bf 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fully-ablative-co2-laser-excision-of-cutaneous-lesions-a-case-series-including-p-61eadbc7ce6135fa 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tolerance-of-methotrexate-co-administered-with-pegloticase-in-patients-with-unco-7f3259a1243d82b3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-benefit-of-routine-pet-ct-imaging-in-asymptomatic-head-and-neck-squ-a01c2272b379ada0 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practical-lessons-in-the-global-scaling-of-clinical-ai-from-one-hospital-to-over-d823dc98459196b5 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systemic-and-mucosal-antibody-responses-against-neisseria-gonorrhoeae-ng-outer-m-7a0211afbe545718 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-efficacy-and-safety-of-cd19-chimeric-antigen-receptor-t-cell-therapy-bc4ebc4c756dba65 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synthetic-lethality-in-cancer-mechanisms-therapeutic-exploitation-and-clinical-t-1f3bebf9bae27ae3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asymmetrical-consent-in-ambient-clinical-ai-rethinking-patient-recording-rights-e70ad24154760143 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carotid-intima-media-thickness-in-beta-thalassemia-a-systematic-review-and-meta-305f74b84c51fd60 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictors-of-morbidity-and-mortality-in-malignancy-related-ascitic-fluid-infect-d88edb300cf290a3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacotherapy-of-irritable-bowel-syndrome-with-constipation-in-children-an-upd-afbf506f2debfc3c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-preoperative-pain-neuroscience-education-on-pain-catastrophizing-and-e-421cbac901807b13 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-patient-reported-outcome-measurement-in-fibromyalgia-clinical-trials-a645cfade04ad851 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/professional-socialization-and-competency-based-role-development-in-clinical-eth-8af2a02fe55fbcbc 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-ai-in-medicine-challenges-for-responsible-development-and-the-case-for-c-26ffe98b6e3b2465 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/performance-status-over-chronology-determinants-of-curative-versus-palliative-tr-13b5296c766e71c2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-adaptation-in-male-high-altitude-workers-through-pressurization-a-rand-5bafac1786fd222c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ranibizumab-port-delivery-system-for-neovascular-age-related-macular-degeneratio-d7aa2ef6ee7adaae 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/procomb-a-practical-and-robust-design-with-randomization-to-optimize-dose-combin-290fbb808edc5459 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-sickle-cell-hemoglobin-genotypes-on-clinical-outcomes-among-i-plasmodi-d38e4ae0b0ee8c10 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-biological-mechanisms-to-causal-inference-quantitative-systems-pharmacology-3681a18664af4d7e 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/volumetric-modulated-arc-therapy-for-lung-cancer-correlation-between-dose-and-vo-6490752166bf0195 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transvaginal-drainage-vs-laparoscopy-for-tubo-ovarian-abscess-6cbf99995376ed2c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07837336-an-evaluation-of-nutritional-status-body-composition-and-dietary-int-ac0a45c501a1eb6d 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07837089-increasing-engagement-with-digital-behavioral-health-ef6671fec5e10550 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836764-validation-of-1-minute-sit-to-stand-test-for-assessment-of-breathles-8859db9c2c87a48e 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836738-effect-of-stellate-ganglion-block-on-sleep-quality-in-patients-with-5b8e8e776e4c1c8d 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836686-clinical-and-radiographic-success-of-modified-lstr-techniques-in-pri-6cb9d89901a63027 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836452-a-phase-1-first-in-human-study-of-city-rbp4-in-healthy-volunteers-an-37c0c1ff6e99544a 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836439-comparing-graston-technique-and-diacutaneous-fibrolysis-for-pain-dis-e09cd2476cb3651f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836205-brain-activity-and-changes-in-consciousness-during-general-anesthesi-b453ee4141f9c01a 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836101-study-of-sarilumab-with-immune-checkpoint-inhibitor-rechallenge-in-p-2356a03863440eaa 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836088-a-clinical-study-on-using-multimodal-ultrasound-to-assess-muscle-mas-7d4fef44519e2a4f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07836036-evaluation-of-ras-inhibitor-treatment-in-participants-with-advanced-97efdfb4531195db 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07835997-radicle-relaxationtm-cix-a-study-assessing-the-impact-of-health-and-934bffecad7e6f1a 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07835945-comparison-of-arterial-and-capillary-blood-gas-analyses-in-patients-529f238adbd0acd5 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07830212-diagnostic-performance-of-acp3-targeted-pet-imaging-in-patients-with-565d43acb3c87207 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07830173-effects-of-task-oriented-training-on-balance-with-or-without-texture-3015b6561b54636c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825857-randomized-controlled-trial-of-tirzepatide-for-methamphetamine-use-d-23e6cd17cc91d8df 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07678606-association-between-4d-mri-parameters-and-the-clinical-characteristi-96a7cb0cf013b2e6 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07661810-patient-controlled-remimazolam-sedation-under-spinal-anesthesia-137f2a8674e26ee0 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07643922-endovascular-therapy-for-cerebral-vasospasm-after-aneurysmal-subarac-8f6d74f8cf9d0947 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07631377-the-lalelalung-study-digital-stethoscope-clinical-evaluation-beb6ad86a49511a4 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07610395-trial-comparing-the-safety-and-efficacy-of-two-different-oral-vpv-do-87a303f89eb88c16 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07549321-a-safety-and-efficacy-study-of-hu14-in-high-risk-neuroblastoma-patie-43b06e17d6f6ecf0 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07530705-efficacy-and-safety-of-subcutaneous-injection-of-xh-02-in-the-treatm-f412cd4960e5cf43 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07527052-emerging-technologies-and-teen-mental-health-1ddeb4440ccb88cf 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07522944-ai-guided-personalized-relaxation-for-hemodialysis-patients-a62638bab807b3f4 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07518407-dietary-insights-and-nutritional-education-in-adults-on-glp-1-therap-4dec0f2fe0a882e7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07502352-remotely-delivered-cognitive-behavioral-stress-management-for-breast-91150ea8bc706ee0 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07388550-phase-i-open-label-safety-trial-of-pembrolizumab-for-neurological-po-c8883fe8549f9913 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07343024-methods-of-identifying-effective-off-guideline-treatments-for-advanc-ca2a1b38930bebd7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07242300-efficacy-and-safety-of-recombinant-botulinum-toxin-type-a-eveotox-fo-045a31d11416acd0 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07237295-communityrx-kidney-health-d9146459a64c0ff2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07225075-pivotal-study-of-the-silk-vista-baby-flow-diverters-in-the-treatment-bc87ac8f8819f15d 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07169630-pet-imaging-of-phosphodiesterase-4-pde4-in-volunteers-with-alzheimer-ad9bf3a66aac9969 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07156175-a-study-to-investigate-the-efficacy-and-safety-of-sar444336-in-adult-b02814ea75fb9a86 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07094412-patient-engaged-development-and-testing-of-educational-content-on-si-27ba66199a75081e 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07087249-feasibility-and-preliminary-effects-of-a-therapeutic-approach-using-d219d987db0fd1a3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07005297-clinical-genetics-branch-eligibility-screening-survey-e7dec4054d0f1b0f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06926283-a-study-of-dxc008-in-patients-with-prostate-cancer-and-other-solid-t-2fa107a99237b6d4 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06922786-hemadsorption-to-enhance-drug-elimination-in-intoxications-84ac6507d560994b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06878066-thrombolysis-in-factor-xa-inhibitors-trial-3f17a0f3421a802b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06824987-dose-ranging-safety-tolerability-and-efficacy-study-of-azd2373-in-pa-92b855aa8d4ba3fa 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06774885-role-of-folic-acid-in-the-management-of-adjuvant-endocrine-therapy-i-417f6298e18d101c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06659341-a-phase-i-study-of-bay3498264-given-together-with-sotorasib-in-parti-85034d93db98e407 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06633536-real-life-treatment-outcomes-of-ravulizumab-in-pnh-2cd6c195b7a76415 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06630013-a-new-ultrasound-score-for-swallowing-disorders-diagnosis-in-difficu-abb34b6abc54acc3 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06619587-a-study-to-evaluate-safety-pharmacokinetics-and-activity-of-gdc-7035-31c0e9a9b3d7a2cf 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06558214-optimus-prime-safety-and-feasibility-of-optune-gio-integrated-with-m-c4f3b9d8c7fc609e 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06500702-a-study-to-evaluate-the-efficacy-and-safety-of-frexalimab-brivekimig-e8eca76edaae6e69 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06389591-rna-lipid-particle-rna-lp-vaccines-for-recurrent-adult-glioblastoma-93050016a66deac6 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06305676-biomarker-approach-to-screening-for-the-early-detection-of-hpv-relat-104230ccfe36130b 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06014489-a-trial-to-assess-cobicistat-boosted-venetoclax-in-combination-with-e7d8687b4e0bc8c2 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05624528-a-clinical-trial-of-tolcapone-in-obsessive-compulsive-disorder-6738dd1b07616e6f 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04989504-testing-the-application-of-mepitel-film-during-radiation-therapy-to-a505af7d533aa90c 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04812925-a-phase-3-study-to-evaluate-the-safety-and-efficacy-of-efgartigimod-caa7445c3958c388 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04628767-testing-the-addition-of-medi4736-durvalumab-to-chemotherapy-before-s-d432900cd209dde8 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04591639-the-dapa-memri-trial-9f8a6fec825fbaa7 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04433455-influencing-factors-of-cerebrovascular-disease-and-cognition-in-hemo-430cbbfd790ca1de 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04400695-a-study-of-rc48-adc-for-the-treatment-of-locally-advanced-or-metasta-e349c8a3a71c2f58 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04222413-metarrestin-ml-246-in-subjects-with-metastatic-solid-tumors-fba3643f3c2c4144 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02444936-zostavax-in-persons-imminently-receiving-chemotherapy-for-solid-orga-ddb176532249fbec 2026-09-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rocket-pharmaceuticals-rckt-gets-fda-alignment-on-heart-drug-trial-can-it-ease-s-7185c26cdd11880d 2026-09-22T23:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-britain-working-review-update-a-national-growth-opportunity-september-2026-b449a68a7ec408e5 2026-09-22T23:01:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-stigma-fades-reverse-mergers-boom-in-biotech-174a6012d4b759f8 2026-09-22T22:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-takes-issue-with-empower-pharmacy-s-glp-1-production-in-new-warning-letter-bbcc7bc0792288c1 2026-09-22T22:48:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-overlooked-role-of-containers-in-chemical-and-pharmaceutical-operations-d9a479d7a99df2f6 2026-09-22T22:09:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-breaks-ground-on-6-5b-houston-pharmaceutical-manufacturing-facility-9c9b191a0f0915cd 2026-09-22T21:44:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-may-be-getting-a-better-deal-than-expected-with-medicare-s-bridge-program-0be7d11290c417d3 2026-09-22T21:22:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-yipin-pharmaceutical-raises-tens-of-millions-in-yuan-for-anaesthetics-pu-df3f73952434bb15 2026-09-22T21:18:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/biopharma-biological-safety-cabinets-aseptic-technique-for-sterile-drug-manufact-50ac51026318a92a 2026-09-22T20:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/vht-vs-xbi-is-diversified-healthcare-exposure-or-biotech-stocks-the-smarter-choi-0db424becee8ba71 2026-09-22T20:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-drug-meets-goals-of-key-test-in-common-autoimmune-disease-with-no-approved-562c53f4bdd9952b 2026-09-22T20:03:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-cell-tests-and-computer-models-gain-formal-place-in-fda-rules-for-drug-saf-4288d02f95194a5d 2026-09-22T20:00:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/celldex-therapeutics-upgraded-to-buy-after-posi-03401a823e3c1eb5 2026-09-22T19:59:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-a-precision-medicine-trial-leveraging-blood-based-tumor-genomics-832a33c89b017818 2026-09-22T19:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-soars-36-on-clinical-trial-results-an-important-step-3d9507f6b4483b3a 2026-09-22T19:55:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-european-african-vaccine-initiative-eavi-accelerating-preventive-450f5665b25341fd 2026-09-22T19:55:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-services-for-environmental-exposure-and-health-assessment-in-euro-53b48a7be88525ab 2026-09-22T19:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/on-the-job-training-program-helps-greenwood-resident-into-biotech-career-811eb59219a9358c 2026-09-22T19:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/direxion-daily-s-p-biotech-bear-3x-shares-declares-quarterly-distribution-of-0-0-ccfddfb80ed3a79a 2026-09-22T19:52:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/ulefnersen-meets-primary-end-point-in-phase-3-fusion-trial-for-fus-als-004c41caee9d8e4e 2026-09-22T19:41:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-nasdaq-legn-shareholder-plans-2-715-ads-rule-144-sale-841a12d86e050982 2026-09-22T19:31:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-reports-a-phase-3-win-with-sjogren-s-drug-candidate-4d19987a7b90f4bd 2026-09-22T19:06:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-nj-pharmaceutical-company-lays-off-hundreds-9bb21c3e4fe5cb52 2026-09-22T19:03:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/nine-european-drugmakers-note-concern-over-region-s-pharma-investments-pharmexec-d2f1bdf40f76425d 2026-09-22T19:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-drugmakers-say-they-are-losing-ground-to-us-and-chinese-rivals-0d402f8f3ef33843 2026-09-22T18:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/former-legend-biotech-nasdaq-legn-officer-lines-up-1-3m-stock-sale-a09773669bac8e93 2026-09-22T18:34:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-builds-oncology-pipeline-around-bitac-platform-public-market-f355446610826911 2026-09-22T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/did-ceo-appointment-just-shift-legend-biotech-stock-investment-narrative-39b39a15e61896b9 2026-09-22T18:06:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/caris-life-sciences-coasts-past-a-buy-point-why-this-texas-biotech-researcher-de-bc7b2a82a6bfdea0 2026-09-22T18:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-rules-to-advance-non-animal-innovative-testing-in-human-drug-develop-c6422f067acfdab8 2026-09-22T17:47:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-secures-new-radioligand-in-900m-deal-as-competition-strengthens-50d67d023b86cc61 2026-09-22T17:22:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-representative-clinical-research-advancing-inclusivity-in-europe-ce5cc956533fb572 2026-09-22T17:18:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-suspends-assistant-drug-controller-over-alleged-lapses-in-counterfeit-954ba4d2ecda5f99 2026-09-22T17:01:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-an-innovative-analytical-platform-to-investigate-the-effect-and-t-22d02dfce8336ab4 2026-09-22T16:48:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-autism-innovative-medicine-studies-2-trials-36292d3d44288306 2026-09-22T16:48:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-s-kidney-drug-success-sparks-a-22-surge-for-this-rival-biotech-860d4568cb022503 2026-09-22T16:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-modernizes-drug-regulations-to-formalize-support-for-nams-7dde384d2183288c 2026-09-22T16:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fake-medicine-racket-assistant-drug-controller-omkareshwar-suspended-aa6b284cdda1363b 2026-09-22T15:57:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-rule-on-animal-testing-for-new-drugs-98a07a874a31de1b 2026-09-22T15:52:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-drug-crackdowns-test-india-s-regulatory-enforcement-muscle-ba2109dbf55a7346 2026-09-22T15:48:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-drug-safety-testing-rules-to-embrace-non-animal-methods-cedfedd050abc998 2026-09-22T15:38:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/generic-drug-user-fee-reauthorization-amidst-alleged-concerns-of-safety-and-effi-c661778b45f1c06e 2026-09-22T15:38:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-participates-in-ustr-s-section-301-investigation-into-germany-to-address-e44e409ff6d1d1c8 2026-09-22T15:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-temperature-control-is-now-pharma-s-make-or-break-variable-0b39008986dae1a7 2026-09-22T15:34:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/rs-5-05-crore-spurious-drug-racket-case-24-pharma-licences-16-cancelled-and-8-su-2a0c3f8f2c032d62 2026-09-22T15:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/zealand-pharma-announces-initiation-of-the-registrational-phase-3-zupreme-progra-478c3cbbf4c8be0c 2026-09-22T15:15:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-inc-stock-amgn-moved-up-by-3-90-on-sep-22-facts-behind-the-movement-638e1517a3957b7d 2026-09-22T15:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/notifiable-diseases-causative-agents-reports-for-2026-32900b46450305d4 2026-09-22T15:06:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/rotavirus-vaccination-programme-information-for-healthcare-practitioners-53785302d776c5f3 2026-09-22T15:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-reasons-to-have-your-flu-vaccine-when-pregnant-poster-617282f23f9f2cc4 2026-09-22T14:59:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-spend-over-25-000-2026-a8b4b8d9bbff80c2 2026-09-22T14:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimicrobial-resistance-awareness-toolkit-for-healthcare-providers-0c0f57c6f41d20ce 2026-09-22T14:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-buy-moderna-stock-why-many-wall-street-analysts-say-no-9e67b14c2180f083 2026-09-22T14:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-biotech-stocks-with-key-clinical-readouts-expected-this-fall-fdfbfae8d3ac9708 2026-09-22T14:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-takeda-s-orzeyful-as-first-drug-to-treat-narcolepsy-type-1-cause-49d3fb93ffe19a13 2026-09-22T14:43:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-backed-iambic-files-for-ipo-disclosing-new-clinic-and-dealmaking-details-9081c31813b92024 2026-09-22T14:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-ipo-blitz-continues-with-4-new-biotech-filings-347251671248c048 2026-09-22T14:23:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-horizon-acquired-fusion-protein-eases-sjogren-s-severity-in-ph-3-win-fabca74fb5c275a3 2026-09-22T14:20:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-and-pace-make-new-bacteria-available-to-support-research-into-tackling-ant-03949b464e5bf1c5 2026-09-22T14:19:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-preliminary-positive-data-from-open-label-extension-of-phase-3-study-fasedie-a43f8824c131b981 2026-09-22T14:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-stakeholders-can-avert-340b-rebate-disruption-766ebeb8cd517505 2026-09-22T14:14:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-announces-positive-topline-results-from-phase-3-fusion-study-of-ulefnersen-772a4e1e1109bf31 2026-09-22T14:11:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-announces-transformative-phase-3-fusion-results-for-ulefnersen-bringing-t-b70c8b2f7386a8a2 2026-09-22T14:11:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/travere-ceo-eric-dube-to-step-down-after-transforming-the-rare-disease-biotech-89bdf641a2b15d7c 2026-09-22T14:10:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-s-midstage-data-amplify-kidney-disease-market-opportunity-523fc055ccc416fc 2026-09-22T14:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-alerts-and-statements-65b7066201a76f64 2026-09-22T14:07:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-publishes-2026-food-code-c8977096a5309312 2026-09-22T14:07:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-sued-with-former-lot-network-canon-patent-by-biotech-npe-181c0bc7aa670f0e 2026-09-22T14:03:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/changes-to-the-definition-of-deprivation-of-liberty-6ef57301ec10516e 2026-09-22T13:52:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-ibogaine-all-about-the-psychoactive-drug-presley-gerber-took-for-treatme-10da3bcc8d406517 2026-09-22T13:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/x-chem-announces-phase-3-milestone-in-collaboration-with-relay-therapeutics-2ed0320843199e26 2026-09-22T13:51:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-the-classroom-to-research-rethinking-school-non-attendance-as-a-complex-pub-370891176b9691ed 2026-09-22T13:47:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-obesity-drug-enicepatide-delivers-15-5-weight-loss-in-phase-2-diabetes-tri-456c0904bdf4161e 2026-09-22T13:42:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-dazodalibep-phase-3-trial-clears-sjogren-s-hurdle-ce20313f496b35b5 2026-09-22T13:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-proposed-law-could-give-qualifying-botanical-drugs-12-years-of-market-exclusiv-49f868a028738c3d 2026-09-22T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comienza-en-lisboa-el-xv-encuentro-de-la-red-eami-con-el-objetivo-de-establecer-a43077edfe8b6ead 2026-09-22T13:23:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-heads-to-fda-as-ionis-partnered-als-drug-hits-primary-phase-3-endpoint-7548c69d954fe247 2026-09-22T13:22:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-appoints-dr-michael-blough-as-chief-clinical-development-officer-d976afbd9022e8d7 2026-09-22T13:15:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/tb-bcg-and-your-baby-74fb0616222bda49 2026-09-22T13:05:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-announces-positive-topline-phase-3-results-for-dazodalibep-in-moderate-to-6063bc2e687b62fc 2026-09-22T13:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/sjogren-s-disease-has-no-fda-approved-medicines-amgen-s-treatment-improved-disea-be1c1e5896371af6 2026-09-22T13:02:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-depression-and-ptsd-trials-get-new-lead-at-optimi-health-opth-41c95a683e26fe4e 2026-09-22T13:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-announces-positive-topline-phase-3-results-for-dazodalibep-in-moderate-to-1ba12e27f284c0f1 2026-09-22T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-appoints-dr-michael-blough-as-chief-clinical-development-officer-b962f1ca3661de64 2026-09-22T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-lung-cancer-treatment-showed-90-5-disease-control-in-an-interim-trial-assessme-65b591b14180f7f7 2026-09-22T12:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-reports-pivotal-phase-3-clinical-trial-progress-in-advanced-n-d50277e15a8ec3c4 2026-09-22T12:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-data-social-anxiety-scores-improved-31-points-in-four-months-with-vi-c63a4ba9a63823a2 2026-09-22T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wisner-baum-investigates-generic-drug-quality-as-2026-patent-cliff-accelerates-c-579b2debb3e49258 2026-09-22T12:19:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/wisner-baum-investigates-generic-drug-quality-as-2026-patent-cliff-accelerates-c-6d1013a4bee3ce65 2026-09-22T12:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-announces-transformative-phase-3-fusion-results-for-ulefnersen-bringing-t-d5ff980a261f735c 2026-09-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/claros-technologies-announces-continued-commercial-expansion-into-europe-and-ent-21dc3bd5985bea1b 2026-09-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-debuts-aa-signaturetm-in-the-united-states-with-skin360-its-3fb68c46a13552f5 2026-09-22T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-rare-seizure-disorder-has-no-approved-treatments-a-trial-has-dosed-its-first-8857792eb4fd05eb 2026-09-22T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-depression-data-could-define-the-case-for-cybin-stock-bf3ee7c531131e23 2026-09-22T11:25:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/newron-presents-h1-2026-results-and-provides-corporate-update-12c4c38dc6d0be1a 2026-09-22T11:24:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/celldex-reports-positive-phase-3-results-for-barzolvolimab-in-chronic-spontaneou-0017f5ea9d432ed0 2026-09-22T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celldex-announces-positive-results-from-phase-3-embarq-csu1-c8dfd9af985de52b 2026-09-22T10:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bofa-securities-names-top-biotech-stock-amid-sector-rally-65a732f8b3124bfc 2026-09-22T10:56:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-merck-drug-cut-the-risk-of-worsening-disease-by-76-the-fda-updated-its-label-35639d1ef2653d3e 2026-09-22T10:50:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-phenylephrine-hydrochloride-prices-hold-firm-as-q4-pharmaceutical-demand-stre-0149dcbbdb4b1dc3 2026-09-22T10:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-update-to-the-label-for-winrevairtm-sotatercept-csrk-to-include-d63bea0d0db63aa3 2026-09-22T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-update-to-the-label-for-winrevairtm-sotatercept-csrk-to-include-e2755dc1ca6275fc 2026-09-22T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-for-medicines-good-clinical-practice-inspections-68a2c21adf64b7b1 2026-09-22T10:42:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-f39731160de90db0 2026-09-22T10:37:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-600-fda-postmarket-drug-studies-are-behind-schedule-while-many-of-the-med-f28350f4fcac615b 2026-09-22T10:15:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-admet-ai-for-medicines-safety-survey-a86c0a5b77beeed2 2026-09-22T10:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/harmoni-gi1-a-phase-iii-trial-featuring-ivonescimab-plus-chemotherapy-compared-t-5397d986a24a195a 2026-09-22T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/direct-nitrite-analysis-simplifies-tests-of-pharmaceutical-excipients-for-risk-c-4b362d430ed610ea 2026-09-22T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-2b9ea682e34169f8 2026-09-22T09:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-22-september-2026-5ba9abe7a8a91f88 2026-09-22T09:23:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/mannkind-corporation-mnkd-stock-analysis-exploring-a-127-68-potential-upside-in-88d42183e45cec68 2026-09-22T09:21:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/book-review-the-age-of-cures-by-barry-werth-50b9ec628976b5a2 2026-09-22T09:00:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/boryung-signs-277-mil-taxotere-supply-deal-with-china-s-yifan-6f397d63d69e2daf 2026-09-22T08:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-hikma-pharmaceutical-director-pdmr-shareholding-bb695b3e1242f838 2026-09-22T08:32:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-and-university-of-oxford-scientists-uncover-genetic-changes-in-the-bacteri-619305ae10369373 2026-09-22T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/voluntary-scheme-aggregate-net-sales-and-payment-information-august-2026-1002643f3a56701e 2026-09-22T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/vpag-quarterly-net-sales-and-payment-information-e87d48f3b7220662 2026-09-22T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemical-hazards-compendium-2cf1a7b32dba1e24 2026-09-22T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-health-impacts-from-industrial-sources-of-pfas-a-rapid-review-ed4c661ce7265e41 2026-09-22T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/per-and-polyfluoroalkyl-substances-pfas-general-information-49da969af76edf3b 2026-09-22T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanyang-precision-chairman-countersues-former-hanmi-pharmaceutical-executives-29f8aa0fd33812f7 2026-09-22T08:20:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-s-2026-single-trial-default-standard-reframes-the-dual-pivotal-debate-for-sp-db564c899dadd3aa 2026-09-22T07:55:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/submicron-ir-for-pharmaceutical-research-development-and-quality-f91eaac67fdb6ecb 2026-09-22T07:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sant-98561788d726bcd6 2026-09-22T07:40:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/greece-to-prioritise-biosimilars-legislation-during-2027-eu-presidency-says-mini-7c952cb632ab6e86 2026-09-22T07:33:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/mayer-brown-represents-underwriters-on-teva-pharmaceutical-s-us-4-9-billion-seni-c8c0fec7c979c997 2026-09-22T07:28:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/iambic-maintains-momentum-from-string-of-big-pharma-partnerships-by-aiming-for-i-14246701c70fe37f 2026-09-22T07:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/trevi-therapeutics-stock-trades-at-usd-14-71-as-biotech-data-matters-663f1d5418a1fc34 2026-09-22T07:13:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-aspen-s-priyen-naidu-drives-a-human-centred-approach-to-technology-f2ab4450d8792b6a 2026-09-22T07:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/bank-of-america-corp-de-invests-38-35-million-in-ultragenyx-pharmaceutical-inc-r-127cbc20e446c4bf 2026-09-22T07:10:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-on-success-ipsen-receives-two-new-gold-brandon-hall-awards-d9486765e1c17bb8 2026-09-22T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merry-life-biomedical-starts-phase-2-trial-of-tml-6-for-early-alzheimer-s-045429441a897961 2026-09-22T06:45:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ec-approves-obicetrapib-as-oral-cetp-inhibitor-for-hypercholesterolemia-ae296af74503e57a 2026-09-22T06:40:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-nonclinical-testing-regulations-140133928ca7c94d 2026-09-22T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-clinical-endpoints-rethinking-als-drug-development-through-disease-biolog-b7cd7818b37e9411 2026-09-22T06:05:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-european-commission-approval-of-rinvoq-upadacitinib-for-the-tre-cadbbf2157ab9b29 2026-09-22T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-biotech-self-reliance-moment-102921bdf8bc7232 2026-09-22T05:50:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-best-glp-1-stocks-for-2026-and-how-to-invest-99408731658b95c2 2026-09-22T05:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boryung-scores-277m-anti-cancer-drug-supply-deal-in-china-d65692bc15e5f4fc 2026-09-22T05:02:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ad-hoc-announcement-pursuant-to-art-53-lr-roche-announces-positive-phase-ii-resu-ca3349841e8c60a5 2026-09-22T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthnet-mea-to-commercialise-comide-er-methylphenidate-er-in-uae-under-exclusi-25f7252f14d192bd 2026-09-22T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/child-resistant-locking-closures-market-to-2035-pharmaceutical-safety-mandates-d-ee831d2ecb1081b6 2026-09-22T04:46:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-news-96d7107e3a341182 2026-09-22T04:26:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-finally-moves-to-comply-with-2022-law-ending-animal-testing-mandate-3c5286ce175b5ebd 2026-09-22T04:07:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-qia-backed-iambic-therapeutics-files-for-us-ipo-as-biotech-boom-rolls-on-478bd63e265078d4 2026-09-22T03:35:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-moves-away-from-animal-testing-how-organoids-ai-organs-on-chips-could-imp-8ae12dc92c9fbd34 2026-09-22T03:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boryung-signs-277-million-taxotere-supply-deal-with-china-s-yifan-pharmaceutical-a71b4ed4f2241099 2026-09-22T03:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/melbourne-biotech-turns-to-stem-cell-brain-models-in-alzheimer-s-push-7ea3ae37b3c8e127 2026-09-22T02:35:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-strict-checks-on-drug-supply-chain-9e99b919fddbd074 2026-09-22T02:29:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-breast-cancer-combo-wins-approval-2625666fc10dfe92 2026-09-22T01:26:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-offer-insights-on-healthcare-companies-helus-pharma-help-ultragenyx-pha-eb82ae5a7d95e0ef 2026-09-22T01:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-envista-holdin-90aff1940631b27a 2026-09-22T01:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-wellbeing-and-boryung-expand-korea-hospital-use-of-livnec-injection-chosunbiz-f8357be306326357 2026-09-22T00:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-details-phase-3-sleep-apnea-trial-for-ex-metsera-obesity-drug-9b66bc3b08304ba5 2026-09-22T00:38:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-glp-1-users-should-know-about-the-potential-risk-of-a-rare-type-of-vision-l-d11a80ef91435ad7 2026-09-22T00:17:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/cullinan-therapeutics-inc-common-stock-cgem-stock-price-news-quote-history-9e08eae6d576bb60 2026-09-22T00:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-2122447c5946b5e1 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-institute-notice-of-meeting-8918f24bc0866cb9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-e3d513e458366039 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-to-omb-for-review-and-approv-774090bba85bb2af 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nonclinical-testing-terminology-5eba25885ce1826a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-to-omb-for-review-and-approv-c3c6da23622a87ae 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/submission-for-omb-review-30-day-comment-request-the-impact-and-costs-of-promoti-1981b0d77e209b56 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-ed0ae1132b37b44c 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-environmental-health-sciences-notice-of-meeting-request-fo-9ec32231184cff8d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-leader-clearlax-5db04f3e1a797e11 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-92295e664ceab33b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/properly-fueling-your-child-for-sports-9a38989fbb516ab5 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/client-side-ephemeral-de-identification-of-protected-health-information-phi-in-m-1723769fa40654cb 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identification-of-ca2-as-a-potential-candidate-gene-involved-in-the-therapeutic-468ef38d57294912 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/outcome-evaluation-of-percutaneous-coronary-intervention-vs-medical-therapy-alon-8c7ce15ef14f8bd4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-3-dual-single-pill-combinations-for-blood-pressure-lowering-a-seco-109f27c8ec4ad6fe 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lutetium-177-radiopharmaceuticals-in-cancer-care-progress-and-challenges-d843582ed6f93cf2 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/original-rdna-semaglutide-versus-synthetic-copies-differences-and-clinical-impli-ce9bab7fe2f3a574 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-drug-survival-and-treatment-outcome-of-ixekizumab-in-patients-with-sp-277345d1212fc9c3 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-efficacy-and-impact-on-rehospitalization-of-qishen-granules-in-patient-17f7306f6553327e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-acute-biliary-pancreatitis-after-semaglutide-dose-escalation-in-an-a-a60c1f8f70d97d5a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evidence-domain-translation-in-the-lyme-disease-controversy-over-persistent-post-cdd3ac8c01611d6d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-cannabinoid-based-interventions-for-low-back-pain-and-mig-ad36c424c4a5f258 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimising-clinical-trial-design-choices-in-inflammatory-bowel-disease-9300fe46133159e1 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apomorphine-and-psilocybin-to-improve-recovery-from-coma-in-the-intensive-care-u-7e20535216661dd8 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoparticle-pharmacomicrobiomics-reprogramming-the-microbiome-immune-axis-for-c-19c17144a628d4ac 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-mineral-trioxide-aggregate-diode-and-erbium-chromium-d-65739071b0d85441 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-precision-targeted-therapy-for-egfr-mutant-non-small-cell-lung-cancer-b4e2bd97ff9e6410 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-iii-trial-of-sodium-dichloroacetate-for-pyruvate-dehydrogenase-complex-def-317f74ebeaf4db1b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotypic-age-metrics-for-risk-stratification-of-chronic-disease-burden-and-all-865700ea345ac530 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regimen-stratified-bayesian-model-based-meta-analysis-of-targeted-biologics-in-g-27d0dea64c7f9ddf 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-pharmacokinetics-pharmacodynamics-and-target-mediated-drug-disposition-mo-ed4b412b6f6c0ff8 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/summary-for-patients-tobacco-use-treatment-synopsis-of-the-2026-u-s-department-o-07d3fe471f477728 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hybrid-endoscopic-submucosal-dissection-enhances-efficiency-with-comparable-cura-59f35ebeba6339bc 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-risks-and-implementation-challenges-of-artificial-intelligence-as-a-for-0aaebc5fc67cb1f4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/to-what-extent-is-water-hydration-the-best-method-of-maintaining-voice-protectio-c0b14f3feb98d6fc 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-and-limitations-of-tumor-microenvironment-responsive-nanocarriers-for-tar-a541e35ac2a228eb 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethical-legal-and-societal-implications-in-xenotransplantation-elsi-a-korean-reg-574b7c8e38dc1ea4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practicing-in-resource-limited-and-siloed-settings-b8a360d6cc716831 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synbiotic-hqp08-supplementation-for-hair-loss-and-depressive-symptoms-an-open-la-d810c0348c9d2a53 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-participatory-strategies-for-prevention-of-dengue-and-leptospir-8b622e47d75a3a2e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-cardiotoxicity-in-pediatric-patients-with-acute-lymphoblastic-leukemia-and-66bd0483b1ad137d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-tumour-biology-into-surgical-decision-making-for-metastatic-colorect-72069f85a27f2b65 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asparagine-synthetase-deficiency-a-novel-asns-variant-and-a-systematic-review-of-7688496f64879380 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/economic-evaluation-of-primary-health-care-integration-and-targeted-mass-drug-ad-23f6f417faae079e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-following-a-traditional-chinese-medicine-foot-bath-preparation-71dccefa5ac0c66e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-post-procedural-parenteral-anticoagulation-therapy-and-clini-aa105c9902a1b506 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thromboembolic-prophylaxis-in-childhood-idiopathic-nephrotic-syndrome-from-patho-561cd01380060c71 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrasound-defined-fatty-liver-and-the-risk-of-progression-from-preclinical-to-c-f9a84b6d726a3f6e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematoma-expansion-in-intracerebral-hemorrhage-neuroimaging-biomarkers-radiomics-e09c758c16081ca4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-non-invasive-brain-stimulation-from-basic-science-to-clinical-applicat-57c6e566091c722c 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-fracture-stabilization-to-functional-recovery-a-prospective-clinical-radiol-b0de384d30fed29f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiological-outcomes-after-philos-locking-plate-fixa-tion-of-proxi-6cb1d9db4ee8d196 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/magnetic-resonance-imaging-evaluation-of-oblique-injuries-introduction-of-the-de-8fc08014efbffe9e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-reproducible-framework-for-auditing-the-trustworthiness-of-clinical-machine-le-e156ce2fb89f21be 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-statistical-similarity-a-clinical-validation-framework-for-synthetic-acut-72e3848e5ab24c81 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-association-between-clinical-activity-and-inflammatory-response-in-odontogen-bd41993f007c7d9a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-lean-beef-on-resistance-training-induced-strength-and-body-compositio-7dbccd69d52aea28 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antioxidant-premedication-reduces-mitochondrial-and-nuclear-dna-damage-repair-in-cecfc8008ef47d6f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ct-derived-myocardial-extracellular-volume-current-evidence-clinical-utility-and-f91615e1f0f6a045 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-phosphate-supplementation-after-newly-detected-hypophosphatemia-in-older-i-5ee50f7a22451580 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-between-social-determinants-of-health-and-clinical-diagnosis-time-o-ba252f64579ea133 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-stroke-crisis-in-ageing-societies-global-trends-risk-factors-and-clinical-va-eebc145ad0ea6bea 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-by-maurer-and-fontana-to-letter-regarding-article-coramitug-a-humanized-b092e4d1b40d77b4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-3-dual-single-pill-combinations-for-blood-pressure-lowering-a-seco-934d9095d9196874 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychological-pathways-from-disease-activity-to-quality-of-life-in-ulcerative-co-0133cc63b78f7bb5 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/my-unbearable-wife-gave-me-a-brain-tumor-subjective-theories-of-illness-and-reco-d9c4caf1f4a588e9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-therapists-need-to-be-their-own-clients-the-influence-of-intersectional-pri-12d08479260be075 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contributions-of-semiotic-cultural-psychology-for-interventions-in-clinical-psyc-cf12230181a710fb 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-literacy-antibiotic-use-behaviors-and-awareness-of-antimicrobial-resistan-7a7abb1fc6fe4ec9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-introducing-automated-plan-checking-in-radiation-therapy-effe-220fbd73db8233f8 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-effectiveness-safety-and-tolerability-of-ozenoxacin-2-lotion-vs-clind-75efa1fd26813f4c 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bacterial-outer-membrane-vesicles-in-colorectal-cancer-interdomain-communication-95e0d6534503eb25 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-early-systolic-blood-pressure-and-clinical-outcomes-in-non-c-69ae09590efea90e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-combined-repetitive-transcranial-magnetic-stimulation-and-occupation-b74d503d8324ad1e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacovigilance-practices-educational-interventions-and-barriers-to-reporting-535468794e77582d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/occupational-allergies-clinical-presentation-epidemiology-diagnosis-and-preventi-d3e45acd9d403f28 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-conceptual-disease-model-of-atopic-dermatitis-using-data-from-t-b724371d717c237f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anti-tnf-refractory-inflammatory-bowel-disease-associated-with-a-novel-xiap-fram-b48dd066032a9779 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-cuprous-oxide-nanoparticles-green-synthesized-using-artemisia-dracuncu-cc51fb0cd6ece9b8 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-evaluation-of-a-hydroxyurea-loaded-invasome-hydrogel-for-enhance-994c6bdc360fa4cc 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/photocatalytic-treatment-of-organic-and-pharmaceutical-pollutants-in-wastewater-fb6ba995d39dc801 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tissue-specific-aging-clocks-map-structured-aging-modulatory-drug-score-patterns-9b721b6fd4c871b6 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-accuracy-amp-clinical-importance-of-ai-confidence-for-extremity-fract-cf31f9fe3c4a8ca6 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-previous-appendicectomy-influence-disease-expression-in-axial-spondyloarth-e9e0c066f4387e8f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-performance-of-glass-hybrid-and-short-fiber-reinforced-composite-restor-651b546e41d9bbe2 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-interchangeability-of-22c3-and-28-8-pd-l1-assays-for-patient-selection-343e8ac84fe0cb4f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glaucoma-in-hospitalized-older-adults-polypharmacy-multimorbidity-and-therapy-di-fbced7d96caeaf15 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/specific-treatment-of-attr-cm-in-germany-expert-consensus-of-the-german-society-4b5e24406ecb15a6 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regimen-stratified-bayesian-model-based-meta-analysis-of-targeted-biologics-in-g-760b3481681182f4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-what-vlms-don-t-say-validation-metrics-hide-clinical-terminology-erasu-ad6cc70c31430f76 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-blood-biomarkers-after-traumatic-brain-injury-a-subanalysis-of-the-b-62e62e5a6d913481 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07834671-research-on-respiratory-support-decision-making-for-mechanically-ven-18f7097ea8b88c2f 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07833722-management-of-hypokalemia-in-intensive-care-patients-e3b9772dbefc93f6 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07833553-comparison-of-efficacy-of-caudal-versus-transforaminal-epidural-ster-ba6604bc010f1f4b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07832422-ischemic-compression-and-low-level-laser-therapy-for-myofascial-low-d513a21624e08e3e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07826013-the-effect-of-horticultural-therapy-on-anxiety-and-quality-of-life-aeeb3468d1ba64e9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07783802-a-study-of-clazakizumab-ly5724886-in-adults-with-elevated-hscrp-and-29441caf9fd10fa6 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07775313-base-edited-hematopoietic-stem-progenitor-cell-gene-therapy-for-trea-598ef3dcb0ccb96b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07767487-a-study-of-ly4226695-in-healthy-participants-5cb65fa6ef63d898 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07737756-a-real-world-medical-chart-review-of-spinal-muscular-atrophy-patient-67bc8c57e8f46d84 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07619547-longitudinal-immunophenotyping-of-patients-with-inflammatory-bowel-d-3a796411228812d2 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07507760-oral-decitabine-plus-ivosidenib-as-first-line-for-older-unfit-adult-72d54845c186722b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07504601-investigating-the-analgesic-potential-of-2r-6r-hnk-in-acute-pain-in-7d802ea0b5cc5a4e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07488676-a-study-of-asp546c-in-adults-with-gastroesophageal-cancer-pancreatic-8d01bc3f698a8cf8 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07437976-a-natural-history-of-genetic-and-environmental-predictors-of-puberta-6b2ccb1e0c1c166d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07409272-a-study-to-evaluate-the-effectiveness-and-safety-of-setidegrasib-giv-09ad5ffe87abbd3b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07222709-a-study-to-assess-the-adverse-events-and-how-oral-abbv-1042-moves-th-19ae8bf9c118cc7b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07222189-a-study-to-investigate-the-long-term-safety-tolerability-and-efficac-4c589d37fe3b3d76 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07137442-distinguishing-tics-and-functional-tics-using-clinical-neurophysiolo-e0a0f7cc00953d72 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07053423-a-study-to-investigate-airway-inflammation-with-dupilumab-subcutaneo-f76e86c6aa568fa4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06948097-syk-inhibition-in-mitigating-lung-allograft-rejection-similar-a-tria-28f73f1ac769add4 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06875310-a-study-of-adagrasib-plus-pembrolizumab-plus-chemotherapy-vs-placebo-b1d1bb9e85e90d8c 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06833944-high-intensity-interval-training-in-the-treatment-of-familial-hyperc-1b8bcbea5515768a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06828042-safety-and-efficacy-of-universal-cd19-targeting-car-t-cells-in-refra-46bf8248aff6d69d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06641908-anti-gd2-adc-m3554-in-advanced-solid-tumors-333d9dc4d4693020 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06585787-a-study-to-evaluate-karxt-as-a-treatment-for-psychosis-associated-wi-68a1e1572e63aeec 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06453044-mosunetuzumab-and-polatuzumab-vedotin-for-the-treatment-of-patients-f92dc5572b576547 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06393452-safety-pharmacokinetics-and-efficacy-of-pp405-in-adults-with-aga-cf7ba5e394b1e7a5 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06281665-treatment-with-aspirin-after-preeclampsia-tap-trial-d452b736868de309 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06226883-a-phase-2-study-to-evaluate-morf-057-in-adults-with-moderately-to-se-5f3287f5b75539d0 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06128551-study-of-elironrasib-and-daraxonrasib-as-monotherapies-and-combinati-018bc1740e4ec72a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06109272-a-study-to-assess-the-dose-adverse-events-and-change-in-disease-acti-3cbaca2f6fede566 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06081894-a-trial-to-evaluate-the-efficacy-and-safety-of-aficamten-compared-to-3f0db88811c38c18 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05825274-tdcs-to-treat-drug-resistant-epilepsy-75be45242a7ab4de 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05713799-trial-of-the-combination-of-alpha-lipoic-acid-and-mirabegron-in-wome-58ca62d5ec6a8459 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05564390-myelomatch-a-screening-study-to-assign-people-with-myeloid-cancer-to-24330c5ca77ac0cb 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05419024-imaging-and-biopsy-of-people-with-hiv-1-undergoing-analytic-treatmen-ba9c2ed4984d9b75 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05201066-roll-over-study-for-patients-who-have-completed-a-prior-novartis-spo-f4d66c80a684873d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04928846-a-study-to-assess-disease-activity-and-adverse-events-of-intravenous-aad3d7c2569dbe63 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04925479-study-to-determine-the-dose-and-safety-of-asciminib-in-pediatric-pat-36818f90875f077b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04639830-electrophysiologic-sleep-phenotyping-and-sleep-dependent-neuro-matur-f66afd5ddf8abb8d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04384367-efficacy-and-safety-of-rizatriptan-naproxen-10-550-mg-in-the-acute-t-b4d7fed8ac67cb46 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04269902-testing-early-treatment-for-patients-with-high-risk-chronic-lymphocy-cf81092206932f4e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03766009-increasing-patients-engagement-in-breast-cancer-surgery-decision-mak-9cb70c96b7ebe325 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03602599-chronic-graft-versus-host-disease-in-the-oral-cavity-of-patients-fol-917cfe1b45e00a8d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03459287-study-to-evaluate-the-efficacy-safety-of-the-intercept-blood-system-27fa67412869567a 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03253705-samples-from-human-subjects-to-facilitate-basic-translational-and-cl-dd8e4dde62e55019 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02262832-compassionate-use-of-metreleptin-in-previously-treated-people-with-g-b70e5c26c71574b9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02116764-analysis-of-patients-treated-for-chronic-granulomatous-disease-since-9b8692f247eb9b9b 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01925196-natural-history-and-biomarkers-of-amyotrophic-lateral-sclerosis-and-85158fa590642c6d 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01857934-therapy-for-children-with-advanced-stage-neuroblastoma-4a846ae16a327054 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01247597-dicer1-related-pleuropulmonary-blastoma-cancer-predisposition-syndro-483746454e3e0819 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00092222-virotherapy-and-natural-history-study-of-khsv-associated-multricentr-0a1ef180e9bc1d96 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00043472-removal-of-the-ovaries-fallopian-tubes-and-ca-125-screening-to-reduc-03a60ad923366b92 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00034424-cause-of-familial-testicular-cancer-b37185d4ec3be3ca 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00024622-pet-scanning-in-parkinson-s-disease-db6af6973e31a489 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00023049-genetic-analysis-of-hereditary-disorders-of-hearing-and-balance-65bd947aa9000148 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00004847-diagnosis-of-pheochromocytoma-05c9db90843e0e42 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001846-collection-and-distribution-of-blood-components-from-healthy-donors-2ef5bdb84e8cdf6e 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001595-an-investigation-of-pituitary-tumors-and-related-hypothalmic-disorde-44f1228058efa690 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001254-evaluating-pancreatic-tumors-in-patients-with-zollinger-ellison-synd-c749f4fce25c54a9 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-9b7f052101582566 2026-09-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amcham-imss-deal-pledges-us-44-million-to-bring-clinical-trials-to-mexican-publi-052095dbcfb7da9a 2026-09-21T23:39:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nice-recommends-enhertu-for-her2-low-advanced-breast-cancer-in-england-9d334852ef112a45 2026-09-21T22:50:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/drummond-warns-rubio-of-national-security-risk-in-pharmaceutical-supply-chain-5a65cb2ace796337 2026-09-21T22:48:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-and-warnings-third-glutathione-recall-issued-over-endotoxin-contamin-07b548b075a272fe 2026-09-21T22:39:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-rulemaking-chatter-lifts-hong-kong-s-china-biotech-names-4fcfe264207382d9 2026-09-21T22:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-qia-backed-iambic-therapeutics-files-for-us-ipo-as-biotech-boom-rolls-on-6bcac29ff06fe76b 2026-09-21T21:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-logistics-market-to-reach-usd-194-0-billion-by-2034-at-7-7-cagr-d-405b29a18e79aec5 2026-09-21T21:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-and-leveraged-etfs-lead-market-d-9c02833c76771b58 2026-09-21T21:28:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-breaks-ground-on-6-5b-houston-plant-078eb0965183eec9 2026-09-21T21:21:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/dompe-settlement-highlights-doj-continued-scrutiny-of-pharmaceutical-manufacture-433de672942d089b 2026-09-21T21:15:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/iam-ipo-news-small-molecule-biotech-iambic-therapeutics-files-for-a-100-million-3bc12612e27dfbee 2026-09-21T21:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-breaks-ground-on-6-5b-pharmaceutical-factory-in-houston-2f381a479b3555a2 2026-09-21T20:58:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/screening-china-origin-biotech-ip-a-new-u-s-eu-divide-fe79769761ea8dd8 2026-09-21T20:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/nvidia-qia-backed-iambic-therapeutics-files-for-us-ipo-as-biotech-boom-rolls-on-4b5e30b480cbde92 2026-09-21T20:38:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicus-pfizer-deal-was-not-a-fire-sale-a-strategic-bet-on-de-risked-adc-drug-8e03cd57f1797c93 2026-09-21T20:35:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/buerger-s-disease-clinical-trial-pipeline-gains-momentum-3-91e1bc0bbb6b2bea 2026-09-21T20:24:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-glp-1-shortage-is-over-mass-market-compounding-should-be-too-5d8cd6869a85189b 2026-09-21T20:06:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-connected-peninsula-company-plots-ipo-as-it-takes-on-eczema-and-more-0871b8e09373ffce 2026-09-21T19:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-topline-phase-3-study-results-lumateperone-for-manic-episodes-in-bipola-ea5127591948df34 2026-09-21T19:34:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-teva-why-is-it-back-in-the-spotlight-feca7b108b11fdaf 2026-09-21T19:11:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-milan-leadership-summit-returns-with-supply-chain-focus-543b72ef7ec0a6e6 2026-09-21T19:06:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/faq-how-the-generous-model-applies-mfn-pricing-to-medicaid-3108639fbd284b85 2026-09-21T19:04:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-analyses-of-hlp003-for-the-adjunctive-treatment-of-mdd-610c32551287df6e 2026-09-21T19:04:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-forms-ai-powered-drug-discovery-partnership-with-iambic-pharmexec-7df1eac9f5ddbb27 2026-09-21T18:57:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-regulations-to-expand-alternatives-to-animal-testing-in-drug-develop-0ab1dcb84feb442a 2026-09-21T18:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/s2s-china-selects-10-biotech-finalists-to-pitch-global-investors-at-westlake-uni-cc798694b80a8b1b 2026-09-21T18:33:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/sec-fda-information-sharing-mou-implications-for-pharma-and-biotech-f12ad8cd85d5f095 2026-09-21T18:24:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmosa-biopharm-s-inhaled-drug-l608-wins-fda-approval-for-phase-2-trial-shares-623a9af03fd0b72d 2026-09-21T18:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-sciences-real-estate-trends-what-to-expect-3bd7b4d3a44b9c76 2026-09-21T18:05:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-watch-and-pharma-industry-news-72f24107382921a8 2026-09-21T17:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-regulations-to-advance-innovative-alternatives-to-animal-testing-2a5644680d80e2c1 2026-09-21T17:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-racket-kingpin-s-pharmacy-stayed-open-after-raid-health-officer-suspended-710aba0a714d4a51 2026-09-21T17:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-c-f-depot-licence-suspension-case-k-taka-health-dept-warns-consumers-over-54ab0d264ee858a9 2026-09-21T17:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-developer-adarx-seeks-1-74-billion-valuation-in-us-ipo-da6c89fec62607a7 2026-09-21T16:55:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-biotech-stock-crashed-28-today-after-announcing-second-reverse-share-split-b0b395313df17574 2026-09-21T16:20:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenetic-to-acquire-santersus-in-net-targeting-biotech-combination-ec88c0dae17857a4 2026-09-21T16:15:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-etfs-to-buy-as-cancer-drug-breakthroughs-accelerate-bd41f997cae1257c 2026-09-21T16:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengaluru-assistant-drug-controller-suspended-in-counterfeit-drug-case-3638b689e7e0c3d9 2026-09-21T15:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-commission-approves-roche-s-susvimo-for-the-treatment-of-neovascular-ag-5503298c000d9a8a 2026-09-21T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-surges-9-as-phase-3-melanoma-data-wins-presidential-symposium-slot-merck-3da8f65777798006 2026-09-21T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-of-my-top-small-cap-biotech-picks-made-a-move-here-s-how-i-trade-it-6eb55c5568c32d22 2026-09-21T15:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bmy-vs-gild-which-biotech-stock-looks-more-attractive-now-6c620882c75be90d 2026-09-21T15:08:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-top-7-atypical-psychedelics-a-brief-clinical-guide-3d93abb04fc90f32 2026-09-21T15:06:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-roundup-on-the-cannabis-sector-psychedelic-sector-a4229cf49083a849 2026-09-21T15:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/bytedance-baidu-hengrui-novo-nordisk-driving-breakthroughs-in-ai-pharmaceutical-fbcbc6c19d988c7c 2026-09-21T15:01:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-and-biotech-industry-audit-services-for-gmp-gxp-and-supplier-compliance-2ecc2a1cefcf64f8 2026-09-21T14:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-wants-pro-life-states-to-keep-waiting-b6f6153c4948a5f2 2026-09-21T14:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-group-sehk-1093-expands-its-pipeline-is-the-stock-still-unde-873fbda566f6532f 2026-09-21T14:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-announces-irb-approval-and-clinical-site-readiness-to-initiate-p-2dfc2ee296889841 2026-09-21T14:45:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/plug-and-play-seattle-picks-11-startups-for-4th-cohort-from-space-robotics-to-bi-a4ef32ff512f3201 2026-09-21T14:42:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/beijing-unveils-blueprint-for-biomedical-dominance-by-2030-d2e6d08e6ff0538c 2026-09-21T14:41:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/concord-biotech-bonus-issue-sparks-rally-pharma-stock-jumps-6-on-maiden-share-re-3ca3b429b4874d3e 2026-09-21T14:28:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/evita-clinical-trial-evaluates-oral-vitamin-c-for-pre-cancerous-blood-disorders-8e446074c31c386e 2026-09-21T14:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serbian-biotech-startup-takes-its-journey-from-belgrade-to-cambridge-with-docume-ac0ba1a6f705851f 2026-09-21T13:59:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-updates-regulations-to-advance-alternatives-to-animal-testing-efae5931c8e859cd 2026-09-21T13:45:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/reunion-del-comite-de-medicamentos-veterinarios-de-septiembre-de-2026-224e8a08e13866ca 2026-09-21T13:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-16-drug-licences-suspended-08-others-in-connection-with-alleged-dist-51785b064dcf2ded 2026-09-21T13:35:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-pharma-reform-strategic-implications-for-us-drugmakers-8f7f8ee4ad186bb7 2026-09-21T13:27:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-targets-25-share-of-global-first-in-class-drugs-in-new-5-year-plan-0e7df4b725539007 2026-09-21T13:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-stock-price-expected-to-rise-barclays-anal-81130dfa0ccc6837 2026-09-21T13:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-new-cholesterol-drugs-get-their-first-global-approval-in-europe-61a68e250907fc8e 2026-09-21T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-opens-expedited-drug-trial-pilot-to-cut-development-delays-f3806e23c82077de 2026-09-21T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-public-appointments-2026-to-2027-92f3e9c4047ba1dc 2026-09-21T12:59:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-tlx-lines-up-us-1-65b-cancer-drug-merger-and-a-big-revenue-jump-8adff125aee08116 2026-09-21T12:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/adrx-ipo-news-sirna-biotech-adarx-pharmaceuticals-sets-terms-for-350-million-ipo-7c6df0ecf3d07353 2026-09-21T12:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-inc-bofa-global-research-raises-price-objective-to-400-from-392-76033b6bd017aee9 2026-09-21T12:46:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-china-biotech-licensing-expected-to-thrive-as-washington-softens-stance-news-7bfa8d1d5a5b74b0 2026-09-21T12:40:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/bofa-adjusts-price-target-on-krystal-biotech-to-400-from-392-keeps-buy-rating-3e1641c6da3c6b68 2026-09-21T12:34:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/factbox-weight-loss-drug-developers-line-up-to-tap-lucrative-market-as-competiti-5514ab11a1196d72 2026-09-21T12:28:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/rhelion-subsidiary-supplies-psilocybin-for-phase-3-palliative-care-trial-0d4d220a9ee9c49e 2026-09-21T12:11:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/denmark-eyes-shortage-substitution-protocols-as-industry-urges-tight-limits-d1dc310ade3ee8de 2026-09-21T12:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccine-5-years-and-over-pgd-and-vgd-6776102a716b3a92 2026-09-21T12:10:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/arch-biopartners-under-pressure-clinical-stage-biotech-faces-renewed-selling-as-327b8f6542f8321e 2026-09-21T12:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-targets-25-of-global-first-in-class-drugs-by-2030-in-new-pharma-five-year-f8d103925f821267 2026-09-21T12:06:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-2-trial-suggests-vitamin-c-may-benefit-people-with-pre-cancer-blood-disord-64b38f62af9ca22e 2026-09-21T12:05:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/filament-ships-psilocybin-drug-pex010-for-phase-3-trial-on-psychological-distres-00504eb35086a553 2026-09-21T12:03:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-loss-drug-developers-line-up-to-tap-lucrative-market-as-competition-heats-54efba15b344cc0f 2026-09-21T12:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-c-f-depot-licence-suspended-as-karnataka-probes-fake-drug-racket-eb671632b4449c57 2026-09-21T12:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/imaavy-affected-lots-may-contain-glass-particles-9a9a8e6dd55fc1e3 2026-09-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/caplyta-lumateperone-shows-significant-and-rapid-improvement-in-bipolar-mania-in-14963d1b5f3d3bc5 2026-09-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-drug-price-plan-targets-foreign-freeloaders-but-shoots-american-innovato-5e14093c8aaa4a87 2026-09-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-iambic-announce-collaboration-to-accelerate-ai-driven-drug-discovery-6b060a185e233d47 2026-09-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rhelion-life-sciences-wholly-owned-subsidiary-filament-health-delivers-pex010-to-2398f0f9f087f4a7 2026-09-21T11:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-doses-without-hallucinations-will-be-tested-in-end-of-life-care-6c1213d2afac37ae 2026-09-21T11:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-employs-37-000-ai-agents-for-end-to-end-drug-development-8f7d97a93a576cdc 2026-09-21T11:46:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyllene-appoints-seasoned-biotech-exec-as-cfo-74f91b753010fd2c 2026-09-21T11:40:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-exports-continue-to-strengthen-the-swedish-economy-6d1e9ae333cb8b5f 2026-09-21T11:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-ema-y-hma-abren-el-proceso-de-comentarios-sobre-la-nueva-guia-de-eu-in-para-i-b9a7929b040a0936 2026-09-21T11:26:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-minister-says-pfizer-c-f-agency-failed-to-aid-fake-drug-probe-d544ad166f836728 2026-09-21T11:23:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-community-based-scale-up-of-integrated-community-health-worker-le-05286051f35c02ca 2026-09-21T11:22:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-microwave-photonics-platform-for-cancer-detection-and-treatment-4e2c58f5b234309a 2026-09-21T11:22:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-the-interaction-between-chronic-pain-and-genetics-in-contributing-5d67fb178fa044ee 2026-09-21T11:22:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-towards-predictive-computational-platform-for-drug-solubilization-1268e26242a4e7b4 2026-09-21T11:22:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-controlling-reactive-species-delivery-in-cold-plasma-jets-a-key-c-7546c6a43992920d 2026-09-21T11:22:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-electrochemical-carboxylic-acid-exchange-for-sustainable-drug-dev-e80014a705f27d3b 2026-09-21T11:22:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/brazil-pharmaceutical-distributors-face-mounting-financial-pressure-2eeef9a7b9aca460 2026-09-21T11:20:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/sichuan-biokin-pharmaceutical-s-unit-receives-milestone-payment-from-bristol-mye-ca99112d5b22276b 2026-09-21T11:16:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelics-are-wall-street-s-next-trip-why-this-biotech-stock-is-already-up-20-52049d1cb6186539 2026-09-21T11:08:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial-7d805f10ecf38946 2026-09-21T11:03:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/serbian-biotech-startup-takes-its-journey-from-belgrade-to-cambridge-with-docume-4e3af3cef35b6b21 2026-09-21T11:02:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/serbian-biotech-startup-takes-its-journey-from-belgrade-to-cambridge-with-docume-993c912068e3ffbe 2026-09-21T11:02:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-announces-last-patient-completes-last-visit-in-phase-2a-inform-ms-trial-121aeb1f6cd0e04c 2026-09-21T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alkermes-announces-positive-phase-1b-results-demonstrating-clinical-proof-of-con-e143bd6657dbae3b 2026-09-21T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-inline-refractive-index-monitoring-can-improve-real-time-peptide-manufacturi-6daaaf2be2a7405b 2026-09-21T10:54:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/singapore-draws-international-biotech-vcs-as-asia-pacific-life-sciences-sector-t-8b267d226e97ee94 2026-09-21T10:53:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-group-co-ltd-to-go-ex-dividend-on-september-22nd-2026-with-7e95578a30c6b612 2026-09-21T10:48:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-s-keytruda-qlextm-pembrolizumab-and-berahyaluronidase-alfa-pmph-approved-i-cb6eee590ac0416c 2026-09-21T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-nyse-teva-legal-chief-files-273k-share-sale-notice-e62f1c4bffd47859 2026-09-21T10:40:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/tekpac-s-intelligent-packaging-increases-output-for-patch-manufacturer-5fc87af611260110 2026-09-21T10:30:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-has-approved-29-u-k-led-cancer-drugs-since-2021-now-a-u-k-regulator-will-a64efa1f5f19d8b7 2026-09-21T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/os-therapies-completes-fda-type-c-statistical-methods-meeting-and-provides-updat-79fead0c1f7c2adf 2026-09-21T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-secures-full-fda-nod-for-inluriyo-verzenio-breast-cancer-combo-986279ff4c2ee3b2 2026-09-21T10:29:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-buys-three-non-incretin-obesity-programs-from-kallyope-1771b5edb75f4697 2026-09-21T10:29:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-aug-16bd5e27d65a23b1 2026-09-21T10:28:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-apply-for-a-variation-to-your-marketing-authorisation-2a4014b9e82727c7 2026-09-21T10:28:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-reform-of-eu-drug-regulations-what-will-change-for-patients-1b494b7bc3bbb314 2026-09-21T10:25:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/metavallon-backs-parkinson-s-biotech-anacalypsis-in-first-of-its-kind-greek-deal-a0596c80e643d916 2026-09-21T10:14:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-collaboration-to-advance-a-novel-therapy-for-alzheimer-s-disease-f02f2d6a6aefabfc 2026-09-21T10:09:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-busts-fake-drug-racket-pfizer-depot-7-other-firms-face-licence-suspens-3be6e17a0c46130a 2026-09-21T10:09:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-treasury-reportedly-drafting-rules-to-preserve-pharma-licensing-deals-with-ch-267bf55a61b7fc6a 2026-09-21T10:06:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-stock-craters-30-on-drug-trial-setback-its-failure-could-be-this-biotech-s-56a2fa84d3bb02c3 2026-09-21T10:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cannabinoids-vs-opioids-is-chronic-pain-treatment-at-a-turning-point-6360efc5a5b20214 2026-09-21T10:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-tide-of-china-biotech-deals-seen-as-us-curb-fears-fade-analysts-aaba7a319c133b2c 2026-09-21T10:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-finance-report-england-2025-to-2026-edfdf55f46596236 2026-09-21T09:52:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-activity-report-england-2025-to-2026-d04cfc1369caa66d 2026-09-21T09:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-43-report-data-to-week-42-dat-99cbb355a95c8f35 2026-09-21T09:51:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-18-october-2026-673a62d4be0d46e6 2026-09-21T09:51:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-43-report-data-to-week-42-data-up-t-d32e68d6017bb7c3 2026-09-21T09:51:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-mortality-monitoring-report-england-winter-2025-to-2026-625b82782f2a1916 2026-09-21T09:51:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-39-report-data-to-week-38-data-up-t-b701a0f0114ed05c 2026-09-21T09:50:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/d-d-pharmatech-s-head-of-r-d-park-eun-ji-newco-bridges-early-stage-biotech-firms-b72d729bb82a03d9 2026-09-21T09:45:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgium-s-novadip-biosciences-raises-10-4-million-to-fund-pivotal-clinical-trial-1c00f7f63d3d96ab 2026-09-21T09:40:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/thousands-invited-to-register-for-public-panel-for-independent-commission-on-adu-52b360f1b8267410 2026-09-21T09:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-chinese-biopharma-stocks-retail-investors-are-watching-for-licensing-deals-f9c5948024fb39f8 2026-09-21T09:24:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ultragenyx-pharmaceutical-inc-nasdaq-rare-is-in-focus-now-2794a473faf0e70f 2026-09-21T09:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sarepta-therapeutics-srpt-stock-analysis-navigating-the-biotech-waters-with-a-fo-00f2039c62c0d646 2026-09-21T09:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-legn-stock-analysis-unveiling-a-175-potential-upside-bcd9d089c6ca5a63 2026-09-21T09:22:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-inc-krys-stock-analysis-a-look-at-its-14-36-potential-upside-9a61874672731d38 2026-09-21T09:21:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/exelixis-inc-exel-stock-analysis-navigating-biotech-with-strong-revenue-growth-a-5788861c9117fa48 2026-09-21T09:21:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvalent-inc-nuvl-stock-analysis-navigating-the-biotech-landscape-with-a-clinica-7e778788f7bae560 2026-09-21T09:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-extremely-bullish-as-telix-beams-into-novartis-territory-with-1-6b-itm-130dcd4d2d8d5288 2026-09-21T09:19:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-enhanced-surveillance-form-969ec8a257418767 2026-09-21T09:15:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-pharmaceuticals-vrtx-stock-analysis-a-biotech-powerhouse-with-11-97-poten-386828f0479eef3f 2026-09-21T09:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/mycoplasma-genitalium-antimicrobial-resistance-surveillance-mars-8b728d0038ccd66f 2026-09-21T09:14:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-commercial-opportunities-9e4f936a0befa657 2026-09-21T09:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-suspends-pfizer-c-f-depot-licence-in-fake-drug-case-warns-consumers-ov-61ae4f712869af8f 2026-09-21T08:58:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewon-pharmaceutical-brings-shinbaro-in-house-to-expand-south-korea-osteoarthri-06deb3f19266a298 2026-09-21T08:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cue-chalks-up-phase-2-hives-win-for-xolair-challenger-dca24fea5b2e4874 2026-09-21T08:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-spurious-drugs-racket-fda-cancels-16-drug-licences-suspends-pfizer-c-f-583b24989cc671ce 2026-09-21T08:49:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/retension-and-lilly-backed-trex-bio-both-set-out-plans-to-join-biotech-ipo-stamp-d978dc40cc95aef6 2026-09-21T08:29:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bofa-securities-lifts-sino-biopharmaceutical-target-to-hk-7-3-bullish-on-chinese-b25213c517e317db 2026-09-21T08:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nykredit-a-s-takes-position-in-teva-pharmaceutical-industries-ltd-teva-8ef68b53d2f7b566 2026-09-21T08:12:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-bytedance-enter-ai-drug-discovery-the-next-coding-faces-critical-data-949e67c2cfec7bcb 2026-09-21T08:10:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-achieves-top-10-ranking-for-integrated-reporting-excellence-11891286e263540b 2026-09-21T08:04:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/buy-sun-pharmaceutical-industries-target-of-rs-2070-geojit-financial-services-05d4bece45133dba 2026-09-21T08:01:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-may-202-2cc50be828051e6c 2026-09-21T07:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-39-report-data-to-week-38-dat-1bbeb1fdd2fcb78d 2026-09-21T07:43:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/aston-university-joins-forces-with-biotech-firm-to-develop-realistic-human-skin-5439803eb98b58fb 2026-09-21T07:39:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-s-inventera-reports-phase-3-success-for-mri-contrast-agent-plans-reg-7e38950a6ba7475b 2026-09-21T07:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antengene-starts-phase-iii-clinch-3-trial-of-atg-022-in-advanced-gastric-cancer-02e84e96f3c002c3 2026-09-21T07:33:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-plans-more-support-for-pharma-innovation-f77ec0948695270f 2026-09-21T07:09:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventera-s-mri-contrast-agent-passes-phase-3-trial-in-korea-22fdf31a869b455e 2026-09-21T06:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/interview-mash-moves-beyond-clinical-graveyard-as-focus-shifts-to-targets-biomar-778863fe92e5aac3 2026-09-21T06:49:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/lavengratinib-shows-100-response-rate-in-lowest-dose-achondroplasia-cohort-c1eaa9b89bb2e951 2026-09-21T06:38:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-b2b1f4cf310740f2 2026-09-21T06:31:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurotech-international-initiates-phase-3-beyond-harmony-trial-with-first-patien-bc6f61556b31fc81 2026-09-21T06:20:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-aspen-betting-on-the-right-hiv-prevention-product-14903d010e56bd11 2026-09-21T06:19:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/copenhagen-biotech-takes-first-step-toward-european-approval-eyes-major-reformul-88ce2eac112529e9 2026-09-21T06:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-c-f-depot-licence-suspension-case-k-taka-health-dept-warns-consumers-over-62b3da0dab88be39 2026-09-21T06:13:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/beacon-lights-path-to-fda-approval-with-pivotal-trial-win-for-rare-vision-loss-g-de3d6ab41f73e76c 2026-09-21T05:57:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cicc-cuts-alibaba-health-target-price-to-hk-4-5-bullish-on-pharmaceutical-busine-2ef4c2c59948d673 2026-09-21T05:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sunshine-guojian-pharmaceutical-co-ltd-xssc-688336-added-to-ftse-all-world-index-f7d596060f75cd57 2026-09-21T05:21:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/matica-bio-joins-hands-with-bondwell-for-protein-production-82d9ae6b6395045f 2026-09-21T05:10:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/cybin-eyes-q4-phase-3-data-for-depression-drug-hlp003-fe46f092d7c7b986 2026-09-21T05:02:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/cybin-eyes-q4-phase-3-data-for-depression-drug-hlp003-0c74433ec5a2cf09 2026-09-21T05:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aluminum-pvc-blister-film-market-forecast-to-2035-pharmaceutical-demand-drives-5-953d6d97f21cf2cb 2026-09-21T05:01:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-week-ahead-xlv-beats-the-market-here-are-the-stocks-readouts-and-events-8162588003ba2afa 2026-09-21T04:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-china-pharmaceutical-company-ltd-xssc-600812-dropped-from-ftse-all-world-i-b96971880c9cd718 2026-09-21T04:35:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/heilongjiang-zbd-pharmaceutical-co-ltd-xssc-603567-dropped-from-ftse-all-world-i-4353837e375a403a 2026-09-21T04:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-phase-iii-diabetes-trial-start-require-action-from-uni-bio-science-shares-033cbff8c0320fac 2026-09-21T04:28:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/sansure-biotech-inc-xssc-688289-dropped-from-ftse-all-world-index-58517ea7bc89902e 2026-09-21T04:27:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug-deals-a80913ab3deb4527 2026-09-21T04:20:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-boya-bio-pharmaceutical-group-co-ltd-xsec-300294-dropped-from-ft-b7061d9fea7cd209 2026-09-21T04:11:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-warns-texas-beverage-companies-about-acidified-food-unapproved-drug-claims-5909ec9e189f3706 2026-09-21T04:02:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/par-health-issues-voluntary-nationwide-recall-of-two-lots-of-dexmedetomidine-hcl-488b45799ea71d6a 2026-09-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-icu-medical-llc-issues-voluntary-nationwide-recall-of-0-9-sodium-chloride-61a649d42d701917 2026-09-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ventilator-recall-coopersurgical-removes-inca-infant-nasal-cpap-sets-f3698262eaa2b3c4 2026-09-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenience-kit-correction-avid-medical-issues-correction-for-kits-containing-hu-1b4aecd26284ce1a 2026-09-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fake-pfizer-labels-expired-vials-seized-karnataka-fda-cancels-16-licences-suspen-94d0597343aefd1e 2026-09-21T03:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matica-bio-to-expand-into-protein-process-development-with-us-bondwell-999cb539da410bad 2026-09-21T03:26:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/celltrion-wins-ema-approval-to-modify-phase-3-trial-for-darzalex-biosimilar-ct-p-b83c8c64d39982d8 2026-09-21T03:25:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/shenqi-pharmaceutical-share-price-skyrockets-160-the-stock-is-truly-magical-2c0bba098ab6dc55 2026-09-21T03:14:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/nyrada-raises-fresh-capital-to-fund-xolatryp-phase-iia-and-pipeline-expansion-4c148b1b6b22f576 2026-09-21T03:10:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/kolon-tissuegene-ceo-noh-moon-jong-steps-down-after-tg-c-phase-3-failure-93ba35e01c4a0a62 2026-09-21T02:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-cancels-16-suspends-8-drug-licences-in-counterfeit-medicine-crackd-f0e2dfff72f4bb07 2026-09-21T02:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-uncovers-farmhouse-drug-scam-with-fake-pfizer-labels-fa113abe91479c41 2026-09-21T02:12:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/abl-bio-s-credibility-in-doubt-as-market-cap-drops-by-10-trillion-won-in-eight-m-6125fa47849c124e 2026-09-21T01:56:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cha-biotech-s-us-unit-matica-expands-beyond-cgt-into-protein-cdmo-3e1fa8b19d2893e9 2026-09-21T01:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kolon-tissuegene-shifts-to-sole-leadership-as-no-resigns-after-tg-c-setback-chos-78b39badd6d85917 2026-09-21T01:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-cancels-16-drug-licences-after-rs-5-05-crore-spurious-medicine-rac-71f3f5a689bc8cb1 2026-09-21T01:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-says-hs-10374-meets-co-primary-endpoints-in-phase-iii-plaq-c406088c5e696e9d 2026-09-21T01:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-anti-aging-to-biotech-taiwan-looks-to-take-its-exosomes-global-8b1cffaebe2d4f7a 2026-09-21T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antengene-announces-first-patient-dosed-in-pivotal-phase-iii-clinch-3-study-of-a-46d88b9387463d03 2026-09-21T00:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-pharma-announces-pivotal-phase-3-clinical-trial-of-hs-1037-5e494e720e07789d 2026-09-21T00:24:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/nephrotic-syndrome-clinical-trial-pipeline-gains-momentum-3-3dcb122cc4863365 2026-09-21T00:24:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-20d1e45ad8f41ec4 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-97a3580102cfaf35 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-f7733853b6214ae0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-tem-11a455d22d2f487e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-sta-3764daf81725a8e8 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-pri-46565154b7c80bf6 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-pro-a46738e923f10604 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-intermediaries-and-approaches-to-strengthen-public-health-data-exchange-4fc8495db52da975 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/request-for-information-on-electromagnetic-fields-emfs-radiofrequency-rf-radiati-adf4d970aa383e2a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitation-of-nominations-for-membership-on-the-national-vaccine-advisory-comm-7829fc374a16ba21 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-medicare-rural-hospital-flexibility-program-evalu-34665635a9d20190 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-state-offices-of-rural-health-coordination-and-de-f3a019ef42d0893b 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esther-villanueva-valdes-m-d-decision-and-order-6920fac42a4abfcb 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedules-of-controlled-substances-placement-of-diphenidine-in-schedule-i-0219f45fb611f4fb 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/john-ramsay-walters-m-d-decision-and-order-508288de44a083a6 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-2cd2bb9dfe90d36a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-90b2d8c9d1af74ac 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-rural-quality-improvement-technical-assistance-pr-9960416381329507 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gillette-clearshield-sport-active-clear-3342fe14a84cbd5f 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-varenicline-02efa8fdb5517fcb 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-children-s-expands-newborn-screening-to-identify-virus-that-can-5be78e10f5542c12 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/probabilistic-risk-benefit-profile-of-ticagrelor-monotherapy-after-short-dual-an-3278045bfe1393ff 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ursodeoxycholic-acid-and-parkinson-s-disease-risk-an-emulated-target-trial-in-uk-3bf601e48ab349ea 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translational-hepatology-from-bedside-to-global-policy-how-robust-clinical-and-t-a0c8421b1a395ac1 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medication-adherence-behavior-assessed-using-a-digital-bottle-cap-retrospective-b6449429f083bef6 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/magnitude-of-portal-pressure-reduction-and-clinical-outcomes-in-randomized-trial-0db7424106729228 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-regulatory-acceptability-of-hierarchical-composite-endpoints-in-inf-8fdddd6693552588 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-and-first-in-human-phase-i-trial-of-mt200605-a-novel-trkb-agonist-fo-1829f78db2d42e94 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-and-safety-of-a-modified-release-psilocybin-formulation-a-sad-p-b737575b41477429 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-varespladib-after-antivenom-administration-for-snakebite-a-phase-ii-r-afcd084db9e9d883 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/individual-level-agreement-between-coverage-surveys-and-treatment-registers-in-m-6b191c5974aba604 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supporting-the-primary-outcomes-of-the-mirai-trial-for-the-adjunctive-digital-th-24ef5a380338f8fe 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoparticle-based-drug-delivery-systems-improve-antimalarial-efficacy-and-vacci-7a917205bf4d7799 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-label-dose-escalation-trial-of-psilocybin-assisted-therapy-for-bipolar-i-7d4b0378b381ef49 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-free-remission-in-early-peripheral-spondyloarthritis-including-psoriatic-ar-0aa0a17d1dd07f91 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-comparison-of-intravenous-immunoglobulin-and-subcutaneous-efgartigimod-in-p-e1eaafb71fea5d75 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-silevimig-a-novel-bispecific-anti-rabies-monoclonal-antibody-with-71691d68809bef4f 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-pharmacist-led-medication-review-on-drug-related-problems-among-outpat-d98465ff90ef3962 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-orthodontic-management-of-impacted-teeth-associated-with-retained-p-4cc1e189c772934d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contemporary-classifications-of-alzheimer-s-disease-a-critical-review-of-clinica-881e2ebbb9a0f093 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-effects-of-myofascial-release-and-bowen-therapy-in-patients-with-tex-0ca1011620b24697 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/redefining-post-xenotransplantation-surveillance-leveraging-metagenomic-next-gen-b5529587c7664a12 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-answers-to-agents-what-must-change-before-generative-and-agentic-ai-become-29d767d349ffc4c0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-label-dose-escalation-trial-of-psilocybin-assisted-therapy-for-bipolar-i-d6af23c5c79be8b0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanotechnology-for-drug-delivery-systems-in-colorectal-cancer-recent-development-407dba257167da55 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-artificial-intelligence-in-hepatology-when-deep-learning-me-a568d88464097fac 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyethylene-glycol-based-bowel-preparation-and-gut-dysbiosis-clinical-implicati-0b34416aee8a965b 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/b3c94bebd28f7b8a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-dispensary-pharmacists-perspectives-on-the-responsible-implementation-cfbe71d78e165236 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-wound-healing-with-a-bilayer-biodegradable-synthetic-matrix-in-post-ef236746b1d49e2c 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-longitudinal-analysis-of-the-clinical-practice-of-ketamine-assisted-psychother-6ab9b95624cbf138 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-cut-tumor-slices-a-biomimetic-tool-for-accelerating-oncological-develo-7226c7cb1b69ee04 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-a-large-language-model-chatgpt-5-for-detecting-potential-drug-drug-in-816f2974050e0720 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/explainable-ai-based-prognostication-of-patients-with-resectable-colorectal-live-2fbabdacdf9df95d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-individualized-surgical-pathways-in-elderly-patients-with-s-8be373a0ada7c9ac 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cholesterol-in-hematological-malignancies-metabolism-mechanisms-and-clinical-imp-9a30fa29c2722f2e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiomics-and-deep-learning-for-immune-checkpoint-inhibitor-outcomes-imaging-der-c24c9e0431952223 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-hypertension-and-endocrine-pathways-molecular-and-clinical-perspective-f45527b617e638a0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-metabolic-indices-with-in-stent-restenosis-and-its-angiographic-s-e1466792d8c505f7 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-alcohol-opioid-and-cannabis-use-disorders-screening-af0d522dc83a2f40 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-endovascular-stenting-versus-bypass-surgery-for-aortoiliac-c8a13ad848e43792 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-data-analysis-and-improved-cytochrome-p450-site-of-metabolism-predi-c9f109a994421cca 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlation-of-hematological-parameters-with-serum-ferritin-in-pregnant-women-fr-c9a73dba51df0812 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/semaglutide-effects-on-insulin-sensitivity-and-cell-function-in-patients-with-sc-75140098b7871905 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/myopia-control-effect-of-continuous-versus-sinusoidal-photobiomodulation-therapy-56eab16e14bc0b7e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-system-for-independent-evaluation-of-clinical-prediction-models-while-preservi-8fb78fb786fc2a3e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clostridium-ramosum-bacteremia-clinical-significance-and-outcomes-in-a-multicent-aed8148e87cde446 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-surgical-management-of-humeral-fractures-in-dogs-630477cc2610da7a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-prediction-with-time-varying-predictors-in-pediatric-hospital-medicine-e1b6797d232c89eb 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/72120-role-of-cross-coupling-reactions-in-drug-discovery-and-development-c3d94fd4f2f85350 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-clinical-and-laboratory-findings-associated-with-mortality-during-continuo-9407e7b095fca8cf 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-trial-of-burr-hole-surgery-with-or-without-irrigation-for-chronic-sub-1a791efcaca9175c 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mir-107-serves-as-a-clinical-biomarker-for-acute-pancreatitis-and-promotes-infla-184ec7a1bcd62e51 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-age-and-outcomes-of-evidence-based-feeding-protocol-versus-u-55c081db85ef4e3d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-randomized-controlled-trial-of-the-unified-treatment-for-emotion-regulation-an-95ba566aa1d0d048 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-environmental-burden-of-the-neuro-conda-trial-b843a9e61763332f 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-liberations-two-physiological-targets-implications-of-the-x-copd-trial-d4756dae96dd95bf 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-genetic-spectrum-of-dual-rare-genetic-diseases-revealed-by-whole-ex-c11cb01b29dfbeac 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparing-the-effectiveness-of-sexual-education-lactofem-probiotic-supplementati-6de2093c73f923ae 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-tricalcium-phosphate-grafting-on-implant-stability-and-peri-implant-ra-6c4647c34f739ce5 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-clinical-outcomes-and-learning-curve-study-of-robot-assisted-precision-ost-e633bc562db9c390 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reproductive-health-factors-associated-with-clinical-breast-examination-uptake-a-1fb1bdc964c44801 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-it-possible-to-implement-the-dialog-routine-outcome-monitoring-system-in-a-ps-154907870f8fd3d8 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/controlled-evaluation-of-architectural-classifier-and-training-refinements-in-mo-9b6b5ebafa237da4 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogenic-platelet-rich-plasma-in-joint-pathologies-a-scoping-review-of-basic-sc-ccb0239c5507a987 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-case-abstracts-presented-at-the-2026-vascular-scientific-sessions-of-th-17356abbdb3b6348 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiographic-outcomes-of-immediately-loaded-dental-implants-after-t-77d68a80ff7a1256 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extended-follow-up-of-botensilimab-plus-balstilimab-in-an-expanded-cohort-of-mic-8871580c40903541 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-clinical-and-immunologic-patterns-of-interferon-release-assays-implicat-ca8762f7c7c8cfc5 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-83b94f56544f36fa 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-case-of-acute-mania-and-rhabdomyolysis-associated-with-long-term-daily-psilocy-5e9ff14ba01f20d2 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-linezolid-based-treatment-of-nocardia-otitidiscaviarum-pneumonia-in-a-75522611e0215260 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-significance-of-i-streptococcus-mitis-i-bacteremia-cb2e2d34699715bf 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-kdigo-2026-clinical-practice-guideline-for-anemia-in-chronic-kidne-a000d38d61280e8d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-of-tuberculosis-preventive-treatment-among-people-receiving-or-about-to-i-749f45684f85b3a3 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plga-nanoparticles-co-loaded-with-resveratrol-and-doxycycline-for-dual-action-pe-939ca4ac398814e2 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-probiotic-supplementation-on-psychological-stress-in-healthy-adults-wi-a783c04adb8a175d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/history-of-instruments-and-technology-in-the-clinical-neurosciences-1-a-new-colu-20dd0b4b14d65df6 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-renal-replacement-therapy-and-short-term-mortality-in-higher-risk-kdigo-st-24cf7609b60ad216 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/features-and-a-specific-pattern-of-cerebral-perfusion-in-patients-with-lewy-body-355df3a541cce01e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplemental-material-for-an-intervention-based-on-acceptance-and-commitment-the-1d4752ceee3f7ec7 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanomaterial-driven-innovation-integrating-catalytic-quinoline-synthesis-and-ant-8cf496cf1a6deeee 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-frontal-qrs-t-angle-and-cardiovascular-disease-a-narrative-review-of-electro-cbbb96a76080672a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/omental-infarction-mimicking-acute-appendicitis-a-case-series-and-systematic-rev-abd897ddb9f816d8 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bergen-barbers-a-student-run-haircut-and-grooming-service-to-enhance-empathy-cli-2d783afe88dd1ff0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/technology-profiles-in-fda-approved-new-molecular-entities-2013-2024-a-latent-cl-14b45ca875a5e683 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-pre-study-patient-interviews-to-refine-electronic-patient-reported-outcome-180e87a5a4637f62 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/qualitatssicherung-in-der-notfallmedizin-klinische-routinedaten-zur-kontinuierli-9ef90c7e92ec7796 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laparoscopic-visualisation-of-the-ureters-using-near-infrared-fluorescence-imagi-39abad0ed5393be8 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vagus-nerve-stimulation-in-rheumatic-diseases-linking-autonomic-nervous-system-r-fc25d41224e56bfa 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/masking-effect-in-the-spanish-spontaneous-reporting-database-fedra-ed8e769df5841923 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multicenter-randomized-double-blinded-placebo-controlled-phase-2-trial-to-eval-b630ccd85cfbb5fa 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shared-output-aptamer-gated-dna-nanodevices-program-nbasparda-trans-cleavage-for-4dd58d1aa5180db7 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-effectiveness-of-sialendoscopy-in-radioactive-iodine-induced-sialadenit-0b3e7d49e37b1880 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/osteomyelitis-epidemiology-classification-pathophysiology-clinical-features-diag-d34e3ed15fd784bd 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atypical-varicella-like-presentation-of-an-imported-mpox-case-in-austria-confirm-17058169ca24c758 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enabling-bioprocess-upscaling-prediction-through-hybrid-modelling-and-transfer-l-49d7f1ddf8c48684 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-free-remission-in-early-peripheral-spondyloarthritis-including-psoriatic-ar-6c81cca77d0e9b70 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-approaches-to-macrophage-activation-syndrome-in-real-life-and-prioriti-102fe79d4968ac65 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831876-a-study-of-ear-nerve-stimulation-to-treat-eye-inflammation-e4573db9274a7699 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831837-evaluation-and-implementation-of-digital-health-ecosystem-in-academi-fdcdcc46b03062f5 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831304-randomized-prospective-trial-on-the-cost-effectiveness-of-photon-cou-447db65ba37a6fcc 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831265-a-prospective-randomized-controlled-trial-of-dynamic-fixation-for-co-55d0b71452ea5131 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831226-safety-and-immunogenicity-of-the-recombinant-malaria-vaccines-in-hea-2bcd3e04222cd35a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07831161-safety-and-efficacy-of-autologous-natural-killer-cell-therapy-chank-7684ab7dca353214 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07830836-physiotherapy-and-osteopathic-treatment-for-pain-in-the-cervical-and-20384e7f0eeba594 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07830355-immunotherapy-plus-anlotinib-after-surgery-for-esophageal-squamous-c-5dd9b5e748bcb337 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07830004-plasmatic-biomarkers-associated-with-short-term-luspatercept-treatme-9f16e1451340d3d9 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07829978-impact-of-diagnostic-and-therapeutic-upper-and-lower-gastrointestina-2f65ffa869894003 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07829809-serum-adropin-as-an-indicator-of-endothelial-dysfunction-and-disease-595c2cf7ea30a7af 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819747-resources-and-education-for-addressing-chronic-health-reach-5c8914fdbf6ad407 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07796373-nemtabrutinib-for-chronic-lymphocytic-leukemia-cll-small-lymphocytic-38cf1b9c433f4464 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07793383-adaptive-decision-support-for-addiction-treatment-adapt-serial-rando-c8142426532c5676 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07744152-a-study-to-test-how-well-different-doses-of-bi-3822971-are-tolerated-89d0e68398e8cbf3 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07705880-a-novel-clinical-decision-support-tool-to-predict-submucosal-invasiv-73c69ebdf5d8163e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07693751-a-study-to-assess-safety-and-efficacy-of-sot109-in-patients-with-adv-14346cd0d70e71ff 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07616206-cadisegliatin-as-adjunctive-therapy-to-insulin-in-participants-with-5af473b6b56cac59 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07577661-combination-upper-airway-electrical-and-pharmacological-stimulation-898bbd982429e10a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07572240-a-clinical-trial-to-assess-the-effect-of-ap-brain-collagen-peptides-c72f6d5ff4530877 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07495943-effects-of-2-aticyto-complex-and-d-ribose-on-pain-and-clinical-cours-101475d12f61e662 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07266831-a-clinical-study-of-islatravir-and-ulonivirine-for-people-with-hiv-1-eee6bd7200b16053 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07262346-the-phase-id-clinical-trial-of-hydronidone-capsules-b492d9ed0ab0ced8 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07248839-a-study-to-assess-the-drug-levels-and-safety-of-bms-986435-in-partic-6bcf7865fc797437 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07237217-guided-group-telehealth-to-deliver-evidence-based-therapeutic-care-t-429f74fb322a7209 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07232030-barostim-enabled-neurohormonal-intervention-for-improving-treatment-b8fbe5404be54fc1 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07211633-a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-safety-rad-9469e73414b30703 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07194044-metastatic-ewing-s-trial-testing-schedule-enhancement-to-improve-out-15ff028aa39b88b0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07161037-phase-2a-study-of-vx-407-in-participants-with-adpkd-who-have-a-subse-5b834aa1cbecaacd 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07111065-fast-for-dm-fatty-acid-supplementation-trial-fast-for-dermatomyositi-ed2b3f59cab40468 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991738-177lu-dota-eb-tate-in-adult-patients-with-metastatic-radioactive-iod-8bb88397e09523fd 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06980077-ivonescimab-for-the-treatment-of-thymic-cancer-e1c7cd84dfd11be5 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06948110-deciphering-the-genetic-architecture-of-autoimmune-diseases-353665cab37b522a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06904066-autologous-t-cells-transduced-with-retroviral-vectors-expressing-tcr-8a1bed717e911091 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06876142-combination-therapy-mirdametinib-and-sirolimus-for-ras-mutated-relap-84e0260330113171 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06843213-teaching-health-resilience-in-a-hospital-setting-a-peer-led-interven-728fcecdf8ae1e52 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06840262-target-muscle-re-innervation-and-regenerative-peripheral-nerve-inter-108eb92d9877d646 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06732401-testing-the-addition-of-azd6738-ceralasertib-to-immunotherapy-to-inc-c8470b82beaaa53e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06549595-a-study-of-surovatamig-azd0486-plus-rituximab-in-previously-untreate-07a6329d0563476d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06473532-text4hf-a-randomized-controlled-trial-of-a-tailored-text-messaging-i-ff5a3fb7b713be45 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06375915-precision-medicine-in-patients-with-unresectable-cholangiocarcinoma-1a7cbd79e9ebb164 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06368388-establishing-personalized-phage-therapy-and-its-comparative-cost-in-0a7ef44acf69cabe 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06337318-comparing-rituximab-and-mosunetuzumab-drug-treatments-for-people-wit-f9c0f74dff068b0e 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06326047-a-research-study-comparing-how-well-different-doses-of-the-medicine-f6ec57cf0b2fe58d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06210373-assessment-of-efficacy-and-safety-of-the-use-of-two-eye-gel-products-0073804eb26c0a5c 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06149793-sglt2-inhibitor-therapy-in-cystic-fibrosis-related-diabetes-7fdca58a4e7cc302 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06120244-establishment-of-biobank-of-nasal-epithelium-samples-from-healthy-vo-147d3c56bb9915e2 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06038032-improving-health-behaviours-for-life-after-endometrial-cancer-trial-4118e5d6f2fdb4fe 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06005740-a-phase-1-first-in-human-study-of-torl-4-500-in-patients-with-advanc-c709207ba78bf3a0 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05842330-benefits-of-adhd-treatment-in-detained-people-06046ff851a60e9f 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05383274-optilume-post-approval-clinical-evaluation-of-andrology-parameters-bc64816ab9b77eb5 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05041309-long-term-follow-up-study-after-gene-modified-cell-treatment-in-kite-de88c2de50133c8a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04984005-the-interaction-and-regulation-mechanism-of-different-exercise-patte-093e891995b9f987 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04512209-characterization-of-biophysical-stromal-properties-in-human-cancer-t-4b671ba1b3860be3 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04359732-assessment-of-response-to-ncrt-for-gej-cancer-using-a-fully-integrat-8c8a048767bc00f6 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04018092-the-revitalize-study-in-older-adults-at-risk-for-alzheimer-s-disease-dbe5d764e71a0caa 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03226704-leukapheresis-for-car-or-adoptive-cell-therapy-manufacturing-8859eb3be74c76ca 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03223103-safety-and-immunogenicity-of-personalized-genomic-vaccine-and-tumor-f248e56d06f14a0a 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02003222-combination-chemotherapy-with-or-without-blinatumomab-in-treating-pa-489f33c4c086296d 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01496625-national-eye-institute-biorepository-for-retinal-diseases-99078260bf2b6307 2026-09-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-halts-trading-ahead-of-phase-3-trial-update-aa25a9abde83efd3 2026-09-20T23:48:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/click-estock-aribio-holdings-set-to-announce-ar1001-phase-3-results-rapid-commer-cc4b1439181b24d5 2026-09-20T23:37:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-team-to-drive-improvements-in-cancer-care-417d32b858766792 2026-09-20T23:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/market-movers-rx-west-pharmaceutical-services-leads-gainers-d11ab73a9d464311 2026-09-20T22:53:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/battles-in-u-s-war-on-cancer-being-waged-at-white-plains-hospital-d5ac453bc8b5b463 2026-09-20T21:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-escalates-warnings-on-compounded-glp-1-drugs-but-its-own-data-reveal-importa-784876c401fb6a60 2026-09-20T20:22:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-bet-on-biology-why-one-modality-is-never-enough-in-lung-cancer-22ddcff0c7b1d6de 2026-09-20T19:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-the-trial-fails-was-it-the-drug-or-the-design-7d9fc4711d67aecd 2026-09-20T19:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/liminal-biosciences-stock-remains-without-fresh-data-in-latest-search-window-e69750d05b62c05d 2026-09-20T18:36:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/igm-biosciences-stock-trades-quietly-amid-lack-of-fresh-data-7fcb87bd5c7cfbbd 2026-09-20T17:53:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/spurious-drugs-karnataka-fda-cancels-16-drug-licences-of-retailers-wholesalers-483f672ee324efee 2026-09-20T17:46:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-cancels-16-drug-licences-of-retailers-wholesalers-over-spurious-medici-2c63099044d2094e 2026-09-20T16:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-real-start-of-every-biotech-story-is-not-a-lab-but-the-funding-decision-c8c47d90798c3214 2026-09-20T16:42:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/counterfeit-drug-racket-karnataka-fda-cancels-licences-of-16-firms-suspends-eigh-75a62da78792156d 2026-09-20T16:27:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/k-taka-fda-cancels-16-drug-licences-of-retailers-wholesalers-c3da9512d4ad2b56 2026-09-20T16:19:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/spurious-drug-racket-busted-at-bidadi-farmhouse-rs-5-crore-stock-seized-37c1c944ca0872f9 2026-09-20T16:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-biotech-start-ups-need-patient-capital-to-drive-novel-drug-innovation-in-7b639daf4e308b1a 2026-09-20T16:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-reviewing-contraceptives-tied-to-meningioma-risk-e58870d2131fdd90 2026-09-20T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bidadi-fake-drug-racket-fallout-widens-karnataka-fda-cancels-16-licences-suspend-f5da6067ed6d5f34 2026-09-20T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cheap-drugs-fake-labels-non-functional-qr-codes-karnataka-fda-cancels-16-licence-30805af09704bb40 2026-09-20T15:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-busts-fake-drug-racket-suspends-license-of-pfizer-depot-7-other-firms-5a01456374a081c9 2026-09-20T15:39:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/novocure-nvcr-breaks-out-on-q2-2026-earnings-optune-pax-driving-recovery-d29aa8bbd69d100a 2026-09-20T15:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-16-suspends-eight-drug-licences-in-karnataka-india-news-ba30705170e35c28 2026-09-20T15:25:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sartorius-stedim-stock-holds-steady-as-investors-digest-recent-results-357e977aebe6ec21 2026-09-20T15:08:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-no-neurodevelopmental-risk-in-prenatal-covid-19-except-speech-60978aa7141468f4 2026-09-20T15:06:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fake-drug-racket-case-why-did-karnataka-fda-take-action-against-pfizer-and-other-c891e75d1209a28e 2026-09-20T14:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/retension-pharmaceuticals-trex-bio-file-for-us-ipo-as-biotech-momentum-continues-3e00c4b5d346cd8c 2026-09-20T14:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-16-licences-cancelled-over-suspected-fake-drug-supply-0e40f8f1294379fe 2026-09-20T14:36:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-stock-holds-near-fair-value-as-valuation-debate-int-4a13daa556aa57de 2026-09-20T14:28:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-drawing-attention-to-west-pharmaceutical-services-wst-92b5c124882ba4d9 2026-09-20T14:07:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-digital-transformation-in-the-pharmaceutical-sector-61a20ba6a4cf5dbb 2026-09-20T14:06:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-society-calls-for-stronger-drug-regulation-f2db6216a77cc7af 2026-09-20T14:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-biotech-firm-innata-bio-moves-headquarters-to-philadelphia-s-lilly-gateway-la-c364a610699ace50 2026-09-20T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-cancels-16-pharmacy-licences-over-spurious-drug-racket-f06b08fa08cf993b 2026-09-20T13:57:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/fake-drugs-karnataka-cancels-16-licenses-suspends-8-including-that-of-pfizer-dep-72248dc68285db68 2026-09-20T13:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investors-dumped-ionis-pharmaceuticals-stock-but-wall-street-hasn-t-budged-from-ff4660a6a8ea5bfa 2026-09-20T13:55:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/spurious-drug-racket-busted-at-farmhouse-in-karnataka-s-bidadi-24-pharma-licence-55071d8965d7b532 2026-09-20T13:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-ultragenyx-pharmaceutical-rare-cheap-on-fayuvi-fda-approval-ba65c38fdef312f2 2026-09-20T13:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-gets-fda-clearance-to-start-phase-3-trial-for-new-depression-treatme-1999373cc534630c 2026-09-20T13:34:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-warned-covid-vaccine-safety-tool-was-broken-then-silenced-doctor-who-told-th-f38dbda48e4ec923 2026-09-20T13:20:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/gh-research-buy-gh001-trd-advancement-presses-on-and-expansion-opportunities-325030f39a18e63e 2026-09-20T13:19:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fake-drug-racket-16-pharmacy-licences-cancelled-action-against-pfizer-08c4014b4de08ea9 2026-09-20T13:03:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-hpp-drug-candidate-wins-fda-priority-review-79549cc13ba282da 2026-09-20T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-raises-more-than-1-1-billion-for-public-biotech-fund-bring-8a89e2c526ed56c6 2026-09-20T12:50:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-protest-expansion-of-non-face-to-face-care-and-medication-delivery-2d8c26b6369332e5 2026-09-20T11:41:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/bytedance-s-favored-child-unveils-the-capital-game-of-the-ai-pharmaceutical-indu-604a2f26528da009 2026-09-20T11:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-price-today-teva-pharmaceutical-industries-limited-stock-price-quote-chart-8ccacc4f83865af8 2026-09-20T11:07:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/hospital-pharmacies-drug-distributors-come-under-fda-scanner-8b044166b5548d2a 2026-09-20T10:32:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-wall-street-analysts-think-argenx-can-soar-more-than-40-here-s-why-they-re-rig-f513a4249132800f 2026-09-20T10:31:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cue-biopharma-announces-positive-topline-results-from-cue-221-phase-2-study-in-c-8b819eb2bbb81bc1 2026-09-20T10:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/multilayer-composite-filter-cartridges-market-forecast-to-2035-driven-by-tighten-48c160638f5d9a44 2026-09-20T10:16:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-wall-street-analysts-think-argenx-can-soar-more-than-40-here-s-why-they-re-rig-9739b0ac2a71928b 2026-09-20T10:12:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/nashik-fda-seizes-food-stock-worth-48-81-lakh-during-festive-inspection-drive-732b4a4f83191eb5 2026-09-20T10:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cue-biopharma-reports-positive-phase-2-topline-results-for-cue-221-in-chronic-sp-01dd38d09c11110d 2026-09-20T10:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-stock-falls-as-clinical-setbacks-weigh-despite-cosentyx-eu-boost-ae4da72e806448ab 2026-09-20T09:27:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-nih-funding-crisis-that-could-reshape-biotech-for-years-to-come-b62b5f7bdd7a60de 2026-09-20T09:18:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-price-today-teva-pharmaceutical-industries-limited-stock-price-quote-chart-8ba310a09d4d3d79 2026-09-20T09:04:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisers-narrowly-vote-to-add-6-peptides-to-a-drug-compounding-list-what-s-n-05eb0af1ede61b6f 2026-09-20T08:59:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmps-stock-clocks-muted-gains-but-analysts-back-psychedelic-drug-s-durability-ah-6a4a3cae17e5d82c 2026-09-20T08:43:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/kathmandu-pharmaceutical-association-urges-legal-operation-of-pharmacies-3039b3bd045c8d73 2026-09-20T08:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-stock-holds-a-moderate-buy-rating-f8faf2c1ee001e7e 2026-09-20T08:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-excited-to-advance-legend-biotech-s-mission-and-transform-patient-o-c737cea7423c9618 2026-09-20T07:17:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/liver-injury-fda-warning-for-tavneos-patients-0a86acc18b6c86db 2026-09-20T06:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-need-to-balance-business-livelihoods-with-public-health-says-maharashtra-fda-cadd731e9a9abe0c 2026-09-20T05:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-tightens-china-unit-controls-after-receivables-risk-chosunb-99641c81ca75d958 2026-09-20T05:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-cafe-visited-by-tom-holland-matt-damon-and-christopher-nolan-loses-licenc-66f4b9289871ea70 2026-09-20T04:45:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/rest-of-asia-pacific-process-analytical-technology-market-size-share-trends-grow-63a8de689d51c9aa 2026-09-20T04:22:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-truth-about-msg-1968-prank-letter-that-started-a-50-decade-myth-bdfbbbdceed9e3fb 2026-09-20T04:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-wst-could-be-10-undervalued-on-glp-1-and-annex-1-de-450d25329be4d6e4 2026-09-20T03:54:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/kaist-develops-new-catalyst-technology-for-complex-pharmaceutical-synthesis-c3c0f350dea7f0f8 2026-09-20T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/croda-opens-global-biotech-r-d-centre-in-uk-185f240d9d5e36c2 2026-09-20T02:49:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-builds-biology-lab-in-san-francisco-to-accelerate-drug-discovery-d780d94f7dedf9a9 2026-09-20T02:39:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-launches-silverskin-re-pmc-reusable-thermal-cover-for-pharmaceutical-air-f-9773a41f94db98a1 2026-09-20T02:35:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-declares-bid-for-global-drug-innovation-dominance-by-2030-7e1f328ec4984e65 2026-09-20T01:59:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-opens-san-francisco-biology-lab-to-speed-preclinical-drug-r-d-chosunbi-749840280cf686cd 2026-09-20T01:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-cosmetics-with-high-function-and-high-content-ingredients-are-eme-d5bdb04201e31beb 2026-09-20T01:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-congo-expands-ebola-vaccination-to-ituri-over-3-700-vaccinated-047055f5d7c00cad 2026-09-20T01:23:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/raid-on-abl-bio-shakes-confidence-in-k-biotech-sector-61fe57bbfb60db99 2026-09-20T00:39:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/stanford-s-virtual-biotech-turns-37-000-ai-agents-into-a-drug-discovery-factory-6211ed771f1838af 2026-09-20T00:20:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-need-a-shot-in-the-arm-after-brutal-july-could-astrazeneca-bristo-0c28c1010a46e800 2026-09-20T00:06:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-minoxidil-extra-strength-for-men-977d1821a90473a4 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scaling-network-medicine-with-llms-for-combinatorial-drug-repurposing-in-er-sup-6831238485e9666a 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-evidence-hierarchies-an-intervention-aware-contextual-systems-framework-f-03b7fbeb7b66b404 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-rsv-vaccination-clinical-efficacy-safety-and-global-policy-consideratio-056354f354e6f3f1 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/industry-defined-opportunities-for-advancing-big-data-capabilities-in-biopharmac-89e95ba78fccf391 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-scenarios-of-suboptimal-response-to-rituximab-in-relapsing-anca-associa-4a7a4924c8388882 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-semaglutide-on-thigh-skeletal-muscle-volume-fat-infiltration-and-physi-86fb8f8ebd173309 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-genetic-polymorphisms-with-response-to-preoperative-nsaids-in-end-a32600b1deb47680 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-therapeutic-strategies-and-clinical-development-of-investigational-agen-5ad2563cda00a9aa 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-two-commercially-available-topical-gels-as-adjuncts-to-3e242aaa23a99262 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-inflammatory-biomarker-changes-after-intravenous-ketamine-9ffa70defb76dc3a 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-dermoscopic-and-histopathological-correlation-of-pigmented-skin-lesions-c6145a7d2a81fae7 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dynamic-interactions-between-tumor-associated-macrophages-and-breast-cancer-cell-b1c9964f3d00bdfc 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-drug-repurposing-potential-of-natural-products-molecular-targets-pharmac-3b6b1335f539e8b8 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concurrent-use-of-herbal-medicines-and-prescription-drugs-and-potential-herb-dru-1b19d6e302bf62e7 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vital-pulp-therapy-contemporary-concepts-materials-and-clinical-outcomes-a-narra-39cd8515ac92c91e 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-traditional-endodontics-with-vital-pulp-therapy-a-contemporary-revie-0c1584bd96cb3876 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-pelvic-inflammatory-disease-pid-among-women-of-reproductive-and-perimeno-08a675571af30cfd 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/7-clinical-significance-and-imaging-techniques-of-weight-bearing-radiography-6b4f8857f8b4dbed 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-outcomes-of-patients-without-an-attendant-admitted-to-the-e-0c9a353a1ee8ffeb 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-outcome-of-louse-borne-relapsing-fever-among-patients-seen-2033a2162f917eb0 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microwave-breast-imaging-a-review-of-clinical-potential-and-technological-advanc-5e9290688094301c 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-ophthalmology-from-diagnostic-accuracy-to-clinical-ap-1fd69aa3ee10e722 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/culture-conversion-and-drug-susceptibility-in-drug-resistant-pulmonary-tuberculo-760f453f0ef28ed1 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bone-specific-alkaline-phosphatase-as-a-marker-of-bone-formation-clinical-and-im-bb8c60f2f1a2bbf9 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evolving-molecular-epidemiology-and-antimicrobial-resistance-of-streptococcus-ag-f4af1e23a3a99148 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-mechanisms-epidemiology-and-clinical-implications-of-macrolide-resista-4b7c7553c8d37028 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/macrolide-resistant-mycoplasma-pneumoniae-laboratory-diagnosis-and-epidemiology-00c61260210edeaf 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/generative-ai-for-drug-discovery-gpt-2-and-lstm-based-models-for-designing-egfr-be331195ce66e861 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-critical-examination-of-the-principle-of-proportionality-in-indonesian-food-an-fcf1c94dc7be344c 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mesenchymal-stem-cells-as-a-therapeutic-treatment-for-osteogenesis-imperfecta-cu-e072c0f354a4ea8d 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-serum-anion-gap-and-angiographic-severity-of-coronary-artery-dise-7fec8997e4390d0d 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-the-severity-and-persistence-of-depressive-symptoms-in-patients-with-a-cafa3d208182786f 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-imaging-to-intervention-insights-from-nuclear-imagingin-revascularization-s-42a53e36ac487ef0 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pop-culture-psychopathy-how-media-exposure-affects-laypersons-recognition-of-cli-105ad74b143a54ea 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-generalizability-gap-in-aortic-stenosis-analysis-of-87-clinical-trials-vs-re-462f7fdf6223115c 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/premature-children-s-developmental-outcomes-following-a-cognitive-behavioral-the-5c454b005b379d8b 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-smart-water-flosser-on-oral-health-in-children-aged-3-6-years-a-ra-b063cc8927bd0054 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-hd-tdcs-with-task-oriented-upper-limb-training-after-stroke-a-rand-6f59653cb40a0544 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pleomorphic-adenoma-of-the-upper-lip-a-case-report-with-histopathological-and-cl-792dd50f5fa1863e 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charlson-comorbidity-index-in-predicting-postoperative-complications-and-long-te-4da7c00fc6503664 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-value-of-tissue-mrna-and-microrna-expression-profiles-for-differentia-2bddcda45b23b852 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-functional-and-clinical-outcomes-following-intramedullary-nailing-6fb028cd952f9fd5 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-retrospective-clinical-analysis-of-amir-kabir-s-migraine-a-microhistorical-app-dad5b514d33c37f9 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/online-education-program-communication-effectiveness-and-communication-self-effi-c61939f87ae542ac 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tarlatamab-treatment-for-metastatic-small-cell-neuroendocrine-carcinoma-of-the-b-665d1ff5d5c710e5 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unexpected-lack-of-efficacy-of-liposomal-encapsulated-daunorubicin-cytarabine-in-f3201b034cab8a05 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-pcwg4-a-missed-opportunity-to-make-bone-protective-agents-mandatory-for-7a9a4131b9d688d0 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-beyond-response-rates-interpreting-long-term-benefit-in-checkmate-743-a-680b2d81daece5b2 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-statistical-significance-methodologic-fragility-and-censoring-bias-in-the-5888645062177c61 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rituximab-maintenance-added-to-ibrutinib-containing-therapy-in-younger-untreated-f591e24ba0a91e9b 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarker-stratified-phase-ii-trial-of-trastuzumab-rezetecan-in-advanced-salivar-e9a9c59fc3d6e970 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pcwg4-a-missed-opportunity-to-make-bone-protective-agents-mandatory-for-patients-ad9901af9cd08618 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/balancing-risk-benefit-and-reality-navigating-early-phase-studies-in-pediatric-d-b48bafd2e92e4718 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/darolutamide-alone-and-in-combination-with-goserelin-in-androgen-receptor-positi-392f7023f6ac4646 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mosunetuzumab-with-response-adapted-polatuzumab-vedotin-and-obinutuzumab-in-untr-e44840b20d6dfe8c 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laser-interstitial-thermal-therapy-for-brain-tumors-a-prospective-multicenter-an-09e60a65ac19d6f3 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-follow-up-of-jcog1008-a-randomized-phase-ii-iii-trial-of-chemoradiothe-b4cc18dcf9a39115 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-improved-surveillance-of-leprosy-drug-resistance-in-madagascar-a-pilot-8c4a97f423db1efe 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-factors-associated-with-lower-pole-ptosis-recurrence-after-83dea2b3c8709bc6 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scalable-clinical-proteomics-from-dna-rna-extraction-flowthroughs-enables-integr-67f4d99a37666c5e 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-drug-interaction-between-alpinetin-and-glimepiride-and-its-potential-mechan-3fe3d3d640e3aac3 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/individualized-breast-cancer-survival-prediction-in-clinical-practice-a-seer-der-3515bc4647f92f29 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vestibular-rehabilitation-therapy-in-turkey-insights-into-physical-therapists-cl-e15ab512d701d115 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delayed-antiretroviral-refills-as-an-early-clinical-alert-a-pharmacist-led-strat-5ed4eb24ac199b96 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-external-validation-of-prediction-models-for-a-trial-informed-op-734bcdaeee93453a 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bedside-infrared-thermometry-compared-with-continuous-zero-heat-flux-thermometry-3288242dafa136ce 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-marine-drug-plitidepsin-alleviates-osteoporosis-in-estrogen-deficient-mice-b-515952451def30c3 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-sustainability-and-risk-assessment-of-spectrophotometric-methods-for-37c16b3a77f6077e 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multicenter-dataset-describing-emotional-intelligence-and-counseling-self-effica-6689624137da0a45 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-serum-cotinine-levels-and-prostate-related-clinical-endpoint-c4f852f4c83f757b 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-the-impact-of-multiple-long-term-conditions-mltc-on-the-completion-e5c5b1b4afada493 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interest-in-geriatric-medicine-training-among-health-and-social-care-professiona-9f3f04d231090ca3 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-who-isop-pharmacovigilance-curriculum-2026-update-caba9d183fe05317 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-regulatory-mechanisms-and-clinical-significance-of-iqgap2-deficiency-in-606950dc4cbfd91d 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identification-of-sst-as-a-glioblastoma-diagnostic-biomarker-via-integrated-bulk-68922ea308c6ef9b 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/slfn5-correlates-with-tumor-immune-microenvironment-and-clinical-outcomes-of-imm-9ab3dc157165f755 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/confounding-by-indication-in-the-evaluation-of-neoadjuvant-chemotherapy-a-sequen-a053b317c6b33cac 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-data-latency-gap-automated-extraction-of-genomic-biomarkers-from-un-5a6e7536de41241b 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-trial-comparing-esophageal-resection-versus-substitution-alone-for-co-2c1a150a1149681d 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-genetic-polymorphisms-with-response-to-preoperative-nsaids-in-end-27f802965350b2c4 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metabolomics-of-immunosenescence-bridging-blood-biomarkers-and-metabolic-pathway-71710cedb23a4736 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/persistent-foot-and-ankle-pain-in-rheumatoid-arthritis-remission-what-is-the-tre-ec95eeebc6741fa8 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncogene-driven-genomic-profiles-are-linked-to-poor-overall-survival-in-muscle-i-ad57ae7a9b681197 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visual-snow-syndrome-as-a-neuropsychiatric-network-disorder-clinical-features-me-8b7cb71781bfa6e8 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-clinical-and-follow-up-data-in-patients-with-mycosis-fungoides-a-1-78724b981987fd8f 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fear-of-isotretinoin-in-moderate-to-severe-acne-clinical-impact-and-a-new-assess-b676c6d7f12c9224 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imaging-in-gynecological-disease-32-clinical-and-ultrasound-characteristics-of-e-d66a8d1c162ad3b3 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statins-as-repurposed-anticancer-agents-regulated-cell-death-the-tumor-immune-mi-876ff52221583627 2026-09-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/muireann-counihan-the-school-of-pharmacy-and-pharmaceutical-sciences-c41c155632d597a0 2026-09-19T23:15:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/krx-healthcare-shifts-to-large-caps-as-korea-favors-new-tech-biomed-chosunbiz-b426b824b83acf3d 2026-09-19T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-voice-the-school-of-pharmacy-and-pharmaceutical-sciences-241a1a36f55a527c 2026-09-19T22:50:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-common-shares-outstanding-of-indrayani-biotech-ltd-right-2026-25-06-26-for-d681acd0241805f0 2026-09-19T21:04:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/return-on-assets-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-ind-501f187a0924faec 2026-09-19T21:04:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-current-asset-value-per-share-of-indrayani-biotech-ltd-right-2026-25-06-26-f-e6b6622493611352 2026-09-19T21:03:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-debt-per-share-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-16236a055fbe9757 2026-09-19T21:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/quick-ratio-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-6581b40f0bba1e8d 2026-09-19T21:02:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/messenger-rna-based-flu-vaccine-makes-its-debut-in-u-s-pharmacies-who-can-get-it-efefc51acff05862 2026-09-19T21:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventory-turnover-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-i-5671ae1604807dc6 2026-09-19T20:59:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-ind-4dff78ae4aa050db 2026-09-19T20:59:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/capex-per-share-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indr-944f01d354552ab8 2026-09-19T20:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/debt-to-equity-ratio-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-310711ff40bee6dd 2026-09-19T20:56:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-cash-flow-ratio-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-9af57061cd64e28a 2026-09-19T20:55:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/book-value-per-share-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-fc227e4d6c502179 2026-09-19T20:55:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/debt-to-assets-ratio-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-ad7a8697f95d971c 2026-09-19T20:55:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-indrayani-biotech-ltd-right-2026-25-06-26-fo-7d4300fa5e85e482 2026-09-19T20:55:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/operating-margin-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-ind-a7fd04be177b342e 2026-09-19T20:54:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-margin-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-44ae08b901252b4e 2026-09-19T20:54:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-biotech-without-humans-stanford-deploys-37-000-agents-to-hunt-new-therapies-d11375b86fdfc5b8 2026-09-19T20:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-migraine-franchise-scored-a-big-win-is-this-dividend-king-a-no-brainer-b83b918d40843782 2026-09-19T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-migraine-franchise-scored-a-big-win-is-this-dividend-king-a-no-brainer-76f1564f042c6f89 2026-09-19T19:48:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/indrayani-biotech-ltd-right-2026-25-06-26-for-shares-revenue-breakdown-bse-indra-ba030f2dd73a0499 2026-09-19T18:45:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/operating-expenses-excl-cogs-of-indrayani-biotech-ltd-right-2026-25-06-26-for-sh-2736dd784b3621df 2026-09-19T18:22:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/aap-ki-nazro-se-kuch-bachta-nahi-mallika-sherawat-thanks-fda-chief-tukaram-mundh-74720aa7f91d7267 2026-09-19T17:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-globe-and-mail-exozymes-sets-date-for-2026-shareholders-meeting-506f62da92cff1d7 2026-09-19T17:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/book-value-per-share-of-teva-pharmaceutical-industries-limited-ls-906517-b020b70e7daa0d95 2026-09-19T17:02:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/secret-contracts-reveal-undisclosed-terms-in-trump-s-drug-pricing-deals-bcbb413fb30f9d63 2026-09-19T17:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/dftx-vs-cmps-which-stock-has-more-upside-from-trump-s-new-psychedelic-therapy-pu-ef64dcf5e3960581 2026-09-19T16:56:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-of-goods-sold-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-i-b0630789d0593e12 2026-09-19T16:51:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-charity-launches-ebola-vaccination-study-in-drc-5ceb6dd202441036 2026-09-19T16:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pretax-income-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-25138c424a649553 2026-09-19T16:30:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-revenue-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-e381ce93b7e938a6 2026-09-19T16:29:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-operating-expenses-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-91c124a406c23076 2026-09-19T16:29:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/cash-flow-from-operating-activities-of-indrayani-biotech-ltd-right-2026-25-06-26-231dd929df858043 2026-09-19T16:28:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-direct-to-patient-is-redefining-drug-pricing-f6ef53a75af94d90 2026-09-19T16:27:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cash-flow-from-financing-activities-of-indrayani-biotech-ltd-right-2026-25-06-26-5f765c6bb4d289be 2026-09-19T16:26:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cash-flow-from-investing-activities-of-indrayani-biotech-ltd-right-2026-25-06-26-f5e9efda9ca345a9 2026-09-19T16:25:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/average-basic-shares-outstanding-of-indrayani-biotech-ltd-right-2026-25-06-26-fo-ff947f5470cc2ca9 2026-09-19T16:24:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-cash-flow-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-a3b2458b02b59529 2026-09-19T16:19:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-consider-september-19th-5211e452c4824f48 2026-09-19T16:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-melanoma-vaccine-was-hailed-as-a-breakthrough-which-cancers-are-next-9724080badd419c9 2026-09-19T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/operating-income-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-ind-22b6730b871044c2 2026-09-19T15:33:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/discontinued-operations-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-739c09f0cac42098 2026-09-19T15:32:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-income-before-discontinued-operations-of-indrayani-biotech-ltd-right-2026-25-29c58a19d8e3561c 2026-09-19T15:32:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-operating-income-total-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shar-f8f77254f0db8c18 2026-09-19T15:31:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebit-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-3d34754992cd42f7 2026-09-19T15:31:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-stock-holds-moderate-buy-rating-as-annex-1-work-shapes-outlo-3c0fd62fb4220ec9 2026-09-19T15:29:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/preferred-dividends-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-7b282f168c26acd9 2026-09-19T15:28:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/diluted-shares-outstanding-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shar-fe37fa0a86d75c4c 2026-09-19T15:28:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/indrayani-biotech-ltd-right-2026-25-06-26-for-shares-7015c7d5b069f15a 2026-09-19T15:25:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/dilution-adjustment-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-2a92242613664e93 2026-09-19T15:24:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-income-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-7bf5aee9b121472e 2026-09-19T15:23:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/taxes-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-105d223587366115 2026-09-19T15:23:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/equity-in-earnings-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-i-6152711dc8c0ba7a 2026-09-19T15:23:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebitda-of-indrayani-biotech-ltd-right-2026-25-06-26-for-shares-bse-indra-re-a4a85e2a8c739394 2026-09-19T15:22:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncolytics-biotech-stock-lacks-a-fresh-catalyst-and-stays-near-0-77-4ef9f2145181d3bb 2026-09-19T14:17:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-drawing-fresh-attention-to-biomarin-pharmaceutical-bmrn-dd7670b3b7f47046 2026-09-19T14:12:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-investors-are-reacting-to-ultragenyx-pharmaceutical-rare-first-in-disease-ge-39556364aa63f8c2 2026-09-19T14:10:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/oveporexton-met-primary-key-secondary-end-points-in-phase-3-studies-f55b262789759abc 2026-09-19T14:10:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/doctors-without-borders-launches-ebola-vaccination-study-in-dr-congo-bfd423e85dc532e3 2026-09-19T14:02:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-transparency-bill-stripped-of-critical-provisions-ahead-of-senate-vote-b7b7e4539be30c15 2026-09-19T14:01:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-olympia-coffee-house-where-christopher-nolan-and-matt-damon-had-chai-fa-45ca75e3790f9d9d 2026-09-19T13:44:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/egg-recall-linked-to-salmonella-upgraded-to-highest-risk-level-by-fda-151a459787e48b10 2026-09-19T13:40:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/collegium-pharmaceutical-stock-edges-lower-as-analysts-keep-moderate-buy-stance-474386a21dda61b3 2026-09-19T13:33:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-nolan-tom-holland-had-chai-mumbai-cafe-faces-fda-licence-suspension-653993cb5cb20817 2026-09-19T13:04:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-21-09-120-anni-della-clinica-mangiagalli-celebriamo-la-culla-d-itali-b6f1cc699352db07 2026-09-19T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opthea-limited-stock-steadies-as-phase-3-trial-progress-drives-investor-focus-7dd5c0af77aa118a 2026-09-19T12:29:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-3-million-bottles-of-eye-drops-sold-at-cvs-kroger-more-voluntarily-rec-841b0d51339f6bee 2026-09-19T12:26:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/mallika-sherawat-praises-maharashtra-fda-commissioner-tukaram-mundhe-amid-state-3d5cc3b648250527 2026-09-19T12:15:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/macrogenics-stock-edges-lower-as-biotech-analysts-highlight-risk-and-upside-e9cf4e74587d279d 2026-09-19T12:15:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-tiny-biotech-is-beating-mrna-iova-and-sls-here-s-how-a-billionaire-fueled-i-f9fadbaa2502bed3 2026-09-19T12:01:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-tumori-in-eta-pediatrica-favorire-le-prospettive-di-guarigione-ne-533dc6a088ec60ce 2026-09-19T11:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/latus-bio-adds-biotech-veterans-as-gene-therapies-enter-clinic-d758e89343372953 2026-09-19T11:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/chip-tech-to-biotech-ce2e02f56139299f 2026-09-19T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/basic-earnings-per-share-basic-eps-of-indrayani-biotech-ltd-right-2026-25-06-26-6078a04cee3109b7 2026-09-19T11:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-insider-trading-activity-2026-249623a1453a3bf2 2026-09-19T10:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-10-pharmaceutical-manufacturing-companies-in-africa-in-2026-b4a1093df370deb8 2026-09-19T10:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/emirates-biotech-uae-university-partner-on-food-waste-plant-for-biogas-compost-5fbfd1099eb088db 2026-09-19T10:33:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/cassava-sciences-stock-holds-near-recent-lows-as-biotech-losses-and-mixed-sentim-d4ec6f7ef586a00b 2026-09-19T10:10:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-examines-use-of-testosterone-prescriptions-for-menopause-ad0f106a02d24ff0 2026-09-19T10:05:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/tirupati-group-appoints-uday-k-potdar-as-chief-financial-officer-339f006e241d5b8d 2026-09-19T10:01:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-approves-marine-biotech-policy-targets-6-8-bn-blue-bioeconomy-by-2031-2fb7e60f353058d0 2026-09-19T10:00:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/another-novartis-failure-novo-drops-the-nordisk-and-more-12d3d548f946c7a8 2026-09-19T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccinex-stock-holds-at-1-00-dollars-as-investors-await-fresh-trial-and-earnings-e39c8770527cfb72 2026-09-19T09:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/ordinary-people-pay-price-iran-medicine-shortages-deepen-as-war-continues-25bdcfd142278ade 2026-09-19T09:30:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-joke-to-amitabh-rekha-reference-samay-raina-s-latest-latent-episo-32630065385d1595 2026-09-19T09:27:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-wins-fda-approval-for-mimrylo-triggers-275m-payout-to-protagonist-819356fbe3d593e7 2026-09-19T09:16:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekend-longforms-organ-donation-false-pregnancy-tests-cancer-drug-ai-for-diagno-94dc4d3b8d04d5d9 2026-09-19T09:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicine-shortages-deepen-in-iran-amid-war-shipping-restrictions-1722387ef29ee867 2026-09-19T08:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ganpati-meets-food-safety-navi-mumbai-pandal-honours-tukaram-mundhes-fda-work-wi-8edca60af6c53510 2026-09-19T07:37:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/equity-in-earnings-of-zhuhai-trinomab-pharmaceutical-co-ltd-class-a-sse-688806-e04ee5f175d57b5a 2026-09-19T07:27:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-book-forward-of-henan-taloph-pharmaceutical-stock-co-ltd-class-a-sse-60-2bc42da5d2afe758 2026-09-19T07:27:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-s-tev-749-olanzapine-lai-shows-80-stabilization-rate-in-schizophrenia-trial-90a9d7a77742a0d4 2026-09-19T06:42:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-imlunestrant-plus-abemaciclib-for-esr1-mutated-breast-cancer-3c625593f647ec48 2026-09-19T06:37:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/alumna-employs-biotech-to-create-sustainable-livestock-production-f241526028de166d 2026-09-19T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remember-when-christopher-nolan-and-tom-holland-visited-now-this-legendary-colab-a24659359e79565b 2026-09-19T05:28:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuphoria-to-be-acquired-by-scancell-in-all-stock-merger-b15a4e3511e1bdbf 2026-09-19T05:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iraq-customs-clarifies-duties-on-pharmaceuticals-vitamins-and-supplements-8cc25463c2e436b0 2026-09-19T05:13:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmtech-weekly-roundup-september-18-2026-177f47cf9e1b228b 2026-09-19T05:07:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/welcome-to-the-mammosphere-f5899a492f6d03cd 2026-09-19T02:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-annex-1-upgrades-at-west-pharmaceutical-services-wst-have-changed-its-invest-c6d42c01254a7c15 2026-09-19T02:42:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-latest-news-today-on-september-19th-2026-train-blocks-fda-action-universi-425568d9eca4bec5 2026-09-19T02:41:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-halts-one-lung-cancer-trial-after-mixed-phase-3-results-aba6e0c9f3b21761 2026-09-19T02:26:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hearing-psychedelics-launch-needs-balanced-regulation-without-limiting-acces-81cc63fd87c8c2d5 2026-09-19T02:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-amgen-tezspire-meets-phase-iii-eoe-trial-endpoints-f0706148fc31c54c 2026-09-19T01:34:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/homilia-te-deum-una-casa-edificada-sobre-roca-470e28c9f1d5d8c9 2026-09-19T00:08:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/transarterial-infusion-chemotherapy-and-embolization-as-a-novel-neoadjuvant-ther-7aac60eaf852135b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neo-bcv-induces-macrophage-associated-immunometabolic-remodeling-and-anti-tumor-0c165255b6a8071f 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-center-for-mucosal-immunobiology-and-rheumatic-disease-pathogenesis-ad-ce3f4f297554093f 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-assessment-of-sound-waves-from-liver-vessels-via-artificial-intelligen-726e97171cd2884b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-center-for-mucosal-immunobiology-and-rheumatic-disease-pathogenesis-su-a66a38a35676dd79 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-impact-of-environmental-factors-on-lewy-body-dementia-combining-cl-bcec376208ebe47b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mechanisms-of-action-of-peripheral-nerve-stimulation-for-the-treatment-dcccb23cc737b2e0 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-behavioral-science-strategies-to-increase-hypertension-diagnosis-and-t-e095a6e97192775b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-determining-the-shared-neuronal-network-mechanisms-of-focal-epileptic-b6d3e635ed9140d5 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-archery-artificial-intelligence-based-radiotherapy-treatment-planning-b823331c39831fc2 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-innovative-rapid-enabling-affordable-point-of-care-hpv-self-testing-st-008d3825e5485c4a 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-elucidating-how-transcription-factors-mafa-and-mafb-and-mitochondrial-46ddd28a0a3e6fd6 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-nutrition-late-fetal-and-neonatal-mortality-in-the-african-context-fabc6b96044ad32b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-resource-core-221219f1b12f5ae7 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-methodology-core-c191a15254234951 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-admin-core-875561f00d160f13 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-american-joint-replacement-research-collaborative-ajrr-c-6d0ec3548e3e09ad 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-helicobacter-infection-and-liver-cancer-risk-among-african-americans-a-c51972987d6896c9 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-suhuang-zhike-capsule-for-post-infectious-cough-a-multice-36ac1b41d34dc91e 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncolytic-virotherapy-at-the-tumor-microenvironment-car-therapy-interface-mechan-1b8e4997e496b446 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-antihypertensive-de-escalation-a-secondary-analysis-of-systolic-bl-8788c16a1547f799 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-abcb1-genetic-polymorphisms-with-treatment-outcomes-in-patie-874fb86fbbc60b16 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safe-medicine-storage-and-disposal-among-pharmacy-and-engineering-students-a-kap-e3e2d4de32f25ed1 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mpox-outbreak-in-cote-d-ivoire-during-2024-epidemiological-clinical-virological-2027dc5ac6527c47 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regenerative-medicine-in-the-management-of-musculoskeletal-pain-mechanisms-clini-d650a4d034f3b544 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-of-minimally-invasive-technologies-in-the-treatment-of-obstruc-b2e082ddcb04ca29 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-physicians-in-child-and-adolescent-psychiatry-exploring-the-therapeu-95303ae91b93ede6 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/examination-of-international-strategies-and-collaborative-efforts-in-responding-dcbf1a1c7f477fb6 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-gs-441524-in-the-management-of-feline-infectious-peritonitis-a-clini-2b94abafbc0802b3 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-nfl-and-gfap-levels-and-their-association-with-anxiety-depression-in-alzhe-38114244d078d939 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takotsubo-syndrome-a-review-of-psychobiological-mechanisms-and-clinical-practice-796f14de12226bad 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-correlation-to-intervention-translating-the-psychological-network-of-adoles-b02a37b1b055f61e 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-thiet-lap-ca-hai-tham-so-cua-bieu-o-kiem-soat-noi-kiem-hanh-lang-can-tre-a089bde4f7254a16 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-khao-sat-chi-so-triglyceride-glucose-lt-b-gt-lt-b-gt-tyg-lt-b-gt-lt-b-gt-9aa3330e763554d0 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-site-of-pain-fascial-continuity-and-integrated-clinical-reasoning-in-0df9516427501ea6 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proenkephalin-penkid-in-renal-dysfunction-an-integrative-review-of-laboratory-an-93660ff9cfd11b01 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regenerative-medicine-at-the-crossroads-of-innovation-evidence-and-clinical-resp-05677a7f689b1c65 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-laboratory-profile-of-i-mycoplasma-pneumoniae-i-pneumonia-among-chi-552f7c94137766f9 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inguinal-hernia-as-a-systemic-enzyme-dysfunction-disorder-a-prospective-comparat-e64f9953548400b0 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-psychological-impact-of-covid-19-and-mental-relaxation-practices-by-amateur-073b7c79da9ccae2 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethnomedicinal-utilization-of-rauwolfia-serpentina-l-benth-ex-kurz-7d5ee8c80c1d7646 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/computational-exploration-revealed-nicotiflorin-as-a-potent-dpp4-inhibitor-for-d-5a77b6dc254be1b5 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-validation-of-a-reverse-phase-high-performance-liquid-chromatogr-ec3e92366fb1a9ce 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/citrate-versus-heparin-anticoagulation-during-crrt-with-mg350-hemoadsorption-in-fd82283ab4495bfc 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-treatment-outcomes-of-pleural-effusion-and-empyema-thoracis-bbe452d5da9517d3 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-lymphoma-recurrence-following-autologous-stem-cell-trans-bcec6940d14004db 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phytochemical-dark-matter-unlocking-the-untapped-chemical-diversity-of-medicinal-341f859e1c659ac5 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oroxylin-a-loaded-microemulsion-gel-a-promising-approach-for-anti-gout-therapy-a-7d7fc2b7ca4b7e5b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plant-protein-microcapsules-for-nutraceutical-delivery-3b5fb647884c6359 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-control-evaluation-of-different-brands-of-paracetamol-tablets-available-c006a743158b4b8c 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-correlation-between-the-severity-of-periodontitis-and-alzheimer-s-disea-48dd87cd72f1219b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-hemorrhagic-transformation-in-acute-ischemic-stroke-using-a-machine-l-38c2eae679ddb40b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-adding-gait-retraining-with-visual-feedback-to-resistance-balance-tra-1e167cbe3a805226 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-intensity-transcranial-electrical-stimulation-for-schizophrenia-a-triple-bli-e89af31c21e6c675 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-indications-and-determinants-of-field-of-view-selection-in-cone-beam-co-502e081a3fdf5538 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systemic-antibiotic-use-in-paediatric-odontogenic-infections-a-systematic-review-c467c59adf57184a 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asymmetrical-bilateral-ureteral-duplication-a-cadaveric-case-report-illustrating-c69d3b4b913c453c 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/minimally-invasive-needle-arthroscopy-versus-conventional-arthroscopy-for-treatm-6fc5da0721eea615 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-companion-based-emotional-care-on-treatment-adherence-and-physiologic-51e959a4f87a7502 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/self-medication-among-pharmacy-technician-students-in-offa-nigeria-implications-5a745c612e38bddc 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/school-based-hygiene-intervention-to-prevent-helicobacter-pylori-infection-among-fb3eeb7f9942f557 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-a-smartphone-intervention-to-improve-hiv-prevention-and-care-outcomes-bd52996327321260 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceived-risk-of-cardiovascular-diseases-in-the-italian-population-a-baseline-c-1d63a7e202355d83 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-progressive-muscle-relaxation-training-in-post-traumatic-stress-diso-96a07acf7bd3c00a 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potentially-inappropriate-medication-use-and-selected-drug-related-problems-amon-7b866e4c8c711bc1 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-concomitant-grade-i-degenerative-spondylolisthesis-on-clinical-and-rad-b3aa13f3b078fc7d 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/giddy-up-can-we-reduce-dropouts-in-a-discrete-choice-experiment-by-including-an-19993b5edd03242d 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partial-mock-up-guided-rehabilitation-of-severe-tooth-wear-a-clinical-technique-ff05853f0fa3d358 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/care-gaps-following-newly-detected-dipstick-proteinuria-in-treated-hypertension-f6038d0fa7cd35f9 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systematic-benchmarking-of-evaluation-paradigms-safety-boundaries-and-clinical-r-b9d82694e09b72b9 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thermodynamic-molecular-interdependencies-and-causal-determinants-governing-phar-10f10c771e7ee1bf 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-hitop-and-clinical-staging-a-developmental-framework-for-multidimens-b476eea2461db944 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-clinical-outcomes-of-a-hydrofilic-extended-depth-of-focus-intraocular-e572e5d1e90d64cf 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-antihypertensive-de-escalation-a-secondary-analysis-of-systolic-bl-aa5240ab42a1ed19 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sertraline-e9737e737cba8913 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/salicylates-50f1ce7783b22311 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nitrous-oxide-6c11750953e77a2e 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metamfetamine-123bf776ae9e5ebd 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lithium-paracetamol-d20337e1f8385dbe 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dicycloverine-0773d3ef428c7525 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diamorphine-95e6194fbd91bf71 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daptomycin-3c236bfd74a7ae7e 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amlodipine-propranolol-fa0af215e5fdd4ed 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deciphering-the-interaction-landscape-of-ndm-1-with-a-novel-lactam-based-inhibit-50512220ed8c509d 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/piper-betle-essential-oil-enhances-antibiotic-susceptibility-and-attenuates-quor-de37c35cede42ef5 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-a-card-game-based-intervention-in-alleviating-preoperative-anxi-15dbe051b2ff20ba 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/micellar-systems-with-hydrophobic-core-stabilized-polyethyleneimine-enabling-tim-687784dcfb17eba7 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-based-smoke-removal-in-robotic-urooncologic-surgery-a-clinical-pilot-study-4053782a128a77b3 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/conceptual-growth-curves-of-oropharyngeal-soft-tissues-and-craniofacial-skeletal-d450161164c51a8c 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brief-cognitive-behavioral-therapy-for-suicide-prevention-among-racially-and-eth-0036a6580553d84c 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nature-based-interventions-in-practice-a-scoping-review-of-social-work-literatur-37b90182012c11fc 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systematic-review-and-network-meta-analysis-for-the-2026-update-of-the-evidence-a7b29411b4772e4d 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adverse-event-risks-and-prognostic-factors-associated-with-endoscopic-laryngopha-70d33963692fe251 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-low-level-laser-therapy-in-the-rehabilitation-of-knee-meniscus-d2ca201f02c9cb87 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-microvascular-footprint-of-lupus-nailfold-capillaroscopy-findings-in-egyptia-9a72384817265498 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integration-of-early-palliative-care-in-cancer-treatment-a-meta-analysis-of-39-r-2e2b33d95289c590 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/outcomes-of-surgical-intervention-in-retinal-detachment-in-stickler-syndrome-a-s-d4130766d2a7171b 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-brain-volumetry-and-functional-connectivity-during-resting-state-in-eb430aad5af9a35e 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-tms-is-associated-with-changes-of-subgenual-cingulate-default-mode-n-8dc272ce8dd99d43 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-based-pharmacotherapeutic-learning-structured-around-the-prescribing-optimi-58d9c0cc03a64972 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genetically-supported-targets-and-drug-repurposing-for-sleep-disorders-a-mendeli-996bda825dee064a 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-diagnostic-accuracy-to-clinical-utility-methodological-considerations-on-co-9df4003c012e3774 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-continuing-or-withholding-angiotensin-axis-blockers-prior-to-elective-595c845626078b7c 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/operationalization-of-the-african-medicines-agency-retrospective-evaluation-of-t-159de1ff28a10a52 2026-09-19T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/retension-pharmaceuticals-trex-bio-file-for-us-ipo-as-biotech-momentum-continues-2f48405acfbfdc68 2026-09-18T23:59:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoth-s-pivot-from-biotech-to-space-tech-sparks-massive-rally-in-stock-retail-und-fea1a8d486dec34b 2026-09-18T23:43:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-is-operating-a-lab-that-conducts-biology-experiments-c2a67f2be86581ad 2026-09-18T23:13:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-think-axsome-therapeutics-stock-could-soar-35-over-the-next-12-months-i-e56809726c192c50 2026-09-18T23:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/omnideployment-the-future-of-pharmaceutical-commercialization-1f60f5db440b5bd7 2026-09-18T22:53:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-think-axsome-therapeutics-stock-could-soar-35-over-the-next-12-months-i-765166c7c178a647 2026-09-18T22:51:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/marshall-raises-alarm-over-glp-1-drug-supply-chain-94e3f4e2dce5d374 2026-09-18T22:46:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-think-axsome-therapeutics-stock-could-soar-35-over-the-next-12-months-i-4d1ca8ecf7dd9852 2026-09-18T22:38:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/retension-pharmaceuticals-trex-bio-file-for-us-ipo-as-biotech-momentum-continues-9706597300d79daa 2026-09-18T22:35:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/hundreds-of-drugs-and-devices-approved-by-the-fda-are-missing-key-safety-studies-c92efb17bc851318 2026-09-18T22:32:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-specter-of-ai-enabled-bioweapons-is-a-wake-up-call-for-biotech-1e7372ba15a5f576 2026-09-18T22:28:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-examines-use-of-testosterone-prescriptions-for-menopause-c359720bb3a5c490 2026-09-18T22:26:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-think-axsome-therapeutics-stock-could-soar-35-over-the-next-12-months-i-028baa1e5af406d9 2026-09-18T22:22:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-company-puts-37-000-ai-agents-to-work-on-drug-discovery-0ab60bbf89b1de5e 2026-09-18T22:11:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/consulta-publica-requerimientos-tecnicos-administrativos-cb077950f600650a 2026-09-18T21:42:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/trxb-ipo-news-autoimmune-and-inflammatory-diseases-biotech-trex-bio-files-for-a-f91025b93b89cfb7 2026-09-18T21:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mizuho-s-jared-holz-data-doesn-t-show-a-strong-link-between-biotech-and-interest-55a37aa704a9bd07 2026-09-18T21:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-eli-lilly-breast-cancer-drug-combination-19d02ea866c7101b 2026-09-18T21:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-eli-lilly-breast-cancer-drug-combination-inluriyo-and-verzenio-2dc2e9a373a655fe 2026-09-18T21:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-throughput-aav-affinity-chromatography-screening-99009d14e786d1a1 2026-09-18T21:27:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mirum-pharmaceuticals-falls-7-1-as-investors-appear-to-reassess-near-term-biotec-1d2cd1c93d265677 2026-09-18T21:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-extends-mfn-pricing-to-every-state-medicaid-program-46597a1d0cb97779 2026-09-18T21:19:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/retension-pharmaceuticals-clinical-stage-biopharma-for-hypertension-files-for-na-500bd9025ece2e61 2026-09-18T21:18:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-levacetylleucine-to-treat-ataxia-in-adult-pediatric-patients-with-a-d2e36698305e5a0e 2026-09-18T21:04:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-moderna-s-mrna-seasonal-flu-vaccine-b34d6e90abb860ab 2026-09-18T21:04:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/moleculin-biotech-disclosed-failure-to-satisfy-a-continued-listing-rule-or-stand-e8243697e82aa9a0 2026-09-18T21:03:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/investment-fund-tied-to-teva-nyse-teva-director-plans-share-sale-2f066a6ddabc3077 2026-09-18T21:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-announces-irb-approval-to-initiate-phase-2a-clinical-trial-of-nu-a1ad04495c6460fd 2026-09-18T20:59:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-announces-irb-approval-to-initiate-phase-2a-clinical-trial-of-nu-eb20b4f8617ed6ba 2026-09-18T20:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-launches-pilot-program-to-speed-early-clinical-trials-e9db1ce137d303a4 2026-09-18T20:52:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-fayuvi-pharmexec-a23663528c3d4358 2026-09-18T20:45:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/saved-by-wife-s-cpr-bay-area-survivor-leads-heart-walk-to-build-nation-of-lifesa-ec36780d62d0d2bd 2026-09-18T20:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-ipo-window-keeps-opening-09264c228e834eae 2026-09-18T20:23:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/geron-corporation-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-928c95dbf2da8b91 2026-09-18T20:10:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-this-biotech-just-erased-its-one-day-50-pop-69c3a9008e5f3dad 2026-09-18T20:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amneal-announces-fda-approval-and-launch-of-lanreotide-injection-717b592a47d5528f 2026-09-18T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-taps-anthropic-s-claude-to-speed-drug-discovery-6bb9050bfd33342b 2026-09-18T19:57:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-to-announce-all-50-states-joining-medicaid-drug-pricing-model-7e1e4bb1b9a04278 2026-09-18T19:46:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-to-announce-all-50-states-joining-medicaid-drug-pricing-model-843f8dad1754e2e8 2026-09-18T19:41:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/vantuil-pereira-e-reconduzido-a-decania-do-centro-de-filosofia-e-ciencias-humana-b4aa1e29c3408934 2026-09-18T19:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-may-kill-us-all-but-biotech-is-the-bigger-threat-to-stocks-cabot-street-check-f6aae46ec1c2910c 2026-09-18T19:36:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-adds-capital-markets-veteran-as-cfo-while-advancing-bitac-on-a0783c107c82669c 2026-09-18T19:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/japan-approves-t-dxd-combo-and-dato-dxd-for-first-line-metastatic-breast-cancer-2e49898c769c590a 2026-09-18T19:11:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/steve-marshall-offers-warning-to-rubio-about-chinese-national-security-threat-in-f029735522effd19 2026-09-18T19:05:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-plans-to-transform-3m-biotech-sector-into-522b-powerhouse-by-2030-f0565aa05697d5e2 2026-09-18T19:05:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/kailera-therapeutics-hold-due-to-need-for-progress-on-weight-loss-differentiatio-ae1f507693f6964a 2026-09-18T19:02:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-sehk-3696-advances-rentosertib-into-phase-3-trials-df912cbea33fd048 2026-09-18T18:45:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ibtrozi-label-update-with-49-7-month-dor-in-ros1-nsclc-5fd4f5cd632ba7ac 2026-09-18T18:44:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-food-safety-advisory-for-ganpati-mahaprasad-5cb211e0958c2aff 2026-09-18T18:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-inluriyo-in-combination-with-verzenio-for-adults-with-er-her2-e-26acb00ee3b4851e 2026-09-18T18:41:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-seizes-593kg-expired-ghee-in-akola-959cf32ca802af8a 2026-09-18T18:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-personalised-medicine-by-using-an-advanced-point-of-care-tool-for-8b4326c6c0ba25cc 2026-09-18T18:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-future-of-alcl-novel-therapies-origins-bio-markers-and-mechanism-27cd89b4f8f7af8c 2026-09-18T18:26:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-reducing-the-impact-of-major-environmental-challenges-on-mental-h-31bc826d56d240c6 2026-09-18T18:26:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-transforming-into-a-sustainable-european-pharmaceutical-sector-28dd3912c72b3695 2026-09-18T18:26:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-understanding-predicting-and-treating-depression-in-pregnancy-to-3a9a37311258eec2 2026-09-18T18:26:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/xene-stock-drops-30-on-phase-3-trial-halt-price-to-sales-ratio-signals-market-sk-7c05d70fbabc3156 2026-09-18T18:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-3-95-million-fayuvi-secures-first-ever-fda-approval-for-sanfilippo-1aea3c06c9330b77 2026-09-18T18:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genmab-stock-gains-as-petosemtamab-phase-3-start-and-strong-q2-figures-support-v-c1aa15b564b629fc 2026-09-18T18:20:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/palatin-technologies-inc-common-stock-nyse-ptn-share-price-ptn-stock-news-ptn-sh-b0999d2cb09b2ab1 2026-09-18T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-nasdaq-vrxa-appoints-raju-willener-as-cfo-9709b95d0f9b3358 2026-09-18T18:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-this-biotech-stock-too-cheap-to-ignore-after-its-latest-pullback-91f5f5b430dc71f5 2026-09-18T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-drug-to-treat-alexander-disease-approved-by-the-fda-after-three-decades-of-34a9482c55fea16c 2026-09-18T17:55:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-legend-biotech-legn-undervalued-following-its-new-ceo-appointment-066eb92b1b6f57ca 2026-09-18T17:53:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-plunges-30-after-depression-trial-halt-abef9e9d0f20f74a 2026-09-18T17:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-reinforces-its-commitment-to-radiation-safety-at-iaea-general-conference-1042c5a1d277999b 2026-09-18T17:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-legend-biotech-legn-undervalued-following-its-new-ceo-appointment-a9f1a69f6fd68a4e 2026-09-18T17:30:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-cockroaches-rat-droppings-found-in-new-poona-club-kitchen-fda-suspends-lice-2cb12354e9616079 2026-09-18T17:28:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-this-biotech-stock-too-cheap-to-ignore-after-its-latest-pullback-8a72dc88fe000b4e 2026-09-18T17:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-opened-a-market-for-experimental-medicines-now-it-should-watch-who-shows-b84ace46a9df7e13 2026-09-18T17:14:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-seizes-adulterated-food-worth-rs-56-36-lakh-banned-gutkha-worth-rs-20-2-b25b754ddcb9cba2 2026-09-18T17:08:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-hoc-live-the-china-biotech-debate-goes-to-washington-601b5ca4af133974 2026-09-18T17:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agriculture-studies-networks-for-food-security-agri-net-jica-c3fe72a28b1dd90d 2026-09-18T17:04:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-priority-review-to-azn-s-filing-for-rare-bone-disease-drug-284dec142f29d460 2026-09-18T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aard-investor-alert-aardvark-therapeutics-inc-securities-class-action-notice-con-b5a869d6fef920bf 2026-09-18T16:54:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say-d48516f28aaf5220 2026-09-18T16:54:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/radar-st-84ce3e802a2d1e73 2026-09-18T16:52:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/umd-students-band-together-to-protect-birds-b1696d7be266e817 2026-09-18T16:50:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/big-lake-agrivoltaics-project-shows-promise-of-mixing-farming-solar-power-e943f5608c414bf6 2026-09-18T16:50:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/umd-engineers-building-brighter-futures-from-duluth-to-kenya-5875172bba4f6965 2026-09-18T16:49:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/hornets-are-sending-minnesotans-to-the-er-and-into-party-mode-3a7c2094446f40fc 2026-09-18T16:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-authoritarian-mindset-can-t-handle-dissent-from-his-appointees-0f72e70f2f17c74b 2026-09-18T16:48:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/glass-pumpkin-patch-at-the-arboretum-d02dfdd728c01c10 2026-09-18T16:48:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-ai-agents-satisfy-cgmp-documentation-requirements-609a4915047af303 2026-09-18T16:35:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-s-patidegib-gel-nears-key-milestone-with-completed-phase-3-gorlin-syndro-22fa92c124816b79 2026-09-18T16:33:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/dallas-clinical-research-unit-sponsor-overview-f49234afe6268753 2026-09-18T16:33:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-biotech-stocks-to-watch-as-potential-takeover-targets-471a060d652d759a 2026-09-18T16:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-ev-dose-is-not-what-it-seems-quantitative-mismatch-between-particle-number-f47a7c5a1a3284b4 2026-09-18T16:29:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/xene-files-nda-for-epilepsy-drug-falls-on-depression-studies-setback-d69eea09fb83040d 2026-09-18T16:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-false-attack-on-vivek-ramaswamy-raises-a-harder-question-who-hears-the-correct-740dd3f761e3a48c 2026-09-18T16:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/semi-mechanistic-joint-population-pharmacokinetic-modeling-of-the-novel-antitube-ebec18c2810c96c6 2026-09-18T16:02:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/mabxience-sandoz-partner-on-emicizumab-biosimilar-deal-a640a1a39a3338f8 2026-09-18T15:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1b-to-biotech-fund-84639908b0e2b140 2026-09-18T15:50:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-options-buzz-uthr-nmra-ewtx-904141373556fd38 2026-09-18T15:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/all-50-states-sign-up-for-trump-s-medicaid-most-favored-nation-plan-770767e418ae8a3a 2026-09-18T15:41:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-have-to-be-bilingual-to-participate-in-circle-u-activities-c8b706a758c482a8 2026-09-18T15:39:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/attorney-general-marshall-leads-coalition-alerts-national-security-council-to-ex-3be9dd83d1d6ace8 2026-09-18T15:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-expands-its-boston-footprint-with-new-research-center-61c8eaa9d2c59da9 2026-09-18T15:33:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-trial-suggests-lsd-could-help-treat-anxiety-one-patient-meets-god-the-o-cb4c52a47721d100 2026-09-18T15:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/naver-s-venture-capital-arm-invests-in-u-s-ai-precision-medicine-startup-imprime-0a2754cf400de157 2026-09-18T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emirates-biotech-and-partner-launch-uae-organic-waste-to-biogas-pilot-7528d116c86d5b63 2026-09-18T15:24:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/refreshed-novo-corrals-3-new-early-stage-obesity-drugs-from-kallyope-40f3fb0496b9f73e 2026-09-18T15:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-circle-u-helped-me-define-my-career-path-81b7d487eea3e910 2026-09-18T15:21:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/m-a-roundup-lisata-therapeutics-acquires-marea-therapeutics-mabxience-enters-col-82f692d91f282f5e 2026-09-18T15:18:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-week-in-charts-gsk-s-china-deals-the-300m-ipo-club-and-selling-the-news-136aee8ad04163b2 2026-09-18T15:17:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-stock-reaction-is-overblown-analyst-00ea9c26fd548a87 2026-09-18T15:14:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-metabolic-disease-heterogeneity-definition-prevention-and-remissi-02382b733dd4e87c 2026-09-18T15:12:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-next-generation-therapeutics-for-vascular-diseases-3a4c8847c4d7458e 2026-09-18T15:11:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-the-treatment-gap-in-cannabis-use-disorder-ad222fb9336b9389 2026-09-18T15:09:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/david-oliwenstein-biopharma-s-confidential-trial-data-is-the-next-insider-tradin-503b6bc20674765a 2026-09-18T15:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-biotech-and-personalization-are-reshaping-the-beauty-industry-by-2030-932bc402d6e4135f 2026-09-18T15:04:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-adrs-slip-in-us-trading-as-biotech-splits-5d79b846c95a7a75 2026-09-18T15:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/37-000-ai-agents-are-running-a-virtual-biotech-at-stanford-486a0da87125e24a 2026-09-18T14:52:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-highlights-new-real-world-data-supporting-the-effectiveness-of-vraylar-at-0a7b9d49f4f19d38 2026-09-18T14:50:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-rare-bayry-win-approvals-sion-cuts-jobs-gsk-deals-azn-rhhby-lead-a1a9090f97fd12fd 2026-09-18T14:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-sees-large-volume-increase-after-analyst-u-02e90aaa7ef82c7c 2026-09-18T14:42:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-rebate-timing-distorts-a-pharmacy-s-340b-books-3fc20171d90a422c 2026-09-18T14:41:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-price-target-raised-to-32-00-e4b617ea41d02a41 2026-09-18T14:38:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-covid-19-test-validation-approved-products-8740f36d3b2718d0 2026-09-18T14:38:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-catalyst-stocks-with-binary-events-coming-up-0e77c7de51362b23 2026-09-18T14:36:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-gene-therapy-for-sanfilippo-syndrome-type-a-ddacc8fe3f2a7e07 2026-09-18T14:32:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/spn-exclusive-an-early-look-at-mcc-s-completed-3-million-biotech-lab-68ba636d342ac5cf 2026-09-18T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pixclara-first-fet-pet-agent-for-glioma-imaging-29a803462ba6b015 2026-09-18T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wclc-2026-the-lung-cancer-drug-development-readouts-that-caught-our-eye-bdd8893065a78593 2026-09-18T14:26:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-how-can-sponsors-respond-to-clinical-trial-customs-delays-6f1b84efeb049467 2026-09-18T14:24:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-debate-defesa-da-democracia-confrontos-e-estrategias-de-comunicacao-em-reun-9eb7532f7d41d72a 2026-09-18T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-pharma-asia-china-deals-safe-from-coins-key-wclc-data-legend-s-new-ceo-c23fdc3b607774da 2026-09-18T14:20:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-the-pharmtech-ai-pulse-check-expert-video-series-c9a61784abb684de 2026-09-18T14:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-administrative-and-engagement-core-f26bbefd42b0b169 2026-09-18T14:18:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-administrative-and-engagement-core-6e3732f25a90d180 2026-09-18T14:14:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/shilpa-medicare-says-us-fda-inspection-at-hyderabad-unit-ends-with-one-observati-f743582fc9896554 2026-09-18T14:14:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/aard-investor-alert-aardvark-therapeutics-inc-securities-class-action-notice-con-b0fff291ba5a6cc1 2026-09-18T14:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nordic-perspectives-on-education-a-two-book-launch-335960b186ef8c7d 2026-09-18T14:06:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-ai-system-advances-drug-discovery-with-37-000-agents-6df6d3ca1fbffbc8 2026-09-18T14:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-closer-look-at-the-50-billion-rural-health-transformation-program-76a13771919bcee8 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bucks-county-biotech-hub-and-doylestown-hospital-land-state-grants-for-new-proje-8665c163a0e7a8bc 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regional-signaling-controls-stem-cell-mediated-regeneration-in-an-invertebrate-c-04c94807eadc3cd8 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/collagen-i-promotes-cancer-cell-survival-via-amino-acid-import-and-mtorc1-s6-act-8a92da132dac0e52 2026-09-18T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-targets-oral-macrocycles-with-1-4bn-orbis-partnership-6671ed6a26e6a1c2 2026-09-18T13:52:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-chu-de-toulouse-debute-les-inclusions-dans-l-etude-impulsion-41595d44ba4dcd69 2026-09-18T13:47:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-drawing-fresh-attention-to-takeda-pharmaceutical-tse-4502-8ed4853f5f8b35eb 2026-09-18T13:44:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-fayuvi-for-pediatric-patients-with-sanfilippo-syndrome-type-a-5545014fb7bcfcc5 2026-09-18T13:40:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-growing-world-of-biopharma-prediction-markets-765a66b0e486f7cc 2026-09-18T13:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/veradermics-buy-before-the-catalysts-nyse-mane-90826b45a2962049 2026-09-18T13:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-did-briacell-therapeutics-tsx-bct-surge-18-876-on-17-september-2026-f95e9b8306d04846 2026-09-18T13:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shingles-can-cause-severe-chronic-pain-new-research-on-how-exosomes-alter-neuron-2a6301bdbff0f775 2026-09-18T13:33:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-westchester-fairfield-leaders-advocate-for-health-and-raise-funds-critical-for-78121da21d239558 2026-09-18T13:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-brings-its-personal-care-and-custom-specialties-activities-together-withi-48e0fd6157eea57e 2026-09-18T13:27:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-withdraws-publication-of-covid-shingles-vaccine-research-findings-0c9137b444e2e92a 2026-09-18T13:21:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/reasons-to-add-west-pharmaceutical-stock-to-your-portfolio-now-a987741149fa9bd2 2026-09-18T13:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-policy-analysis-and-dissemination-core-pad-07e77f33d530a346 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-data-analysis-and-modeling-core-dam-ecf914abbee2725e 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-admin-core-1075ff64c40976ca 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modeling-the-impact-of-tobacco-use-and-regulations-on-vulnerable-popul-e14a50574f1f1a72 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-assessing-the-impact-of-flavor-restrictions-on-smoking-and-vaping-f9f6e3f8a3356005 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modeling-the-process-of-nicotine-addiction-among-youths-and-young-adul-3d310209127444b2 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modeling-the-impact-of-novel-tobacco-product-use-on-smoking-and-long-t-66b323a5dfdcbb51 2026-09-18T13:17:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/suny-funding-to-advance-tech-that-could-improve-patient-care-9e34ce94de8cee0f 2026-09-18T13:15:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-tcrt-meds-surge-xene-nuwe-sink-caabe3a95f74fd25 2026-09-18T13:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aces-alumna-employs-biotech-to-create-sustainable-livestock-production-bcccea6733969c2c 2026-09-18T13:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-admin-core-d34258ded3909f66 2026-09-18T13:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-admin-core-575edfa47c738e19 2026-09-18T13:06:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/stanford-virtual-biotech-links-target-expression-patterns-to-higher-drug-success-4f2cc92095f808d2 2026-09-18T13:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-admin-core-e3024742b734e757 2026-09-18T13:04:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-fiscal-conditions-context-on-medicaid-budgets-for-fy-2027-a4d0ffddaeb7db7d 2026-09-18T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chutes-ladders-legend-poaches-novartis-vet-to-boost-commercial-potential-e80965543b112e35 2026-09-18T12:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/auszeichnungen-fur-herausragende-forschung-und-innovation-in-der-infektiologie-2e2b4d68c515c033 2026-09-18T12:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-genuity-group-increases-ultragenyx-pharmaceutical-nasdaq-rare-price-ta-7cfbe3170174b2c9 2026-09-18T12:45:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-1-administrative-core-2df5e8f80a663f4b 2026-09-18T12:44:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharma-to-cut-98-jobs-as-smartdose-production-winds-down-in-arizona-47ebb0bb9de0badd 2026-09-18T12:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unc-global-affairs-encourages-more-study-abroad-in-japan-b882c10bbd673b89 2026-09-18T12:34:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-cells-that-cheat-death-and-rebuild-damaged-tissue-2ba232951401badc 2026-09-18T12:30:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-highlights-new-real-world-data-supporting-the-effectiveness-of-vraylar-ca-4c1f376b38b218c5 2026-09-18T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-starts-phase-2a-trial-for-nu-3-to-treat-diabetic-foot-ulcers-wit-e4b94f11fe4c68f0 2026-09-18T12:24:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/zealand-pharma-nears-eu-approval-of-short-bowel-drug-us-still-lags-behind-eced985d54b48cce 2026-09-18T12:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jahresbericht-des-krebsregisters-der-kantone-zurich-zug-schaffhausen-und-schwyz-63636ce70813c644 2026-09-18T12:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cantor-fitzgerald-forecasts-strong-price-appreciation-for-ultragenyx-pharmaceuti-a94686663212042b 2026-09-18T12:13:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-gel-for-infected-diabetic-foot-ulcers-is-ready-for-a-clinical-trial-9baca5ba6094011d 2026-09-18T12:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lakewood-amedex-biotherapeutics-announces-irb-approval-and-clinical-site-readine-6c633ac91c89ca34 2026-09-18T12:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ligand-pharmaceuticals-owning-it-gives-you-a-stake-across-biotech-nasdaq-lgnd-a5490902b4f252f8 2026-09-18T12:06:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-potential-new-gout-pill-targets-a-700m-market-as-xortx-therapeutics-xrtx-detai-d4962edf67bdcc12 2026-09-18T12:05:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/countering-motor-neuron-degeneration-with-base-editing-155eca28b20c8601 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishment-of-two-new-on-site-laboratories-approved-465c999c4a9c1229 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/signatm-artist-and-signatm-artist-evo-b43f2d2ea4307776 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/counterfeit-laser-hair-removal-and-therapy-devices-found-in-some-clinics-and-may-48182ef1961b6594 2026-09-18T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukri-space-lab-hosts-first-uk-pm-and-head-of-nato-meeting-484a0b72310be070 2026-09-18T11:33:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cosmetics-branch-licenses-admet-predictor-from-simulations-plus-352c5408e9b74fe0 2026-09-18T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-releases-2026-food-code-addresses-advances-in-food-safety-science-bcfb88336ca8b1cf 2026-09-18T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-congratulates-ultragenyx-on-u-s-fda-approval-of-fayuvitm-gen-08da3da710ebe595 2026-09-18T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/das-universitatsklinikum-heidelberg-ist-grundungsmitglied-von-medi-cus-bff2845ac3e34d06 2026-09-18T11:29:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-unveils-a-new-five-year-plan-for-developing-pharmaceutical-industry-44919095069d11e6 2026-09-18T11:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-action-rodent-droppings-live-cockroaches-found-in-new-poona-club-kitche-bb758074ecbcb628 2026-09-18T11:12:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-executive-mfn-deals-aren-t-enough-q-a-with-joe-cunningham-48c869a29e6c3e7f 2026-09-18T11:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-mfn-innovation-concerns-568aea26781afe55 2026-09-18T11:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/shining-a-light-on-uterine-cancer-rising-incidence-and-mortality-persistent-ineq-b6df0ffb13807c1d 2026-09-18T11:00:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-to-report-results-for-third-quarter-2026-on-october-29-2026-915d65a4fe2302cb 2026-09-18T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-reddy-s-laboratories-nse-drreddy-lenacapavir-licensing-agreement-update-d8133fe75a5e6799 2026-09-18T10:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-us-weighs-allowing-most-pharma-licensing-deals-with-china-sources-say-9eef7f5883b17b66 2026-09-18T10:55:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-receives-positive-eu-chmp-opinion-for-keytruda-pembrolizumab-plus-padcev-e-9dda3e8e04d1e9ea 2026-09-18T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chmp-recommends-eu-approval-of-roche-s-ocrevus-for-children-and-adolescents-with-7987b36e70396aa4 2026-09-18T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-launches-your-hive-of-whole-health-to-support-whole-person-care-for-people-6fb49d94bbe3b4f2 2026-09-18T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-targets-3-5-trillion-yuan-pharmaceutical-industry-by-2030-ea3e6220b6b84bbf 2026-09-18T10:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-and-devices-reach-patients-before-required-safety-studies-finish-and-feder-548b50c37e1139d5 2026-09-18T10:31:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-sellas-immunotherapy-study-long-delayed-will-end-in-failure-4f39356374c8bccb 2026-09-18T10:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/investors-pour-over-30b-into-longevity-biotech-companies-8159bc55d8a873ce 2026-09-18T10:15:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvectis-pharma-haisco-licensing-deal-revitalises-biotech-but-no-rush-to-invest-9e5025881f0236a4 2026-09-18T10:15:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/chicago-biotech-inomagen-lands-up-to-2-9m-for-gene-therapy-targeting-afib-2314e0a3b1c7a48d 2026-09-18T10:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investors-pour-over-30b-into-longevity-biotech-companies-fe16e000e0bbdcc4 2026-09-18T10:13:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-the-latest-with-mfn-pricing-and-what-it-means-to-pharma-611640f35e9de0d0 2026-09-18T10:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-india-acquires-pfizer-s-minipress-brands-for-150-million-717f175a2a74699d 2026-09-18T10:04:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/alterity-therapeutics-nasdaq-athe-to-outline-msa-drug-plans-at-asx-smidcaps-conf-1fca461c030238b6 2026-09-18T10:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-pauses-phase-3-depression-trials-after-psychosis-events-c474442598d818f4 2026-09-18T10:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clear-labels-act-stripped-of-key-provisions-before-senate-vote-81d6841a7d217e7c 2026-09-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clear-watering-down-drug-transparency-bill-stripped-of-critical-provisions-ahe-5a903264c20ac795 2026-09-18T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-key-to-success-is-being-willing-to-understand-the-energy-system-9887c5050e48720d 2026-09-18T09:57:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/these-blood-thinners-may-have-an-unexpected-benefit-for-alzheimer-s-patients-daa8fc27301148bf 2026-09-18T09:48:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cantor-fitzgerald-maintains-overweight-rating-on-ultragenyx-pharmaceutical-39-pr-90bfb8ef4162d81e 2026-09-18T09:41:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-bets-on-ai-designed-macrocycles-in-orbis-oral-drugs-deal-3d2fb0a79abc2e12 2026-09-18T09:28:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/grunenthal-prices-850m-euros-of-notes-to-refinance-and-fund-expansion-51639ee1c0a91b88 2026-09-18T09:24:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapport-therapeutics-inc-rapp-stock-analysis-a-clinical-stage-biotech-with-a-49-bb04e31254be6de9 2026-09-18T09:19:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/celcuity-inc-celc-stock-analysis-unpacking-an-89-32-potential-upside-in-biotech-ed1c905c6f09d8a1 2026-09-18T09:19:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/oruka-therapeutics-inc-orka-stock-analysis-a-58-6-potential-upside-beckons-biote-d636f4afe1bf33f2 2026-09-18T09:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-pharmaceuticals-oric-stock-analysis-a-60-upside-potential-with-strong-buy-r-8623ff2cd166514b 2026-09-18T09:19:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/primo-capital-launches-biotech-venture-fund-for-italy-s-lazio-region-b6ff7a9c7111e9f9 2026-09-18T09:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-journey-to-self-discovery-the-story-of-a-circle-u-student-fellow-5fea8b858725c8ae 2026-09-18T09:06:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drugs-and-devices-have-been-on-the-market-for-years-but-fda-ordered-studies-f50b3d6ed1b0bc0d 2026-09-18T09:03:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-specter-of-ai-enabled-bioweapons-is-a-wake-up-call-for-biotech-f0e619b6ad1a6523 2026-09-18T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-marketing-authorisations-granted-in-2026-0fc9c2c1015a12a7 2026-09-18T08:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/decision-parallel-import-licences-granted-in-2026-f337a3e18a403d26 2026-09-18T08:52:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/lb-pharmaceuticals-rated-buy-with-85-base-value-150-potential-if-phase-3-succeed-9332fe094c538a69 2026-09-18T08:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mhra-consultation-on-statutory-fees-2026-4e7ecd381fcc9a03 2026-09-18T08:45:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-mnov-36-pbls-10-abcl-9-hae-neo-140ed34b93773a97 2026-09-18T08:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boehringer-discontinues-phase-iii-easi-kidney-trial-of-vicadrostat-5d694399009054c9 2026-09-18T08:35:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-asx-dxb-action3-kidney-disease-trial-remains-central-to-development-path-aa84609d9f537b5b 2026-09-18T08:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hexavalent-combination-vaccine-programme-guidance-83f6b178f952c923 2026-09-18T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/0366002724-ur-test-120ml-sterile-108d430e0a4ba326 2026-09-18T08:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vendanges-sur-le-site-hospitalier-des-hus-de-la-robertsau-pour-les-residents-de-c010efcb07425afd 2026-09-18T08:13:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-guide-to-sarms-definition-side-effects-and-dangers-e67630b4d57afdc1 2026-09-18T08:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomedicine-powerhouse-china-targets-quarter-of-global-first-in-class-drugs-6b7e17dcbf9db5c6 2026-09-18T08:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/herzmedizin-und-anatomie-beim-festival-der-wissenschaft-und-neugier-ae5897933fcd4fa9 2026-09-18T07:42:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-dumps-100m-orum-degrader-antibody-conjugate-after-glimpsing-phase-1-data-24ceb75fbe9947ce 2026-09-18T07:41:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-shift-puts-this-corner-of-biotech-back-in-favor-9c761ffe135492bb 2026-09-18T07:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-i-keep-going-back-to-ukraine-during-wartime-df612d9b073be5dc 2026-09-18T07:26:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/millimeterarbeit-gegen-lungentumoren-die-music-studie-53be2a6ee6a105b4 2026-09-18T07:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/pawbio-animal-health-biologics-services-1a048e6660565241 2026-09-18T07:13:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/tumore-al-seno-in-humanitas-torna-paziente-diplomata-e54455d5d56e61c1 2026-09-18T07:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/chronisch-entzundliche-darmerkrankungen-im-fokus-a1687f02fff393f7 2026-09-18T07:03:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-brings-ems-professionals-to-omaha-for-training-4f1f1a30c9c75fcb 2026-09-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-s-alex-zhavoronkov-bets-china-and-ai-can-deliver-the-drug-indu-bf58fc441aef28ac 2026-09-18T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anna-maria-fjordb-ge-discussed-ethnographic-findings-on-digitalisation-and-judic-741ca0d3539fbc98 2026-09-18T06:58:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflammation-biotech-electra-charges-up-with-350m-from-upsized-ipo-58f7ac98a3c81cd2 2026-09-18T06:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/candidate-christy-knorr-tours-unmc-9c858ca4e9103a33 2026-09-18T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/employee-giving-campaign-runs-through-sept-25-3d755fdad3d90840 2026-09-18T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-klepser-to-lead-session-on-culture-by-design-673f758cb628666c 2026-09-18T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-for-the-record-sept-18-2026-26f128b25ad022fc 2026-09-18T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aspen-leader-shares-insights-on-advancing-healthcare-transformation-across-afric-e197406ab7edc88c 2026-09-18T06:40:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundationone-cdx-alk-9df8eafd03eb3fda 2026-09-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-obtains-approval-for-foundationone-cdx-cancer-genomic-profile-as-a-compan-a1b0d45f052647e4 2026-09-18T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-and-jolly-good-launch-new-content-for-faceduo-dementia-care-support-vr-un-2392b089dce1c64f 2026-09-18T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fete-de-la-science-2026-b279a061dcc65a5c 2026-09-18T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tissue-repair-asx-trp-phase-3-wound-healing-trial-remains-central-to-development-7287d50919577414 2026-09-18T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-unveils-15th-five-year-plan-for-pharmaceutical-industry-targeting-over-20-2ab6174a22012261 2026-09-18T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/department-of-energy-launches-215-million-race-to-build-quantum-computer-by-2028-041c6521fc4b9518 2026-09-18T05:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccination-in-the-social-care-sector-63cb5603bb33eecd 2026-09-18T05:45:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-iconic-olympia-coffee-house-where-hollywood-stars-matt-damon-tom-hollan-3519d16b037f1ec4 2026-09-18T05:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-latest-iphone-apple-watch-and-airpods-lineups-arrive-in-stores-worldwide-ec905d3774ad7d98 2026-09-18T05:02:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/etra-ipo-news-antibody-biotech-electra-therapeutics-prices-upsized-ipo-at-15-mid-bd92cafd24c85550 2026-09-18T04:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-7-10-15-943b204f7d94498a 2026-09-18T04:57:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/slv-revenue-fell-14-and-net-loss-widened-as-biotech-demand-dropped-but-drug-deve-44b2d4b9fcc80835 2026-09-18T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympia-coffee-house-loses-its-food-licence-after-fda-inspection-c7bc392f739245b5 2026-09-18T04:37:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-shares-rise-after-hours-following-fda-approval-ultragenyx-pharmaceuti-4517cfdb85b67294 2026-09-18T04:26:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-restore-a-brain-protein-and-reverse-signs-of-aging-in-mice-e17168fca74ee1f1 2026-09-18T04:25:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/satellite-reveals-a-world-of-weird-rivers-shaped-by-humans-742307336c51ecc0 2026-09-18T04:10:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-fda-suspends-food-licences-of-seven-eateries-over-safety-violations-9073bad5e1dd6410 2026-09-18T04:07:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/characteristics-of-low-voltage-zones-in-patients-with-heart-failure-with-preserv-5bb4200b0c0df75e 2026-09-18T04:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sodium-chloride-flush-recall-spectra-medical-removes-sodium-chloride-injection-u-7107a3ff7b54e80c 2026-09-18T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nitric-oxide-delivery-system-correction-noxbox-updates-use-instructions-for-noxb-a4f02b1fa9701d35 2026-09-18T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ozempic-can-change-your-body-can-it-change-your-life-d702a2323ab8162e 2026-09-18T03:52:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-reddy-s-labs-agrees-to-licensing-deal-with-gilead-for-once-yearly-lenacapavir-c6e21fe407ab9575 2026-09-18T03:38:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-olympia-coffee-house-where-christopher-nolan-stopped-for-chai-loses-lic-bb4065e6955e1adc 2026-09-18T03:35:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-safety-crackdown-fda-suspends-licences-of-seven-mumbai-establishments-1bc5a4018c01d902 2026-09-18T03:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innate-pharma-ipha-q2-2026-earnings-call-transcript-2453cef2f5f167e5 2026-09-18T03:07:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/51cc077bbc6c89d0 2026-09-18T03:01:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-pmda-atc-mrct-gcp-inspection-seminar-2027-applications-open-47b48c196c8a8540 2026-09-18T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-samd-page-updated-guide-revised-seminar-videos-and-materials-published-co-619e30c9b864d6f8 2026-09-18T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-cafe-mondegar-licence-over-food-safety-lapses-wider-crackdown-hits-dbf096ce62824842 2026-09-18T02:46:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-new-rules-let-licensed-clinics-sell-drugs-that-cleared-only-phase-1-sa-9e447bd6f824af4e 2026-09-18T02:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/feb-19-2026-dhl-group-expands-airfreight-cold-chain-network-to-advance-global-he-b4b7754991d65e96 2026-09-18T02:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-shaanxi-panlong-pharmaceutical-group-co-ltd-class-a-stocks-474793fb82a908a6 2026-09-18T02:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-ultragenyx-pharmaceutical-rare-reasonable-after-its-fda-gene-therapy-approval-92ee3504e9cb0a80 2026-09-18T01:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-high-court-asks-thane-restaurant-to-approach-food-safety-commissioner-ove-cb94d91d3cc4472d 2026-09-18T01:43:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/simulations-plus-expands-fda-adoption-of-admet-predictor-with-new-licenses-for-t-e883165e7f599585 2026-09-18T01:26:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-amasses-350m-in-biotech-s-latest-big-ipo-978099deecfc2361 2026-09-18T01:16:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-astrazeneca-s-new-breast-cancer-drug-etracama-to-enter-korea-4a59ef93e0c56fb3 2026-09-18T00:50:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-tucsco-10-6-c99883a9f629ce01 2026-09-18T00:43:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-s-350m-ipo-will-help-it-become-a-commercial-biotech-64654e6782d6b4d8 2026-09-18T00:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-therapeutics-announces-pricing-of-upsized-350-0-million-initial-public-o-5224881caefa3cfa 2026-09-18T00:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/area-biotech-looks-ahead-7f2eaf55a0c8b74a 2026-09-18T00:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-retail-investors-buy-68-3b-won-in-sejong-medical-c5ee1465e913cc8f 2026-09-18T00:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-dd6239a9df91643d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-9e9bc01d14832eeb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-universal-visual-foundation-model-for-computational-cytopathology-d4d82831813740f5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plau-orchestrates-pancreatic-cancer-progression-via-pi3k-akt-mtorc1-mediated-upr-2b4792a26625613e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/driver-gene-based-prognostic-model-benchmarked-against-machine-learning-survival-3946a0322044cb5b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genetically-engineered-dendritic-cells-in-cancer-immunotherapy-from-immune-repro-a85c64c747074436 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-derived-organoids-enable-ex-vivo-drug-response-profiling-for-precision-m-1aed3005ec38f796 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serotonin-neurons-in-the-dorsal-raphe-control-food-craving-like-behavior-during-9b1cc1d30ce78bfd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reciprocal-connections-dynamically-build-consensus-between-neocortical-areas-2904d1c3185e72a1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-parallel-neural-ectoderm-progenitors-contribute-to-the-developing-brain-27601ed7284656cc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-expression-of-concern-swi-snf-mutant-cancers-depend-on-catalytic-and-n-fa22820503a0bb23 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-genes-shape-personality-and-experience-8e6ff560799a1d26 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/briefing-chat-evidence-mounts-for-hidden-chambers-beyond-tutankhamun-s-tomb-1b83b75edd571e59 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-companies-doubled-down-on-science-after-us-tech-restrictions-f5dc675196375a6e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-for-rna-therapy-man-with-rare-motor-neuron-disease-improves-after-treatmen-39d5d7d56656617a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-make-a-brain-new-experiments-challenge-existing-picture-07a3594b08ae66da 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-cracked-the-navier-stokes-challenge-what-does-that-mean-for-physics-7e18c82588b27860 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-pushes-for-space-independence-amid-geopolitical-rifts-2bcc4551592c59fc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cognitive-resilience-helps-to-predict-alzheimer-s-dementia-61ec2e4b02e7618b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-research-funding-took-me-out-of-the-lab-and-into-leadership-b04ee2454e589d00 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-myostatin-targeted-antibody-approved-for-spinal-muscular-atrophy-2956859569b7854d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-value-of-speed-for-drug-developers-1de79cdc9775c318 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-vaccine-injury-compensation-program-list-of-petitions-received-6091ed1340d56d14 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electronic-submission-template-for-medical-device-premarket-approval-application-84868d5f9c7d515f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-604ead149a445115 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biosimilar-user-fee-act-iii-future-needs-in-the-development-of-interchangeable-p-fe5a68d526ec88a9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-allergy-and-infectious-diseases-amended-notice-of-meeting-dcb583623cf5f6f4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-post-award-reporting-requirements-inc-48f728e96892f8f4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-phs-applications-and-pre-award-report-45801451bb9edd47 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-delta-region-community-health-systems-development-8a467900dbe269e1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthy-start-self-measured-blood-pressure-monitoring-9a807fe7b2052867 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/infant-toddler-court-program-national-resource-center-87bdf4a836c3d8db 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/target-animal-safety-evaluation-for-veterinary-monoclonal-antibody-products-draf-c6d6364c139b35de 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-library-of-medicine-notice-of-partially-closed-meeting-4cae51d99da667c3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-3df8df59fcecf4b6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-center-for-advancing-translational-sciences-amended-notice-of-meeting-ce1fbb114382a049 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-national-rural-health-policy-community-and-collab-d1edde2289a9483f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-national-rural-health-information-clearinghouse-p-80273b101abb5b18 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-rural-residency-planning-and-development-technica-bad78a3fbc8146b7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-type-1-hybrid-study-of-for-you-for-me-for-us-30b5efe173bb6597 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advanced-mri-evaluation-of-abdominal-aortic-aneurysms-e24a64112da04a77 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-c-data-2216f2b3fdb1d3c7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-b-tissue-procurement-and-processing-0a8ac06e9929e2bd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-multi-omics-peripheral-nerve-atlas-enables-fine-mapping-of-pain-molecu-5b6fa68817118046 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-hiv-testing-and-communication-skills-training-to-reduce-hiv-risk-and-i-6edf3a7da701e407 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-improving-measurement-of-pregnancy-outcomes-in-the-united-states-8c90de707f4753f2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-antigen-presentation-during-trypanosoma-cruzi-infection-in-search-of-a-edfeb24144d5644b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mir-21-induced-neuroprotection-after-stroke-99f8cf0fb68cbe0d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-novel-fungerp-targeting-refractory-candida-urinary-tract-infections-b190c40b7297d4dd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-accelerator-for-the-rapid-development-of-countermeasures-targeting-dru-5929a9902c569f03 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-novaseq-x-plus-sequencing-system-98873f680820450a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-hybrid-effectiveness-implementation-trial-of-a-urine-point-of-care-a-389945be55285ff4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-dissecting-the-intestinal-niche-for-regulatory-t-cells-aa0916b65d0ef37d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-tgf-and-smad-signaling-components-in-esophageal-adenocarcinoma-b665d0dc7a445366 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-csrd-research-career-scientist-award-application-ddcebe072c98ebdd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-neurosteroid-intervention-for-ptsd-in-iraq-afghanistan-era-veterans-69cddd261baec6b1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-radio-a-novel-radiomics-toolkit-to-predict-and-characterize-response-t-6bfb00a543d3e40e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-injuries-of-the-corneal-endothelium-8a83a63e9b665707 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-blr-d-research-career-scientist-award-application-a2d0734b0d107736 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-role-of-carbon-dioxide-in-mediating-host-parasite-interactions-in-24772eea09b3c71f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mr-biomarkers-of-inflammation-in-knee-osteoarthritis-d125cf30ab86fbe1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-repeated-transurethral-interventions-and-progressive-urethral-strictur-d119db74581b93df 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mapping-dna-repair-and-error-prone-dna-synthesis-in-geriatric-skin-7295233ac9640a99 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigating-the-mechanisms-of-aggressive-prostate-cancer-in-african-c9a3991cceb16e4d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mechanisms-regulating-cytomegalovirus-600e0403fc4edd63 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-immunomodulatory-biomaterials-for-regenerative-healing-of-burn-wounds-eeb069680645cb46 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-lysophosphatidic-acid-mediates-cardiac-inflammation-and-heart-failure-a33e75401c701302 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-immune-basis-for-hippocampal-cholinergic-deficits-in-pyridostigmine-tr-43fd17e32a455baa 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-brain-capillary-endothelial-cell-energetics-and-neurovascular-uncoupli-67ecae84fd3dd301 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-neurobiological-mechanisms-of-untreated-pain-and-depression-to-rel-28000ab737d42ad6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-immune-control-of-chronic-viral-infection-in-solid-organ-transplantati-dbd0048c425b5117 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-approaches-to-studying-social-motivation-in-schizophrenia-79754ee93deb8935 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-contributions-of-mild-traumatic-brain-injury-to-neurodegeneration-due-da636182f9665352 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-specialized-metabolites-of-medicinal-and-poisonous-insect-pathogenic-f-1c096378167351bf 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-identifying-molecular-markers-that-predict-relapse-after-therapy-disco-ec8ac62e21eaad27 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sex-differences-in-trauma-inflammation-and-brain-function-and-the-impl-37e40a5016989fbc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-pilot-clinical-study-to-assess-safety-and-efficacy-of-external-ventric-2842b8881b9feceb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-venlafaxine-hydrochloride-extended-release-64e61a51289aa7ad 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-forbattra-varden-vid-kronisk-njursjukdom-da50b1e1d961632c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/han-breddar-sin-traumaforskning-med-stod-fran-forskar-at-48a89c1bf1f7d034 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erc-utmarkelse-for-allmanhetens-engagemang-kring-beroring-och-kittlighet-ad92c23fe3cf202f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cascade-watch-a-quality-improvement-approach-to-identifying-and-mitigating-presc-5e4c9b87f73175ce 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-perspectives-on-generative-artificial-intelligence-tools-in-pharmacy-9364bf8b6a1b9432 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pill-splitting-for-sustainability-reducing-the-cost-and-environmental-impact-of-e1421773d0d87402 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practice-tips-for-successful-point-of-care-testing-programs-in-pharmacies-a53ecfbdb2e94510 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-artificial-intelligence-across-the-cancer-drug-discovery-pipeline-us-d7efd9830701ac32 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaco-multiomics-in-major-depressive-disorder-a-narrative-review-and-proposed-42e75faf60364346 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-clinical-research-participation-among-medicare-beneficia-b7de054f5c62fdeb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-benchmarking-to-global-leadership-singapore-s-health-sciences-authority-s-j-c9dff2d33578c9dd 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-narrative-review-of-emerging-chemoprotective-agents-for-chemotherapy-induced-t-0a67f03191c1e550 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-trial-landscape-of-bispecific-antibodies-in-non-small-cell-lung-can-bcb034023b34aa44 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-systems-microbiology-framework-for-reproducible-multi-dataset-omics-integratio-b779bce51648b197 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-traditional-chinese-medicine-to-enhance-the-efficacy-and-reduce-toxici-f47001b561f23943 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bibliometric-and-clinical-trial-landscape-of-hepatoblastoma-2000-2024-a-multi-da-82994bbd094b43d4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-artificial-intelligence-with-liposomal-nanocarriers-for-advanced-dru-a576c0cffb41e1f3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-therapeutic-potential-of-psilocybin-a-comprehensive-review-of-clin-18fbd0a8d3e6166f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-proposal-for-the-use-of-an-innovative-two-stage-pk-clinical-adaptive-trial-in-259fad7aaebedffc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-actionable-biomarkers-in-psychiatry-a-collaborative-roadmap-for-precision-3822ea97dcf33660 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-fish-oil-as-an-adjunct-therapy-to-metformin-on-vascular-and-cardiac-he-eed8d16ad9a91c90 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multicentre-2-2-factorial-randomised-open-label-trial-of-neuromodulators-and-cou-290e7376ed15fbd5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-liposomal-bupivacaine-and-modified-cocktail-analgesia-for-postoper-00ef96b8cb7b90ac 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4d-bioprinting-in-advanced-cancer-model-technologies-drug-delivery-and-translati-a91d066d3ef86f8b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-better-system-managing-the-adverse-effects-of-prescribed-medicines-cluster-ran-00393ae94924b1c2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-response-event-free-survival-and-treatment-free-remission-in-myeloprol-a3419594c5926b84 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recall-and-understanding-of-hiv-related-counseling-messages-among-progestin-impl-d1a39d7a8676809b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mh-penile-002-a-phase-ii-prospective-single-arm-trial-of-neoadjuvant-anti-egfr-a-91c0cd19bf609415 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dietary-flavonoids-target-the-gut-liver-axis-for-the-management-of-cholestatic-l-00373b92e1923e19 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phthalazine-as-a-medically-versatile-polyheterocyclic-core-with-underexplored-an-378d8fb50f37bcc7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-anxiety-reducing-effects-of-aroma-stones-with-bergamot-essenti-b4ab905f9994f143 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/method-development-validation-and-estimation-of-single-synthetic-drug-tafamidis-6c0d9c088549a9f2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-patient-reported-outcomes-in-non-english-speaking-patients-undergoi-ac4dc44140853a67 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bacteriological-quality-of-pharmaceutical-effluents-in-awka-nigeria-37de73039abf6f90 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-screening-colonoscopy-in-adults-aged-75-years-and-ol-6d12f15e1391ea8c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-curcumin-in-neurogenesis-and-neuroprotection-in-alzheimer-s-disease-4243af857122205a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opioid-management-for-the-primary-care-physician-a-practical-guideline-based-cli-170f2da712920c3f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanocarriers-for-targeted-drug-delivery-in-cancer-therapy-innovations-and-challe-1c2dc318af7f590f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dual-attention-ensemble-residual-learning-for-robust-diabetic-retinopathy-classi-633f8b4a39b678e6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hand-function-and-oral-hygiene-performance-among-children-with-down-syndrome-a-c-ede1867ad511fb59 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dynamics-and-structure-of-criminal-offenses-related-to-illicit-drug-trafficking-27b75901169137cf 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/applying-the-american-school-counselor-association-asca-ethical-and-legal-standa-8dcb561e1a538c12 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-cardiopulmonary-bypass-duration-on-intensive-care-and-hospital-length-15f8968488fed16d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-retrograde-autologous-priming-on-hematocrit-trajectory-and-transfu-5d9c48524efc7152 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aquagenic-palmoplantar-keratoderma-clinical-histopathological-and-ultrastructura-f28fff81510d6c3b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combination-therapy-of-biologic-and-non-biologic-systemic-agents-in-psoriasis-a-eb16a4d585839d3a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-neurological-burden-of-cirrhosis-a-comprehensive-clinical-review-of-mechanis-387c5cf15a238ed8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xinshuaifang-improves-oxidative-stress-injury-and-myocardial-remodeling-in-acute-ea34efe2d9af33f7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dencichine-ameliorates-hepatic-fibrosis-by-modulating-the-pi3k-akt-signaling-pat-1feafa88df28df14 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bmscs-promote-apoptosis-in-glioma-cells-by-inhibiting-stat3-phosphorylation-b0ab18bf9d391818 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-clinical-and-magnetic-resonance-imaging-findings-in-intracranial-hem-0c206b485101e9e9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-sleep-disordered-breathing-a-taxonomy-of-methods-dat-4212fb2e9998d4f0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/appropriateness-of-antibiotic-prescribing-in-dental-practice-results-of-two-clin-9e717dd8a6e0113d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-effects-of-digital-literacy-training-on-college-students-self-lead-bc9eb38a15681b18 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanism-aware-and-safety-validated-ai-for-drug-repurposing-a-critical-review-a-fe666815e2b4145a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporal-and-clinical-heterogeneity-of-double-m-protein-multiple-myeloma-diagnos-c674cc6b45f5fa7f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-skin-related-adverse-events-during-mirdametinib-treatment-for-nf1-pns-e-9244fb4fa5c44f88 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-landscape-of-bladder-cancer-treatment-a-brief-report-on-new-develop-2a53d6280762f04b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-antenatal-breast-milk-expression-or-postnatal-dietary-intervention-on-8cf881177dc218d1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-for-a-randomized-controlled-trial-comparing-penetrating-needling-1ca63ddbb2ae5d59 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sacituzumab-govitecan-in-metastatic-breast-cancer-a-systematic-review-and-meta-a-9e64e28209a31e7b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spatial-multi-omics-guided-drug-development-in-inflammatory-bowel-disease-from-m-9d2a193694c20310 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidimensional-efficacy-characterization-of-xeligekimab-in-moderate-to-severe-54a1dbdb991fe995 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-metabolic-links-between-hypothyroidism-and-metabolic-syndrome-a-rev-26b2ca25872be00b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-guideline-compliant-prescriptions-of-benzodiazepines-and-z-drugs-effects-of-c82e1f698d7a330b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-early-predictors-of-metabolic-syndrome-among-adolescents-0979e56242690ce4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rare-case-report-of-lateral-periodontal-cyst-86813d462bd1795c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/soluble-urokinase-type-plasminogen-activator-receptor-in-glomerular-disease-a-ma-e62ed0c5b157c549 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-flow-nasal-cannula-in-adult-acute-care-physiological-mechanisms-clinical-ev-8f7e270a8cc693dc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-nanopore-based-genomic-characterization-of-macrolide-resistance-in-clinic-b0635c7940c6e532 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nucleic-acids-in-medicinal-plants-and-their-pharmaceutical-potential-5a69fb06fb585d6a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-value-of-urinary-albumin-creatinine-ratio-in-predicting-vision-threat-11c3ec9b9f2d15fc 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visual-and-accommodative-outcomes-after-femtosecond-lasik-with-and-without-monov-8f815f409c403df3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-manual-diaphragmatic-release-technique-on-exercise-capacity-and-sleep-a526395573a1476f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/collaborative-clinical-research-ethics-and-regulatory-governance-in-sub-saharan-a80d218f6a293c6d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saikosaponin-d-ameliorates-non-alcoholic-steatohepatitis-by-inhibiting-sting-med-d926f3f53f604836 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pubertal-delay-in-patients-with-paternally-derived-15q11-2-q13-duplication-syndr-97e9e561d7acd17b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/degradation-of-pharmaceutical-pollutants-in-wastewater-via-cellulose-microsphere-8720e55e1d533a4b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-wearable-gadgets-for-personalization-of-drug-therapy-in-human-and-vete-ad56ba1a0ef26dd0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leveraging-community-health-workers-for-the-promotion-of-breast-cancer-awareness-755600d79ec1f2d3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-telerehabilitation-based-exercise-and-monitoring-program-and-it-be132e0c48930f0a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-novel-covalent-cdk7-inhibitor-potently-induces-apoptosis-in-acute-mye-92e394580899b083 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differentiable-latent-structure-discovery-for-interpretable-forecasting-in-clini-0cd199136d6e8b1f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practice-variation-in-hospital-care-for-pelvic-organ-prolapse-and-urinary-incont-3d823e631c47eefe 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-financial-correlates-of-suicide-attempts-among-patients-with-gambli-02d0125d246d53ed 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-childhood-systemic-lupus-erythematosus-complicated-b-7f3038027461f1c3 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-phase-iii-trial-with-a-factorial-design-assessing-the-efficacy-and-sa-7ec071caeffd2817 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-induced-phospholipidosis-following-haematopoietic-stem-cell-transplantation-ab9302e7e11d6b1d 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-combined-hepatic-arterial-infusion-chemotherapy-with-target-ff41a7de4710bf07 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ludwig-s-angina-in-somalia-clinical-characteristics-emergency-management-and-out-db48f21f0e692542 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/powered-by-curiosity-the-emerge-model-for-advancing-clinical-research-leadership-97ddb4d925def0ac 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-survivorship-of-transfibular-trabecular-metal-total-ankle-arthroplasty-045567ef15fb6238 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-effects-of-radial-extracorporeal-shock-wave-therapy-in-addition-to-ph-7f21e74b24247cd4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ensuring-x-ray-safety-in-merowe-sudan-78999d828fcc67c9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nomenclature-standardization-and-health-care-technology-management-0fd3438ec1bfdb35 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peri-plate-gas-detected-on-cervical-ct-as-an-exploratory-imaging-indicator-of-es-d84e1111a3a9cba7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/general-dermatology-and-dermatology-in-primary-health-care-3ec6d2b585374c21 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-acneiform-eruption-with-deucravacitinib-systematic-review-and-meta-an-8a8d04909efec9c9 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determinants-of-community-pharmacists-intention-to-provide-pharmacist-driven-vac-e1abbf554c80558c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecologically-inspired-green-walls-addressing-structural-and-biological-barriers-6db5246f66fa54fb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-associated-factors-of-cognitive-impairment-in-patients-with-major-9ec172616c914ae2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-paediatric-ocular-rosacea-clinical-spectrum-diagnostic-clues-and-tre-aa7a7e67addf65f1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-transcutaneous-auricular-vagus-nerve-stimulation-on-postoperative-gast-b4866bdcf6032b2f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/worried-but-not-intending-when-expressive-suppression-dampens-the-motivational-r-bc40ea7445eb3ada 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-based-mediated-reactivation-of-fetal-hemoglobin-as-a-therapeutic-strategy-ba092edcd3d852ce 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-actionable-biomarkers-in-psychiatry-a-collaborative-roadmap-for-precision-bf1ceccfe95ee9d2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-in-the-bottle-regulatory-insights-on-genetically-modified-microorganisms-1653567a20408884 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transitional-atrioventricular-septal-defect-diagnostic-variability-and-its-clini-29af8aaaec811944 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-comprehensive-review-of-the-phytochemistry-pharmacological-activities-and-clin-ed40f39cb8e477e4 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-hybrid-bilstm-transformer-model-for-drug-synergy-prediction-f1cf6f42f7410d30 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-metabolic-epigenetic-axis-in-cardiovascular-disease-acylation-modifications-a9f5a8adcdf04488 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concentration-to-dose-ratio-differences-between-once-daily-tacrolimus-formulatio-c6d84cc0da0ba231 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-expert-consensus-on-the-clinical-application-of-sulodexide-in-vascula-e5031bffd8f56f9f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translating-deep-learning-innovations-into-clinical-medical-imaging-practice-eaa12e49e6dd3a61 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-current-frequent-and-multi-substance-use-among-adult-eve-a28e96d8b4e51e85 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hyperadrenergic-and-neuropathic-features-based-on-clinical-autonomic-testing-in-6c45958fcb4f3502 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heliotropium-indicum-protects-against-estradiol-benzoate-induced-endometrial-hyp-4151ed057f65fcf8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selenium-nanoparticles-enhanced-testicular-thermoregulatory-mechanisms-by-modula-3fbecd66a2f53d28 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioactive-peptides-in-cancer-and-inflammation-mechanisms-model-systems-and-clini-507b06865a134476 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-images-nasal-type-extranodal-natural-killer-t-cell-lymphoma-mimicking-a-7fe393f29eb26cc7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commentary-on-canadian-study-on-timing-of-methadone-take-homes-5227cedcaf677bb8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-of-community-based-rehabilitation-for-people-with-schizophren-7f065e1266547228 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07829185-modified-folfirinox-and-pentamidine-in-advanced-and-metastatic-pancr-78fa3add49b7bb72 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828626-benefits-of-retained-insulin-for-good-health-e0b0dd20ad9f57c0 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828613-accelerated-flap-coverage-versus-standard-timing-in-the-treatment-of-acf8dea393ecdeb1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828587-effects-of-orofascial-myofunctional-therapy-and-cervical-stabilizati-b01c7ef45f20a1eb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828379-post-market-active-surveillance-and-health-economic-evaluation-of-ce-ea4b9a41fb3ab625 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828314-patient-priorities-in-the-management-of-early-oesophageal-cancer-a-d-c1c5d07e8d45cb6f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828236-phase-1-trial-of-lm-llo-tt-and-gemcitabine-in-unresectable-pancreati-14e0f1e100ed9769 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828223-cardiac-improvement-by-eplerenone-among-patients-under-cyclosporine-15c1ebccbe3914a8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828210-neuroaid-patient-reported-outcomes-in-patients-with-mild-to-moderate-aebf40e5cadccc25 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828080-clinical-outcomes-of-primary-cementless-total-hip-arthroplasty-using-b8092242ac89b7ab 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07828067-short-versus-standard-dental-implants-clinical-and-biomarker-outcome-7d7695cddc772f99 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827833-clinical-performance-and-failure-rates-of-restorations-following-ped-5c6076eaa01acf7a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827573-a-study-to-learn-how-well-participants-with-a-specific-type-of-early-8265b1ae972fd33e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827326-clinical-utility-of-needle-based-confocal-laser-endomicroscopy-for-p-68c540e9ca7775bb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827170-bacillus-probiotics-with-bismuth-quadruple-therapy-for-helicobacter-4694cb3f6bb3e8b8 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07827144-a-study-to-test-how-well-different-doses-of-bi-4060107-are-tolerated-2178f7ba02d8077f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07806916-efficacy-and-safety-of-efgartigimod-in-the-treatment-of-guillain-bar-f67ec03dd482061e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07743476-bone-marrow-imaging-and-clinical-outcomes-across-hematologic-oncolog-e022df71fdff851f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07683104-natural-history-of-trisomy-8-associated-autoinflammatory-disease-tri-a10b26c09d1352ed 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07617337-aqua07-in-patients-with-alk-positive-non-small-cell-lung-cancer-9575a10c54b83efb 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07585968-safety-and-effectiveness-of-the-sphere-9tm-catheter-and-afferatm-abl-6e22d8fa3f907fc6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07576452-first-lines-of-biologics-in-patients-with-ulcerative-colitis-a-rando-6f24cff714c98475 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07567833-longitudinal-study-of-retinal-function-in-eyes-treated-for-diabetic-81b93e4ee1654505 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07520383-nanopulse-laser-therapy-266285f6b1cfdf8f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07472049-symptomatic-and-systemic-atherosclerotic-plaque-activity-in-patients-2655d0dda387168f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07224152-nbtxr3-with-radiation-therapy-alone-for-locally-advanced-non-small-c-3d8d0ac6f10837d7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07204964-a-study-to-evaluate-the-immune-response-and-safety-of-an-influenza-v-a165910ebe79d288 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07181109-zilebesiran-in-patients-with-hypertension-not-adequately-controlled-3cffe79ee8aab051 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07047118-a-study-of-jsb462-luxdegalutamide-plus-lutetium-177lu-vipivotide-tet-c964db7ee09b20b1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06948981-gt719-injection-for-the-treatment-of-recurrent-refractory-cd19-posit-dca6471439e80ee7 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06888193-a-study-to-assess-the-concentration-of-bimekizumab-in-mature-breast-b55c9f50bb539f7c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06859762-a-first-in-human-study-of-yl217-in-patients-with-advanced-solid-tumo-c4eaace35a78886b 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06790784-faricimab-prp-vs-vitrectomy-endolaser-for-treatment-of-pdr-514938e04219b871 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06746688-a-first-in-human-clinical-trial-assessing-the-safety-of-es2b-c001-s0-17414cc8604923e5 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06665646-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-hiltonol-b217282ad3e5577e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06340360-a-phase-2b-study-to-evaluate-rezpegaldesleukin-rezpeg-in-the-treatme-361399e578bce777 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06274749-effects-of-urolithin-a-supplementation-on-glucose-metabolism-in-heal-597167a31fc2a3ba 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06236880-a-phase-2a-study-to-evaluate-the-safety-and-tolerability-of-gm-2505-68ae07b9ae661840 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06208306-a-study-to-investigate-long-term-safety-and-tolerability-of-itepekim-795e6ff774e38b35 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06198712-a-study-to-evaluate-the-pharmacokinetics-and-safety-of-etavopivat-in-89892e79fdf869e6 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06140147-protocolized-reduction-of-non-resuscitation-fluids-versus-usual-care-760c20ac150f2923 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06126276-testing-the-use-of-neratinib-or-the-combination-of-neratinib-and-pal-d0a38b42801b4a0e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06058377-adding-an-immunotherapy-drug-medi4736-durvalumab-to-the-usual-chemot-2e48b979fc6c9737 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05863052-analyzing-clinical-outcomes-and-genomic-data-of-american-indian-pati-1bdf5bf93f324809 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05853406-determination-of-a-minimal-clinically-important-difference-of-the-fu-048ead8a89cb979a 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05554406-testing-new-therapies-for-patients-with-acute-myeloid-leukemia-who-a-7ba612c389b9cb0e 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04291755-development-and-analysis-of-a-stool-bank-for-cancer-patients-794566bc56e70a73 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04248582-cryotherapy-for-locally-advanced-esophageal-cancer-04dd1c30299a7143 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04208178-study-of-alpelisib-byl719-in-combination-with-trastuzumab-and-pertuz-96d9a1e3348be3e2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04127578-phase-1-2a-clinical-trial-of-pr001-ly3884961-in-patients-with-parkin-77b63db4617f76e2 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03776487-nivolumab-ipilimumab-and-chemoradiation-in-treating-patients-with-re-51b58236c902783c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03630991-edetate-calcium-disodium-or-succimer-in-treating-patients-with-acute-6989090ed6697ab1 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03508752-neurocognitive-decline-in-patients-with-brain-metastases-b33656dd6da1ef6c 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02610855-effect-of-treatment-on-activity-and-muscle-function-in-pediatric-pat-baaa89fe2dea3b78 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02579967-pilot-trial-of-allogeneic-blood-or-marrow-transplantation-for-primar-8c7901845d5d7951 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02119611-deep-brain-stimulation-therapy-in-movement-disorders-3557cb2032e18f4f 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01035879-study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinet-2a57cef36373f475 2026-09-18T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-complexities-of-340b-rebate-tracking-345d5ee106e9a4f8 2026-09-17T23:38:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/padcevtm-enfortumab-vedotin-in-combination-with-keytruda-pembrolizumab-receives-8cf462a80b8a5d5c 2026-09-17T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-s-strikes-on-pharmaceutical-warehouses-threaten-ukrainians-access-to-medi-1481cd7f4bb09f30 2026-09-17T23:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-biotech-companies-pitch-at-5th-annual-biodiscovery-summit-685693dd844a95e0 2026-09-17T23:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-oral-drug-indicated-to-treat-dermatomyositis-in-adults-64759fb9feb9d221 2026-09-17T22:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-map-hidden-protein-network-that-helps-red-blood-cells-adapt-to-oxygen-7afbbb0fc95ddfd1 2026-09-17T22:07:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/icb-homenageia-luiz-eurico-nasciutti-e-da-nome-do-professor-a-auditorio-7e639652208cc3c8 2026-09-17T22:06:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/these-biotech-stocks-are-cheap-based-on-1-fundamental-measure-815f0f905b0e25d8 2026-09-17T21:53:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/convergence-eu-officials-tout-pending-pharmaceutical-reforms-7ec250273dd2050a 2026-09-17T21:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-regulators-urge-more-research-on-testosterone-therapy-for-women-as-experts-de-80bb0693f610f163 2026-09-17T21:20:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-pushes-for-testosterone-therapies-for-women-breaking-down-barriers-d67e892928966c35 2026-09-17T21:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-commemoration-of-world-patient-safety-day-novo-indonesia-invites-the-communit-c729bf0bf9594fa9 2026-09-17T21:18:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-0a2c211f558a4086 2026-09-17T21:17:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-ag-biotech-firm-sets-up-north-american-hq-in-indiana-e82697c880a79273 2026-09-17T21:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patidegib-gel-completes-phase-3-follow-up-in-gorlin-syndrome-613e04e4d96cacfe 2026-09-17T21:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-use-patient-feedback-in-clinical-trial-design-7307a00bb66a4178 2026-09-17T20:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ultragenyx-s-gene-therapy-fayuvi-for-rare-neurodegenerative-disorde-3a99a3afac6a189b 2026-09-17T20:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharmaceutical-industry-has-seven-years-to-solve-a-12-digit-problem-2ce095089f5a385f 2026-09-17T20:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-emitio-carta-de-cierre-por-la-subsanacion-de-los-incumplimientos-detectado-5e048f3571d027fb 2026-09-17T20:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/recon-senate-hearing-set-for-fda-nominee-novo-partners-with-anthropic-for-ai-dru-74e2264d9dcc1de7 2026-09-17T20:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-kidney-drug-cut-teens-urine-protein-by-75-versus-placebo-1fc57cd2c9a56347 2026-09-17T20:18:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/jornada-en-conmemoracion-del-dia-mundial-de-la-prevencion-del-suicidio-en-la-unl-dfd3ffb3bbe8c879 2026-09-17T20:18:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-pediatric-empaveli-data-published-in-clinical-journal-of-the-american-so-5091818a62b05fe0 2026-09-17T20:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-announces-azetukalner-nda-submission-to-fda-for-focal-seizures-and-provide-037241532935d25e 2026-09-17T20:17:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-pediatric-empaveli-data-published-in-clinical-journal-of-the-american-so-18c673b3e90bf413 2026-09-17T20:16:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-shrinking-return-on-investment-for-nordic-innovation-1ab4bf8551082130 2026-09-17T20:09:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/carolina-to-celebrate-america-250-through-poetry-performances-discussions-and-mo-0887df79ba556182 2026-09-17T20:06:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-submits-a-seizure-drug-to-fda-while-pausing-new-depression-trial-enrollmen-ed814c8e3c5c404e 2026-09-17T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-announces-azetukalner-nda-submission-to-fda-for-focal-d78208d6a611a635 2026-09-17T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biolinerx-ltd-nasdaq-blrx-share-price-blrx-stock-news-blrx-share-price-updates-7f60262f5eff496b 2026-09-17T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-announces-approval-of-fayuvitm-gene-therapy-the-first-ever-fda-approv-aba207598fd4c499 2026-09-17T19:57:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/goa-therapeutics-emerges-from-stealth-with-15-5-million-in-funding-and-unveils-g-4c38cf3c6f2869ef 2026-09-17T19:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-biotech-companies-pitch-at-5th-annual-biodiscovery-summit-bf6d2c55316ea44d 2026-09-17T19:49:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-immunology-reverse-merger-comes-with-180m-for-next-gen-inflammation-drug-ce7961c09de04bad 2026-09-17T19:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-new-indication-for-kerendia-pharmexec-6d2c25c3e5f2cd54 2026-09-17T19:45:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-bi-weekly-new-multiplex-immunofluorescence-tool-a-human-genome-datab-a5d3e08006cbc4b2 2026-09-17T19:39:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-partners-with-orbis-deepening-investment-in-oral-peptide-drugs-c47b027e3b02888a 2026-09-17T19:37:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-gene-therapy-for-pediatric-patients-with-sanfilippo-syndrome-4b753211a5d929e8 2026-09-17T19:37:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-pharmaceutical-packaging-trends-to-know-a8bfd26f9dca5759 2026-09-17T19:33:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-approval-to-taletrectinib-for-advanced-ros1-nsclc-76a13c8a51eb8ee0 2026-09-17T19:24:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/17-09-il-policlinico-di-milano-si-illumina-di-arancione-per-la-giornata-nazional-4a1539b5441c3634 2026-09-17T19:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/construction-industry-champions-heart-health-through-campaign-169f417446778731 2026-09-17T19:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-utah-highway-safety-office-urge-parents-to-rethink-common-c-8a0fb893e9226bb4 2026-09-17T19:14:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvation-bio-announces-fda-approval-of-supplemental-new-drug-application-for-ibt-93dcf2b2af896b8e 2026-09-17T18:34:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-grand-opening-of-its-innovation-center-boston-to-drive-advanceme-f51da51b1bf34aa9 2026-09-17T18:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-shares-climb-as-hemophilia-therapy-gains-key-eu-backing-73dc852253e72a50 2026-09-17T18:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-realities-of-china-s-prolific-biotech-rise-are-felt-at-fda-1795c883b63f206a 2026-09-17T18:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-framework-uses-ai-scientists-to-pursue-probe-drug-discovery-19244671a207ef09 2026-09-17T18:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wegovy-for-children-under-12-sparks-obesity-debate-67a99e0bdea0cb68 2026-09-17T18:15:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/live-from-dc-can-the-fda-steer-clinical-trials-back-to-the-us-post-hoc-live-25792fcad212d192 2026-09-17T18:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/stricter-fda-norms-cast-shadow-on-ganesh-mandals-mahaprasad-plans-only-250-enrol-2c7c8c07d156ef63 2026-09-17T18:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-biotech-company-puts-thousands-of-ai-scientist-agents-to-work-on-drug-di-723a870ca063cacd 2026-09-17T18:04:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/linsitinib-phase-3-orbit-trial-doses-first-patients-for-thyroid-eye-disease-270fe24b398334c2 2026-09-17T18:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-7d73d424dcb1e9e9 2026-09-17T17:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-research-increased-investment-signal-landmark-year-for-food-is-medic-037665fb995f5136 2026-09-17T17:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transferencia-a-municipios-facultad-de-ciencias-exactas-25750730448c9187 2026-09-17T17:29:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/iqhq-hands-vacant-biotech-building-back-to-lender-as-bay-area-life-sciences-slum-4369a9fe64919d18 2026-09-17T17:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-tak-gets-priority-review-can-zasocitinib-win-in-psoriasis-3598469b22effd81 2026-09-17T17:08:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/maryland-makes-its-case-as-a-model-for-u-s-biotech-supply-chain-security-3ddb3271125dc205 2026-09-17T16:57:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/frances-oldham-kelsey-the-pharmacologist-who-stopped-thalidomide-73c1c740e2953127 2026-09-17T16:52:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-novo-nordisk-stock-trading-higher-today-novo-nordisk-nyse-nvo-146fc47e146018ac 2026-09-17T16:44:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/altis-labs-raises-us-25-million-series-a-co-led-by-orbimed-to-accelerate-clinica-938f7b0684c81129 2026-09-17T16:44:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-targets-first-line-itp-market-with-new-phase-3-romiplostim-trial-b2b5a50b508a6418 2026-09-17T16:39:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-eases-compounding-rules-for-preemie-nutrition-packs-as-supply-shortage-looms-8798c0cbcd5cf433 2026-09-17T16:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-stock-gains-attention-as-ide-849-moves-toward-phase-3-d8645ee5bb43994f 2026-09-17T16:33:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-much-does-a-tms-machine-cost-pricing-and-total-cost-of-ownership-compared-fo-4d06c42d3d7ea456 2026-09-17T16:33:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/unc-health-school-of-medicine-leaders-build-connections-in-ireland-b835479b32f4a15a 2026-09-17T16:29:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-biotech-company-had-268-million-in-cash-after-a-failed-drug-trial-it-announced-f6d2b2fc48d86112 2026-09-17T16:19:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/marlaina-goedel-marks-two-years-insulin-free-after-becoming-the-first-patient-in-c146a8c3d88155c5 2026-09-17T16:19:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-eledon-s-push-to-transform-type-1-diabetes-care-78d5e3a63d6b0ed6 2026-09-17T16:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eu-joint-clinical-assessment-turning-hta-reform-into-a-market-access-advanta-dd9e756bfa433d56 2026-09-17T16:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-immunology-joins-biotech-reverse-merger-boom-with-aethlon-deal-b8f9ff2d896dff1e 2026-09-17T16:09:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-snda-for-taletrectinib-in-ros1-nsclc-53ff6cb7f80eb90a 2026-09-17T16:07:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-diagnoses-a-major-factor-in-allina-health-s-doctors-strike-23be44412a8b9da9 2026-09-17T15:56:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-challengers-why-it-will-be-hard-in-a-midterm-likely-to-herald-change-to-oust-97f56f6d2eef548e 2026-09-17T15:55:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-minnesota-s-sentencing-guidelines-why-fraud-cases-rarely-lead-to-prison-68d9f5fccba4cc1a 2026-09-17T15:55:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-your-health-vaccine-recommendations-091737b5dba58c68 2026-09-17T15:54:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/days-after-maharashtra-fda-revelation-medicine-safety-act-sought-to-prevent-expl-62dece922f3831a3 2026-09-17T15:34:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-inside-the-ndc-12-transition-f8240ebebcaa2280 2026-09-17T15:34:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/there-s-a-biotech-stock-on-josh-brown-s-list-that-s-ignoring-the-market-noise-an-00acfc4984bf14ef 2026-09-17T15:32:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-mechanism-discovered-that-helps-cells-prevent-errors-during-dna-replicatio-799e041dbb008041 2026-09-17T15:25:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/moving-forward-with-purpose-77635de00e54261e 2026-09-17T15:15:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-rochester-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-he-83ecf322ceaf42b9 2026-09-17T15:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-es-du-chu-vos-factures-et-leur-mode-de-transmission-evoluent-4dc4dbcbdd7a58d6 2026-09-17T15:01:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/retour-sur-le-1eseminaire-prevenir-dedie-aux-professionnel-les-du-chu-2e56edc628cd51e6 2026-09-17T14:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-phase-3-etentamig-results-and-data-from-broad-multiple-myeloma-29444dd186815626 2026-09-17T14:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-maryland-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-hea-ad7cc39c4825b3a6 2026-09-17T14:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/classement-newsweek-gustave-roussy-premier-centre-de-lutte-contre-le-cancer-en-e-4e1ce4ca95c94eb3 2026-09-17T14:52:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/becas-internacionales-de-la-subsecretaria-de-relaciones-internacionales-e-interj-dfa8f436132d68d8 2026-09-17T14:45:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-escalator-legend-biotech-biomarin-turn-therapeutics-and-more-59a1bb9970ad70be 2026-09-17T14:43:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-popular-fermented-food-may-help-flush-nanoplastics-from-the-body-95f0ba92fb6fd6eb 2026-09-17T14:42:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/southern-virginia-heart-walk-brings-community-businesses-together-to-fight-heart-f5b148de4b03b26b 2026-09-17T14:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-named-to-time-s-world-s-top-healthtech-companies-for-the-second-c-9311e95b20857983 2026-09-17T14:35:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-opens-new-grand-junction-physical-therapy-clinic-ecdbd2602eeb335c 2026-09-17T14:34:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/centanafadine-may-offer-second-line-option-for-patients-with-adhd-if-stimulants-3e160ac2fc5ea8b2 2026-09-17T14:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-startup-to-test-psychedelic-like-drug-against-parkinson-s-symptom-b4ed51ead7a85a49 2026-09-17T14:34:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-108-year-old-olympia-coffee-house-canteen-shut-over-meat-blood-in-fridg-44d3da3e71e7b39b 2026-09-17T14:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/5th-circuit-panel-seems-skeptical-of-louisiana-abortion-pill-case-aa9c158dc8721073 2026-09-17T14:32:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-excess-mortality-a-guide-to-the-main-reports-12c7784e1f020f77 2026-09-17T14:31:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-arrest-survivors-sisters-advocate-for-health-and-raise-funds-critical-fo-88a18b7d57821017 2026-09-17T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuer-biodrucker-fur-die-plastisch-und-handchirurgische-klinik-7c40774901042ea9 2026-09-17T14:29:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-mumbai-s-olympia-coffee-house-nair-hospital-canteen-ove-937781874be6692b 2026-09-17T14:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/creating-value-through-early-phase-trial-design-how-the-fda-s-single-phase-3-piv-990fc2d9ece24c53 2026-09-17T14:15:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/pet-come-si-svolge-l-esame-3a1f061b28f6012b 2026-09-17T14:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/usz-erreicht-spitzenplatze-in-elf-fachbereichen-e640f37cd5d6e7b6 2026-09-17T14:12:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-20-september-2026-7353f08bd7424352 2026-09-17T14:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-eliminates-outdated-uv-filters-as-regulatory-modernization-continues-2732866e9bc52a42 2026-09-17T14:09:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/aquestive-resubmits-nda-for-sublingual-epinephrine-film-anaphylm-after-fda-crl-cbe278ad7206f20a 2026-09-17T14:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-company-receives-second-grant-to-develop-gene-therapy-for-afib-8bff45b3daa50406 2026-09-17T14:03:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-definium-s-lsd-based-drug-meets-endpoints-in-gad-study-9946f77790c4ebaf 2026-09-17T14:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/minister-of-state-for-social-care-and-mental-health-speech-on-dementia-4b19c9af5602321d 2026-09-17T14:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-puget-sound-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-228ecfcb192837c8 2026-09-17T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quand-l-ia-remet-en-question-la-prise-en-charge-des-victimes-d-infarctus-du-myoc-5d9e791bbdde1e14 2026-09-17T13:57:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-radiology-saves-lives-european-commission-president-von-der-leyen-hig-2fafb3df665b5695 2026-09-17T13:57:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fed-rate-hike-won-t-hold-biotech-down-despite-climbing-capital-costs-f2607a72bd40fecd 2026-09-17T13:43:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-novartis-devastating-m-a-losses-long-live-the-executive-willing-to-try-1e02e33acfc9b6f0 2026-09-17T13:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacy-researcher-develops-treatment-for-mosquito-borne-virus-378d3039ffeae71a 2026-09-17T13:38:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/altis-labs-ai-imaging-endpoint-predicts-overall-survival-benefit-in-phase-3-lung-bd3f1bdba2973e05 2026-09-17T13:37:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-central-virginia-leaders-advocate-for-health-and-raise-funds-critical-for-figh-1385cc8b03f49fd4 2026-09-17T13:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-raises-123-million-series-c-to-advance-oral-thyroid-eye-disea-ce33343ebad3dfb2 2026-09-17T13:30:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/trust-in-america-s-food-safety-system-is-crumbling-congress-can-restore-it-93cfc4dd56f3e77f 2026-09-17T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ibtrozi-for-locally-advanced-or-metastatic-ros1-nsclc-41cf331ea6cf4701 2026-09-17T13:23:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-discovery-stock-up-50-in-1-year-why-it-rallied-f7e3a6bd438b8317 2026-09-17T13:22:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-biotech-ipo-prospects-testing-investor-appetite-2e6e9f9857fd271b 2026-09-17T13:21:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-error-en-el-etiquetado-de-las-protesis-vasculares-silver-c6caa0a9382e566d 2026-09-17T13:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/chair-appointed-to-lead-tees-esk-and-wear-valleys-trust-inquiry-242a5861e8dd65d0 2026-09-17T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abclon-global-phase-3-trial-for-ac101-to-wrap-in-2027-dual-targeting-adc-trials-807ffe3f89f9a483 2026-09-17T13:01:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-greater-washington-region-leaders-advocate-for-health-and-raise-funds-crit-e169275d47aa7823 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/6-san-diego-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-he-07e6369e95026acc 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-orange-county-leaders-advocate-for-health-and-raise-funds-critical-for-fightin-ac3fdca06ad0aac4 2026-09-17T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiofrequency-rf-safety-considerations-for-wireless-cardiotocography-ctg-monito-ae4383240e38c90d 2026-09-17T12:59:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/creatina-5-0-8ce63b00b277d512 2026-09-17T12:52:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/editors-picks-september-2026-drug-resistance-breast-cancer-treatment-covid-19-an-ca8bd5ac0be95b61 2026-09-17T12:52:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeffrey-barrettin-tavoitteena-on-sairauksien-havaitseminen-aiemmin-ja-tarkemmin-9d7dbbbd15943811 2026-09-17T12:49:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-technologies-announces-last-patient-last-visit-in-pivotal-phase-3-clinic-748f1465d191515c 2026-09-17T12:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alumna-preserves-dolly-parton-s-literacy-legacy-statewide-d00d4d503383679c 2026-09-17T12:44:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/cm3-caps-cm3-powder-250g-pink-grapefruit-e200f93ecbd03131 2026-09-17T12:39:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-technologies-slgl-hits-key-phase-3-gorlin-milestone-29a6a1657afaa450 2026-09-17T12:30:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-patient-safety-day-when-being-disbelieved-becomes-a-patient-safety-issueby-d13b18200dd9ab2f 2026-09-17T12:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-skin-cancer-trial-reaches-its-final-visit-sol-gel-expects-results-in-late-nove-265a07288f881304 2026-09-17T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-to-present-phase-3-etentamig-results-and-data-from-broad-multiple-myeloma-3861cacd7165fe8b 2026-09-17T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-irritability-long-after-concussions-in-veterans-is-linked-to-ptsd-ch-8cbe15644c31b9c9 2026-09-17T12:18:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/genmab-stock-gains-as-hc-wainwright-lifts-q3-earnings-estimates-and-phase-3-peto-373b2c3b309071fe 2026-09-17T12:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effects-of-financial-incentives-are-often-underestimated-d7d29eb243b4af93 2026-09-17T12:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-you-really-shouldn-t-overcook-your-proteins-e42fa4a2df65e838 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-oxalate-reagent-kit-e550250a7b0c93ec 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapicidetm-pa-high-level-disinfectant-bc00a62bf84be4e9 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/philips-ingenia-achieva-and-intera-mr-systems-76648b3b19c78211 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-long-island-leaders-advocate-for-health-and-raise-funds-critical-for-fighting-871326a26c6bc78c 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-presents-new-clinical-data-evaluating-skin-quality-improveme-b8a40f46cc9abc67 2026-09-17T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/class-4-medicines-defect-notification-martindale-pharmaceuticals-ltd-clobazam-ma-212604759061b3b7 2026-09-17T11:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/democrats-pump-and-dump-attacks-against-vivek-ramaswamy-don-t-add-up-da22e8191dbb38b2 2026-09-17T11:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-la-noche-de-los-lapices-recuperar-la-historia-para-construir-nuevas-f4b63b1a1ae128a8 2026-09-17T11:47:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fennec-pharmaceuticals-announces-oral-presentation-of-detailed-results-from-inve-e87af58248a92da4 2026-09-17T11:46:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-immunology-goes-public-via-reverse-merger-as-eczema-drug-heads-toward-clin-ac5eaa2ebdb610e1 2026-09-17T11:40:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvation-bio-announces-fda-approval-of-supplemental-new-drug-application-for-ibt-74142b5856010ab0 2026-09-17T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidelberger-forschungsprojekt-gibt-ns-opfern-namen-und-geschichte-zuruck-619686dc49c6e31a 2026-09-17T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-autumn-programme-resources-3e4d4b5a8c8a27bc 2026-09-17T11:14:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-natural-gut-compound-that-helps-heal-the-intestine-70b8ceac267e05a3 2026-09-17T11:13:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergy-film-that-cuts-dosing-time-resubmitted-by-aquestive-nasdaq-aqst-1ba0b5ab1fe3f8d6 2026-09-17T11:03:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-signing-of-mou-with-king-abdullah-international-391b307649c2487b 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyllene-therapeutics-appoints-seasoned-biotech-executive-dr-marc-grasso-as-chief-b2a33d9a332c8832 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hovione-pharmaceutical-company-opens-31k-sq-ft-facility-in-east-windsor-adding-a-63b3a40a0c111755 2026-09-17T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-presents-sotyktu-deucravacitinib-data-showing-durable-effic-ab59c6531d46fb79 2026-09-17T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-explores-macrocycles-potential-in-1-4b-cardiometabolic-pact-with-danish-bio-83b246e22760048d 2026-09-17T10:56:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/textbooks-may-have-misdrawn-this-basic-brain-structure-for-100-years-7581a3479b32e04e 2026-09-17T10:54:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/symposium-indigenous-relationships-with-time-47fe510eed976233 2026-09-17T10:46:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/70mg-4ml-962d855db4c60637 2026-09-17T10:35:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-biotech-hedge-fund-births-a-new-immunology-company-81b7beb45c9e906f 2026-09-17T10:34:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/innate-pharma-ipha-extends-cash-runway-to-q1-2028-after-sobi-deal-and-30m-share-356bebb27c4a8704 2026-09-17T10:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/recovering-lives-preventing-social-exclusion-six-years-supporting-home-recovery-3bdf027939b055c5 2026-09-17T10:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-ordered-studies-of-many-drugs-devices-on-the-market-are-not-done-86a4a800b65f63b0 2026-09-17T10:32:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/children-s-public-health-nursing-workforce-and-activity-2025-cf1dc915acbdddd5 2026-09-17T10:26:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-reddy-s-enters-royalty-free-agreement-with-gilead-for-annual-lenacapavir-hiv-425716ba2f3f604b 2026-09-17T10:22:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/upfront-cash-hits-innate-pharma-ipha-as-lymphoma-drug-pact-takes-effect-b9face9e737abc29 2026-09-17T10:22:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-companies-prepare-production-in-orbit-channel-newsasia-69453acee50ff8ba 2026-09-17T10:18:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/southnord-artfest-2026-roots-en-route-bee1bb7e9ad69218 2026-09-17T10:10:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/get-the-care-you-need-where-you-need-it-df971658819361e2 2026-09-17T10:08:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-apollo-bc-advanced-perfused-platform-for-breast-cancer-therapy-re-e0b3d1094d7d5a18 2026-09-17T10:03:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-extended-reality-technologies-research-and-training-in-healthcare-09b8df81b2fae8bf 2026-09-17T10:03:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-re-wiring-tumor-immune-evasive-plasticity-with-mrna-therapy-c5d902cadf530a9e 2026-09-17T10:03:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-international-staff-exchange-for-preterm-birth-early-diagnosis-an-ac5c4ef903559990 2026-09-17T10:03:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/testosterone-for-menopausal-women-fda-review-sparks-debate-a4d78420495e25b5 2026-09-17T10:01:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-stands-out-once-again-in-the-2026-shanghai-thematic-rankin-46ce1d0268d638fc 2026-09-17T09:43:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-company-roche-succeeds-in-phase-3-trial-of-cancer-drug-6ebb3f484a643754 2026-09-17T09:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-be-on-tour-2026-klinische-studies-zijn-een-strategisch-pluspunt-voor-pati-78f02618f856aad7 2026-09-17T09:22:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-has-a-grip-on-america-s-pharmaceutical-industry-and-that-s-a-threat-on-nat-56163250b91fc512 2026-09-17T09:13:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/de-lancering-van-een-concurrentiekrachtbarometer-voor-de-biofarmaceutische-indus-68cf590c40dc0e6d 2026-09-17T09:05:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/life-changing-cancer-treatment-could-transform-care-for-autoimmune-conditions-664000b9a06fd29f 2026-09-17T09:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/boehringer-halts-phase-iii-kidney-trial-of-vicadrostat-jardiance-combination-0741a91de32987de 2026-09-17T08:57:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/benchmarking-the-foundation-of-reliable-ai-in-biomedicine-b0c86ba0d683f2e0 2026-09-17T08:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/longeveron-s-phase-2b-stem-cell-flop-spurs-cost-cutting-exploration-of-all-optio-5a694be2f452f7d3 2026-09-17T08:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-s-fda-overhaul-how-a-food-safety-watchdog-is-now-taking-on-drug-p-223ff0e222293168 2026-09-17T08:33:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/measles-epidemiology-2023-to-2026-1387e9c40489bd37 2026-09-17T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/salmonella-outbreak-update-dbba55fa25793323 2026-09-17T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioscience-and-health-technology-sector-statistics-2024-to-2025-76d66d939a9818b2 2026-09-17T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioscience-and-health-technology-sector-statistics-6c8da0610eecb0b8 2026-09-17T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/informationstag-pankreaszysten-wann-ist-eine-behandlung-notwendig-e06e284e6f7f97ef 2026-09-17T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/revolution-medicines-just-hit-a-major-milestone-is-the-stock-a-buy-a1dc82995834a458 2026-09-17T08:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/migrant-health-guide-bdf31ac2db51f874 2026-09-17T08:16:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunisation-patient-group-direction-pgd-templates-1af7ede7c1c283c6 2026-09-17T08:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-connects-with-120-korean-biotechs-in-search-for-r-d-licensing-deals-6032fe94dde44e6f 2026-09-17T07:54:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ovmedi-s-knee-pain-relief-device-wins-fda-breakthrough-device-designation-f419ab739f1617a4 2026-09-17T07:50:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtu-packaging-cooperation-is-key-b7cc7f88c1ecb9e2 2026-09-17T07:44:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/was-einen-starken-forschungsstandort-ausmacht-c7dadc2f0a981335 2026-09-17T07:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/generative-ai-in-research-build-your-confidence-with-the-new-eur-online-module-767063a0e5d287dd 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-expands-faecal-dx-antigen-testing-platform-in-the-united-kingdom-with-taen-b529781628a7a773 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/school-of-nursing-earns-national-heed-award-for-inclusive-excellence-29847b6adccee306 2026-09-17T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gemeinsam-die-universitatsmedizin-in-bayern-starken-5e2ecb52b4188f5e 2026-09-17T06:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/mmi-marks-five-years-in-state-of-the-art-building-50d06298edd2b99c 2026-09-17T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/title-ix-office-begins-new-professional-development-series-ff66984912be811a 2026-09-17T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-ai-drug-development-milestones-land-in-a-single-day-as-novo-nordisk-eli-li-84c7a7e7c962ec5e 2026-09-17T06:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-constitution-day-d98419201ae9733f 2026-09-17T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-s-lung-cancer-drug-posts-impressive-overall-survival-data-cicc-raises-targ-f61410636fb8d53a 2026-09-17T06:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iii-celestimo-87908e384e7148f6 2026-09-17T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-phase-iii-celestimo-study-results-for-lunsumio-in-relapsed-or-re-a71e89ddbda78c93 2026-09-17T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/israel-national-biotech-innovation-center-inbi-launches-with-anat-cohen-dayag-as-8dca37929128a225 2026-09-17T06:29:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-biotech-stock-roundup-these-are-the-top-performers-in-2026-9150468048a7f3f7 2026-09-17T06:24:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-raids-12-establishments-seizes-food-worth-56-36-lakh-in-festive-food-sa-814c0d81f0358e5e 2026-09-17T06:18:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-startet-zentrale-ki-plattform-fur-klinik-forschung-lehre-und-verwaltung-89e5b497a98fecf5 2026-09-17T06:02:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/patienternas-erfarenheter-hjalper-varden-att-bli-sakrare-2fd987b01dd45f54 2026-09-17T06:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellules-familiales-c-est-quoi-le-microchimerisme-8a5315b67884f4dc 2026-09-17T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-genscript-biotech-stock-surging-today-cfcf0dd9005195ab 2026-09-17T05:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-6-10-16-eadf968f3e2a6944 2026-09-17T05:22:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-genscript-biotech-stock-surging-today-by-investing-com-e81c2f3bca3a32c8 2026-09-17T05:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-mesothelioma-drug-turns-cancer-s-own-defenses-against-it-d5f48e25cd3a7e54 2026-09-17T05:11:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-lunsumio-based-regimen-significantly-improves-progression-free-survival-a306a35baacb9b1f 2026-09-17T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/basic-earnings-per-share-basic-eps-of-gin-hwa-biotech-inc-tpex-7806-f0510930868fe55c 2026-09-17T04:30:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailoring-the-atrioventricular-interval-during-left-bundle-branch-pacing-playing-d55d36d142955481 2026-09-17T04:15:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/c6051a8af9b974d2 2026-09-17T04:14:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/05ab89cd21c399c2 2026-09-17T04:13:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-morality-of-making-money-by-drug-companies-what-judges-say-61b4f0f088d8ff7f 2026-09-17T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-health-advantage-in-black-and-green-rice-a1d37df894608434 2026-09-17T03:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-pharmaceutical-industry-ushering-in-a-new-narrative-industry-giants-are-c-10a842d86305115c 2026-09-17T03:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-accelerates-global-access-planning-for-investigational-once-yearly-lenaca-490cc4e240733c69 2026-09-17T03:31:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-discusses-ships-for-america-act-at-hudson-institute-af2fe1a8917adc7f 2026-09-17T03:19:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-implementation-of-pdg-harmonized-texts-into-japanese-pharmacopoeia-648515e15bc0dc92 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-cdx-approved-for-identifying-eligible-patients-updated-622cb0bc906cde46 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-opsumit-partial-change-approval-8b926a0ff49051b4 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-list-of-approved-medical-devices-april-2004-to-december-2025-b9c1596fbadb2d5c 2026-09-17T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-21-09-e-23-09-controlli-gratuiti-per-prevenire-i-tumori-testa-collo-43d771103813000c 2026-09-17T02:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hidden-immune-organ-in-the-skull-may-help-fight-brain-cancer-cb58b17dbed624b7 2026-09-17T02:43:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-the-pharmaceutical-industry-embracing-a-new-narrative-industry-giants-are-col-2b76358db7efbe16 2026-09-17T02:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/anthropic-s-drug-discovery-partners-ai-pharmaceutical-orders-set-to-double-next-94b555d4be014da6 2026-09-17T02:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-korean-nuclear-test-sets-off-years-of-earthquakes-cf7db1f6465d1f2d 2026-09-17T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-forests-burn-can-we-replant-trees-ready-for-a-warmer-world-128739f835fd523d 2026-09-17T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-green-lights-1st-new-sunscreen-ingredient-in-years-4d1f139bc83cf3e9 2026-09-17T01:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/puma-biotechnology-nasdaq-pbyi-director-exercises-50k-options-sells-62k-shares-4587cf2f7f1ab95b 2026-09-17T01:13:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-with-emotional-intelligence-in-the-pharmaceutical-and-biopharma-industry-8a25c40b31642bdd 2026-09-17T01:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-to-support-the-protection-of-japanese-crested-ibis-habitats-for-the-16th-b696997410e8a3c4 2026-09-17T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-teva-pharmaceutical-industries-ltd-rstock-cc93b96ead8637d1 2026-09-17T00:57:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/greater-access-to-help-needed-for-women-with-nausea-during-pregnancy-44936c86b6095aaa 2026-09-17T00:42:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/bytedance-spin-off-ai-pharmaceutical-division-secures-massive-2-billion-yuan-fir-e94c7127fad69d8a 2026-09-17T00:30:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-unlp-busca-actualizar-el-sistema-de-boleto-educativo-gratuito-bb1a8f9c105b87b5 2026-09-17T00:18:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-de-su-asesinato-rendimos-homenaje-a-sergio-karakachoff-c0d9a09f2a74861f 2026-09-17T00:18:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/encuentro-de-secretarios-administrativos-por-la-nueva-ordenanza-101-a355412d3efc8e61 2026-09-17T00:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/inscripcion-al-jardin-maternal-de-la-unlp-745eaae45cdb5ef0 2026-09-17T00:12:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/se-prepara-la-segunda-jornada-de-deportes-electronicos-9d81b52f78266908 2026-09-17T00:11:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-board-member-receives-new-options-and-rsus-0fda544b57675dd6 2026-09-17T00:07:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-fac321c3b6b02e2a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-filed-form-6-k-d667b90b40c7dbc4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pioneering-research-team-and-emerging-scholars-lead-uct-s-success-at-nrf-awards-08f4f6f4a2c58d9b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-microsatellite-instability-detection-in-precision-on-6a2a9824b5cf6d3d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/levetiracetam-therapeutically-targets-gabaergic-synapses-in-diffuse-midline-glio-5521cb0cfbf33f83 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gene-editing-using-large-insertions-b56e263edfad4029 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-genomic-deletion-of-malic-enzyme-2-confers-collateral-lethalit-464dd1ffc6734db4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-consumer-and-societal-values-perceptions-and-preferences-on-high-cost-ge-81b2d1eba7414653 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-a-team-of-ais-discovered-a-promising-lung-cancer-drug-6cf2b7d138e9d94e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-fast-are-you-ageing-ask-ai-86ffad19c6215ecb 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/take-a-risk-or-play-it-safe-neuronal-tug-of-war-helps-the-brain-decide-472015102d7f088a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/who-gets-credit-in-the-ai-era-openai-maths-bombshell-sparks-debate-337c4603c1cbf927 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mercury-is-shrinking-with-age-faster-than-thought-c1a37d230b37b35e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schoolhouse-meals-serve-up-an-income-bump-eee98c0d76e7273a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-new-evidence-for-hidden-chambers-beyond-tutankhamun-s-tomb-8c7871f23e0df62f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recommendations-for-the-development-of-blood-collection-processing-and-storage-s-b8c6b7db48c7e21e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-e6707987ea0046b9 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-exemption-from-premarket-notification-radiology-computer-aided-d-1da78c63c52f8524 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-and-medicaid-programs-application-from-dnv-healthcare-usa-inc-dnv-for-c-44f3c570867b78f3 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-information-collection-activity-diaper-distribution-demonstration-and-r-2a2324bd5db6fe4b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-colgate-optic-white-stain-fighter-fresh-mint-59f2e1ee1aa6b868 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-dramamine-orange-824cec4fdecf7bba 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-coltalin-dm-786e98cf271da27e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lymph-tonic-ii-51c8deccecb971b8 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-d9900f0738cb018f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/undersoker-sambanden-mellan-sociala-villkor-och-psykisk-ohalsa-9c4a5c6e43587264 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-undersoker-hur-matstrupscancer-kan-forebyggas-b2587fd59e8fa345 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kvinnor-upplevde-mindre-smarta-vid-spiralinsattning-med-ny-metod-94bbb5df87fc47e1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clintec-faculty-day-samlade-forskning-samverkan-och-framtidsfragor-d930cc81fe7effd5 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brister-i-var-tredje-journal-vid-utredning-av-mojliga-cancersymtom-34d21f33f335d0a7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengt-fadeel-keynote-talare-vid-eurotox-2026-2f5972eb8e18c29a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-success-prediction-from-open-registry-text-using-classical-machin-119b20e7ebb0443e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-data-and-theory-hybrid-modelling-for-pharmaceutical-crystallisation-pro-8e9a75aca67b45fc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-novel-anti-cancer-agents-targeting-triple-negative-breast-cancer-2b40c9b7cbdecfb0 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newer-antibiotics-for-drug-resistant-gram-negative-infections-in-immunocompromis-ac2c79a70fe51225 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efbemalenograstim-alfa-as-prophylaxis-for-chemotherapy-induced-neutropenia-in-pa-a5b8d9f8fd1c9d88 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/access-to-early-phase-oncology-trials-trajectories-and-outcomes-of-more-than-26-498c11844354525e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-rsv-vaccination-clinical-efficacy-safety-and-global-policy-consideratio-cc3e6e4559d1157d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-number-of-previous-malaria-episodes-and-treatment-failure-am-d33f9375429dd2d2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-functional-prognostic-model-predicts-progression-free-survival-in-patients-wit-12143bad94beabe2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incentivizing-challenging-drug-discovery-from-reducing-failure-to-quantifying-un-db5f865d210d7a05 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-safety-and-pharmacokinetics-of-bgm0504-a-dual-glp-1-gip-receptor-a-f1d9e7e14bcc5461 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-impd-deficiencies-in-the-clinical-trial-approval-process-2d5ea4123aeb939a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chitosans-and-chitosan-derivatives-in-pharmaceuticals-that-reached-clinical-tria-7dc4f0e025688551 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/economic-outcomes-of-dalbavancin-versus-standard-therapy-in-staphylococcus-aureu-fb4c42c3642ddadf 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amyloid-beta-targeting-monoclonal-antibodies-in-early-alzheimer-s-disease-a-coch-acaa29fe56896555 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds0101-with-pembrolizumab-in-hpv16-positive-recurrent-metastatic-head-and-neck-9b0b01f694d1ac61 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-virtual-biotech-a-multi-agent-ai-framework-for-therapeutic-discovery-and-dev-8aebfc32b4201382 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-olanzapine-on-chemotherapy-related-anxiety-in-pediatric-cancer-patien-ee558ad45c46ba67 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanostructured-lipid-carriers-for-intranasal-cannabidiol-delivery-in-dravet-and-b8989db3000516aa 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-response-screening-the-mmv-pathogen-box-reveals-the-mitochondrial-bc1-com-10cec4bb4b7e08bc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/screening-the-mmv-pathogen-box-reveals-the-mitochondrial-bc1-complex-as-a-drug-t-17cf47f0595fc2f2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/respuesta-clinica-y-predictores-de-mortalidad-en-pacientes-con-ventilacion-mecan-bad3f71736007fb9 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/routine-immediate-postoperative-chest-radiography-after-minimally-invasive-pulmo-4aa500f12b8a1c92 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-systemic-oral-cellulose-based-superabsorbent-hydrogels-for-weight-management-1e7367eb1f656e51 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-and-mid-term-outcomes-of-primary-versus-redo-pericardiectomy-for-c-1a635c7aa54495a5 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-prosthesis-survival-after-total-hip-arthroplasty-in-young-women-with-d-319dd339550173cf 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spectrum-of-hereditary-ataxia-in-omani-children-46c98951ca8fdde4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidental-misdiagnosed-intrahepatic-cholangiocarcinoma-and-combined-hepatocellu-c0bd4395c613f23d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-diagnostic-delay-amplify-drug-resistance-in-tuberculosis-a-critical-integrat-e8ff8bb311e6bad4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiological-characteristics-of-pediatric-skull-fractures-and-their-ab36bd523cdbec99 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organoboronic-acids-as-co-formers-in-pharmaceutical-crystal-engineering-d4e373881148a581 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interventions-to-reduce-antibiotic-prescribing-in-small-animal-veterinary-practi-4006c75ca92b7120 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promater-protocol-for-a-randomized-controlled-trial-of-a-digital-self-guided-int-c7b2846433ae325f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-enabled-passive-digital-phenotyping-of-experiential-negative-symptoms-in-schi-9e28b9b0c36b8694 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/waveband-resolved-nonlinear-characterization-of-serf-magnetocardiography-signals-edca74eb526ec354 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-volume-ii-tumour-microenvironment-in-cancer-research-and-drug-discover-7fe50959d7c1a534 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-value-of-probiotics-as-adjunctive-therapy-for-diabetic-nephropathy-a-me-13c9984fdb8213cd 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-research-trends-in-tuberculosis-drug-resistance-mechanisms-a-bibliometric-a1b5946382edc9eb 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/off-target-drug-repurposing-for-rare-and-ultra-rare-cancers-towards-a-scalable-t-049d863795cd2bca 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-integrated-tam-aida-model-for-digital-health-technology-adoption-evidence-fro-27a9d20c4f65a064 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-factors-and-short-term-outcomes-of-lower-limb-fractures-in-diabetic-patient-08bb6d6c5ead5d38 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-impact-of-mydriatic-drops-on-intraocular-pressure-variations-acr-21669ad105ec4b61 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unraveling-the-mystery-of-status-epilepticus-a-retrospective-study-at-a-tertiary-a9048ab8cd680ff1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microplastic-exposure-in-everyday-life-an-awareness-based-kap-study-among-the-in-46559a8bb0d2738f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-simulated-long-term-brushing-and-acid-exposure-on-the-surface-properti-202a2db61a3f0909 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-of-primary-headache-disorders-in-patients-with-epilepsy-and-res-b4e9273ab4be4795 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-predictors-of-early-multidomain-symptomatic-recovery-in-hospitalized-pa-35b55f37f9e3dce4 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clinical-study-on-multidimensional-phenotypic-parameters-of-gender-and-age-dif-98810244e0a54730 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mind-over-cervix-using-virtual-reality-to-improve-anxiety-and-pain-during-outpat-f47ec1626d949d07 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-preoperative-coenzyme-q10-supplementation-on-oxidative-stress-and-wou-74761ebb3a19b789 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anatomical-features-and-hemodynamic-aspects-of-vascular-anastomoses-in-reconstru-5267a214891b3b54 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/to-eat-or-not-to-eat-dietary-patterns-and-the-clinical-recognition-of-insulinoma-77c4e9d24c7b9904 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypercholesterolemia-in-underweight-individuals-mechanisms-clinical-significance-f5008e8cc58ce6a6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasopharyngeal-carcinoma-epidemiology-risk-factors-signaling-pathways-clinical-f-9be3d020f20b2d04 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-clinical-education-assce-a-scoping-review-of-use-and-experiences-o-3e91b28930af36ca 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/express-longitudinal-circulating-mirna-profiling-identifies-pharmacodynamic-biom-b4eccbcf06de3c8e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-kidney-health-in-focus-a-scientific-statement-from-the-american-heart-as-528fafe1392aeedc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-and-systemic-risk-factors-of-dental-biofilm-induced-gingivitis-and-their-c-3aa6ba93a69d0a95 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-the-long-term-risk-of-type-2-diabetes-and-cardiovascular-disease-with-278ebe7d9c1b0a9e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurofeedback-for-functional-neurological-disorders-future-directions-for-resear-9f18be548ab7c6f8 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/water-and-liquid-soap-cleaning-of-removable-orthodontic-appliances-a-triple-blin-f4be5b10c5e36833 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-microbiologic-predictors-of-progression-to-infection-among-children-981a1a8b318f2fc1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-internal-validation-of-an-ehr-machine-learning-model-for-clinica-f6dc3fc0d96a01f1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-a-three-month-exercise-programme-on-cognition-mood-and-neurogenesis-t-d2be6075925e41cc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-endogenous-carbon-monoxide-for-cancer-selective-drug-synthesis-23780c69301d10a7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modulating-the-periodontal-wound-microenvironment-through-oxygen-therapy-a-narra-c1466eabbd8e63ab 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-dual-role-of-cholesterol-metabolism-in-hepatocellular-carcinoma-mechanisms-t-52c334fe86bb524b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpreting-positive-and-inverse-disproportionality-signals-in-spontaneous-repo-1200b13c43ca8e4c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glucagon-like-peptide-1-receptor-agonists-and-neovascular-age-related-macular-de-525d52014b3f883c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sub-acute-clinical-leaflet-thrombosis-after-transcatheter-aortic-valve-implantat-c4a7c6391d426847 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-buffered-vs-non-buffered-4-articaine-local-anaesthetic-solution-in-a-4ab465f7d4e61830 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/surgical-resection-of-a-liver-metastasis-from-an-ovarian-granulosa-cell-tumor-mi-72fc1923a67b60b6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-silico-and-hansen-solubility-parameters-guided-hme-3d-printed-tablets-boostin-30492068315baa08 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-import-forecasting-for-supply-chain-decision-support-a-comparativ-1fbb7af35c0e9d08 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vitro-anti-inflammatory-evaluation-gene-expression-hr-lc-ms-profiling-and-in-3d700e8cd593a619 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-agroenvironmental-clinical-link-of-proteus-mirabilis-genomic-epidemiology-cl-b5598d5aee03a1b2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-magnetic-resonance-enterography-for-pediatric-crohn-s-diseas-87bd48bb81c7cd25 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-development-and-optimisation-of-an-amorphous-solid-dispersion-based-etori-91b0613d64d9403e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-clinical-mediation-in-end-of-life-disputes-a-procedural-justice-analysis-bd4d4e19235b69df 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07826130-nano-silver-fluoride-and-photobiomodulation-therapy-for-hypersensiti-b4a4f724abc4bfdc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825870-outcomes-of-fluoroscopy-guided-transdiscal-splanchnic-nerve-neurolys-3f7abb7852e2ca56 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825701-individual-patient-expanded-access-for-velzatinib-gsk6042981-in-pati-2ea78bb102116063 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07825064-cevostamab-in-combination-with-pomalidomide-and-dexamethasone-after-77853e3edda2daa1 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823959-cbc-based-inflammatory-indices-in-newly-diagnosed-multiple-myeloma-375a05e3b59697a6 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07767890-a-study-of-the-safety-and-effectiveness-of-onasemnogene-abeparvovec-4ce5877dc35d6e35 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07660081-effects-of-acetyl-l-carnitine-supplementation-on-clinical-metabolic-b7ede323169891dc 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07659782-a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-non-sm-18e7ce25a19f9095 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07656636-perforated-appendicitis-and-postoperative-antibiotics-pilot-trial-8d7d89a727dcd441 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07630974-a-study-of-ifinatamab-deruxtecan-in-pediatric-participants-with-rela-ebb34d1e74d8f582 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07625644-bl-m14d1-plus-atezolizumab-vs-standard-of-care-in-first-line-extensi-c2a444214ae9ea17 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07596849-a-study-to-assess-efficacy-and-safety-of-efgartigimod-ph20-sc-pfs-in-a040a5fe30d6eb53 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07574541-multitargeted-recombinant-ad5-psa-muc-1-brachyury-based-immunotherap-0f3af0b930fedd23 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07545291-a-spiritual-health-intervention-path-for-improving-spiritual-religio-655772e97f709724 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07505706-patient-journey-in-palliative-care-within-the-novo-hospital-group-32ce4588df512269 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07490860-a-restorative-justice-based-lung-cancer-screening-decision-making-su-2fd16cf28dd0e41c 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07456696-an-evaluation-of-the-safety-and-efficacy-of-tsnd-201-for-the-treatme-311ad94fea94556e 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07361432-digital-treatment-for-chronic-pain-and-addiction-in-veterans-with-op-e6b77566701e13ee 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07339111-phase-3-pivotal-trial-comparing-cartistem-and-surgical-comparator-fo-b4f1a62c1bd31e3a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07289243-treatment-for-benign-prostatic-obstruction-transperineal-laser-ablat-87889351226ce165 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07227415-symbiotic-gu-08-a-study-to-learn-about-the-medicine-called-pf-086344-31b83c018be3344a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07172802-a-study-of-gi-108-an-anti-cd73-igg4-fc-il-2v-bispecific-fusion-prote-a9136767e2878860 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07049926-substudy-03c-a-study-of-combination-therapies-in-participants-with-r-9a8ad78617f16916 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06952504-a-study-to-compare-sacituzumab-tirumotecan-mk-2870-in-combination-wi-e71573a13633e252 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06790498-long-term-follow-up-study-of-participants-exposed-to-renal-autologou-eceefa5a26235e17 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06733363-a-cruciferous-vegetable-eating-program-for-the-reduction-of-cancer-r-2e0ed65d37bf5c25 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06695897-a-non-interventional-observational-study-to-assess-long-term-efficac-989a95c98505c144 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06672146-comparing-new-treatments-for-people-with-newly-diagnosed-acute-myelo-51f701006c42f5e7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06671483-a-study-of-zasocitinib-in-adults-with-psoriatic-arthritis-who-have-n-1c4edd0ea261b148 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06668558-venetoclax-azacitidine-in-patients-with-acute-myeloid-leukemia-6ae38f1adf5a26be 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06623409-safety-and-immunogenicity-of-v540b-in-healthy-adults-v540b-002-0be620543c58503a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06615973-screening-for-social-determinants-of-health-sdoh-and-cognitive-funct-69af5e89852e6a1a 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06605222-a-trial-of-shr-7787-injection-in-patients-with-advanced-solid-tumors-92aa4f67912a2b5b 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06583018-mindfulness-based-lifestyle-modification-programme-for-caregivers-of-b685dc0802101154 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06529523-tislelizumab-in-people-with-colorectal-cancer-be34c9bd54aa73d7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06353386-substudy-01a-safety-and-efficacy-of-opevesostat-mk-5684-based-treatm-cf0dc71aa337d086 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06148025-antibiotics-and-vaccine-immune-responses-study-4cacf1b74715f1ac 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06098833-treatment-of-neonatal-encephalopathy-with-oral-sildenafil-suspension-266e9b61d1feb456 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05902351-natural-history-study-for-charcot-marie-tooth-disease-9441c73624d11e73 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05744921-a-study-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-p-cae51eeebebbb8c7 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05603728-exactech-shoulder-post-market-clinical-follow-up-study-2904fd6614d479e2 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05564377-targeted-therapy-directed-by-genetic-testing-in-treating-patients-wi-2008e0086f4d7541 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05492851-trial-comparing-three-single-dose-injections-for-knee-osteoarthritis-de11a108dbea0d77 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05267639-clinical-outcomes-with-passive-mpks-vs-powered-prosthetic-knees-dd38e09a93e675aa 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05136196-bicazo-a-study-combining-two-immunotherapies-cabozantinib-and-nivolu-3eb3d3ab47dbf20d 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04638803-a-phase-0-open-label-crossover-microdose-pharmacokinetic-study-of-pr-4b9d4c2f14fe6101 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00921232-assessment-of-the-burden-within-the-dyad-patient-caregiver-f81c9d6a05b874bf 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-b5536bfbcfaf8e3f 2026-09-17T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-sanofi-gilead-weigh-ai-readiness-and-validation-risk-at-pda-fda-conference-f9f6c159e3cb593a 2026-09-16T23:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-announces-personnel-change-956652823d3f43cd 2026-09-16T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-s-lab-made-antibody-shot-for-celiac-shows-hopeful-results-ecbc01d07dffb77c 2026-09-16T22:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pedro-resources-takes-250k-bridge-loan-from-insiders-as-it-eyes-biotech-pivot-9861b7f2fe548a26 2026-09-16T22:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-receives-4-2-million-nih-award-to-continue-all-of-us-enrollment-883c35c953fde48c 2026-09-16T22:05:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-21-09-fattori-di-rischio-e-differenti-scenari-nella-masld-una-sfida-quo-9b5ebdf1cefe3ce4 2026-09-16T21:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-biotech-s-us-75-000-second-life-23b198dbdacbdaef 2026-09-16T21:58:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/iconthin-biotech-marks-10-years-of-microalgae-innovation-as-astadaily-expands-ca-b776a2d708fd1090 2026-09-16T21:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-hit-with-lawsuit-over-its-proposed-opdivo-biosimilar-1f2484de4e80d755 2026-09-16T21:23:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-ipo-stock-tracker-how-newly-public-biotechs-are-performing-077ec10ed091a6c5 2026-09-16T21:10:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-zhejiang-anglikang-pharmaceutical-co-ltd-class-a-stocks-0cba90adc2365995 2026-09-16T20:53:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-finance-netherlands-ii-issues-eur-1-bln-of-4-250-senior-note-0f9644fe8abe7fc0 2026-09-16T20:39:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/use-of-probenecid-as-an-anti-virulence-agent-against-listeria-monocytogenes-3bfbddee45820887 2026-09-16T20:35:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/hawley-pushes-republicans-to-back-national-abortion-pill-ban-99866c89c28fe8a0 2026-09-16T20:32:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ada-family-day-at-the-dallas-zoo-d802a9e5bea6be67 2026-09-16T20:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-this-biotech-stock-just-got-a-rare-double-upgrade-7e7dcd156623785d 2026-09-16T20:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-comemora-20-anos-do-curso-de-biblioteconomia-e-gestao-de-unidades-de-inform-aa541f68d0cecdb6 2026-09-16T20:18:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-pharmaceuticals-buy-on-pixclara-fda-approval-and-tlx591-tx-part-2-advancem-e547720d3a6557d1 2026-09-16T20:10:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-tar-heel-army-rotc-cadets-earn-recondo-badge-baaf02bcf6b204ed 2026-09-16T20:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-75-million-payment-is-triggered-as-innate-pharma-starts-a-cancer-trial-81224f5f9fdca6c4 2026-09-16T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ers-2026-obesity-an-independent-obstruction-to-biologic-treated-asthma-8fe9aca8139f27b2 2026-09-16T19:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-researchers-to-establish-countywide-effort-to-catch-early-warning-sign-310e63d12e70c99b 2026-09-16T19:35:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthrough-study-finds-possible-causes-of-cardiac-fibrosis-in-hlhs-fb08546c24883418 2026-09-16T19:28:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-saint-joseph-hospital-earns-magnet-recognition-with-distinc-3c60775d657ec064 2026-09-16T19:18:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/litigation-involving-reproductive-health-and-rights-in-the-federal-courts-8a4c7a103016ef0f 2026-09-16T19:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-ropes-in-123m-for-oral-thyroid-eye-disease-drug-545cdd139d817376 2026-09-16T19:11:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/mayer-brown-represents-underwriters-on-teva-pharmaceutical-s-us-4-9-billion-seni-3890078c3ce9091a 2026-09-16T19:09:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-good-samaritan-hospital-introduces-ladies-night-out-f12b373d9531245f 2026-09-16T18:58:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/thanks-trump-why-canada-may-become-the-european-union-s-first-ever-associate-mem-159cd5ace0912083 2026-09-16T18:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/tauber-se-reunio-con-la-vicegobernadora-bonaerense-veronica-magario-bc55f6fe953d0941 2026-09-16T18:48:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-conversation-with-scientific-advisory-board-member-and-evolutionary-biologist-78e562fb61dca9a4 2026-09-16T18:40:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-gains-a-way-to-get-drugs-into-the-brain-buying-sironax-tech-for-125m-29a20728c63ef2a3 2026-09-16T18:35:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-kagoshima-university-explore-new-areas-for-research-and-training-collabora-7f84458cdc414908 2026-09-16T18:24:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-ever-drug-to-treat-life-threatening-disease-a-landmark-moment-47b6edd63729a568 2026-09-16T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-rafiki-holds-a-workshop-to-advance-drug-discovery-and-development-in-afric-6ae1b0a8fe5e9c37 2026-09-16T18:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-fortalecio-la-cooperacion-regulatoria-regional-en-la-reunion-anual-latinoa-a27b9b1eefa3aeaa 2026-09-16T18:07:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-car-in-your-garage-can-power-your-house-66c17fe910c507ab 2026-09-16T18:04:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrate-university-day-at-the-bell-tower-at-night-178b10df9de9e5e2 2026-09-16T17:53:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-behind-the-scenes-of-logipharma-usa-2026-d71d1ef69cd0003a 2026-09-16T17:43:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-and-partners-launch-handbook-to-strengthen-suicide-prevention-088712614b0aebed 2026-09-16T17:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/looking-beyond-short-term-turmoil-syngene-is-investing-for-the-future-ff2542fffd1088f1 2026-09-16T17:28:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-vivs-fda-approvals-pdufa-dates-drug-alerts-2026-vivs-9890ddb010a5431b 2026-09-16T17:18:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypertension-clinical-trial-pipeline-accelerates-as-100-pharma-companies-rigorou-0af55f774e29cf90 2026-09-16T17:15:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/examination-of-import-data-chemical-compounds-in-medicines-commonly-advertised-t-763641fbdc28ea5a 2026-09-16T17:14:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-will-novo-nordisk-be-in-5-years-as-the-glp-1-market-gets-more-crowded-b3961869c0ece775 2026-09-16T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-s-first-homegrown-obesity-drug-eppe-set-for-launch-this-year-challen-ab6bb3ea6dbff378 2026-09-16T16:58:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/617-billion-longevity-biotech-market-takes-shape-72fd4fdc99cabefc 2026-09-16T16:56:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogren-s-investors-c33dcbb7609e0cdd 2026-09-16T16:42:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-smidcap-stock-mizuho-analyst-highlights-immx-1a04bb2a75230e6e 2026-09-16T16:29:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-sustainability-modular-design-transform-pharmaceutical-manufacturing-094f4e78a7fc3cd5 2026-09-16T16:27:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-statewide-efforts-to-improve-heart-health-bbfbb0b44276a31f 2026-09-16T16:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-will-novo-nordisk-be-in-5-years-as-the-glp-1-market-gets-more-crowded-64b65b9c3b270224 2026-09-16T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-a-new-leadership-chapter-at-legend-biotech-5d204a30db404f28 2026-09-16T16:14:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ammonium-sulfate-fermentation-market-forecast-to-2035-biotech-demand-drives-grow-7089e7cb4d4ed2cf 2026-09-16T16:01:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-accelerates-biotech-promise-increasing-security-risks-86b42c82b5278c6d 2026-09-16T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-recipient-honours-organ-donors-with-transplant-games-overture-91018807af22fe2f 2026-09-16T15:50:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-reaches-hiv-prep-agreements-hong-kong-investigates-cloudbreak-ipo-9f9b09cdff1fc0b2 2026-09-16T15:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sicadi-resultados-de-categorizacion-de-docentes-investigadores-as-de-la-unlp-e34068010678089c 2026-09-16T15:36:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-treatments-drive-smarter-sustainable-pharmaceutical-packaging-38172df7a6199e47 2026-09-16T15:34:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/raw-material-complexities-and-strategies-with-for-advanced-therapies-75982b30edb4c2d1 2026-09-16T15:33:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/legionellosis-in-residents-of-england-and-wales-2025-ddbdab6f2a833e23 2026-09-16T15:33:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasa-hubble-fellowship-program-2027-803e4575d6d906d0 2026-09-16T15:25:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-counting-sheep-to-forty-winks-three-tips-to-get-your-kids-back-on-a-healthy-a507f783ecee492d 2026-09-16T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooking-class-livestream-italian-ground-turkey-frittata-d84cf9acb61ad274 2026-09-16T15:09:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-adrs-inched-up-as-telecom-and-biotech-led-472ac474aa915400 2026-09-16T15:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-s-giving-the-biotech-industry-sweeping-authority-to-sell-unapproved-drug-2190e459be361d76 2026-09-16T15:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/naoko-takebe-md-phd-joins-wilmot-to-build-early-phase-clinical-trials-and-develo-7441cb8dd9acd00e 2026-09-16T15:04:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cold-mortality-monitoring-report-england-winter-2024-to-2025-6966878552215588 2026-09-16T15:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/kibow-biotech-wins-2026-webaward-for-best-science-website-52d6a8ecf05d157c 2026-09-16T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-what-is-behind-the-variation-in-efficacy-f2db9c17e19f1a25 2026-09-16T14:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/bauchaortenaneurysma-nach-evar-neue-wege-zur-besseren-nachsorge-fad268c1acffb4b9 2026-09-16T14:57:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-shortages-a426e4f99d62d81a 2026-09-16T14:50:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/law-firm-leader-to-chair-2026-long-island-heart-stroke-ball-ff797735c0b6f755 2026-09-16T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivre-avec-et-apres-un-cancer-les-promesses-et-les-defis-de-la-sante-numerique-945e8a65c5d7a4f3 2026-09-16T14:46:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/estates-safety-fund-initial-schemes-and-associated-funding-allocations-2026-to-2-578511fd55580096 2026-09-16T14:42:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-ends-als-program-after-phase-2-flop-adding-to-r-d-woes-da0b1c01b0e1cfd3 2026-09-16T14:28:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/buy-european-incentivising-eu-based-pharmaceutical-manufacturing-f0be7ec5d4a13c8d 2026-09-16T14:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/people-on-the-move-ingrid-zhang-named-chief-executive-officer-of-legend-biotech-fa8e3ddf53ecd71a 2026-09-16T14:17:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-493b66e4547da753 2026-09-16T14:12:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-novartis-veteran-ingrid-zhang-as-new-ceo-c36c83304cfb057b 2026-09-16T14:12:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-disagio-adolescenziale-in-lombardia-25mila-accessi-in-ps-policlin-daa6272d4426e2dc 2026-09-16T14:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-unveils-theme-for-2027-annual-conference-d04f966c0b3615d9 2026-09-16T14:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-an-immune-false-alarm-that-may-drive-rapid-aging-00104e3c1b86bb4e 2026-09-16T14:05:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-engineered-bacterial-symbiont-maps-micron-scale-sugar-gradients-in-the-honeyb-c00843ed0d57862a 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-a-phage-anti-defense-weapon-into-an-immunity-trigger-93d45ca39f2aeaae 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spamoal-is-a-deep-learning-method-that-enables-accurate-spatial-domain-identific-cf38688d6c4c0b39 2026-09-16T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celebrating-what-holds-us-on-iphone-18-pro-f697be91e8bd515c 2026-09-16T13:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/supreme-court-preserves-broad-access-to-abortion-drug-mifepristone-7f64cc35a1f5e3e3 2026-09-16T13:58:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/carolina-housing-is-built-on-student-feedback-2c16247fc949a7a2 2026-09-16T13:58:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/eschback-launches-leader-standard-work-capability-in-seqonis-platform-d6bbb1809a7eb5ff 2026-09-16T13:54:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-examination-results-top-position-for-heidelberg-medical-students-53c49699f7c9000c 2026-09-16T13:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/collegium-pharmaceutical-at-h-c-wainwright-pushing-beyond-pain-by-investing-com-7acb87745e02bc6a 2026-09-16T13:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/arrowhead-achieves-clinical-validation-for-new-drug-platform-a8d024929ce7f48e 2026-09-16T13:39:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/sen-warren-demands-to-see-trump-drug-pricing-pharma-contracts-accuses-rfk-jr-of-b2c1b39832ead5db 2026-09-16T13:36:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-launches-phase-3-mdma-assisted-therapy-trial-for-ptsd-targeting-ve-9bb879d09f021f92 2026-09-16T13:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-can-our-genes-tell-us-about-preventing-myeloma-fb0d068098d74476 2026-09-16T13:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/10-ai-biotech-firms-in-northern-metropolis-to-get-early-cross-border-data-access-8d6ce46540846e4e 2026-09-16T13:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-risks-provider-misconduct-and-a-21-year-old-s-death-sharpen-safety-warning-5194dfbd227784a9 2026-09-16T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-risks-provider-misconduct-and-a-21-year-old-s-6b7a9c26ed278664 2026-09-16T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-information-for-healthcare-practitioners-2a8cecfc3a4c1e42 2026-09-16T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pbm-entity-no-pharmaceutical-company-directly-contracted-with-15e0f87edc35ede0 2026-09-16T13:18:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-submission-advice-support-for-innovative-medicines-b8e46373a16aa9af 2026-09-16T13:16:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-meds-tpst-cupr-chart-the-course-b8cbe9650f92187b 2026-09-16T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-projet-de-recherche-pour-en-finir-avec-le-risque-de-noyade-des-personnes-lary-6ad6ce0ec9a9cf84 2026-09-16T13:13:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-ex-novartis-exec-as-ceo-601341f40ad47d08 2026-09-16T13:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/calgary-based-biotech-founders-announced-as-recipients-of-canada-s-top-40-under-01c6c7755adde338 2026-09-16T13:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinphar-pharmaceutical-fy2026-h1-earnings-call-gross-margin-hits-record-45-4-aug-2c92cc8d92f59c34 2026-09-16T13:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-locks-down-120m-pact-to-deploy-automated-production-platform-for-unnamed-com-dedd8983f9a5d6b6 2026-09-16T13:02:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-the-green-book-chapter-d276b249e49e4dc1 2026-09-16T13:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/finally-a-chance-to-breathe-christiana-gets-care-for-hirschsprung-s-disease-c3e13beb67f44b5a 2026-09-16T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-plant-setup-in-india-9388a1cfa87e6157 2026-09-16T12:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-the-whole-grain-sweet-spot-for-better-heart-health-74fe8c2892b5b3af 2026-09-16T12:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-concede-titulo-de-professora-emerita-a-ana-luiza-coelho-netto-07641e2218bdf689 2026-09-16T12:52:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-biotech-news-key-moves-to-watch-in-september-2026-78cb8609a164864f 2026-09-16T12:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-cuts-98-scottsdale-jobs-after-product-sale-02c12ed5bda7592e 2026-09-16T12:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-pays-sironax-125m-to-acquire-platform-for-crossing-the-blood-brain-barr-57efc9bfdd6fbe18 2026-09-16T12:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ciclo-de-talleres-para-investigadores-de-la-unlp-2026-tercera-edicion-d1bb67ca66d66070 2026-09-16T12:31:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-unveils-new-namkindtm-drug-toxicity-data-at-eurotox-2026-demonstrat-7c307c64eb413c4e 2026-09-16T12:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/curiosity-guides-law-school-s-first-strait-fellow-1018a0e7604d6563 2026-09-16T12:26:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-opth-lines-up-phase-3-mdma-ptsd-trial-for-veterans-5e5dca7bb97f51cb 2026-09-16T12:25:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimi-health-expands-clinical-program-with-phase-3-trial-evaluating-mdma-assist-3138d9050b7df197 2026-09-16T12:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenetic-to-merge-with-santersus-ceding-85-of-combined-biotech-to-swiss-investors-38ce4de6437ed570 2026-09-16T12:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-bacteria-or-chemicals-how-methanol-and-formaldehyde-form-abiotically-in-8f865ceb512ae516 2026-09-16T12:07:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-human-gut-model-detected-drug-toxicity-before-cells-were-harmed-49f74bd75e06bac9 2026-09-16T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-unveils-new-namkindtm-drug-toxicity-data-at-9728338ec7150c0b 2026-09-16T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezera-announces-plans-to-launch-the-reveal-pad-multi-center-study-investigating-8bbac5a19abb9435 2026-09-16T12:04:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/kendall-square-biotech-incubator-launches-program-to-draw-international-startups-e128c3dc2e07ddaa 2026-09-16T12:00:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rolling-with-the-waves-ac90c33b7cf09730 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-experiences-accessing-health-information-online-trusted-sources-and-cont-1be2bf56f59deca5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/platinum-naturals-easymulti-stress-men-affected-lots-incorrectly-labelled-for-vi-317c64c8990d36f5 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ndi-passive-spherestm-2106148f4021c722 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellispace-critical-care-and-anesthesia-0d5a41697926527e 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-o-day-tells-fierce-how-gilead-s-cancer-inflammation-expansion-has-reached-cr-7c635c6900bbfbe7 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-banana-faces-an-existential-threat-can-biotech-save-it-6fa7858cd1651577 2026-09-16T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-accelerates-supply-chain-heat-decarbonization-e278b969d389bded 2026-09-16T11:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-dr-jakob-nikolas-kather-wird-hopp-stiftungsprofessor-fur-kunstliche-in-8b53026d890c4691 2026-09-16T11:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-west-pharmaceutical-services-stock-outperforming-the-nasdaq-0f730f5a4482fb08 2026-09-16T11:50:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/globalpharma-and-princefarma-sign-mou-to-advance-pharmaceutical-distribution-in-e4c13edf0ce21061 2026-09-16T11:48:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-memoriam-rob-van-der-wal-8b01f45490929bc1 2026-09-16T11:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-activation-of-university-of-florida-health-as-newe-84699260c629525c 2026-09-16T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascendis-regains-obesity-rights-as-novo-exits-monthly-glp-1-deal-cf9dc0b84009e824 2026-09-16T11:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/rs-11-iv-sold-for-rs-325-maharashtra-fda-chief-tukaram-mundhe-flags-huge-markup-55f2cfe5530ce4a7 2026-09-16T11:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-5bn-scaleup-fund-will-not-fix-biotech-s-funding-gap-even-its-backers-sa-4944433c0dc34ac8 2026-09-16T11:17:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-sek19-3m-to-13-guarantee-and-a-sek50m-equity-facility-5269a621b698e7d9 2026-09-16T11:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-first-patients-dosed-in-global-phase-3-orbit-pivota-d75552e00382cd47 2026-09-16T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-neurons-flourish-in-mouse-brains-offering-a-new-view-of-neurodevelopmental-ee7d34769d2e1775 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-therapeutics-announces-123-million-series-c-financing-to-advance-phase-3-d-5cf553c7190d4864 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-gets-123m-for-phase-3-trial-of-ex-astellas-drug-in-thyroid-eye-disease-3e28cc7677d34261 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-acquires-covetai-to-advance-veterinary-workflow-intelligence-81cfc6189054a50d 2026-09-16T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-la-actualizacion-de-la-informacion-de-seguridad-de-los-medic-9860b82efb555986 2026-09-16T10:59:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-dividend-1d1e3cf8ca63c361 2026-09-16T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sling-reels-in-123m-series-c-to-fund-oral-tepezza-rival-through-phase-3-trial-7ef90bc333acc0d4 2026-09-16T10:57:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-recuerda-como-evitar-errores-de-medicacion-por-sobredosificacion-con-vi-e10c84f344062da2 2026-09-16T10:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/msd-7b118228b3a79e32 2026-09-16T10:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sclerodermia-humanitas-partecipa-alla-giornata-del-ciclamino-ef1b80297605f7c9 2026-09-16T10:42:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/six-neighbourhood-health-trailblazers-to-transform-care-e6da2526d470fa64 2026-09-16T10:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-fda-clearance-for-ligasuretm-ras-maryland-instrument-on-the-adeda03ace33da07 2026-09-16T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-harpnet-harnessing-resolution-pharmacology-for-next-generation-th-ca5334805d0493f8 2026-09-16T10:27:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-invest-in-the-vaneck-biotech-etf-bbh-03686cfedea3aa38 2026-09-16T10:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ingrid-zhang-appointed-ceo-of-legend-biotech-amid-mid-september-2026-industry-le-5ed0fa87667a5ca9 2026-09-16T10:15:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/tv-drug-ads-could-lose-their-website-shortcut-for-risk-details-under-an-fda-rule-bc0a0495d16ec398 2026-09-16T10:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/9ad3c82bb027f830 2026-09-16T10:08:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-warnt-vor-personalabbau-und-schlechterer-patientenversorgung-954f5acc34729d49 2026-09-16T10:07:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/8f0cd19707f1caf3 2026-09-16T10:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/775198a373c05713 2026-09-16T10:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/4644adfcfbaf2ab9 2026-09-16T10:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctt-pharma-corporate-updates-7cb9f05535b4eb81 2026-09-16T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/reunion-del-comite-de-medicamentos-de-uso-humano-de-septiembre-de-2026-cf9a2cb6077912c0 2026-09-16T09:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kim-yong-min-named-2026-jw-sungcheon-award-recipient-85a5f990849a0bc3 2026-09-16T09:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-wins-2026-national-contribution-award-05149f7f49635776 2026-09-16T09:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kpbma-holds-korea-thailand-pharmaceutical-forum-in-bangkok-ec594cbe6f8df10b 2026-09-16T09:26:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotient-sciences-named-among-gen-s-10-cdmo-up-comers-2026-b8121582b4e6e4a1 2026-09-16T09:26:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-c37ed3be97b94076 2026-09-16T09:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/uusi-maisteriohjelma-tarjoaa-ruokaviennin-kansainvalista-osaamista-00472ee05d3deed5 2026-09-16T09:23:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-reshaping-the-cdmo-sponsor-relationship-dbb6c49855c23d14 2026-09-16T09:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/gewebeproben-mit-ki-besser-verstehen-und-fur-schnelle-diagnostik-in-der-klinik-n-625e35e46fdfa6ca 2026-09-16T09:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esophageal-cancer-d33c851864a42cf9 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/trial-of-a-maternal-diet-rich-in-eggs-and-peanuts-to-reduce-infant-allergy-6e5f763803c3f227 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/blinatumomab-for-replacing-chemotherapy-in-pediatric-acute-lymphoblastic-leukemi-656f2fd54806b226 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/colonoscopy-intervals-and-colorectal-cancer-incidence-after-adenoma-removal-b01c3d5581aa8100 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/late-onset-pompe-disease-404537abf6a4be48 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/blinatumomab-a-new-standard-of-care-in-acute-lymphoblastic-leukemia-61676a3aac71c835 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/sodium-bicarbonate-in-critical-illness-a-new-chapter-for-the-book-2b3d56ad81f12f4a 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-allergen-consumption-and-infant-food-allergy-reassurance-not-prescripti-5027d4c78ebd64f4 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-more-is-not-better-colonoscopy-surveillance-after-high-risk-adenomas-72846a6bb69fea41 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-26-2026-a-62-year-old-woman-with-memory-loss-anhedonia-and-temporal-wasting-27613684b99c331b 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/initial-screening-for-colorectal-cancer-a0055ed7a0c3aafa 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/endovascular-therapy-for-post-thrombotic-syndrome-a-randomized-trial-fc9f3efb263205d3 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/antidotes-for-anticoagulation-reversal-dc97b7c61919c4af 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-closure-or-anticoagulation-for-atrial-fibrillation-e09511939c474025 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-transplantation-in-highly-sensitized-persons-after-car-t-cell-therapy-8d07755a7813a838 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-adenovirus-b3-induced-immune-thrombocytopenia-and-thrombosis-95f0f6ec097ad37b 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/colorectal-cancer-risk-among-patients-with-serrated-polyps-896d7970ef229514 2026-09-16T09:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-we-underestimating-the-pharmaceutical-potential-of-the-cannabis-plant-579d1a341447e83f 2026-09-16T08:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/domestic-pharmaceutical-and-bio-stocks-which-are-considered-representative-growt-3fc642a021ab05a4 2026-09-16T08:47:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-establishes-public-private-pharmaceutical-industry-innovation-council-647569a7800a757d 2026-09-16T08:44:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2019-to-2023-e85b4ee4f5630c49 2026-09-16T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/migrant-health-country-of-origin-health-protection-advice-712e66654b02af33 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2018-to-2022-2e081caa376a5196 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/sti-quarterly-surveillance-reports-provisional-data-24f79f77d1898abf 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-95d573354d6fb70d 2026-09-16T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-august-2026-a91ff0b95960e676 2026-09-16T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/bovine-tuberculosis-tb-public-health-management-466209379572520b 2026-09-16T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-into-the-radiological-impact-of-the-routine-transport-of-radiopharmaceuti-80b294175a4a0760 2026-09-16T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-canonical-helm-representations-for-sequence-level-peptide-registration-d7409182dc2c1913 2026-09-16T08:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-25-jsmo-kfcr-408a09bcda0795e9 2026-09-16T08:09:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-system-enables-the-early-detection-of-drug-induced-liver-toxicities-in-pri-3a721253fe2bd48e 2026-09-16T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-biotech-corefx-chooses-cork-as-its-european-r-d-hq-718cbbd0532ecf2c 2026-09-16T07:55:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-named-to-forbes-china-esg-50-list-2026-for-green-crdmo-and-digita-732f52b3717008fc 2026-09-16T07:54:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-decades-of-discovery-at-embl-2b387676ab26e237 2026-09-16T07:48:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-a-clear-picture-of-uk-health-research-funding-5fb0da3202bb024b 2026-09-16T07:41:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinpoong-seeks-phase-3-ind-amendment-for-stroke-drug-sp-8203-7c73c2ad1ef58a01 2026-09-16T07:19:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/l-essentiel-de-la-generosite-2025-3705f63f541d6466 2026-09-16T07:14:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-is-changing-the-talent-biotech-companies-compete-to-hire-6b1fee41fba14396 2026-09-16T07:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/unmc-brings-ai-expertise-to-6-million-nsf-crop-resilience-project-806a9377b6c1a0e4 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rapid-crispr-based-nanodroplet-assay-enables-direct-clinical-identification-of-383aab66d4afc385 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibodies-against-hla-e-vl9-enhance-nk-cell-and-cd8-t-cell-cytotoxicity-against-be5059520bb191a9 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-molecular-landscape-of-hypertrophic-cardiomyopathy-across-disease-stages-and-969611e720976693 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unanticipated-global-emergence-and-evolution-of-pneumocystis-jirovecii-mutations-1e7c214fc39615f4 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineered-probiotics-for-tumor-targeted-combination-chemoimmunotherapy-f74cc42b18728ff5 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serotonin-measurement-by-lab-on-a-contact-lens-in-porcine-and-human-tears-1a26cb4fd814317b 2026-09-16T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-1-500-patients-have-taken-part-in-the-clinic-prehabilitation-program-f8328961b65fbbb2 2026-09-16T06:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decarolis-named-director-of-sponsored-programs-administration-ff1c9934438d7007 2026-09-16T06:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trutakna-meets-all-endpoints-in-phase-3-iga-nephropathy-trial-final-analysis-b7255873d1b753fb 2026-09-16T06:46:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/crb-913-obesity-drug-shows-5-weight-loss-in-phase-1b-trial-3275d98d0fe2e371 2026-09-16T06:46:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/foundationone-cdx-braf-v600-braf-31eefd4b67f97474 2026-09-16T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-obtains-approval-for-foundationone-cdx-cancer-genomic-profile-as-a-compan-26f849ad79ecca25 2026-09-16T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymfentra-xcopri-projected-to-become-korea-s-1st-1-billion-blockbuster-drugs-in-1b9ece210cf9d90a 2026-09-16T06:19:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-achieves-clinical-proof-of-mechanism-for-the-next-generation-of-pre-cisio-a3abc4b621039f07 2026-09-16T06:02:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sa-har-vgr-byggt-en-modell-for-specialistlakares-fortbildning-da64b4d7e3b0264f 2026-09-16T06:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/vom-spitalbett-in-den-olympia-bob-2b5738cc36b7f3c2 2026-09-16T06:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-names-new-ceo-96784a8d02bcdd18 2026-09-16T05:52:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cambium-bio-raises-5m-to-fund-pivotal-phase-3-eye-disease-trial-025f102bc09a7c21 2026-09-16T05:29:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-mnov-8-rvty-8-txg-6-tlx-9-sdgr-12-7011727fdf19ea41 2026-09-16T05:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebr-aligns-with-fda-on-wise-labelling-293f0065e2540e00 2026-09-16T05:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-cafe-mondegar-licence-over-food-safety-violations-ffef6c2b8885044b 2026-09-16T05:08:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengiall-india-s-first-indigenous-dengue-vaccine-could-arrive-by-2027-3fcef4b37a7f1fed 2026-09-16T04:34:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-teva-starts-direct-nyse-share-trading-in-shift-fr-49f9efdcc94f4670 2026-09-16T04:24:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-tak-insider-sale-chief-transformation-o-d2af8d6500810d52 2026-09-16T04:19:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-ventricular-pacing-associated-cardiomyopathy-revealing-myocardial-vulnerabi-3cc98d06ff440cac 2026-09-16T03:58:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-covid-19-tracker-b43544edf907cec3 2026-09-16T03:58:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/leadless-pacemaker-implant-location-as-a-predictor-of-pacing-induced-cardiomyopa-3f898d5fd08f03a7 2026-09-16T03:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/alternating-va-intervals-what-is-the-mechanism-eca4f20c1cb4ac08 2026-09-16T03:46:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fuhrendes-biotech-unternehmen-entscheidet-sich-weltweit-fur-veeva-vault-crm-8c0c10dd0f0dba7e 2026-09-16T03:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-hangzhou-biotest-biotech-co-ltd-class-a-stocks-fc0b09bee485f86c 2026-09-16T03:38:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-mumbai-s-iconic-cafe-mondegar-3-other-eateries-6541d36f26d84549 2026-09-16T03:23:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-clinical-stage-cancer-stocks-with-pristine-balance-sheets-f682c41718245b06 2026-09-16T03:09:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmosa-biopharm-s-inhaled-drug-l606-wins-china-approval-to-launch-global-phase-ac7ff245c1936bfe 2026-09-16T03:08:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-ceo-christopher-giordano-acquires-20-087-in-shares-921f29d813284c41 2026-09-16T03:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultra-processed-foods-linked-to-hidden-muscle-fat-that-may-threaten-your-knees-d87f3d7b4cce43bd 2026-09-16T03:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-approves-world-s-first-drug-to-treat-muscle-atrophy-in-sma-5dd33ab3b8a374af 2026-09-16T02:58:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-guanhao-biotech-co-ltd-class-a-stocks-b31fd0b4dd031d92 2026-09-16T02:46:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-find-a-hidden-retinal-defense-against-vision-loss-0ba2a68267fea301 2026-09-16T02:37:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-ras-targeting-drug-for-pancreatic-cancer-4302da7134eee7fd 2026-09-16T02:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/4aa2ad97c1732445 2026-09-16T02:26:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/coo-6ad1affec3bea53b 2026-09-16T02:25:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceo-ad504be3639ec741 2026-09-16T02:23:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/408f0fda6531a81f 2026-09-16T02:22:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-37b77efbf922052c 2026-09-16T02:18:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-anos-los-lapices-siguen-escribiendo-y-son-honoris-causa-de-la-unlp-6c7f199371003580 2026-09-16T02:14:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinguiremos-con-el-doctorado-honoris-causa-a-los-militantes-estudiantiles-de-629241cb090f6c8e 2026-09-16T02:14:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-us-750-million-cancer-drug-deal-highlights-china-s-rise-as-biotech-player-019202f18c332040 2026-09-16T02:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-seeks-feedback-on-widening-access-to-febuxostat-for-people-with-gout-3692c364cf534524 2026-09-16T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-58cffabf971dd26a 2026-09-16T01:55:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-midweek-pulse-xbi-loses-steam-after-hot-2026-run-here-are-the-stocks-and-7ea3ba7251b2718a 2026-09-16T01:51:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-midweek-pulse-xbi-loses-steam-after-hot-2026-run-here-are-the-stocks-and-941d72ff3dff7f07 2026-09-16T01:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-reversed-biological-age-in-older-adults-in-just-4-weeks-738a0a4357926dd9 2026-09-16T01:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/perriello-discusses-biotech-s-future-with-local-leaders-f075c4ce96759b01 2026-09-16T01:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-says-phase-3-trutakna-trial-slowed-iga-nephropathy-progression-5e494faeaa8a90ad 2026-09-16T01:11:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/researchers-file-first-amendment-challenge-to-nih-grant-screening-e4014935a740ba41 2026-09-16T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tvtx-lgnd-stocks-in-spotlight-ahead-of-monday-s-fda-call-on-kidney-drug-filspari-fa6238499aaae213 2026-09-16T00:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-executive-survey-finds-emerging-biotech-ceos-increasingly-rely-on-f8dc02c36dd7a25e 2026-09-16T00:16:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-afe8e7e7d5c3f9a6 2026-09-16T00:15:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/en-otsuka-pharmaceutical-obtains-marketing-approval-for-enofeed-liquid-for-enter-5c5b3d702f486c51 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-antibody-driven-response-to-anti-pd-1-blockade-c9984854653c1ff1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishment-and-characterization-of-primary-retinoblastoma-cell-lines-a-compre-cfac4ec02c19cc2a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictive-and-instructive-cerebellar-encoding-of-dopamine-reward-drives-motivat-a85d22452d6058ed 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hippocampal-astrocytic-sequences-emerge-during-learning-and-memory-recall-8a32f1644356b364 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebv-reactivation-priming-of-the-peripheral-immune-system-in-multiple-sclerosis-r-cd6069644ba7186d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-specific-biological-aging-clocks-across-organs-and-omics-83fe2665d8ae7b6d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factor-ix-padua-aav-gene-therapy-in-adolescents-with-hemophilia-b-a-phase-1-tria-51c2bc7b509e2f74 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/liquid-biopsy-for-early-detection-of-pancreatic-ductal-adenocarcinoma-6015e08250c6d78e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pioneering-breast-cancer-drug-that-nips-resistance-in-the-bud-db40981eeca6218d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanisms-of-transcriptional-regulation-by-salicylic-acid-receptors-a6885e265c9723fd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflection-points-and-transitions-in-alzheimer-s-disease-fb32e0e5136c04b1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intratumor-delivery-of-a-novel-plasmid-combination-induces-high-levels-of-metast-79bbbc4147b72673 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transplanted-human-brain-tissue-takes-root-in-mice-without-a-cortex-f9421dd9f535ff09 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-most-stars-don-t-have-outbursts-like-the-sun-s-7175721ec3a0048a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-program-medicare-appeals-adjustment-to-the-amount-in-controversy-thresh-94915c4cbe3169f1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-program-public-meeting-for-new-revisions-to-the-healthcare-common-proce-0dc0a936f4b41fa5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-047468a183772e00 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunity-to-co-sponsor-events-with-the-office-of-research-integrity-e16a1d817cc2ee30 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-owned-inventions-availability-for-licensing-8cbe3facb1cb1897 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-e0e51e61efa854a9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-request-30-day-public-comment-request-f6ec9d29697e1d9e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/order-under-sections-362-and-365-of-the-public-health-service-act-continuing-the-6789f7d61c90e383 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-4931405acdc3599d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-nih-intramural-reporting-of-research-9f712e6427b6b151 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbiology-devices-panel-of-the-medical-devices-advisory-committee-notice-of-m-7f94431e812d15dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-aaf3803810a2f900 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metoprolol-succinate-58aa54dba058a8bb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-fentanyl-citrate-1-000-mcg-100-ml-10mcg-ml-injection-solution-in-100-65416d938a4cacb1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-povidone-iodine-1-25-proparacaine-hcl-0-5-ophthalmic-solution-10-ml-15228ce34fbc9101 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-fluphenazine-hydrochloride-f187618179191e55 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-dextrose-injection-usp-70-2000-ml-bags-rx-only-baxter-healthcare-cor-96a4e2350f212a64 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-getinge-pvc-thoracic-catheter-soft-pvc-straight-10-per-case-size-m-72118112a2f89dfe 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-ams-convenience-kit-dsaek-pack-rx-part-number-ams12394b-d352f83bcc3442e8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-bravo-cf-capsule-delivery-device-5-pack-product-number-fgs-0635-br-fe5a15f2664647b6 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-kit-single-shot-epidural-20-cs-ref-59553-kit-single-shot-epidural-44059486d69e4a26 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-product-name-dermav-laser-system-model-catalog-number-dermav-medic-7b02f8e22e19a921 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-medicalyte-liquid-bicarbonate-concentrate-ref-bc-100-and-bc-201-1f7bc94a9c3351a1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-heartsine-sam-350p-350p-us-device-us-english-2-min-cpr-udi-di-code-2a57bbf2b51e47e6 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-halyard-iv-start-kit-non-sterile-ref-kriv26-02-1e4cb9cd8fcb7e87 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-products-that-contain-the-pericare-wipes-surestep-foley-tray-syste-2217b02470d5d96b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wallenbergstiftelserna-beviljar-ai-stod-till-fyra-forskargrupper-vid-ki-269b0feada1a5a2b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-bana-vag-for-nya-behandlingar-av-hudsjukdomar-123a8d0c9e3c54ad 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/okande-cancertrender-bland-unga-vuxna-ecaa398ef104a372 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-utvecklar-statistiska-metoder-for-battre-brostcancervard-8eba6cbff21b3a27 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/langre-tid-mellan-koloskopier-kan-vara-sakert-a98e6a08d8bfea0c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ki-starker-positionerna-i-arets-shanghai-amnesrankning-484868928f5a1a0b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clintec-forskare-inleder-samarbete-for-att-utveckla-nytt-naringsprotein-for-svar-059b8d3a1c617f61 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-aging-awards-21-1m-for-cleveland-alzheimer-s-disease-resea-7c0c0070442dcafa 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-s-world-class-care-now-available-to-more-bermuda-residents-56da421e905c6660 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-why-young-adults-may-develop-early-fatty-liver-disease-6ea37405cd1da8d8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-of-ivonescimab-plus-chemotherapy-versus-chemotherapy-alone-in-3ba43af9cd1b5d50 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/target-silence-replace-a-review-on-rna-based-drugs-in-modern-medicine-86c6e6c517022d28 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-pharmacokinetic-modeling-and-clinical-translation-of-sig001-a-novel-0f8274f9428d0b25 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-polypodium-vulgare-l-root-decoction-in-symptom-management-of-hospita-f5cb32bde84659cc 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/external-validation-and-bayesian-forecasting-of-rivaroxaban-population-pharmacok-82d49a3ef5a12e41 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/institutional-conflicts-of-interest-in-health-related-research-a-scoping-review-5b12d2d5d58373d3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/population-pharmacokinetics-and-dosing-simulations-for-paliperidone-palmitate-35-f6ab85031067f279 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preventive-effect-of-goshajinkigan-on-paclitaxel-induced-peripheral-neuropathy-a-1b63c5735578dbb2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-safety-and-preliminary-efficacy-of-allogeneic-human-induced-pluripotent-f939394a7224b6bc 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-discovery-transformative-clinical-trial-models-in-neuro-oncology-861f521c65901d41 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-cardiovascular-prevention-in-people-living-with-hiv-rethinking-statin-th-addd0c519bcd6a6d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-core-outcome-measurement-set-for-studies-of-community-pharmacis-b9a0e88376d523c1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multicenter-phase-ii-trial-of-ramucirumab-plus-irinotecan-for-early-recurrence-92cff0c7356abaea 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-should-clinical-practice-guidelines-change-a-critical-appraisal-of-the-esvs-f64e38876882f22b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhalable-dry-powders-of-antimicrobial-agents-in-respiratory-diseases-febd296d8249145d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/barriers-and-evidence-informed-strategies-for-the-high-quality-development-of-dr-f07d9f7c8e6532c0 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-spiral-basket-geometry-on-procedural-efficiency-and-device-escalat-3e9eeedca0cb4d53 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-mask-of-delirium-uncovering-a-presumed-cardioembolic-stroke-through-comprehe-ef13b4747a34df72 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitof-an-integrated-ai-framework-for-forecasting-and-structured-reporting-in-cli-92bbf44c143caa6e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-abstract-interpreting-research-and-avoiding-clinical-traps-in-emergin-7cbbccfd1ee4c5b8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-anticoagulant-related-nephropathy-associated-with-vitamin-k-antagonists-81cedfa5bb50a11c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introductory-chapter-the-evolving-landscape-of-biomarkers-in-cancer-detection-an-ceb49675711378a1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-effect-of-aqueous-extract-of-azanza-garckeana-fruit-on-fertili-4a4cb3fe56758aa3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-surgical-outcomes-of-retroperitoneal-unicentric-cas-afcd2297f84e5ad9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-transcutaneous-electrical-acupoint-stimulation-on-colonic-spasm-durin-360fb6c6fc59753a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-2-from-nikolov-d-nikolov-g-kitova-l-kitov-s-kitova-m-f-mihaylova-aa-2026-4616545417902bdb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/review-of-aligner-materials-and-their-clinical-applications-a-literature-review-393d4d6ab5bd9c14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-of-ohet72-nanocrystals-into-nanostructured-microparticles-for-pulmon-b1f7a2598f504136 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chia-seed-allergy-emerging-clinical-evidence-molecular-allergens-and-the-unresol-facb4541734c3403 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-hydrogen-inhalation-and-postoperative-pain-after-endoscopic-discec-722474615b8d9e0d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/equivocal-dopamine-transporter-imaging-integrating-visual-assessment-quantificat-fc6783a086ee78ab 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neural-interfaces-for-bidirectional-sensory-restoration-in-limb-prostheses-curre-5c6660fd982425f1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-limb-ischemia-during-pregnancy-a-case-report-and-narrative-review-of-the-l-f51dd976cf886305 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-botulinum-toxin-injection-on-masticatory-muscle-activity-in-sleep-bru-302744fb35ec2609 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vivo-comparison-of-laser-fluorescence-near-infrared-transillumination-and-con-4347cb2b342715db 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aging-in-schizophrenia-clinical-biological-and-psychosocial-perspectives-3357f8913b674d08 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-in-pediatric-acute-lymphoblastic-leukemia-a-retrospective-coho-b454992a5aa3bec2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcutaneous-auricular-vagus-nerve-stimulation-targets-the-brain-gut-axis-to-t-c7ed69eab8b988b5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mafld-is-linked-to-lower-hbv-dna-levels-in-chronic-hepatitis-b-clinical-and-tran-89e3837cbe2b6f2c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpretable-machine-learning-models-using-early-dynamic-clinical-features-to-p-2f08580acd61747f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-internal-validation-of-a-clinical-nomogram-for-identifying-lupus-8cf07557b9131fc2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roles-of-community-drug-distributors-in-health-and-development-activities-post-o-449965f56fbda972 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-the-oxidative-myocardium-ros-responsive-biomaterials-for-precision-c-f850207104621730 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-framework-of-microbial-genomic-database-for-clinical-metagenomic-pathogen-diag-45db2974831d7577 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-their-relationship-with-tigecycline-exposure-in-critically-fd1c7aa5123cab7e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-standardized-continuous-glucose-monitoring-validation-lessons-from-the-si-d07f20738b0bc797 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/partial-clinical-remission-in-type-1-diabetes-pancreatic-cell-functional-reserve-6253910902309061 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-artificial-intelligence-to-build-the-radiology-clinical-trial-office-of-th-b61603ea2320a841 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-universal-biocode-framework-2-0-a-philosophical-numerical-integration-of-mul-66d5897507ba8e2e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-month-clinical-outcomes-and-exploratory-gait-changes-after-intra-articular-4792c080c51d3b2d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-short-versus-long-course-antibiotic-therapy-in-pseudomonas-8d14d9e4f063d84b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effectiveness-of-bcw-based-family-participated-digital-assisted-intervention-f1f13e21ba0263ea 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-interaction-with-inhibitors-prediction-of-exposure-of-drugs-following-drug-1b93a2c92477e7f9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/entre-la-pluma-y-el-proceso-b456813cf4482395 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biliary-duct-invasion-in-colorectal-liver-metastases-prevalence-and-clinicopatho-6fa6ce0eaa4d7609 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-liver-failure-temporally-associated-with-intensive-consumption-of-plantago-b97af186d1e65650 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-identifies-microbiome-and-clinical-predictors-of-sustained-weig-f676385b82b8952c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circumferential-pulmonary-vein-isolation-cpvi-with-adjunctive-linear-ablation-vs-a47b925fa38d3406 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reproducibility-driven-clinical-translation-of-spatial-multi-omics-in-precision-82d5d75d1a1a0777 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feasibility-and-implementation-of-a-final-year-objective-structured-clinical-exa-ee2af8b9f3f65723 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skeletal-displacements-and-upper-airway-changes-following-tooth-borne-and-tooth-a8d9c8c27c81400d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroanatomical-correlates-of-transdiagnostic-clinical-phenotypes-in-major-depre-4dd2840f07cc0f2a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-partner-administered-endorphin-massage-before-cesarean-birth-on-preope-788a98637fee02dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-behavioral-and-symbolic-interventions-in-cocaine-use-disorder-a-pros-0c0822164a542188 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-warm-acupuncture-at-zusanli-st36-and-zhongwan-cv12-combined-with-f757e0ad9523dc71 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-aacr-cancer-progress-report-2026-i-1314c8aee227b6fc 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-year-clinical-outcomes-of-vagus-nerve-stimulation-for-higher-grade-treatment-7df4dbe3f0664ae5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-procedural-angiography-based-physiological-indices-and-clinical-outcomes-af-317af6e3847c728e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-epistemological-threshold-from-corps-objet-to-nursing-theory-in-the-clinical-fb164486a8f877ca 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-of-cancer-survivors-diagnosed-within-the-past-20-years-accounts-for-6-076ec70e6db1dc14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-optimization-or-rescue-interpreting-week-24-disease-control-after-abrocitin-4ca84c39e4415760 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-situated-nature-of-validity-exploring-cultural-dependency-in-clinical-teache-6b769038838f3fab 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adverse-childhood-experiences-and-cognitive-functional-aging-trajectories-a-nati-5c694f37b4aaf83e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expression-of-concern-regulation-of-the-breast-cancer-stem-cell-phenotype-by-hyp-142cf341eac8a2fd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factor-ix-padua-aav-gene-therapy-in-adolescents-with-hemophilia-b-a-phase-1-tria-caf86e20d800d79d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-efficacy-with-daraxonrasib-demonstrated-in-ras-mutant-nsclc-c71e341500d43920 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/structure-based-drug-design-of-quinoline-cyp8b1-inhibitors-for-the-potential-tre-456543ff4bf951da 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/measuring-ai-progress-in-drug-discovery-a-reproducible-leaderboard-for-the-tox21-b60ea7d5a1499fa1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-of-metabolic-syndrome-among-adult-population-in-pakistan-a-systematic-2d50b0f09c28aafb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bile-acid-based-therapeutics-recent-advances-in-bile-acid-conjugates-and-derivat-a1c51191c2d63fbf 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinapic-acid-from-plant-biosynthesis-to-translational-prospects-a-critical-revie-a18d856bb31e48c9 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-of-laponite-clay-mineral-as-an-excipient-in-pharmaceuticals-cosmetics-and-e70dbd0ba7fac1dd 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prophylactic-and-therapeutic-effects-of-aspirin-in-cancer-2b6c5055ad36bfec 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthostatic-hypertension-clinical-spectrum-and-gaps-in-knowledge-94d78edfefdc7fce 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/role-of-glycosylated-small-noncoding-rnas-in-tumor-mechanism-function-and-clinic-252270806604a20b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychiatric-consultation-outcomes-in-deep-brain-stimulation-candidacy-clinical-a-8ceb7d66de01cabf 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-seawater-based-nasal-irrigation-on-nasal-congestion-in-in-2bd10283b66ded68 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-presenilin-1-variant-p-scp-phe283val-scp-in-early-onset-mild-cognitive-i-afc9f2e92940044e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stripping-based-approach-for-the-recovery-of-volatile-fatty-acids-from-anaerobic-6145224ecbb3a9b7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-circumferential-calcification-and-acquired-minimum-lumen-area-on-1-yea-9e1ca065c87ef7a8 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-guided-phenotypic-drug-repurposing-against-i-streptococc-47fae4e027c30a26 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monitoring-changes-in-clinical-trial-primary-outcomes-using-large-language-model-7383880a066a1eac 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823699-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-b18be769e7dd385c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823517-llm-generated-medical-summaries-during-hospitalization-to-improve-pa-882b39bcb56522fa 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823244-quality-of-recovery-after-primary-breast-cancer-surgery-comparing-th-260cc0f61eab388a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07823062-specialist-review-of-harm-ratings-for-clinical-responses-acronym-noh-3ff667fc25d0606f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07822685-multicenter-clinical-study-on-the-efficacy-and-esthetic-outcomes-of-df2825dda186a931 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810010-phase-2b-study-of-a-respiratory-syncytial-virus-and-human-metapneumo-8db7a3db2904b52f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07806773-study-of-tub-040-in-participants-with-unresectable-or-metastatic-non-bf451d76c6d0d11a 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07688707-acute-effects-of-cervical-manual-therapy-on-eye-blood-flow-6444a0014219b05e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07667400-docetaxel-and-sx-682-in-recurrent-metastatic-head-and-neck-squamous-eb782075b524b62c 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07663318-a-phase-1-study-to-evaluate-the-relative-bioavailability-of-octreoti-e4a65dc45d4f3b1b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07532902-a-study-of-bms-986504-with-standard-of-care-therapy-for-people-with-3f6f510d3d3c7507 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07449962-effect-of-counselling-using-lifestyle-medicine-assessment-tool-on-hy-72760a91433e4062 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07370480-knee-osteoarthritis-and-thermal-spa-treatment-0111d73736bf1248 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07243171-a-phase-ib-iia-study-to-evaluate-the-safety-tolerability-pharmacokin-45b30195ca87a7b3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07225634-a-study-of-combogesic-iv-intravenous-in-pediatric-patients-with-acut-7b86c149b77d7c29 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07080242-evaluating-bl-m14d1-in-subjects-with-locally-advanced-or-metastatic-30ee71cd4473032b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07061080-refractory-advanced-digestive-neuroendocrine-carcinomas-treated-with-00dc43390d3c06c5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07060547-investigating-hepquant-duo-test-as-a-biomarker-in-alcohol-related-li-f927b4b6d8c5f719 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07052903-triton-cm-a-study-to-evaluate-nucresiran-in-patients-with-transthyre-d944a3ade90606be 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06927999-an-outpatient-study-of-the-efficacy-of-ars-2-in-patients-with-chroni-dc39c06a5edb889e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06735664-zanubrutinib-in-combination-with-odronextamab-for-the-treatment-of-p-33485fe3d07c85a0 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06686251-evaluation-of-the-efficacy-of-diagnostic-support-algorithms-in-chest-f01aeb081e8adf32 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06606990-testing-how-the-body-responds-to-the-drug-cx-5461-pidnarulex-in-pati-b090c9b3d5c67e70 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06497556-a-study-evaluating-the-efficacy-and-safety-of-divarasib-versus-sotor-c73a6844b830f91f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06345495-high-dose-ruxolitinib-and-allogeneic-stem-cell-transplantation-in-my-642c45e95322fb42 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06345027-chimeric-antigen-receptor-treatment-targeting-cd70-seventy-bb7644971c14a29e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06233942-phase-1a-1b-first-in-human-study-of-bg-c9074-alone-and-in-combinatio-c5317bf6b5ad7cf3 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06173518-a-study-of-cd19-targeted-car-t-cell-therapy-in-pediatric-patients-wi-892481086f48db14 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06104020-effect-of-liberal-versus-restrictive-intraoperative-fluid-therapy-on-e45e5d896ef5d276 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05987241-testing-the-role-of-dna-released-from-tumor-cells-into-the-blood-in-6e15e5c490cca791 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05950581-treatment-of-skeletal-class-ii-malocclusion-with-modified-twin-block-92667869ab997e0d 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05913388-gb1211-and-pembrolizumab-versus-pembrolizumab-and-placebo-in-patient-b251540f83cc4e19 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05857865-single-session-psychotherapy-for-young-kids-through-patient-engageme-363cc4111d228ea1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05763797-developing-a-culturally-relevant-supportive-care-program-for-black-p-ece8f851c645adf2 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05751668-finding-an-effective-dose-of-gm1-to-reduce-or-prevent-neuropathy-num-e8719bfacbe11f3f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05464576-tumor-staging-t-of-bladder-tumours-correlation-of-mri-and-anatomopat-ca9c339eed6a8ecb 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05440617-biorepository-in-participants-who-undergo-otc-for-gonadotoxic-therap-701d52a84cb29125 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05364606-patient-specific-talus-spacer-post-approval-study-a02f2660f852629f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05343013-tas-102-with-or-without-celecoxib-in-ctdna-defined-minimal-residual-03dbdae8ce8d08c4 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05316688-a-fluorescent-tumor-marking-agent-tozuleristide-for-imaging-oral-cav-1606a97bf1f6cd46 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04866134-a-study-of-eras-007-as-monotherapy-or-in-combination-with-eras-601-i-95f872e2ad976cd5 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04808427-pilot-study-to-investigate-magnetic-resonance-mr-image-guided-focal-b4623e9007f72207 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04760652-cognitive-behavioral-therapy-following-esketamine-for-major-depressi-4106eab7fe215ec7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04461483-a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-720ad15c855bc477 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04077099-a-study-of-regn5093-in-adult-patients-with-mesenchymal-epithelial-tr-9b4e20efe61d11da 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03572465-quantitative-ultrasound-techniques-for-diagnosis-of-nonalcoholic-ste-fec4f2b26065618b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02146170-tissue-procurement-and-natural-history-study-of-people-with-non-smal-bd3c1921a726f965 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01629498-image-guided-intensity-modulated-photon-or-proton-beam-radiation-the-105bb6dad105cbc6 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01568697-oral-bacteria-and-immune-system-problems-involved-in-gum-disease-per-2851c8e90bcff2a1 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01498263-inherited-diseases-caregiving-and-social-networks-516e94c56e9b605f 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01445483-neuropsychological-changes-in-patients-receiving-radiation-therapy-f-698e4e99ebedb3c7 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01443468-clinical-and-genetic-studies-of-li-fraumeni-syndrome-562b3d53b8340d6e 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01432847-cell-collection-to-study-eye-diseases-3f7d97feaf79bb2b 2026-09-16T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaneck-pharmaceutical-etf-vs-vaneck-biotech-etf-which-fund-is-better-for-drug-in-b9bc71be1ddc8dc6 2026-09-15T23:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tom-perriello-joins-biotech-leaders-in-discussing-the-future-of-the-industry-13f2b46b03a0976a 2026-09-15T22:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recon-experts-press-fda-to-set-safety-access-standards-for-psychedelic-drugs-gsk-3665e6a8d1db5683 2026-09-15T22:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hearing-on-psychedelic-medicine-reveals-a-field-divided-on-the-road-to-appro-66ed1628669a29ac 2026-09-15T22:11:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/21-cfr-part-820-qmsr-what-changed-and-how-to-comply-bdd37ce77b959bde 2026-09-15T21:55:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/australian-biotech-sues-grail-over-multi-cancer-blood-test-c5040893d12c96e8 2026-09-15T21:21:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelic-drug-trials-patient-safety-take-spotlight-at-fda-hearing-3c3aa5cc1f9daeff 2026-09-15T20:56:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/capa-management-5-elements-of-an-effective-capa-system-0ca14dd7350e28ab 2026-09-15T20:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-aardvark-thera-528a6f2157cc4e25 2026-09-15T20:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-2e29865224852ac9 2026-09-15T20:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-e4e73548800141d8 2026-09-15T20:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-veteran-ingrid-zhang-tapped-to-lead-legend-biotech-0e9909e2fc0033ed 2026-09-15T20:04:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-cheplapharm-form-strategic-partnership-pharmexec-251834663ca8ba0d 2026-09-15T19:48:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-bolsters-oncology-pipeline-with-750m-chimagen-tce-deal-826c82260bc41af2 2026-09-15T19:48:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/if-you-name-it-you-can-tame-it-102ad926a350c9a5 2026-09-15T19:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-biotech-etf-pick-is-on-a-roll-there-s-plenty-of-reasons-to-stay-bullish-bc9825efc83646e6 2026-09-15T19:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-is-rewriting-the-rules-for-medicine-and-biotech-in-mass-2641f3cd0e60363a 2026-09-15T19:19:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-canonical-helm-representations-for-sequence-level-peptide-registration-1daac6a9a95951c5 2026-09-15T19:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-lands-10-year-120m-commercial-cell-therapy-manufacturing-deal-7056cd82be379659 2026-09-15T18:58:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/raising-kids-in-a-digital-world-with-less-fear-more-strategy-9c6c928fc1781741 2026-09-15T18:54:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-uconn-school-of-pharmacy-alumni-will-be-recognized-at-the-2026-uconn-schoo-1fefb87b25eb0c92 2026-09-15T18:51:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-strikes-damaged-ukrainian-pharma-hub-logistic-center-steel-plant-killing-853d697821a8fef7 2026-09-15T18:50:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/retatrutide-for-weight-loss-what-to-know-about-the-triple-agonist-drug-ca720d73d7fd444f 2026-09-15T18:35:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-oric-doubles-down-on-prostate-cancer-with-phase-3-launch-f66cc21c17ead25d 2026-09-15T18:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-and-west-valley-city-unveil-plans-for-major-new-medical-cam-0c88cab57bef4e35 2026-09-15T18:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/kff-tracker-america-first-mou-bilateral-global-health-agreements-e54c4408e718605b 2026-09-15T18:12:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugstore-museum-hooks-visitors-with-old-timey-treats-and-pharmaceutical-history-61f4e7444ae094a1 2026-09-15T18:12:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-stock-surges-tuesday-what-s-driving-the-action-267c6d7b38426214 2026-09-15T18:12:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-secures-130m-financing-for-phase-3-mash-trial-ba60422f9573fe01 2026-09-15T18:03:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/iq-oq-pq-explained-2026-process-validation-guide-e94487244e4749c5 2026-09-15T18:01:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/29a-convocatoria-del-fondo-regional-para-proyectos-de-cooperacion-triangular-002ec6ed68b7ec77 2026-09-15T17:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-to-build-new-pharmaceutical-manufacturing-facility-in-bend-49861c4b3456de31 2026-09-15T17:46:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/iso-14971-risk-management-for-medical-devices-2026-guide-219c6abcfbfaa90d 2026-09-15T17:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-ai-biotech-isomorphic-labs-is-not-slowing-down-exec-says-a015998a3add4c6b 2026-09-15T17:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbe-vs-rsph-is-a-biotech-etf-or-equal-weight-healthcare-etf-the-better-choice-fo-98e58d141079b271 2026-09-15T17:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-safety-communications-9827bff184a3fa3a 2026-09-15T17:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-you-survive-the-oregon-trail-an-emergency-medicine-doctor-offers-tips-on-h-c88c6bb91a76a3f1 2026-09-15T17:17:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-trump-backs-psychedelics-research-fda-weighs-safety-and-access-standards-5288c954840a3a9a 2026-09-15T17:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-sellas-life-sciences-39fff20cebd8d953 2026-09-15T17:08:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-personalized-disease-prediction-and-prevention-in-chronic-inflamm-dc682383b7c99e54 2026-09-15T17:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-bridging-gaps-in-mental-health-support-a-comprehensive-european-s-9e9a95fdd93723af 2026-09-15T17:06:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/genfit-plans-phase-2-liver-failure-trial-after-acquiring-immunomodulator-from-in-a5b612c6084d9b58 2026-09-15T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/external-data-accelerator-your-standards-first-team-and-technology-for-conforman-d396193ebbd13297 2026-09-15T16:57:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/iso-13485-explained-medical-device-qms-requirements-2026-6706a1c61f947803 2026-09-15T16:54:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-cost-avoidance-advancing-unit-level-pharmaceutical-economics-in-health-sy-a6670ef0c8744a77 2026-09-15T16:53:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/lineberger-building-technology-base-for-better-cancer-vaccines-9117c3b12ec6706d 2026-09-15T16:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbe-vs-rsph-is-a-biotech-etf-or-equal-weight-healthcare-etf-the-better-choice-fo-8d536855447ea87f 2026-09-15T16:43:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-therapeutics-vera-stock-surges-following-promising-origin3-trial-results-0dcc1dff0d8c2ccf 2026-09-15T16:37:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cafe-mondegar-among-4-mumbai-outlets-suspended-by-fda-over-food-safety-violation-198e42aafbca49fe 2026-09-15T16:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-response-to-the-thirlwall-inquiry-ff462750db59e27b 2026-09-15T16:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jornada-en-conmemoracion-del-dia-mundial-del-alzheimer-en-la-unlp-0662c09aeb82f613 2026-09-15T16:23:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-energy-uc-irvine-never-used-47d02add849c9ba3 2026-09-15T16:21:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-to-act-on-thirlwall-patient-safety-recommendations-8e24371ba7eef03b 2026-09-15T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skyhawk-therapeutics-announces-final-fifteen-month-results-from-phase-1-2-clinic-a77c77723be25e10 2026-09-15T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-tumour-host-interactions-in-liver-cancer-of-childhood-and-adults-777a915ed3a87482 2026-09-15T16:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-expanding-the-european-ehrxf-to-share-and-effectively-use-health-1332b9417654bb6b 2026-09-15T16:18:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-virtual-brain-twin-for-personalised-treatment-of-psychiatric-diso-c73fc5eb4b7281e6 2026-09-15T16:18:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ich-kann-zeigen-was-ich-kann-schon-in-jungem-alter-bd19b1665f8d76d6 2026-09-15T16:04:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-queueing-science-could-fix-hub-staffing-guesswork-8b1c0f65b7491859 2026-09-15T16:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/topical-sildenafil-cream-associated-with-lower-systemic-exposure-vs-oral-sildena-799a969fefc2448f 2026-09-15T15:57:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/bezisterim-may-help-with-some-long-covid-symptoms-drug-s-developer-reports-in-ea-dd98e1666787e33f 2026-09-15T15:54:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/waltham-biotech-cuts-nearly-half-its-workforce-after-cystic-fibrosis-drug-fails-154605cf755a25bf 2026-09-15T15:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-signs-10-year-120m-deal-to-automate-commercial-cell-therapy-manufact-adbe486e7d89146b 2026-09-15T15:52:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/guy-s-pharmacy-launches-medicine-collection-lockers-81967b05e661e7b2 2026-09-15T15:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-shot-against-four-dengue-strains-what-india-s-home-grown-dengiall-vaccine-co-1d2bfa01ec868da0 2026-09-15T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenio-de-colaboracion-con-la-defensoria-de-la-ninez-bee014f00dc8db5c 2026-09-15T15:38:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-entrepreneur-philip-goelet-joins-whitehead-institute-board-of-directors-73e5ecc85fa4e229 2026-09-15T15:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-researchers-awarded-1m-wall-fellowships-to-advance-human-and-ecosystem-healt-44c569f2963ac6a1 2026-09-15T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concursos-nodocentes-983118a1cfff9744 2026-09-15T15:28:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-micro-de-la-maternite-un-podcast-pour-s-informer-sur-sa-grossesse-53d9972b3d11bf70 2026-09-15T15:19:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-curi-bio-s-letter-of-intent-into-istand-program-to-qualify-3d-neurom-00b00f0510c84820 2026-09-15T15:06:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/smelling-chocolate-helped-men-complete-more-reps-without-feeling-more-tired-d83c990ebb92dc03 2026-09-15T15:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-a-playbook-for-dscsa-value-beyond-compliance-eb0d87a1e73b22ed 2026-09-15T15:02:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-better-ways-of-screening-drugs-could-soon-lead-to-thousands-fewer-animal-tes-0d8c9553c4016f5c 2026-09-15T15:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubiquitin-marks-abnormal-glycogen-for-destruction-to-protect-the-brain-a4e2ef403604f771 2026-09-15T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-2e56b8e582b343fa 2026-09-15T14:59:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-75f7dce44dd8df60 2026-09-15T14:58:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-advisory-panel-ukap-enquiry-form-38f5d243521e9931 2026-09-15T14:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/imvax-announces-additional-data-from-phase-2b-clinical-trial-of-igv-001-in-newly-d5d0f8a72497251b 2026-09-15T14:48:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-industry-wrote-montana-s-right-to-try-law-now-they-re-running-the-sh-d462381332cb2633 2026-09-15T14:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-primary-children-s-hospitals-once-again-ranked-among-nation-002824e58ab7f154 2026-09-15T14:41:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-raises-33m-for-cancer-drug-development-73485c033219a385 2026-09-15T14:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-hears-80-speakers-on-psychedelic-drug-therapy-standards-08469c1399c0a84a 2026-09-15T14:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-a-major-brain-shift-between-ages-50-and-75-aa4a9d132a2808ca 2026-09-15T14:28:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-and-biolabs-university-of-toronto-open-applications-for-abbvie-biotech-in-4f7584c7886f13aa 2026-09-15T14:27:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-ai-trust-gap-slowing-healthcare-provider-adoption-survey-reveals-c9537e83af37e3d8 2026-09-15T14:24:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-to-acquire-potential-best-in-class-t-cell-engager-tce-for-multiple-myeloma-f-62e7d22436b47e77 2026-09-15T14:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/supporting-complex-phase-i-studies-through-integrated-imaging-and-specialized-as-0e0c38380763ff9c 2026-09-15T14:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/defining-ad-disease-flares-vs-drug-effects-a-comparative-analysis-of-phase-3-sys-9b3a6140d8d68e9f 2026-09-15T14:14:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/stakeholders-urge-fda-to-define-data-treatment-standards-as-psychedelic-drugs-ne-f1bbb0b0fd948389 2026-09-15T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-reform-cmc-risk-reshoring-us-trials-top-of-mind-ahead-of-pdufa-viii-a6dd2bd949ba3468 2026-09-15T14:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/r1-32-like-public-antibodies-acquire-tolerance-to-sars-cov-2-antigenic-drift-thr-7fa3df58a8d5fc96 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-acute-inflammation-triggered-by-infection-promote-cancer-progression-702deb6ae40a1b0b 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclic-tri-adenylate-controls-a-carf-tm-effector-in-type-ii-panoptes-anti-phage-07d85a1a86f7eeeb 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atlastin-2-mediated-endoplasmic-reticulum-membrane-tethering-is-critical-for-fla-7a3fae0ad4a441cd 2026-09-15T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connect-s-dupixent-rival-flunks-phase-2-asthma-trial-but-biotech-sees-reasons-fo-df8ae3f97c319dcf 2026-09-15T13:55:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-drugmakers-are-testing-in-kids-as-young-as-6-15423b2c677d102a 2026-09-15T13:53:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-psychedelics-hearing-tackles-questions-about-treatments-6d105a363d636f01 2026-09-15T13:52:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/despite-3-patient-deaths-cullinan-taiho-plan-fda-filing-for-lung-cancer-pill-on-ccce6f34ab127e2a 2026-09-15T13:51:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-new-drug-trial-approvals-at-cspc-pharmaceutical-group-stock-has-changed-its-286c1b7011894676 2026-09-15T13:50:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-11-october-2026-f8d136078761e069 2026-09-15T13:45:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-42-report-data-to-week-41-data-up-t-c191b99be464c1cd 2026-09-15T13:45:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-42-report-data-to-week-41-dat-81e64c216725e952 2026-09-15T13:45:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-61814d75375f6c45 2026-09-15T13:43:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-reports-phase-iii-benefit-for-trastuzumab-botidotin-in-her2-positi-5456029ae019c373 2026-09-15T13:38:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-clarifies-post-marketing-requirements-for-isembyld-after-fda-approv-af85aacc1f2d7ef7 2026-09-15T13:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-corporation-announces-ceo-changes-22b3bb122bfb973d 2026-09-15T13:20:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-overlooked-science-of-ecoa-when-good-clinical-outcome-assessments-still-prod-a1cf5235c4a8deff 2026-09-15T13:19:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-320-pain-professionals-attended-ensysce-s-symposium-on-complex-pain-e8c78633cfca9b32 2026-09-15T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-plan-for-england-d59ff0423140ac07 2026-09-15T13:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-340b-rebate-tracking-really-demands-from-pharmacies-1036825346f0ecd9 2026-09-15T13:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-084ce903ab0026f7 2026-09-15T13:05:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-held-a-public-hearing-on-psychedelic-therapies-as-trump-s-push-to-speed-appr-bbfdc7e67a996d89 2026-09-15T13:02:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-can-focused-ultrasound-treat-tremor-and-movement-symptoms-in-parkinson-s-dis-7207a68b37946004 2026-09-15T13:02:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-americans-really-want-from-drug-ads-2bb4904fef97820f 2026-09-15T13:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-accepts-curi-bio-s-letter-of-intent-into-istand-program-to-qualify-3d-neurom-6855aa6ae0b3f446 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-names-novartis-executive-as-ceo-504f6ae79a3fda8f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/they-had-a-plan-how-sophia-s-parents-found-care-for-rohhad-syndrome-a0e028ec4c72bb5f 2026-09-15T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-covid-19-inquiry-53a03ab2ca904c16 2026-09-15T12:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-clarifies-post-marketing-requirements-for-isembyld-after-fda-approv-94118c4ce3f4d105 2026-09-15T12:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-group-announces-swissmedic-approval-of-cerbios-expanded-reduced-folates-prod-0e7a73cb46e0db15 2026-09-15T12:50:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-taps-novartis-veteran-zhang-as-ceo-151b6723d1790a16 2026-09-15T12:42:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-creating-an-individual-data-return-template-a-patient-centered-approach-by-ci-8088f2b95ea81f5a 2026-09-15T12:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-pledges-up-to-237m-per-program-in-cns-genetic-med-collab-with-canadian-bio-4810915a9a39abc1 2026-09-15T12:42:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-raises-definium-therapeutics-price-target-on-trial-results-823ad11d724e1346 2026-09-15T12:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-adults-with-multiple-or-complex-health-conditions-face-significant-challe-07e5b9e1d7bf6098 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-access-and-affordability-for-adults-with-multiple-or-complex-health-40f35f4aa2e21f66 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-the-pga-tour-and-2026-presidents-8c59bede56b31042 2026-09-15T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccination-of-people-with-uncertain-or-incomplete-immunisation-2614a700ef581637 2026-09-15T12:24:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/let-s-talk-with-sorrisi-in-rosa-10-anni-insieme-a936d1bccd7f37c2 2026-09-15T12:21:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/maia-biotechnology-announces-insider-share-purchases-by-board-member-and-ceo-ami-5517cde72350edd4 2026-09-15T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-habilita-una-nueva-aplicacion-para-presentar-telematicamente-la-declara-ced439fd208ddf21 2026-09-15T12:09:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/compass-pathways-just-answered-the-durability-question-now-comes-the-harder-prob-91b82d6d78659f27 2026-09-15T12:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nkgen-biotech-to-present-on-troculeucel-for-75400b55930fb023 2026-09-15T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-a7a8016caf9792c3 2026-09-15T12:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/lenders-take-over-big-biotech-projects-from-developers-amid-weak-market-0da1139c9a272cf0 2026-09-15T12:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-levanto-la-inhibicion-de-importacion-dispuesta-a-la-firma-glam-distribucio-407da0257e07bbac 2026-09-15T12:02:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-legend-biotech-nasdaq-legn-ceo-could-get-10m-a-year-in-stock-grants-83bafaed24e453a0 2026-09-15T12:01:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ai-agents-invent-their-own-language-if-you-let-them-chat-9beb98df1bc5cd4b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organika-gummies-foreign-site-not-listed-on-site-licence-a84ecb8691e76e80 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-target-product-profile-where-clinical-development-meets-commercial-reality-49a27a3d5b010a47 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-appoints-ingrid-zhang-as-chief-executive-officer-72bd3e18ed2e0548 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturin-7332490dba27ec05 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allergan-aesthetics-to-advance-scientific-dialogue-on-skin-longevity-aging-biolo-22d33810a0bd348b 2026-09-15T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-gets-breakthrough-therapy-designation-for-lung-cancer-drug-9a2411f77c5ff047 2026-09-15T11:50:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-formulation-development-solubility-enhancement-modified-release-and-a-50a246e993c73d45 2026-09-15T11:42:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-psychedelics-hearing-focuses-on-boosting-therapeutic-innovations-while-adher-564e03b72c9d5388 2026-09-15T11:41:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-inhibio-las-actividades-productivas-de-la-firma-ripezzi-s-r-l-y-prohibio-e-d13a499acca0a29e 2026-09-15T11:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-announces-topline-results-from-phase-2-address-lc-trial-evaluating-bezist-7ad61d619ea60776 2026-09-15T11:37:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/thirlwall-inquiry-report-e6a6b02f944b9e08 2026-09-15T11:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-doubles-down-on-china-biotech-paying-up-to-750-million-for-global-rights-to-7d22f9ea6a2666d5 2026-09-15T11:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-estimated-17-20-million-u-s-adults-live-with-long-covid-biovie-reports-benefi-eae313323506dbb4 2026-09-15T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/address-by-prof-mojisola-christianah-adeyeye-at-the-49th-annual-international-co-a2a7d60bb2244405 2026-09-15T11:23:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-urged-to-strengthen-psychedelic-drug-standards-c4b252a4c0a4515c 2026-09-15T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-1b21a6d7086131d4 2026-09-15T11:16:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-doubles-down-on-chimagen-with-750m-multiple-myeloma-wager-9bba28a103be6682 2026-09-15T11:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-cell-and-gene-therapies-ffe94a9bf1b673cb 2026-09-15T11:10:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/inherited-retinal-disorders-and-rare-ocular-disease-801219118a193010 2026-09-15T11:04:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-10705eb8501f8596 2026-09-15T11:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/leading-biotech-selects-veeva-vault-crm-globally-15d9a37158cd8455 2026-09-15T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dompe-u-s-pays-32-million-to-resolve-co-pay-foundation-kickback-allegations-foll-a18a9b45edf7a74d 2026-09-15T11:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/sacking-football-managers-does-not-improve-performance-study-finds-03c01ac7a2e8e41e 2026-09-15T11:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-performed-in-the-microbiology-department-of-vall-d-hebron-university-hos-a8d24f15864f0602 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocular-therapeutixtm-announces-positive-pre-nda-meeting-with-u-s-fda-for-axpaxli-df8feae142024a4b 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/debut-engineers-new-biotech-ingredient-for-hyperpigmentation-bd42adb0c0606c65 2026-09-15T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-kidney-drug-trutakna-shows-strong-final-results-in-phase-3-trial-df6628efe3598540 2026-09-15T10:53:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/meiji-group-to-showcase-japanese-quality-cmo-cdmo-services-and-a-global-manufact-e52ed07ed40f30ac 2026-09-15T10:49:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-gum-disease-before-it-starts-with-ai-9fb6b31196acfe4a 2026-09-15T10:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-trustees-announced-as-cancer-research-uk-strengthens-research-and-governance-b0e6efe05865e793 2026-09-15T10:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-u-s-eradicated-this-flesh-eating-parasite-now-it-s-back-0a632145778feae0 2026-09-15T10:39:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/vera-therapeutics-secures-strong-final-phase-3-data-for-kidney-drug-trutakna-36d5522ea33843a0 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-tulane-is-spotting-startup-gems-inside-stacks-of-academic-research-1f9769591bca433c 2026-09-15T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-halts-development-of-experimental-obesity-drug-after-phase-1-setback-d54510d85ed65bb4 2026-09-15T10:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/widow-s-bay-triumphs-as-most-decorated-freshman-comedy-in-emmy-history-73c1fed3e66c3e88 2026-09-15T10:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/veterans-and-doctors-urged-psychedelic-therapy-safety-standards-at-fda-hearing-w-fa6fb35f2fa9db3d 2026-09-15T10:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/preorder-dci-s-new-2026-27-economic-report-on-pharmaceutical-wholesalers-and-spe-cf342a4bd277e1b1 2026-09-15T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-radiology-abdomen-publishes-debut-articles-e0267cdf86aedfca 2026-09-15T09:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/florrax-pharmaceutical-updates-glp-core-tablet-product-information-in-dailymed-d-d44690b1b2608954 2026-09-15T09:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-new-nih-research-center-on-vaccine-harms-takes-shape-9fff0ee16aaaf112 2026-09-15T09:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-august-2026-1b10eeb5524e0803 2026-09-15T09:50:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/benemeat-warns-uk-eu-trade-deal-could-put-wider-biotech-ambitions-at-risk-fe6a683c0c2b29a5 2026-09-15T09:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/lorraine-hill-joins-industry-leaders-in-conversation-on-gender-leadership-and-th-7d42b07921023b67 2026-09-15T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wclc-lung-cancer-news-from-biontech-akeso-and-roche-40c82f5f181ab638 2026-09-15T09:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-fda-and-ema-now-accept-from-real-world-data-240492ab4fd2c3b1 2026-09-15T09:17:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/chief-medical-officer-of-precision-for-medicine-line-between-phase-1-and-2-trial-5f656497ea653dbf 2026-09-15T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connecting-data-people-and-patients-how-ai-is-advancing-neuroscience-clinical-tr-fbb7dc892cca538a 2026-09-15T09:10:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/century-adds-biotech-veteran-as-cell-therapies-near-milestones-1287adafcb6350ae 2026-09-15T09:10:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-get-caught-out-by-flu-this-winter-as-nhsggc-expands-vaccine-clinics-237642de4684a825 2026-09-15T09:08:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/day-1-is-ai-in-biotech-real-growth-or-hype-24ea2945d48f00f2 2026-09-15T09:05:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-regulation-and-the-dynamic-nature-of-ai-0c1651051d68903b 2026-09-15T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-driving-simcere-pharmaceutical-group-sehk-2096-higher-today-38c1d46a98971355 2026-09-15T08:56:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-biotech-ai-trade-finds-real-fuel-e3b1dea7cc9273dc 2026-09-15T08:56:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-15-september-2026-a7c5aa202e8d1a2b 2026-09-15T08:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanyang-precision-chairman-faces-breach-of-trust-embezzlement-allegations-7630c5cc0a515910 2026-09-15T08:51:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/qasim-treated-by-specialists-with-all-the-rare-blood-available-across-the-countr-cf8bbd18e6915c1a 2026-09-15T08:42:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/bloodborne-virus-testing-in-prisons-and-other-places-of-detention-19658f88bc805354 2026-09-15T08:30:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/leprosy-notifications-to-uk-national-surveillance-2001-to-2025-cbea52de19821e05 2026-09-15T08:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fratture-costali-nuove-frontiere-chirurgiche-mininvasive-al-policlinico-di-milan-ae965af1975ddb4c 2026-09-15T08:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-interest-in-chugai-pharmaceutical-co-ltd-unsponsored-adr-otcmkts-chgcy-exp-0ad45629e5c18f34 2026-09-15T08:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-science-unpicking-data-diversity-and-inclusive-research-design-e2ec926d17ea3e7c 2026-09-15T08:22:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-s-co-ceo-has-big-hopes-that-fibrosis-drug-can-reverse-aging-too-05298b94b951aeb6 2026-09-15T08:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/deutsche-bank-upgrades-astrazeneca-stock-rating-to-hold-on-trial-results-e24cf6dc3282e01a 2026-09-15T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-manufacturing-company-abec-opens-north-carolina-facility-35b14667e72d9b33 2026-09-15T08:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbsrc-publishes-refreshed-edi-action-plan-for-2026-to-2028-5b9f44f6886b921c 2026-09-15T08:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/passaparola-28-09-02-10-h-open-week-malattie-cardiovascolari-84f3f324009bddd2 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/every-electron-counts-most-detailed-protein-structure-to-date-revealed-05e3072f40e0c0d6 2026-09-15T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yprime-guide-supply-management-critical-to-irt-trial-success-for-biotech-sponsor-ff618748e3e73b3e 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-s-dt120-odt-meets-primary-endpoint-in-phase-3-gad-study-ffdc87d33d747dda 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-just-handed-psychedelic-drug-sponsors-a-framework-now-the-hard-part-star-0df868a4710c99b2 2026-09-15T07:58:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-company-uses-biotech-to-develop-more-effective-biological-pesticides-584a7468194ba384 2026-09-15T07:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-mourns-the-passing-of-prof-filipe-caseiro-alves-30d53a422912c304 2026-09-15T07:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-advanced-bhv-7000-to-pivotal-trials-without-answering-a-question-the-fd-8ef994cf536ab4e7 2026-09-15T07:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-ras-inhibitors-what-comes-next-in-pancreatic-cancer-ecf1adfe3a0130a8 2026-09-15T07:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hannah-benisty-and-maximilian-stammnitz-join-ar-i-crg-mountain-genomics-talent-p-4c62b23e8d169932 2026-09-15T07:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-nutx-8-iova-7-atrc-cnc-con-4690179e4c18e9cd 2026-09-15T07:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-facing-fda-decision-in-october-2026-32d5468f90b77d0b 2026-09-15T07:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-op-een-kantelpunt-innovatie-en-effectieve-toegang-in-de-gezondheidszorg-94c6bad5eeed7e20 2026-09-15T07:10:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/eur-and-erasmus-mc-once-again-achieved-nearly-100-open-access-in-2025-29ceeb281f399463 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-news-world-report-names-uc-davis-children-s-hospital-among-best-children-s-h-81eff130777decf6 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remembering-ernest-e-tschannen-d11bb7fa3dc7a927 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/northern-nevada-based-cancer-care-specialists-joins-uc-davis-cancer-care-network-7f2acb3d8d3957d1 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-wildfire-smoke-exposure-grows-uc-davis-researchers-seek-answers-92f9b79dafc9784f 2026-09-15T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/huons-teams-with-3-biotechs-on-mrna-adc-peptide-drug-projects-e922bd96adfa7ffa 2026-09-15T06:56:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/9-22-nhk-e-cdb01965a93c2f77 2026-09-15T06:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1bn-to-public-biotech-fund-taking-total-commitments-ff6f44cd37484361 2026-09-15T06:56:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-eu-biotech-act-must-deliver-practical-improvements-for-clinical-trials-i-cd6fa0b28c6148ce 2026-09-15T06:55:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/sionna-to-test-sion-451-and-sion-2222-combo-in-cf-phase-2a-trial-502cb66a8d1bb08a 2026-09-15T06:48:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinpoong-revises-phase-3-stroke-trial-plan-for-sp-8203-a8cf77fc47a9bc04 2026-09-15T06:45:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-invests-80-million-to-expand-biotech-production-in-slovakia-e5631308d237f1b5 2026-09-15T06:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/keeps-biopharma-s-idetrexed-wins-korean-phase-2-ind-approval-c048c54abe2e3304 2026-09-15T06:21:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-firm-boryung-to-split-off-sales-marketing-divisions-ef1110c02ba6eaa5 2026-09-15T05:49:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/purity-with-purpose-clariant-health-care-raises-the-bar-for-pharmaceutical-excip-ed1ca819e43d20f0 2026-09-15T05:28:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-could-get-its-first-indigenous-dengue-vaccine-by-2027-icmr-dg-reveals-time-544de43e0a215d6e 2026-09-15T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-mochida-pharmaceutical-co-ltd-stocks-c9e7c6384cd77f6b 2026-09-15T04:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/esophageal-ph-monitoring-capsule-recall-medtronic-and-given-imaging-remove-esoph-d9cf1ce94eb38542 2026-09-15T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-10-000-patients-reveal-what-works-best-for-knee-arthritis-pain-relief-efa56f58b8e874fb 2026-09-15T03:57:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-to-spend-billions-on-visionary-plan-to-boost-fish-habitat-9c70e872ffcd363a 2026-09-15T03:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-native-biotech-yudao-bio-raises-30m-series-c-76640c7b47244685 2026-09-15T03:07:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-vs-vertex-pharmaceuticals-value-stability-vs-high-growth-biotech-investmen-cf23a82612abdb43 2026-09-15T02:47:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/openai-breakthrough-triggers-existential-crisis-in-math-845ad0abedc726d4 2026-09-15T02:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2027-5a1abac55f9bda0e 2026-09-15T02:36:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-nuclear-courses-to-power-south-australia-s-future-aukus-workforce-b519f116eb423145 2026-09-15T02:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-best-biotech-stocks-for-2026-and-how-to-invest-95a8df16f2907324 2026-09-15T01:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/test-seoul-biotech-startups-enter-boston-pipeline-through-labcentral-950b2083d7c96caf 2026-09-15T01:30:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-biopharma-complexity-why-long-term-partnerships-matter-39b1115d3c1f4806 2026-09-15T01:21:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/propriedade-intelectual-e-eficiencia-regulatoria-como-motores-do-bem-estar-regio-47eb0fde5a9a0cb3 2026-09-15T01:16:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-detection-biotech-lodges-patent-suit-against-rival-97957de1513c39f1 2026-09-15T01:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellectual-property-and-regulatory-efficiency-as-drivers-of-regional-well-bein-0e91412e61ed6c95 2026-09-15T01:04:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-from-the-fda-s-hearing-on-psychedelic-drugs-9a4b8269165dba38 2026-09-15T01:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/bsr-sdic-biotech-seek-cooperation-on-ethanol-biofuels-96d7ccba31ab201d 2026-09-15T00:58:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-biotech-giant-lonza-breaks-ground-on-major-bend-expansion-6a4e618ea7fbf639 2026-09-15T00:55:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/propiedad-intelectual-y-eficiencia-regulatoria-como-motores-del-bienestar-region-636ab545130e30a3 2026-09-15T00:13:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-8a0e637c0b3e4dbe 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-6f021ed602180448 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-3c1d884d0596108b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineering-botulinum-neurotoxin-into-anti-cancer-agents-a961c38b9f672a2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intracranial-recordings-in-humans-reveal-differential-contributions-of-medial-an-727fada75d1c43ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-breakthrough-for-ras-driven-cancers-fb8906a37f894648 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-versatile-nanopore-identifies-four-classes-of-analytes-simultaneously-1d1ed26f07ad5c33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ensuring-safety-and-accountability-in-china-s-biomedical-translation-system-24d508374c9320bb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petition-048a-peripheral-artery-disease-findin-f6d3e799437ce4e2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-trade-center-health-program-petitions-048-and-051a-stroke-finding-of-insuf-75f442dab1d68f6e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-grant-of-an-exclusive-patent-license-development-and-commercializati-f2565eb7e1fb798e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-0626beb47d66f9d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-b8a95ad8905e26c2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-information-collection-activity-multistate-financial-institution-data-m-3021d4ff81f706b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-cancer-institute-notice-of-closed-meeting-421eb7f1bbe8c043 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-considerations-for-the-design-of-rare-disease-clinical-investigation-ebf052b141198824 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vill-knacka-hjartats-genetiska-kod-9a93a6184f8cdb67 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/till-minne-av-jan-ake-gustafsson-1943-2026-157d552849da7002 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-avhandling-undersoker-hur-dna-reparation-och-amnesomsattning-paverkar-immunsv-a92b2f175e0d7a03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hjarnans-blodflode-kopplas-till-trotthet-efter-covid-f64ebc22e61c93a4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-children-s-named-among-the-nation-s-best-children-s-hospitals-882b1ccab9ab1c35 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jama-8ec86eab73be8490 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/audio-highlights-august-21-2026-cdf70b6bc9b1aa3f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gestational-hypertension-has-increased-affecting-1-in-10-pregnancies-cd46702af2461f9d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-freeze-dried-plasma-product-in-the-us-91551b9c452b7fca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-drugs-linked-to-lower-fracture-risk-in-people-with-type-2-diabetes-ac0db8b55f56cfc2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-acetaminophen-and-naproxen-sodium-combination-drug-23f6a2ff6b0ab515 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-e-scooters-more-dangerous-than-motorcycles-and-bicycles-9309e6f9174b333c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aap-acog-speak-out-against-executive-order-fd97f969adb97da8 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-organoid-era-0d1d74c17c3dfac6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyclospora-outbreak-reveals-gaps-in-foodborne-disease-surveillance-9c1923e37ef042aa 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-life-worth-saving-87e8ab3b696abb6d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1s-from-gut-hormone-discovery-to-a-public-health-revolution-dc098d40197dcc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-original-yes-66773534912b3190 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unspoken-7afae036d0f0f51f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healing-through-catharsis-in-poetry-c1c641915b1e651e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-to-inpatient-management-for-boarding-emergency-department-patients-4c8a954c5150c6af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-autonomous-ai-exceed-ai-aided-physicians-as-the-best-medical-care-f1019c797800d26e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-2af5f79a317fd31b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-workforce-well-being-reply-3b9c300a95d19024 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-guidance-for-author-use-of-ai-in-medical-publication-bb959e0d57595750 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-assisted-inverse-design-of-biopharmaceutical-formulations-and-d-98e3167acbc19088 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-era-in-the-treatment-of-metabolic-dysfunction-associated-steatotic-liver-d-bc2991c82cd3907f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-and-safety-comparison-of-cycloserine-capsules-and-their-generic-b2e30b35cb0877d2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpreting-pain-mood-associations-in-a-secondary-analysis-of-a-bariatric-surge-9d4328af0863d5bb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-a-pharmacist-adherence-intervention-on-medication-beliefs-and-drug-rel-99f047c3077794f3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-ranking-of-her2-targeted-tkis-in-advanced-breast-cancer-a-ba-c1503da3f127d928 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inclusion-of-pregnant-and-lactating-women-in-tb-treatment-and-vaccine-trials-cb167a4c14bdf8bd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-treatment-outcomes-and-adverse-events-during-bpalm-therapy-for-rifamp-f4b1c939da56cf4e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/myeloma-associated-sporadic-late-onset-nemaline-myopathy-successfully-treated-wi-e9813ff2c742dd5a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sino-us-drugqa-a-benchmark-for-evaluating-large-language-models-in-cross-jurisdi-7f21a4c4b8fdb607 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-and-healthcare-professional-attitudes-and-trial-experiences-with-a-subcu-deb55836712fc0bd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-sepsis-therapy-and-modern-trial-designs-6af234581ed4f8bb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-evolution-of-rtog-and-nrg-oncology-cns-tumors-clinical-trials-008e69c6d31dc2f5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-dl-3-n-butylphthalide-in-spinocerebellar-ataxia-type-3-03bffa217093407e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-the-concept-of-disease-modification-in-an-evolving-parkinson-s-diseas-3f058d83599284df 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategies-to-improve-recruitment-to-randomised-trials-0ac5abbd484efccb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-influence-of-pharmacogenetics-on-the-treatment-related-outcomes-of-antidepre-66a4c7490f5ffe5e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-treatment-adherence-among-patients-receiving-care-for-sexu-43adcc1d39fbcea3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adolescent-centered-cannabis-messaging-in-clinical-settings-preliminary-qualitat-b8d6c3a5e7c2239f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delays-in-malignant-neck-mass-diagnosis-missed-opportunities-in-clinical-decisio-9b3c51828bc44be9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-clinical-examination-for-detecting-knee-effusion-impac-faed480839f597f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harnessing-bioinformatics-to-decode-drug-resistance-and-guide-vaccine-design-in-6de558308b79a690 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/afp-commissioner-urges-conversation-about-link-between-australians-level-of-illi-928113742fc8c7bc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-signs-the-forgotten-art-part-3-ten-more-bedside-signs-every-clinician-s-dad7c35192128594 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-computer-aided-detection-for-adenoma-detection-promising-but-context-5c32ac5fe4accd6f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-support-for-precolonoscopy-cancer-triage-a-rule-out-oriented-m-4254b4df21b60a7b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceptions-of-nursing-undergraduates-regarding-their-clinical-placements-a-qual-25bbee34a69cbf71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-factors-associated-with-anxiety-disorders-in-adults-with-childhood-hypo-f5f1bbf61b678653 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-bolus-sequential-triple-rule-out-ct-angiography-image-quality-and-radiati-2523fc6a940efa2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-there-a-way-to-break-the-glass-ceiling-in-the-diagnosis-and-treatment-of-extr-6dbfbb9ae0d485db 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychometric-evaluation-of-the-romanian-quality-of-life-in-adult-cancer-survivor-e4c61b7530a11b5d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-making-after-receptor-conversion-following-neoadjuvant-therapy-f9281e61f8e9684d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematological-versus-clinical-predictors-of-tumor-grade-in-endometrial-cancer-a-89a0af042aa922cc 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pathological-complete-response-and-residual-disease-patterns-after-neoadjuvant-c-938b06a557f15426 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psoas-compartment-block-versus-medial-branch-block-for-low-back-pain-a-narrative-c097443763d57ce9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-bdnf-in-subacute-stroke-effects-of-a-four-week-aerobic-exercise-interventi-4795366c5aa72614 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-and-ayahuasca-in-treatment-resistant-depression-clinical-evidence-met-a68c95b0c85d72ba 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ct-perfusion-guided-thrombolysis-in-the-extended-window-from-trial-eligibility-t-18ab636f06709701 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-clinical-and-structural-outcomes-of-a-standardized-ultrasound-guided-8cc2048e61bc5867 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/triglycerides-and-ovarian-response-in-diminished-ovarian-reserve-a-two-sample-me-719c3490b9f0ca02 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-modeling-of-small-molecule-pharmaceutical-solubility-in-324bb23bea21ac32 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reconciling-conflicting-evidence-on-stress-ulcer-prophylaxis-in-critically-ill-c-adbb7e278ab70fac 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-changes-in-serum-soluble-c5b-9-levels-following-immunomodulatory-th-ba34b9f9ee5c0b19 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patterns-of-scholarly-literature-use-in-health-sciences-theses-a-citation-analys-285cd602f16b2cf0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-changing-landscape-of-sudden-cardiac-arrest-in-young-adults-a-meta-analysis-fbbda51b82965c5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-survey-of-deep-learning-models-and-their-applications-in-text-recognition-98030a04077e78b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/need-assessment-of-oral-health-policy-curriculum-knowing-and-teaching-gaps-among-f665dec0108303b3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiographic-assessment-and-orthodontic-intervention-effects-on-orthodontically-a33f050d65702b81 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-course-and-management-of-pancreatic-pseudocyst-perforation-1451c95dbc284797 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ha-dmf-hybrid-attention-based-deep-matrix-factorization-for-drug-combination-syn-c24c4f1099f6ff20 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/latent-profiles-of-characteristics-related-to-humanistic-caring-ability-among-cl-0d8da2c3b8ec7537 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-mr-guided-focused-ultrasound-enhanced-liquid-biopsy-sonobiopsy-for-the-a28e33a00a204c71 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/folic-acid-and-folate-6ec44d09f02a259d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-consuming-school-meals-enriched-with-fish-powder-on-zinc-status-of-sc-bcea81312a3014e4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-delivery-oriented-solubility-enhancement-of-curcumin-in-choline-chloride-ba-7f86f7046d0bf6bf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-simultaneous-aerobic-exercise-and-cognitive-training-in-persons-with-56b2210303292630 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cryotkr-study-protocol-for-a-monocentric-randomised-controlled-trial-assessing-c-3ae306237195969c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-paradigm-for-treating-recurrent-platinum-resistant-ovarian-cancer-synergis-e57cce58ff1c8144 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-participation-in-breast-cancer-screening-through-a-tailored-reminder-l-af8d35afed59550e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-simvastatin-versus-calcium-hydroxide-intracanal-medications-on-postope-59c7eb81fdc92fb1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-everolimus-plus-exemestane-versus-fulvestrant-in-patients-w-c3c64b64c82bc02f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fresh-elective-single-versus-double-embryo-transfer-and-healthy-singleton-birth-d8684b6d846abf0e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-features-and-treatment-outcomes-in-erythema-elevatum-et-diutinum-a-syst-ac19a3d21703b2b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-to-clonal-expansion-of-alveolar-fibroblast-progeny-drives-pulmonary-fibr-44ff2f7168a840cf 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrigendum-to-elevated-microrna-187-causes-cardiac-endothelial-dysplasia-to-pro-4c75f672d5d76622 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/going-to-the-source-pancreatic-lymph-nodes-maintain-stem-like-cd8-t-cells-in-hum-fcc64c04b96ae8b6 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-by-zhao-et-al-to-letter-regarding-article-dapagliflozin-to-reduce-early-015b0a731e1227ad 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-by-xu-et-al-regarding-article-dapagliflozin-to-reduce-early-recurrence-af-0c94dd0016b3241f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s5-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-c64c84a98cc49b03 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s9-from-crb-701-a-second-generation-nectin-4-targeted-antibody-drug-conjug-46b13aa809978329 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-molecular-and-clinical-determinants-of-targeted-therapy-treatment-in-b-d06dc5130b76a1b9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-investigational-clinical-trial-agents-versus-conventional-second-salva-3384c787b95169af 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s1-from-molecular-and-clinical-determinants-of-targeted-the-2e8b6f4b1a694aa3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s2-from-the-first-in-human-encit01-trial-comparing-second-v-096e4c3ff1996058 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s1-from-clinical-validation-of-a-multiplex-urine-biomarker-a-7c8fdcec85ec6c1f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/egfr-mutation-subtype-and-risk-of-brain-metastases-from-non-small-cell-lung-canc-43f1c6aa42c24d86 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/music-based-interventions-in-adult-stroke-rehabilitation-a-narrative-review-of-c-44e89f5c937bfc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eyes-reveal-systemic-secrets-diverse-systemic-associations-in-branch-retinal-f14042c63a7b3d2f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-integrated-approach-combining-receptor-based-ensemble-screening-and-i-in-vivo-69ead253511a7684 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-aluminum-oxide-nanoparticle-effects-on-camelina-sativa-pe-0f2efb614e70ad3b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimicrobial-stewardship-in-acute-exacerbations-of-copd-a-qualitative-study-of-0a4c60baff493e28 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-pharmacokinetic-and-pharmacological-profiling-of-b339-a-novel-sarm1-502265a87702e721 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-flexible-horizon-clinical-decision-support-model-for-dementia-early-detection-313a9702ec48c9d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-risk-profiles-of-heart-failure-and-non-heart-failure-major-adverse-card-6c2a7deeff11c8d1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meteorological-factors-and-primary-care-consultation-patterns-in-rheumatoid-arth-4244589e5dac6fa5 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-symptom-map-based-education-in-the-management-of-premenstrual-s-924bc4bf234159ed 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraocular-pressure-and-optical-coherence-tomography-parameters-in-pediatric-hy-a8a26bf8cc758a93 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transabdominal-lumbar-approach-tala-versus-retroperitoneal-approach-for-robot-as-35da7dabb4be8947 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decoding-nano-bio-interactions-gene-regulatory-networks-in-advanced-drug-loading-f65ffa6872396158 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2n-bots-a-dual-responsive-cross-scale-synergistic-strategy-for-hierarchical-drug-39e7bb594a62e3dd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guided-bone-regeneration-using-titanium-mesh-and-xenogeneic-graft-alone-histolog-9eaf093f0ac6237b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prescription-drug-use-among-us-adults-4ae68c0022c8c414 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-dose-intravenous-vitamin-c-and-mortality-and-organ-dysfunction-in-severe-bu-e3878b61ca52e0c3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821411-a-real-world-study-of-ofatumumab-in-multiple-sclerosis-patients-in-g-c3246e2c2eb31624 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07821372-a-plant-based-diet-in-the-treatment-of-coronary-microvascular-dysfun-d655ef745e9b86ec 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820839-digital-stimulation-and-anxiety-and-sleep-quality-in-intensive-care-dfd765dc4e02acd3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820436-interactive-robot-guided-exercise-program-for-cancer-related-fatigue-28b46cb5a6ff0c06 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07820345-development-and-evaluation-of-low-cost-non-animal-biological-simulat-a2263ed273f54b88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819812-thiotepa-based-conditioning-for-haploidentical-hsct-in-older-patient-19834e1645f4c992 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819669-video-assisted-thoracoscopic-surgery-combined-with-radiofrequency-ab-35c734308ccb4db1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819487-a-community-health-worker-service-to-address-acute-care-utilization-b002158db6f8417b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819474-optimizing-tumor-infiltrating-lymphocyte-til-harvest-site-and-patien-7b856cffb66c1902 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818590-the-effect-of-nanoparticle-coating-of-orthodontic-brackets-on-the-ra-45cd5b663cc584f2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816380-a-phase-iii-study-to-evaluate-the-efficacy-and-safety-of-jyp0322-in-642a98b45b02f543 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07811219-resp-fit-a-respiratory-muscle-strength-training-intervention-for-cop-72b0a308d3f1fc5e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794072-digital-patient-engagement-in-technology-supported-neurorehabilitati-4d24420e01be64f4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07771439-a-study-to-investigate-the-efficacy-and-safety-of-belumosudil-compar-bb9961730e105b96 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07758543-combined-effects-of-proprioceptive-neuromuscular-facilitation-pnf-an-49d5ff3b502e2814 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07748403-a-study-of-the-safety-and-efficacy-of-prime-editing-pm577-in-partici-ea321f8bd62b726d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07687160-spiro-first-a-pragmatic-primary-care-embedded-pilot-trial-of-renin-g-4a0d9b3a533c4615 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07686380-il-15-superagonist-with-or-without-vaccine-in-biochemically-recurren-cfd5e39e4ab2fd00 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07605130-efficacy-and-safety-study-of-digital-cognitive-training-and-pcsk9-in-a328d58cb1f68e10 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07573462-a-study-to-learn-about-the-safety-of-an-expanded-pneumococcal-vaccin-78503e06c71ea34d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07548034-ultrasound-guided-needle-percutaneous-electrolysis-with-therapeutic-2d98465a53615160 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07455513-a-novel-tobacco-cessation-resource-for-smokers-with-a-diagnosed-or-s-babb569f21565b13 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07424677-study-of-saroglitazar-magnesium-for-pbc-patients-with-incomplete-res-04db30873bd4378a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07399730-ravulizumab-outcomes-in-polish-patients-with-ahus-627560c9e573fc75 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384195-a-study-to-assess-efficacy-and-safety-of-n-acetyl-ged-0507-34-levo-g-07f4a720d62cbd5b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07384052-safety-and-feasibility-of-intranasal-insulin-in-patients-with-spinal-67f5e5a3a02a354d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07223190-a-study-evaluating-subcutaneous-versus-intravenous-blinatumomab-in-n-5094280ab239ca2d 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217704-using-18f-fapi-pet-to-detect-metastatic-disease-in-patients-that-hav-6a2e440643c6f86b 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07217223-spaced-transcranial-direct-current-stimulation-for-treatment-resista-a196dd6caa7e573c 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07186673-hall-technique-vs-conventional-crown-restoration-in-permanent-molars-5c65b44ea921789e 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07076888-aerobic-exercises-and-hemodialysis-patients-3a82acc449e28cf4 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06991751-a-natural-history-of-cardiometabolic-disease-among-us-bhutanese-deve-74080274b3baf1da 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06971601-diagnostic-validity-ofclinical-tests-for-infrapatellar-fat-pad-impin-6b42f1c6883002b2 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06968195-autologous-car-t-cells-targeting-gpc3-rpcar01-for-the-treatment-of-a-d41a860ed00a1eb9 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06909357-creation-of-an-infrastructure-to-support-delivery-of-mhealth-interve-91ee37745d2dd9cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06901531-a-study-of-zolbetuximab-together-with-pembrolizumab-and-chemotherapy-def392f8fcb82573 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06855498-rollover-study-for-participants-previously-enrolled-in-clinical-tria-6eaab02a97d67e85 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06687603-multi-site-detection-of-barrett-s-esophagus-in-patients-without-chro-06c9322cd8de53b7 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06642649-evaluation-and-comparison-between-general-anesthesia-vs-two-types-of-9dde98cb658819cb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06487481-study-of-preoperative-radiation-therapy-in-participants-with-resecta-fc044139700317d0 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06357377-a-study-of-the-safety-dosing-and-delivery-of-neo100-in-patients-with-729aeb3d065dda50 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06215118-a-study-to-learn-about-the-effects-of-the-combination-of-elranatamab-7661da673166f2fd 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05854498-liposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-with-m-42ae3aeaaa80f865 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05800873-evaluate-the-efficacy-safety-pharmacokinetics-and-pharmacodynamics-o-9b82b9f2b79798e1 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05648500-a-research-study-to-evaluate-the-effects-of-a-new-oral-medicine-call-9fea27ee297e8372 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05646212-integrating-treatment-for-mental-disorders-in-methadone-clinics-in-u-9262aea7de481f33 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05609630-study-of-oral-upadacitinib-and-subcutaneous-intravenous-tocilizumab-cf3986ca70e378eb 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05593003-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-8192cb0cac23aaca 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04969315-tt-4-and-tt-10-as-single-agents-and-in-combination-in-subjects-with-47e40ceba085b186 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03602092-observational-registry-data-on-gist-patients-c42decc4fe5bee88 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03233347-doxorubicin-vinblastine-dacarbazine-brentuximab-vedotin-and-nivoluma-edfaf2b3161a17d3 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02974621-cediranib-maleate-and-olaparib-compared-to-bevacizumab-in-treating-p-7e4d87d92032d636 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01920737-a-novel-pediatric-inspired-regimen-with-reduced-myelosuppressive-dru-e45ceb892be60f2a 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00501800-genetic-epidemiology-of-ovarian-aging-eb1fa7f9595e246f 2026-09-15T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-should-increase-transparency-of-medicare-drug-rebate-not-undermine-ph-a001818b52e871a3 2026-09-14T23:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-invests-in-bend-with-new-spray-drying-pharmaceutical-facility-5ef61dcb2124809c 2026-09-14T23:14:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-dose-of-pharmaceutical-lsd-cut-anxiety-scores-five-points-below-placebo-1b96a9edbdfd9952 2026-09-14T23:00:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-holds-public-hearing-on-psychedelic-drugs-as-trump-driven-push-gathers-pace-8758d5eb9f517c42 2026-09-14T23:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-announces-peer-reviewed-publication-of-phase-1-sil-deef3fa964ffa073 2026-09-14T22:45:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-scivision-biotech-inc-stocks-389ec0e5dfc677b4 2026-09-14T22:22:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/click-e-stock-sk-biopharmaceuticals-no-adverse-reactions-in-over-1-200-clinical-6b7d899aeecf60d4 2026-09-14T22:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-responses-in-health-and-disease-un-encuentro-internacional-para-avanzar-04ce29e0296cd3e9 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-cultural-weight-of-a-psychedelic-approval-looms-fda-hearing-focuses-on-access-3dd0f695022b3990 2026-09-14T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-parkinson-s-trial-alignment-principle-498f395aef067b18 2026-09-14T21:58:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-manufacturing-exozymes-picks-curia-as-commercial-scale-manufacturing-part-8072a8f65738427c 2026-09-14T21:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/all-eyes-should-be-on-patient-centricity-in-clinical-research-04df9b05d4503427 2026-09-14T21:47:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cooper-green-adds-enrollment-specialists-at-uab-st-vincent-s-birmingham-uab-st-v-50e37213c7932bab 2026-09-14T21:00:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-relationship-between-glp-1-use-and-trust-in-pharmaceutical-companies-dd4ad4ab4492d263 2026-09-14T21:00:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-community-credit-union-executive-to-lead-2026-heart-walk-and-citywide-push-3dc710a6d091f198 2026-09-14T20:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-a-potent-greenhouse-gas-into-a-valuable-pharmaceutical-building-block-us-c3c09f1b357c34f0 2026-09-14T20:20:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacyte-biotech-2026-revenue-0-net-income-5-79m-eps-0-54-10-q-summary-51393d86a7f3306b 2026-09-14T20:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-upcoming-launches-and-data-readouts-signal-a-major-4dc2a9d2d1a843d6 2026-09-14T20:07:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/pmcb-10-q-filings-pharmacyte-biotech-inc-sec-10-q-565620d7f0c71385 2026-09-14T20:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-200-long-covid-patients-joined-a-drug-trial-biovie-will-discuss-results-tu-67da8678a80a17b2 2026-09-14T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benitec-biopharma-releases-full-year-2026-financial-results-and-provides-operati-951019e6c4827bd3 2026-09-14T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-medical-exhibits-prosense-cryoablation-for-breast-cancer-at-eusobi-2026-ddd8fe79c74d2705 2026-09-14T19:52:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-biologics-signs-usd-262-million-manufacturing-agreement-with-european-ph-fb7c4ed0f909f1f4 2026-09-14T19:48:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-major-launches-and-data-readouts-drive-a-pivotal-s-717627c4307b728c 2026-09-14T19:38:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-enters-rebrand-pharmexec-2c787093e950878f 2026-09-14T19:34:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/avoiding-a-sticky-situation-how-cells-stop-messenger-rnas-from-clumping-together-744314666fbd69b8 2026-09-14T19:26:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-and-warnings-zicam-nasal-swabs-recalled-foreign-pills-found-in-trazo-5ad8aa6171d7227b 2026-09-14T19:21:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-apptec-hires-sander-lurie-on-health-issues-b699ab16252ac6c6 2026-09-14T19:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-treatment-improves-blood-flow-in-ph-ild-patients-lungs-bb0b8901943710d3 2026-09-14T19:11:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-tuberculosis-vaccine-enters-phase-3-trials-cd8a20823059bee8 2026-09-14T19:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/with-just-6k-left-nymox-pharmaceutical-nymxf-discloses-doubt-it-can-keep-operati-e8db46bea5f1a743 2026-09-14T19:08:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-covid-vaccine-was-a-historic-success-could-its-cancer-vaccine-be-even-1cd1b0f3582ae845 2026-09-14T18:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-b5f7831b8f22e544 2026-09-14T18:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-raises-11-3-million-in-initial-pipe-led-by-patrick-soon-shiong-2a0574d4a6e16d59 2026-09-14T18:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-covid-vaccine-was-a-historic-success-could-its-cancer-vaccine-be-even-1e52ab6864cf2c8e 2026-09-14T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-to-hold-psychedelic-drug-hearing-amid-trump-push-what-it-means-for-depres-533440f01f0e6121 2026-09-14T17:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fda-hepatic-impairment-guidance-what-it-means-for-your-next-dedicated-study-304156041da363ea 2026-09-14T17:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-krystal-biotech-krys-cheap-on-its-cantor-conference-spotlight-0c18fece4209bc40 2026-09-14T17:38:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/btig-raises-cullinan-oncology-stock-price-target-on-trial-data-22cf64853e80f8c8 2026-09-14T17:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/owkin-highlights-ai-driven-forecasting-for-phase-3-clinical-trial-outcomes-f2af50f70696c2db 2026-09-14T17:29:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-updates-for-apple-s-software-platforms-are-now-available-7e168732e05224a3 2026-09-14T17:10:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/siri-ai-a-profoundly-more-capable-and-personal-assistant-is-here-f931fcd3fd7e990f 2026-09-14T17:09:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/gensci-registers-phase-i-trial-of-four-target-retinal-fusion-protein-across-thre-b4aea070a721fd83 2026-09-14T17:09:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-s-new-child-safety-features-now-available-926b88dd00a7451e 2026-09-14T17:08:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-cans-early-experimental-obesity-drug-after-high-bar-not-met-778b1d9c286a2c43 2026-09-14T16:45:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-naomi-running-strong-with-latent-autoimmune-diabetes-in-adults-9fcf72340a5b9eb4 2026-09-14T16:38:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-what-is-behind-the-fresh-attention-4d40e1b350ba2828 2026-09-14T16:24:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/experts-urge-fda-to-set-clear-safety-and-access-standards-for-psychedelic-drugs-a9e99d59823fe228 2026-09-14T16:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-day-at-camp-discovery-base-at-beaumont-05644ac40d5a0317 2026-09-14T16:17:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-ada-family-day-at-the-louisiana-children-s-museum-e820ec776aac4f44 2026-09-14T16:09:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-screening-cooperation-for-efficient-processes-and-digital-networking-fd28a98854e7f430 2026-09-14T16:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/promising-biotech-stocks-to-follow-today-september-14th-ef83ca4efd667b1b 2026-09-14T16:04:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-pharma-accelerating-development-with-microsoft-the-microsoft-cloud-blog-484d640992178bbb 2026-09-14T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-path-to-stability-at-fda-188b02c94a11daad 2026-09-14T15:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/divided-we-fall-new-book-explores-polarization-citizenship-and-canada-s-democrat-7782838c31c3bd75 2026-09-14T15:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extracting-cbd-from-artisanal-practice-to-industrial-production-ccc31add2fafeeeb 2026-09-14T15:51:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-reports-earnings-results-for-the-half-year-ended-j-da34acb47d55b873 2026-09-14T15:50:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-mln-pipe-financing-b6b99a80672f80c4 2026-09-14T15:37:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-reports-initial-closing-of-private-financing-6a8c3eab1e9ee839 2026-09-14T15:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-more-nordisk-novo-s-latest-trim-is-in-its-name-ac18f90a0e95918d 2026-09-14T15:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-partial-clinical-hold-on-biohaven-s-epilepsy-drug-days-after-795-mill-fb310141e51e479d 2026-09-14T15:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/severine-technicienne-de-laboratoire-2c74bfe257c1dad0 2026-09-14T15:23:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/souraya-technicienne-de-fabrication-9d9c0b4535f10a0f 2026-09-14T15:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-2026-to-2027-quarterly-da-854a7f00c802afc8 2026-09-14T15:13:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-biotech-industry-trends-reshaping-the-healthcare-market-1fff79779a254128 2026-09-14T15:13:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fabien-pharmacien-3a609789b2007f1e 2026-09-14T15:11:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-seeks-to-raise-150m-for-drug-development-93d25e67402257ae 2026-09-14T15:07:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/midcap-biotech-outlook-cmps-leads-on-trend-momentum-and-catalyst-timing-9644863c7fee914b 2026-09-14T15:02:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/2025-2025-bb92cb39bafb6027 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saved-by-cpr-at-15-college-freshman-leads-walk-to-build-a-nation-of-lifesavers-029ca01991841a12 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-scientists-uncover-why-some-huntington-disease-patients-decline-years-earlie-a58ece91b665ae4b 2026-09-14T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacometric-analysis-of-givinostat-to-support-individualized-dosing-recommend-ee9f071f11247a73 2026-09-14T14:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-medicine-57c9c5f343002163 2026-09-14T14:54:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengue-the-green-book-chapter-d659d5bcdd75ad40 2026-09-14T14:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-grants-priority-review-to-zasocitinib-for-moderate-to-severe-pso-1e9daa76b6caf233 2026-09-14T14:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotech-announces-initial-closing-of-up-to-22-3-million-pipe-financing-and-t-ca8e381455767ccd 2026-09-14T14:43:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pds-biotechnology-raises-11-3-million-in-initial-closing-of-pipe-led-by-nant-cap-920b0390e9a9b55d 2026-09-14T14:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gustave-roussy-et-the-lancet-lancent-une-serie-de-conferences-internationales-su-4e55915d5469cf26 2026-09-14T14:39:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-government-response-to-the-covid-19-inquiry-module-3-report-82255ac20476e0dc 2026-09-14T14:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-ambition-to-delivery-is-the-national-cancer-plan-properly-funded-9c09e27be00761eb 2026-09-14T14:32:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cancer-biotech-raises-11-3-million-the-los-angeles-times-owner-joins-its-board-36c5c0123605f906 2026-09-14T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gotistobart-lung-cancer-drug-candidate-prolonged-lives-in-trial-8e786176d108948a 2026-09-14T14:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-therapeutics-dftx-stock-soars-20-on-successful-phase-3-anxiety-trial-re-b93947691e55d7f8 2026-09-14T14:23:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevenzione-dei-tumori-testa-collo-torna-la-make-sense-campaign-9cd20a882d33d472 2026-09-14T14:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/stifel-cuts-olema-pharmaceuticals-price-target-on-trial-concerns-by-investing-co-aff64a0df39e3aa2 2026-09-14T14:19:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-selected-as-new-home-of-uc-global-health-institute-56cd186455bc9ef2 2026-09-14T14:17:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivek-malhotra-awarded-the-febs-theodor-bucher-lecture-and-medal-2027-5ccbb2fe92bb7765 2026-09-14T14:17:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/nifst-stakeholders-seek-evidence-based-regulation-of-low-calorie-sweeteners-85989083eb27fcb7 2026-09-14T14:12:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-appoints-robert-plenge-to-board-of-directors-b4f7261b09af2577 2026-09-14T14:09:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunocore-achieves-full-enrollment-in-phase-3-tebe-am-melanoma-study-16e530c8f0b3f5f0 2026-09-14T14:02:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezilient3-trial-efficacy-and-safety-data-of-zipalertinib-in-egfr-exon-20-insert-781f2e368253f241 2026-09-14T14:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/recce-pharmaceuticals-asx-rce-phase-3-diabetic-foot-infection-trial-and-mena-lic-38124a0b87aac230 2026-09-14T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-e256990a7d983a8b 2026-09-14T13:54:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-fortalece-cooperacao-com-centro-educacional-da-china-127812ec28885465 2026-09-14T13:52:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-are-embl-pierre-chazelas-on-connecting-people-to-support-science-758939b5b4ff1538 2026-09-14T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-touts-lung-cancer-data-from-two-drugs-8d677a7a22389a58 2026-09-14T13:38:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/bringing-a-high-potential-bispecific-back-from-the-brink-22fd8da9d83fa842 2026-09-14T13:32:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-growth-trust-extends-strong-performance-in-2026-d9b4635f68450caa 2026-09-14T13:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-and-lesotho-strengthen-regional-collaboration-for-regulatory-excellence-45f1f401fec36a52 2026-09-14T13:23:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cu-anschutz-scientists-discover-why-shingles-pain-can-last-after-virus-is-gone-cd4689c91381e211 2026-09-14T13:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-at-morgan-stanley-conference-growth-broadens-fe0c6b0b57907f44 2026-09-14T13:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edoardo-porro-il-pioniere-dell-ostetricia-che-ha-rivoluzionato-il-parto-e-ispira-a84e601e62ba77d6 2026-09-14T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-great-repricing-seven-assumptions-that-no-longer-hold-f2ecd76baf8525c8 2026-09-14T13:13:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-dr-michael-c-burgess-we-need-a-new-playbook-to-guard-against-counterfe-ac7bd868d307f45e 2026-09-14T13:09:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2019-to-2023-800293e4e71f3202 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-inc-nasdaq-bmrn-appoints-bms-r-d-chief-robert-plenge-to-d11aa567c7551aa2 2026-09-14T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/skontaktuj-sie-z-nami-90650b1f2a327e6a 2026-09-14T13:03:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cells-that-help-the-tumor-the-family-history-of-tregs-reconstructed-2b4eb336a58ed5a6 2026-09-14T13:02:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/wysokiej-jakosci-sterylne-ampu-ki-dla-przemys-u-farmaceutycznego-2b9391d5780cc4b9 2026-09-14T13:02:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/rabies-post-exposure-risk-assessment-d5bf37390bb160f1 2026-09-14T13:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/krtl-biotech-appoints-federal-controlled-substance-compliance-specialist-justin-4350832aa88145f3 2026-09-14T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dare-bioscience-announces-peer-reviewed-publication-of-phase-1-sildenafil-cream-05d0eae494a7f684 2026-09-14T12:59:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/organon-announces-us-fda-has-accepted-for-review-a-supplemental-new-drug-applica-6c0c0422506d902f 2026-09-14T12:57:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-aims-for-342m-ipo-to-power-inflammatory-drug-s-push-through-phase-3-0240e717903fd159 2026-09-14T12:52:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-discover-strange-link-between-low-vitamin-d-and-pain-40b149eb395340fe 2026-09-14T12:52:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-small-drug-stocks-poised-to-benefit-from-a-biotech-recovery-570bf916e68b800a 2026-09-14T12:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/contattaci-9aceed417471446a 2026-09-14T12:47:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ampolle-sterili-di-alta-qualita-per-l-industria-farmaceutica-4fbfcda611c6fce7 2026-09-14T12:46:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-looking-to-offload-orthopedics-unit-in-20b-deal-to-apollo-bloomberg-dc98416c34c5142a 2026-09-14T12:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gatc-health-joins-critical-path-institute-s-new-approach-methodologies-developer-05166a46c1038966 2026-09-14T12:38:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiff-oncology-and-nerviano-medical-sciences-amend-their-2017-exclusive-licens-5715a4c53623c959 2026-09-14T12:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-monthly-fact-sheet-as-at-31-august-2026-a063b8d62d709d23 2026-09-14T12:38:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/etra-ipo-news-antibody-biotech-electra-therapeutics-sets-terms-for-325-million-i-0ecc46d14794d0ab 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/geovax-and-cepi-enter-agreement-to-utilize-cepi-centralised-laboratory-network-t-68dec5d4551f2cf9 2026-09-14T12:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-cancer-drug-rights-dispute-settled-by-cardiff-and-nerviano-21e0f50be19d2e22 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acto-named-among-everest-group-s-top-50tm-pharmaceutical-technology-providers-fo-5184e9ed11a3026d 2026-09-14T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-nasdaq-bntx-lung-cancer-drug-extends-survival-vs-chemo-in-phase-3-c6832e849c4d7d59 2026-09-14T12:29:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-shift-in-biotech-manufacturing-canva-0f67a9758151f283 2026-09-14T12:28:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biographie-jeremie-calais-170c54ede4f814fa 2026-09-14T12:18:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/leios-therapeutics-announces-positive-end-of-phase-2-meeting-with-fda-for-10xb-1-573671facadcb78f 2026-09-14T12:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/pulsed-field-ablation-for-perimitral-atrial-flutter-with-involvement-of-the-vein-3053caae0965f2e5 2026-09-14T12:11:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-and-autoimmune-trials-define-legend-biotech-legn-cell-therapy-pipeline-e925d7051366c5a6 2026-09-14T12:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/briacell-bctx-phase-3-trial-safety-endorsement-highlights-market-s-cautious-outl-2ca36055c44df42a 2026-09-14T12:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-ethanol-infusion-via-the-vein-of-marshall-on-atrial-tachyarrhythmia-wi-f49a7307965e473a 2026-09-14T12:05:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-safety-monitoring-board-recommends-continuing-briacell-s-phase-3-metastatic-00b5e7c605eb755f 2026-09-14T12:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/correcting-false-health-claims-and-navigating-ai-generated-information-the-monit-4519fa1f68040a9e 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tzield-teplizumab-and-the-risk-of-viral-reactivation-fc9f7bdef9b658ae 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-48-hour-home-treatment-for-postpartum-depression-enters-a-new-study-about-120-6e444e94543dfa0a 2026-09-14T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-slumps-as-legal-scrutiny-hits-phase-3-trial-1f83efc08a3e0313 2026-09-14T11:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-food-and-drug-administration-seizes-unsafe-dairy-products-e5136b5fcb9275cd 2026-09-14T11:43:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/etf-movement-china-asset-management-hang-seng-biotech-etf-03069-surges-over-4-am-2b7d5a6e5fdce085 2026-09-14T11:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-anxiety-treatment-met-every-key-goal-in-a-late-stage-trial-an-fda-meeting-is-0e9b1cfebc675f16 2026-09-14T11:33:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-launches-exchange-offer-to-complete-separation-of-minimed-group-inc-e382312e420e5aaa 2026-09-14T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-breast-cancer-trial-gets-a-seventh-recommendation-to-continue-5b0431d8e7492c3c 2026-09-14T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-nasdaq-bmrn-forms-tight-breakout-setup-with-strong-techn-8e3a96b30e8b630e 2026-09-14T11:20:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmazz-inc-receives-u-s-fda-orphan-drug-designation-for-sovateltide-for-the-tr-a207e4ccbfb768c7 2026-09-14T11:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunocore-announces-target-enrollment-achieved-in-phase-3-tebe-am-trial-of-kimm-23a53a59beab5bbe 2026-09-14T11:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nmn-2026-9-14-ceda7cee25400dc0 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-ag-biotech-company-plans-north-american-headquarters-in-indiana-4a390f206c0be123 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-therapeutics-announces-positive-topline-results-from-phase-3-panorama-s-2905618d20aa212a 2026-09-14T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-stock-holds-near-highs-after-strong-quarterly-beat-and-fresh-a94b2b2446bb6792 2026-09-14T10:57:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/definium-lsd-drug-goes-3-for-3-with-another-pivotal-anxiety-trial-win-fdd1cdfaac12bcca 2026-09-14T10:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/162-million-boost-for-vital-uk-life-sciences-and-materials-research-235994a400950216 2026-09-14T10:54:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-s-muscle-targeting-sma-therapy-isemblyd-lands-fda-approval-0c43d37e656f57b8 2026-09-14T10:50:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-advances-intelligent-robotics-to-transform-the-future-of-pharmacy-care-at-fai-6ee22ebbf5529230 2026-09-14T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-income-stocks-to-buy-for-september-14th-8c2cf2061f8628db 2026-09-14T10:44:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/stifel-cuts-olema-pharmaceuticals-price-target-on-trial-concerns-0d5c9b3f2acc7cac 2026-09-14T10:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lonza-deepens-us-bet-with-commercial-plant-in-oregon-a29a78ec68bd0365 2026-09-14T10:40:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-telix-s-brain-cancer-imaging-drug-pixclara-449ed5b34cc35511 2026-09-14T10:34:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-accepts-new-drug-application-under-priority-review-for-takeda-s-zasociti-66c11273bfee998e 2026-09-14T10:31:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/alcon-warns-that-us-proposal-could-cause-companies-to-abandon-europe-53d56b7bd75bdab8 2026-09-14T10:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-s-proposed-drug-ad-rule-is-a-blueprint-for-violating-the-first-amendment-7fa4cc4a983c3d2f 2026-09-14T10:30:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-clinical-trial-attacks-pancreatic-cancer-with-laser-light-50201537c62719b8 2026-09-14T10:30:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-priority-review-to-takeda-nyse-tak-pill-for-severe-psoriasis-d7295820babd3de5 2026-09-14T10:26:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-rehabilitation-gym-on-hospital-ward-to-help-speed-up-recovery-4acf1c7f7d1c1105 2026-09-14T10:16:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-provides-keytruda-at-no-cost-for-a-cancer-trial-7d3d50d0d822e36e 2026-09-14T10:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-tumor-dna-guided-de-escalation-or-escalation-of-adjuvant-therapy-in-6efa02bc12c5e37f 2026-09-14T10:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/morocco-s-pharmaceutical-trade-deficit-to-reach-1-4-billion-by-2030-9d175f14f5356cfb 2026-09-14T10:10:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/speaker-fees-and-buy-and-bill-keep-doctors-loyal-to-pharma-0bcba66a606f3cfa 2026-09-14T10:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-fragmented-contract-processes-are-slowing-pharmaceutical-operations-cd7413f3e757257d 2026-09-14T10:06:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-western-mass-be-to-food-s-future-what-boston-is-to-biotech-umass-is-bettin-6f37059da1382faf 2026-09-14T10:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-corruption-is-structural-systemic-and-profitable-new-rev-b115c9249c53f64e 2026-09-14T10:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-makes-16-5-half-year-return-as-surge-in-listed-drug-developers-outwe-edb7b30944ab4575 2026-09-14T09:54:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-notches-ph-3-lung-cancer-win-but-trails-gsk-on-survival-fc45ac29de42f42d 2026-09-14T09:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-fourth-ukrainian-pharmaceutical-warehouse-has-burned-in-a-russian-strike-since-6eb47225c106b55a 2026-09-14T09:41:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-supplement-formulators-can-borrow-from-pharmaceutical-delivery-science-f3579b8398254e3c 2026-09-14T09:39:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pm-stresses-strengthening-egypt-s-pharmaceutical-industry-regulatory-system-8e45ce9f3a140f23 2026-09-14T09:33:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-ltd-2026-q2-results-earnings-call-presentation-otcmkts-fcb651dd64e3d3c2 2026-09-14T09:31:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-at-scale-how-the-boom-in-semaglutide-is-reshaping-cold-chain-packaging-dc829a089b2d700f 2026-09-14T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gotistobart-nearly-doubles-survival-in-pretreated-squamous-lung-cancer-838a3314261d298d 2026-09-14T09:29:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-drug-policy-may-raise-south-korea-prices-57fd68f8da342994 2026-09-14T09:24:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ganpati-prasad-under-fda-watch-maharashtra-societies-told-to-follow-new-food-saf-630ea4175c9525b9 2026-09-14T09:21:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-wins-fda-approval-for-isembyld-6fd7f56f5e278d83 2026-09-14T09:18:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-the-exit-ip-strategy-for-venture-backed-biotech-patent-united-kingdom-90eb104909dcff8f 2026-09-14T09:13:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/school-food-standards-updating-the-legislative-framework-16a7f62ad22e947e 2026-09-14T09:12:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/act-align-accelerate-europe-s-biotech-turning-point-aad0b26991fea488 2026-09-14T09:03:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/confirmatory-evidence-for-all-fda-s-approval-of-lytenava-for-wet-amd-shows-how-n-40abfb0b46f31586 2026-09-14T09:03:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-mois-de-sensibilisation-aux-cancers-du-sang-un-don-de-soi-au-benefice-a64c10f00e1b7c23 2026-09-14T09:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/spain-pushes-eu-wide-market-access-toolbox-for-innovative-biotech-medicines-830f72c452b45ef1 2026-09-14T09:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-has-a-chokehold-on-your-medicine-cabinet-it-s-a-national-security-threat-b390c227c0199626 2026-09-14T09:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-and-mdic-launch-efs-explorer-to-streamline-early-feasibility-study-site-c08463bbda9d1653 2026-09-14T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aortic-structure-may-affect-midlife-rise-in-pulse-pressure-aortic-stiffness-in-w-885a55e18f82e78f 2026-09-14T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endometriose-les-hus-font-evoluer-la-prise-en-charge-des-patientes-577022fed901a9a3 2026-09-14T08:50:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-blijft-bij-europese-top-in-life-sciences-maar-europa-verliest-de-innovati-4a7b735814fa31da 2026-09-14T08:48:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-stocks-rise-on-monday-on-tech-biotech-gains-trigiant-jumps-47-98c47dac2ec6c611 2026-09-14T08:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-says-lung-cancer-drug-candidate-prolonged-lives-in-trial-bb6ddfdd81a51991 2026-09-14T08:36:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-prefix-is-no-shield-against-confusion-delhi-high-court-protects-biochem-eb4e0aa061fc398a 2026-09-14T08:31:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-says-lung-cancer-drug-candidate-prolonged-lives-in-trial-048c025d7109ee38 2026-09-14T08:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-our-tax-system-so-complicated-ad58788275115c48 2026-09-14T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-clinical-research-delivery-key-performance-indicators-data-to-september-2026-72c636c8940d0e12 2026-09-14T08:29:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-will-adapt-to-the-changing-healthcare-market-with-a-new-visual-identity-f1df41c04eb14b89 2026-09-14T08:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentation-du-futur-chantier-des-facades-garonne-de-la-grave-a-la-fondation-du-b3785df73f23ae8c 2026-09-14T08:27:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-trump-s-pharmaceutical-plan-threatens-europe-higher-drug-prices-and-delays-i-50b78795a90ba91a 2026-09-14T08:20:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-strikes-fourth-ukrainian-pharmaceutical-warehouse-in-september-video-ed18c40308c28339 2026-09-14T08:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/prestigious-fellowship-to-uncover-how-our-gut-microbiome-tackles-dietary-xenobio-f2b2dd7865722ae7 2026-09-14T08:15:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-and-oncoc4-report-updated-phase-3-data-showing-gotistobart-nearly-doubl-32e2f4d485c7d29e 2026-09-14T08:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiho-pharmaceutical-co-ltd-taiho-oncology-inc-and-cullinan-therapeutics-inc-rep-f211a6db7e1ef0dd 2026-09-14T08:05:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/quarterly-epidemiological-commentary-mandatory-mrsa-mssa-and-gram-negative-bacte-476c46b5e267decc 2026-09-14T08:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-s-gotistobart-a-breakthrough-in-lung-cancer-treatment-3d84066f3e6cd42a 2026-09-14T08:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-presents-positive-registrational-data-to-potentially-expand-jideytro-zidesam-5158b9a00bd20f9f 2026-09-14T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-s-experimental-treatment-extended-survival-to-18-5-months-versus-10-0e0798bc527d2105 2026-09-14T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivian-l-borrero-rac-achieves-recognition-for-40-years-of-leadership-and-contrib-24dc3b41c574ff62 2026-09-14T07:57:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/amivantamab-plus-chemotherapy-achieves-34-3-month-os-in-egfr-exon-20-insertion-l-0da3afd250e51aeb 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/tam-peli-extends-survival-to-13-3-months-in-relapsed-small-cell-lung-cancer-353338a24f94a9c6 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/mri-surveillance-alone-outperforms-mri-plus-radiation-in-sclc-trial-d1b659ade107b12a 2026-09-14T07:38:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/emmaus-cedars-sinai-extend-pact-b072a5bba6875f3f 2026-09-14T07:38:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/challenges-facing-chinese-biotech-deals-de6788d32d76210d 2026-09-14T07:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korean-pharmaceutical-company-plans-to-produce-medicines-in-kazakhstan-2b892242f692f4bd 2026-09-14T07:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/kazakhstan-and-south-korea-agree-on-joint-pharmaceutical-production-7d2e8b6386b25bcf 2026-09-14T07:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-s-zasocitinib-wins-fda-priority-review-in-bid-to-redefine-oral-psoriasis-3f04a01589462c27 2026-09-14T07:34:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/kazakhstan-and-south-korea-agree-on-joint-pharmaceutical-production-fed78451972c2e24 2026-09-14T07:30:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-is-what-rotterdam-needs-to-become-the-best-city-in-which-to-grow-up-98f022969713553c 2026-09-14T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spotlight-on-innovative-pharmaceutical-companies-after-drug-pricing-reform-alteo-9d24cab8a2d849de 2026-09-14T07:20:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-new-brain-cancer-imaging-agent-from-telix-dfce838ed16dbfa7 2026-09-14T07:07:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-started-getting-migraines-when-i-was-only-seven-083db6cc3484ec92 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-accepts-new-drug-application-under-priority-review-for-takeda-s-zasociti-ef17f61352cd7eaa 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spirit-halloween-raises-funds-for-uc-davis-child-life-81066505649e810d 2026-09-14T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statement-on-pabs-instrument-at-the-eighth-meeting-of-the-intergovernmental-work-46d8f7c7cf3e1461 2026-09-14T06:58:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminart-resultat-i-regionvalet-4d0566344a58c227 2026-09-14T06:53:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-drug-plan-could-prompt-companies-to-raise-prices-outside-the-us-86468b2325ec3197 2026-09-14T06:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenya-explores-merck-partnership-in-biotechnology-and-local-pharmaceutical-manuf-4e4830bb94d8ddf5 2026-09-14T06:51:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/nouveau-guide-destine-aux-promoteurs-pour-la-procedure-synchronisee-des-etudes-c-bf1ed68763a3326d 2026-09-14T06:48:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/trastuzumab-botidotin-shows-11-1-month-pfs-vs-t-dm1-in-phase-3-trial-564267db7516eeaa 2026-09-14T06:43:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-biotech-catalysts-to-watch-this-fall-rare-rapp-and-pcvx-nasdaq-rare-b87c087230a5836e 2026-09-14T06:37:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-pharmaceutical-new-drug-application-filing-accepted-for-review-in-china-f-5a0a1f604c868dd6 2026-09-14T06:37:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-6-d8d8ed54ead18b74 2026-09-14T06:35:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fourth-russian-attack-on-pharmaceutical-warehouse-this-month-facility-on-fire-in-fe9e711ab6f60d1d 2026-09-14T06:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/huons-teams-up-with-three-biotech-startups-for-joint-new-drug-development-expand-79cfd35f6eadf712 2026-09-14T06:33:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ad0e5b477a2967ca 2026-09-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personnel-changes-7dcc223d059f37ef 2026-09-14T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guide-destine-aux-promoteurs-pour-la-procedure-synchronisee-des-etudes-combinees-d566a9c40a897724 2026-09-14T06:22:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/9lione-a-pharmaceutical-distribution-dx-company-raises-120-million-in-series-a-l-977358ce07543d12 2026-09-14T06:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-biotech-opportunities-reports-august-nav-of-2-92-per-share-by-investing-com-f389326bb2eef80a 2026-09-14T06:10:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacta-appoints-mats-blom-to-the-board-of-directors-as-chair-of-audit-committee-9cdbf75a711b7e6c 2026-09-14T06:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-rtw-biotech-opp-monthly-valuation-update-and-factsheet-2f129452d79a9f29 2026-09-14T06:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/violetta-zujovic-les-neurosciences-sur-plusieurs-fronts-f54a85ba6105ae1d 2026-09-14T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yuhan-corporation-unveils-clinical-trial-design-for-oral-her2-cancer-drug-yh4294-e92301864336810f 2026-09-14T05:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-delays-review-of-exelixis-zanzalintinib-by-3-months-no-new-safety-issues-fou-406d52a642bf2331 2026-09-14T05:44:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewon-pharmaceutical-hosts-vietnamese-delegation-at-smart-factory-c66774a452dccbe7 2026-09-14T05:37:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/223-10-7-39c7257649d8d3fd 2026-09-14T05:29:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-cmg-pharmaceutical-co-ltd-krx-058820-402e367de1aa6bfc 2026-09-14T05:20:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-viiv-s-tivicay-pd-for-newborn-hiv-patients-bc39eeceea971edb 2026-09-14T05:16:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/6fff47f596154c3c 2026-09-14T05:13:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/allan-shaw-biotech-s-real-risk-isn-t-dilution-it-s-building-a-brand-of-generic-b90057b607ebcb91 2026-09-14T05:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/noxopharm-moves-lupus-skin-therapy-toward-next-human-trial-4c0656af8b7f5c97 2026-09-14T05:04:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-10-31-508e7734f0ab565e 2026-09-14T04:55:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-best-gene-editing-stocks-for-2026-and-how-to-invest-2370cdd322149d26 2026-09-14T04:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rebuilding-food-safety-regulation-in-the-united-states-c37766891763882d 2026-09-14T04:23:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-years-on-ff6ab05ab218af7e 2026-09-14T04:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-monotherapy-demonstrates-a-statistically-significant-clinically-mean-de95279f4726a52b 2026-09-14T03:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-9d2c4846e90ee934 2026-09-14T03:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-drug-delayed-lung-cancer-progression-by-6-months-in-a-trial-85662fec9375d10a 2026-09-14T03:56:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-warns-us-over-alleged-espionage-targeting-ai-chip-biotech-companies-bf9f9adcacb5b3da 2026-09-14T03:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/79-were-alive-eight-years-later-on-astrazeneca-s-lung-cancer-drug-versus-64-on-p-98fd92d7250b9744 2026-09-14T02:18:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-destiny-lung04-trial-shows-first-line-trastuzumab-deruxtecan-significant-547549369a0f3eab 2026-09-14T02:13:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmac-proposal-to-improve-access-to-medicines-for-people-with-high-blood-press-216d352b0acc20da 2026-09-14T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cullinan-taiho-showcase-6-month-survival-benefit-in-phase-3-trial-for-advanced-l-ac746721ed14d229 2026-09-14T01:44:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-pharmaceutical-r-d-infrastructure-competition-key-trends-strategies-in-a02a6e13d45ee46d 2026-09-14T01:11:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eastward-shift-in-the-biotech-world-why-india-and-china-could-lead-the-next-c7351acce8a9a57e 2026-09-14T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-s-new-drug-application-for-zasocitinib-receives-fda-priority-review-b3718f83bf05a0c3 2026-09-14T00:19:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-d8ea6923c50c50be 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-8f0a4cbe341f351b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-47a909258d7896e0 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-e03dfe4679ebf435 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-new-drug-application-filing-accepted-for-review-in-china-for-stn1012700-a-f5d677282047d1cf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-tumor-dna-guided-de-escalation-or-escalation-of-adjuvant-therapy-in-33260be14e789b13 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-valine-metabolism-and-ferroptosis-to-overcome-chemoresistance-in-pdac-8977c572ca4c3019 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/simultaneous-speech-and-gesture-decoding-for-multimodal-communication-in-paralys-918f9abd51cba68b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/overlapping-representations-in-the-ventral-hippocampus-support-rapid-fear-memory-d3ac9eddc90bfec9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-engineered-nanopore-identifies-saccharides-amino-acids-peptides-and-ribonucle-8d5782171936be08 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-irvine-labs-inc-1350cffdd1f6ab38 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-cambrex-high-point-inc-008e3b2bc6e1d789 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-dce179460387c8ae 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcing-the-intent-to-award-a-single-source-supplement-for-expanding-outreach-f9898d8cf2a86252 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitation-for-nominations-to-serve-on-the-advisory-council-to-support-grandpa-6ebc6e265a932df5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/solicitation-for-nominations-to-serve-on-the-family-caregiving-advisory-council-31910611e58db2c4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-8f8b60381133a48a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/office-of-the-national-coordinator-for-health-information-technology-health-info-b544a4acb9b8b8f6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-b02f31e37dc3ec91 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-nih-electronic-application-system-for-1920dece3f62af8f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/draft-nih-biosafety-policy-for-research-involving-biohazards-29b2690afa1577d6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-captopril-547edab21215108d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/smart-pharmaceutical-packaging-market-forecast-report-featuring-segment-analysis-55a8d6ef43850c1d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-advances-of-the-year-in-autologous-cellular-therapy-in-melanoma-and-solid-tu-1f92b0ebe41572ce 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implications-of-potential-us-fda-approval-of-psychedelics-or-psychedelic-adjacen-8b3f3520f48b0627 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/who-is-reporting-recovery-concerns-about-guardian-completed-qor-15-in-a-pediatri-4c9b2bf763f392d9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-repurposing-for-metabolic-associated-fatty-liver-disease-current-evidence-c-0683786fc25ff344 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cross-species-translation-and-target-dependent-pharmacology-of-galnac-sirnas-usi-2cd880d6284b4f61 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-empagliflozin-with-or-without-carvedilol-on-tricuspid-regurgitation-an-cb87b3dc852772c7 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-associations-between-glp-1-receptor-agonists-and-polyendocrine-metabol-279694c5d785fc3a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-drug-delivery-systems-for-osteoarthritis-therapy-exosomes-microparti-7c5862e323d3c0b2 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-celecoxib-combined-with-jintiange-capsules-for-the-treatm-e71b3692cb8b1294 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lipoprotein-a-in-japan-an-expert-consensus-statement-9e5280d6ea38688c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/encarcelando-eslabones-descartables-microtrafico-en-mujeres-bolivianas-y-su-vinc-78099e7bb631f301 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endoscopic-retrograde-cholangiopancreatography-versus-endoscopic-ultrasound-guid-06fe4129655d1ee6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-outcome-of-sac-ligation-versus-no-sac-ligation-in-pediatric-patien-532a18f6cf6f4daa 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-trial-of-periumbilical-incision-versus-intraumbilical-incision-in-em-3b7d7e84584d0075 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/penicillin-a-journey-from-a-magic-bullet-to-a-resistant-drug-9f783258c6f90946 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-community-alongside-clinical-practice-community-music-therapy-as-soci-e648dcea05dfc2dc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tuberculosis-resistente-a-farmacos-y-factores-asociados-en-santa-fe-2021-2024-c10ac6bde98c4961 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-silico-adme-toxicity-profiling-of-3-4-dithia-1-azabicyclo-3-2-0-heptan-7-one-caf23f7a863538aa 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genicular-artery-embolization-in-primary-and-secondary-knee-osteoarthritis-clini-9bb5724954bb9262 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-tep-and-lichtenstein-repair-in-bilateral-inguinal-hernia-su-75f20d92150782da 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-incidental-colorectal-fdg-avid-lesions-on-oncologic-18f-ed6e93d4e1e114be 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-soft-tissue-mobilization-and-kinesio-taping-on-sportive-performanc-99d998bcb0793088 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unveiling-ai-augmented-periodontal-decision-making-a-comparative-clinical-evalua-afd3857e16b239eb 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/utilization-of-long-acting-injectable-antipsychotics-and-clozapine-in-coordinate-b1a839103df3000d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-translational-nephrology-in-global-primary-care-bridging-innovation-pre-7f9c25f39ef7100a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-fine-needle-aspiration-i-vs-i-fine-needle-biopsy-in-so-dbf723366d924d81 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rural-urban-differences-in-breast-cancer-epidemiology-nutritional-status-and-cli-bbc480129a89ee6a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quasi-experimental-trial-examining-the-effectiveness-of-driver-training-modules-b9eb6d77db7b1dab 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-translation-of-fisetin-for-age-related-diseases-current-evidence-and-fu-3668d87d5ee7a0ca 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asthma-and-sinonasal-diseases-shared-clinical-comorbidities-inflammatory-pathway-afac4b7bf1e62340 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preoperative-frailty-inflammation-phenotypes-and-early-functional-and-patient-re-7f649c25063dbf2a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prenatal-and-postnatal-identification-of-phelan-mcdermid-syndrome-in-a-tertiary-1992aa669c4b0d5e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-differential-posterior-tibial-slope-on-clinical-outcomes-following-42a7ccaaa95fd46c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paired-urinary-cytology-and-targeted-fgfr3-s249c-r248c-mutation-detection-in-uri-4f195e94a047b77e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-granzyme-b-in-parkinson-s-disease-a-case-control-study-of-diagnostic-assoc-915548369384ad65 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-ankaferd-hemostat-mouthwash-for-high-grade-oral-mucositis-d-dd6bbd11a2889475 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/responsible-clinical-ai-in-dentistry-trust-professional-autonomy-and-perceptions-bf5bf089fe84f1c4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-global-burden-of-eustachian-tube-dysfunction-in-older-patients-pathophysiolo-458aaa33a1cfbbdc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-advances-in-spinal-muscular-atrophy-a-review-of-clinical-safety-and-d99e25370b464471 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-minimum-discard-volume-for-central-venous-catheter-sampling-valida-face44472c6caf57 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-colorectal-cancer-multidisciplinary-decision-making-c-5b2c364273f7c68c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/piwil4-from-biological-characteristics-to-disease-pathogenesis-and-clinical-appl-fe625d656dadd63f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secretory-carrier-membrane-protein-3-modulates-nuclear-erk1-2-signaling-and-drug-f0a176772406d686 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicinal-mushrooms-and-type-2-diabetes-mechanistic-insights-translational-evide-c67fcbde1cdfbd95 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-effects-of-probiotic-supplementations-on-metabolic-syndrome-a-syste-3ee1432f47c34b56 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/controlled-low-central-venous-pressure-after-cardiopulmonary-bypass-reduces-acut-377e84517695fe80 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-microbe-interactions-in-pediatric-ulcerative-colitis-clinical-features-pa-a9a0449f50bfee25 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-checkpoint-inhibitor-associated-arrhythmias-clinical-challenges-artificia-ae5d84fef5706750 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/porous-silicon-nanoparticles-in-drug-delivery-regenerative-medicine-and-biosensi-1227a29e48efd94e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/closed-loop-non-invasive-ventilation-in-critical-care-current-evidence-and-clini-2f6f8236ab093dda 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-biofertigation-for-enhancing-growth-and-yield-of-blackgram-vigna-m-ac7b85d563f235a6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-phytochemical-screening-and-in-vitro-anthelmintic-evaluation-of-etha-ce97e601cabab040 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modified-tibial-plateau-leveling-osteotomy-using-a-precontoured-plate-achieves-s-73e5b5184a8265e7 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-computational-study-of-some-cancer-causing-s100-proteins-interacting-with-a-li-03ed20d4c40a4d43 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-care-for-patients-with-leprosy-impact-on-treatment-adherence-and-008e2fd16c1d0c1c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-external-validation-of-a-machine-learning-based-clinical-predict-4d88db5e80c48cba 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-of-pretreatment-neutrophil-to-lymphocyte-ratio-and-thyroid-related-dbbd59bacc22f2b8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-reminiscence-therapy-on-the-resilience-and-satisfaction-with-care-d442db71ae84ac7c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beta-lactam-dose-optimization-using-therapeutic-drug-monitoring-in-pediatric-pat-e3ca0a48c61a6b6b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparation-of-transdermal-patch-as-a-drug-delivery-system-for-treatment-of-urin-b682b2e2a273a1b5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interference-by-saline-based-reconstitution-of-lyophilized-quality-control-plasm-4b8636f570f38727 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-celecoxib-combined-with-jintiange-capsules-for-the-treatm-f8b897f6293fe297 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-resting-and-dobutamine-stress-myocardial-work-in-cirrho-2c6fc0ec97666692 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-therapist-adoption-of-evidence-based-practices-with-the-loci-strategy-49a6ac97edcbf0df 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-the-role-experiences-of-clinical-nurse-educators-in-the-process-of-i-5723d793e7d5ea7c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-survey-on-the-current-clinical-use-and-perceptions-of-warm-needle-acupuncture-ecb43b6a39884080 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-safety-of-curcumin-for-the-prevention-and-treatment-of-rad-3adc6b63e3e0b97b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-invasive-biofeedback-assisted-vs-conventional-pelvic-floor-muscle-training-c-c024152c1924ea13 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-implementation-changes-in-the-procurement-volume-and-patterns-of-oral-hypog-12f2a4df784c8026 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-infective-endocarditis-in-children-a-single-center-o-155b307787d443f8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-clinical-value-of-mir-122-expression-and-genetic-locus-variants-in-ped-2c58e79476f42db4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-prognostic-model-integrating-systemic-inflammation-and-clinical-features-for-o-4ba9b87bf15bafe3 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preventability-of-adverse-drug-reactions-to-anticancer-drugs-insights-from-the-d-6e0304153ab4cab5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-intraoperative-systolic-blood-pressure-variability-and-clinical-o-ba5dfdd788dcf654 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-drug-delivery-systems-for-osteoarthritis-therapy-exosomes-microparti-e0b306b586959ea6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paired-oral-clinical-specimens-reveal-the-underlying-ecology-supporting-the-emer-452251b0fbaa9af4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/library-strategies-differentially-shape-microbial-functional-and-host-signals-in-ed7d88ee8c97421b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/palmar-plantar-ligament-injuries-in-five-horses-clinical-findings-comparative-di-5236f722da22c599 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pseudoangiomatous-stromal-hyperplasia-of-the-breast-clinical-radiologic-and-hist-ab64f7b05784a45f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-pharmacy-professionals-workplace-satisfaction-in-a-conflict-affect-b9bccd32f45054ac 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-future-of-pharmaceuticals-strategic-foresight-in-an-era-of-uncertainty-aa902f719a466343 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-progress-in-gene-therapy-for-rpgr-associated-x-linked-retinitis-pigment-54539ea3fc0cc69f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogen-bonded-poly-vinyl-alcohol-tannic-acid-quercetin-hydrogels-for-localized-ac652fd7b3c4269d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-in-vitro-i-assessments-for-pharmacokinetic-drug-drug-interaction-potential-of-cf08e40435812d90 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogen-rich-water-ingestion-alleviates-downhill-running-induced-muscle-sorenes-d0207f0a4e64aea6 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nat10-as-a-context-dependent-epitranscriptomic-hub-governing-cancer-drug-resista-22f80dfb63466a0b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-vascular-and-cardiac-parameters-on-quality-of-life-in-patients-undergo-a52b60a8304f8b42 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/old-drug-with-new-application-spironolactone-suppresses-panx-1-mediated-ca2-infl-01c4d8120aeb176c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/craniofacial-morphology-and-dental-age-assessment-in-pediatric-craniosynostosis-4c9a55058c7e2458 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-burdens-of-long-term-cadaver-pool-storage-solutions-a-screening-cr-4d8320b83900e71e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/practical-computational-exploration-of-chemical-reaction-space-assessing-the-che-e45d4b674d9e7dbf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neonatal-ventilation-training-using-a-low-cost-high-fidelity-simulator-in-a-low-352ce6c5484f86fe 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07819110-radicle-healthtm-vip-a-study-assessing-the-impact-of-health-and-well-306e35e216d7a229 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818395-spatial-multi-omics-of-perineural-invasion-microenvironment-and-prog-9eae5da708518537 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07818174-graded-motor-imagery-effects-on-body-perception-disturbance-in-compl-6fa37c136a3eadb5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07817186-clinical-trial-of-a-mek-inhibitor-for-rasopathy-associated-severe-in-cfc658dba67c417c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07817004-qlm2010-comparative-pharmacokinetic-study-with-2-minute-intravenous-90a7bd456c2fdff5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816731-effect-of-face-to-face-and-virtual-reality-based-salutogenesis-nursi-b72760fa4d356199 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816666-torvutatug-samrotecan-with-or-without-bevacizumab-as-maintenance-tre-ef10e449d172cc7f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07815678-first-in-human-study-of-the-safety-tolerability-pharmacokinetics-and-7bfba9cc2885eb22 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810478-criteria-based-rehabilitation-after-tibial-fracture-fixation-a-rando-a829f93786110c1b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07739459-study-of-zanubrutinib-in-older-patients-with-previously-untreated-ch-8e97594244b216f5 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07673913-relationship-of-peripheral-inflammatory-and-neuroprotective-biomarke-2ca4185331048bcb 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07554339-a-clinical-trial-of-calderasib-mk-1084-and-durvalumab-in-people-with-8682652bb67ca21f 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07516184-explore-the-diagnostic-value-of-bronchodilation-test-with-portable-o-5c13347c1faf4c64 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07513389-omission-of-postoperative-radiation-in-hpv-associated-oropharyngeal-54433fa6534bad2b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07465757-a-study-of-alisertib-and-paclitaxel-in-patients-with-small-cell-lung-dde461375ff0295b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07451899-tb-type-and-spirometry-result-vs-functional-capacity-based-on-6mwt-i-21d29ab24081d675 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07218146-a-study-of-zl-1310-versus-investigator-s-choice-of-therapy-in-partic-767ee1cfeea38d53 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07098351-efficacy-and-safety-of-nalfurafine-hydrochloride-odt-for-moderate-to-095639059132fe18 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06899308-health-surveillance-at-constructor-university-bremen-cub-5de96b94d7255aa9 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06860698-the-impact-of-chronic-e-cigarette-usage-on-microvascular-health-fd1ed5abb1124fed 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06820463-a-study-to-evaluate-the-adverse-events-and-efficacy-of-intravenous-i-8e023f916ad246b4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06797661-insights-into-the-pathophysiology-of-neurovascular-uncoupling-in-pat-88c52fa05421580c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06794125-an-evaluation-of-dose-escalation-for-intrathoracic-tumours-03fc06b394cbb28a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06789198-peptide-vaccine-for-fibrolamellar-hepatocellular-carcinoma-patients-73706391bfa20375 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06590051-amg-335-expanded-access-program-for-igg4-related-disease-c8325929e8dbbc09 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06549153-act-together-acting-on-cancer-testing-together-a08de136fdf3c7c8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06282575-efficacy-and-safety-of-zanidatamab-with-standard-of-care-therapy-aga-f51095141a5f7f25 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06263283-impact-of-an-educational-physiotherapy-yoga-intervention-on-perceive-9a1f907fc02817ea 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06065748-a-study-to-evaluate-efficacy-and-safety-of-giredestrant-compared-wit-0ef2bd2d0a1567bf 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05827081-phase-iiib-study-of-ribociclib-et-in-early-breast-cancer-af4028810169a04c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05642195-evaluation-of-a-cancer-lysate-vaccine-and-montanide-registered-trade-6c3881e00781f72d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05482516-evaluating-novel-therapies-in-ctdna-positive-gi-cancers-6ccbf36dce5d5e63 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05172245-testing-the-addition-of-ipatasertib-to-usual-chemotherapy-and-radiat-f6b6c429408def1b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05041387-data-collection-of-standard-care-of-patients-in-the-emg-section-ac1d0af4063522b8 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04751409-evaluating-the-impact-of-limited-compared-with-intense-post-operativ-3914dd6bd3bf878c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04708067-hypofractionated-radiation-therapy-and-bintrafusp-alfa-for-the-treat-cbd312bb31198efe 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04543617-a-study-of-atezolizumab-with-or-without-tiragolumab-in-participants-78dab5b9bab22eb7 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04449549-rapid-analysis-and-response-evaluation-of-combination-anti-neoplasti-ff3252eaf85eba3c 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04221750-diet-and-exercise-plus-metformin-to-treat-frailty-in-obese-seniors-5d3925a3863eaf7b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04115631-a-comparison-of-three-chemotherapy-regimens-for-the-treatment-of-pat-12d28c00c5a80ada 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04021329-efficacy-of-eye-movement-desensitization-reprocessing-versus-cogniti-3e36390b02b80510 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03683433-enasidenib-and-azacitidine-in-treating-patients-with-recurrent-or-re-cbfde361bf4fd7fc 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03533582-cisplatin-and-combination-chemotherapy-in-treating-children-and-youn-b835c20426c4e184 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03214562-venetoclax-with-combination-chemotherapy-in-treating-patients-with-n-1046bc1f29df907e 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03137511-optimizing-access-to-care-through-new-technologies-a-randomized-stud-4da9fa163d38b237 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02698579-long-term-follow-up-of-participants-with-cerebral-adrenoleukodystrop-d760eb80889e1868 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01660984-natural-history-study-of-children-and-adults-with-medullary-thyroid-5dc6ce49fdf8cca4 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01630278-early-ibuprofen-treatment-of-patent-ductus-arteriosus-pda-in-prematu-9425d0c4c406003d 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01386034-effects-of-oral-citrulline-on-protein-metabolism-in-patients-with-in-2d6bd6a6fb3bf396 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01061255-stress-and-clinical-reasoning-in-medical-students-c8bea47dc082710b 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00841724-study-of-a-reduced-toxicity-submyeloablative-conditioning-regimen-pr-a06f1679c838c0a1 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00791635-longitudinal-evaluation-of-women-undergoing-pelvic-surgery-for-the-t-44d99c489e3f4c7a 2026-09-14T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-second-drug-hits-fda-safety-hurdle-78904628f6a4b1e0 2026-09-13T23:59:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-ge-healthcare-to-buy-sofie-biosciences-for-1-billion-as-part-of-pharmaceu-76ac7840b032d4ac 2026-09-13T23:44:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/kipspharma-receives-ind-approval-for-domestic-phase-2-trial-of-idetrexed-1e64d7af2db82ac9 2026-09-13T23:36:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-demonstrates-6-month-median-progression-free-surv-4f45197febb26aa1 2026-09-13T23:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-prepares-frontline-fda-bid-for-jideytro-its-first-lung-cancer-drug-0f6add197193563c 2026-09-13T23:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-dispersants-market-forecast-to-2035-biologics-and-cell-therapy-dr-20b76c50b6aa2cee 2026-09-13T22:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-us-medicare-pricing-policies-could-reshape-global-pharmaceutical-markets-796dc218c7715e5a 2026-09-13T22:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-stock-faces-pressure-after-rival-s-clinical-trial-miss-2ebdc81c4c996a43 2026-09-13T22:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gas-preheating-modules-market-forecast-to-2035-growth-driven-by-semiconductor-an-b55c48aa66aef3e6 2026-09-13T21:26:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-advances-medical-cannabis-as-neocannbio-builds-gmp-capacity-chosunbi-24a6a75a7ed952d4 2026-09-13T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-journey-from-ebola-to-innovative-treatments-8194ac8c0bba5c74 2026-09-13T20:58:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/emyria-to-speak-at-us-fda-hearing-3c0cbf4041772dcb 2026-09-13T20:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/servier-partnering-day-connecting-pharma-biotech-and-academia-for-new-opportunit-e9b0088d23d43ad2 2026-09-13T20:54:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncy-stock-on-track-for-worst-day-in-about-a-year-ahead-of-fda-decision-on-lead-781ead4101837786 2026-09-13T20:37:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-kerala-pappadam-rules-to-old-monk-scrutiny-when-routine-food-and-drug-enfor-1a02121b9e57e7f2 2026-09-13T20:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-snaps-2-day-slide-sellas-sls009-aml-trial-spotlights-big-pharma-drug-c-f36c0d0b6d235967 2026-09-13T20:03:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-falls-on-2b-notes-deal-is-the-cancer-rally-still-intact-4f0abf3080032390 2026-09-13T17:52:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-zhejiang-chengyi-pharmaceutical-co-ltd-class-a-stocks-a4002021b818d1df 2026-09-13T17:38:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-breakthrough-cancer-vaccine-fueled-a-biotech-rally-can-it-last-16c0e73db8d97a9a 2026-09-13T17:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-stocks-to-watch-today-september-13th-ac86db9ba49d8ae3 2026-09-13T16:04:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptides-approved-so-far-have-limited-human-research-748b4e7ba137702b 2026-09-13T15:52:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/makinde-others-to-grace-psn-oyo-2026-world-pharmacists-day-f74cb2bf371b0c73 2026-09-13T15:32:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-sponsor-s-playbook-for-irt-success-cc08578ef00a6ee4 2026-09-13T15:15:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/dbvt-slides-as-dbv-technologies-leads-european-biotech-declines-bfb64ba5124bdf18 2026-09-13T15:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-trade-this-2-billion-biotech-name-moving-quickly-toward-profit-e72df0c44deb6bd8 2026-09-13T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-small-cap-biotechs-with-binary-catalysts-on-the-calendar-451f0e34f912ed8e 2026-09-13T14:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-small-cap-biotechs-with-binary-catalysts-on-the-calendar-3c11057fc1f82d23 2026-09-13T14:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-drugs-from-other-states-emerge-as-new-challenge-for-punjab-police-964229af63a04d03 2026-09-13T13:58:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/yesterday-when-i-was-young-how-grief-and-music-motivate-this-hong-kong-biotech-s-6bbb76fd500ed8c5 2026-09-13T12:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/drinking-water-in-pet-bottles-found-safe-fda-402bb54191a107af 2026-09-13T12:33:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-stock-stabilizes-after-trial-setbacks-as-investor-pushes-for-board-shak-91c49459cb9bde0d 2026-09-13T12:19:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/roivant-sciences-diverse-exposure-to-biotech-niches-through-vants-nasdaq-roiv-f755b46573c262a0 2026-09-13T11:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/punjab-sees-shift-in-drug-trade-heroin-availability-falls-pharmaceutical-narcoti-3c356b6a4ec030fc 2026-09-13T11:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heroin-supply-falls-in-punjab-but-pharma-drugs-from-other-states-emerge-as-new-c-553dd4232e825186 2026-09-13T11:13:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-hebei-changshan-biochemical-pharmaceutical-co-ltd-class-a-stoc-12d05f5761881b7d 2026-09-13T11:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-patent-office-issues-draft-guidelines-for-pharma-biotech-patents-f5ea25ff845c0d58 2026-09-13T10:20:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/kardigan-funded-precision-cardiology-offers-more-than-pipeline-diversification-903862474345a45e 2026-09-13T10:10:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/aan-ahs-issue-updated-guideline-on-migraine-prevention-atogepant-meets-end-point-fba9ebb04f21030b 2026-09-13T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientist-challenges-pharmaceutical-ceo-7d668b086603b6da 2026-09-13T09:34:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mirum-s-azure-3-trial-a-new-switch-strategy-in-chronic-hepatitis-d-7e2f82ccd93e8fa1 2026-09-13T09:17:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-waiting-times-latest-updates-and-analysis-bd327724e0706e0a 2026-09-13T09:00:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-and-civic-groups-in-south-korea-rally-to-block-telemedicine-drug-del-b3f335563b1d4740 2026-09-13T08:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kush-choksi-promoted-to-assistant-vice-president-business-development-at-strides-67d859a68cdf70fc 2026-09-13T08:25:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/russians-attack-ukraine-s-second-largest-pharmaceutical-warehouse-twice-e64594d4abfd7904 2026-09-13T08:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merali-family-acquires-stake-in-sh330-million-mombasa-glass-plant-534ff22c2cb25d15 2026-09-13T08:06:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-state-teachers-retirement-system-grows-holdings-in-teva-pharmaceutica-401670e366181271 2026-09-13T08:06:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-patent-office-releases-draft-pharma-and-biotech-patent-rules-745c2dc8449c8b47 2026-09-13T08:04:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ris-rez-reduced-risk-of-death-by-54-versus-topotecan-in-patients-with-relapsed-s-bc1325534320d150 2026-09-13T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcaz-remedica-medicine-recall-zimbabwe-for-nifedipine-levodopa-4a21d23560bf1cee 2026-09-13T07:29:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitapivat-just-rewrote-the-treatment-floor-for-transfusion-dependent-thalassaemi-0e1aeb228fea5f5f 2026-09-13T07:28:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-patent-office-proposes-new-guidelines-for-pharma-patent-examination-5171aedfc3e70ab9 2026-09-13T07:21:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/tam-peli-meets-primary-endpoint-for-relapsed-small-cell-lung-cancer-in-phase-iii-ac7af87a08f589ad 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/iza-bren-2-5-mg-kg-dose-advances-to-phase-3-in-egfr-mutated-nsclc-70789e99d842e835 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-exits-laa-closure-market-sells-laminar-program-to-jaguar-laa-77731cf65f918dd3 2026-09-13T06:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/aurobindo-s-curateq-biologics-reports-positive-phase-3-results-for-omalizumab-bi-65c6bb10b421292e 2026-09-13T06:07:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ntla-stock-surges-35-overnight-retail-mood-peaks-ahead-of-first-ever-phase-3-rea-d5beb93535a18e5e 2026-09-13T05:49:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/supreme-court-asked-to-restore-access-to-mail-order-abortion-pill-mifepristone-20d9cb41edbc928e 2026-09-13T04:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-drug-combination-falls-short-in-first-line-pd-l1-high-metastatic-lung-c-355a95d6d905ce35 2026-09-13T04:02:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/centric-compounding-issues-nationwide-recall-of-glutathione-myer-s-cocktail-and-b5a72d52260ba24e 2026-09-13T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/confined-simulations-offer-a-new-route-to-predict-nucleation-82eaeca0ca42a42b 2026-09-13T03:51:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/holiferm-and-organica-uk-combine-to-build-integrated-biotech-and-sustainable-pro-326ddd6adcb0a06e 2026-09-13T02:17:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-summit-s-ivonescimab-tops-keytruda-in-lung-cancer-survival-with-strong-dat-63d1edeae3bf3d46 2026-09-13T01:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-gilead-s-failed-trodelvy-lung-cancer-trial-shows-better-china-results-76c37bd818cc89c6 2026-09-13T01:44:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/bhushan-malpure-elevated-to-head-of-marketing-at-cipla-9e97a17d55f1f388 2026-09-13T01:26:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyester-thermal-ribbon-material-market-forecast-to-2035-driven-by-coding-and-m-423a025c3eff05f6 2026-09-13T00:41:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-cancer-drug-cut-death-risk-54-in-a-phase-iii-trial-aa806bf235967344 2026-09-13T00:13:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-collaborator-medilink-announces-phase-iii-data-for-tam-peli-showing-sign-59cd66eaa83f33ab 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-her2-expression-and-erbb2-alterations-in-bladder-cancer-4ea80dc605ea0fc0 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/linezolid-in-the-era-of-bedaquiline-pretomanid-linezolid-based-regimens-an-indis-8e924ce3b153dea5 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-tolerability-of-linezolid-to-treat-tuberculosis-a-systematic-review-a-fb2e66d13330fbbb 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-intranasal-dexmedetomidine-on-the-night-before-surgery-on-postoperati-b455bbb5732697fe 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ppi-misuse-in-bangladesh-confronting-a-silent-epidemic-through-deprescribing-and-0aaa10e40e28ee8c 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implications-of-potential-us-fda-approval-of-psychedelics-or-psychedelic-adjacen-22a00289bf033253 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-and-safety-interactions-between-aildenafil-and-clarithromycin-ci-9c218951a83f2a36 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-analysis-of-her2-expression-and-erbb2-alterations-in-bladder-cancer-a725c901a29fc8a8 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transfascial-paraspinal-versus-conventional-open-posterior-pedicle-screw-fixatio-702e3f0c54fd95bc 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-fever-hides-fire-a-systematic-review-of-clinical-and-digital-approaches-to-3b1675982556c63d 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-clinical-biological-and-echocardiographic-factors-independently-assoc-d9399d45b2a33f73 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-interpretable-machine-learning-technique-for-chronic-kidney-disease-diagnosis-a36eb0bcde8fec07 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hemodynamic-assessment-of-different-septic-shock-resuscitation-strategies-a-comp-2e608c74e044dc35 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-daily-versus-thrice-weekly-antituberculosis-therapy-for-drug-susceptible-0c5ecbecd8d647ea 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotypic-biofilm-formation-and-detection-of-biofilm-associated-genes-in-multid-36922277a1ca5ce2 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-dupilumab-therapy-in-atopic-dermatitis-and-prurigo-nodularis-clinical-3093d0df68a96ae7 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/directions-for-improving-drug-provision-for-outpatients-with-diabetes-mellitus-c70325f08c56201e 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-the-informativeness-of-the-snot-22-questionnaire-in-patients-with-4e9dcdbe265cd94a 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/altered-pharmacokinetics-and-drug-dosing-in-obese-patients-a-traditional-review-e229aee037800092 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethical-ai-for-crisis-response-a-dynamic-policy-orchestrator-for-prescriptive-re-430bd70d0146756a 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-spectrum-and-electroencephalographic-correlation-in-subacute-sclerosing-22af5f8f19051f51 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metabolic-consequences-of-vitamin-b6-deficiency-and-their-impact-on-lipid-metabo-27d51c561cbb492d 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subclinical-thyroid-dysfunction-when-to-treat-and-when-to-observe-a-comprehensiv-6559b87113af5617 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-public-acceptance-of-the-official-medicine-label-and-mobile-verificat-5ced3fb490225291 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-in-vitro-antimicrobial-susceptibility-profiles-of-mycobacterium-abscessus-fa989aa6b0f056d5 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determinants-of-adverse-drug-reaction-reporting-for-antimalarial-medicines-a-mix-7f511f27b1f61e6c 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-surgical-immune-proteomic-profiles-in-serum-identify-inflamed-and-suppressed-4dc9fd98b8b9ad71 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bibliometric-analysis-of-clinical-trials-on-tobacco-use-and-mental-health-resear-6825e6a1bf36f0a8 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-implementation-of-a-multi-attribute-quality-robustness-scoring-f-d6af0f220fb3e1dd 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-undiagnosed-child-adhd-on-family-outcomes-e35f9938b3a191a5 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meaning-centered-psychotherapy-for-existential-distress-and-demoralization-in-ad-0771ba15c32a9d1b 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-of-life-caregiver-burden-and-clinical-correlates-in-kabuki-syndrome-a-cr-4bd71d62b7107c31 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/establishing-non-fasting-lipid-reference-intervals-and-clinical-decision-limits-f81e8304eb1fab70 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-interplay-between-interoception-and-dissociative-experiences-insig-6419b2b230094dd4 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/influence-of-gingival-thickness-on-clinical-outcomes-following-surgical-scalpel-1c459f18acc6a61b 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-usability-of-an-explainable-ai-decision-support-tool-and-evaluation-of-f5c3a6def263501a 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-efficacy-and-safety-of-celecoxib-for-postoperative-pain-in-major-orthopedic-c41f40b2e490fa69 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/age-dependent-performance-of-conventional-trauma-scores-in-older-trauma-patients-df5cb966635b6338 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-effectiveness-of-telitacicept-in-ebv-seropositive-patients-with-syste-fe93f7a17f0003a4 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodal-analysis-of-dental-radiographs-and-clinical-data-for-cardiovascular-r-13110790ce722d04 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/construction-of-a-large-scale-biomedical-corpus-for-nlp-based-clinical-evidence-66d27e28a834d045 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prophylactic-home-based-exercises-during-radiotherapy-in-head-and-neck-cancer-a-22d5403dc9d4314f 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-femoral-impingement-index-predicts-inferior-clinical-outcomes-in-men-undergo-d48f8a53f53a1bb0 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-case-of-a-40-year-old-female-with-speech-disturbance-2192f4e6b9718ab9 2026-09-13T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-biopharma-gets-phase-2-approval-for-covid-19-vaccine-bfab50deecd04760 2026-09-12T23:26:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-bioepis-named-top-job-creating-company-eb946f6413a4e87a 2026-09-12T23:26:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-adc-lays-down-marker-for-lung-cancer-scrap-with-merck-d370de291343afb9 2026-09-12T22:57:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-ag-stock-price-vrxa-stock-chart-market-cap-news-today-4961193ae7b32abd 2026-09-12T22:56:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/adio-signs-strategic-deal-with-german-biotech-company-bayer-ac2bbec6d7c144ab 2026-09-12T22:02:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/germantown-s-seraxis-announces-merger-to-form-diabetes-focused-biotech-company-040970b898a6533a 2026-09-12T22:00:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/danish-pharmaceutical-novo-nordisk-introduces-ozempic-wegovy-drugs-in-kenya-eea7db5abbecd051 2026-09-12T21:12:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/medpacto-trials-revive-deal-prospects-as-theragen-etex-weighs-holding-stake-chos-8c985c2657981640 2026-09-12T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-wellbeing-bets-on-fat-shot-and-mounjaro-tie-up-to-drive-korea-growth-chosunbi-d96f47c9ea58eba2 2026-09-12T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-hand-foot-syndrome-risks-mapped-in-huge-fda-analysis-238ae56f04af0703 2026-09-12T20:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-speakers-the-complete-guide-to-find-book-hire-a-keynote-for-corpo-8a1ec198d20550d6 2026-09-12T20:33:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-supply-chains-urged-to-begin-ndc-12-transition-planning-immediate-6e46cc9019edde23 2026-09-12T20:30:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/trial-setback-might-change-the-case-for-investing-in-ultragenyx-stock-rare-3e2680d41502b831 2026-09-12T19:29:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-your-ndc-12-roadmap-should-start-now-01536b53d86921d0 2026-09-12T19:29:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cms-s-hemp-cbd-program-has-a-physician-problem-mmj-appeal-pending-44ea6724fd164998 2026-09-12T19:23:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-plan-to-leap-ahead-in-race-for-next-big-weight-loss-drug-f45ef54de9ee97d7 2026-09-12T19:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/donald-trump-talked-about-a-united-ireland-in-dublin-not-the-september-29-pharma-471e8e5510cb1b5f 2026-09-12T19:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/outsourcing-formulation-activities-may-advance-drug-development-5944d75d5ad4da59 2026-09-12T18:04:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cdc-confirm-cyclosporiasis-outbreak-linked-to-taylor-farms-lettuce-under-con-c3bf319fa3d66a29 2026-09-12T18:02:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-direxion-daily-pharmaceutical-medical-bull-3x-shares-pill-affects-rotational-37342cd9f0425108 2026-09-12T18:02:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-news-live-updates-maharashtra-fda-crackdown-paneer-khoya-curd-butter-wort-e460d700b4c871ee 2026-09-12T17:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rfk-jr-says-fda-will-act-on-petition-to-reexamine-some-ingredients-in-ultra-proc-612c000bde7480b5 2026-09-12T17:46:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-bill-would-give-fda-approved-botanical-drugs-12-years-of-market-exclusiv-e80660ca90099e5b 2026-09-12T17:23:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/mbrx-stock-drops-25-as-moleculin-biotech-s-interim-cancer-trial-data-falls-short-d8f025f87aa6b36f 2026-09-12T17:12:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cathie-wood-s-biotech-bet-intellia-secured-an-fda-priority-review-for-rare-genet-5f7c852de259bb0e 2026-09-12T17:11:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-cabio-biotech-wuhan-co-ltd-class-a-stocks-a33d8632bf3d3697 2026-09-12T17:07:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-cyber-outer-space-biotech-critical-tech-shaping-opportunities-of-future-cbcbdcf9f3438d5c 2026-09-12T16:40:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-emerald-3-trial-stride-lenvatinib-plus-tace-in-embolization-eligible-hcc-d89f76dc4e0b7264 2026-09-12T16:27:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-biotech-stocks-with-highly-anticipated-pending-results-685f8dc34535c878 2026-09-12T16:18:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/promising-biotech-stocks-to-keep-an-eye-on-september-12th-efe64c7ece99109b 2026-09-12T16:07:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/perioperative-immunotherapy-more-than-doubles-event-free-survival-in-early-stage-583f131177b9b417 2026-09-12T16:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cms-s-hemp-cbd-program-has-a-physician-problem-mmj-appeal-pending-7d101e291adc8983 2026-09-12T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-ganesh-mandals-cancel-mahaprasad-over-fda-rules-15dff49a023b8fef 2026-09-12T15:11:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/4dmedicaltm-expands-into-europe-with-acquisition-of-ai-lung-imaging-leader-conte-d4bde6caa2380947 2026-09-12T14:37:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-officer-may-come-and-go-but-a-trustworthy-institution-must-endure-says-tukara-a4fd43de647a7b40 2026-09-12T14:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-small-cap-biotech-is-having-its-best-week-in-a-month-here-s-what-s-driving-681ea6d29eda7205 2026-09-12T14:26:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-drug-conjugate-hits-recommended-phase-3-dose-in-egfr-mutated-lung-cance-2e7532b9f25e2b0c 2026-09-12T14:22:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/strata-mental-health-solutions-receives-compass-pathways-grant-for-comp360-provi-5e7e3f29061c4e4e 2026-09-12T13:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-festive-crackdown-sweets-paneer-khoya-curd-butter-worth-rs-4-45-3758912ef772f17c 2026-09-12T13:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-publishes-peer-reviewed-article-on-piclidenoson-and-namodenoson-potenti-0af5a6d68d575775 2026-09-12T13:47:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-drug-pricing-deals-and-policy-uncertainty-create-unreadable-market-landsca-049be17091ba1587 2026-09-12T13:36:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/fundly-ai-raises-4-9-million-to-expand-b2b-pharma-platform-c50ea0daee21a08b 2026-09-12T13:14:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/technical-analysis-of-state-street-spdr-s-p-biotech-etf-cryptocom-xbiusd-p-251011cd265c51ab 2026-09-12T13:06:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/afghan-indian-officials-discuss-pharmaceutical-cooperation-b51c7c0a0b565719 2026-09-12T13:01:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/evotec-stock-holds-near-52-week-low-as-revenue-drops-in-first-half-cef31d0bcd8eed64 2026-09-12T12:59:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/b2b-pharma-platform-fundly-ai-raises-4-million-to-expand-commerce-payments-and-c-c143e24ddef24c12 2026-09-12T12:54:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-gras-rule-would-require-notice-not-additive-approval-91e1ec2ab4df24bb 2026-09-12T12:51:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-atogepant-delivers-positive-phase-3-results-in-menstrual-migraine-9b5b3859971b5d2e 2026-09-12T12:30:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-debt-refinance-require-action-from-teva-teva-investors-85e0988c5562c871 2026-09-12T12:26:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/uzbekistan-health-agency-partex-ai-to-develop-digital-solutions-9f48d894eef80e20 2026-09-12T12:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-joint-venture-partners-to-manufacture-pharmaceutical-products-in-moscow-ka-dc137a5820db4ea6 2026-09-12T12:03:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/aignostics-joins-techcyte-fusion-partner-program-to-bring-pathosearch-to-fusion-268f98a10d966dcf 2026-09-12T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-1-study-supports-recommended-phase-3-dose-for-investigational-egfr-x-her3-9b4c556986e84b1d 2026-09-12T11:41:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/honoring-the-legacy-of-the-hiv-epidemic-9504bc9f97748da3 2026-09-12T11:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/celiac-artery-dissection-a7c4d8bdbb2b28f3 2026-09-12T11:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/uzbekistan-presents-pharmaceutical-products-in-south-korea-b84311811128667d 2026-09-12T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-breast-cancer-drug-etcamah-fails-serena-4-trial-4c465fc11872fde1 2026-09-12T11:16:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/zhu-baoguo-founder-of-taitai-oral-liquid-steps-down-as-chairman-of-two-chinese-l-33a6de160dc6d765 2026-09-12T10:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/azerbaijan-s-pharmaceutical-spending-rises-nearly-22-42364ddbd6b7dcf1 2026-09-12T10:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-bundle-branch-capture-during-left-bundle-branch-area-pacing-a-diagnostic-ac-76d8625b0c598ad9 2026-09-12T10:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-reassessment-of-prophylactic-antibiotics-in-low-infection-risk-electrophysiolo-ff6fbad6086d4761 2026-09-12T10:07:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-court-adviser-backs-challenge-to-pharmaceutical-wastewater-charges-f5177be301b558f1 2026-09-12T09:38:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-warns-public-against-unregistered-tirzepatide-product-874e29e432742269 2026-09-12T09:24:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/mesoblast-completes-phase-3-trial-dosing-for-chronic-back-pain-therapy-663a24f4517ade40 2026-09-12T09:09:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyprus-tip-off-led-to-greek-raid-on-illegal-drug-laboratory-linked-to-mazonakis-5f9d99378c2c09f4 2026-09-12T09:04:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/100-million-investment-plan-clears-way-for-bigger-pivot-park-176bf58aa84aed4b 2026-09-12T08:55:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/advanced-breast-cancer-drug-fails-key-clinical-trial-days-after-regulatory-appro-098d437bd645687d 2026-09-12T08:50:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-pension-service-acquires-112-357-shares-of-teva-pharmaceutical-industri-260337801488a062 2026-09-12T08:37:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifth-circuit-panel-hears-case-on-restricting-mail-order-abortion-pill-507d815126a994ba 2026-09-12T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-west-pharmaceutical-services-wst-cheap-following-its-recent-run-up-9d80bd8465e3c4d8 2026-09-12T08:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparing-healthcare-etfs-broad-vs-focused-exposure-516ea007c530dc21 2026-09-12T08:13:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/courageous-madiee-honoured-as-nhsggc-winners-recognised-at-scottish-children-s-h-f1a6e0d4d7b97823 2026-09-12T08:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/relmada-s-ndv-01-bladder-cancer-trial-moves-into-phase-3-what-investors-should-w-6ae6a2ee7fa3d97e 2026-09-12T08:00:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/pakistan-pharma-industry-medicine-prices-drug-supply-pharmaceutical-policy-aaj-n-12b516d606ae7852 2026-09-12T07:00:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/pakistan-pharma-industry-medicine-prices-drug-supply-pharmaceutical-policy-aaj-n-ef0a623ac1e73cec 2026-09-12T07:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-raids-11-thane-farsan-manufacturers-seizes-food-stock-worth-20-48-lakh-b5b76e392e3e4591 2026-09-12T06:57:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-14-pharma-stocks-to-buy-in-india-september-2026-1ca08eb69cc1f994 2026-09-12T06:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jpmorgan-initiates-dianthus-stock-at-overweight-135-target-by-investing-com-eeff66b407baecfd 2026-09-12T06:49:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-accepts-ncx-470-nda-for-review-in-glaucoma-treatment-cfc222df1edb77f1 2026-09-12T06:44:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-registration-mandatory-for-ganesh-mandals-distributing-prasad-fb8b05dd2f28ecd1 2026-09-12T06:36:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/thai-fda-reports-over-52m-baht-peptide-haul-on-september-11-a6e10730598338f8 2026-09-12T06:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/illegal-weight-loss-products-worth-b50-million-seized-e7dc688eef2faddd 2026-09-12T05:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-s-drug-agency-lags-behind-1960s-fda-d3716d4263c37159 2026-09-12T04:52:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/frost-sullivan-presents-the-global-gene-therapy-crdmo-technology-innovation-lead-a3f7024e958c3afe 2026-09-12T04:25:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/acquired-hemophilia-a-clinical-trial-pipeline-gains-momentum-c128454433b644e0 2026-09-12T04:18:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/vietnam-vaccine-joint-stock-company-d68bb00762a34154 2026-09-12T04:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracing-and-technology-at-the-food-and-drug-administration-fbfa4ab87a9c4f5c 2026-09-12T04:09:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-faces-a-reckoning-three-trial-failures-in-eight-days-test-the-limits-of-f4e0f13966bf3133 2026-09-12T03:50:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/suspect-escapes-after-pursuit-following-drug-use-call-at-sequim-longhouse-6127b7b4572c5641 2026-09-12T03:38:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-and-michael-polansky-found-ai-biotech-company-77cc0d4530cd162b 2026-09-12T03:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/k-bio-firms-make-trillion-won-bets-to-secure-overseas-new-drugs-jkn-8615c51b08db3bfa 2026-09-12T03:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-should-be-an-ai-powered-innovation-hub-and-not-just-a-low-cost-hub-dr-mahe-4c8e80ec418106a5 2026-09-12T03:29:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-seizes-paneer-from-four-trucks-in-budhwar-peth-ahead-of-ganeshotsav-cel-e9086992498407f7 2026-09-12T03:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/journal-of-pharmaceutical-investigation-records-strong-citation-growth-with-5-5-690954f81d3094bf 2026-09-12T03:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbv-stock-gains-on-winning-fda-approval-for-rare-blood-cancer-drug-1cabfd1aed67f747 2026-09-12T02:21:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/genscript-biotech-1548-hk-synthetic-expert-call-transcript-11-sep-2026-de67dd4d07cf5638 2026-09-12T02:19:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-company-expanding-adding-jobs-in-hauppauge-d80f5da0a5cd0868 2026-09-12T02:18:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-bnr-stock-rallies-while-losses-still-deepen-6fa40a99877d8199 2026-09-12T01:32:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-startups-qualify-for-r-d-tax-credits-more-often-than-they-realize-k-38-c-99f5d2da9c4c0918 2026-09-12T01:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-completes-ataibeckley-deal-adding-investigational-depression-pipeline-21206a1893121249 2026-09-12T01:00:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-posts-phase-3-win-and-fda-filing-in-hypochondroplas-ddd070aa04ad5d21 2026-09-12T00:52:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-bill-seeks-to-fix-drug-preclusion-provision-to-boost-dietary-supplement-inno-4a7fbbe7147f63f6 2026-09-12T00:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mitochondrial-energetic-failures-in-men-and-women-across-trajectories-31cd531596d3e6fd 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-botswana-smoking-abstinence-reinforcement-trial-bsmart-b440b5808d9bca4b 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-enhancing-cervical-cancer-screening-and-treatment-in-women-living-with-572495050c5fa56d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-clinical-trials-for-rare-renal-cell-carcinoma-subtypes-consensus-state-a87b4cb04bc0e94e 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-development-of-abl206-a-novel-bispecific-antibody-drug-conjugate-tar-c2acbf42d805d70c 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlation-between-peak-expiratory-flow-rate-and-single-breath-count-in-patient-44cbb583fbb6fbdd 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/angina-bullosa-hemorrhagica-of-the-buccal-mucosa-a-diagnostic-challenge-in-an-or-c499811e3eb18f87 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-myiasis-a-structured-review-of-risk-factors-clinical-presentation-and-treat-a135c68806420554 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-d-dependent-rickets-type-1a-recognizing-clinical-clues-to-avoid-delayed-98e6b364df2a9e62 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-lightweight-hybrid-cnn-transformer-model-for-early-retinal-disease-screening-i-ebb3e4a15bbb9858 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biblical-solutions-to-depression-a-critical-theological-pastoral-and-clinical-ex-769d167106a170c8 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-contamination-control-trends-identified-in-recent-fda-warning-letters-ec206a6030b88158 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bactifind-an-offline-first-mobile-application-integrating-multiple-diagnostic-an-a90360d7fb045a26 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-lstm-neural-networks-with-moving-average-features-for-short-term-stoc-2126b75c8d06bfc9 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-improving-measurement-and-priorities-for-assessment-in-cl-0b36c70adde672df 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenotype-detection-of-biofilm-from-serratia-and-staphylococcus-aureus-isolated-e177cef720d9a902 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/147092de57e5fedc 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-public-health-and-clinical-workers-thought-about-climate-change-related-heal-db145f0e4a3b5085 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-anatomical-profile-of-patients-undergoing-cryoballoon-left-common-p-ba1b007a5bfe8cb3 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-analysis-of-the-cytokine-and-adipokine-profile-and-their-association-fce51a280cd65e62 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparation-of-highly-functionalized-lt-i-gt-ortho-lt-i-gt-naphthoquinone-methid-95395027a0c57261 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/highly-efficient-cellular-uptake-and-membrane-permeability-of-cell-penetrating-p-93591645586f0f0d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-machine-learning-based-clinical-decision-support-system-developed-using-the-ni-dc6299db2e41b493 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-combined-exercise-training-and-bicycle-ergonomic-adaptation-on-cyclin-9b7295e862750c9a 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcriptomic-profiling-of-paired-clinical-leishmania-mundinia-martiniquensis-i-b36bf486134862d1 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-the-dna-repair-chromatin-modifier-protein-smyd3-as-a-novel-epigenetics-cb63efdfe9501123 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-imaging-characteristics-of-cervical-ossification-of-the-posterior-l-73868998a7563784 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-randomized-controlled-trial-of-a-computer-based-intervention-to-increase-inter-e37187b75de3a1bc 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relationship-between-the-oral-microbiome-and-post-surgery-aspiration-pneumonia-i-05661ba74407e6e7 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-radiological-outcomes-between-stemless-and-stemmed-anatomic-total-s-a760dfc92dc37bf5 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prophylactic-administration-of-caffeine-reduces-bronchopulmonary-dysplasia-in-ve-d03f54d0dfedd103 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/model-construction-and-validation-of-dual-energy-ct-multi-parameters-combined-wi-54c3ed37fa0f89ab 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oliceridine-versus-sufentanil-based-postoperative-pcia-after-orthopedic-fracture-55887b1a9cc29bb9 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncovering-drug-related-problems-in-hospitalised-cancer-patients-and-their-assoc-efc4570e5b32231c 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-of-i-bla-i-sub-ndm-5-sub-in-i-providencia-rettgeri-i-and-i-morganella-m-befc2442fad249cc 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-year-experience-with-rapid-pcr-for-carbapenemase-producing-enterobacteriaceae-d7ace291c1e0dd6d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sample-size-calculation-for-the-sequential-multiple-assignment-randomized-trial-b663246046ad92ac 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translation-cultural-adaptation-and-validation-of-the-italian-food-allergy-quali-bf4cfc77b705b2e7 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-insufficient-publication-of-early-phase-clinical-trials-in-oncology-3892fd431663f8c1 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-i-lacticaseibacillus-rhamnosus-i-lra05-i-limosilactobacil-d6c57838e315bd89 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-calcium-dynamics-and-risk-of-all-cause-hospitalization-and-mortality-in-he-1b56fc841056cc7c 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotic-timing-in-immunocompromised-patients-effective-therapy-as-one-piece-o-3e7e6c16bfba0086 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nucleotide-binding-oligomerization-domain-2-independent-colonization-by-i-turici-2670991088fd6e2d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-and-systemic-therapy-a70251322316a57d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-positive-and-negative-peer-modelling-versus-neutral-social-interactio-b8eb188f4c130a5a 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-cyp2c19-i-genotype-guided-p2y12-inhibitor-therapy-optimization-in-patients-at-eaf494461dbb7efa 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovative-therapies-under-clinical-development-for-als-treatment-part-2-biologi-8f189a5884c96a74 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-sensorimotor-training-on-pain-disability-kinesiophobia-and-quality-of-43617167d13bd661 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-hematological-profiles-of-patients-with-burning-mouth-syndrome-acro-022457e51f90569e 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/body-composition-geography-and-ethnicity-understanding-the-associations-with-hea-83511d3ec99ead0c 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/osteoporosis-in-internal-medicine-outpatients-sex-specific-disparities-in-preval-be9fba067a2d76f0 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multiple-drugs-79b281295c5b0029 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laxatives-e366fbaab16cdd6e 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lacosamide-trazodone-b8041cc37ac44beb 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immune-globulin-34c51d4da30e4ce6 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carbamazepine-4d56aaef213bd843 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anabolic-steroids-19eb37cacfa42305 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amfetamine-086d459f4e7fe4f2 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-drug-conjugate-related-pulmonary-aes-in-patients-with-lung-cancer-47aa3ae7f1966794 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-detection-and-intervention-in-at-risk-mental-states-rationale-structure-an-6929ea0ddf9d2682 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-clinical-trial-design-in-low-back-pain-insights-from-studies-of-gabape-021af854b4928b1e 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporal-adaptive-transfer-learning-for-clinical-language-models-d7c2ca1be9632c5d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-statistically-validated-ensemble-learning-framework-for-diabetes-prediction-us-2198a09ac2ef6a74 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dentofacial-injuries-associated-with-e-scooter-use-a-narrative-review-of-the-int-25eb538c97f0ffca 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-different-endoscopic-frontal-sinus-surgical-approaches-in-p-898283f0015f373f 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-course-and-treatment-outcomes-of-vulvar-condylomas-in-immunocompromised-6b3bbccb333263de 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-nos1ap-concentration-association-with-clinical-polymorphism-of-schizophren-7ec98554276649f2 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-blended-learning-approach-to-online-dbt-skills-training-preliminary-clinical-o-47b9555f795b973d 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-genomics-reveals-genotype-phenotype-concordance-and-cryptic-resistom-623e614c1127a63a 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rapid-molecular-detection-method-for-streptococcus-agalactiae-based-on-bacteri-46af29dbe8480bc6 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/histological-validation-of-barium-filled-vascular-channels-detected-by-high-reso-c3e6ce88dd5aaccb 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/behavioural-and-psychological-symptom-determinants-of-carer-burden-across-clinic-7864b1d2a21d3d14 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-vitro-approaches-for-modelling-gut-liver-crosstalk-in-drug-induced-liver-inju-62e7d0628aaa74b9 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connective-tissue-graft-wall-technique-for-mandibular-class-ii-furcation-defects-abd37892f8f7e0d0 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-biorelevant-in-vitro-release-system-and-level-a-in-vitro-in-viv-9bf74a4eaa5cf8e2 2026-09-12T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-the-fda-s-new-psychedelic-framework-actually-means-for-the-clinic-82547d1a0aed17aa 2026-09-11T23:49:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-wins-fda-approval-for-first-drug-to-target-sma-muscle-loss-54ed2153766193cd 2026-09-11T23:33:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-completes-acquisition-of-ataibeckley-initiates-delisting-from-nasdaq-b-307af7d5f1d1afb4 2026-09-11T23:30:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-presentation-for-h-c-wainwright-28th-annual-global-b54d735160584d88 2026-09-11T22:36:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugging-the-undruggable-the-melbourne-biotech-taking-on-the-world-e50fad8ac922c69e 2026-09-11T22:24:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-hospital-callahan-eye-urgent-care-opens-oct-1-b93bd7e432fdee23 2026-09-11T21:36:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/montana-cancer-survivor-treated-at-intermountain-health-encourages-screening-sha-28410fd601118b39 2026-09-11T21:01:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-power-of-shared-pregnancy-parents-build-bonds-before-babies-arrival-fcf57aa7a103999e 2026-09-11T20:58:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-sanjiu-medical-pharmaceutical-co-ltd-approves-interim-dividend-f-7f694037475f400a 2026-09-11T20:52:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-boya-bio-pharmaceutical-group-co-ltd-announces-board-changes-fbae6992f109587a 2026-09-11T20:51:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-announces-major-senior-notes-financing-61e3a7f427a0147b 2026-09-11T20:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-tavapadon-change-parkinson-s-care-0b231a547acc5969 2026-09-11T20:40:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/axios-live-research-and-manufacturing-investments-boost-philadelphia-s-biotech-r-7d5c80b74d9a41bd 2026-09-11T20:37:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-cu-anschutz-is-bringing-precision-medicine-to-patients-with-rare-cancers-77494d93a0251cf0 2026-09-11T20:29:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/exel-stock-slides-after-fda-adds-three-months-to-cancer-drug-review-william-blai-a4e0d321ec05963d 2026-09-11T20:19:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-summit-trial-tests-axs-05-for-smoking-cessation-c2a2ddb8654b9893 2026-09-11T20:12:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoscope-advances-gene-agnostic-therapy-for-severe-vision-loss-in-rp-a59d314d59074156 2026-09-11T20:07:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/palatin-technologies-inc-common-stock-nasdaq-ptn-share-price-ptn-stock-news-ptn-56ba7f89d76a22c6 2026-09-11T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-stock-gains-after-insider-sale-and-strong-q2-figures-84d8fd9320071891 2026-09-11T19:52:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-extends-review-of-exelixis-drug-application-for-metastatic-colorectal-cancer-d62b22daff2084bc 2026-09-11T19:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacometrics-approach-group-in-japan-2026-6c2638ee6aa9c3ef 2026-09-11T19:33:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-emitio-una-carta-de-advertencia-a-csl-behring-s-a-por-incumplimientos-a-la-6974219701c6349a 2026-09-11T19:32:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-leva-160-criancas-e-jovens-de-projetos-sociais-para-conhecer-o-museu-do-fute-4098df87dd694d31 2026-09-11T19:19:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-vence-premio-lupa-de-ouro-2024-na-categoria-prescricao-sistema-nervoso-centr-2a5f835cfb516b43 2026-09-11T19:17:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/assisted-dying-bill-defeated-in-house-of-commons-dd8a68cc3b3c1663 2026-09-11T19:07:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/staunch-biotech-competition-spurs-new-secretive-tactics-shifts-investor-approach-bef2c24268292855 2026-09-11T19:07:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-extends-review-of-exelixis-cancer-drug-9bbcf3e5299b2c9a 2026-09-11T19:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-bets-on-brazil-to-expand-dengue-vaccine-sales-4712091b388d5fff 2026-09-11T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-fda-approved-apds-treatment-for-kids-4-11-comes-from-pharming-group-n-v-ph-6045c809c3fc0ab8 2026-09-11T18:59:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/thailand-seeks-pharma-deals-to-expand-medical-research-and-production-505d03828b78bd99 2026-09-11T18:52:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/gout-pipeline-2026-fda-updates-therapy-innovations-and-clinical-trial-landscape-687f3aa04173aaa0 2026-09-11T18:34:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-more-effectively-using-registries-to-support-patient-centered-reg-59f274e1114bf6a6 2026-09-11T18:34:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-accelerating-drug-repurposing-for-rare-neurological-neurometaboli-c16144d3c82284b1 2026-09-11T18:32:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-intranasal-rapid-acting-vaccine-for-all-seasonal-and-pandemic-inf-b7dc8c5747d85bdf 2026-09-11T18:32:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-advancing-a-vaccine-targeting-genetic-amyotrophic-lateral-scleros-f895ba56b82d2329 2026-09-11T18:27:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-a-personalized-prevention-roadmap-for-the-future-healthcare-1c2ab4d4a8f60b84 2026-09-11T18:27:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-boosting-the-reduction-of-the-environmental-impact-of-pharmaceuti-82c038d6089768d0 2026-09-11T18:27:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/gepe-homenajea-a-violeta-parra-en-el-primer-capitulo-de-sesiones-violeta-0c91b5936a8fa25b 2026-09-11T18:26:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-primary-children-s-hospital-behavioral-health-campus-in-tay-2af8b7459568d5ab 2026-09-11T18:23:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/opc-pharmaceutical-joint-stock-company-announces-change-in-certificate-of-busine-fe6de6c8360ed9ba 2026-09-11T18:21:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-adpkd-clinical-trials-and-emerging-treatments-1666a61c4f75424b 2026-09-11T18:21:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/neonc-technologies-holdings-briacell-therapeutics-and-oncolytics-biotech-have-re-fc8f2dcdb12dee3b 2026-09-11T18:21:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/healey-meets-with-biotech-startups-to-hear-about-financing-needs-d431d6eccb964475 2026-09-11T18:06:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/exelixis-stock-slips-as-fda-delays-cancer-drug-review-analyst-weighs-in-05e0e8ddba9506b8 2026-09-11T18:02:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/exelixis-stock-slips-as-fda-delays-cancer-drug-review-exelixis-nasdaq-exel-34a54ae1f51149f0 2026-09-11T18:02:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/patients-already-in-biohaven-epilepsy-trials-keep-dosing-as-fda-pauses-new-enrol-62a9fc396951761c 2026-09-11T18:01:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukrainian-pharma-exporters-urge-govt-to-establish-procedures-for-renewing-gmp-ce-1a18bf1597d22baf 2026-09-11T17:51:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/leen-kawas-how-to-build-more-resilient-medicine-supply-chains-8d03a93b3e0cc9a0 2026-09-11T17:48:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cybin-cn-help-falls-5-91-as-clinical-stage-risk-and-phase-3-expectations-pressur-cdbe00e558c3223e 2026-09-11T17:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-biologics-news-articles-wuxi-biologics-september-2026-4fbbb869e0d6c610 2026-09-11T17:29:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-picks-from-needham-company-for-second-half-of-2026-ee74fb0087d5cc48 2026-09-11T17:28:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/gregg-gorniak-on-turning-dscsa-compliance-into-strategic-opportunity-b1bece38c56b9d17 2026-09-11T17:27:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-this-new-opportunity-be-worth-billions-for-novo-nordisk-75f42972835db65c 2026-09-11T17:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sartorius-stedim-stock-gains-support-as-q2-margins-hold-and-analysts-stay-positi-f53652650cff630f 2026-09-11T17:12:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/freedom-broker-expects-a-correction-in-the-u-s-biotech-sector-2c9dd0505e15f6d0 2026-09-11T16:55:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/system-secures-us-20-million-as-peptide-wellness-market-accelerates-10b30ecfaa2a980c 2026-09-11T16:53:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/mapping-the-global-health-landscape-analysis-of-fourteen-international-organizat-33d8898ace4c99cb 2026-09-11T16:51:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/scancell-s-phase-3-melanoma-vaccine-trial-moves-toward-launch-raising-long-term-f055cd7f8d7dbdcf 2026-09-11T16:41:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-patients-with-the-same-cancer-respond-differently-to-treatment-a60157c4a2114df7 2026-09-11T16:27:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-jnj-wins-fda-nod-axgn-hcwb-strike-deals-roiv-azn-gpcr-lead-clinical-ee700ea0e8ab3089 2026-09-11T16:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-drops-10-on-a-trial-it-didn-t-even-run-2a676a36e7440c76 2026-09-11T16:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychedelics-are-on-the-fda-s-mind-098b13158b5d2c80 2026-09-11T16:04:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-extends-review-of-exelixis-colorectal-cancer-drug-candidate-2245083406727d54 2026-09-11T16:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/get-ready-to-experience-iphone-18-pro-the-new-apple-watch-lineup-and-airpods-5-70bc6108de1cb820 2026-09-11T16:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/obispos-de-chile-invitan-a-mirar-el-futuro-desde-la-unidad-y-la-amistad-civica-687b28b510873c86 2026-09-11T15:56:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-199-eatery-licences-over-hygiene-7923dd3ae5553ace 2026-09-11T15:55:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/clarity-on-ai-responsibilities-in-healthcare-needed-national-commission-says-9f92ea5d94637140 2026-09-11T15:52:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmtech-weekly-roundup-september-11-2026-86af1c68f7295979 2026-09-11T15:47:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-fda-drug-approvals-august-2026-391a20e49e8f59a6 2026-09-11T15:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pancreatic-cancer-drug-may-also-help-fight-treatment-resistant-lung-cancer-aafc03201b52ab40 2026-09-11T15:44:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/gregg-gorniak-what-changed-in-five-years-of-dscsa-ca123a64e61f2012 2026-09-11T15:40:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/simultaneous-anaerobic-bioreactor-could-accelerate-sustainable-biomanufacturing-ae1dbbfbb1b962fd 2026-09-11T15:36:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-final-approval-to-cabozantinib-capsules-across-multiple-solid-tumor-i-5fa070859ffd2443 2026-09-11T15:33:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/yarrow-brings-in-more-cash-abbvie-drug-succeeds-in-menstrual-migraine-trial-5b5adec38efa9e62 2026-09-11T15:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/duopharma-biotech-detects-unauthorised-system-access-attempt-01f83664a547773a 2026-09-11T15:27:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-2026-state-of-fsp-outsourcing-challenges-trends-opportunities-and-the-future-e1304765287cb6bf 2026-09-11T15:25:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-grants-orphan-drug-status-to-lundbeck-s-asedebart-for-cushing-1eb4b1bc267f4c3f 2026-09-11T15:22:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-shows-early-treatment-can-prevent-long-term-complications-in-crohn-s-disea-9c251dfc6b471112 2026-09-11T15:17:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-by-cnbc-tv18-on-tradingview-2026-09-11-cnbctv-df10e080b094b-0-4a5c05ed391864b9 2026-09-11T15:17:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-ratios-at-birth-in-the-uk-2018-to-2022-7dbac71278ce6443 2026-09-11T15:09:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-learning-system-detects-lesions-in-sacroiliac-joints-576cfe05e4d10fd9 2026-09-11T15:01:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/ptc-therapeutics-at-cantor-healthcare-conference-sephience-drives-growth-by-inve-b5e34fc199f16124 2026-09-11T14:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-vaginal-estrogen-cream-erase-signs-of-aging-on-your-face-cfa50efd375d796a 2026-09-11T14:37:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsr-exempt-expedited-or-full-board-a-plain-language-guide-to-potential-review-p-704a9c14b9f895c7 2026-09-11T14:33:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-expands-hyrnuo-use-in-her2-mutated-lung-cancer-c8473990dcc2cb27 2026-09-11T14:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-at-eaie-2026-in-glasgow-2555c9d7acba3bc7 2026-09-11T14:12:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-pharma-s-next-ai-challenge-is-supervision-not-adoption-627d3deb812bd7dd 2026-09-11T14:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-extends-review-of-exelixis-cancer-drug-8757b11d14127d07 2026-09-11T14:05:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-conversations-on-america-s-global-biotech-leadership-0e8139d8aefabfa4 2026-09-11T14:04:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-mosquito-s-carbon-dioxide-sense-gets-an-internal-boost-660f6d577d9b575e 2026-09-11T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-drags-peers-down-with-triple-asset-stumble-4768c8eda32578b3 2026-09-11T13:52:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-delays-approval-decision-for-exelixis-tyrosine-kinase-inhibitor-in-colorecta-ab8e72d19005bfd7 2026-09-11T13:52:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-future-of-ras-inhibitors-b9331991fc80225f 2026-09-11T13:48:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-pharmaceutical-logistics-comes-together-d3a682022830edce 2026-09-11T13:47:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-things-to-know-in-life-sciences-week-of-sept-7-2026-421ed658cac3010f 2026-09-11T13:45:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-extends-exelixis-zanzalintinib-review-by-three-months-pushing-decision-to-ma-71428bb12c3e3400 2026-09-11T13:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/usfda-imposes-partial-clinical-hold-on-biohaven-s-epilepsy-drug-over-rodent-find-92a0f4f1b1601737 2026-09-11T13:43:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pneumococcal-disease-cases-caused-by-serotypes-not-covered-by-pcv13-ce6e5496ced9fd89 2026-09-11T13:42:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/pneumococcal-disease-cases-caused-by-serotypes-covered-by-pcv13-2ddf38f53562a4bd 2026-09-11T13:42:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-shortages-keep-disrupting-patient-care-6e2e3af5fd0b345d 2026-09-11T13:41:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-completes-acquisition-of-ataibeckley-initiates-delisting-from-nasdaq-69f1dc69cfd406a7 2026-09-11T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-holdings-and-leading-international-funds-are-investing-nearly-dkk-60m-in-a-7baec2cae950d5a3 2026-09-11T13:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-investor-urges-novartis-for-stronger-acquisition-oversight-after-m-a-and-tri-75168779bfdde9ca 2026-09-11T13:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-j-p-mcaleer-lapiplasty-s4a-c860f176fc4016d3 2026-09-11T13:22:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-extends-review-of-exelixis-cancer-drug-97cc7bfefd52c9ea 2026-09-11T13:19:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotuesdays-exoz-selects-curia-as-cdmo-for-nct-b539ce4877e2546e 2026-09-11T13:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-simple-allometric-scaling-why-time-course-methods-win-for-first-in-human-90f7d76ac6aac887 2026-09-11T13:12:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ers-2026-bmi-type-2-inflammation-and-asthma-attack-risk-3aedc94d1f105ada 2026-09-11T13:08:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-light-emitting-nanoparticles-can-detect-subtle-chemical-differences-to-enhan-67d29ed1f086abd0 2026-09-11T13:01:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/lundbeck-drug-candidate-granted-another-us-fda-designation-9f040c75940d5b94 2026-09-11T13:00:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-atogepant-delivers-positive-phase-3-results-in-menstrual-migraine-b94ffc90724c6cb9 2026-09-11T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-etcamah-falls-short-of-key-phase-iii-endpoint-in-breast-cancer-tri-5928c45ebac516f1 2026-09-11T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-biotech-growth-needs-more-long-term-capital-says-expert-b0d7e83756aece93 2026-09-11T12:31:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-week-in-science-poop-concrete-hot-ice-and-more-42a5bda2583b76a4 2026-09-11T12:30:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/singapore-launches-biotech-focused-boston-hub-to-build-on-centuries-old-bond-b89995faef2f0ae8 2026-09-11T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-adds-1-1b-to-small-and-mid-sized-biotech-fund-ee5879e810cd4a42 2026-09-11T12:29:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenya-s-wealthy-merali-family-acquires-stake-in-pharmaceutical-glass-plant-0ddbfae56327c1a6 2026-09-11T12:26:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/eppendorf-launches-refrigerated-centrifuge-5811-r-aaa328684245d693 2026-09-11T12:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-an-outbreak-of-acute-respiratory-infection-in-an-adult-social-care-settin-4b8ec42924935cd1 2026-09-11T12:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-bet-big-on-drugmakers-vaneck-pharmaceutical-etf-vs-invesco-healthcare-6bf4962a35aab8ac 2026-09-11T12:13:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-download-biotech-s-future-and-cheaper-cleaner-steel-69a3d6cc2f2a0a2f 2026-09-11T12:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sterlitech-launches-benchtop-membrane-filtration-systems-4c0ec37e526d2019 2026-09-11T12:03:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-extends-review-of-exelixis-drug-application-for-metastatic-colorectal-cancer-623f07bc4551e9d8 2026-09-11T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-tadpoles-that-don-t-care-about-their-siblings-7e961abb62e65a59 2026-09-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyoto-university-signs-agreement-with-taiwan-s-ministry-of-education-regarding-t-70f2152d11fe2ee5 2026-09-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/profitable-biotech-incyte-forms-handle-as-institutional-buyers-load-up-on-stock-e395f7467425a742 2026-09-11T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transition-of-the-icelandic-medicines-agency-s-website-in-full-swing-c750fd2961bf03e7 2026-09-11T11:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-cancer-vaccines-biggest-barriers-to-market-a1a5e5c1027f15da 2026-09-11T11:56:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-extends-review-of-exelixis-cancer-drug-deaffdf4f5a748a4 2026-09-11T11:49:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-evaluo-y-libero-mas-de-430-lotes-de-vacunas-entre-junio-de-2025-y-mayo-de-379e0cb77fd0e730 2026-09-11T11:49:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/belgie-moet-nu-investeren-in-digitale-pathologie-om-morgen-betere-zorg-te-bieden-dcf73ec3e17b867f 2026-09-11T11:47:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-extends-review-timeline-for-exelixis-cancer-drug-19d15b23009bb8c7 2026-09-11T11:33:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/frost-sullivan-presents-the-global-gene-therapy-crdmo-technology-innovation-lead-05419dc90ac4e4e3 2026-09-11T11:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moins-de-papier-plus-de-numerique-nous-faisons-evoluer-nos-pratiques-f705c926a8b8c902 2026-09-11T11:26:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-restored-my-hope-how-the-margaret-foti-scholarship-helped-tsedey-tsegaye-recl-d8dd083fb1cdb03f 2026-09-11T11:03:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-s-epilepsy-drug-hit-with-fda-clinical-hold-115921639fbaab9b 2026-09-11T11:02:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-investors-may-respond-to-sellas-life-sciences-group-sls-phase-3-trial-nears-36e1e2f8d7b894f7 2026-09-11T10:29:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-early-scale-cpc-biotech-and-multiply-labs-smoothen-cell-therapy-automation-b-cb9bcf29049b507a 2026-09-11T10:27:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-says-nda-for-120-mg-biosimilar-denosumab-hlx14-accepted-c33c1fb7dab637a0 2026-09-11T10:26:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrkon-risks-explained-keytruda-dependence-patent-expiry-clinical-trials-and-toke-0f495729ddaa03b6 2026-09-11T10:21:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/poland-s-case-against-eu-wastewater-rules-boosted-by-advocate-general-opinion-0cb3bd178f9e4c11 2026-09-11T10:18:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/angelman-drug-partner-for-research-alliance-iii-racc-eyes-2029-data-6f76cf896ec6330e 2026-09-11T10:04:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/set-yourself-up-for-a-strong-2027-2-pharmaceutical-stocks-to-buy-in-september-7c5df69ea3cb3fa3 2026-09-11T09:53:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-shares-phase-3-results-for-imfinzi-plus-imdelltra-in-extensive-stage-bb2e83d5304d0724 2026-09-11T09:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-tartan-army-to-biotech-deepening-scotland-s-ties-with-boston-through-new-li-882a8830a7c1ede8 2026-09-11T09:40:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidelberger-medizin-studierende-weiter-absolute-spitze-in-deutschland-a3b75b24af9c64e8 2026-09-11T09:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/az-s-copd-drug-cuts-flare-ups-in-two-phase-3-trials-1e42b428339da8ba 2026-09-11T09:35:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/set-yourself-up-for-a-strong-2027-2-pharmaceutical-stocks-to-buy-in-september-8cc69ed199f1afbf 2026-09-11T09:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/head-of-german-venture-fund-sees-big-potential-in-danish-biotech-but-investors-a-cbacdcd980c6a8e4 2026-09-11T09:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-you-working-with-the-non-clinical-package-for-clinical-trial-applications-se-381cb66138accd14 2026-09-11T09:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-and-innovate-uk-back-creative-technology-growth-d664080335809652 2026-09-11T09:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/rewriting-the-rules-of-genetic-medicine-with-trna-therapeutics-beyond-biotech-aee67803a2f832f6 2026-09-11T09:33:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/trial-misses-prompt-shake-up-call-from-major-novartis-stockholder-9b04ea1f348cb183 2026-09-11T09:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-regulators-ask-when-ai-touches-a-drug-application-601c189441f030a0 2026-09-11T09:27:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-approvals-positive-study-results-and-a-partnership-deal-to-fast-track-new-me-4a3eb1cbd863abcd 2026-09-11T09:25:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-inc-announces-acceptance-of-new-drug-application-for-12-deaaab0cc42dfe4b 2026-09-11T09:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-drug-meets-phase-3-goal-in-menstrual-migraine-f35f3b3a549baf53 2026-09-11T09:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-the-under-35s-shaping-the-future-of-biotech-0e01cfbafd7d371b 2026-09-11T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aprecia-pharmaceuticals-am-is-an-important-expansion-of-the-pharmaceutical-manuf-fa4992349a80da17 2026-09-11T08:51:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/anavex-life-sciences-to-discuss-pediatric-inclusion-in-rett-syndrome-trial-by-in-b5f75a08654d2790 2026-09-11T08:49:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-for-climate-resilience-fund-31985e360beccdf6 2026-09-11T08:43:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/reporter-s-notebook-k-biopharma-licensing-deals-are-getting-better-not-just-bigg-744ac6deb31a7e39 2026-09-11T08:24:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-13-september-2026-1016782b910b7d0c 2026-09-11T08:22:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/astadaily-earns-purity-award-from-clean-label-project-d798f43275060d64 2026-09-11T08:20:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-shines-clinches-top-awards-at-2026-mombasa-show-3c6be8c342fba20d 2026-09-11T08:15:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/jpmorgan-initiates-dianthus-stock-at-overweight-135-target-76d704bda903e96f 2026-09-11T08:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reporter-s-notebook-k-biopharma-licensing-deals-are-getting-better-not-just-bigg-c15b62c6b02b8567 2026-09-11T08:02:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-students-must-step-out-of-comfort-zones-embrace-multiple-roles-suchitra-bd66bfb839665905 2026-09-11T07:57:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ny-musikstudio-en-fristad-for-psykiatrins-patienter-pa-ostra-sjukhuset-a68408fbdebd8435 2026-09-11T07:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-our-homes-beat-the-heat-homes-study-shares-findings-with-industry-players-c2aa31f165f2f89b 2026-09-11T07:52:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/becoming-a-father-at-22-from-panic-to-i-ll-sort-this-out-dee51676d35e30fd 2026-09-11T07:49:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clears-prelude-s-prt13722-phase-1-trial-in-hr-positive-breast-cancer-33a29eff5efb8a93 2026-09-11T07:33:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/schlaganfall-wenn-die-ursache-im-herzen-liegt-65b4e83a1cca5f14 2026-09-11T07:27:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/1-c1452426600a2f51 2026-09-11T07:22:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/limitless-biotech-coupon-code-pct15-save-15-on-research-peptides-b07e64035e883a26 2026-09-11T07:22:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenanga-launches-world-first-hang-seng-biotech-index-structured-warrants-258d523c61bb1937 2026-09-11T07:16:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/marquis-who-s-who-honors-kenneth-hesterman-for-expertise-in-pharmaceutical-accou-4cd9960720360d81 2026-09-11T07:02:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-urine-sample-for-the-early-detection-of-bladder-cancer-85437ac46d9d7803 2026-09-11T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-23-million-nih-grant-to-continue-uc-davis-alzheimer-s-disease-research-center-2807887438c5fbcf 2026-09-11T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-excipients-market-to-reach-usd-24-88-billion-by-2035-at-8-1-cagr-e55ec71af1e14859 2026-09-11T06:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tpi-function-in-pulsed-field-ablation-for-atrial-fibrillation-hemolysis-control-7b5a4fd26d967e25 2026-09-11T06:56:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/velocity-clinical-stitch-expand-partnership-across-70-sites-to-boost-screening-a-e913a53837fd85f4 2026-09-11T06:48:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-says-closely-watched-cholesterol-study-failed-to-meet-goal-c974947767e107ee 2026-09-11T06:45:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/advanced-conduction-disease-after-incident-heart-failure-in-myotonic-dystrophy-t-ece2a0a551be89b6 2026-09-11T06:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-study-shows-aqivc-superior-to-comparators-in-older-adults-b7ea1dfa91dfde4e 2026-09-11T06:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/pamca-returns-to-nairobi-as-africa-s-mosquitoes-evolve-cfd6e041c1128d8b 2026-09-11T06:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/raumklimastrategie-beschlossen-das-usz-geht-den-nachsten-schritt-718eaa1f0e3383e7 2026-09-11T06:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-rtw-biotech-opp-additional-investment-in-encoded-therapeutics-06ce266c777880ac 2026-09-11T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/orzeyful-approval-might-change-the-case-for-investing-in-takeda-stock-8b50302be3cb1bfe 2026-09-11T05:58:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-strong-biotech-ip-strategies-get-right-and-where-weak-ones-break-down-a2b121fe65165341 2026-09-11T05:43:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-climate-change-threatens-pharmaceutical-companies-6987587302b518a2 2026-09-11T05:13:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/henlius-86cc303c86469a6e 2026-09-11T05:10:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/former-head-of-takeda-pharmaceutical-dies-at-80-6fc269c48465eb75 2026-09-11T05:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mikhail-davis-embody-the-fda-s-stabilization-seehafer-signals-ai-revolution-is-c-4e2f6e7d4e38ba0f 2026-09-11T04:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-biotech-ab-publ-sto-acti-is-breakeven-near-585e562e6ced9952 2026-09-11T04:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-partially-halts-trials-of-sk-biopharmaceuticals-epilepsy-drug-candidate-e77116af26fe1e1f 2026-09-11T04:17:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-senior-vp-favorite-sells-2-77m-in-stock-9fe9896a7541d2cb 2026-09-11T04:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jiangsu-handian-biotech-lands-tens-of-millions-of-yuan-in-strategic-round-89239b47de33a798 2026-09-11T04:01:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/ex-takeda-pharmaceutical-head-hasegawa-dies-at-80-07ac3ad58f8939ed 2026-09-11T03:54:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-secures-additional-funding-for-phase-3-clinical-tria-54c8d0d78e14ca49 2026-09-11T03:19:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-asx-par-draws-final-us-2-million-tranche-as-phase-3-a44324072bfb26c8 2026-09-11T03:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-halts-sk-biopharm-s-opcalim-novartis-12-billion-drug-fails-phase-3-0ab09b28ac07fe98 2026-09-11T03:10:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-secures-additional-funding-for-phase-3-clinical-tria-ddb4fb8de8310392 2026-09-11T03:07:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/laser-therapy-offers-new-hope-for-inoperable-pancreatic-tumors-aa7039f94cc04951 2026-09-11T03:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-aims-high-at-92-target-but-clinical-risks-remain-cdae87387dc82248 2026-09-11T02:54:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-aggregation-drives-ai-s-impact-on-clinical-supply-chains-c09c4abbac6eea8f 2026-09-11T02:41:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-28-000-bottles-of-blood-pressure-drug-recalled-fda-11bf9d424e5e5c88 2026-09-11T02:31:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-s-food-safety-crackdown-what-the-viral-raids-don-t-show-869bc1b6b56998d4 2026-09-11T02:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-november-2026-cancer-treatments-ctac-meeting-3a6d1f5f98e260f8 2026-09-11T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-1-1b-to-biotech-public-fund-lifting-it-to-2-8b-e142f1ed47f39964 2026-09-11T01:48:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/genscript-biotech-to-place-77-1-million-shares-at-hk-30-50-per-share-586a45444917dbb9 2026-09-11T01:29:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-iipa-debate-2026-ku-fda-plan-major-food-safety-awareness-push-in-j-k-415bf82849db4727 2026-09-11T01:24:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-teva-pharmaceutical-industries-nyse-teva-still-a-bargain-or-fully-priced-22afb570e071b7c5 2026-09-11T01:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-teva-pharmaceutical-industries-nyse-teva-still-a-bargain-or-fully-priced-a490fd25a3336a5e 2026-09-11T01:15:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-genencell-treatment-with-elevated-liver-enzymes-approved-for-clinical-775a5811d53df627 2026-09-11T01:11:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-pauses-new-enrollment-in-biohaven-s-epilepsy-drug-trials-f4e06e3e7cd27817 2026-09-11T01:05:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-hold-on-opacalim-trials-sk-biopharmaceuticals-says-limited-relevance-73bbabf1168b65b2 2026-09-11T00:38:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardenal-chomali-preside-misa-por-detenidos-desaparecidos-y-llama-a-fortalecer-l-e27592fe19ea6fd6 2026-09-11T00:16:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-s-food-order-for-festivals-what-maharashtra-fda-commissioner-said-3dd813ddcd70dbc5 2026-09-11T00:10:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/megazonecloud-begins-building-hanmi-pharmaceutical-s-quality-assurance-ai-agent-34906fa2a5c01536 2026-09-11T00:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/estante-de-livros-chineses-e-inaugurada-na-ufrj-ba5635de3c8611e1 2026-09-11T00:05:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-advances-new-injectable-obesity-drug-in-key-phase-3-trial-55906840ab9c4121 2026-09-11T00:01:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-130362fb32f7b414 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mmsdh-facilitates-acsl4-propionylation-to-counteract-ferroptosis-upon-hypoxia-an-048f3b03d8770171 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selective-oestrogen-receptor-degrader-class-grows-with-new-cancer-approval-a84ec3e924294e24 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-heart-lung-and-blood-institute-notice-of-meeting-a3006d086a794e13 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-cardiovascular-devices-classification-of-the-cardiovascular-mach-212eaf111483ed36 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-omb-review-comment-reque-577ad723f444fe54 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emran-mohammad-rn-aprn-cnp-decision-and-order-c222547fc36d6725 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/joseph-john-stubbers-iii-d-o-decision-and-order-56e3d57bd217be2e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cheryl-white-n-p-decision-and-order-6910fc9ec09361e7 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/craig-cohen-dpm-decision-and-order-bac086480e607f05 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-appalachian-region-healthcare-support-program-eb7a15e20f6e765d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-infant-toddler-court-program-state-awards-556a097130f48a79 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-public-comment-requ-cbd46bd70ec39a02 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amending-over-the-counter-monograph-m020-sunscreen-drug-products-for-over-the-co-bf1f21ba8881a138 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-med-93720515e76d644f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-c7cf00b962ad7623 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-rural-hospital-stabilization-pilot-program-f42ef2358c137743 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-aging-amended-notice-of-meeting-05a388dc6e88ab98 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-diabetes-and-digestive-and-kidney-diseases-amended-notice-943f33d3924a19c8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-e4c7ec9101c7b4ed 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-genetic-and-neuronal-mechanisms-that-regulate-zebrafish-sleep-13963d17da15b192 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-identifying-mechanisms-of-maternal-infant-obesity-risk-transmission-th-5231320863d40b50 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-physical-cellular-and-molecular-control-of-tissue-fission-and-fusion-04ca988f136f85e7 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-interplay-between-the-cellular-dna-damage-response-and-the-hpv-life-cy-11e4aa4c9fc5da58 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-air-pollution-and-well-being-assessing-risks-and-enhancing-education-i-ee55a9ff20a89d7f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-transforming-systems-of-care-to-address-hiv-hiv-risk-and-substance-use-248d94971a013933 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-crcns-ecologically-realistic-perceptual-decision-making-0a71407f4b58d973 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-keyscope-the-key-to-sustainable-cancer-diagnosis-and-treatment-in-ugan-a4174514e3e0b43c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-enhancing-cervical-cancer-screening-and-treatment-in-women-living-with-10047beacd58691e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-consortium-for-advancing-management-and-prevention-of-cancer-in-people-892eb8de67da1184 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-revealing-proteoforms-the-driving-effectors-of-biological-function-2d464cb898bb03e1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-systems-analysis-and-improvement-approach-to-optimize-the-cardiometabo-bad474e70a448c79 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-unraveling-the-roles-of-slc25a22-and-slc25a46-in-mitochondrial-metabol-e875aed539e1af27 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-treatment-of-health-complications-due-to-female-genital-mutilation-cut-05d8ea4c2011fd18 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-cellular-mechanisms-promoting-early-reactivation-of-latent-hiv-across-083341066da96588 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-influence-of-pregnancy-and-early-life-metabolome-and-lipidome-on-child-e8bde56982663740 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-change-sensitive-assessment-of-emotion-dysregulation-in-asd-across-the-ab37e17f67981468 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advancing-exponential-family-random-graph-model-estimation-and-power-a-08a2eed8582c9695 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-innate-immune-cell-subtypes-involved-in-infant-responses-to-protein-co-0d97096435da2bfe 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-decoding-the-modified-small-rnas-that-drive-tlr7-8-mediated-neuroinfla-c06e5786963f87a6 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mentoring-patient-oriented-research-to-individualize-care-for-hospital-c05b48e9767819b0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-physiological-and-pathological-insights-into-trem2-ctf-cleavage-by-sec-06b7032c08c76925 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-joint-harmonization-of-structural-and-functional-connectivity-and-its-380b3d0cb2f0953d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mammalian-bile-acid-chemosensation-and-its-role-in-social-assessment-4fb20783373054c1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-neuro-pasc-brain-fog-and-fatigue-is-caused-by-a-dysbiotic-gut-microbio-6f5074567336a61a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-pi3k-pathways-in-molecular-selection-for-adjuvant-aspirin-treatment-of-56c348060631fb45 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-circadian-regulation-of-nutrient-metabolism-the-role-of-melatonin-in-p-92a5833570756147 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-analysis-of-longitudinal-multi-omics-data-for-prediction-of-preterm-bi-d02b1cdc35374778 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-therapeutic-development-to-target-tau-using-immunotherapy-and-crispr-b-454a655ce0a627b4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-regulation-of-gut-lipid-metabolism-and-sexually-dimorphic-longevity-by-1c5696b9b3cd1dac 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mitigating-the-renal-consequences-of-extreme-heat-in-older-adults-9f4efc5d28590b19 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-aligning-hospital-admission-decisions-with-health-priorities-of-people-a1c5e62744490229 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-pragmatic-randomized-controlled-trial-of-brief-meaning-centered-psyc-426c3af4d2b40a69 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-supporting-families-in-coping-with-parental-cancer-a-multi-site-random-bc1c70fc8f81b21b 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-p3-mechanisms-of-single-strand-break-repair-and-their-regulation-by-po-a9c644e0970c6d16 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-structural-cell-biology-of-dna-repair-machine-1c16bbc5d03ffe17 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigating-the-effects-of-increasing-o-glcnacylation-in-alzheimer-s-1a06e0a7f2449041 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-community-and-digital-technology-strategy-to-reduce-the-burden-of-hpv-e1ce3f3e95a1585b 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-dying-while-poor-investigating-multi-level-determinants-of-end-of-life-b4a3479d296e37cd 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-facilitation-of-information-exchange-for-shared-decision-making-for-lu-acac740f06a63d5f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-personalizing-clinical-decision-support-for-heart-failure-treatment-to-692ae6600d5b8adf 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-an-intervention-to-reduce-cancer-associated-thrombosis-through-improve-312e90f62789b56a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-estrogen-s-neuroprotective-effects-on-the-brain-barrier-in-restrictive-bf7a000e2783eecb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-effect-of-rcr-healing-on-5y-clinical-outcomes-and-degenerative-shoulde-ae16c61c713aaa76 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sch-ai-empowered-wearable-multimodal-sensors-ai-medallion-for-noninvas-341e0ad672592f92 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-evaluating-patient-performance-of-postoperative-incentive-spirometry-8ef170441db539e3 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-optical-modulation-of-quantum-nanomaterial-surface-chemistries-to-func-e8a2b03a3df418c9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-hippocampal-precision-mapping-to-characterize-pathophysiology-in-amci-e243e5ed972c1d09 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-lrrk2-associated-mechanisms-of-granulovacuolar-degeneration-body-forma-4a9888fac6f80238 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-improving-alcohol-treatment-outcomes-for-women-across-the-lifespan-374ad0678f4bd97d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-3-sex-differences-in-neurovascular-and-autonomic-regulation-pr-454d65063590db95 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-1-impact-of-prenatal-immune-dysregulation-on-sex-differences-i-ba1c72630a82d685 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-close-kin-mark-recapture-methods-to-characterize-suppression-of-aedes-520d9c237287b34a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-role-of-the-ubiquitin-independent-proteasome-system-pathway-in-tau-deg-d7a3266a405559e2 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-adapting-and-pilot-testing-a-relationship-strengthening-intervention-t-1664af83108df395 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-molecular-pathogenesis-and-therapy-of-systemic-histiocytic-neoplasms-4f4c8166a8937ba0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pregabalin-72be2b8a2c6a4b2a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gabapentin-e7ed5954963887e9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-79ce84d8af08c8dc 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-race-for-the-next-big-weight-loss-drug-is-on-and-china-wants-in-4ca0025474e6d592 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-a-new-standardised-treatment-protocol-based-on-initi-e56b8bfccea093ab 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-specific-efficacy-of-acetazolamide-for-acute-mountain-sickness-a-randomised-ee87c8ca10895aa3 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-controlled-trial-comparing-7-day-fexuprazan-based-and-14-day-rabepraz-de2512808b31ca6a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-services-do-people-seek-when-they-visit-a-community-pharmacy-care-clinic-d0b530ddc5e44386 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-patients-with-heart-failure-a-contemporary-practice-tool-for-pharmacist-7c408d6b46d4237c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medication-safety-in-indigenous-communities-challenges-and-interventions-1bf49ca019f7d0e2 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-year-analysis-of-publications-by-quebec-hospital-pharmacists-8f6c95173b5e694f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-related-problems-in-older-adults-with-mild-cognitive-impairment-or-dementia-96f624acc8f4f4a9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/management-of-a-patient-with-a-ticagrelor-rosuvastatin-interaction-an-algorithm-9d231ffd5b5bc159 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-call-for-the-generalist-pharmacist-bdb545612f6c918f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spinal-muscular-atrophy-biology-pathogenesis-and-therapeutic-advances-b415d007b404949e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/herbal-extracts-and-plant-derived-bioactives-in-atopic-dermatitis-evidence-mecha-cd9cfcdb3b30d4c3 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/folfox-based-transarterial-infusion-chemotherapy-for-unresectable-colorectal-can-bea5551d37e257af 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tranexamic-acid-to-prevent-anastomotic-leak-after-rectal-cancer-surgery-protocol-799805d4b0b3f8bb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotic-impregnated-bone-graft-to-prevent-infection-after-total-hip-arthropla-5268d85be60fdd94 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-safety-and-exploratory-efficacy-of-onradivir-in-children-with-a-7df919b8089e655f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heiguteng-zhuifeng-huoluo-capsule-alleviates-osteoarthritis-associated-with-glyc-e816d5aada6daaeb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-optimization-of-deuruxolitinib-in-adults-with-alopecia-areata-a-phase-2-ran-732d8bf97a9e319a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-tdcs-primed-itbs-in-major-depressive-disorder-a-randomized-sham-cont-b40827847a532095 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trastuzumab-botidotin-versus-trastuzumab-emtansine-in-human-epidermal-growth-fac-d39b584c172d264d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plasma-versus-whole-blood-tacrolimus-concentration-and-outcomes-after-kidney-tra-43fea2d7c00d92c0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-cachexia-related-status-with-treatment-outcomes-in-advanced-gastr-ed9766cd557e0e5b 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lessons-from-cohort-studies-of-targetable-metabolic-deficiencies-in-lung-cancer-b1c038f3fdf3e636 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/late-onset-multiple-acyl-coa-dehydrogenase-deficiency-madd-glutaric-acidemia-typ-26ad462a8ff18b6e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/benchmarking-drug-library-compliance-and-alert-rates-in-smart-infusion-pumps-a-m-cc042761c50bfb5e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-management-of-generalized-drug-influenced-gingival-enlargement-a-clin-a0dff0eeba02fdca 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-phenotypes-and-factors-associated-with-systemic-involvement-in-pediatri-bb23bbedc93d5e22 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ictal-interictal-continuum-a-comprehensive-review-for-the-clinical-epileptol-1d28a0773cd7a283 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-medical-procedure-in-needle-stick-injuries-among-healthcare-practi-a625c88de71da316 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/knowledge-attitudes-and-practices-regarding-hypertension-prevention-among-medica-95ce3ccfb7d13a35 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acupuncture-care-for-a-patient-with-tennis-elbow-lateral-elbow-tendinopathy-a-ca-55448e3e6a6b64ce 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-ll-see-it-when-i-believe-it-73965d6ba86bbf24 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-practitioner-s-guide-to-ericksonian-choice-architecture-7ba5e46554ae733e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-olfactory-training-and-topical-corticosteroids-for-persistent-p-284ef17782a9bce4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/future-directions-b7312a04957ae1cb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teaching-the-invisible-a-game-based-simulation-for-learning-health-care-economic-7ea5cdfe5504fe20 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-diagnostic-identification-of-cholestatic-liver-diseases-using-integrated-cli-89d880bf052825c6 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemical-fingerprinting-and-simultaneous-determination-of-main-compounds-combine-c618963982a18705 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/localization-of-advanced-drug-delivery-manufacturing-in-saudi-arabia-through-tec-a5d3d641a0ae9b7d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fused-spinopelvic-angle-in-adult-spinal-deformity-with-pure-sagittal-malalignmen-a50ebbefa1722eb4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictive-analysis-of-social-determinants-of-health-in-posterior-cervical-spine-990d69caca0e348f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-physical-therapy-and-mortality-in-older-patients-with-heart-9c687d7a8b736236 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrus-microstent-combined-with-cataract-surgery-in-pseudoexfoliation-glaucoma-v-da281f09101151ea 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/functional-status-and-postoperative-outcomes-after-left-pancreatectomy-for-pancr-ece63d7def3a3618 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-approach-and-therapeutic-management-of-spontaneous-esophageal-perfora-729725021ca6e7c5 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-implementation-and-clinical-validation-of-a-whole-genome-sequencing-non-inva-5efd029892d9731c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-stratification-of-acute-symptomatic-anterior-circulation-intracranial-ather-060335b18fc361ee 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clinical-study-of-simotang-oral-liquid-combined-with-shenque-acupoint-applicat-d4b5d7677424f285 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fusion-level-selection-in-posterior-hemivertebra-resection-for-congenital-scolio-4356d58d5169b806 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-ai-in-clinical-decision-support-a-framework-for-reciprocal-human-ai-i-1420c6c6866df483 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-of-radix-arnebiae-oil-in-patients-undergoing-incision-and-drai-58f0e461772494f1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fetal-behavior-as-a-window-to-later-gross-motor-function-a-10-year-follow-up-of-c8f670e65987c96e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-laboratory-criteria-for-a-differentiated-approach-to-the-management-d489377a752957d5 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-dapagliflozin-in-the-treatment-of-patients-with-signs-of-cardio-rena-d4a6bb4196d21d84 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-rationale-for-individualizing-secondary-prevention-in-patients-with-ath-c7a775dd082043ba 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edukasi-tentang-hoaks-obat-dan-kesehatan-di-media-sosial-dengan-bijak-berselanca-5fa5e8f4010bbf01 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-surgical-outcomes-of-split-cord-malformations-a-ret-a259bf8535951c1f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-prevent-for-cardiokidney-outcomes-in-ckd-076f0a826668143c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/executive-functions-and-conceptual-models-a-first-look-at-a-complex-topic-commen-237f2f36d13ca767 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-computed-tomography-and-magnetic-resonance-imaging-education-into-a-916bc317b1b11c9c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparation-and-characterization-of-chitosan-co-acrylamide-hydrogels-for-control-6272337bb2bce876 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-guideline-directed-medical-therapy-at-discharge-through-collaborative-61c425f8c65f8565 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-relevance-of-accuracy-in-in-house-3d-printing-in-craniomaxillofacial-su-5d29ff74d526eef8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-theory-based-health-education-intervention-in-improving-exclusive-brea-3c22484e4d298979 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-feasibility-usability-and-preliminary-effects-of-an-mhealth-in-61c938230b152285 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-cavaterm-thermal-balloon-endometrial-ablation-in-women-with-9a5696678c3b99a8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alveolar-ridge-preservation-using-advanced-platelet-rich-fibrin-versus-concentra-642458687bb7b17c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-therapeutic-efficacy-of-a-modified-ketogenic-diet-in-children-wit-7bdc14cebb6eaee3 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-low-dose-esketamine-on-quality-of-recovery-after-gynecologic-laparosco-9565882e22d28941 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/salivary-lysozymes-anti-inflammatory-cardiac-medications-and-cardiovascular-mort-595fc7d8250f6e70 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-association-between-hormonal-contraceptives-and-lower-extremity-injuries-in-7f2bf0b2935043e0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncertainty-and-novel-clinical-trial-designs-in-oncology-when-should-equipoise-m-9d09e54cf8511c76 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-discrimination-to-decision-external-validation-and-clinical-utility-of-a-di-fc08c4cab53491f2 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oculomics-and-cardiovascular-disease-from-enthusiasm-to-clinical-reality-845c121fddcc7236 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitral-regurgitation-and-severe-aortic-stenosis-clinical-characteristics-prognos-56a6b86519668248 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-intratumoral-medi1191-an-il12-mrna-lipid-nanoparticle-plu-9feec652d62b5a63 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spatiotemporal-mapping-of-tertiary-lymphoid-structure-heterogeneity-shapes-immun-b878c7a6750a845e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differentiation-between-bipolar-versus-unipolar-depression-by-ai-based-multimoda-10811a17d96af235 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lignan-rich-norway-spruce-i-picea-abies-i-resin-extract-exhibits-anti-inflammato-bbbefd8591a7808a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alcohol-and-other-drug-policies-for-health-care-workplaces-evaluation-of-the-con-e99cec33373f8f7b 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-public-health-advertising-and-the-health-belief-model-to-predict-dia-a0939aee5e67c757 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interesting-hurdles-in-the-solution-of-pharmaceutical-crystal-structures-using-p-3e514e35adab43a8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anterior-palpability-and-proptosis-as-clinical-predictors-of-ptosis-in-lacrimal-450fcdb8e69e20a6 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-factors-are-associated-with-shoulder-joint-pain-in-male-swimmers-including-2d4ac870140b4056 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/value-based-healthcare-scaling-value-based-care-through-surgeon-leadership-452cfb461f6acbc0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-ctcae-in-oncology-drug-evaluation-cross-agency-review-of-regulatory-and-heal-e2676d3716a504eb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-the-pre-hospital-chain-of-survival-for-out-of-hospital-cardiac-arr-95603fb884f8a5ca 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimized-dosing-of-momelotinib-in-myelofibrosis-through-quantitative-medicine-a-82759c408af8a2d1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implementing-structured-and-collaborative-clinical-planning-for-comprehensive-hi-2ee6f77428200007 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-daffodils-to-drug-leads-amaryllidaceae-alkaloids-target-protein-translation-d152f81dc448462f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maladaptive-movement-in-eating-disorders-clinical-correlates-and-cross-cultural-88f05d3f85a94292 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gut-microecology-and-cardiovascular-disease-core-pathogenic-mechanisms-and-clini-3c2babc6119fff71 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burnout-factors-for-pediatric-psychologists-across-career-stages-70a346964a211cd9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oligoclonal-band-count-as-a-marker-of-mri-lesion-burden-and-clinical-profile-in-750eee9cb00a292e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-mri-features-associated-with-remission-following-biological-therapy-0d857f7086779929 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/repeated-perioperative-hypersensitivity-reactions-and-positive-challenge-testing-a6d40ff19fd054a0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-of-nonsteroidal-anti-inflammatory-drug-use-in-traumatic-brain-injury-579799c9f9af014a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-of-loading-dose-vigabatrin-administered-via-enteral-tube-in-par-90af192c98b082d8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/responsible-implementation-of-ehr-based-clinical-prediction-models-beyond-perfor-eecda7cc2a55f5b8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816575-comparative-efficacy-of-alpha-hydroxy-acids-with-and-without-nanocar-d7ef75d6761b1a5d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816510-combination-of-oral-antifungal-treatment-for-refractory-dermatophyto-702068d4be42e1c4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07816328-investigation-of-a-remibrutinib-and-omalizumab-based-treatment-algor-03dcb9b7e3a5e14f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07815626-phase-3-study-to-evaluate-the-efficacy-and-safety-of-human-growth-ho-6269ee1ed4d7a47c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07815301-gradual-tapering-or-discontinuation-of-beta-blockers-after-stabiliza-7fc2e5dc6cbb93d7 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07814365-pbi-for-low-risk-breast-cancer-a312bf3a7dc39711 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07813949-evaluation-of-clinical-performance-shade-matching-and-patient-satisf-7c074338dfdf4687 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07714538-breath-research-narrow-validation-for-gastrointestinal-cancer-detect-8b45a742a232789e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07597746-effects-of-a-combined-repetitive-transcranial-magnetic-stimulation-a-8effc8546335d7ad 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07597161-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-38094db28f64d38d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07593079-prostate-specific-membrane-antigen-psma-imaging-for-detection-of-res-b3e776fd82076549 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07575685-enhancing-cancer-care-restoreme-app-for-personalized-nutrition-and-a-35ec302ac93c9811 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07566156-enfortumab-vedotin-in-combination-with-pembrolizumab-vs-concurrent-c-5e6eb7a3af17cfa1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07557420-efficacy-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-d9d2b2f8a4ba8e14 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07489378-nci-childhood-cancer-data-initiative-ccdi-led-pediatric-adolescent-a-c53e59732f23426f 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07416786-validation-of-nad-measurements-for-human-clinical-studies-38d39bd6fb10bbc7 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07391774-testing-whether-hormone-therapy-with-ribociclib-is-as-effective-as-c-950c4ddcb9c97097 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07388537-evaluation-of-the-clinical-spectrum-of-diabetes-and-obesity-in-youth-3033397525ec41f9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07370974-effect-of-clinical-hypnosis-in-preoperative-anxiety-among-patients-u-4cedb6dad168e6e8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07278739-testing-an-educational-program-to-improve-goals-of-care-conversation-4133918c2dd23ca2 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07226349-a-study-of-bg-75098-alone-and-in-combination-with-other-agents-in-ad-60a0ce7404bbdbf3 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07103109-impact-of-proximal-motor-control-exercise-on-scapular-muscles-activa-602738f19bfdff82 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07091149-digital-cognitive-behavioral-treatment-of-insomnia-in-youth-an-rct-e-3868d1851c216b7b 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06921850-a-study-to-assess-the-pharmacokinetics-and-safety-of-bimekizumab-in-05eaad6aa11825f1 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06920511-cognitive-rehabilitation-with-virtual-reality-in-parkinson-disease-93602a996fb80ba0 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06899633-multicenter-observational-descriptive-study-of-the-diagnosis-course-0e77eb58f35b55e8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06681662-ephedrine-for-reducing-onset-time-of-rocurinium-in-elderly-patients-b768979f5853708d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06562803-efficacy-and-safety-of-cytokine-adsorption-and-plasma-exchange-in-pa-06361ddfe1bd13c4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06429761-phase-4-study-to-assess-the-safety-of-trastuzumab-deruxtecan-in-indi-8c232c7e7eca860c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06292845-ex-vivo-tumor-visualization-and-resection-margin-assessment-using-to-458aae9925424cc4 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06200246-cardio-vascular-energy-transfer-and-ventriculo-arterial-coupling-in-ef954c69ea799072 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06200155-psilocybin-assisted-psychotherapy-in-patients-with-advanced-cancer-o-0d46d0afc351195a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05985954-open-label-phase-1b-study-of-ulixertinib-and-cetuximab-or-ulixertini-f33b527d6a3e103a 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05924464-group-preconception-care-for-fertility-patients-592f3e630e81ffb8 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05920356-a-study-evaluating-sotorasib-platinum-doublet-combination-versus-pem-b413c482bc01e9dc 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05885555-a-study-of-ianalumab-vay736-in-patients-with-primary-immune-thromboc-0ecf7df0b9c75450 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05630794-testing-for-safety-and-colorectal-cancer-preventive-effects-of-onc20-79ca405eef852ea9 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05206357-study-of-the-adverse-events-and-change-in-disease-state-of-pediatric-2875f81dc33b08ab 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05201248-a-study-to-evaluate-adverse-events-and-change-in-disease-activity-of-7f89db7d619c8711 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05081609-a-study-to-investigate-safety-and-tolerability-of-transcon-il-2-alon-57848da0e56e142c 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05019885-the-efficacy-of-a-subanesthetic-doses-of-iv-ketamine-in-the-treatmen-87333c25d030c5eb 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04787848-chronic-widespread-pain-in-hiv-novel-mechanisms-and-therapeutics-d7b23319aa2468ca 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04166409-a-study-of-the-drugs-selumetinib-vs-carboplatin-and-vincristine-in-p-f4da250f1508000e 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04032470-boston-scientific-registry-of-deep-brain-stimulation-for-treatment-o-3c738a9bbf06c5fe 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03100149-a-study-to-evaluate-the-efficacy-of-prasinezumab-ro7046015-prx002-in-1ec734dd69af80b5 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02880618-barostim-therapytm-in-heart-failure-with-reduced-ejection-fraction-a442fc9d8a1ae147 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02824471-sickle-cell-disease-biofluid-chip-technology-scd-biochip-a841f72986de811d 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01679132-barostim-neo-hypertension-pivotal-trial-fddc5137d692f938 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00047996-blood-collection-for-research-related-to-certain-diseases-involving-ec5b5f5ff1528310 2026-09-11T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/copd-clinical-trial-pipeline-gains-momentum-65-companies-lead-the-charge-in-pion-51928ee57120909b 2026-09-10T23:46:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-clinical-trial-pipeline-gains-momentum-80-companies-lead-the-charge-in-p-00145e11b672a229 2026-09-10T23:46:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-s-2026-ipos-deliver-broad-gains-through-august-5be01e38f285a85a 2026-09-10T23:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ctt-pharmaceutical-holdings-ceo-ryan-khouri-buys-175-in-stock-ba8ba3e61a362f04 2026-09-10T23:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trials-new-mrna-cancer-vaccine-plus-keytruda-sharply-improves-melanoma-77a6de9d73d0071d 2026-09-10T22:14:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-genuity-maintains-buy-on-helus-pharma-cuts-target-to-42-d3a308a8f221ddf5 2026-09-10T22:08:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/jaha-dos-biomarcadores-novedosos-en-sangre-predicen-la-presencia-de-ateroscleros-aeacc0ecc5841ed9 2026-09-10T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presidential-leadership-series-features-trustee-and-former-takeda-ceo-christophe-38714faec7ed3737 2026-09-10T21:57:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpc-biotech-multiply-labs-develop-robot-ready-cell-therapy-connector-21a5a057220ff310 2026-09-10T21:54:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-sr-vp-chief-hr-officer-sold-shares-worth-over-2-7m-e4a012d0bc83cc78 2026-09-10T21:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-nyse-wst-hr-chief-sells-stock-outside-a-10b5-1-plan-f09f4eb3b8e82826 2026-09-10T21:37:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-regulators-prepare-the-pharma-industry-for-future-changes-as-legislatio-fea13585a4f31be1 2026-09-10T21:32:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-phase-2-clinical-trial-initiating-in-2027-evaluating-psilocybin-assisted-the-b453b9741c0dd011 2026-09-10T21:10:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/david-samra-calls-for-novartis-board-shake-up-pharmexec-d325baf3d1a4dd3e 2026-09-10T21:06:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-inc-stock-outperforms-competitors-on-strong-trading-8d201788bc6ff87c 2026-09-10T21:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-at-cantor-healthcare-conference-pipeline-gains-pace-da48474dd512d462 2026-09-10T20:42:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fertility-tests-are-not-a-reproductive-crystal-ball-635f8bb498bae2dd 2026-09-10T20:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/overview-of-president-trump-s-executive-actions-impacting-lgbtq-health-ee863ce31c942462 2026-09-10T20:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-receives-fda-510-k-clearance-for-n-22-humeral-head-and-init-b62e8e38c63bfbf3 2026-09-10T20:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-nyse-wst-awards-ceo-37k-options-and-14-8k-rsus-vesting-throu-02890534117bc52a 2026-09-10T19:40:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-trading-with-fortress-biotech-inc-9-375-series-a-cumulative-redeemable-7b2183f89cc3ac84 2026-09-10T19:10:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantum-biopharma-advances-multiple-sclerosis-drug-lucid-ms-toward-phase-2-trial-f972f351fbcb86aa 2026-09-10T19:02:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/committee-will-weigh-biotech-innovation-against-security-risks-6d75b2b5f7c94bf9 2026-09-10T18:42:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-shares-plunge-as-fda-halts-new-enrollment-in-epilepsy-drug-trials-ba8d221d153c02a0 2026-09-10T18:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/saberes-que-transforman-el-legado-vivo-del-programa-de-artesania-uc-86522bffa808e89c 2026-09-10T18:40:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-longitudinal-endpoint-data-to-anticipate-study-complexity-f8f987198adbaa2a 2026-09-10T18:40:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/encoded-secures-275m-for-dravet-syndrome-gene-therapy-ac2b33bda3009e77 2026-09-10T18:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-seeks-public-input-on-advancing-botanical-drug-development-ed74359bca572fc5 2026-09-10T18:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-declares-quarterly-dividend-260df77eb2bfb636 2026-09-10T18:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-best-psychedelic-stocks-for-2026-and-how-to-invest-723c0a3c104e3b21 2026-09-10T18:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemical-structure-formula-and-name-support-written-description-of-pharmaceutica-1d77f969ae2d3e5c 2026-09-10T18:11:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/governo-quer-elevar-para-70-producao-nacional-de-medicamentos-ate-2033-diz-alckm-45ff5007486fe816 2026-09-10T18:06:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantum-biopharma-s-lucid-ms-advances-toward-phase-2-multiple-sclerosis-trial-af-2e6eaca0773422e8 2026-09-10T17:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-pauses-new-enrollment-in-biohaven-s-epilepsy-drug-trials-088c0078107ecbf8 2026-09-10T17:37:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-extends-migraine-leadership-with-positive-phase-3-atogepant-results-in-me-5770650b6a275938 2026-09-10T17:04:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/hplc-degasser-upgraded-biotech-fluidics-launches-the-degasi-ng-platform-28b7579689b125bf 2026-09-10T17:03:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-products-with-device-only-patents-a-cross-sectional-analysis-5b12204246d6eec3 2026-09-10T16:47:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-actualiza-los-criterios-regulatorios-para-software-como-dispositivo-medico-ce78e29882f4f325 2026-09-10T16:46:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-drug-shows-significant-reductions-in-menstrual-migraine-days-0a66926b0c3b14b1 2026-09-10T16:41:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-news-from-around-the-world-96b51f3fd7c4a507 2026-09-10T16:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nord-ceo-welcomes-fda-leadership-appointments-emphasizes-stability-and-innovatio-b4e668cc31a78b95 2026-09-10T16:38:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clears-clinical-trial-using-car-t-cells-to-fight-colorectal-cancer-2531b537a44fed1e 2026-09-10T16:37:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/seattle-biotech-brainchild-bio-raises-116m-to-advance-car-t-therapy-for-childhoo-6c114812ad208cfb 2026-09-10T16:34:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/centanafadine-receives-fda-approval-for-the-treatment-of-adhd-dd04c8e056bb32a3 2026-09-10T16:34:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-injury-costs-recovery-scheme-april-2025-to-march-2026-02e29b54f45a8fc7 2026-09-10T16:26:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-biotech-stocks-to-add-to-your-watchlist-september-10th-d8ab2eff220ca406 2026-09-10T16:04:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-marca-presenca-pelo-quinto-ano-no-sertoes-em-parceria-com-o-piloto-fabio-pir-1307c08898e771d3 2026-09-10T16:02:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/xocova-offers-new-post-exposure-covid-19-prevention-option-for-adolescents-180741a4ba145920 2026-09-10T15:57:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-inicia-sua-quarta-participacao-no-sertoes-com-ems-rally-team-e-foco-no-titul-b653b4f53dcc12be 2026-09-10T15:50:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/hsil-extends-biotech-index-to-malaysia-s-warrant-market-7d7be353577cf20e 2026-09-10T15:26:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/kala-shankle-on-what-comes-next-for-national-licensure-74efa622bca91473 2026-09-10T15:23:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/minister-agrees-to-review-pharmacy-amendments-to-health-bill-46a2c884d11eb4a4 2026-09-10T15:19:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-changes-the-how-not-the-what-ccddb8218dba7492 2026-09-10T15:15:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerating-decision-ready-hepatic-pk-data-adaptive-strategy-and-integrated-exe-791d6fbfc92cfa4f 2026-09-10T15:03:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/create-design-controls-automatically-from-jira-greenlight-guru-cf077f3b67f86fa0 2026-09-10T14:56:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/roivant-at-citi-summit-cash-rich-biotech-leans-on-three-pillars-60ac4a42be1a796f 2026-09-10T14:55:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-trial-of-experimental-dm1-treatment-fails-to-hit-main-goal-47fea7492ee4aa03 2026-09-10T14:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-pauses-new-enrollment-in-biohaven-s-epilepsy-drug-trials-2130c9870ed50f98 2026-09-10T14:45:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-limited-reports-earnings-results-for-the-second-quarter-end-fe9932e3452b9015 2026-09-10T14:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-pauses-new-enrollment-in-biohaven-s-epilepsy-drug-trials-dfd4d9a9539fb316 2026-09-10T14:36:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifth-circuit-judges-press-louisiana-on-standing-as-mifepristone-stays-available-7803e41623ffd424 2026-09-10T14:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-past-endpoints-11-winners-fared-as-the-biotech-industry-rebounded-b43f9ce8182c04f8 2026-09-10T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-security-market-competitive-landscape-analyzed-across-leading-glo-ae872b3a3ec772bd 2026-09-10T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/greater-philadelphia-regional-life-sciences-roundup-september-10-2026-a692fddd69a19c9d 2026-09-10T14:28:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/ugme-class-of-2030-orientation-the-day-in-photos-f10ec5cbc1c174d0 2026-09-10T14:25:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/fmhs-events-and-calls-for-submission-e6e74878c3630093 2026-09-10T14:23:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/glenmark-and-south-piedmont-open-2-7-million-pharmaceutical-training-facility-0b4260fbc2643d82 2026-09-10T14:18:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cracks-down-on-unsafe-food-banned-products-17cbcad470576ff1 2026-09-10T14:14:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/stalled-generous-globe-and-guard-initiatives-create-international-pricing-uncert-01e4dff956d74dff 2026-09-10T14:13:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/recurrent-synapses-between-co-2-sensitive-olfactory-sensory-neurons-enable-robus-9d8af55f9fc6d529 2026-09-10T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-health-equity-champions-can-learn-from-pharmaceutical-sales-9d780c13222a1501 2026-09-10T13:59:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-partial-hold-on-biohaven-s-ion-channel-drug-f305595bf9c3c703 2026-09-10T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-confirms-permanent-loss-of-canada-s-last-arctic-epishelf-lake-6836b26efd2d3e43 2026-09-10T13:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-at-the-edge-of-the-ice-1144c76bcfb276ca 2026-09-10T13:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-raids-11-food-units-in-thane-seizes-materials-worth-rs-20-48-lak-972c412bea901a86 2026-09-10T13:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-nets-1-1b-in-long-running-fund-aimed-at-small-midsize-biot-6cbd4c5bcf9742eb 2026-09-10T13:44:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-pharmaceuticals-seeks-ipo-on-strong-collaboration-deal-with-abbvie-pending-5dba419255f531e9 2026-09-10T13:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-enters-cooperative-research-and-development-agreement-with-national-cance-9c28ffcdb1c0cf0f 2026-09-10T13:40:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-expands-bayer-lung-cancer-drug-approval-71178ea7131e5c0a 2026-09-10T13:39:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/scenic-biotech-appoints-renowned-neurology-drug-development-leader-dr-judith-wal-b0c70810964568e8 2026-09-10T13:33:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-biologics-signs-usd-262-million-manufacturing-agreement-with-european-ph-d2defa9f379bb988 2026-09-10T13:32:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-enters-cooperative-research-and-development-4ff7c827c11dfc18 2026-09-10T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-at-wells-fargo-conference-growth-outlook-lifts-7e95f35a8d9d2806 2026-09-10T13:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scynexis-appoints-sanjay-subramanian-cfo-as-biotech-advances-rare-disease-pipeli-7ffff17544555b0f 2026-09-10T13:28:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/family-medicine-graduate-student-orientation-aa32c6010dd166f9 2026-09-10T13:28:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-expansion-of-community-mental-health-support-across-england-a2cb994842375abb 2026-09-10T13:27:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-cancer-vaccines-biggest-barriers-to-market-5a32cb9618b921d8 2026-09-10T13:26:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-s-long-serving-r-d-chief-andy-plump-to-retire-in-wake-of-pipeline-success-59af07bbf36e86fb 2026-09-10T13:25:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-releases-q2-2026-financial-results-8819331f3d074a9a 2026-09-10T13:22:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/update-starton-therapeutics-to-present-at-medinvest-biotech-pharma-conference-d467c5ff3d6873eb 2026-09-10T13:19:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-tnon-aeon-surge-coo-cdt-slide-a99c6eadfee151c8 2026-09-10T13:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-seeks-fda-meeting-to-plan-phase-3-trial-for-parkinson-s-drug-candidate-4c45ecc8dc428588 2026-09-10T13:16:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cannara-biotech-secures-58m-credit-facility-with-bmo-and-td-5c15a8e996887473 2026-09-10T13:07:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/latest-figures-highlight-ongoing-meningitis-b-risk-for-students-d7de382570d1ec44 2026-09-10T13:06:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-q2-revenue-falls-9-3-to-rmb134-7m-cafe7127e11ce51e 2026-09-10T13:04:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-health-insurers-to-blame-for-our-health-system-problems-b146c3f089b79f8a 2026-09-10T13:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-driving-rising-health-premiums-6c0b90c6add56b59 2026-09-10T13:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-do-we-get-for-the-cut-health-insurers-take-64604c79ab60ab45 2026-09-10T13:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/who-do-we-trust-to-decide-what-health-care-gets-covered-and-at-what-price-a12a76d78a3fd871 2026-09-10T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-treatment-is-approved-for-menstrual-migraine-abbvie-s-drug-cut-migraine-days-6a69b46a841b8f13 2026-09-10T12:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-dhl-s-new-singapore-hub-and-pharma-rethinks-go-to-market-6f1e39d1bd379b78 2026-09-10T12:53:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/forum-estadao-discute-os-principais-desafios-e-avancos-da-oncologia-no-pais-inte-be4eab5a1b852f43 2026-09-10T12:40:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/geovax-provides-nasdaq-listing-update-and-reaffirms-focus-on-advancing-strategic-e2e455613a5a2210 2026-09-10T12:37:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-cell-surface-protein-research-with-site-specific-labelling-4b2c27c5d4f0630d 2026-09-10T12:34:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/19-75-million-boost-for-collaborations-between-universities-64fc54073949c854 2026-09-10T12:23:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncolytics-biotech-reports-preclinical-pelareorep-activity-maintained-with-ras-i-acb108f11ddc1118 2026-09-10T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-i-ve-learned-christoph-muller-67cfb4f4418975cd 2026-09-10T12:18:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/daesang-expands-into-pharmaceutical-grade-amino-acids-7525345f8975eea5 2026-09-10T12:15:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-experimental-cancer-treatment-combination-reduced-tumor-growth-in-early-tests-915d2ac78c60b6c6 2026-09-10T12:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-investigational-cell-therapy-for-alzheimer-s-and-parkinson-s-will-be-presente-9bd92b46dfeadd3f 2026-09-10T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-look-at-cleanassure-by-freudenberg-medical-1781dee31e7a4af8 2026-09-10T12:00:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-is-more-than-a-color-how-nature-inspired-a-new-sustainable-way-to-make-whi-be7f14ea37b3f588 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dead-or-alive-plankton-support-marine-ecosystems-3ff4a37051d1d827 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imn-screws-system-advanced-locking-screw-ec5f499d9db6b051 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/generic-acetaminophen-by-teva-recalled-because-it-may-contain-foreign-material-7343823d673bcc9f 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dxc-500i-clinical-analyzer-and-dxc-500-au-clinical-chemistry-analyzer-0e5e9773dfcba50d 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centricity-high-acuity-anesthesia-2ada63128acd97cc 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-on-five-year-remission-with-a-myeloma-treatment-will-be-presented-in-scotla-a31339569a772091 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-adds-over-1-1-billion-to-frazier-life-sciences-public-fund-ff2d53372ace82ec 2026-09-10T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-biohaven-pharmaceutical-stock-sliding-today-d8352213f625eea5 2026-09-10T11:46:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-booming-business-on-wall-street-would-love-more-biotechs-to-quietly-die-23a99c530fc41a86 2026-09-10T11:46:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/eyepoint-updates-duravyu-phase-3-wet-amd-data-a001c4dce8827879 2026-09-10T11:38:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cervomed-announces-initial-results-from-the-phase-2a-clinical-trial-of-neflamapi-8e9e18b565ad084e 2026-09-10T11:34:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-hair-brand-vegamour-snapped-up-by-kvd-beauty-owner-belle-brands-9e5b5f7223daebe3 2026-09-10T11:30:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cervomed-announces-initial-results-from-the-phase-2a-clinical-trial-of-neflamapi-93171a452257b7a9 2026-09-10T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-s-q2-revenue-falls-net-loss-widens-on-central-laboratory-we-3a2bfe5a57b7c6c6 2026-09-10T11:29:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/von-arzneimitteltherapiesicherheit-bis-zur-schmerzlinderung-durch-virtuelle-real-eb7b306334d2b673 2026-09-10T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-rock-biotech-reports-second-quarter-2026-financial-results-and-business-3604b6a838f831f6 2026-09-10T11:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prelude-therapeutics-receives-fda-clearance-of-investigational-new-drug-ind-appl-173e26866817c76e 2026-09-10T11:13:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-simulation-help-foundation-trainee-pharmacists-prepare-for-prescribing-754b389753a9f647 2026-09-10T11:12:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/migraine-and-acne-included-in-new-prescribing-pharmacy-first-pathways-3ea2469614a56a9c 2026-09-10T11:12:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/uzbekistan-pharmaceutical-output-reaches-uzs-3-5-trillion-in-seven-months-e698870d82152c1b 2026-09-10T11:10:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-1-2-clinical-trial-of-opgx-best1-shows-positive-results-for-inherited-reti-693efb757e3769e0 2026-09-10T11:09:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/podcast-key-readouts-from-esc-and-ers-37928ee094726d75 2026-09-10T11:00:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-suicide-risk-research-will-join-five-posters-on-a-treatment-e30968146e5d4bba 2026-09-10T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharm-s-in-licensed-epilepsy-drug-opcalim-hits-partial-fda-clinical-hold-58e7c243c85a1a2c 2026-09-10T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-appoints-permanent-fda-cber-cder-heads-40d9e998d4d06de3 2026-09-10T10:52:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/spain-pushes-for-access-toolbox-in-eu-biotech-rules-1688a317e36915f9 2026-09-10T10:48:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/inauguration-ceremony-of-the-nafdac-pharmacist-reserve-group-3142b109dbb0e447 2026-09-10T10:45:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-appeals-court-skeptical-of-bid-to-curtail-abortion-pill-access-078244ed36863e9c 2026-09-10T10:40:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-the-danish-medicines-agency-s-atmp-open-house-c8681c32f51f75b3 2026-09-10T10:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/web-emission-vagues-de-chaleur-notre-sante-a-l-epreuve-54266f2899693882 2026-09-10T10:37:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-to-expect-from-uniqure-s-upcoming-huntington-s-gene-therapy-readout-e0aa083eeef3c734 2026-09-10T10:36:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/roivant-is-one-of-the-savviest-dealmakers-in-biotech-it-also-has-a-secret-weapon-c406bfe29c9a43b3 2026-09-10T10:36:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/squarepoint-ops-llc-sells-106-171-shares-of-ultragenyx-pharmaceutical-inc-rare-aaef604b00280d03 2026-09-10T10:16:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-prices-4-9-billion-senior-notes-offering-and-anno-b1e8ff5e4e7ab9df 2026-09-10T10:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-honors-three-ai-pioneers-in-digital-pathology-at-the-38th-european-congr-bb219b407d1583a9 2026-09-10T10:03:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinic-barcelona-publishes-its-2025-annual-report-cfa0536b2b9aa4a5 2026-09-10T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/power-optimization-solution-ends-costly-grid-related-shutdowns-at-major-pharmace-895389c9339efb13 2026-09-10T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-pharmaceutical-ingredients-market-demand-insights-ee7be79d74ee8b32 2026-09-10T09:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-assessment-27-countries-how-eu-joint-reviews-work-afdce1a4bab2fa1a 2026-09-10T09:44:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-the-er-is-not-an-option-milestone-s-cmo-on-bringing-afib-rate-control-home-e2e99f9bbe1ee809 2026-09-10T09:36:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-co-ltd-takeda-announces-planned-retirement-of-president-of-cc51e8d4bc8214ff 2026-09-10T09:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-announces-planned-retirement-of-president-of-research-deve-57aa87713cda8888 2026-09-10T09:34:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/systech-launches-traceiq-0628e750134c6813 2026-09-10T09:33:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ud-s-star-campus-is-helping-companies-foster-innovation-in-biotech-bfd0e22feb57c6cb 2026-09-10T09:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukri-modernises-grant-assessment-for-the-age-of-ai-2c2df1992e38e8cd 2026-09-10T09:30:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-growth-trust-stands-out-in-a-stronger-biotechnology-sector-0c5fc1ee6f1de77b 2026-09-10T09:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/me-therapeutics-stock-faces-downside-pressure-as-biotech-risk-and-preclinical-un-1ec2178796d0ffa0 2026-09-10T09:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biocorrx-inc-appoints-former-acting-white-house-drug-policy-director-richard-j-b-f65963320838259a 2026-09-10T09:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yourgene-insight-dpyd-assay-gets-ivdr-accreditation-0f45b3e7e51c89f2 2026-09-10T09:10:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-places-partial-clinical-hold-on-sk-biopharm-s-epilepsy-drug-candidate-opacal-826dea09fcfc58cc 2026-09-10T09:10:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/scattidiuntempo-1906-2026-ricorrono-i-120-anni-della-clinica-mangiagalli-la-stor-06b11bd7394f420e 2026-09-10T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mog-fda-35ed387f5c4715ce 2026-09-10T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-announces-u-s-fda-grants-priority-review-for-enspryng-for-myelin-oligodend-399e802924ad2be2 2026-09-10T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/samsung-biologics-signs-350-8-billion-long-term-cmo-deal-with-european-pharmaceu-f69633ea36eaf3ad 2026-09-10T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-fluidics-launch-degasi-ng-platform-03359e408ef2f244 2026-09-10T08:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/dong-a-socio-holdings-to-rename-itself-dong-a-pharmaceutical-after-otc-merger-811dc3505dca9b48 2026-09-10T08:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-fluidics-upgrades-its-degasi-inline-degasser-range-2e8eb202eff2dd75 2026-09-10T08:35:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-evidence-matters-seema-meloni-on-making-data-meaningful-ec1cdcab294170da 2026-09-10T08:33:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/mpox-clade-ib-and-clade-iib-outbreak-epidemiological-overview-99d096b3fc6f5884 2026-09-10T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-laboratory-confirmed-cases-in-england-2025-to-2026-26816bdfcbfa7f60 2026-09-10T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/newly-discovered-dna-protection-mechanism-linked-to-human-brain-development-1361f9933871ce51 2026-09-10T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/venture-investor-danish-biotech-innovation-has-caught-up-with-sweden-3b75feb145abd779 2026-09-10T08:20:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-packaging-market-c2e9bc2e819d9a7b 2026-09-10T08:16:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-caused-by-bundibugyo-virus-democratic-republic-of-the-congo-22eadb56d9fb8544 2026-09-10T08:16:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/eur-sustainability-award-for-the-integrated-implementation-of-eu-sustainability-be137edb6dcc76e2 2026-09-10T08:01:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/gov-healey-eyes-changes-to-life-sciences-programs-as-early-stage-biotechs-strugg-17782bbe9a7546e8 2026-09-10T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parkinson-fortschritt-nutzen-besser-behandeln-4f6396829f47025e 2026-09-10T07:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scenic-biotech-appoints-renowned-neurology-drug-development-leader-dr-judith-wal-e6c409ade4de9fa6 2026-09-10T07:51:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/farmak-expands-its-panjest-dietary-supplement-range-with-new-panjest-lactase-1456adc2ff5a83e5 2026-09-10T07:34:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-6-september-2026-10a6be24e936e540 2026-09-10T07:34:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-quarterly-data-up-820ecbff0a7a966c 2026-09-10T07:29:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-quarterly-data-up-335870a76488db42 2026-09-10T07:28:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-quarterly-data-up-ae1ac0815b2896b3 2026-09-10T07:27:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-quarterly-data-up-bfc75e0710215140 2026-09-10T07:26:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-names-permanent-leaders-of-fda-drug-and-vaccine-centers-setting-the-directio-a1123af1f2b72c44 2026-09-10T07:19:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/scientists-reveal-what-damages-the-dna-in-most-prostate-cancers-5899b86a7bf6bf46 2026-09-10T07:17:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/medizinischer-fortschritt-benotigt-klinische-forschung-5da317b44ecb54c4 2026-09-10T07:15:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/uzl-newsletter-nr-44-vom-august-2026-7ee55da1c045c7cd 2026-09-10T07:12:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-of-principles-of-resilience-a-book-marking-farmak-s-100-year-history-hono-74deacc7845d554a 2026-09-10T07:09:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-shingrix-recombinant-zoster-vaccine-prefilled-syringe-presentation-approve-0b079b33cbbfd08d 2026-09-10T07:00:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-treatment-improves-the-main-symptoms-of-narcolepsy-f26678046fcfa5ce 2026-09-10T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cpap-clinic-helps-children-overcome-barriers-to-sleep-apnea-treatment-04fbd64b4122553b 2026-09-10T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-weeks-to-hours-how-dermloop-brings-specialist-care-closer-to-patients-825ce867cacee4fb 2026-09-10T06:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/volodymyr-kostiuk-named-best-ceo-in-ukraine-s-pharmaceutical-industry-0778741b6843ea49 2026-09-10T06:50:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/bakom-kulisserna-pa-goteborgsvarvet-sa-tryggas-sveriges-storsta-loparfest-2e2e5b094c312be4 2026-09-10T06:49:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-begins-phase-iii-trial-of-ai-discovered-drug-rentosertib-for-i-dadb1e5c66814ac8 2026-09-10T06:46:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/psi-cro-to-present-agile-models-for-emerging-biotech-at-oct-new-england-833dc325de531768 2026-09-10T06:46:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/seismic-pharmaceuticals-enrolls-first-patient-in-phase-3-trial-of-istaroxime-for-2b1bb847cd17d245 2026-09-10T06:46:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/genencell-scandal-revives-korea-s-kosdaq-bio-rout-as-trust-erodes-and-risk-mount-fb54093710b5acb6 2026-09-10T06:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/faire-repousser-les-membres-bientot-possible-364f6959737a0def 2026-09-10T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/researchers-identify-genetic-clues-that-could-reveal-aggressive-prostate-cancer-a4be9a0d744f528a 2026-09-10T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-and-partners-call-for-stronger-research-regulation-to-advance-african-trad-293020589a173ae5 2026-09-10T05:53:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-salmon-by-products-targeted-in-12-8m-biotech-deal-c8108b005d948e22 2026-09-10T05:04:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-grants-priority-review-for-roche-s-enspryng-for-mogad-an-autoimmune-dise-74fecb34511c53e2 2026-09-10T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stavros-nicolaou-represents-aspen-at-the-9th-annual-sadc-industrialisation-week-07118bf02b625030 2026-09-10T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/finnish-aq-biotech-raises-2-5m-to-scale-cancer-screening-in-china-4d00cc33ac6dddf2 2026-09-10T04:29:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/david-hochman-on-the-state-of-medtech-podcast-b55eef03d66537c5 2026-09-10T04:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidural-kit-correction-medical-action-industries-issues-correction-for-epidural-851483f20d7ce5fa 2026-09-10T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harbour-biomed-advances-long-acting-antibody-candidate-to-phase-3-trial-bb7175ea04a5f45e 2026-09-10T03:42:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/celltrion-wins-approval-to-amend-phase-3-trial-plan-for-darzalex-biosimilar-ct-p-79d50f23bd08e7ef 2026-09-10T03:35:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-partner-reports-positive-asthma-phase-2-trial-results-1881334f1adeeee7 2026-09-10T03:34:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-conduction-system-versus-right-ventricular-pacing-after-tav-b74bf55ddc57dea7 2026-09-10T03:10:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-remede-system-7f6e3ec0b271b2e3 2026-09-10T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kenanga-investment-bank-introduces-world-s-first-hang-seng-biotech-index-structu-2d2c97ee8f163699 2026-09-10T02:54:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanjing-zhongchun-biotech-rooted-in-the-ancient-capital-a-reliable-partner-in-fi-f233ef0f32fa8f8a 2026-09-10T02:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/aces-alumna-employs-biotech-to-create-sustainable-livestock-production-d26bebab03c30cc8 2026-09-10T02:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/sevabertinib-as-a-first-line-targeted-therapy-for-patients-with-her2-mutated-non-b843fcc5b5d08209 2026-09-10T02:21:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/flinders-launches-ai-accelerator-in-partnership-with-google-cloud-12d1cba948077256 2026-09-10T01:15:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/menicon-supports-outdoor-play-initiative-to-promote-children-s-eye-health-and-my-600b2fa73bd94143 2026-09-10T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-doses-first-patient-in-genesis-ipf-3-the-world-s-first-phase-i-e40660aaa25393ab 2026-09-10T00:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-device-quality-assurance-vs-quality-control-explained-d56980f0218d46a1 2026-09-10T00:15:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/padilla-visits-uc-irvine-to-spotlight-research-and-innovation-e7c97eb15c7fe09d 2026-09-10T00:02:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-urges-students-to-complete-a-five-minute-health-checklist-before-freshers-11f9f26205601a44 2026-09-10T00:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-9f35af525cd09cc9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-flu-vaccine-wins-fda-approval-794f11bdc3078e06 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomimetic-cells-for-studying-t-cell-mechanotransduction-caa1f2bf27e50feb 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synthetic-biology-9f5a18a79b8c0e10 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/green-innovation-gmbh-withdrawal-of-food-additive-petition-animal-use-d90074417ad7c799 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fee-rate-for-using-a-priority-review-voucher-in-fiscal-year-2027-091f27d76fcd85b3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-2abdf53dea0a6290 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-center-for-advancing-translational-sciences-notice-of-public-online-rou-60eabdf6f3844b70 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-cardiovascular-devices-classification-of-the-mechanical-deviatio-e4a18073cc69ba43 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-cardiovascular-devices-classification-of-the-temperature-regulat-1550b33975ad5831 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-cardiovascular-devices-classification-of-the-extravascular-suppo-cc4f76058ba83528 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classificatio-95c9753661159e4c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-ear-nose-and-throat-devices-classification-of-the-cooperative-po-053f86715c0fa357 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-gastroenterology-urology-devices-classification-of-the-implanted-19651965512a4fdc 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-radiology-devices-classification-of-the-vaginal-hydrogel-packing-cf0bb5f7ee0efe46 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-devices-general-hospital-and-personal-use-devices-classification-of-the-e53ed8cdd83debac 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-supplemental-funding-medicare-rural-hospital-flexibility-program-bc670a4d8a9047aa 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcing-the-intent-to-award-a-single-source-supplement-to-the-senior-medicare-1c16ee7d1b83e6c7 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cyclosporine-modfied-a6d253855d22b67f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-leader-classic-clean-dandruff-d806c99c20b2ae3b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-medique-diotame-instydose-25ae29bd5a256211 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jengufun-lidocaine-knee-patch-d987cf5acb650821 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ojiog-wart-remover-cream-9702c66fcfb37f5e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-dcsily-liquid-wart-corn-remover-208bcba970ddc18f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-homwis-anti-itch-cream-bfbf31ecfa3fbdd9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bcbcyc-numbing-cream-bbcb989736c17729 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-chlorhexidine-gluconate-oral-rinse-ea5dde66b2d96157 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-neutrogena-ultra-sheer-body-mist-sunscreen-broad-spectrum-spf-74cc8ba03b9f332f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-levothyroxine-sodium-59a8e4e39999537c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jaythari-oral-suspension-989fee11d5360723 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hydra-finish-spf-15-e01de48d98714fc3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pepto-gas-plus-bloating-63f97f5c174849cc 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-relevea-pain-relief-patch-038d2243fb164fff 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pur-confort-spf-15-094b85966a9188ab 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-c88aec3fbae0a600 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pepto-nausea-motion-sickness-f48e435b8095e554 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lidocaine-hydrochloride-79f8b7dbbdfa5ddb 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-esmolol-hydrochloride-f15ba9c5c88c80f4 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-glatiramer-acetate-7c2e61a5df21fedc 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cough-and-cold-hbp-a2871ed87d6aadf3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gabapentin-63969ed75d438963 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-xarelto-4f7303fabac14592 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metoprolol-tartrate-d2eab39e5993bfc8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-dual-species-plant-derived-extracellular-vesicle-and-growth-factors-formulatio-ee7dfa1151cbf405 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/industry-updates-from-the-field-of-stem-cell-research-and-regenerative-medicine-3a503cfbd5875d78 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/egfr-and-potassium-guided-stewardship-of-sglt2-inhibitors-and-finerenone-in-albu-9b39aa9f59ad7ad8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jingtong-granules-for-cervicogenic-headache-clinical-efficacy-mechanisms-and-tra-b52d003a2dada477 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alzheimer-s-prevention-drug-trial-is-a-statin-for-the-brain-on-the-horizon-ee133516c3264597 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-healing-of-a-chronic-distal-toe-ulcer-with-tendon-exposure-using-the-0bb23bb3ab12d71c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-of-plasma-metagenomic-next-generation-sequencing-to-guide-antibiotic-t-dd8149e44eb5700d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-colonoscopy-and-fecal-immunochemical-testing-versus-usual-care-a90d22f4b14aa146 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leveraging-neural-network-models-for-drug-repurposing-a-case-study-on-cardiac-hy-0d81dc8e871644e8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vanderbilt-integrated-community-tms-for-opioid-recovery-victory-study-protocol-f-535e523f37442b50 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/loberamisal-for-acute-ischemic-stroke-the-lais-randomized-clinical-trial-e300cef805bc32f6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-barriers-in-neurostimulation-for-pediatric-drug-resistant-epileps-8c28990dc1be1172 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parenting-process-of-mothers-raising-low-birth-weight-infants-without-medical-te-bb80f8cd84fd4176 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-effect-discrepancy-between-pfs-and-os-in-antibody-drug-conjugate-trial-f2f94cf97134b20f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vancomycin-rescues-sensitivity-to-isoniazid-in-clinical-isolates-of-drug-resista-39ec4e312b3f4baf 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-ii-study-assessing-the-feasibility-and-clinical-efficacy-of-adaptive-imm-81f3d3cf71002166 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advance-id-bacterial-and-fungal-infections-review-antimicrobial-resistance-resea-c72b95484edc5868 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-retrospective-analysis-of-clinical-outcomes-following-human-deviations-from-al-60989f4665caf7ce 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-efficacy-of-tegoprazan-compared-with-esomeprazole-in-patients-with-no-52cea9f1e59c7bc3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-function-of-angiotensin-converting-enzyme-inhibitors-in-chronic-kidney-disea-8f6ef8fb6d240f67 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposals-for-individually-safe-and-realistic-correction-of-antipsychotics-in-ho-05a9f8821c95edf5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-rubric-for-assessing-essential-basic-social-skills-required-at-0a0ac5300f3dfbc9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-reduced-dose-versus-standard-dose-remdesivir-in-patients-65b51af77de0a252 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characteristics-of-medication-errors-prevented-by-community-pharmacists-during-t-8fd3fea7f73d36c4 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacist-secondment-implementation-of-ward-based-pharmaceutical-services-and-c-c92b42fe2d16eb49 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/continuous-intervention-by-an-antimicrobial-stewardship-pharmacist-contributes-t-046de463fe7b026c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identification-of-risk-factors-for-lithium-associated-renal-impairment-a-multice-5f41a254316a4f7a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-treatment-continuation-and-tolerability-using-the-urine-protein-to-7d9c0f2639c5f082 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implementation-of-the-electronic-tracing-report-system-and-evaluation-of-its-use-71b92bcdcc397e3b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introduction-fcc82029050d3cfc 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidemiology-of-acute-kidney-injury-aki-and-sepsis-associated-aki-in-critically-b6d5977523dd237c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-a-telephonic-reminder-on-fasting-duration-in-children-undergoing-c-81dd7d56c74043e5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-sternomental-and-hyomental-distance-based-dynamic-airw-9b0a21c89b21e9a8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phantom-plethysmography-a-pulse-oximeter-artifact-caused-by-ambient-light-9d789979f52ddb2d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thoracic-continuous-spinal-anesthesia-for-prolonged-thoracolumbar-fixation-and-k-39160d2fd342c76e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/morphine-ketamine-combination-for-acute-trauma-analgesia-unanswered-questions-be-a688b64ea7fdcefb 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-responses-and-6-month-clinical-outcomes-in-sarcoidosis-a-longitudina-1dfb2b94343d3422 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-patient-performed-cleaning-methods-on-the-integrity-of-1841900d0724de48 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-risk-factors-and-treatment-outcomes-of-diabetic-foot-ulcers-a-p-4373b3d863bde44d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-brain-natriuretic-peptide-and-intradialytic-hypotension-in-h-a365fbb4949ebe9d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-atrial-appendage-occlusion-vs-oral-anticoagulants-current-evidence-and-deba-5f809c5eb8e4f23b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electrotherapy-in-pediatric-rehabilitation-a-structured-narrative-review-of-clin-d2236a91b304d8e6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cbct-based-anatomical-assessment-of-lingual-bone-availability-relevant-to-the-me-4d89c9009e1b662a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personality-and-coming-to-terms-with-cancer-a-cross-sectional-study-of-five-fact-0ead1686b1643e4b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-interleukin-17-across-airway-disease-phenotypes-a-single-center-obse-2fdf11ea2437bca3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-age-on-success-of-3d-printed-cranial-remolding-orthoses-for-deformatio-9aa46e3dc891e64d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exercise-induced-bronchoconstriction-in-school-aged-children-born-very-preterm-p-ae54f67e30689774 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multilevel-mechanisms-and-clinical-efficacy-of-psilocybin-in-depression-treatmen-c152eb701a32b92c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/user-centered-design-approach-to-dynamic-clinical-decision-support-in-primary-pr-311b856abb73970d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-huang-et-al-accuracy-and-agreement-of-a-45-mg-versus-a-75-mg-13c-urea-c3adf5d3af9f3d93 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-new-treatments-in-pediatric-brain-tumors-a7ae81bda7df0329 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-mitochondrial-support-to-mitohormetic-readiness-a-micronutrient-centric-ext-f324d9fbecf27cf9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-ethanol-sclerotherapy-on-pelvic-pain-and-quality-of-life-in-patients-w-272a8ec4a97d9120 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-live-birth-rates-between-calorie-restricted-diet-and-metformin-pri-e6f52d6cd1926e2d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shunt-pathophysiological-mechanisms-and-clinical-implications-of-ineffective-cir-3955f02cf56865e4 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypericin-and-hyperforin-from-st-john-s-wort-are-potent-intestinal-ugt-inhibitor-10d289e1efb49df5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/foxc1-drives-lung-cancer-metastasis-and-functions-as-a-target-for-ai-enabled-ant-1defa9cda85e5e4f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-a-negative-trial-timing-molecular-residual-disease-and-antibody-biology-i-bb05374d7dd1fb5e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acupuncture-for-chronic-tinnitus-study-protocol-for-a-clinical-trial-with-audito-8863c954452a2b82 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/control-effect-of-dual-mechanism-myopia-control-lenses-on-myopia-in-children-and-7da4cb5525ea95aa 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-warrant-in-medical-llm-evaluation-459f9d52d16df761 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presidential-inaugural-address-2026-expanding-computer-based-testing-strengtheni-15fe341fe4ecbd79 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-and-the-right-to-a-fair-trial-in-the-context-of-ensuring-b0afc141737b48ad 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/larval-density-development-and-distribution-of-costelytra-giveni-in-a-first-year-dfa5c9918d6a640a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-contribution-of-instagram-influencers-to-drug-literacy-a-digital-communicati-9b940a97b351f178 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-year-comparison-of-three-maintenance-doses-of-vitamin-d3-600-1000-and-2000-i-7d271c298d361625 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-drug-interactions-and-pharmacological-complexity-as-prognostic-determinants-36411921172495c4 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-thyrotropin-meets-growth-hormone-clinical-challenges-of-a-mixed-gh-tsh-secr-582838b0171f14b7 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/indications-of-a-dependent-invention-for-the-use-of-which-a-compulsory-license-m-090bbb27c034b7e9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-clinical-and-cephalometric-assessment-a-comparative-review-b29ec57ce2d2f40a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/photodynamic-therapy-of-onychomycosis-modern-photosensitizers-and-clinical-effic-64ce2376748684d7 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/procedural-and-clinical-outcomes-of-second-generation-robotic-assisted-versus-ma-2ff0a102943ed8cd 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-troponin-in-pediatric-cardiology-toward-standardized-interpretive-framew-c21aedff40641d2d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-comparative-evaluation-of-p-tau217-stability-in-serum-and-plasma-using-two-val-e3b099e3c956cdd5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/din-spec-91532-a-process-oriented-framework-for-quality-assurance-in-clinical-ma-af7479e9fd68713e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-factors-related-to-cardiac-conduction-disturbance-in-patients-with-wild-1960f220eca28d40 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-hospital-associated-disability-in-patients-with-acute-decompe-5990a34ce35f7358 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-intensity-statins-and-the-post-discharge-clinical-outcomes-at-1-year-after-6772e5c513209aca 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endomyocardial-biopsy-and-clinical-outcomes-in-acute-myocarditis-multicenter-coh-ad26290eeb8a3c67 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/detection-of-crystalline-ibuprofen-components-in-ibuprofen-loaded-sba-15-mesopor-7138db2e1588d3b6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-water-related-lt-i-gt-t-lt-i-gt-lt-sub-gt-2-lt-sub-gt-relaxation-b-0d37b85783605e80 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-therapeutic-impact-of-targeting-brk-in-epithelial-derived-cancer-c-de1a23859be6977e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/realgar-transforming-solution-triggers-ferroptosis-associated-death-in-nb4-leuke-a1c5b8ee91dfa235 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/critical-medicines-lists-in-japan-and-the-european-union-insights-into-supply-re-b3c63434f9bb8e7d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrophobic-compounds-in-the-lt-i-gt-paeonia-suffruticosa-lt-i-gt-root-cortex-re-fcc2875b79003b62 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/153abr-clinical-procedure-applications-d0e4148b0fd3773b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-safety-tolerability-and-antitumor-activity-of-zipalertinib-among-patient-9348373953769dba 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-efficacy-and-safety-of-anselamimab-in-immunoglobulin-light-chain-amyloid-94141529a1094132 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-liv-959d85f1292c4974 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-role-of-risk-reducing-bilateral-mastectomy-in-i-brca1-i-and-i-brca2-i-p-775da0d78d9dcbd0 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-olaparib-in-metastatic-breast-cancer-the-impact-of-prior-cyclin-depende-d2c1227aecb440ba 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intismeran-autogene-plus-pembrolizumab-versus-pembrolizumab-alone-in-high-risk-r-d4126ebab8f61724 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/he-was-always-there-f0fcbcf89c659ca0 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/olaparib-in-metastatic-breast-cancer-the-impact-of-prior-cyclin-dependent-kinase-df42a6f811bc75a6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combi-i-long-term-overall-survival-with-spartalizumab-plus-dabrafenib-and-tramet-952659f5b36f2fcf 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/role-of-risk-reducing-bilateral-mastectomy-in-i-brca1-i-and-i-brca2-i-pathogenic-82dafac178eac60b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/developing-a-histology-based-artificial-intelligence-biomarker-to-predict-adjuva-7a52e5237fb6ed1f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-artificial-intelligence-direct-systemic-therapy-decisions-in-pancreatic-c-c4a0a33b2312faed 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sustaining-high-reliability-amid-artificial-intelligence-adoption-in-oncology-593d81fb37071e65 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-drug-development-challenges-of-increasingly-available-therapies-ca545af2dd113f6f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-tumor-genomic-profile-on-adjuvant-chemotherapy-efficacy-in-resected-pa-3334b8a840da9cbe 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-validation-of-a-computational-histology-artificial-intelligence-ea25f506da3e0dd0 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-ii-clinical-study-of-adebrelimab-and-bevacizumab-combined-with-cisplatin-c-c6e26ef3d70cbaea 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/magrolimab-plus-azacitidine-versus-placebo-plus-azacitidine-in-patients-with-unt-f50f60a602c26239 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spotlighting-rising-researcher-lucas-attia-from-drug-nanoparticle-engineering-to-80d678c9fb2b6243 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-changes-in-cardiovascular-measures-following-speed-agility-and-quick-7d38e12c591165cb 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/performance-of-artificial-intelligence-chatbots-in-restorative-dentistry-a-compa-9b191fa00532fd63 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sterile-neutrophilic-pseudomembranous-conjunctivitis-associated-with-tisotumab-v-d38695f0b78e7a1b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-two-tooth-whitening-treatments-a-randomized-split-mouth-clinical-t-c0c6e1e2d0ef8771 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-observation-on-four-finger-pushing-manipulation-combined-with-acupunctu-a2814a38ddb8384a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-inter-assay-discrepancies-and-regression-derived-correc-3228176469d0ff16 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clinical-prediction-model-for-self-harm-after-adolescent-traumatic-brain-injur-e24ad5ae8d0cc3dd 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vancomycin-rescues-sensitivity-to-isoniazid-in-clinical-isolates-of-drug-resista-e8b7cbd1c4a03064 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-tests-don-t-fit-the-rules-regulatory-challenges-for-agnostic-metagenomic-ne-331f129d805b783b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/indications-techniques-and-complications-associated-with-pterygoid-implants-a-sy-83a100367b3cf247 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-yield-of-brain-mri-in-pediatric-short-stature-hypothalamic-pituitary-74fd0b47c4324c38 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-development-and-initial-validation-of-the-perinatal-intrusions-interpretatio-e0c5c555f7035197 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-influence-of-social-media-on-users-intention-to-participate-in-clinical-tria-e5c75968b8839648 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-gouging-in-the-b2b-pharmaceutical-market-a-systematic-review-of-unethical-c525db114cfe942a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypnosis-for-postoperative-pain-management-following-colectomies-a-single-center-2399ea4259a39d8e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-failure-among-people-with-hiv-prescription-of-guideline-directed-medical-t-13740b1e548b1bb9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-user-centric-patient-educational-intervention-in-clinical-practice-helping-wom-65d17fa745ccd8e6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autophagy-activation-in-granulosa-cells-as-a-mechanism-of-astaxanthin-action-evi-837d5d6cedcc31a1 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/silk-sericin-fibroin-composite-drug-delivery-systems-for-lung-cancer-mechanistic-8a8fa26cb15838c7 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-guided-imagery-supported-psychoeducation-on-self-esteem-perceived-str-081b38975cbead8e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/applying-natural-language-processing-to-address-healthcare-bias-using-care-sd-to-ef4b247727690352 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-fear-became-the-barrier-to-care-lessons-of-a-clinical-rapid-response-during-40975bffd5c0cbd9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-virtual-reality-cardiopulmonary-bypass-simulator-versus-conventional-halstedia-ac64a873d60ef83c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-lipid-ingestion-is-sensed-the-mechanisms-underlying-intestinal-hormone-secre-22afd06b3217a312 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differential-detection-of-tau-aggregation-species-using-a-small-molecule-probe-f-d66e0f055a747884 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-treatment-prediction-of-ebv-dna-status-in-nasopharyngeal-carcinoma-using-ce-a68cbee4efda910c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-artificial-intelligence-and-quantum-chemistry-for-sustainable-pharma-2d6f3ac18e807696 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-correction-colonoscopy-and-fecal-immunochemical-testing-versus-usual-care-55d47fa59cf1d06d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aptamer-functionalized-dna-frameworks-as-targeted-drug-buffers-for-concentration-80b9dd9403406b46 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-explainable-ai-framework-for-early-mental-health-screening-and-clinical-decis-d1bcabc444546af5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trust-and-the-reliability-of-ai-algorithms-for-clinical-decision-making-support-9e4b561742c5eac6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potenzial-und-herausforderungen-von-large-language-models-in-der-klinischen-ents-aab5af7bbb512e77 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-deubiquitinating-enzyme-regulatory-network-in-malignant-progression-of-breas-1ae6f24cf43a9983 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-laboratory-and-radiological-factors-associated-with-posterior-reversibl-ada55e4fd84835f5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agreement-between-artificial-intelligence-and-periodontists-in-the-detection-of-19457d539500c908 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preserving-beta-cell-function-in-children-and-adolescents-with-newly-diagnosed-s-57b94481282b6072 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07813208-ph-all-in-chinese-children-diagnosis-treatment-and-survival-eb09a4a0ca15599d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07812636-tirzepatide-and-levonorgestrel-iud-therapy-for-ein-and-early-stage-e-62fa618027a35796 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07812402-the-effect-of-factors-affecting-bone-mineral-density-measurement-res-2973f03482cf3684 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07812142-retrospective-analysis-of-the-second-year-of-safety-surveillance-of-2d8c760820377312 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07811817-the-outcomes-of-sympathetic-cardiac-denervation-on-postoperative-atr-6898ffb279287097 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07807579-impact-of-dexmedetomidine-versus-propofol-on-intracranial-pressure-i-3ebfbb09eb810a2c 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07802639-treatment-for-asymmetric-crying-facies-6a5482072b6db189 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07796880-neoadjuvant-culmerciclib-combined-with-endocrine-therapy-for-hormone-236a6ff0dd7aaab3 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07757334-trauma-focused-group-therapy-for-adults-with-trauma-related-symptoms-938497b4eae7f668 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07755800-impact-of-an-arginine-containing-toothpaste-on-the-subgingival-micro-a66ba8f161165838 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07619014-comparison-of-the-effectiveness-of-miswak-and-manual-toothbrush-in-r-61752a5ba9670351 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07510737-the-effect-of-cross-training-on-clinical-and-functional-outcomes-in-7510d95205e24ef6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07490925-transpulmonary-pressure-guided-mechanical-ventilation-strategy-in-ri-67a89935b4d97fdb 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07403487-phase-ii-trial-of-rc1416-injection-in-asthma-3a70f1e833dd11d1 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07346768-evaluation-of-anterior-neck-ultrasound-in-predicting-difficult-airwa-e45c6f540528963b 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07301333-a-study-of-single-and-multiple-doses-of-hrs-6257-in-healthy-subjects-b397d0795f6d989a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07252245-pre-hospital-triage-of-patients-at-intermediate-and-high-risk-for-ac-80a6b5fc1f6fe45d 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07195734-testing-the-addition-of-chemotherapy-or-chemo-immunotherapy-to-the-u-eaef4d5ec3a3e699 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07000253-timing-of-comprehensive-local-treatment-after-first-line-systemic-th-342d10d4c9ccc441 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06834984-ritual-synbiotic-a-dietary-supplement-designed-to-impact-gastrointes-812e09906b02af8f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06728592-emergency-stroke-unit-for-acute-cerebrovascular-events-a-prospective-ce25f2838db0d108 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06687369-a-study-to-compare-pharmacokinetics-efficacy-safety-and-immunogenici-f27ee34c79201243 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06646627-clinical-trial-of-autologous-b7-h3-car-t-cells-in-reoccurent-platinu-64da8d624df467f8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06485622-outcome-and-improvement-of-different-treatment-in-arteriosclerosis-o-9e6f55f052856edc 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06473857-design-implementation-and-evaluation-of-an-intervention-within-video-e815a59dea39ec4a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06360822-increasing-equity-in-lung-cancer-screening-b4a214aae70631f2 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06345079-cessation-of-somatostatin-analogues-after-prrt-in-mid-hind-gut-and-p-ed61837c12c16b51 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06339177-hemophagocytic-lymphohistiocytosis-hlh-evaluation-and-research-of-cl-98ebc57a25bf0463 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06277401-exercise-in-patients-with-hypermobile-joints-and-knee-pain-b27705bc9cf79ce5 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06040125-debunking-the-frailty-sarcopenia-adt-axis-in-metastatic-prostate-can-128757a54a83f5c8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06024746-a-study-to-determine-the-efficacy-and-safety-of-finerenone-and-sglt2-da7f590809573fe2 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06014827-biologically-guided-radiation-therapy-bgrt-and-stereotactic-body-rad-d9c90c38d3384a71 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05960461-families-moving-forward-fmf-connect-pro-for-mental-health-providers-c10658528e77ed2e 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05726526-ckd-specific-telemonitoring-platform-to-minimize-adverse-outcomes-in-6ed1dd4b247198a9 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05692687-a-post-market-clinical-study-to-evaluate-the-safety-and-performance-d750517fead1c294 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05413343-clinical-study-on-monitoring-the-plasma-concentration-of-ceftazidime-1798b3f69bd38b0f 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05027386-apatinib-mesylate-combined-with-it-regimen-for-the-treatment-of-recu-f8c8487f9f0e5b11 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04864054-gpc3-targeted-t-cell-therapy-ect204-in-adults-with-advanced-hcc-4ac96ef3c3032db6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04288869-change-in-brain-perfusion-during-induction-of-general-anesthesia-0597049227a260ac 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03964532-talave-induction-talazoparib-followed-by-combination-of-talazoparib-ef82b804574ba6bf 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03952637-a-phase-1-2-study-of-intravenous-gene-transfer-with-an-aav9-vector-e-a43bede94f74abe6 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03424005-a-study-evaluating-the-efficacy-and-safety-of-multiple-treatment-com-7cf230def61e35fe 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03077061-peri-implantitis-reconstructive-surgical-therapy-8ced217a0ad67979 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01471834-verification-of-the-efficacy-and-safety-of-the-barostim-neo-system-i-92140cd6f7208e5a 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01426165-effect-of-magnesium-sulfate-infusion-rate-on-magnesium-retention-in-d3fa07dc21a48b44 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01087320-genome-medical-sequencing-for-gene-discovery-3e5a241c98c3dee8 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01029873-quilt-2-008-study-of-alt-801-with-cisplatin-in-patients-with-metasta-aa0122aaeeb4afc4 2026-09-10T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-target-price-raised-to-650-000-as-roche-deal-value-reflecte-7b981f6d3cd04d61 2026-09-09T23:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-rare-after-aspire-miss-and-genglycos-win-has-valuation-3ffec4f293a82118 2026-09-09T23:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/portage-biotech-alp-financials-2026-income-statement-and-balance-sheet-alp-a532834d0e460662 2026-09-09T23:15:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/iso-standards-for-medical-devices-the-ultimate-list-2026-128d2e7d06ebd366 2026-09-09T23:08:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/thyroid-cancer-symptoms-diagnosis-and-treatment-video-podcast-881f68b96c068af1 2026-09-09T23:03:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-announces-exclusive-partnership-with-alm-ortho-to-introduce-822e606e1d0ef0ff 2026-09-09T22:54:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/rebuilding-mexico-s-pharmaceutical-supply-chain-3e5a86b66630a924 2026-09-09T22:42:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-pill-for-peanut-milk-egg-allergies-enters-phase-3-trial-9b77f26228e19997 2026-09-09T22:35:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pgme-orientation-2026-the-day-in-photos-0e2eac1a6c139f19 2026-09-09T22:23:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/orientation-welcomes-new-students-to-the-ingram-school-of-nursing-646256e922b87384 2026-09-09T22:04:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-nams-versus-animal-models-context-of-use-as-the-governing-framework-for-i-abc5d42ed449704f 2026-09-09T22:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/spot-students-ready-for-the-new-academic-year-64e378f380af650a 2026-09-09T21:57:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/louisiana-ag-takes-fda-and-pharmaceutical-companies-to-court-over-abortion-pills-1ec522bb7e31fbae 2026-09-09T21:53:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/louisiana-ag-takes-fda-and-pharmaceutical-companies-to-court-over-abortion-pills-2bbc103d0de45256 2026-09-09T21:46:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fmhs-grad-maimouna-mbengue-wins-pathy-fellowship-d4531f8e9f14ccf3 2026-09-09T21:41:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/biden-era-by-mail-abortion-pills-can-t-be-halted-despite-safety-data-gap-appeals-e16ccb2f49768bd5 2026-09-09T21:39:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-names-four-senior-fda-officials-in-leadership-reorganization-54cf11cc363bef01 2026-09-09T21:34:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/amelie-quesnel-vallee-and-guillaume-bourque-named-royal-society-of-canada-fellow-b4b1a51aff8fca99 2026-09-09T21:28:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/generation-park-is-creating-a-national-pharmaceutical-hub-in-houston-bba29ce5588183be 2026-09-09T21:10:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-alcoa-a-practical-guide-for-clinical-research-32115ec8562ef74a 2026-09-09T21:04:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/com-fatima-bernardes-ems-estreia-conceito-e-mais-saude-em-nova-campanha-instituc-a762d167963bdaa2 2026-09-09T20:50:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-intermountain-health-flight-ambulance-services-base-at-intermountain-st-geor-ffb4713fee38943c 2026-09-09T20:48:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/injecao-de-inovacao-e7025cdb9550d361 2026-09-09T20:35:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/primeira-caneta-nacional-ozivy-vende-200-mil-unidades-e-semaglutida-supera-tirze-228d595f9d87a9da 2026-09-09T20:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fatima-bernardes-mostra-os-bastidores-da-ems-fb8bf94f27edfdfa 2026-09-09T20:26:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-device-reporting-mdr-how-to-take-advantage-of-your-electronic-records-8a960caaa460f85c 2026-09-09T20:13:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-annalina-che-the-scientist-behind-biotech-start-up-darkfin-labs-c8d101f77eaedcec 2026-09-09T20:08:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/placebos-in-cancer-clinical-trials-what-patients-need-to-know-242a8672b78243ea 2026-09-09T20:06:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/seismic-pharmaceuticals-commences-global-phase-3-trial-of-istaroxime-in-patients-08ecec56915041b8 2026-09-09T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shareholders-back-every-proposal-at-purple-biotech-ppbt-2026-meeting-8cc35989e741aa3e 2026-09-09T20:02:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecrf-electronic-case-report-form-in-clinical-trials-f5ace629de542ee5 2026-09-09T19:40:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-milk-banking-cold-chain-protecting-donor-milk-from-collection-to-nicu-deli-bbcc66dbc4527e45 2026-09-09T19:39:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/technology-transfer-success-drivers-and-obstacles-explained-f93565e6205cc9ff 2026-09-09T19:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/interfarma-participa-de-debates-sobre-futuro-da-saude-e-doencas-raras-em-brasili-f7562ff76d58385e 2026-09-09T19:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-appeals-court-skeptical-of-bid-to-curtail-abortion-pill-access-b55e1d7b8d59e539 2026-09-09T18:57:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-s-twice-yearly-asthma-candidate-skb378-advances-into-phase-iii-6e6421b7f6e08843 2026-09-09T18:54:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/award-winning-pi-school-gives-postdocs-practical-skills-needed-to-lead-research-34d2bd1d63d2291b 2026-09-09T18:37:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kelun-biotech-s-twice-yearly-asthma-candidate-skb378-advances-into-phase-iii-c198555d2578e70f 2026-09-09T18:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-appeals-court-skeptical-of-bid-to-curtail-abortion-pill-access-6e050300f86774f7 2026-09-09T18:31:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/wall-street-slashes-dyne-therapeutics-targets-after-novartis-dm1-trial-failure-f71e254e2955835d 2026-09-09T18:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-actually-belongs-in-the-live-siv-c03e3cfa7da0fa25 2026-09-09T18:20:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/nueva-convocatoria-para-realizar-practicas-preprofesionales-0a0fa80b13f1b170 2026-09-09T18:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-and-tunisian-officials-break-ground-on-renovation-of-ministry-of-health-phar-ba2e86b24a145546 2026-09-09T18:19:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-unveils-iphone-duo-93ec92300ed4b311 2026-09-09T18:15:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cientificos-uc-desarrollan-cinco-nuevas-variedades-de-quinoa-chilena-3355c0493392ed49 2026-09-09T18:02:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/leukemia-drug-data-suggested-a-different-way-to-treat-diabetes-a-new-biotech-wil-951cf12440ea5591 2026-09-09T17:57:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-advances-health-and-fitness-capabilities-using-apple-intelligence-7fc0a5659beeaad4 2026-09-09T17:52:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-unveils-apple-watch-ultra-4-42862b892184ebda 2026-09-09T17:51:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-apple-watch-series-12-with-the-all-new-health-sensing-system-395acb6ef5554ce1 2026-09-09T17:50:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-introduces-airpods-5-with-best-in-class-open-ear-active-noise-cancellation-cfbd238140f6e2de 2026-09-09T17:34:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-steps-big-results-montana-woman-finds-success-through-intermountain-health-ad354f3233b57fb0 2026-09-09T17:33:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-debuts-iphone-18-pro-and-iphone-18-pro-max-2ed4348f4bfe1aa0 2026-09-09T17:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cualtos-opens-registration-for-the-bachelor-s-degree-in-pharmaceutical-chemistry-cd37687b38cd07c5 2026-09-09T17:22:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezera-announces-ruvonoflast-met-its-primary-inflammation-endpoint-and-demonstra-1597c0187ffb9339 2026-09-09T16:51:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/appeals-court-skeptical-that-louisiana-can-sue-fda-over-mifepristone-being-maile-a16892c426e35ef1 2026-09-09T16:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-sheila-wang-among-canada-s-most-powerful-women-top-100-award-winners-96890f1b11450a80 2026-09-09T16:47:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/dia-japan-2026-annual-meeting-luncheon-seminar-ff8bb433c101a171 2026-09-09T16:45:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-today-satya-niketan-collapse-a-wake-up-call-to-act-but-why-wait-for-tragedi-9e4d71030a910565 2026-09-09T16:37:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-s-r-d-commercial-approach-shifts-amid-global-policy-evolution-65d9e6dd72fa76dc 2026-09-09T16:35:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-fluidics-releases-upgraded-degasi-inline-degasser-range-147cc76d79d3987c 2026-09-09T16:32:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-uses-space-to-help-cells-regenerate-bodily-structures-12b843a0aabf818f 2026-09-09T16:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-uses-space-to-help-cells-regenerate-bodily-structures-75ef1e4053d689b2 2026-09-09T16:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alpha-genesis-backs-biotech-startups-with-50m-agi-ventures-fund-99f88ef051673c6f 2026-09-09T16:19:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kura-spins-diabetes-work-into-a-lilly-backed-biotech-startup-ee94fc840173114d 2026-09-09T16:14:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-consider-september-9th-b898d2190cfcaabb 2026-09-09T16:07:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ima-group-to-showcase-all-in-one-solutions-at-cphi-milan-8f37948273925931 2026-09-09T16:06:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/faq-inside-the-latest-mfn-deals-signed-by-nine-drugmakers-03b08aa8809af0e0 2026-09-09T16:03:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-state-s-abortion-ruling-could-affect-all-50-0b0a9758c1ef7862 2026-09-09T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-biotech-stories-heating-up-right-now-f51da81af50695d6 2026-09-09T15:55:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-fills-four-senior-roles-including-top-officials-for-drugs-vaccines-and-tobac-12068fd76e56966c 2026-09-09T15:55:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-and-metabolic-peptide-therapeutics-bioanalytical-strategy-is-a-key-factor-5e4623bcf35a9b4b 2026-09-09T15:50:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-designates-raju-willener-as-cfo-801ec29de9a56a5a 2026-09-09T15:46:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-050bf26e4894b2ca 2026-09-09T15:46:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-changes-to-section-75-of-nhs-act-2006-impact-assessment-5f9809bc31c7871f 2026-09-09T15:46:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-patient-safety-measures-impact-assessments-092abe2dadcce996 2026-09-09T15:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-role-and-functions-of-the-restructured-dhsc-fact-sheet-89c454d704f2bab3 2026-09-09T15:46:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-structural-measures-to-icbs-and-foundation-trusts-impact-assessments-7a34cf0996abe91d 2026-09-09T15:46:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-providers-fact-sheet-ad8fa072da7a9f6e 2026-09-09T15:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-icbs-as-strategic-commissioners-fact-sheet-6de16d25a204e1ef 2026-09-09T15:46:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-promoting-visiting-impact-assessment-8e5c43f577238ed7 2026-09-09T15:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-mhra-reforms-impact-assessments-d4da977182c6d068 2026-09-09T15:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-medical-device-licensing-regime-impact-assessment-27313ede92bd836d 2026-09-09T15:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-changes-to-pharmacy-appeals-process-impact-assessment-a5f9700a9414e0ed 2026-09-09T15:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-abolishing-nhs-england-impact-assessment-00de0de68dc58510 2026-09-09T15:45:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-icbs-as-strategic-commissioners-equality-impact-assessment-61dc9515198e3cd9 2026-09-09T15:45:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-impact-assessments-summary-744fa7c4f88e3806 2026-09-09T15:45:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-abolishing-nhs-england-equality-impact-assessment-a15632314deab107 2026-09-09T15:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-equality-impact-assessments-summary-8eeb40343ce210f9 2026-09-09T15:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/wall-street-weighs-impact-on-dyn-stock-post-novartis-phase-3-failure-rbc-says-th-ab7d5395de69c328 2026-09-09T15:41:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-promoting-visiting-equality-impact-assessment-33c1a8f7b32a87b9 2026-09-09T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-bill-medicines-and-medical-devices-regulatory-reforms-fact-sheet-7269b5ea8e00e2df 2026-09-09T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-s-del-desiran-misses-primary-endpoint-in-phase-3-dm1-trial-99ce4a179960b851 2026-09-09T15:31:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-food-licenses-of-railway-catering-supplier-20-eateries-1bf82f8f784bec1c 2026-09-09T15:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-kelly-and-ben-living-with-type-1-diabetes-across-generations-aef66af0f4fa5d94 2026-09-09T15:27:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-biggest-ndc-12-risk-sits-in-the-handoffs-3d5e69a55011a8ea 2026-09-09T15:23:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/psi-cro-at-oct-new-england-2026-building-agile-cro-models-for-emerging-biotech-s-4f761b9e371e8aff 2026-09-09T15:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-appoints-will-romanowicz-as-chief-legal-officer-afae0ccb67b0f1c9 2026-09-09T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-appeals-court-hears-baseless-challenge-to-the-abortion-pill-mifepristone-940486b7c14cf63f 2026-09-09T14:56:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-receives-2026-innovation-award-from-sonora-quest-laboratories-147bc4d09ba4c6ba 2026-09-09T14:55:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/beeline-medicines-19dae1080a3df20c 2026-09-09T14:52:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-e52f52c046719662 2026-09-09T14:38:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-account-teams-call-claimguardrx-their-smartest-teammate-24ca28a696436c27 2026-09-09T14:24:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-proprietary-llm-behind-claimguardrx-s-detect-and-respond-engine-756b5ec033050dc5 2026-09-09T14:24:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/kura-creates-lilly-backed-spinout-armed-with-50m-to-advance-next-gen-diabetes-th-f97b4a180f77d74c 2026-09-09T14:20:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/macrogenics-inexpensive-adc-tce-biotech-with-multiple-catalysts-ahead-nasdaq-mgn-3992c5961012659d 2026-09-09T14:15:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-doses-first-patient-in-phase-3-trial-d00198a17e0c725f 2026-09-09T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leerink-partners-initiates-coverage-on-teva-pharmaceutical-industries-nyse-teva-b4f76e98ec172cbd 2026-09-09T14:08:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/brain-structural-and-functional-connectivity-converge-prenatally-but-diverge-aft-005c1fd3ff1a83fe 2026-09-09T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-transition-to-home-why-confidence-is-critical-to-patient-success-f53fe705f45b7442 2026-09-09T13:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/matica-bio-bondwell-partner-on-texas-biotech-d0f4351f2a06e4f3 2026-09-09T13:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-order-directs-federal-push-on-psychedelic-drug-research-and-review-7a02808d8f427079 2026-09-09T13:48:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-participa-de-pesquisa-sobre-ampliacao-do-acesso-a-saude-e-reducao-de-desigu-b590ad185965270e 2026-09-09T13:47:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/parestesia-cos-e-e-quali-sono-i-sintomi-32ffb998988e97fc 2026-09-09T13:47:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrp-launches-2026-27-scholarship-and-grant-application-season-4a9b54371cfd920f 2026-09-09T13:45:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/doctoral-mobility-results-of-the-call-for-projects-between-universite-paris-cite-62144fa5e1972e3c 2026-09-09T13:45:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/orexin-discoverers-awarded-prestigious-lasker-award-0889c17faef35301 2026-09-09T13:43:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/luma-locks-down-15-year-410m-fund-for-life-science-investments-2229e6c1a7656df9 2026-09-09T13:43:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-52-week-topline-open-label-data-from-phase-3-comp005-trial-the-power-of-anot-3ee7227f8517bd81 2026-09-09T13:38:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/nutriband-ceo-gareth-sheridan-to-attend-inaugural-nasdaq-lab-biotech-summit-1307e17da858ae68 2026-09-09T13:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tyra-rolls-toward-pivotal-cancer-study-even-as-stock-deflates-06453e4e0f97fa39 2026-09-09T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/five-years-at-bio-mexico-gaining-ground-in-global-biotech-ec0a6f6068da0a75 2026-09-09T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matica-biotechnology-and-bondwell-technologies-collaborate-to-advance-texas-biot-cf7873ac652d7f27 2026-09-09T13:09:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/guggenheim-reveals-top-biotech-stock-after-positive-clinical-trial-data-c106ca309e8a6793 2026-09-09T13:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocugen-doses-first-patient-in-phase-3-ga-gene-therapy-trial-32970696c462f25b 2026-09-09T13:06:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/viral-haemorrhagic-fever-acdp-algorithm-and-guidance-on-management-of-patients-a442005e4b179daf 2026-09-09T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-biotech-announces-completion-of-treatment-in-phase-3-enlighted-trial-of-p-39acc0eee159b7fc 2026-09-09T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suddenly-this-summer-biotech-breaks-open-with-drug-approvals-ipos-will-it-last-25bef14c1bde5876 2026-09-09T12:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glicemia-valori-e-misurazione-48cb6c3554f79bb5 2026-09-09T12:49:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/nordic-biotech-ceos-reveal-secret-to-major-funding-and-pharma-deals-a3efea1f52140818 2026-09-09T12:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-ignore-the-insider-selling-in-biomarin-pharmaceutical-c392d2b0a526d595 2026-09-09T12:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/nitrosamines-from-detection-to-understanding-c0e645b8909bb3aa 2026-09-09T12:36:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-molecule-to-product-how-integrated-drug-product-solutions-are-becoming-a-cr-1d63d345e74a22e4 2026-09-09T12:35:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-dispuso-la-baja-de-habilitacion-de-la-firma-rehue-s-a-y-prohibio-sus-produ-95c8696ba780c6c0 2026-09-09T12:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmasource-podcast-how-exoz-is-running-a-10-cdmo-rfp-for-cdmo-selection-3a007b19e8cf1ab3 2026-09-09T12:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-paid-pilot-will-test-trinity-biotech-cooling-fluids-in-ai-data-centers-7fd633709f73fc8c 2026-09-09T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/over-1-5-billion-to-help-nhs-withstand-year-round-pressure-cbf84c3935b064e9 2026-09-09T12:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-narcolepsy-drug-showed-median-reductions-of-up-to-88-8-in-sudden-muscle-loss-a-0ff7d04798652a97 2026-09-09T12:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukri-investment-supports-new-uk-space-strategy-d7b16384846c3685 2026-09-09T12:20:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-ai-to-the-death-of-the-default-what-cancer-science-will-look-like-in-the-ne-f7b1746843a2e0f3 2026-09-09T12:18:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/le-chu-de-lille-lance-une-grande-campagne-marque-employeur-62511726140a54a7 2026-09-09T12:13:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-mandatory-surveillance-of-mrsa-mssa-gram-negative-bacteraemia-and-c-diff-35523ec4937619f8 2026-09-09T12:13:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/atmospheric-nox-may-contribute-to-ndsri-formation-study-shows-717a069d3a62c417 2026-09-09T12:12:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-back-to-back-phase-3-failures-for-pelacarsen-and-del-desiran-send-share-2bac2be2f578a969 2026-09-09T12:10:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-research-on-bioengineering-of-the-mitochondrial-genome-72e3edc8e3bcffc9 2026-09-09T12:09:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-health-expo-to-showcase-trillion-dollar-growth-across-pharma-biotech-longe-6803da287ace71b1 2026-09-09T12:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-may-2e45bd7b86003737 2026-09-09T12:06:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-apri-b7f6f80136a72c29 2026-09-09T12:06:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-marc-a9688d88c3a30590 2026-09-09T12:05:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-febr-df1ca0002f7ddc6b 2026-09-09T12:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-june-a0324311fd4d4714 2026-09-09T12:05:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-july-e4a658a591d9a33e 2026-09-09T12:04:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-augu-e29136a0758c031f 2026-09-09T12:04:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-sept-dd9b886471b7e27e 2026-09-09T12:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-octo-63ff575955c0b169 2026-09-09T12:04:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-janu-6665f6d4d545e2ad 2026-09-09T12:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-pays-50m-milestone-as-mrt-6160-enters-phase-2-for-sjogren-s-disease-168b743c3496ab83 2026-09-09T12:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-dece-b514e806327cec75 2026-09-09T12:03:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-nove-9bc61a228a7791a8 2026-09-09T12:03:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-octo-b016e524e13c6091 2026-09-09T12:02:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-sept-700ae1d4dc61471f 2026-09-09T12:01:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezera-announces-ruvonoflast-met-its-primary-inflammation-551bfbb3756d9d66 2026-09-09T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-surface-design-achieves-over-100-millionfold-tuning-of-porous-liquid-v-fe598ab7291e868d 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-3-f66515bf33b9f262 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-chugai-researchers-behind-the-discovery-of-hemlibra-for-hemophilia-a-recei-818232e0bd38792c 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veradius-unity-and-bv-pulsera-mobile-c-arm-system-9in-and-12in-versions-0cb1d977b3032a6a 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/philips-ingenia-achieva-and-intera-mr-systems-b7e6009e9e3fb961 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nodthera-inc-changes-name-to-rezera-inc-and-announces-ruvonoflast-phase-3-develo-e4a7e3b646456dbf 2026-09-09T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/court-of-appeals-hears-oral-arguments-in-louisiana-abortion-pill-lawsuit-50fa9321f5302288 2026-09-09T11:50:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/dyne-therapeutics-remains-a-buy-even-as-novartis-trial-failure-hits-dm1-class-na-eccaccfab2da6505 2026-09-09T11:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ganesh-chaturthi-2026-mumbai-s-12-000-ganesh-mandals-under-fda-scanner-over-pras-be7950d397f186f7 2026-09-09T11:27:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/mirum-pharmaceuticals-hires-lmh-strategic-solutions-284e103ab1270aa8 2026-09-09T11:24:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/guy-s-and-st-thomas-plans-transition-to-a-new-trust-chair-7489ecf6beb24f00 2026-09-09T11:21:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-guidance-data-and-analysis-cf4d903cf180377a 2026-09-09T11:16:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-client-level-data-england-quarterly-update-to-june-2027-bab1705385315cda 2026-09-09T11:15:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-taps-anthropic-and-microsoft-as-it-puts-clinical-trial-agents-into-producti-b05376b8a9e14ff3 2026-09-09T11:15:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-client-level-data-england-quarterly-update-to-september-2026-404dfd4156db3fd3 2026-09-09T11:15:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-1-2-clinical-9da1ba6971e41fb4 2026-09-09T11:06:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/kane-biotech-to-host-commercial-update-webcast-on-september-16-9a8886880a182539 2026-09-09T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cancer-aftermath-of-the-9-11-attacks-on-first-responders-303efa2c2b757e1f 2026-09-09T11:04:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/111-patient-eye-pain-trial-planned-by-okyo-pharma-nasdaq-okyo-84beab271f892e82 2026-09-09T11:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/algorithmic-tool-may-improve-screening-of-patients-for-an-alzheimer-s-clinical-t-562efba4ceb9605d 2026-09-09T11:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-is-still-reviewing-rezolute-s-experimental-drug-no-timeline-is-set-cf406d8464aac8e4 2026-09-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beeline-flies-into-ph-3-as-oral-lupus-drug-soars-past-placebo-303874c2252c60b3 2026-09-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-cancer-biotech-twostep-gets-62-5m-to-take-twist-on-adcs-into-clinic-817e254766ff52c2 2026-09-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matica-biotechnology-and-bondwell-technologies-collaborate-to-advance-texas-biot-0849105330920f96 2026-09-09T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schrodinger-births-new-immunology-and-inflammation-biotech-tectora-therapeutics-3c2ecfcd5bb63fb8 2026-09-09T10:58:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/solstice-rises-with-225m-series-a-to-advance-next-gen-ctla-4-immunotherapy-into-398cbf270d73588b 2026-09-09T10:58:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-manufacturing-questions-facing-chinese-biotech-cf50d2874a8599be 2026-09-09T10:56:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/moonwalk-banks-70m-to-progress-sirna-therapy-for-obesity-de269d2e1175ff14 2026-09-09T10:50:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/unparalleled-opportunity-sandoz-embarks-on-ambitious-biosimilar-growth-strategy-676c4323204a4fcf 2026-09-09T10:49:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/mannkind-and-rose-pharma-inc-enter-licensing-and-collaboration-agreement-to-deve-9e7da1cb20ba16a8 2026-09-09T10:46:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/sindrome-da-trasfusione-feto-fetale-il-volo-in-urgenza-da-cosenza-e-l-intervento-b68d8e83add66d3c 2026-09-09T10:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rapid-acting-short-duration-inhaled-treatment-is-being-developed-for-weight-ma-e383768e6e897a31 2026-09-09T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/compass-pathways-new-52-week-topline-open-label-data-from-phase-3-comp005-trial-6da5752584aa882a 2026-09-09T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-makes-pharmaceutical-speaker-programs-illegal-f87d152b9ae8d979 2026-09-09T10:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-global-eye-cancer-trial-has-dosed-its-first-patient-529d4d314833481c 2026-09-09T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biden-era-abortion-by-mail-rules-face-key-test-at-appeals-court-hearing-0cd9e746f1b92012 2026-09-09T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-university-library-will-be-closed-on-17-september-d3e018df8589945d 2026-09-09T09:58:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/nafdac-and-nhrec-announce-new-dates-for-mandatory-stakeholders-training-on-clini-c75adb4ff13bd3af 2026-09-09T09:53:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-among-independent-f32c88a42723b612 2026-09-09T09:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuromuscular-drug-from-novartis-fails-in-key-study-adding-to-pressure-on-compan-7599cd1f8178910a 2026-09-09T09:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/une-revue-de-reference-publiee-dans-le-new-england-journal-of-medicine-sur-les-m-c41958e668e318f7 2026-09-09T09:34:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pack-expo-seamless-pharma-processes-for-north-america-f8720d1ba6186698 2026-09-09T09:27:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/wissen-und-praxis-hand-in-hand-expertinnen-und-experten-aus-der-zahnerhaltungsku-b89cf8a5453f7c93 2026-09-09T09:20:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-information-sheet-for-category-4-returnees-from-an-ebola-affected-3451106449dc4cbd 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-information-sheet-for-category-3-returnees-from-an-ebola-affected-66d6f6455dcf6d66 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-information-sheet-for-category-2-returnees-from-an-ebola-affected-0ad9eb86ec575c6f 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-information-sheet-for-category-1-returnees-from-an-ebola-affected-24c7b8b02c106176 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-and-marburg-contact-matrix-for-returning-workers-scheme-and-non-uk-exposur-dedb115fc574e9fe 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-virus-disease-clinical-management-and-guidance-74343e283fe62dbc 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-returning-workers-scheme-public-health-advice-3f98a3a732b6c31c 2026-09-09T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/alphagenome-variant-impact-scores-integrated-into-ensembl-vep-75379a89dcda8795 2026-09-09T08:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/barclays-upgrades-sagimet-stock-rating-on-acne-drug-potential-ae3e9d55d7da7baa 2026-09-09T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-infigratinib-shows-meaningful-benefits-beyond-growth-within-52-weeks-in-chi-0c539f69c1cd457c 2026-09-09T08:04:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-sleep-apnea-measure-rose-10-4-with-an-experimental-drug-versus-49-2-with-place-90e8edbb76843343 2026-09-09T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mosliciguat-advances-to-phase-3-phrontier-trial-after-phocus-study-shows-20-pvr-7689bcdaf1ae338a 2026-09-09T07:34:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/proteomic-aging-clocks-just-changed-what-a-phase-2a-trial-has-to-prove-2ad189fe17c2661b 2026-09-09T07:34:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicine-shortages-grow-in-iran-as-us-tightens-sanctions-blockade-ecd987fe722f5a4e 2026-09-09T07:20:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-covid-19-pandemic-memorial-site-opens-to-the-public-b345a4d4e0c90543 2026-09-09T07:00:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-questions-that-could-determine-alzheimer-s-next-chapter-16943d6949229332 2026-09-09T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deconstructing-lsd-for-therapeutic-discoveries-a1f7df396e8e403c 2026-09-09T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reading-app-boosts-kids-literacy-6d79f19cd6e0090c 2026-09-09T06:44:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cracks-down-on-food-safety-violators-5fff85b007469683 2026-09-09T06:07:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-food-licenses-of-railway-catering-supplier-20-eateries-c5fd85665f97fc76 2026-09-09T06:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/steady-stream-of-crossover-rounds-stock-biotech-s-ipo-pipeline-dbbe4746af7c54ed 2026-09-09T04:17:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/electrogram-guided-driver-ablation-versus-posterior-wall-isolation-in-persistent-c190ff9e138460b4 2026-09-09T03:17:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-report-on-the-pmda-hokuriku-branch-10th-anniversary-symposium-c1a0e57e7ec099d8 2026-09-09T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezubio-doses-first-patients-in-phase-i-trial-of-inhaled-respiratory-drug-rz-520-378d2a6eb465cc4d 2026-09-09T02:34:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiwan-s-obigen-pharma-to-unblind-phase-3-botox-trial-early-in-november-year-end-af705b30fbefc4cc 2026-09-09T02:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rezubio-doses-first-patients-in-phase-i-trial-of-inhaled-respiratory-drug-rz-520-1026a08765283c42 2026-09-09T02:01:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/wegovy-and-mounjaro-for-weight-loss-not-funded-a2a3ffb1738d2e00 2026-09-09T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinhan-securities-cuts-alteogen-target-to-520-000-after-novartis-aoc-phase-3-fa-972a02956e1cfc51 2026-09-09T01:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/many-different-paths-may-lead-to-a-role-in-clinical-project-management-96598feaeb50c516 2026-09-09T00:39:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/click-e-stock-one-novartis-new-drug-fails-phase-3-target-price-for-alteogen-lowe-7cafc5a1c226a35d 2026-09-09T00:23:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-9e8f3bd2a58b229c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-0a518003195b02c6 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commensal-nakaseomyces-glabratus-migrates-into-prostate-tumors-to-accelerate-can-010f25245a569d7c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/barriers-and-facilitators-to-the-implementation-of-pharmacogenomic-testing-for-a-3b11d24638e263e0 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/upcoming-fda-approval-decisions-in-q4-2026-bb4afbd907349c67 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-translational-framework-for-extrahepatic-oligonucleotide-delivery-facd5901da0c8825 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporary-policies-for-compounding-certain-starter-parenteral-nutrition-drug-pro-bff9d18f307f05a1 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-es-b6fb3f98dd33049b 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-hum-9e81e95c6000ebb0 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/privacy-act-of-1974-system-of-records-99f349f787d2f97e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-of-regulatory-review-period-for-purposes-of-patent-extension-andem-d38ea0d42ee8ba36 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-pre-8f9c9e790ba2b6a8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-of-regulatory-review-period-for-purposes-of-patent-extension-anzup-eeb61cd6a595bf0b 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-of-regulatory-review-period-for-purposes-of-patent-extension-ankti-9840243fd9e98d18 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-vaccine-injury-compensation-program-list-of-petitions-received-bee1e53401727a8f 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reorganization-of-the-national-center-for-immunization-and-respiratory-diseases-588d95ecfd03eea8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-mucinex-fast-max-liquid-gels-day-night-cold-and-flu-95e4942fca23d639 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-donepezil-178586cc38e5c316 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-zinc-oxide-3cd24fc4898f8e23 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-oxycodone-hydrochloride-40f2b893ea5c9a89 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-nighttime-sleep-aid-berry-flavor-6323e5aee114edcd 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-head-and-shoulders-bare-minimal-ingredients-pure-clean-2in1-cded6e31a1e01ccf 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-mucus-relief-cold-flu-and-sore-throat-maximum-strength-8a6c0d65c6afe6c4 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-scopolamine-f1a02fb6bd212fe9 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pramipexole-dihydrochloride-5f9b5f685b87ac04 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-omeprazole-c5d97c29ca36bcdd 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-drx-choice-children-daytime-cough-and-chest-congestion-63b91d6ec40856ad 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-meclizine-hydrochloride-507cf52bc773bd0a 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-eczema-soothing-moisturizing-cream-14fdbfbd047c6287 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-advanced-healing-345f66e1cadf5176 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-antibacterial-lotions-skin-cleanser-8d113cdbd3dee527 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-theratears-7443966d80f89fae 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-levothyroxine-sodium-bf4d0a9fa3c76075 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-dexamethasone-sodium-phosphate-db4b052a55894258 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-colgate-maxfresh-knockout-773ccc8e9a5ccb0c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bumetanide-0247a524324ef1b4 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-amlodipine-besylate-and-benazepril-hydrochloride-a8908cc07cab864a 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-spironolactone-62d6369d502689be 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibuprofen-3bdfa3f85fe9337e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-senokot-99e4f6f0b2bd039d 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-nicotine-5815f3f89a82e8bd 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bendamustine-hydrochloride-e0bd4b81923aebd2 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metformin-a9fba3d11a436817 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-b0cd29572992f66b 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-trokendi-xr-2cd8d09a3d33ffae 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-broadway-joe-s-pain-cream-histamine-dihydrochloride-0-025-1500mg-cbd-8874178ca1c3b3c5 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-mycophenolate-mofetil-8ae34a31ddc89155 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-trazodone-hydrochloride-3a60bbdcddbc11b7 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-prasugrel-f96ea8b937cb3e21 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-the-one-spf-50-invisible-sunscreen-gel-avobenzone-3-homosalate-7-oct-383fde3feebd8914 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-doxylamine-succinate-and-pyridoxine-hydrochloride-ba3dd12cfc609bc5 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-recall-clindamycin-phosphate-34c817d35658a8bf 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-philips-brilliance-ct-64-brilliance-ct-64-channel-product-code-728-021880a00c9bd2cc 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-medline-convenience-kits-containing-bd-chloraprep-clear-1ml-applic-8ca59c2eb9b76f5e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-baxter-novum-iq-syringe-pump-model-number-40800baxus-b12a7a05d1135afc 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-5008x-hd-hdf-with-twister-blood-tubing-set-part-number-03-5350-8-62a5d920a63cd2f5 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-presource-packs-containing-cliniclean-pericare-wipes-within-bd-uri-50cbdcfd8e2ae423 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-granuflo-dry-acid-concentrate-product-numbers-0fd2251-3b-0fd3251-3-e6156d14a9a79650 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-sta-staclot-protein-s-model-catalog-number-00746-reagent-lot-numbe-01e2625b34b48b07 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-lux-dx-lux-dx-ii-lux-dx-ii-insertable-cardiac-monitor-system-serve-598c46fe92f8e599 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-healon-endocoat-pro-ref-10300012-us-can-healon-duet-pro-ii-ref-103-5f65863fb0fc13b8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-halyard-medical-convenience-kits-labeled-as-1-a-p-pack-205936-mode-556c33708e264886 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-velys-enabling-tech-robotic-assist-station-ref-451611001-3fe35a2e68fc8146 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-recall-medline-convenience-kits-1-blood-culture-tray-pediatric-model-numb-876f6a7d17d12fe8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-microbiological-efficacy-of-the-antibacterial-drug-fluorothiazinone-4649c521622754f8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-70-000-reassessing-the-global-fontan-population-through-citation-chain-an-b1ba1fb432aad77c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomised-phase-iii-trials-of-cancer-prevention-drugs-a-systematic-review-and-p-cf327e72aa0c92f9 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-optimize-healthy-volunteer-screening-and-enrolment-in-clinical-trials-a-q-c8c58268978f61bd 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-i-evaluation-of-siltartoxatug-a-first-in-class-anti-tetanus-monoclonal-ant-49d27eb2412753fb 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-and-investigational-jak-inhibitors-for-rheumatoid-arthritis-efficacy-an-e2920939ed3993b8 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-safety-and-efficacy-of-vornorexant-in-japanese-patients-with-insomnia-f812640c67e38884 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/estimating-and-predicting-clinical-trial-outcomes-in-china-f00f8b31650910e0 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-therapeutics-for-glioblastoma-challenges-and-future-directions-d99035fe859a1890 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celecoxib-plus-topical-flurbiprofen-patch-versus-celecoxib-alone-for-symptomatic-d023a4827f072b8d 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intranasal-midazolam-vs-mouth-dissolving-clobazam-in-terminating-seizures-a-rand-99ac18ed68820c9c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-of-baseline-neutrophil-to-lymphocyte-ratio-with-efficacy-and-toxici-c96f347b709d5107 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neoadjuvant-pertuzumab-biosimilar-hlx11-versus-reference-pertuzumab-for-early-st-7808b92e0e1149cf 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unveiling-novel-transcriptomic-prognostic-biomarkers-for-specific-breast-cancer-42d2894e98971e23 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutics-candidates-and-repurposing-strategies-to-target-parkinson-s-disease-96683c528f323412 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neo-adjuvant-approvals-for-solid-tumors-by-the-us-food-and-drug-administration-2-756ed3abf614efc6 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-3-trial-of-vosoritide-in-children-with-hypochondroplasia-6de4f09ea4b05915 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-antibody-based-therapeutics-in-cancer-antibody-drug-conjugates-b-5c7dfa5fb8bc15f1 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-and-scientific-challenges-in-pediatric-oncology-d3b46ab83794e42f 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-and-forthcoming-pharmacotherapies-for-adolescent-obesity-evidence-based-39c48a47843c9799 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-i-helicobacter-pylori-i-infection-with-insulin-resistance-tumor-n-316790c378779761 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phenomenology-in-pediatric-nursing-lessons-from-studies-of-mothers-caring-for-ch-4f3fffea388d6bfe 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/utilizing-a-smartphone-application-for-perinatal-depression-screening-and-care-l-d1657f9c0ce56b10 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/network-biology-to-artificial-intelligence-building-the-next-generation-of-predi-7049814c4b1b0ea9 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interactions-of-nanoparticles-with-structures-of-the-respiratory-system-nanopart-6e7d20d5c4593f8d 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhaled-nanoliposomes-for-treating-lung-disease-including-a-case-study-of-amikac-5c581901e1fef964 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-delivering-particles-aim-to-breach-the-blood-brain-barrier-6b0773077796d0f1 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanical-basis-of-cortical-cataract-214599f9167e95ce 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07811128-leveraging-digital-health-solutions-to-collect-patient-reported-outc-de9c163ffaa5b58e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810855-using-bedside-ultrasound-to-understand-fluid-management-in-patients-f01e5454fd815262 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07810231-prospective-longitudinal-cohort-study-of-implant-age-pocket-plane-in-f1335f5a7fd090e7 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07809542-brain-network-characteristics-of-pain-patients-based-on-magnetoencep-f1102e08355c2f4a 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07809438-a-comparative-performance-study-between-high-and-standard-resolution-a7b9283bcd325474 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07809399-volumetric-hrct-in-stable-copd-patients-905336f1346cda49 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07809087-feasibility-study-of-an-interactive-wall-based-intervention-program-68f2eb96ca9dbf6e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07809074-mindfulness-and-self-compassion-intervention-for-ostomy-patients-due-928772f3ba63ee88 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07808645-wearable-sleep-eeg-and-auditory-stimulation-in-healthy-adults-a3f895f1435a9f4e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07803471-yiqi-fumai-lyophilized-injection-for-chronic-heart-failure-caused-by-a2f07156d8dd8c5f 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07770919-continuous-theta-burst-stimulation-for-generalized-anxiety-disorder-a11ec2e143861103 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07755748-glaucoma-screening-to-enhance-at-risk-californians-health-survey-res-613aad5046be38a3 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07668518-a-study-of-the-safety-tolerability-pharmacokinetics-and-efficacy-of-53495f0e626ad570 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07645443-feel-good-a-multicenter-trial-of-a-mindfulness-based-group-therapy-i-e6b3a6106587bc2a 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07509034-autologous-b7-h3-chimeric-antigen-receptor-t-cells-in-previously-tre-2b314a9db8642130 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07447557-study-of-intrathecal-elp-02-for-charcot-marie-tooth-disease-type-4j-9df85b59b7760510 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07436728-a-study-of-tak-505-in-adults-with-solid-tumors-0ceaf12c08fe7644 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07241377-a-study-in-healthy-adults-to-compare-the-bioavailability-of-epa-dha-04a145623e5fd712 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07234942-a-study-to-investigate-the-safety-tolerability-pharmacokinetics-and-934403a64baf19fb 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07224763-study-to-evaluate-the-safety-and-efficacy-of-the-ggta1-ko-thymokidne-e7469684f1a340a9 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07210398-mindfulness-based-cognitive-therapy-for-the-chronic-pain-early-cogni-a5c8ad0779df2ad7 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07205107-clindamycin-phosphate-adapalene-and-benzoyl-peroxide-triple-combinat-c2ef75272e264556 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07166094-study-to-assess-the-efficacy-and-safety-of-rina-s-compared-to-treatm-654bf6bd00153589 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06851806-study-of-palivizumab-in-children-with-high-risk-of-severe-respirator-030ea64e3955972a 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06825702-safety-tolerability-and-efficacy-of-intravitreal-kio-104-in-patients-8d4299ce7f4765dc 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06782308-tinnitus-patient-preferences-survey-717b4fa3f14c3c2b 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06578520-effect-of-the-use-of-dapagliflozin-in-patients-with-refractory-heart-ed2d60e95fd26467 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06548412-ctx-009-with-gemcitabine-cisplatin-and-durvalumab-as-first-line-ther-2b2fdba90bbebbba 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06470048-a-clinical-study-to-evaluate-ianalumab-in-participants-with-diffuse-81b10aa4165bd17c 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06410248-triapine-in-combination-with-temozolomide-for-the-treatment-of-patie-0cf1d97b4e719323 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06323161-a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-bo-7b5290a15f28fde0 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06260228-home-based-self-management-and-cognitive-training-changes-lives-hobs-ff1e48edbb3a2369 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06235801-a-phase-i-ii-study-of-gilteritinib-and-momelotinib-for-patients-with-1fe17411a66cc840 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06052631-microneurographic-assessment-of-peripheral-nerves-in-healthy-volunte-19ef87b4db826563 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05706558-retrospective-review-of-esophageal-cancer-at-mskcc-cafd4ee1a7b70879 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05570253-a-study-of-sdx-7320-in-combination-with-eribulin-for-people-with-bre-7c04db2a9102a2ce 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05232071-placebo-controlled-proof-of-concept-study-to-evaluate-the-safety-and-9fcfbde442103736 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05037461-precision-radiotherapy-using-mr-linac-for-pancreatic-neuroendocrine-fcedc2d84f591031 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04847648-air-polishing-in-the-treatment-of-peri-implantitis-7fadfb7a67b10d53 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04542824-trial-of-the-safety-and-efficacy-of-epcoritamab-in-japanese-subjects-8f8b2e5edddf7421 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04124497-a-trial-for-relapsed-and-relapsed-refractory-multiple-myeloma-patien-96886e54e668bcc6 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03625037-first-in-human-fih-trial-in-patients-with-relapsed-progressive-or-re-7c8817969428243d 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03549754-icareme-global-registry-multinational-real-world-evidence-in-cardior-ca8b38986b5aecf0 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03307109-quality-of-life-in-patients-having-a-prosthetic-joint-infection-2572312124caf8f4 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02890329-ipilimumab-and-decitabine-in-treating-patients-with-relapsed-or-refr-cc9d070597ff8255 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02767011-tele-health-electronic-monitoring-to-reduce-post-discharge-complicat-c84b8d01820bce9e 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01568658-genetic-and-physical-study-of-childhood-nerve-and-muscle-disorders-f16cdfe7ad322553 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-ba0de889eb9275a2 2026-09-09T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-begins-phase-1-clinical-trial-of-ebola-vaccine-against-strain-behind-drc-27bba2ce08cb2b5c 2026-09-08T23:53:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-trial-wins-sent-roivant-and-pharvaris-higher-98c19d328893c1ff 2026-09-08T23:38:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-uk-study-links-hot-drink-consumption-to-one-type-of-oesophageal-cancer-9e98c5810375f9c5 2026-09-08T23:01:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-fda-sets-ai-principles-for-drug-development-how-much-evidence-is-enough-a883e1c3fce040a0 2026-09-08T22:40:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-names-permanent-leaders-at-fda-amid-ongoing-controversies-b3c82c9c2a34e326 2026-09-08T22:38:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-life-manifesto-9-september-f304f3e5484c5586 2026-09-08T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharvaris-stock-jumps-after-positive-hae-drug-t-4085528d18522778 2026-09-08T21:57:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-than-heartburn-surgical-options-at-intermountain-health-offer-lasting-relie-bfa34a5b417d7001 2026-09-08T21:46:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-announces-settlement-of-patent-litigation-with-catalyst-ort-821d94e200d46a6b 2026-09-08T21:45:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/appeals-court-to-rule-soon-on-marijuana-rescheduling-as-billions-in-cannabis-tax-e164d6e9b92848d2 2026-09-08T21:19:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-finds-limited-evidence-for-helping-hospitalized-patients-with-alcohol-use-d3ef2acf6a0fa3fe 2026-09-08T21:01:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-six-years-of-bladder-cancer-a-new-bladder-helps-colorado-woman-look-forwar-4774ffd6df6a34c0 2026-09-08T20:57:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/stc-symposium-2026-58th-annual-symposium-113240fdf307ab47 2026-09-08T20:52:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/semaglutide-improves-bmi-category-in-phase-3-pediatric-obesity-trial-0a553bf6e7f7c09b 2026-09-08T20:17:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-a-s-stock-nvo-closed-down-by-3-09-on-sep-8-facts-behind-the-movemen-bf3c0573fb832069 2026-09-08T20:15:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-announces-key-leadership-selections-at-fda-to-promote-innovation-reform-and-da223f20305656e3 2026-09-08T19:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-seattle-from-preclinical-to-clinical-across-therapeutic-modalities-780cce3c4ab94fac 2026-09-08T19:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-san-francisco-assessments-of-qt-prolongation-in-preclinical-and-clinical-de-1e5e298f54285332 2026-09-08T19:42:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/appeals-court-to-rule-soon-on-marijuana-rescheduling-as-billions-in-cannabis-tax-53e03398fc5994dc 2026-09-08T19:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-vancouver-from-bench-to-ind-cta-building-a-strong-preclinical-package-for-f-af77ee29865885ee 2026-09-08T19:31:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-san-francisco-discovery-and-development-of-orally-bioavailable-peptides-fro-df78116d1f6c3289 2026-09-08T19:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/percuplasty-dr-n-campitelli-14a8e17520e2fb4f 2026-09-08T19:27:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/percuplasty-dr-r-pica-05092747566125d9 2026-09-08T19:26:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-gliding-scfe-screw-systemtm-68ab411d28ba3791 2026-09-08T19:19:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/gap-nailtm-endo-exo-medullary-system-62304b1939a5fad0 2026-09-08T19:19:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-lanca-apresentacao-pioneira-no-mundo-em-gotas-para-o-tratamento-do-tdah-e-do-39cec77016ec44f3 2026-09-08T19:16:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/mozarteum-brasileiro-apresenta-orquestra-nacional-jovem-dos-estados-unidos-5d2ce6e3fe2c7fa3 2026-09-08T19:15:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-san-diego-preclinical-development-and-ind-filing-for-antibody-based-therape-bab79b36efe96386 2026-09-08T19:09:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/museu-do-amanha-e-ems-apresentam-debate-sobre-inteligencias-e-saude-com-jurema-w-26ca4f2732e04260 2026-09-08T19:06:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/upcoming-system-modernization-for-our-customers-in-the-united-states-latin-ameri-aae387fd626685cd 2026-09-08T18:59:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/academy-of-surgical-research-42nd-annual-meeting-c0f96998e9208ced 2026-09-08T18:54:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/outubro-rosa-ems-disponibiliza-a-colaboradoras-carreta-do-hospital-de-amor-para-6c2813ff255242e1 2026-09-08T18:51:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/ms-vence-premio-lupa-de-ouro-2024na-categoria-prescricao-sistema-nervoso-central-2749a5cac6319455 2026-09-08T18:44:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/pbss-san-francisco-nonclinical-safety-pharmacology-studies-for-ind-and-regulator-8c73b37a8bba8e8e 2026-09-08T18:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/evento-gratuito-em-salvador-promove-experiencia-interativa-sobre-saude-digestiva-13d899c0e6cfe3e6 2026-09-08T18:41:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantum-biopharma-s-lucid-ms-gets-fda-clearance-for-phase-2-trial-in-multiple-sc-6e1a50fab04737c7 2026-09-08T18:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-falls-10-as-novartis-trial-failure-clouds-a-cholesterol-drug-class-nvs-sto-577262ea46adae76 2026-09-08T17:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-suffers-third-clinical-setback-in-a-week-wiping-out-over-40-billion-in-aecba47d0f5a987e 2026-09-08T16:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-a-cannabis-business-is-betting-on-dogs-to-reach-fda-approval-e63e12a392c30ad2 2026-09-08T16:29:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/calling-campus-home-0bb2da405fb83317 2026-09-08T16:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicaid-chip-monthly-enrollment-tracker-ae0464eb72ac16e6 2026-09-08T16:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-cancer-care-technology-at-intermountain-st-mary-s-hospital-improves-precisio-d031ddb475f9bc42 2026-09-08T16:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-opportunity-fewer-cars-4b53bdcadfdf0f3b 2026-09-08T16:06:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/carlsbad-man-now-back-to-baseball-after-prostate-cancer-9fb1a4e792289469 2026-09-08T15:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-northern-ireland-can-save-almost-6-000-lives-from-cancer-a2c925838ec76bd8 2026-09-08T15:31:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/pneumococcal-vaccination-for-older-adults-and-for-individuals-in-a-clinical-risk-a3c9fa73d91e326d 2026-09-08T15:28:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/house-advances-carter-s-bipartisan-bill-to-reduce-animal-testing-in-drug-develop-f90a2c9708224bfc 2026-09-08T15:28:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-enforces-zero-tolerance-with-major-food-safety-crackdown-a0e97e5aa54ea452 2026-09-08T15:25:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-en-or-lancement-de-deux-nouveaux-programmes-de-recherche-dedies-aux-ca-f7b627426c3f3724 2026-09-08T15:22:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuevos-proyectos-de-consulta-para-la-opinion-publica-f60c4dde925aa14a 2026-09-08T15:16:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-en-or-10-ans-d-avancees-scientifiques-au-service-des-enfants-atteints-224a9d972bb5244e 2026-09-08T15:07:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/freshers-urged-to-get-menb-vaccine-as-students-arrive-in-glasgow-9ecdfb7eb1ff3ca9 2026-09-08T15:03:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/only-known-woolly-dog-pelt-returns-close-to-home-and-for-the-first-time-to-canad-e15654a8ab116319 2026-09-08T14:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-cholesterol-lowering-medicine-fails-phase-3-clouding-lp-a-horizons-1b5ea32d857530a1 2026-09-08T14:52:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-a66e726a10440e23 2026-09-08T14:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-taps-anthropic-s-claude-to-bring-agentic-ai-to-clinical-trials-ead94fcd6e0c0aac 2026-09-08T14:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/growth-rate-coordination-across-the-width-of-a-leaf-preserves-its-flatness-d24f96ecb89ecd41 2026-09-08T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovery-stack-pilot-demonstrates-the-feasibility-and-outcomes-of-a-scientist-d-a8c5a60d1fcb63ea 2026-09-08T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-distribution-of-fitness-effects-of-nonsynonymous-mutations-varies-phylogenet-9cc47ec94843fbdd 2026-09-08T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seaweed-carbon-removal-cannot-keep-up-with-climate-driven-loss-4e8aaeb720bf6257 2026-09-08T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-internet-s-favorite-cat-comes-to-apple-arcade-with-pusheen-s-place-36061410452a077c 2026-09-08T13:59:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/qualitat-statt-quantitat-neue-erkenntnisse-zur-rolle-bestimmter-car-t-zellen-in-47303ac3345f336c 2026-09-08T13:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-pharmaceuticals-gets-85-price-target-des-88a596b142c0403e 2026-09-08T13:49:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/x4-pharma-gains-fda-agreement-to-cut-phase-3-trial-size-to-76-patients-86a2f6c69c45444e 2026-09-08T13:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exozymes-selects-curia-as-commercial-scale-manufacturing-partner-for-nct-e32fe23efc672768 2026-09-08T13:05:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/imdelltra-in-combination-with-imfinzi-demonstrated-landmark-improvement-in-overa-2f50edcb3c7d5463 2026-09-08T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gram-negative-mrsa-mssa-bacteraemia-and-c-difficile-infections-monthly-data-2025-46183ecdfec674cc 2026-09-08T12:46:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/wegovy-for-overweight-young-children-novo-nordisk-s-obesity-drug-shows-effective-3431f97d0f9e3263 2026-09-08T12:30:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-sustainability-report-2025-what-eur-achieved-409318104b9372bd 2026-09-08T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veru-advances-oral-sabizabulin-following-positive-preclinical-data-showing-poten-3888551e81843663 2026-09-08T12:28:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncovering-how-a-key-rna-works-sheds-light-on-one-of-the-major-challenges-in-mod-a603e2fe921939f1 2026-09-08T12:25:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ppwr-mandate-essential-strategies-for-pharma-and-medtech-f748c4fe8d527e31 2026-09-08T12:25:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/liver-cancer-patients-appear-to-be-living-longer-in-a-can-fite-trial-4dcb429a7fce4ae3 2026-09-08T12:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vor-biopharma-vor-completes-enrollment-in-phase-3-trial-as-market-eyes-growth-po-6854d0a7bff59ab1 2026-09-08T12:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/enregistrement-des-antibiotiques-dans-vamreg-e-learning-pour-les-veterinaires-5fb5bf0d85ad7573 2026-09-08T12:16:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-12b-avidity-acquisition-hits-phase-3-speedbump-as-dystrophy-drug-disapp-81a38543b41b14c8 2026-09-08T12:12:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/xfor-gains-fda-nod-for-reduced-trial-size-in-pivotal-phase-3-study-dfe6bf454bee75c8 2026-09-08T12:10:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimizing-tomato-plant-growth-with-microbes-57d2a1bc16d97574 2026-09-08T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insitro-appoints-hideo-makimura-as-chief-medical-officer-to-lead-its-transition-0bcb1ec64f430a65 2026-09-08T11:53:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/tozorakimab-demonstrated-statistically-significant-and-highly-clinically-meaning-4a747bc53373c024 2026-09-08T11:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-announces-next-stage-of-fda-engagement-for-phase-3-parkinson-s-disease-pr-86f2e64a80edb748 2026-09-08T11:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artiva-biotherapeutics-announces-planned-2026-data-readouts-and-phase-3-trial-in-d72d6fed3e722f8c 2026-09-08T11:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nature-medicine-features-a-briacell-trial-among-11-shaping-medicine-in-2026-a2c3aef4540443f1 2026-09-08T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovie-seeks-fda-feedback-on-a-proposed-parkinson-s-trial-of-about-175-patients-ee88e950491954eb 2026-09-08T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/briacell-s-pivotal-phase-3-metastatic-breast-cancer-study-expands-to-leading-can-339c6a459d143c72 2026-09-08T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncologists-say-newly-approved-pancreatic-cancer-drug-is-a-breakthrough-for-trea-81381f05106e10cb 2026-09-08T11:26:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/okyo-pharma-nasdaq-okyo-readies-phase-3-trial-of-eye-pain-drug-urcosimod-90d050241783edad 2026-09-08T11:01:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-50-million-payment-is-coming-to-monte-rosa-as-novartis-starts-a-sjogren-s-tria-31715f4d196d2209 2026-09-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-trial-for-eye-related-muscle-weakness-is-planned-for-2027-vor-bio-finished-b45892b2c443c86f 2026-09-08T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-announces-positive-topline-results-from-registrational-phas-8624811f3ce076b9 2026-09-08T10:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-confere-e76ae3336b1268bc 2026-09-08T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/climate-policy-does-not-start-with-the-individual-but-with-society-872eca64f6426f62 2026-09-08T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henry-schein-to-participate-in-upcoming-investor-conference-in-september-07ba9e773ffd3a95 2026-09-08T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gut-infections-can-train-the-brain-s-immune-defences-9175667d6e260f7f 2026-09-08T10:25:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-update-issue-375-flu-special-2026-1a30d6fa07e93be8 2026-09-08T10:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/up-to-200-000-people-live-with-this-lung-disease-roivant-starts-a-new-trial-d037a53d1ec5911f 2026-09-08T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-s-fda-steps-up-drug-crackdown-in-maharashtra-complaints-jump-557-ecfe5acba6850e4a 2026-09-08T09:56:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-12bn-avidity-bet-falters-on-late-stage-del-desiran-flop-a07058258a6406e4 2026-09-08T09:51:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-need-a-stronger-nursing-voice-to-keep-patients-safe-8b8f02574018a3cc 2026-09-08T09:50:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/congenica-clinical-genomic-interpretation-platform-8dd7d846fd92da03 2026-09-08T09:50:11.311Z weekly 0.7 https://www.pharmaradar360.com/article/2025-26-in-review-cancer-research-uk-drives-major-progress-against-cancer-e6e02f52b68383fa 2026-09-08T09:45:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-heart-drug-fails-phase-3-trial-cutting-genetic-ch-0570ea9380fbcdd9 2026-09-08T09:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-s-role-in-health-care-what-keeps-you-up-at-night-6d1068f9b30fe470 2026-09-08T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characteristics-of-people-infected-with-toxigenic-c-ulcerans-74755f86c69d844a 2026-09-08T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-evidence-reviews-8f54ff16e8d4cd78 2026-09-08T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ame-bridge-management-1a3a141ab51144fc 2026-09-08T08:16:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-and-sec-compare-notes-what-the-new-mou-means-for-fda-regulated-public-compan-5b81d98bc9d3824a 2026-09-08T08:12:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sonntagsvorlesung-bauchfellkrebs-was-umfassende-chirurgie-heute-alles-moglich-ma-05311b996e1af0e3 2026-09-08T07:58:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-major-novartis-falls-10-after-three-drug-trial-setbacks-92f853f4d5272a6c 2026-09-08T07:51:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-bio-presents-results-from-the-phase-2-valiant-trial-of-verekitug-for-th-e4bacc39df389b5c 2026-09-08T07:40:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-bio-reports-phase-2-valiant-trial-results-showing-verekitug-reduced-sev-18afce1d16ed54f2 2026-09-08T07:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-stock-slides-as-centerpiece-of-12b-avidity-buyout-flunks-crucial-phase-369fe1ae5d30a5c0 2026-09-08T07:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-quarterly-dose-cut-asthma-flare-ups-56-versus-a-dummy-treatment-upstream-bio-p-5957ae35a18b8b3f 2026-09-08T07:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rudern-gegen-krebs-benefizregatta-am-12-september-2028d7b5e755a247 2026-09-08T07:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-momentum-towards-bulgaria-s-full-embl-membership-68739d129b62791a 2026-09-08T07:20:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-researchers-celebrated-for-new-insights-into-the-management-of-obesity-601fec9231203ba4 2026-09-08T07:08:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-health-expands-advanced-psychiatric-care-with-opening-of-new-electrocon-e79aba143c8496e7 2026-09-08T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eat-like-me-to-look-like-me-e976087b41cdbd32 2026-09-08T06:47:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-effect-100-days-12-083-actions-as-maharashtra-fda-leads-biggest-s-d98c23d18ab152bc 2026-09-08T06:42:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/nya-regiondirektoren-vill-samla-kraften-i-vastra-gotaland-ccfba7d8bb5732e0 2026-09-08T06:00:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-safety-chief-tukaram-mundhe-s-plan-for-festivals-in-maharashtra-8c168d932d6ebed2 2026-09-08T05:32:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/newron-reports-subscription-for-eur-5-5-million-of-shares-by-investor-group-as-p-9cedb9c94f3df816 2026-09-08T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frazier-life-sciences-appoints-ben-palleiko-as-senior-advisor-and-promotes-adam-297e153d30f3ed65 2026-09-08T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-data-says-about-tukaram-mundhe-s-100-day-stint-as-fda-commissioner-196f7cd7d48755cb 2026-09-08T04:03:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/bmc-medical-co-ltd-recalls-luna-g3-apap-model-lg3600-with-firmware-g3-2-00-76-du-49c4827bc368c793 2026-09-08T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-inspections-expose-drug-safety-gaps-e2b63ad181bd692b 2026-09-08T03:20:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/ana-maria-stuven-recibe-el-premio-nacional-de-historia-2026-dcb163e3d618b755 2026-09-08T03:15:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-jp-drafts-september-2026-part-1-posted-58fb2b9570d86ac0 2026-09-08T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yakkyokukata-jp-drafts-september-2026-part-2-posted-7fc8f7827c7927a1 2026-09-08T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-colesterolo-alto-statine-e-nuovi-farmaci-per-mantenere-valori-ott-0396457fe42e2bb9 2026-09-08T01:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-3c9bb893b8f5ebb3 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-d43e989b55ee68c6 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-filed-form-6-k-9a3be5d9cea2290a 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mark-allen-d-d-s-rescission-of-final-agency-action-and-withdrawal-of-order-to-sh-4ff464311d7f3296 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-public-comment-requ-ba5586ce8851a924 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicare-program-town-hall-meeting-on-the-fiscal-year-2028-applications-for-new-e0882cd256184bcf 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-data-collection-submitted-for-public-comment-and-recommendations-51525e15cfb1b3ee 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-945ea22744a88fc9 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-irvine-labs-inc-06b927a4afc4595e 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-fisher-clinical-services-inc-4f126cd097473cf8 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-cambrex-high-point-inc-e82f843236b1838a 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-fresenius-kabi-usa-llc-a380373346bbc5af 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stephen-bossenberry-m-d-decision-and-order-a19b15ba4f04fad0 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-andersonbrecon-inc-dba-pci-pharma-58475345f958d070 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-33d1d408902e2bdd 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/submission-for-omb-review-30-day-comment-request-data-and-specimen-hub-dash-euni-43d65c3b310c33ea 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-baloom-2-panthenol-hydro-airy-sunscreen-76166a8e1258bb36 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jack-black-sun-guard-sunscreen-spf45-11d1342f09fc9fc4 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gas-relief-mint-flavor-b180d559ff2535ed 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-henry-schein-povidone-iodine-prep-pad-81fbd0914690a99f 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gocovri-82a404236e5a1a35 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-mucus-relief-severe-congestion-and-cough-f710e7b1445ced68 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-remedy-antifungal-with-olivamine-51fd828d06101007 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-intense-therapy-lip-balm-basil-lemon-11c1c2c0cb6eab1b 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-fiber-laxative-6fe5768eb18749f6 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibuprofen-0ab98dedd1f109b5 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-rizatriptan-benzoate-9cb7cd03cb346b6c 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-temazepam-1493397ecc75f9a7 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-telmisartan-and-hydrochlorothiazide-38097fca411de6b8 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-freshmint-premium-anticavity-6130335239e19fe8 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-fluticasone-propionate-and-salmeterol-diskus-90cafa84bcde75b2 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jack-black-intense-lip-therapy-spf25-black-tea-and-blackberry-22eb3fa7f4dac033 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibuprofen-minis-e7d71de53a87003d 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-medline-e5f6e808cb6975c6 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-63f74e54e64d4b8f 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-intense-therapy-lip-balm-pineapple-mint-4b142735c95284f8 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-thyroid-support-113e8b12e807cefd 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-dapagliflozin-34b4fff388ddc511 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pepto-bismol-fast-melts-fresh-berry-flavored-f616d20ad8daef35 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-imatinib-mesylate-893a33ea1b0588f5 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-vicks-zzzquil-nighttime-sleep-aid-diphenhydramine-hcl-free-of-192ef96369f04157 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-clonidine-hydrochloride-f79a41c83c300454 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-prednisone-08ef9ceeba00368e 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-accelerated-share-repurchase-agreement-d3b6ea9ca8945a2a 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-and-yun-announce-expansion-to-mexico-and-across-additional-emea-ma-f40b7d30c789ecd7 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pr-siliq-brodalumab-injection-now-reimbursed-under-alberta-s-public-drug-plan-im-e79ea40f76db38fd 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/outcome-definitions-in-clinical-trial-registrations-a-cross-sectional-study-80ea0dc761f2ea79 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-finding-of-alfentanil-for-hysteroscopy-under-remimazolam-sedation-in-obese-001b1c4206a097fa 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-regain-following-discontinuation-of-glucagon-like-peptide-1-receptor-agon-3d2b27b63ab4136d 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-angiogenesis-in-drug-discovery-current-status-and-future-directions-a0d585ced726991e 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-bench-to-bedside-overcoming-translational-hurdles-in-nanoparticle-research-8edb43f793df5aa0 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptive-ai-based-mobile-simulation-for-drug-calculation-competency-in-nurses-a-a38487112b01837a 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-pharmacokinetics-and-pharmacodynamics-of-the-glp-1-gip-gcg-receptor-agoni-732b3a954859f846 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/butylphthalide-combined-with-tenecteplase-in-mild-disabling-acute-ischaemic-stro-8632aa90834b8816 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cross-sectional-analysis-of-safety-reporting-in-sleep-disorder-clinical-trials-2fd486fc8261752c 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systematic-review-and-meta-analysis-of-intrathecal-drug-delivery-systems-for-the-78fe51bd2837a2ad 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomised-phase-iii-trials-of-cancer-prevention-drugs-a-systematic-review-and-p-e0ab6c687137bfcb 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-bayesian-phase-i-ii-trial-design-to-optimizing-dose-schedule-regimen-with-comp-2fe1ae9d0f6e2108 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-various-types-of-remineralizing-agents-on-the-remineralization-of-mild-6e735d880cd42199 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-microdrop-administration-using-a-bottle-adapter-of-2-5-phenylephri-1bd95ea7d3830788 2026-09-08T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gloria-montenegro-primera-mujer-premio-nacional-de-ciencias-aplicadas-y-tecnolog-1f7178fb0c133adb 2026-09-07T22:18:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulation-un-estudio-liderado-por-el-dr-pablo-garcia-pavia-permite-identificar-a4d5cd573291d7e0 2026-09-07T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-presenta-los-planes-para-el-nuevo-intermountain-lds-hospita-e43ee0403416d545 2026-09-07T18:11:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/physiotherapy-in-peckham-gym-boosts-health-of-people-with-neurological-condition-a35651e1571dfd50 2026-09-07T17:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/scottish-first-as-glasgow-s-royal-hospital-for-children-introduces-minimally-inv-961beaa3e021b4ed 2026-09-07T15:24:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-label-single-dose-randomized-parallel-group-study-of-the-safety-and-rela-20e79555c0c2c5b6 2026-09-07T14:42:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-eligible-for-northern-ireland-mhra-authorised-route-ea4846a98bf6c2a7 2026-09-07T14:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/web-development-opportunity-a437b029f022934f 2026-09-07T14:00:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuit-mediterraneenne-des-chercheuses-l-information-scientifique-a-la-source-908289742a21c728 2026-09-07T13:50:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/site-strategy-for-a-geographically-constrained-parkinsonian-imaging-study-834a84a05715d89b 2026-09-07T13:20:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-first-short-tailed-tsushima-leopard-cat-0fb1cb0804e8cb98 2026-09-07T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-be-on-tour-2026-een-eerste-sessie-om-het-concurrentievermogen-van-belgie-33f88a9a0667cab1 2026-09-07T11:46:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/only-around-half-of-primary-school-children-got-their-flu-vaccine-last-year-403f49a5bd04d397 2026-09-07T11:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/de-toekomst-van-innovatie-hangt-ook-af-van-onze-ziekenhuizen-81958fc9d5ff9a18 2026-09-07T11:39:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/tobacco-and-vapes-packaging-appearance-and-display-b0f65b22298b2fc9 2026-09-07T11:19:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-fordert-zwei-verbundprojekte-unter-heidelberger-federfuhrung-mit-fast-acht-mi-7eb025b82d5324e2 2026-09-07T09:41:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-41-report-data-to-week-40-dat-57a8ff892a5702f4 2026-09-07T09:40:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-4-october-2026-3416de2db5fbba30 2026-09-07T09:40:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-european-joint-programme-on-rare-diseases-d53cc8321f2dea5f 2026-09-07T09:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-harmonised-approach-to-early-feasibility-studies-for-medical-devi-0fb60975f2bf9da6 2026-09-07T09:40:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-41-report-data-to-week-40-data-up-t-544b20cee08c6ce5 2026-09-07T09:32:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-healthy-adaptation-to-pregnancy-postpartum-and-parenthood-82c4989530fdfda2 2026-09-07T09:25:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-and-sleep-action-share-practical-sleep-support-for-babies-and-young-child-f6d1f25220c4ac33 2026-09-07T09:25:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-lpt-laser-based-proton-therapy-syslpt-laser-based-proton-therapy-6966003adb9cf5cc 2026-09-07T09:24:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/it-infrastructure-cyber-security-epic-and-mychart-seminar-85ac3a09b5346e12 2026-09-07T09:18:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/policy-afternoon-explores-how-policy-can-tackle-unequal-neighbourhoods-and-unequ-2576a8ae2a3c7344 2026-09-07T09:08:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/treat-education-as-infrastructure-during-wartime-say-researchers-in-ukraine-ca2341643493eb6d 2026-09-07T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-digital-transformation-amanda-strydom-on-women-technology-and-leadership-b25e6893da42d72b 2026-09-07T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-protection-in-children-and-young-people-s-settings-including-education-cca215b8fd3fb49b 2026-09-07T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/master-programme-strategic-entrepreneurship-once-again-favoured-by-employers-ec26a88947c1fc48 2026-09-07T08:25:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-are-embl-anna-foix-on-doing-a-phd-later-in-life-76268c0809363a41 2026-09-07T07:44:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/amarin-group-esg-3-9-ftse-russell-ea572dc6a605d4a4 2026-09-07T07:35:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/eczema-effects-are-more-than-just-skin-deep-f398f85efaed0b88 2026-09-07T07:06:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/barrier-systems-building-safety-together-478a3ea4b51a3947 2026-09-07T07:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/mysyntegon-fully-integrated-spare-parts-purchasing-cbf47515895dc5f4 2026-09-07T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-37-report-data-to-week-36-dat-12867e0648495a43 2026-09-07T06:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/11-jbda-1e862f8e99770ad1 2026-09-07T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-achievement-related-to-chugai-originated-nemolizumab-receives-the-11th-698ca4f032fd30e5 2026-09-07T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/en-image-le-fabuleux-destin-de-l-adn-15f25ea35e9434b7 2026-09-07T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/residual-surgical-left-atrial-appendage-leaks-thromboembolic-risk-and-anatomy-ta-6447a932fb14f24b 2026-09-07T03:55:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-long-should-we-wait-revisiting-the-observation-period-after-drug-related-adv-07bb0df4f0c7677f 2026-09-07T03:44:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/not-so-innocent-after-all-cardiomyopathy-induced-by-benign-premature-atrial-cont-7ffd2a3c93986746 2026-09-07T03:37:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/pacemaker-implantation-in-patients-with-syncope-bundle-branch-block-and-negative-935629a570b2775c 2026-09-07T03:33:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/clues-from-the-device-individualized-programming-to-solve-a-pacing-facilitated-a-3d96a0e5afebb1c4 2026-09-07T03:32:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/chlorhexidine-or-povidone-iodine-for-cied-procedures-lessons-from-chlovis-and-wr-f2e6a48a8d47ccb7 2026-09-07T03:31:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/spontaneous-termination-of-an-svt-what-is-the-mechanism-d1eeedc4a84dc54b 2026-09-07T03:28:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/issued-hoya-integrated-report-2026-d8470a5c9a9611a7 2026-09-07T03:21:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/hoya-2026-f6a735ff4af36f5a 2026-09-07T02:51:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/una-culla-da-720mila-bambini-773140b0a2a635a6 2026-09-07T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-muscle-for-healthy-ageing-innovative-treatments-for-sarcopenia-153c420c28dd5ab2 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-siloed-biomedical-opportunities-f58e9de00399074a 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hand-sanitizer-vanilla-frosting-502a8098e1a85c7c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-nadolol-9ecde2dfb8ab0283 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-american-safety-and-first-aid-triple-antibiotic-73419f5abf1f0e8e 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-american-safety-first-aid-a829d4721e66769d 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lady-speed-stick-24-7-fresh-fusion-3cc457ca2f39b640 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hydrating-mist-hand-sanitizer-with-silicone-keychain-holder-be-864d678e71f2b91f 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-medi-first-topical-analgesic-3c8148ed4f999e88 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pain-relieving-lidocaine-patch-bf93f3783ab22813 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-candesartan-cilexetil-b916f82c8372ddec 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-mycophenolate-mofetil-b26da168ebd7aaa8 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hydrating-mist-hand-sanitizer-with-silicone-keychain-holder-si-9ffe521131db9c95 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hsenjt-arnica-bruise-cream-3f2dbcb573a9d9c2 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hsenjt-antifungal-cream-b03d186973378fab 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bzk-antiseptic-towelette-7757b41c536188cf 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sting-relief-pad-b2fae5b78e3baa71 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-alcohol-prep-pads-medium-sterile-06e2f1ee977c552c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-3a33edb2c5e2a501 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-speed-stick-power-ultimate-sport-7bc931b75bd52c25 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hand-sanitizer-cherry-sundae-d156d9e332eb3a64 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoparticle-based-strategies-to-enhance-psma-targeted-radioligand-therapy-a-rev-635a306c2914999f 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/receptor-co-targeting-strategies-for-personalized-ovarian-cancer-therapy-0dd4454aa179e36c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analgesic-efficacy-of-continuous-bupivacaine-infusion-versus-liposomal-bupivacai-6c532637b527edad 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/traditional-chinese-medicine-formulation-chang-kang-fang-restores-gut-brain-home-6fbc3185cb8f3567 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/race-neutral-global-lung-function-initiative-2022-equations-alter-copd-trial-eli-eda0654acc27bb27 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-burden-of-the-neuro-conda-trial-8d7252e7b86c49c2 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integration-of-proteomic-aging-clocks-in-a-phase-2a-clinical-trial-supports-simu-7be6a31c09a0d1b6 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-1-1b-open-label-first-in-human-study-of-her2-cd3-cd28-trispecific-t-cell-e-2add2c2c46e5c234 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/salovum-reduces-mortality-in-isolated-severe-traumatic-brain-injury-a-randomized-f5280cc30cebfe6c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/use-of-the-bacterial-lysate-om-85-for-the-primary-prevention-of-wheezing-lower-r-daaaa4b1cdcd0cc5 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-lebanese-community-pharmacists-perceptions-and-practices-towards-p-29b4dbe8992d3edd 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-antidepressant-effects-of-the-mglu2-3-receptor-antagonist-ts-161-in-treatmen-252e248060ef67c5 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apatinib-monotherapy-for-pretreated-advanced-squamous-cell-carcinoma-of-the-peni-b5cf00b7b6810d89 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-fixed-dose-combination-therapy-with-cilostazol-and-rosuva-6f26c99c15c20bdb 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-bioequivalence-guided-pbbm-prediction-for-ibuprofen-diphenhydramine-citr-b4d8d537d00b5eff 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-corticosteroids-in-herpes-simplex-virus-encephalitis-a-meta-analysis-e715ee16f58019ab 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-dose-ticagrelor-combined-with-aspirin-for-preventing-early-neurological-dete-8818d98d390612bd 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selecting-vehicle-comparators-in-dry-eye-disease-clinical-trials-implications-fo-71d14de03c0ea035 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-randomized-controlled-trial-of-a-multimodality-digital-health-intervention-to-c65082810d3a9f7c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-fit-for-purpose-data-for-drug-assessment-in-non-small-cell-lung-cancer-a-db501588ecd6454c 2026-09-07T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnic-en-la-noche-europea-de-los-investigadores-2026-9f569d08feda7000 2026-09-06T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecl-unit-leader-leo-speidel-elected-a-2026-ays-fellow-in-life-sciences-1239c02237fbe4ef 2026-09-06T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-domenica-robotica-in-policlinicomi-un-attivita-del-servizio-pubbl-81e039f24a82bfb5 2026-09-06T11:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-noicaky-fungal-nail-patches-c59b3d0016266246 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-skin-wart-remover-liquid-4a1fa90f63dc48d5 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-inlifay-antifungal-1b0d8445adbc37b5 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-versacloz-84957927c389ee11 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-systematic-review-and-meta-analysis-of-malnutrition-and-metabolic-failure-in-h-578281ce772199cb 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/complete-response-to-tislelizumab-in-an-elderly-patient-with-metastatic-pulmonar-8f9345734e9a9b24 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-registry-based-perspective-of-interventional-clinical-trials-for-duchenne-musc-9f2fc0f042f3f538 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-governance-gap-democratizing-drug-development-through-decision-architecture-becae90846bdc86f 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-evidence-generation-by-linking-randomized-clinical-trials-to-real-worl-5d94e8e18f9c4ad2 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidence-pathogenesis-clinical-manifestations-and-pharmacological-management-of-758f2191ed7760e6 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-invisible-to-enrolled-how-artificial-intelligence-is-reshaping-clinical-tri-53e62a54872a53c7 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-the-first-adalimumab-biosimilar-in-chinese-children-with-352203f85cd9c0f8 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-shelved-pipeline-ai-can-find-strategically-abandoned-medicines-and-bring-the-4f9bf51e7513fec4 2026-09-06T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-lamenta-a-morte-do-professor-emerito-carlos-russo-5747460dcad6af69 2026-09-05T14:42:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recasts-drug-packaging-oversight-with-science-and-risk-based-container-closu-212514b16ec9a406 2026-09-05T14:29:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/oric-stock-holds-steady-as-biotech-eyes-next-trial-and-earnings-0490ce6768597bd1 2026-09-05T14:15:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/vrxa-jumps-as-traders-focus-on-biotech-breakout-setup-ffe5bbb195e962d9 2026-09-05T14:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-lothar-medical-sign-loi-to-commercialize-alds-pro-for-clinical-tr-55866726d735e72b 2026-09-05T14:03:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/annovis-bio-stock-reacts-to-webinar-plan-and-steep-discount-to-analyst-targets-60ea8056814b23fb 2026-09-05T14:02:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-healthcare-professionals-view-greener-pharmaceutical-manufacturing-favo-86972c80169790db 2026-09-05T12:58:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/synh-stock-reflects-syneos-health-s-move-to-go-private-bd6ccbf69dfad23d 2026-09-05T12:31:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/symbiosis-pharmaceutical-services-appoints-jos-vergeest-as-senior-business-devel-90c6b0f056e0860b 2026-09-05T12:29:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-ms-pill-that-beat-standard-therapy-and-cleared-the-safety-bar-its-rival-coul-59dc69ca9441f4d0 2026-09-05T12:23:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/before-the-first-molecule-making-better-target-and-modality-decisions-44248c637b5c8dfc 2026-09-05T11:59:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/bpom-invites-pharmaceutical-industry-to-bolster-clinical-trials-3a5d10ffdcf5d92b 2026-09-05T11:47:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-cancer-vaccine-breakthrough-ignites-sequencing-sector-tempus-ai-s-p-d35b5a3721aae31d 2026-09-05T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-drug-for-alexander-disease-247a4f900fe6e339 2026-09-05T10:47:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-therapeutics-gains-fda-approval-for-casg-2f0879fdfbacbdd9 2026-09-05T10:40:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-beijing-sl-pharmaceutical-co-ltd-class-a-stocks-bbd678d351a029d1 2026-09-05T10:30:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/nykredit-a-s-purchases-new-position-in-teva-pharmaceutical-industries-ltd-teva-49444cde7f7fa55b 2026-09-05T09:42:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/adverum-biotech-advm-free-cash-flow-2024-92-8m-outflow-down-1-2-48a480bd60f45ef8 2026-09-05T09:09:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-discovery-catapult-backs-uk-biotech-innovators-b7fd54a7eaf805c9 2026-09-05T09:06:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-scientists-made-huge-bets-on-impossible-cancer-treatments-they-re-finally-pa-db7a691a13ee6f25 2026-09-05T09:00:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-ltd-nyse-teva-given-average-rating-of-moderate-bu-2b9e2a547e63dda0 2026-09-05T08:33:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/symbol-stock-quote-price-and-forecast-eb86857047c09609 2026-09-05T08:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-rises-overnight-healthcare-execs-tout-aml-drug-as-game-changer-ahead-o-12a417a1f58a5f3b 2026-09-05T07:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhibrx-to-present-inbrx-106-phase-2-data-in-head-and-neck-cancer-study-7bc60e333f0cfecf 2026-09-05T07:31:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-extra-year-that-made-all-the-difference-2d795dc0f906e085 2026-09-05T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tarsus-pharmaceuticals-acquires-alkeus-gildeuretinol-for-stargardt-disease-4dd965f22b50d017 2026-09-05T06:41:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/pelacarsen-fails-to-meet-primary-endpoint-in-phase-3-lp-a-trial-0ea1f443261d0062 2026-09-05T06:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-small-cap-biotech-posted-impressive-brain-cancer-data-but-there-s-a-catch-4e3e96481ca46f3d 2026-09-05T06:32:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-what-is-behind-the-fresh-attention-95db6bebddecf959 2026-09-05T05:39:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-s-breast-cancer-drug-etcamah-gets-us-fda-approval-41925e83fc4b1cbb 2026-09-05T04:56:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-3-japanese-ai-healthcare-stocks-to-watch-in-september-2026-75b00280cb33900d 2026-09-05T04:40:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-grand-pharmaceutical-group-sehk-512-is-back-in-the-spotlight-12d7b62e79cc7d2b 2026-09-05T03:53:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-wst-and-the-glp-1-story-behind-its-fair-value-gap-08239ff0c5b30182 2026-09-05T02:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-lp-a-drug-fails-to-lower-cardiovascular-risk-in-closely-watched-ph-3-tr-4ff0f635ef6e2a9a 2026-09-05T01:18:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-ultragenyx-pharmaceutical-rare-is-down-40-3-after-angelman-trial-failure-and-ec2e08344eda4d1e 2026-09-05T01:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aporte-de-eeuu-ayudara-a-preservar-el-patrimonio-del-observatorio-manuel-foster-cc29731f33779666 2026-09-05T00:11:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/culture-media-alter-retinal-organoid-physiology-promoting-aav-transduction-and-r-e9eb6e7f60399244 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-endoscopic-versus-shunt-treatment-of-hydrocephalus-in-infants-7bb9776f90b8cebc 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mexican-teachers-cohort-study-genetics-and-cognitive-function-8748cd6c311b8bac 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-consortium-for-advancing-management-and-prevention-of-cancer-in-people-cfcd9f1e3695b9aa 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-aina-based-engagement-and-social-epigenomic-pathways-to-metabolic-heal-680bde3ce7adc92c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modeling-second-hit-somatic-mutations-in-hht-to-uncover-mechanisms-of-39b0d54321e66296 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-regulation-of-proteasome-activity-a44ed2c17835a78e 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-bacterial-survival-in-fluctuating-environments-stochastic-switches-rec-015dede062f415e7 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-study-of-the-parp-inhibitor-hwh340-in-advanced-solid-tumors-with-5707e4f10c0de564 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/elucidating-the-release-and-permeation-mechanisms-of-emulsion-type-cataplasms-fr-c42dc6128790d2ba 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-veterans-with-low-back-pain-benefit-from-transcranial-direct-current-stimula-676c5fc09b9b6824 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/persistence-of-immune-responses-5-years-after-vaccination-with-a-single-dose-of-e754be3d277811a2 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-dvdms-photodynamic-therapy-for-dysphagia-in-advanced-esop-f92c804ed3b86aec 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-analysis-of-antiviral-therapies-in-chronic-hcv-patients-clinical-out-4bcf8aa6f1254c3f 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-efficacy-and-safety-of-intraoperative-hyperthermic-intraperitoneal-ch-7f64a205b02b1996 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alianza-terapeutica-y-cambio-clinico-en-psicoterapia-digital-una-revision-sistem-23f9bbee850cb5bf 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seroprevalence-of-helicobacter-pylori-among-patients-attending-ignatius-ajuru-un-e817d25f76b3529f 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-renal-anomalies-associated-with-culture-positive-urinary-tr-6a058814af559638 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-outcomes-of-paediatric-traumatic-brain-injury-an-experience-b5e4628be31d8910 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-and-outcome-of-childhood-cancer-over-2-years-at-a-tertiary-care-0901d6200d429697 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-acute-bacterial-meningitis-prevalence-clinical-profile-and-outcome-lt-b-44fb431196e05a86 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-three-component-drug-regimen-glutamyl-tryptophan-bendazole-asc-940b332fe1c13baf 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-parameters-of-a-combination-drug-containing-imidazolyl-ethylamid-0baeae1ef1811af1 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-chinese-medicine-compound-on-intestinal-bifidobacteria-recovery-and-cd-df2c56cc86dd2216 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/features-of-intestinal-lesions-in-the-clinical-course-of-inflammatory-bowel-dise-970e38ee5edd81b4 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unusual-pulmonary-vein-variations-a-new-case-report-and-its-clinical-significanc-4bf10286dc5f4ada 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-proton-pump-inhibitor-therapy-on-micronutrient-and-cognitive-function-62002486099678ba 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phospholipid-drug-complex-tagged-snedds-lipid-based-approach-for-oral-bioavailab-c7c8e348c293d485 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-magnesium-supplementation-in-hypomagnesemia-on-wound-healing-in-diabet-3235a2566597306d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-parent-s-knowledge-attitude-and-practice-regarding-self-medication-1a082b786f063c53 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-latent-fingerprints-using-air-dried-plant-extract-powders-an-eco-24b27d64d6b9e5da 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-albumin-and-c-reactive-protein-as-predictors-of-intradialytic-hypotension-527e7083789e3728 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/indomethacin-loaded-nano-emulsions-a-promising-topical-platform-for-oral-mucosit-de142850bb89dfba 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-a-structured-educational-intervention-on-internalized-shame-and-8a264b80d1242c1f 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-risk-factors-for-trocar-site-hernia-a-single-center-6acba75f63e42b8d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-phase-i-cardiac-rehabilitation-exercise-training-combined-with-res-7e11f5cc1ac0f5aa 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obstetric-and-non-obstetric-sources-of-maternal-sepsis-and-their-clinical-outcom-89a82e968531c98d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/membrane-dependent-adsorption-of-lacosamide-in-crrt-implications-for-drug-dosing-11985cfa1e92275b 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/computational-mechanistic-analysis-of-olefin-formation-in-ketyl-radical-mediated-387a0d92a6b60c7c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-d3-attenuates-delirium-like-cognitive-impairment-in-a-postoperative-mous-eb241ee61b13fa6d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sleep-disorders-and-type-2-diabetes-mellitus-a-narrative-review-of-evolving-rese-730f270c3499e5e1 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-nutrition-counseling-on-undernutrition-among-children-aged-6-23-months-663f1c3275a7ca69 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-clinic-a-feasibility-trial-of-the-super-skills-for-life-program-for-c-61c73a836a739fb4 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breast-cancer-risk-epigenetic-aging-and-dna-methylation-clocks-dc075747faf8999c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/occurrence-levels-of-alexithymia-in-clinical-nurses-a-systematic-review-and-meta-108c5446f3f8e4c7 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-context-feedback-visibility-cfv-framework-mechanisms-of-ai-empowered-clinica-7efd35f46f69cb99 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/critical-insights-into-metastatic-patterns-of-odontogenic-tumors-clinical-charac-eb9af3d399b9272e 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-consequences-treatment-status-and-parental-awareness-of-traumatic-denta-fc0a1196aaf37063 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-of-vulvovaginal-atrophy-using-vaginal-dilators-in-addition-to-usual-ca-4242fd54c94d016c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-flow-nasal-cannula-versus-standard-oxygen-therapy-for-adult-acute-hypoxemic-d3e330c8f799849a 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/police-drug-seizures-without-arrest-before-and-during-a-decriminalization-pilot-688876b1023a3c02 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-validation-of-a-clinical-prediction-model-for-gastrointestinal-h-1b609f467ec5b699 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zmynd11-mbtd1-rearranged-acute-myeloid-leukemia-in-chinese-adolescents-and-adult-d8038dd60bc332d8 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-recovery-after-intravenous-thrombolysis-for-acute-i-1221e2272189e5a2 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-decision-making-and-management-of-gliomas-in-the-second-trimester-case-9fe4c99be97c0c3e 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/routine-clinical-test-markers-with-mri-anatomical-anchoring-for-dysphagia-risk-i-8d698514170983c8 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-transcriptomic-profiling-identifies-hub-genes-with-diagnostic-and-clinical-3c85b97a8b7e0394 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autonomic-regulation-as-a-mechanistic-pathway-linking-transcutaneous-auricular-v-8b6316e7240ed992 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changing-clinical-presentation-of-pediatric-celiac-disease-over-time-632b1d895da2aaca 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/technology-meets-time-assessing-the-impact-of-clinical-decision-support-tools-fo-aae966df0229d21c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stroke-clinical-documentation-education-program-in-australia-and-new-zealand-c16e50de14a9a450 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/telehealth-in-pediatrics-a-quick-review-4397f75451a924a4 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-case-worst-case-a-multisite-randomized-trial-of-scenario-planning-for-patie-97c9bff1883fe3f8 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/financial-impact-of-a-long-acting-injectable-cabotegravir-rilpivirine-program-a-f2e44332314ebf3f 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-scandinavian-perspective-of-the-projected-lifetime-cost-effectiveness-of-rivar-f7f7bd844069977d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufasomal-nanocarriers-for-enhanced-cardiac-delivery-of-nifedipine-a-novel-strate-afda9338ec3346e3 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-hptlc-method-for-simultaneous-estimation-of-gatifloxacin-and-flur-3592b3a4c663329e 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/age-associations-sex-differences-and-interrelationships-of-five-skeletal-maturit-2bd54d31e65ec6bc 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gastrointestinal-tolerance-and-compliance-during-a-2-week-intervention-of-reform-a1263f1c370bc29d 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investigating-the-short-term-reliability-of-health-related-physical-fitness-asse-5eeefa5eca21ad72 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burden-of-complex-multimorbidity-and-disparities-in-care-and-support-among-older-657be33be128dfb8 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-echocardiography-and-point-of-care-ultrasound-applica-d5c8cbce011330d7 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-recombinant-bacillus-ligniniphilus-l1-laccase-rice-straw-biocha-3b201a8978622e70 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploiting-binary-eutectic-fatty-acid-systems-for-thermoresponsive-nanocarriers-7f4d2fdc58ed3b61 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-efficacy-of-betamethasone-ciprofloxacin-and-saline-impregnated-nasal-a9a8c4422417da23 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulge-progenitor-cells-a-promising-frontier-in-hair-follicle-regeneration-and-cl-3d7c2672d8da15c8 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibody-drug-conjugates-in-the-treatment-of-esophageal-cancer-d07dfe0cb30e9961 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-supervised-exercise-immediately-after-bariatric-surgery-results-from-7145cbcebd22bb81 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cross-tier-implementation-gaps-in-pharmaceutical-waste-management-evidence-from-1b0cb6f2ef757071 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/institutional-phronesis-theorizing-how-us-primary-care-clinicians-navigate-compe-1dfeb77573914e75 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/systemic-evaluation-of-immune-cells-and-cytokines-in-patients-with-different-cli-30b411be4f72f0f0 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concurrent-emergency-head-and-cervical-spine-ct-utilization-temporal-trends-diag-dc8d9f020852509c 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moraxella-species-isolated-from-blood-cultures-in-europe-moraxeu-a-multicentre-s-9dbfe48cf40dc4fa 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibero-american-consensus-on-reactive-arthritis-definition-diagnosis-and-manageme-059966e2abc9b36a 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chloroquine-and-hydroxychloroquine-retinopathy-in-a-cohort-with-rheumatic-diseas-d7f29972f4ddb543 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-practice-guidelines-for-duodenal-cancer-2025-4164950c8ec243b7 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-a-smartphone-based-educational-intervention-on-the-supportive-care-75ad4aa4690acbf1 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-survival-of-esophageal-squamous-cell-carcinoma-achieving-pathological-ed2136739cfc6e80 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-analysis-of-post-neurosurgical-intracranial-infections-distinct-clin-1129b9da52f1058f 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/video-assisted-versus-conventional-surgical-informed-consent-in-visceral-surgery-5313463edb15ecf5 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-88-meets-72-refining-the-clinical-relevance-of-cesarean-scar-disorder-crite-add3ff9d204cc156 2026-09-05T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/retatutride-how-the-hunger-for-a-new-weight-loss-drug-is-feeding-an-industry-of-a21a403b35712d2a 2026-09-04T23:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/retatutride-how-the-hunger-for-a-new-weight-loss-drug-is-feeding-an-industry-of-3263ee450ff58f10 2026-09-04T23:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-president-r-d-suma-krishnan-sells-8-98m-in-stock-df91173fa47ede2e 2026-09-04T23:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/royalty-pharma-announces-update-on-novartis-phase-3-topline-results-for-pelacars-bc1f4aaad1074d58 2026-09-04T23:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-r-d-head-sells-25-000-shares-under-trading-plan-cb1e83004cab11e9 2026-09-04T23:16:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-nasdaq-krys-ceo-sells-25-000-shares-under-trading-plan-769f72394190993e 2026-09-04T23:15:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-limited-teva-discusses-positive-topline-results-f-1d262411b8d372e2 2026-09-04T23:08:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-microstructure-intelligence-matters-in-pharma-canva-4ef5ef0edcc9f338 2026-09-04T22:57:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmtech-weekly-roundup-september-4-2026-7533b9f88b60a135 2026-09-04T22:57:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/budget-for-specialty-pharmaceutical-benefits-set-at-6-73-billion-299e9cedc1dc9a28 2026-09-04T22:25:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-beijing-science-sun-pharmaceutical-co-ltd-class-a-s-f590ad736661f465 2026-09-04T22:18:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/adrx-ipo-news-sirna-biotech-adarx-pharmaceuticals-files-for-a-100-million-ipo-30c48b5f6850499b 2026-09-04T22:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-down-on-retreat-from-risky-biotech-area-health-care-roundup-8a5b670f583adb85 2026-09-04T21:26:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-temperature-controlled-shipping-boxes-market-outlook-to-2035-2902f61bf810da37 2026-09-04T21:21:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/louisiana-et-al-v-food-and-drug-administration-a-case-working-its-way-through-fe-66ad1de31182382d 2026-09-04T21:16:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-experimental-cardiovascular-drug-fails-a-pivotal-study-9ae30b6c2563ebf7 2026-09-04T21:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-a3f827cc018f20b4 2026-09-04T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-rallies-hrt-manufacturers-amid-us-wide-estradiol-patch-shortage-efd1ca9295aa5ff4 2026-09-04T20:37:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-nasdaq-krys-holder-to-sell-25-000-founders-shares-7f15233a6b29e374 2026-09-04T20:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-insider-moves-to-sell-2017-shares-in-a-multimillion-dollar-ca5b3b0ebae69cca 2026-09-04T20:34:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-announces-lp-a-horizon-phase-iii-topline-results-for-pelacarsen-in-pati-867479c87b906007 2026-09-04T20:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anmat-emitio-una-carta-de-advertencia-a-ugal-farmaceutica-s-a-por-incumplimiento-3ee3a16bbcc2f661 2026-09-04T20:25:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clears-ind-for-acepodia-s-dual-payload-adc-ace723-562cd23a52fb1859 2026-09-04T19:55:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-virtus-lifesci-biotech-products-etf-bbp-affects-rotational-strategy-timing-ba10d3e23ea6d928 2026-09-04T19:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-sales-forward-of-ch-biotech-r-d-co-ltd-twse-6534-c184512b86e2c429 2026-09-04T19:31:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-vs-regeneron-which-biotech-giant-is-the-better-buy-right-now-d7df5d6599582fab 2026-09-04T19:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-partners-with-qilu-pharmaceutical-to-commercialize-a-keytruda-biosimilar-i-02acbe0f0bb78c07 2026-09-04T19:27:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/gan-lee-pharmaceuticals-ade7c29f5fb27ce0 2026-09-04T19:22:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-green-light-for-zanvastro-in-alexander-disease-f88683f75405f5fc 2026-09-04T19:04:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-vs-regeneron-which-biotech-giant-is-the-better-buy-right-now-793b08ac95d107c2 2026-09-04T19:03:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-vs-regeneron-which-biotech-giant-is-the-better-buy-right-now-f1e282e1506ed3dc 2026-09-04T18:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-nyse-teva-price-target-raised-to-48-00-at-ubs-gro-3718e94073907b30 2026-09-04T18:45:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/beone-onc-secured-a-pharmaceutical-tariff-exemption-after-more-than-1b-of-u-s-ma-75b7a23003457f36 2026-09-04T18:44:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/porcine-kidney-xenotransplantation-as-a-bridge-to-allotransplantation-a-first-in-5c486e8a729f25d2 2026-09-04T18:16:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-goldman-sachs-group-issues-pessimistic-forecast-for-ultragenyx-pharmaceutica-679089eff3672c38 2026-09-04T18:15:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/jos-vergeest-appointed-at-symbiosis-bringing-three-decades-of-pharmaceutical-exp-5f4fcc7a587f046f 2026-09-04T18:06:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-brain-disorder-gets-its-first-fda-drug-approval-c9ccac9f39aac17f 2026-09-04T17:52:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-pharma-will-navigate-the-ndc-12-transition-1f1847cc4d566e17 2026-09-04T17:51:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-pauses-autoimmune-car-t-trials-following-three-deaths-a0de109acce01059 2026-09-04T17:46:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/h-c-wainwright-maintains-legend-biotech-legn-us-with-buy-rating-maintains-target-6ca84d6d182f68e0 2026-09-04T17:42:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/police-response-insufficient-for-crimes-against-pharmacies-report-owners-d78a9e8392e46ad6 2026-09-04T17:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/call-to-expand-shingles-vaccine-following-cardiovascular-research-bf9e54f857af915a 2026-09-04T17:38:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-zanvastro-pharmexec-ae001a6459d6b4f4 2026-09-04T17:37:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-strikes-again-closes-canteen-at-thane-government-hospital-after-d572cd8cb0d16e22 2026-09-04T17:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicines-discovery-catapult-backs-two-u-k-biotech-companies-tackling-chronic-di-2a91e1113b88c4ae 2026-09-04T17:28:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-biotech-firm-inks-office-deal-in-south-san-francisco-cb565b9f4316a748 2026-09-04T16:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/cockroach-found-in-patient-s-meal-fda-flags-violations-shuts-thane-hospital-cant-ac237dad9aeb2eb7 2026-09-04T16:38:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfizer-s-tilrekimig-eczema-trial-a-fresh-phase-3-catalyst-for-pfe-investors-e00d8772d820793f 2026-09-04T16:34:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-executives-to-speak-at-upcoming-investor-conferences-fe0d7b9078a66a84 2026-09-04T16:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-biotech-wins-a-big-fda-approval-why-wall-street-is-shrugging-12974b5b8bd07770 2026-09-04T16:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trailing-rivals-abbvie-scores-win-with-dual-acting-myeloma-drug-43b029fb663ef74c 2026-09-04T16:10:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/registration-open-for-sacramento-biotech-summit-at-aggie-square-9524742bf36c6654 2026-09-04T16:05:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/genencell-s-book-value-hits-zero-amid-allegations-kim-seung-won-sought-clinical-5a6dd76f4aaac2ed 2026-09-04T16:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-is-revolutionizing-biotech-can-regulation-keep-up-adcb553923ba9ce2 2026-09-04T15:57:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-mfn-expansion-goodrx-s-family-plan-csafe-s-reusable-cover-bb893e9003f89293 2026-09-04T15:44:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-ltd-upgraded-to-investment-grade-by-s-p-global-ra-5a9fbf7fc25733d9 2026-09-04T15:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-wall-street-analyst-spotted-the-trial-freeze-then-came-news-of-three-deaths-25accbeac58f1638 2026-09-04T15:33:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/daiichi-unit-american-regent-recalls-3-epinephrine-batches-on-particulate-leakag-9cab5fe17071222c 2026-09-04T15:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/paul-cooper-named-chief-of-uc-irvine-police-department-abb9a67ac0e5a0bd 2026-09-04T15:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/school-based-prevention-programs-for-gaming-disorder-and-problematic-online-habi-f0615dacb01a5ba6 2026-09-04T15:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/va-secures-10b-in-pharmaceutical-price-reductions-so-far-in-fy-2026-e5596cc90a2b64ca 2026-09-04T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-attacks-teva-pharmaceutical-company-and-world-health-organization-warehou-01cc1de6ad42dde7 2026-09-04T14:51:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-model-decodes-the-language-cells-use-to-communicate-1b89adc9a6e5508d 2026-09-04T14:50:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/former-i-mab-chief-joan-shen-s-neushen-banks-80m-for-3-brain-health-drugs-ac240652b9285082 2026-09-04T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-stock-rises-after-naming-raju-willener-as-cfo-by-investing-com-7a40239d54805b10 2026-09-04T14:43:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-digest-expedited-regulatory-pathways-for-biologics-79b10a02d16847cd 2026-09-04T14:43:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-announces-exclusive-partnership-with-qilu-pharmaceutical-for-the-licensing-b2c729fc50676a80 2026-09-04T14:24:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-indonesia-to-the-world-support-beta-pharmacon-s-manufacturing-excellence-wi-c162257ad511f15b 2026-09-04T14:22:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-is-back-with-h1-progress-smoothing-glide-path-through-end-of-year-truist-2ed583a9b16ec59c 2026-09-04T14:11:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-ions-mist-biib-azn-win-nods-tcrx-nvs-cut-jobs-ovid-vir-data-regn-pas-e786e36eef9e1887 2026-09-04T14:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-appeals-court-to-consider-louisiana-s-arguments-for-banning-telehealth-a-176f77491e2393f9 2026-09-04T14:04:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/q-a-mckesson-s-scott-mooney-on-closing-dscsa-data-exchange-gaps-6c5b4921e97cadab 2026-09-04T14:04:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-april-2025-to-march-2026-bf86900b8a68bc94 2026-09-04T14:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-takes-another-look-at-botanical-drugs-5d3fbf966f8a0faf 2026-09-04T13:51:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cockroach-found-in-patients-meal-fda-shuts-down-kalwa-hospital-canteen-after-ins-a1552b2176401afc 2026-09-04T13:49:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/broad-coalitions-not-party-size-shape-dutch-municipal-government-5d702e3a747027c5 2026-09-04T13:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/ricerca-la-bellezza-nascosta-della-scienza-ultimi-giorni-per-votare-i-ricercator-e395750c745af8ea 2026-09-04T13:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-deals-in-august-2026-648c8cfdb1b56b15 2026-09-04T13:21:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/barclays-issues-pessimistic-forecast-for-ultragenyx-pharmaceutical-nasdaq-rare-s-941455bfd6b4c414 2026-09-04T13:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-biotech-firm-picks-indiana-for-north-american-headquarters-00dcd5724fbe51b3 2026-09-04T13:04:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/clearmind-medicine-stock-slides-friday-what-s-happening-e87647c65615b7b7 2026-09-04T12:59:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/huntsville-biotech-company-diatherix-laboratories-to-close-55-jobs-affected-14e605b10dab7b04 2026-09-04T12:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-potentially-blinding-eye-disease-has-no-fda-approved-therapy-tarsus-bought-a-c-05f52a650d30f2e8 2026-09-04T12:42:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/jeol-launches-benchtop-scanning-electron-microscope-fe29c93ef626d8e3 2026-09-04T12:37:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-year-after-big-pharma-s-pull-back-from-the-uk-what-s-changed-91ea46f4b66d8ec6 2026-09-04T12:36:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-etentamig-cuts-risk-of-progression-by-60-in-phase-3-multiple-myeloma-tr-005918f5e5ae6fbb 2026-09-04T12:31:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/thyroid-medication-lot-recalled-nationwide-98aeb5228b273e29 2026-09-04T12:28:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-gets-phase-3-trial-waiver-for-higher-dose-of-multiple-sclerosis-drug-c9bae14d474c5b7a 2026-09-04T12:26:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-kyoto-university-amgen-scholars-program-concludes-21d40313ec65bb8e 2026-09-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lifepak-35-monitor-defibrillator-6c5b82584c6ee1da 2026-09-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imagertm-ii-angiographic-catheter-31ad1b2e722a9f05 2026-09-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gore-viabahn-endoprosthesis-with-propaten-bioactive-08e5d69ab1e55cb9 2026-09-04T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vrxa-424b-filings-veraxa-biotech-ag-sec-424b-127f1370dd1cec28 2026-09-04T11:51:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/finance-veteran-behind-chf-30b-portfolios-joins-veraxa-biotech-vrxa-as-cfo-87a630a710fcafa4 2026-09-04T11:46:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-names-raju-willener-as-chief-financial-officer-2ada056d45deccc0 2026-09-04T11:36:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/h-c-wainwright-reiterates-legend-biotech-stock-rating-at-buy-3cf72a995f724227 2026-09-04T11:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-secures-a-34-million-non-dilutive-facility-to-fund-key-clinical-mileston-11179059e4b6422a 2026-09-04T11:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/acepodia-announces-fda-clearance-of-ind-application-for-ace723-a-novel-dual-payl-ae666f0288e1ecfe 2026-09-04T11:27:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-drug-substance-to-drug-product-why-integration-matters-in-modern-pharmaceut-6b10776e1e0e3d1e 2026-09-04T11:24:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/lipofit-extreme-fat-burner-recall-fda-finds-toxic-dnp-and-hidden-drug-f7a329c1cd0a7de3 2026-09-04T11:17:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/govt-launches-bio-nivesh-to-drive-private-capital-into-biotech-startups-5267194874c2709e 2026-09-04T11:15:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pipac-pilot-validating-api-platform-3f397b3ff13ce3bd 2026-09-04T11:12:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-pharmaceutical-plant-in-upper-macungie-takes-another-step-forward-95d1e0cf0664292e 2026-09-04T11:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-rating-lowered-to-hold-at-royal-bank-of-ca-97ea518a6d4e3d57 2026-09-04T11:09:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-intensifies-food-safety-checks-across-goa-cb100a065a1e2f6c 2026-09-04T11:09:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/huntsville-biotech-company-to-close-laying-off-55-workers-be095482a50e2d74 2026-09-04T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/auftakt-von-ai4cancercure-nrw-32-5-millionen-euro-gehen-fur-vernetzte-krebsforsc-39e15efd95914110 2026-09-04T10:57:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-organoid-technologies-for-disease-modeling-drug-discovery-and-dev-ee280dd7c9dfc991 2026-09-04T10:44:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-european-rare-diseases-research-alliance-53102f99bfd75eb8 2026-09-04T10:44:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-understanding-frailty-towards-a-future-of-healthy-ageing-9a110880d5f55f8c 2026-09-04T10:44:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-next-generation-x-ray-laser-light-sources-aeb2e2dfc2e128c8 2026-09-04T10:44:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/bright-minds-biosciences-stock-slides-4-82-as-biotech-volatility-bites-is-more-d-5d0ded2b47af50c1 2026-09-04T10:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perkinelmer-acquires-simotech-to-expand-pharma-manufacturing-automation-25f366eb27ff01e4 2026-09-04T10:36:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubs-raises-teva-pharmaceutical-stock-price-target-on-celiac-progress-2a1cb027796bdb4d 2026-09-04T10:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-nets-zanvastro-us-approval-in-first-for-alexander-disease-24d83c4ae6c3e865 2026-09-04T10:34:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/trials-by-design-inside-the-new-good-clinical-practice-guideline-6ced499fbb622cde 2026-09-04T10:31:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-nitrosamine-saga-how-one-impurity-rewrote-global-quality-rules-68994d10af08aad4 2026-09-04T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-fallo-en-determinados-respiradores-newport-ht70-plus-y-pi-82e0e3d07eaa76ab 2026-09-04T10:11:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-to-identify-novel-drug-targets-in-neurological-diseases-f341779c9a2a5b0b 2026-09-04T10:10:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/kylo-11-s-97-lp-a-reduction-from-a-single-dose-rewrites-the-durability-standard-d4a5341776eda0a2 2026-09-04T10:07:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/your-questions-answered-the-biggest-pharma-and-biotech-stories-this-week-2a623b8652ef2c75 2026-09-04T10:07:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/superluminal-raises-60-million-to-take-obesity-drug-into-clinic-c7b6cd6243bba671 2026-09-04T09:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-mexico-spikes-in-gang-violence-lead-to-rising-self-harm-a083cdc56242b8db 2026-09-04T09:43:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/hpm-presenting-at-iqvia-annual-controlled-substances-state-regulatory-conference-cdf24c35673d519f 2026-09-04T09:37:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cee-startup-tech-weekly-new-capital-flows-into-ai-biotech-medtech-and-more-d5cb89512c95cd85 2026-09-04T09:33:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/nsf-launches-three-new-science-and-technology-centres-2965520de44b468f 2026-09-04T09:23:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-ada-yonath-1939-2026-930f49baf750b0a5 2026-09-04T09:20:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-atto-halo-ikt-tvtx-atrc-38a6ce892e6ee1f3 2026-09-04T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/espmh-2026-at-eshpm-eb6b829f1f88c612 2026-09-04T09:14:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/rakovina-therapeutics-shifts-72-of-budget-to-ai-cancer-programs-4fe1118ec6da23ab 2026-09-04T09:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/myamici-and-my-green-lab-collaborate-to-improve-sustainable-lab-purchasing-4d8e208884ea3e93 2026-09-04T09:05:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-tse-4502-wins-mimrylo-approval-is-the-stock-still-trading-faa2c56c2669f565 2026-09-04T09:02:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-sensors-behind-pharmaceutical-monitoring-6be7cd5b8bc3f6cc 2026-09-04T08:53:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-discovery-alone-does-not-change-a-life-biotech-executive-says-eabe16cd0617d45a 2026-09-04T08:52:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-growth-platform-advances-african-swine-fever-research-87c352ca986fb24b 2026-09-04T08:45:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/wellington-management-group-llp-reduces-stock-position-in-ultragenyx-pharmaceuti-8c69afe9c0111bad 2026-09-04T08:45:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-ever-drug-for-alexander-disease-e097dbb9bd0de18e 2026-09-04T08:44:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-has-attacked-a-teva-pharmaceutical-company-warehouse-in-ukraine-twice-da4d0af29b8c3bc4 2026-09-04T08:34:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/melbourne-biotech-immunobiota-progresses-5m-seed-raise-for-world-first-oral-type-b4d5cb9476bd3fbd 2026-09-04T08:27:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/medytox-expands-damages-claim-against-daewoong-pharmaceutical-tenfold-to-500-bil-2f736c6111e11e23 2026-09-04T08:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/communities-across-greater-glasgow-and-clyde-unite-for-suicide-prevention-week-c0943bd5baeaa15a 2026-09-04T08:24:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/boletin-sobre-seguridad-de-medicamentos-de-uso-humano-julio-de-2026-c127410c2324efee 2026-09-04T08:19:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhsggc-celebrates-outstanding-staff-at-clyde-sector-awards-de2a936b5bd44e11 2026-09-04T08:14:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-launches-chewable-eye-nutrition-candy-eye-crunch-60f809e8ab7fce04 2026-09-04T08:06:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-first-map-of-a-male-fly-brain-a-win-for-neuroscience-ba10ebda2378d2e1 2026-09-04T08:00:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/drei-bundesweite-forschungsprojekte-im-netzwerk-universitatsmedizin-unter-heidel-e088e833b5761e85 2026-09-04T07:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-en-or-e61ca6c802092b4b 2026-09-04T07:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-ukraine-warehouse-hit-twice-in-russian-attack-raising-supply-concerns-f938679799fa6ad7 2026-09-04T07:47:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-corsi-per-futuri-papa-al-consultorio-del-policlinico-uno-spazio-d-501e8eb94af25241 2026-09-04T07:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/verstehen-statt-verurteilen-neue-youtube-serie-klart-uber-drogenkonsum-auf-ed6f65626330ac1a 2026-09-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nursing-students-get-rare-firsthand-look-at-critical-care-transport-cb03531a4461095e 2026-09-04T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/argo-s-bw-20805-achieves-96-attack-rate-reduction-in-hae-phase-ii-342c8364b7f69850 2026-09-04T06:40:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-beats-pembrolizumab-on-overall-survival-in-phase-3-nsclc-trial-26a34a5b8cbfe31c 2026-09-04T06:35:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanchorbio-submits-ind-to-u-s-fda-for-hcb303-its-second-tri-specific-immunothera-5b8896c62efe16f0 2026-09-04T06:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisory-no-2026-1020-public-health-warning-against-the-purchase-and-use-of-a6df66299070d3dc 2026-09-04T06:03:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/accelerated-amortized-payment-of-convertible-bond-installment-e9e80f19df8ee3e8 2026-09-04T06:02:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisory-no-2026-1019-public-health-warning-against-the-purchase-and-use-of-d48cd80405cdd564 2026-09-04T05:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanofi-stock-holds-steady-as-pipeline-data-keeps-focus-on-long-term-239bfcdc011eb9f0 2026-09-04T05:49:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/number-of-shareholders-of-aurisco-pharmaceutical-co-ltd-class-a-sse-605116-06b066c3fb923415 2026-09-04T05:45:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-s-once-weekly-hyperinsulinism-drug-advances-in-global-phase-2-321cbe0887abe385 2026-09-04T05:26:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/kangmei-pharmaceutical-banks-on-centralized-procurement-for-expansion-upgrading-694812ab8349f82c 2026-09-04T05:07:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/capital-raising-in-healthtech-singular-photonics-aisel-health-and-trinity-biotec-05ca86013071b2fa 2026-09-04T05:05:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-and-biologics-5th-cir-fifth-circuit-upholds-fda-s-removal-of-tirzepatide-f-3cd04fea308b8823 2026-09-04T05:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-copenhagen-facility-to-strengthen-europe-s-quantum-manufacturing-capabilitie-14213db62a579181 2026-09-04T05:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-bets-nearly-1-3-billion-on-hutchmed-s-attc-platform-as-chinese-innovative-dr-2dedf8f6544a45ac 2026-09-04T04:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-completes-phase-2-dosing-of-rare-disease-drug-ea619ac6bd578fa6 2026-09-04T04:50:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/suven-life-sciences-completes-phase-3-enrollment-for-masupirdine-in-alzheimer-s-2900b13463d2bb5e 2026-09-04T04:47:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/party-drug-mdma-approved-by-new-zealand-to-treat-trauma-8d151b223f52b56b 2026-09-04T04:36:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-biopharma-pushes-into-senior-flu-vaccine-market-with-phase-2-3-trial-1d81c1eda1185c5c 2026-09-04T04:26:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-and-delivery-of-laptops-and-related-accessories-tender-no-amref-04-09-202-8870c5bf152bca5e 2026-09-04T04:20:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-named-official-pharmaceutical-sponsor-of-pga-tour-and-2026-presidents-cup-38bec09ca54775a9 2026-09-04T04:07:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmexcil-to-host-trade-expo-next-week-eyes-1-4-bn-export-opportunities-63091a9298bc8d25 2026-09-04T04:05:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-in-clinical-trials-history-and-impact-4e9a42d030d09131 2026-09-04T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/40kg-expired-chilli-mixed-meat-and-veg-bengaluru-s-chairman-s-club-kitchen-shut-2e3c3c4c0c15fb56 2026-09-04T03:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sen-warren-demands-answers-from-rfk-jr-over-calamitous-response-to-cyclosporiasi-597f451e02e55a45 2026-09-04T03:10:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-on-alert-maharashtra-food-safety-body-rolls-out-hit-list-for-upcoming-festiv-ee15b7cb545e9138 2026-09-04T03:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-secures-a-34-million-non-dilutive-facility-to-fund-key-clinical-mileston-6092f19054abd1ee 2026-09-04T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genscript-biotech-proposes-spin-off-separate-listing-of-probio-unit-5d18af77e433e3d1 2026-09-04T02:53:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/hutchmed-signs-licensing-deal-with-gsk-for-experimental-solid-tumour-drug-89fa778161cb6ca2 2026-09-04T02:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sino-biopharmaceutical-s-gpc3-adc-drug-wins-fda-clinical-trial-approval-shares-s-dd1df1155335a767 2026-09-04T01:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-rare-reports-61-cornstarch-reduction-in-96-week-phase-a8232257af147e0f 2026-09-04T01:38:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-president-trump-posts-on-truth-social-a-request-from-senator-grassley-for-tru-483ddba2b495b9a6 2026-09-04T01:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-secures-non-dilutive-funding-for-key-kidney-disease-programs-9f824b90f99b62c1 2026-09-04T00:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-licenses-china-s-qilu-pharmaceutical-keytruda-biosimilar-us-rights-ed32477bbc498067 2026-09-04T00:02:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-biopharma-wins-korea-approval-to-run-phase-2-3-trials-of-high-strength-flu-sh-aade03aacbdc6c08 2026-09-04T00:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-filed-form-6-k-7fe35a5b8dd5ee97 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newest-glue-degrader-nabs-multiple-myeloma-approval-2bf11e18cd481b9d 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reducing-bureaucracy-and-burden-for-the-repatriation-of-mentally-ill-nationals-b7a59fc750d4cf35 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-development-of-botanical-drug-products-request-for-information-54023367d77f8ebc 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/performance-review-board-members-3d2655a4c40f3ce0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-to-omb-for-review-and-approv-26d2dab5b5978447 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-perceived-norms-about-alcohol-use-and-hiv-sti-prevention-among-adolesc-4a90d5787098a896 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-adhincra-study-addressing-hypertension-care-in-africa-f1880d4aca92881e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-inborn-errors-of-immunity-underlying-herpes-simplex-encephalitis-11d45dc8a77cd184 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-single-session-intervention-and-interpersonal-therapy-for-adolescent-d-fd8666ae37c21612 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-brain-injury-and-dysmaturation-in-newborns-with-congenital-heart-disea-39627100803f5414 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-protein-mri-contrast-agent-for-precision-imaging-lung-f-08ecf70a0837c64e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-regulation-and-role-of-pdc-in-immunopathogenesis-of-hbv-hiv-co-infecti-026e9da61fe27a04 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mapping-the-development-of-episodic-memory-b7e59b6dcf3b5b45 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-genetic-etiologies-of-subclassifiable-ild-study-the-genesis-cohort-stu-392f5e6dc7e3a200 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-career-enhancement-core-702e6d4d6b48801b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-pilot-feasibility-core-8ef4149e6518dfe3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-circuit-logic-and-functional-dissection-of-the-intrinsic-cardiac-nervo-03965b5a14dd6866 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigating-the-function-of-aberrant-rna-in-cancer-992f235d243cb07f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-health-trajectories-during-transitions-into-and-out-of-caregiving-in-l-1373a1f6afc5c1af 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-training-in-the-design-and-development-of-infectious-disease-therapeut-69320fb38c857875 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-digital-biomarker-discovery-with-multimodal-and-longitudinal-wearable-d108ab68ab5915bf 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-phenix-providing-high-quality-software-to-the-research-community-for-c-f84e066bc0f3a9ce 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-career-enhancement-program-e1a6233ff3d39c27 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-2-mechanisms-of-resistance-to-neoantigen-vaccines-in-pdac-2babd0476a227c11 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mechanistic-and-translational-medicine-studies-of-brain-neurophysiolog-26444182a54d8aa9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-support-for-adolescents-living-with-hiv-who-are-transitioning-from-ped-ca8df8d054d80986 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-multidisciplinary-research-training-in-cardiovascular-disease-d10f437790f7a03d 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-alcohol-immunosenescence-senodynamics-in-people-with-hiv-844c976f25e1ffd2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modeling-lennox-gastaut-syndrome-for-improved-clinical-and-neurobehavi-cef1fc5cf0142bde 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-fast-dissolving-mm008-tablet-for-instant-on-demand-non-hormonal-contra-fd5595059acf3241 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-developing-a-cancer-galaxy-computational-workbench-to-meet-emerging-ca-dd2a647b3a0a3088 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-3-overcoming-melanoma-treatment-resistance-with-cytokine-immun-6b6b85269675d864 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-synergistic-epidemics-of-non-communicable-diseases-stigma-depression-a-2ae382487b70b360 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-career-enhancement-core-0127696a617f8ea3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-blood-based-neurodegenerative-disease-biomarkers-environment-and-demen-07f96d4e9d9d0691 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-designer-rna-protein-scaffolds-for-next-generation-therapeutics-e01665542f59d8c2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-contribution-of-the-mammalian-visual-cortex-to-stabilizing-locomot-08ad67efcdace1a9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-shared-resource-core-quantitative-sciences-core-4f7efa5ac7b9fda8 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-icreate-increasing-capacity-for-injury-research-in-eastern-europe-0f4463f83fd16016 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-a-new-combination-therapy-for-pancreatic-ductal-adenoca-b0bdee7b78a2ddff 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-a-nebulized-peptide-biologic-to-combat-severe-neutrophi-30a3d6a3f7fd8ddb 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-rest-respiratory-ear-system-for-cpap-therapy-adherence-fc6fd1230aa20b01 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-scholars-in-oncology-associated-research-soar-78bfa3a7f15b7b9c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-translating-improved-pairing-and-timing-of-drug-combination-strategies-6f1bb2ff8aabce43 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-trajectory-and-architecture-of-tumor-intrinsic-drug-resistance-in-aml-5d44f7854677eb2a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-architecture-and-trajectory-of-acquired-resistance-to-therapy-in-aml-16de371fc9265c8e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-cep-career-enhancement-program-2153170d2887bcbe 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-2-combination-parpi-beti-to-overcome-parpi-resistance-0618f0e4cdf76023 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-administrative-core-e8305ee9afaa9102 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-c-biostatistics-and-bioinformatics-core-7e2ab8b264b7dff0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-1-hypoxia-and-metabolic-dysregulation-as-a-targetable-barrier-dde8075ecd14d88f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-head-and-neck-cancer-spore-1b353ef8931fa9ff 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-long-term-endotypes-of-prematurity-associated-respiratory-disease-leop-b35edd976cac3f79 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-ny-screenplus-a-comprehensive-flexible-multi-disorder-newborn-screenin-c7a75d3127cf9192 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-4-genome-sequencing-core-5800f714c1f80750 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-2-clinical-and-tissue-core-abd9c0d02219dde7 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-1-administrative-core-c8689af17a1c8ecb 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-1-developing-mrd-based-therapeutic-strategy-in-newly-diagnosed-b627777a8d606197 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-regulation-of-lymphatic-endothelial-cell-junction-and-drainage-8b40c848e89ce903 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-risk-factors-for-end-stage-glenohumeral-osteoarthritis-c806c789d3707270 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-quantitative-determination-of-high-order-protein-structure-with-native-bb05b17ac002e8c5 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-multiscale-simulations-of-biological-systems-and-processes-2bcf9e696985e063 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-neurobiological-mechanisms-of-fatigue-in-health-and-after-covid-19-634b0196a37c0929 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-inner-ear-infection-and-innate-immunity-2bea6c71da08275e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-e3-ubiquitin-ligase-chfr-regulates-lung-endothelial-barrier-integrity-f2ce999a4e41a7b5 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-harvard-chan-education-program-in-cancer-prevention-and-control-20366bfa1bd3eb5e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-novel-method-of-non-invasive-brain-stimulation-to-enhance-motor-func-2f313f904e0e4bef 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-targeting-the-immune-synapse-for-programmable-cellular-function-38a3b6e9774a2c97 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-genomics-and-cell-biology-core-e551d89a17876509 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-elucidating-the-network-design-principles-of-biological-signal-process-90ce541482ae3003 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-targeting-cancer-at-the-protein-membrane-interface-6032b5fcee6abdc6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-disc-facet-crosstalk-during-spinal-degeneration-and-repair-02fe177fb1e87fca 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-an-improved-low-endotoxin-clean-genome-e-coli-strain-for-production-of-c15bcbc2d6bbf8de 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-ancestry-and-sex-related-pharmacogenomic-and-metabolomic-signatures-of-eb59b487d83dbe15 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-imaging-biomarkers-of-freezing-of-gait-response-to-deep-brain-stimulat-e1224d40ab1c7544 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-fda-phase-1-development-of-a-novel-nonopioid-cell-and-tissue-permeable-8ca9612f063c4ba6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-new-trem-1-therapy-for-inflammatory-bowel-disease-5cd5aa6e8f7127ac 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-i-institutional-career-development-core-b78cb31851c806a0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-molecular-mechanisms-903aa97933eccf8a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-metabolic-basis-of-disease-phase-2-31df70132afd559b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-de-novo-designed-ras-tools-to-uncover-the-mechanisms-underlying-drug-r-2a1f2d75fbc29809 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-boosting-treatment-effects-on-teenage-binge-drinking-with-a-mechanisti-2b6e01113590389b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-chronic-alcohol-consumption-dysregulates-lung-hyaluronic-acid-512acfa14fcad0e5 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-research-training-program-in-disease-oriented-neuroscience-r25-fd14ee980b8e4b91 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-leveraging-a-card-study-methodology-to-promote-integration-of-genetics-b36ab3b7430423d2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advancing-population-based-research-on-cognitive-aging-and-dementia-wi-17a0fc3e1f3c5f4c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-integrated-multiomics-diagnostics-at-the-point-of-care-for-healthy-liv-874cfd38da16d7f0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-interplay-between-common-and-rare-variants-associated-with-schizophren-83544374771f9174 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-subclinical-kidney-and-cardiovascular-indicators-of-transplant-associa-63831f5867eb3a77 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-exploring-the-molecular-link-between-bioenergetics-latency-and-neuro-c-905c8f127a188450 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-an-ecological-momentary-investigation-of-associations-between-ptsd-alc-5384dbbe46e0691a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advancing-actionability-in-oncology-enhanced-detection-of-head-and-nec-19a40561602e2961 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-audiom-developing-an-indoor-non-visual-mapping-system-24c4b077972cf10a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-optimizing-modiflow-geometry-for-enhanced-efficiency-of-aerosol-drug-d-0482f6e3278f60e4 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-combating-aps-associated-neutrophil-activation-with-colchicine-616040fa692ebcc3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-identifying-unmet-needs-to-support-individuals-impacted-by-misattribut-e14df49f0402bb05 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-modulating-er-stress-induced-lipotoxicity-to-ameliorate-mitochondrial-53d550d3efcd235a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-engineering-neuroresilience-investigating-tardigrade-neuroprotection-t-4a2f5ccd9b6898dc 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-and-validation-of-a-cell-separation-platform-technology-a73c3c5f21ca2644 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-understanding-gastrointestinal-cancer-disparities-among-native-hawaiia-8d3a88cdba97e608 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-2-advanced-dosimetry-modeling-biostatistics-d4d9637e32fc0b0c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-1-biorepository-data-acquisition-c8b6fd1b7eae6ac8 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-3-plasma-and-tissue-biomarkers-in-neoadjuvant-crt-for-egc-f2fec1e3ea8e4312 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-uniprot-ai-driven-scaling-of-protein-knowledge-for-biomedical-research-e3d233090f4dd006 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-engineered-extracellular-vesicles-for-the-delivery-of-mitochondria-and-67f7006edb50c11a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-neural-basis-of-structure-learning-for-value-inference-in-the-orbitofr-c8bccd27e300af9c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-randomized-trial-to-determine-impact-cost-and-cost-effectiveness-of-a1c9695b0d1dd1ed 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-measuring-input-output-operations-of-cortical-neurons-with-large-scale-c10e6d45c8b79ddf 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relationship-between-factors-of-mental-and-physical-health-in-medical-students-5f4b30f8c5cebbd6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personme-a-clinical-trial-for-personalised-psychiatry-from-your-sofa-fdb0d02e2653888e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-women-centred-approach-development-of-a-randomized-controlled-trial-evaluating-164df61e7f370587 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-clinical-trial-of-a-novel-food-insecurity-intervention-for-patients-w-5dafe13c8fbb030e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/switching-from-amisulpride-to-cariprazine-real-world-outcomes-in-patients-with-p-6f6571b1e0beb808 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-label-trial-to-compare-exposures-of-subcutaneous-long-acting-injectable-8c3b310a36dec4f3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agreement-and-divergence-between-clinician-rated-and-self-report-measures-of-dep-70097379c2737666 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/demographic-disparities-in-clinical-trials-of-xanomeline-trospium-for-schizophre-428f2e0cef81b3e7 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/industry-updates-from-the-field-of-stem-cell-research-and-regenerative-medicine-6b48f3f63dfb8db3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anti-lung-cancer-agent-discovery-and-development-a-review-of-cross-platform-corr-3c0fd6667ec34786 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esketamine-for-postoperative-anxiety-after-major-abdominal-tumor-surgery-a-rando-0c34b286b8bdc78f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-regarding-effects-of-desflurane-and-propofol-general-anesth-0a62643203b11b68 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovering-repurposable-drugs-for-alzheimer-s-disease-and-related-dementias-tar-c708395ca028783f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-landscape-analysis-of-japanese-tolerability-assessments-in-oncology-drug-devel-c3535d8f78f44868 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characterizing-time-toxicity-in-lung-cancer-clinical-trials-development-and-appl-a2870b4a04cdc3df 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-pharmacokinetics-of-cl-197-a-potent-compound-with-low-cytotoxicity-ag-ced65a36a1609c65 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-hormone-therapy-for-perimenopausal-and-postmenopausal-women-57a9a2c991633765 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-review-of-seamless-phase-i-ii-trial-designs-towards-oncology-dose-optimization-fc2481260a3cef12 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antimicrobial-susceptibility-patterns-among-urinary-bacterial-isolates-a-descrip-ef8277884994cecd 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-immunological-characteristics-of-atopic-dermatitis-severity-in-chil-aa888a38d7392ed8 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/computed-tomography-portal-venous-reconstruction-assisted-endoscopic-ultrasound-764a4336448750ea 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-in-vitro-evaluation-of-systemic-fungicides-and-bioagents-against-pig-eb3ba59e33cd559f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lt-b-gt-prevalence-clinical-profile-and-risk-factors-of-peripheral-arterial-dise-b265cf5191c80bd0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-complexities-in-vulnerable-populations-a-comprehensive-review-of-hemoph-9aed9920ff9c7dc3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-spectrum-of-adult-patients-with-hypercalcaemia-attending-a-tertiary-26b79d9d01868107 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changing-clinical-characteristics-diagnostic-patterns-and-outcomes-of-tuberculos-8c36d12855f22fad 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-radiation-therapy-as-an-alternative-to-radical-surgery-for-4136b3aadd36e529 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyp2d6-genetic-variation-and-clinical-response-to-donepezil-and-galantamine-in-a-dae04cbba6871929 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflammatory-bowel-disease-in-kazakhstan-phenotypes-disease-activity-and-treatme-be2cf4c817d987d4 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-treatment-patterns-and-clinical-outcomes-after-first-line-therapy-in-dd7ac1900ddf7276 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-21-day-vitamin-d-supplementation-on-sports-performance-and-exercise-i-f6005a17065d504f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autogluon-based-interpretable-machine-learning-for-clinical-risk-stratification-81eb8b46cadb4655 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anastomotic-leak-after-esophagectomy-for-cancer-in-enhanced-recovery-protocol-ve-f978ea451f1a066e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-open-label-randomised-controlled-trial-protocol-evaluating-a-siddha-add-on-re-70da0d96993a362f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-postoperative-neurocognitive-safety-and-recovery-profiles-of-remimazo-7581cfb050d0396e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synergistic-effect-of-insulin-resistance-and-glycemic-variability-on-mortality-i-14988ea6116385ab 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spatial-niches-of-the-colorectal-cancer-microbiome-differences-interrelationship-9d0da07599e2a98e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spontaneous-coronary-artery-dissection-in-sweden-epidemiology-diagnostics-and-cl-7d279917dfad0941 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-review-of-pediatric-fas-associated-death-domain-protein-deficiency-expan-5974ea24c31e9923 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-feasibility-and-image-quality-assessment-of-deep-learning-based-virtual-431565aded3c343a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-coated-balloons-from-evidence-to-practice-and-a-proposed-antithrombotic-the-8903d6bd69ee8461 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-platelet-activation-factor-cd62p-in-the-occurrence-and-development-o-e515fa7fbf10ddd9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-narrative-nursing-competency-training-programme-for-clinical-nu-ac73f915907ab6ef 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-implementing-clinical-alarm-nursing-intervention-program-on-nurses-301ce50e71bf78e4 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-bioinformatics-and-clinical-validation-identify-hbegf-and-th17-marker-9714f384b8270556 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidisciplinary-management-of-concurrent-hypogonadism-diabetes-and-hypothyroid-59828fb4ff13e1a9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-manifestations-and-local-inflammatory-destructive-changes-in-congenital-f286a1d265ae2332 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pfb-03-study-protocol-diagnostic-performance-and-clinical-application-of-sup-18-18cf216d19eb1db4 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subscription-drug-pricing-the-evidence-behind-it-comes-from-two-states-and-they-fb5a681525a81b14 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interlocking-plate-compared-with-conventional-pin-fixation-for-undisplaced-femor-e462acf3cd6625d2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-for-a-participant-and-evaluator-blinded-randomized-controlled-tri-f5fe7a8850145780 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-synthesis-assisted-structure-determination-and-biological-evaluation-of-cy-2e03ad678fc32f11 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/body-mass-index-related-trends-in-adverse-events-with-enfortumab-vedotin-analysi-62f4459ae59076af 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/for-health-study-protocol-for-a-randomized-controlled-feasibility-trial-of-struc-5728f033bb59ce01 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hssynergy-scale-aware-hierarchical-attention-for-interpretable-drug-synergy-pred-738b1b5275bf9512 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceived-psychological-stress-is-associated-with-blood-dna-methylation-differen-26546360e66e8507 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-surgical-pathways-and-outcomes-of-upper-tract-urothelia-0b2cc0f4b7c3d9c8 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ldl-hypercholesterolemia-in-children-genetic-influence-and-response-to-lifestyle-ce7b949c405458cd 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preparing-collaborative-practice-ready-graduates-an-exploration-of-practice-tuto-6e187bf07b2565c7 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/loupes-assisted-versus-conventional-orthodontic-bracket-bonding-a-split-mouth-ra-5d8b95a0486774fd 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-post-exercise-heart-rate-recovery-and-one-year-clinical-dete-09fc48a8c882f1b3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-evaluation-of-a-community-based-football-for-life-ffl-programme-for-men-proto-a9a3a96d06821792 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporoparietal-structural-functional-coupling-abnormalities-in-drug-naive-youth-59e2b1188e53a57b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-adrenaline-use-in-anaphylaxis-in-children-a-cross-s-e0e9ca843f9d2436 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-prenatally-diagnosed-clenched-hand-genetic-associations-f0f844e3be0e1ffe 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/timing-of-planned-birth-in-women-with-gestational-hypertension-or-pre-eclampsia-220e86b5f0bbdf5a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/detection-of-carbapenem-resistance-mechanisms-in-difficult-to-treat-pseudomonas-20d24fbf1ce70185 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/photo-quiz-a-bloody-inoculum-yields-a-near-miss-b4a438157e8f33b1 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-implications-of-misfit-in-multiunit-implant-supported-fixed-dental-pros-3c6c672735c91015 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-h-scp-prf-scp-bone-block-versus-sausage-technique-for-horizontal-r-1ec51d8a720e1352 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fluoride-as-a-modifier-of-metallome-homeostasis-a-systematic-review-of-animal-st-f9ed92d12befcf72 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/posttherapy-18f-fdopa-pet-findings-in-an-anaplastic-pleomorphic-xanthoastrocytom-6d7cc6b10e65372f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-pool-and-late-phase-3d-ring-czt-spect-ct-in-painful-os-peroneum-syndrome-ae1c648046114fa6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-terlipressin-using-continuous-infusion-versus-bolus-in-pati-5482d83eee4908af 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promoting-physical-activity-in-the-context-of-clinical-care-for-people-with-hiv-5b2157f3821a2c90 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-of-shivering-during-intrapartum-cesarean-delivery-under-epidural-anest-57c6111067d38866 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/minimized-atrial-pacing-and-atrial-fibrillation-burden-in-the-danpace-ii-trial-350c940007143658 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/honey-as-a-functional-food-and-nutraceutical-bioactive-properties-health-benefit-be51a8625211aa44 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acceptability-of-alcohol-based-hand-rub-during-neonatal-care-in-rural-ugandan-ho-a82fee9c9418b54d 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-clinical-prognostic-factors-for-radium-223-therapy-in-castration-r-deaee7bbce6c39ee 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multikilogram-scale-process-development-for-a-key-intermediate-of-a-clinical-sta-374c9d9ee5c11a24 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synthesis-and-self-assembly-studies-of-reusable-cholesterol-based-amphiphiles-in-c887f247fda7d9e3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dual-diagnosis-and-drug-related-deaths-2019-2021-an-irish-perspective-b2ae75e4f24f2627 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-factors-and-ergonomic-determinants-of-low-back-pain-in-healthcare-workers-i-d3d19d8f0f0cfce8 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-continuous-lumbar-sympathetic-blockade-enhances-the-effect-of-lumb-9ffefe0de2782043 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-and-care-in-patients-with-posterior-glenohumeral-instability-t-75d4b1e172212738 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-before-and-after-the-introduction-of-clazosentan-in-aneurysmal-cf2997965ba2a2ba 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/z-classification-an-anatomy-based-ridge-sinus-zygoma-classification-and-decision-4ea2c02323803c12 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-a-sodium-fluoride-rinse-on-the-composition-of-early-oral-biofilms-form-5dee5f9feae5edf2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-clinical-outcomes-of-antithrombotic-therapy-in-children-and-young-adu-e73390694d25463c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adoption-patterns-of-anti-vascular-endothelial-growth-factor-therapies-in-retina-c75d4754e8531711 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-causal-effects-of-circulating-metabolites-on-major-depression-dis-9606621b21f1facf 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2d-4d-digit-ratio-and-brain-volumes-in-alcohol-use-disorder-935fa228c7fd1d90 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-specific-differences-in-the-relationship-between-prolactin-and-glucose-metab-e4dfcecb8de4a777 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cvs-call-for-2026-clinical-research-grants-9d5bd7bfcd23e3aa 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/connected-to-others-and-kind-to-self-social-connection-and-self-affiliation-chan-b79d4c9e0419d091 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparing-outcomes-using-low-dose-apixaban-and-anti-xa-monitoring-and-vitamin-k-e54ceb5fe8a7edb2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-derived-tetrahydropyrazines-for-late-stage-i-i-and-i-i-functionalization-of-076dd7bf0676aa81 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-concordance-of-anti-scp-mda5-scp-antibodies-a-multi-8d86068927625843 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07805746-peri-graft-cytokine-profile-influence-of-hematologic-disease-and-don-8e6c8907448967ba 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07805655-radiofrequency-treatment-versus-topical-therapy-for-facial-acne-vulg-e105ca43bc1cdb56 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07805616-prognostic-value-of-2026-aha-acc-clinical-categorization-in-acute-pu-b6099e1cf856e5b2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07805603-hermes-quality-and-safety-of-advanced-respiratory-support-during-pat-cf0e28e1dcd56bb5 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07805330-effects-of-blood-flow-restriction-rehabilitation-on-functional-mobil-15399895d05c5cab 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804914-integrated-digital-health-approach-to-reduce-hazardous-alcohol-use-a-51be9f13bae0a477 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804862-efficacy-and-safety-of-rfa-vs-mwa-for-treatment-of-large-benign-thyr-21fa1bc12fb3885f 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804810-phase-2-clinical-study-of-mwn105-injection-in-participants-with-over-c6373971ef87bc25 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804537-assessment-of-lung-function-lufu-at-sea-level-la-vs-high-altitude-ha-5d7862dbf016a494 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804524-assessment-of-total-pulmonary-resistance-spap-co-between-high-altitu-4ea76c8415117dac 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07804485-assessment-of-total-pulmonary-resistance-spap-co-between-high-altitu-8ca88f6869229b5e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07797790-real-world-patient-experiences-with-inbrija-47c7d0df8d8c143b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792954-a-study-to-learn-about-the-study-medicine-called-pf-08653944-taken-o-995bda1142254fa9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07789678-epidemiological-profile-of-patients-with-idh-mutant-diffuse-gliomas-fc1a760de5691bc7 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07777419-impact-of-subthalamic-nucleus-deep-brain-stimulation-on-cognitive-an-f7491f55bffa8412 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07765888-a-study-to-learn-about-the-study-medicine-called-tilrekimig-in-peopl-67fdcd4960c94571 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07756749-minimal-access-hernia-inguinalis-treatment-of-hernia-25d81963a6899392 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07752472-pstc100-study-in-healthy-adult-subjects-93d2c9efc11a0442 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07703475-a-safety-reactogenicity-and-immunogenicity-trial-of-rvx-scpd9-booste-4dbb03ab6e6cbdd6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07661641-a-study-of-177lu-lu-a9-0631-and-225ac-ac-a9-0642-with-68ga-ga-a9-621-c010ff9b372bbe62 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07600892-pain-at-work-toolkit-definitive-trial-a9ef44442c55c3ae 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07599176-partial-stem-cell-transplant-for-sickle-cell-disease-from-matched-do-d6f5336760d056f1 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07540221-a-study-to-evaluate-the-pharmacokinetics-and-safety-of-xembify-versu-aa54aca5db95b0ce 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07468851-a-study-of-hs-10566-in-patients-with-high-risk-non-muscle-invasive-b-592b8bcc594b8559 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07468071-rollover-study-for-participants-who-have-been-treated-with-and-are-c-26f9d5b014f2d866 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07416604-a-clinical-study-to-evaluate-the-effects-of-nxt007-compared-to-emici-8beab6e252106554 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07416552-a-study-to-investigate-cea-prit-2-0-in-participants-with-metastatic-55abc7deadd2d40d 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07412002-quality-of-end-of-life-care-for-children-with-cancer-033ccf1fcd016dc6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07361562-a-study-of-a-selective-erbb2-inhibitor-cgt4255-in-patients-with-adva-65c0b155cfb2d2fa 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07314957-impact-of-lifestyle-on-health-maintenance-a-randomized-controlled-tr-b60ef72eb6fe40b6 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07252297-the-role-of-universal-cancer-only-marker-six6-in-diagnosing-non-musc-c4220661217a96fc 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07144111-a-study-to-evaluate-the-effect-of-moderate-or-severe-hepatic-impairm-d7a8b07ae4c940d0 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07109336-development-and-prospective-validation-of-a-heterogeneous-treatment-89264028dbc57c55 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07066813-staging-strategies-and-their-association-with-prognosis-and-therapy-d99dee7194218280 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06968988-zanzalintinib-in-combination-with-ipilimumab-and-nivolumab-in-patien-db6e4ff8a5672fd2 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06717334-a-study-of-lung-cancer-screening-in-people-with-unexplained-weight-l-71cf788a91583da7 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06526338-adjuvant-ip-001-treatment-for-hcc-patients-following-surgical-resect-122f7299b94f09ee 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06414408-randomized-directly-observed-therapy-study-to-interpret-clinical-tri-9e0888b508a02045 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06364410-testing-the-combination-of-the-anticancer-drugs-trastuzumab-deruxtec-fcf362fefb5cbc8e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06333392-total-underwater-colonoscopy-tuc-for-improved-colorectal-cancer-scre-e57f0772e54619a5 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06295679-a-study-assessing-repatha-in-combination-with-standard-of-care-soc-c-37b11ef44b4b87e9 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06126224-a-study-to-assess-efficacy-and-safety-of-karxt-for-the-treatment-of-6e3f8c503509bdb3 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06112613-mobile-health-for-adherence-in-breast-cancer-patients-9e2b96ceecc25d96 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06062498-elacestrant-vs-elacestrant-plus-a-cdk4-6-inhibitor-in-patients-with-d538ed33b253c89e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05990946-smartphone-based-remote-symptom-monitoring-to-improve-postoperative-4db774193fdb5643 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05933174-promoting-alternatives-to-sulfonylureas-to-improve-patient-safety-in-dae6234964bbe536 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05906004-post-market-clinical-follow-up-pmcf-study-of-the-pitch-patch-for-the-9b709a78e737ed2a 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05761782-engaging-diverse-and-underserved-communities-in-cancer-awareness-tra-d28f5da13afba930 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05739383-a-study-of-inclisiran-to-prevent-cardiovascular-events-in-high-risk-4e6a86c0c9fb0fdd 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05688605-a-study-of-mrg003-in-the-treatment-of-patients-with-egfr-positive-ad-850b0a572d3e373c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05198830-testing-the-addition-of-an-anti-cancer-drug-trc102-to-the-usual-chem-2e7a02e16da5d13c 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04815356-phase-i-study-of-anti-cd22-chimeric-receptor-t-cells-in-patients-wit-513fac2cb6d24319 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04230356-trial-of-scheduled-versus-treatment-administration-of-donor-derived-ae1b23464ac5486e 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02559778-pediatric-precision-laboratory-advanced-neuroblastoma-therapy-d3ed604345b907c1 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01972919-mr-guided-phase-ii-radiotherapy-dose-escalation-in-unresectable-non-27a21a138424243b 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001778-evaluation-of-patients-with-ham-tsp-0cdbd31a77066891 2026-09-04T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gc-green-cross-receives-ind-approval-for-phase-2-3-clinical-trial-of-high-immuno-cd1bad30dd4bcc4f 2026-09-03T23:55:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-company-diatherix-plans-layoffs-d02964975bdb10a1 2026-09-03T23:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/up-to-20-of-children-with-dravet-syndrome-die-before-adulthood-a-long-term-study-947996a6f30c5d47 2026-09-03T23:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/big-executive-summit-lasting-impacts-on-biotech-adoption-6c3380fbbf5485a3 2026-09-03T23:21:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/heartland-bioworks-tackles-indiana-s-biotech-labor-shortage-0bd50c7c15ea84ef 2026-09-03T22:57:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korean-biotech-licensing-deals-top-21-trillion-but-stock-prices-lag-recove-c19271ffd829b2fc 2026-09-03T22:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-first-drug-to-treat-alexander-disease-2347a8d3e2094a59 2026-09-03T22:45:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/polyrizon-raises-4m-as-intranasal-hydrogel-biotech-taps-single-investor-263d61e403693cc9 2026-09-03T22:32:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/viral-infections-biotech-ena-respiratory-inhales-3-million-from-government-fund-f0f84c97aaa50e53 2026-09-03T22:32:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-vs-moderna-which-is-the-better-cancer-vaccine-stock-to-buy-now-f305da9e4bf862e7 2026-09-03T22:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exclusive-ai-genomics-could-fuel-biotech-etf-re-rating-as-health-care-trades-at-e233c242c5fc5bf7 2026-09-03T22:17:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-drugs-tied-to-higher-male-pattern-hair-loss-risk-06ff0c54eff147c5 2026-09-03T22:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-immunology-el-secreto-de-los-tejidos-que-mas-trabajan-una-buena-limpieza-54c10cbae6474aad 2026-09-03T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nature-medicine-un-estudio-establece-el-papel-de-los-nuevos-tratamientos-para-la-81161d29eab2a70f 2026-09-03T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cnic-y-la-fundacion-ramon-areces-organizan-la-segunda-conferencia-internacional-21401cbef93144bc 2026-09-03T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nuvectis-pharma-draws-top-biotech-funds-after-115m-raise-d3d7564b36eab305 2026-09-03T21:56:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-16-09-policlinico-kids-2-0-91f658a019127404 2026-09-03T21:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yuce-biotech-raises-7-4m-series-b-for-single-molecule-immunodiagnostics-f5fb8efe43098828 2026-09-03T21:34:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/frost-sullivan-released-the-2026-blue-book-on-the-development-of-hong-kong-stock-41de2d3846971aee 2026-09-03T21:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-price-target-cut-to-28-00-by-analysts-at-j-ca3688ee8f6e9d4f 2026-09-03T21:20:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-zilganersen-injection-first-drug-for-alexander-disease-6b9acc160b21d317 2026-09-03T21:15:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-expands-worcester-presence-following-8m-nasa-award-6fc2911f07faac6d 2026-09-03T20:50:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and-deadly-n-a7c1e1e466156811 2026-09-03T20:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-abortion-pill-challenge-delayed-until-after-midterms-e15d10d5d453a121 2026-09-03T20:46:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/latigo-biotherapeutics-reports-second-quarter-2026-financial-results-and-recent-f0c7958de799160f 2026-09-03T20:24:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/former-pfizer-vaccine-chief-joins-vaxcyte-trial-data-is-expected-by-october-s-en-e60f9ae456851bed 2026-09-03T20:12:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivani-medical-announces-participation-in-upcoming-investor-conferences-dbc3fad4d44de039 2026-09-03T20:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-government-moves-to-counter-ex-us-r-d-2eae451673f1d19f 2026-09-03T20:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autonomous-robotics-why-aviation-precedes-the-automotive-industry-and-its-releva-1fc2beeffb57ad43 2026-09-03T19:34:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/superbitetm-dr-cavovarus-b46d8819923dd4e9 2026-09-03T19:33:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/superbitetm-dr-kaplan-a5f0554ed2bd0b51 2026-09-03T19:32:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/superbitetm-dr-vulcano-f3bd993a6f35b781 2026-09-03T19:31:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-30-as-melhores-empresas-do-brasil-2026-e4d3149e92fc302f 2026-09-03T19:31:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-e-abrasso-realizam-campanha-contra-osteoporose-com-exames-gratuitos-na-estac-2f25fc242ac5edca 2026-09-03T19:21:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-delays-mifepristone-lawsuit-until-after-midterms-1f38e6ac46520a46 2026-09-03T19:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-patient-dosed-in-ocu410-phase-3-trial-for-geographic-atrophy-20091e2babf89205 2026-09-03T19:07:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ems-e-patrocinadora-da-orquestra-sinfonica-municipal-de-paraty-e08dd74b645f7492 2026-09-03T19:06:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenure-track-faculty-position-at-whitehead-institute-and-the-massachusetts-insti-3f9b356322b4a350 2026-09-03T19:06:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-apazunersen-fails-phase-iii-trial-pharmexec-efb96fb396d0db45 2026-09-03T19:02:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/pancreatic-cancer-new-fda-approved-drug-doubles-survival-rates-286037f1b916bd32 2026-09-03T18:55:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-startup-brings-decades-of-research-to-the-future-of-lung-care-92df49d3027b2182 2026-09-03T18:36:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-predictive-modeling-in-the-development-of-amorphous-solid-dispers-4a483a3fd54f6a71 2026-09-03T18:32:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/summit-s-ivonescimab-beats-merck-s-keytruda-on-survival-in-chinese-lung-cancer-t-84a274417ccf13a9 2026-09-03T18:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/10x-genomics-wins-latest-round-in-parse-patent-dispute-ca688952e924af96 2026-09-03T18:00:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-proves-promising-in-neuropathic-pain-mouse-study-4a4e30b11d852ce9 2026-09-03T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pancreatic-cancer-drug-shows-early-promise-for-lung-cancer-patients-1f38bf591b8c16d5 2026-09-03T17:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-target-of-unusually-large-options-trading-nasdaq-rare-fd456c7a91727ca6 2026-09-03T17:23:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-a-national-licensure-standard-would-change-wholesaler-operations-501f16e6ab0d98b1 2026-09-03T17:19:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/ian-mccaffery-bio-xaira-therapeutics-5be1beeff5c73bb4 2026-09-03T17:12:27.625Z weekly 0.7 https://www.pharmaradar360.com/article/xaira-therapeutics-962fad68a62400a3 2026-09-03T17:12:06.787Z weekly 0.7 https://www.pharmaradar360.com/article/40m-gift-to-ubc-is-the-largest-ever-to-a-canadian-school-of-nursing-6e611ac4bbe0b4b0 2026-09-03T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-long-shadow-of-early-sugar-consumption-plus-a-reality-check-on-fda-approval-84a9ddf4484e3d92 2026-09-03T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/himalayas-1-bayer-and-oric-double-down-on-prostate-cancer-with-new-phase-3-combo-ba25736961e49283 2026-09-03T16:55:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/house-biotech-caucus-is-weighing-ip-security-and-ai-enabled-biotech-policy-f4c2c41e3be75b77 2026-09-03T16:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-forces-launch-two-attacks-on-teva-ukraine-pharmaceutical-company-warehou-c2bca94b140e013a 2026-09-03T16:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-announces-exclusive-partnership-with-qilu-pharmaceutical-for-the-licensing-6fcbb6a2cc334bea 2026-09-03T16:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-company-in-senegal-produces-first-african-made-clinical-treatment-bcb0ebbefcd25fc6 2026-09-03T16:20:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-eu-pharmaceutical-legislation-why-regulatory-reform-matters-for-ip-teams-c7f706010a11939d 2026-09-03T16:20:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-does-zurzuvae-compare-with-other-antidepressants-for-postpartum-depression-dc1062faa2320f67 2026-09-03T16:12:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-year-long-sop-for-mahaprasad-langar-ahead-of-festivals-to-ensure-food-4a6536f6317c447b 2026-09-03T16:08:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-follow-now-september-3rd-385c65dc54bd1080 2026-09-03T16:05:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/erasmus-days-discover-the-2026-programme-93381544d106d795 2026-09-03T15:52:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-seeks-public-input-to-advance-development-of-botanical-drug-products-31dddb311ddb532f 2026-09-03T15:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-apazunersen-fails-phase-3-angelman-syndrome-trial-889389931e9b0127 2026-09-03T15:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-orders-recall-of-arcan-bitters-over-undeclared-drug-substance-94c8f38c713d3c90 2026-09-03T15:18:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/kali-therapeutics-receives-u-s-fda-clearance-for-kt501-investigational-new-drug-aae488d1a2c414ed 2026-09-03T15:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/twinstrand-s-245m-win-signals-growing-value-of-biotech-patent-monetisation-14eeaebdc54d0c17 2026-09-03T15:11:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/colombia-after-the-earthquake-volunteering-instead-of-a-research-trip-9b2a7110ce9ba114 2026-09-03T15:09:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/nottingham-professor-awarded-international-pharmaceutical-federation-fellowship-3fc85d6768441daa 2026-09-03T15:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/riken-mathematics-ai-symposium-2026-48d23082fc2fd00b 2026-09-03T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-summit-therapeutics-stock-soaring-today-summit-therapeutics-nasdaq-smmt-9318bb4b935a74eb 2026-09-03T14:57:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-announces-positive-topline-results-from-the-phase-3-cervino-trial-showing-e891ac294dba1fe7 2026-09-03T14:55:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ubc-supports-students-with-specific-dietary-needs-and-cultural-food-preferen-1191a4b6e6188de9 2026-09-03T14:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maha-fda-unveils-permanent-food-safety-calendar-for-festivals-778a0301f9805c0f 2026-09-03T14:54:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/seattle-scientists-launch-95-million-ai-biology-effort-02697c531b6efbaa 2026-09-03T14:41:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/avacopan-safety-concerns-grow-amid-liver-injury-signals-reports-us-registry-anal-e2c80021015aa223 2026-09-03T14:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/ind-safety-reporting-what-sites-need-to-submit-f33e0a2a430c1484 2026-09-03T14:28:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/controversial-drug-suspended-due-to-trial-irregularities-71679c947d63120b 2026-09-03T14:24:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-eid-to-diwali-maharashtra-fda-led-by-tukaram-munde-announces-year-round-rul-2c5811935cac6a38 2026-09-03T14:19:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/sweets-cooking-oil-and-community-feasts-to-face-stricter-checks-as-maharashtra-f-cf6cdf0f198ea302 2026-09-03T14:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotechnology-firm-to-double-local-workforce-after-leasing-larger-space-4ee1a174c0f80686 2026-09-03T14:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-2026-oral-and-injectable-glp-1-comparisons-under-the-spotlight-5f57685e1a0a5d60 2026-09-03T14:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognising-animal-flu-viruses-before-the-threat-of-a-pandemic-23bebfa063fe8b84 2026-09-03T14:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-million-investment-to-advance-materials-innovation-8bdc3befa28e0c42 2026-09-03T14:01:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/hyperglycemic-stress-aggravates-diabetic-retinopathy-and-nephropathy-by-promotin-f4bf6d1294d1dd4a 2026-09-03T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carlos-perez-gonzalez-laureat-de-la-bourse-europeenne-erc-starting-grant-d0ad82fe64b306a6 2026-09-03T13:55:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-shares-drop-following-failed-phase-iii-clinical-trial-b3e5d2419e353d3e 2026-09-03T13:52:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-first-look-into-the-heart-of-the-milky-way-35441f436bd6e37b 2026-09-03T13:47:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/eledon-files-islet-cell-transplant-application-plans-phase-3-kidney-trial-9801cbd3516e453e 2026-09-03T13:47:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-hits-new-12-month-low-after-analyst-downgr-4f904266dcbe655d 2026-09-03T13:42:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/keep-your-vaccines-healthy-poster-and-magnet-645e3db5492ab884 2026-09-03T13:41:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-given-new-37-00-price-target-at-canaccord-66c0004b8e1883b9 2026-09-03T13:34:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/hda-proposes-two-year-timeline-for-national-pharmaceutical-distributor-licensure-efa7c2adbb08a13a 2026-09-03T13:27:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-tests-over-30-000-food-samples-more-than-15-000-found-below-stan-5551f8b8d9d45244 2026-09-03T13:26:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-bispecific-shows-promise-in-ph-3-multiple-myeloma-trial-d184def1095d8173 2026-09-03T13:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-stock-craters-as-aspire-trial-failure-triggers-reset-32a5989619a1475c 2026-09-03T13:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-experimental-treatment-cut-the-risk-of-disease-getting-worse-or-death-6-a5494b8f45fd1257 2026-09-03T13:16:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/william-blair-downgrades-ultragenyx-pharmaceutical-nasdaq-rare-to-market-perform-2c38e617623ac224 2026-09-03T13:11:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-bio-market-insights-scaling-without-cells-6334c041855b4f7a 2026-09-03T13:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monte-rosa-therapeutics-high-stakes-drug-pipeline-balanced-by-a-fortress-balance-5b424379b046d58f 2026-09-03T13:06:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/kala-shankle-on-states-timing-and-national-licensure-readiness-a29570559c5d9e91 2026-09-03T13:04:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/safe-food-a-shared-responsibility-not-just-fda-s-job-says-tukaram-mundhe-f656bde45e831364 2026-09-03T13:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-bronzeville-outpatient-center-celebrates-one-year-of-provi-444f886ce2127299 2026-09-03T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suven-life-sciences-completes-phase-3-enrollment-for-masupirdine-in-alzheimer-s-29fbb841320aeeb3 2026-09-03T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mosquito-watch-submit-a-mosquito-bd568f4e70a718ed 2026-09-03T12:50:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-inc-rare-stock-price-live-quotes-charts-nasdaq-3540750ffc4c2259 2026-09-03T12:49:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-crackdown-34-584-food-samples-taken-up-for-testing-between-june-b8d57877366cbdbf 2026-09-03T12:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-rents-cost-housing-associations-billions-in-investment-capacity-ece7ee6be5a54f02 2026-09-03T12:44:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-data-confirms-innovative-pharmaceutical-industry-is-a-major-economic-engine-aba4b07359d611b4 2026-09-03T12:28:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-steps-up-testing-over-37-600-food-drug-samples-collected-in-thre-2f7d0633fe9db2cb 2026-09-03T12:23:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-healthcare-conference-webcast-is-set-for-sept-10-in-new-york-1e8f98d1fcb617e7 2026-09-03T12:21:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/jyong-biotech-announces-participation-in-stockfan-virtual-investor-non-deal-road-9319d9b6ab931362 2026-09-03T12:14:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-to-participate-in-2026-cantor-global-healthcare-conference-6b9c103be781eff3 2026-09-03T12:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-lowered-to-neutral-rating-by-jpmorgan-chas-d6dae5210c2caa66 2026-09-03T12:10:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-rating-lowered-to-neutral-at-robert-w-bair-23e748d6557c1edf 2026-09-03T12:10:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-rating-lowered-to-equal-weight-at-wells-fa-ea8a01bb92c57369 2026-09-03T12:10:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-to-present-at-2026-cantor-global-healthcare-conference-f43166b67934f065 2026-09-03T12:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-the-baltics-northway-biotech-opens-61-million-cell-therapy-and-personal-a87b8ad77b056c33 2026-09-03T12:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suven-life-sciences-completes-424-patient-phase-3-enrollment-for-masupirdine-in-4bcb3472c79eaadb 2026-09-03T12:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/some-of-the-top-biotech-funds-just-bought-into-this-under-the-radar-biotech-nasd-e136ce9977b1d5b4 2026-09-03T12:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/billionaire-family-offices-back-healthcare-and-biotech-startups-in-august-0f2796c3e663921e 2026-09-03T12:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pinpointing-a-key-obstacle-to-renewable-car-macrophage-therapy-a60a8fb5e8bb30cc 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-plant-based-drug-developer-will-join-a-two-language-online-investor-event-sept-b707f8ac9e35c186 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-his-parents-basement-to-your-medicine-cabinet-absci-ceo-college-of-science-e926866d72dc8521 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/priothera-appoints-experienced-biotech-executive-dr-nigel-3a4d080a65e420a3 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/priothera-appoints-experienced-biotech-executive-dr-nigel-clark-as-chief-busines-f6aedf2072e14833 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-research-site-community-selects-2026-scrs-eagle-award-finalists-66a13ba0ec1d379b 2026-09-03T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-angelman-syndrome-drug-fails-late-stage-trial-6b4049d5314ab1c4 2026-09-03T11:49:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-pens-1-3b-hutchmed-deal-for-kras-egfr-cancer-asset-e31680feb091bad4 2026-09-03T11:45:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-appoints-ching-pin-chang-m-d-ph-d-as-executive-vice-president-aae99c988faf7c17 2026-09-03T11:40:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/wcg-releases-checklist-to-speed-protocol-amendment-implementation-at-clinical-tr-892e7f75d733ba22 2026-09-03T11:37:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-atlas-copco-s-compliant-energy-efficient-solutions-keep-pharmaceutical-utili-4f2ebf75ce697e83 2026-09-03T11:26:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/william-blair-downgrades-ultragenyx-pharmaceutical-to-market-perform-from-outper-2b6b1bf8cab32987 2026-09-03T11:21:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/evercore-isi-downgrades-ultragenyx-pharmaceutical-to-in-line-from-outperform-adj-15c7212b50543081 2026-09-03T11:21:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/reading-an-fda-warning-letter-record-volumes-familiar-failures-e3a9b0b861057990 2026-09-03T11:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/investingpro-s-fair-value-model-spotted-puma-biotech-s-95-rally-by-investing-com-67caf919ca21f9d2 2026-09-03T11:13:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortrea-s-45m-early-phase-deal-sets-a-90-day-test-for-sponsors-with-active-studi-9a490a30bde2984f 2026-09-03T11:12:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-apazunersen-fails-phase-3-primary-endpoint-in-angelman-syndrome-4bb02cc4de268cb9 2026-09-03T11:12:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictive-tools-can-confuse-rare-mutations-with-dangerous-ones-3766eee04cbf176c 2026-09-03T11:12:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/eledon-pharmaceuticals-announces-islet-cell-transplantation-ind-submission-first-0cad31bc06f5ac7e 2026-09-03T11:11:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-fails-phase-3-angelman-test-plots-significant-expense-reductions-ebb2a3e917bc4b01 2026-09-03T11:10:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-reminder-smoking-still-causes-cancer-6e7ebe2f2e383826 2026-09-03T11:04:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/insider-buys-additional-chf75k-in-veraxa-biotech-stock-bf2714a4c3eb9204 2026-09-03T11:00:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-case-on-mifepristone-access-until-after-midterm-elections-62f779dda08ba54b 2026-09-03T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/12-people-with-type-1-diabetes-no-longer-needed-insulin-after-transplants-three-69cadbf21e12fe93 2026-09-03T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eledon-pharmaceuticals-announces-islet-cell-transplantation-6051b080334c5705 2026-09-03T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biocytogen-and-qilu-pharmaceutical-sign-agreement-for-vhh-antibody-molecule-025ca1ea06620367 2026-09-03T10:54:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/research-team-develops-solvent-free-tandem-solar-cells-c67a3c08f40e57f5 2026-09-03T10:37:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/abivax-has-still-not-been-acquired-what-s-going-on-9bbd3e7e80750342 2026-09-03T10:34:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/erc-starting-grant-fur-den-heidelberger-neurologen-und-neurowissenschaftler-dr-d-01d036cfabc39059 2026-09-03T10:27:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-s-ivonescimab-extends-survival-in-pd-l1-lung-cancer-4eb5e75d6b19d633 2026-09-03T10:24:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulating-a-moving-target-fda-seeks-comments-on-possible-framework-for-regulati-9ff50e986f196b64 2026-09-03T10:23:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-way-to-improve-the-effectiveness-of-antiangiogenic-drugs-and-immunotherapy-i-2db25801d7a0c5eb 2026-09-03T10:16:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/hutchmed-china-signs-licensing-deal-with-gsk-for-experimental-solid-tumour-drug-6fdc52cd79303468 2026-09-03T10:13:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/last-patient-finishes-72-week-mash-study-for-inventiva-iva-4e1c703a10cc5a32 2026-09-03T10:03:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-does-resilience-mean-in-the-european-forest-erc-starting-grant-for-research-8958ea97d6046b5b 2026-09-03T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heron-therapeutics-stock-trades-at-penny-level-as-biotech-focuses-on-pain-and-on-81fc4b904627f4d4 2026-09-03T09:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/nhs-injury-costs-recovery-scheme-april-2026-to-march-2027-8ea107a36a0e2402 2026-09-03T09:56:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-attacks-major-pharmaceutical-storage-complex-in-kyiv-oblast-b233495bba57634d 2026-09-03T09:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/invasive-mosquito-species-detected-in-east-london-27cbec11478637b5 2026-09-03T09:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-biotech-jumps-5-on-1-4-bonus-issue-dividend-announcements-c9da73fea54f65e9 2026-09-03T09:43:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccines-2026-to-2027-flu-season-b576f8a56dd971ba 2026-09-03T09:42:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-erc-starting-grants-for-scientists-at-universitat-heidelberg-92a95c552c7fd72b 2026-09-03T09:39:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaping-the-future-of-pharma-gelita-s-next-gen-excipients-at-cphi-6157863079aaa604 2026-09-03T09:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ureteric-stent-removal-after-a-kidney-transplant-32c14812b7d96bd0 2026-09-03T09:18:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-biotech-s-board-approves-issuance-of-bonus-shares-in-ratio-of-1-4-a366675af4736ae7 2026-09-03T09:18:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-sleep-data-could-provide-one-week-early-warning-of-flu-and-covid-19-a8c7f093a9fa926c 2026-09-03T09:08:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/children-s-public-health-nursing-workforce-and-activity-2025-38e994035a279a7b 2026-09-03T09:06:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-deepens-cooperation-with-indonesia-s-regulator-c1de9f769fac6bdc 2026-09-03T09:02:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-angelman-syndrome-drug-fails-phase-iii-test-53135297270ca56f 2026-09-03T08:59:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-case-on-mifepristone-access-until-after-midterm-elections-b4af6396308c5ad6 2026-09-03T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-steps-up-cooperation-with-indonesia-3733838a428656a4 2026-09-03T08:51:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/danish-pension-giants-increased-novo-nordisk-stakes-in-h1-6c60e569428329e6 2026-09-03T08:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-science-successful-economy-strong-germany-96b1ee075840cb69 2026-09-03T08:38:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/engagement-guide-for-infection-and-antimicrobial-resistance-amr-174f9e49abc663e7 2026-09-03T08:37:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-riesgo-de-acceso-no-autorizado-en-el-sistema-albert-e-mot-66acbce3cedfd018 2026-09-03T08:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/balancing-tried-and-tested-against-future-innovation-a-strategy-for-boosting-ear-bf066df4a26afb7f 2026-09-03T08:32:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-provider-statistics-england-quarterly-update-to-august-2026-84fd9c0dae4b4c16 2026-09-03T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-provider-statistics-england-background-quality-and-methodology-5a33757363446dec 2026-09-03T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-provider-statistics-england-quarterly-update-e646ed937f385b1f 2026-09-03T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/surveillance-of-respiratory-syncytial-virus-winter-2024-to-2025-c594e08a26c8ca93 2026-09-03T08:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-b306771583db51df 2026-09-03T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-e72ee03f6bc9d959 2026-09-03T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiv-london-annual-data-spotlight-6282540f898afb39 2026-09-03T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-energy-transition-needs-interdisciplinary-thinking-dfcd79298b055f88 2026-09-03T08:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-enabling-the-next-phase-of-complex-molecule-innovation-4e17182ac4042dee 2026-09-03T08:24:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/synpedagogen-ger-vardagen-kontrast-och-struktur-95924ef9fc9926aa 2026-09-03T08:19:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mosquito-control-c8b19194e5a7a25e 2026-09-03T08:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/connected-trials-a82780380136f0f3 2026-09-03T08:08:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-oabi-13-frnm-exel-fth-lfst-2e50687fe324c1c7 2026-09-03T08:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-methods-for-regulator-ready-real-world-evidence-in-nsclc-536d367e74f8ed94 2026-09-03T08:02:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/annji-submits-application-to-u-s-fda-for-phase-3-clinical-trial-of-aj201-5207a59b9553f77e 2026-09-03T07:57:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-del-cese-de-comercializacion-retirada-del-mercado-y-recuperacio-d7c74ef33232d281 2026-09-03T07:56:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-strikes-ukraine-s-largest-pharmaceutical-warehouse-losses-could-reach-bil-3567df19810183c4 2026-09-03T07:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-meets-overall-survival-endpoint-against-pembrolizumab-in-phase-iii-t-ce718663a02288e2 2026-09-03T07:42:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortrea-s-45m-early-phase-acquisition-will-reshape-your-phase-i-startup-timeline-05179ce26d7d3e20 2026-09-03T07:37:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulgarian-pharma-industry-protests-overt-politicisation-of-medicines-policy-700d9b57e0a63a54 2026-09-03T07:36:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/nsabp-b-59-failed-the-real-question-is-why-we-keep-designing-trials-that-can-t-d-48bd1b32fb97c719 2026-09-03T07:32:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-s-angelman-syndrome-drug-fails-pivotal-phase-3-trial-5651d20c84e50171 2026-09-03T07:31:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-looks-41-3-undervalued-on-gf-valuetm-after-phase-3-setback-3472fe9fdebeb9eb 2026-09-03T07:24:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/titan-biotech-board-approves-bonus-share-issuance-b509311b2c6969f4 2026-09-03T07:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/making-rotterdam-my-home-0f5099c60634182b 2026-09-03T07:00:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/universite-paris-cite-on-the-path-to-internationalising-its-programmes-9ddecf58ccd5dad0 2026-09-03T07:00:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-cases-are-rising-how-to-protect-yourself-this-fall-and-winter-c0bbcec00c9cd3d8 2026-09-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/volunteers-help-older-patients-stay-connected-and-clear-minded-during-hospital-s-d26a0e3e18141aa9 2026-09-03T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tender-notice-supply-and-delivery-of-various-medical-equipment-amref-health-afri-d77f3ecace254d76 2026-09-03T06:48:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-competence-development-courses-give-natural-science-teaching-in-primary-an-e20f71074a77549d 2026-09-03T06:48:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/tscan-therapeutics-cuts-75-of-workforce-pauses-phase-3-alloha-2-trial-for-tsc-10-0e615d16ac4309a7 2026-09-03T06:47:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanochon-enrolls-first-patient-in-chondrograft-knee-cartilage-study-84016f09cb28bd9f 2026-09-03T06:42:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-completes-nativ3-phase-3-trial-of-lanifibranor-in-mash-4408a2f67e0410dc 2026-09-03T06:42:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-warehouse-reported-on-fire-after-russian-drone-attack-in-ukraine-f91767780426fb59 2026-09-03T06:13:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/indonesian-regulator-visits-daewoong-research-center-af1f35ce26ac2433 2026-09-03T06:12:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/deployer-la-medecine-genomique-48c472855da1e09c 2026-09-03T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vessl-ai-supplies-sk-biopharmaceuticals-128-nvidia-b200-gpus-to-fuel-r-d-chosunb-83c80d51719dcb02 2026-09-03T05:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-drops-on-phase-3-trial-failure-for-angelman-syndrome-drug-rare-nasdaq-e5e6b1558958846f 2026-09-03T05:55:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-united-pharmaceutical-succeeded-in-re-certifying-the-ukrainian-drug-manufa-0e3667859f8cfb47 2026-09-03T05:49:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-avoid-common-contamination-control-mistakes-in-new-aseptic-facilities-bb17139a7fb32478 2026-09-03T05:48:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/mint-venture-partners-lists-three-biotech-bets-on-kosdaq-2191b8f255058e37 2026-09-03T05:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-agrees-to-pay-110-million-for-hutchmed-cancer-drug-rights-879a2fc3651283b3 2026-09-03T05:27:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/indonesia-s-bpom-visits-daewoong-pharmaceutical-s-magok-r-d-center-to-expand-reg-4de9e02ba3c4cde6 2026-09-03T05:03:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-orders-immediate-recall-of-arcan-bitters-over-drug-adulteration-88aafee8e0afa456 2026-09-03T04:43:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/robotics-ai-in-pharmaceutical-manufacturing-9a735dc6c0868c57 2026-09-03T04:35:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/eisai-and-biogen-announce-china-approval-of-leqembi-sc-ai-for-initiation-treatme-93067c7018dba048 2026-09-03T04:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-outbreak-table-is-showing-17-active-investigations-37464e61b525f64b 2026-09-03T04:06:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/leqembi-lecanemab-subcutaneous-formulation-as-an-initiation-treatment-for-early-110a7765be93bf34 2026-09-03T04:00:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/america-s-new-drug-dealers-have-moved-from-street-corners-to-the-internet-and-th-77877996a0a16e2a 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/b-braun-medical-inc-issues-voluntary-nationwide-recall-of-0-9-sodium-chloride-in-415834284e5488f7 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spinal-cord-stimulator-recall-boston-scientific-removes-infinion-cx-lead-65b558bea0c49e11 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monitoring-system-correction-ge-healthcare-updates-use-instructions-for-portrait-b85b00625bf9b90c 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-heart-pump-controller-purge-cassette-issue-from-abiomed-04c7962787145431 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-breathing-circuit-issue-from-draeger-d5c9d433b1e38f07 2026-09-03T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/israeli-ag-biotech-company-to-set-up-north-american-hq-in-indiana-20bf6997cd4f9e26 2026-09-03T03:52:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/russian-far-east-universities-and-pharma-group-partner-on-marine-based-biotech-7f12b55ceb230d3b 2026-09-03T03:42:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/brandon-capital-s-60m-taypayer-funded-biotech-bets-fcd7d0145adac3bb 2026-09-03T03:42:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-english-translation-of-review-report-akuugo-partial-change-approval-04b818dca2e48622 2026-09-03T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shinsa-points-to-consider-for-the-evaluation-of-the-effects-of-food-on-the-pharm-631aad808822c180 2026-09-03T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-monotherapy-demonstrates-statistically-significant-overall-survival-f35cba7f06714f8d 2026-09-03T02:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncosil-pursues-a-reimbursement-pathway-as-it-prepares-for-us-rollout-d8655e4eb1f3d3f0 2026-09-03T01:48:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-biotech-services-enters-cooperation-agreement-a411b5dd359e3024 2026-09-03T01:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/onconic-therapeutics-wins-south-korea-approval-to-begin-phase-3-h-pylori-trial-c-df56cd87d06f8bb4 2026-09-03T00:19:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/un-tunel-que-cruce-el-estrecho-de-magallanes-academicos-uc-evaluaran-su-factibil-fca9fdecaf50f2eb 2026-09-03T00:09:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-filed-form-8-k-8ed1dc98747e9b33 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/e-walleting-the-sun-challenges-of-affordability-and-justice-for-south-africa-s-e-4f51b97262abead6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-request-30-day-public-comment-request-4b636f3d14fc39a2 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-that-phenaphen-with-codeine-no-3-acetaminophen-codeine-phosphate-o-f6afc4514dc89e2e 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergency-use-authorization-declaration-1407ab0d73e22187 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-mental-health-notice-of-meeting-c93b5de36847c168 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-b1067504549d2a56 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dopaminergic-therapy-selectively-amplifies-hallucination-susceptibility-in-patie-49c44953feeffa09 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/qfr-guided-versus-ivus-guided-with-qfr-confirmation-for-drug-coated-balloon-trea-cdfb448cad6522ee 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/may-2025-therapeutic-delivery-industry-update-6443de1442a3a87f 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pregabalin-for-treatment-resistant-generalised-anxiety-disorder-petra-study-prot-f8c2e7a852449edd 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/counterintuitive-reducing-regression-to-the-mean-worsens-efficiency-in-simulated-8354b66a9153cae3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-human-phase-i-trial-of-hrs-2129-a-selective-nav1-8-inhibitor-safety-tol-00da764d844d1c83 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-an-unresolved-intercurrent-event-in-a-randomized-trial-of-ciprofol-ve-53df0676a4a90bf2 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrasound-guided-infraspinatus-teres-minor-interfascial-block-versus-interscale-8936c7b5b7fed81c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/corrigendum-to-brief-mindfulness-intervention-for-adults-with-cannabis-use-disor-6d5023f773e6048a 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptive-imatinib-regimens-can-mitigate-cumulative-toxicity-while-sustaining-hem-e8d4654532f2c370 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-properties-of-the-clinical-drug-candidate-pri-002-with-regard-to-a7b6ed8d34af1b34 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bicistronic-cd19-cd22-car-t-cell-therapy-in-pediatric-b-cell-acute-lymphoblastic-bafa8b2e322dce4b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanotherapeutics-in-osteosarcoma-advances-in-mirna-nanocarriers-and-targeted-dru-6b38d35cad1fe8ae 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-operator-experience-level-on-clinical-outcomes-of-indirect-and-direct-3b518c5ead5f1d8e 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-efficacy-and-safety-of-pharmacokinetically-guided-and-body-surface-a-ded483ec76c76e68 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/symptom-control-proportion-using-patient-reported-outcomes-by-palliative-care-te-d09f0503cf931f5f 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-pr-interval-with-illness-duration-and-lymphocyte-count-in-asian-a-4b263d4f54a0b591 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydrogen-peroxide-driven-electrophysiological-remodeling-ros-mediated-voltage-ga-8c90b69f5e776ff1 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapy-challenges-and-child-cohorts-where-the-need-to-treat-is-the-only-option-fd0c27352b464ef6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sleep-apnea-hypopnea-in-children-evidence-that-lize-tongqi-decoction-with-acupun-b180aa9cd97330d0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacotherapy-of-heart-failure-impact-of-the-2021-guideline-update-on-guidelin-b4ab87d136ac0e81 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-operator-experience-level-on-clinical-outcomes-of-indirect-and-direct-120dd9ece6ef3538 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioimpedance-from-body-composition-assessment-to-emerging-technologies-in-clinic-e84f95ada897817b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcranial-direct-current-stimulation-in-anorexia-nervosa-a-randomized-sham-co-a4a46e9df1c41167 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cumulative-electrical-risk-score-is-associated-with-appropriate-icd-therapy-in-7ef49eeaf320c373 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-maternal-anti-d-antibody-titers-in-severe-rhd-alloimmun-65404e4c99ff7550 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/limited-predictability-of-traumatic-intracranial-hemorrhage-from-routine-pre-ct-5d2028888b43b239 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-assessment-of-obesity-beyond-body-mass-index-adiposity-evaluation-body-f6993fbb729841a9 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-directional-chromosomal-clustering-of-metabolic-pathway-genes-as-a-layout-pri-67ec43dc5048e366 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fenofibrate-in-ophthalmology-therapeutic-efficacy-and-mechanisms-eb91509f713f76a2 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/validation-of-a-commercial-intraoral-auto-segmentation-algorithm-against-expert-ac559981ac6f5b60 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acceptability-and-feasibility-of-the-ushirikiano-treatment-model-for-kenyan-adol-6b8593f015316a22 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/staff-mediated-doll-therapy-in-chinese-residential-dementia-care-an-exploratory-df2f7edd9923714c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-mature-tertiary-lymphoid-structures-in-a-metastatic-urothelial-carci-5be9ce5a12403608 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-expression-and-clinical-significance-of-sirt5-h2a-and-top2a-in-cervical-canc-22b2131009e25a50 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-stroke-in-inborn-errors-of-metabolism-clinical-characteristics-neuroim-e9a39a60ac1b20b2 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-of-the-galdakao-modified-supine-valdivia-position-vs-the-litho-6f472f987bf194a5 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-soft-endoscopic-treatment-of-herlyn-werner-wunderlich-syndrome-an-in-e6e15ba7a480d0fd 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunogenicity-and-safety-of-a-single-dose-of-adjuvanted-rsvpref3-vaccine-in-adu-314188cb964801b0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-the-boppps-model-combined-with-flipped-classroom-in-clinical-prac-aedb6015c93ab006 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-perioperative-outcomes-of-computer-guided-versus-conventional-plan-812dcb7e8cb1be77 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-therapeutic-targeting-of-cell-death-in-cardiovascular-diseases-from-me-c39a4a66405473be 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-external-fenestration-tevar-in-stanford-type-b-aortic-disse-dfde2ef53d47dfde 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-clinical-prediction-model-for-post-procedural-hemolysis-after-transcatheter-vs-76ab0e3da393a23d 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-safety-of-l-annamycin-a-pooled-analysis-of-five-clinical-trials-e0dfccb4be31a915 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-shortening-and-relapse-control-in-drug-susceptible-pulmonary-tuberculo-d0ffd3b5d5ec68a1 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-initial-validation-of-an-instrument-measuring-the-perceived-impo-73eca2313dc278e8 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-minimal-residual-disease-assessment-in-multiple-myeloma-using-a-stand-2a56eb19997102c5 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-clinical-anthropometric-cardiometabolic-and-autonomic-determinants-of-d2755d97ec2d9e04 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-mrna-neoantigen-vaccines-reach-phase-iii-a-critical-commentary-on-t-4d5cc16668f643ad 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-molecular-engineering-and-artificial-intelligence-to-overcome-clinic-e47531eaa091416c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-feasibility-and-procedural-efficiency-of-a-trephine-based-digital-surgi-054db21b123370f3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crestal-bone-loss-in-mandibular-telescopic-implant-retained-overdenture-with-mil-41243a9cfa7408b3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-correlates-of-follow-up-discontinuation-in-adult-psychiatric-outpatient-e8acf6cef829a517 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evolution-of-the-legal-regulation-of-nicotine-containing-products-in-the-russian-b145c6833a20b0c7 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/criminal-law-characteristics-of-propaganda-of-narcotic-drugs-in-information-and-5eb19c99b74bc4ca 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarkers-in-retinopathy-of-prematurity-expanding-horizons-toward-non-invasive-e061daf423d69334 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-harmonized-reporting-of-alzheimer-s-disease-biomarkers-in-clinical-practi-1c9864ef9fc636f9 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-feasibility-of-ferritin-assay-harmonisation-with-commutable-proof-of-c68a5c131cf180ce 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-testicular-function-in-boys-with-hematological-malignancies-a-pros-85d1a1e7b0937e6f 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-pharmacokinetic-and-pharmacodynamic-study-of-enteric-coated-sustaine-88476cfd2c712d82 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/management-of-job-stress-among-higher-education-academics-a-randomised-controlle-f609565c3431ce3b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-maze-out-a-study-protocol-for-a-randomised-controlled-trial-using-a-m-b8d1d9481acd5f89 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inflammatory-macrophages-promote-metastatic-potential-in-triple-negative-breast-5b1cfa72c034d99b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-association-of-involvement-in-clinical-activities-and-job-satisfaction-among-0c2113447c240a0c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-dimensional-human-ipsc-derived-cardiac-organoids-for-antifibrotic-drug-screeni-327080c375c27d07 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s3-from-a-patient-derived-xenograft-repository-capturing-cl-1bb875fc355d151b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s5-from-a-patient-derived-xenograft-repository-capturing-cl-dbca5a634b2d4be6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s6-from-a-patient-derived-xenograft-repository-capturing-cl-6b0c8c46f89bbe20 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-2-from-safety-and-clinical-outcomes-of-a-first-in-human-tri-7e5419b380288ee6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-2-from-safety-and-clinical-outcomes-of-a-first-in-human-tria-69bb7cc4cdc06ac2 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s4-from-tumor-infiltrating-clonal-hematopoiesis-is-associate-cf4a365d08ef7264 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s5-from-tumor-infiltrating-clonal-hematopoiesis-is-associate-2cfa8f429c2213bc 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-global-longitudinal-strain-and-pacing-induced-cardiomyopathy-cfa4490a36473a3c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/macrophage-foxo1-inhibition-protects-against-hyperglycaemia-associated-kidney-in-529780b59f9a549c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-endoscopic-ultrasound-guided-fine-needle-biopsy-in-radiologic-4cb4a79654db3e5d 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncommon-benign-tumour-of-the-scalp-9c6984be86a129db 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-trial-of-oral-infigratinib-in-children-with-achondroplasia-beadc928530874a3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-demographic-characterization-of-tinnitus-and-factors-associated-wit-69e6ccebc5aa439e 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-repeated-exposure-to-an-identical-multi-user-virtual-reality-anaphylax-ef38074b9f59984b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomized-trial-comparing-effects-of-high-speed-cued-yoga-and-hatha-yoga-on-cog-cc2e015ee5653ae0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/limited-benchmarks-constrain-the-conclusions-of-a-general-purpose-versus-clinica-e58ff25e96475cc6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-limited-benchmarks-constrain-the-conclusions-of-a-general-purpose-versu-a56657bf155b0abc 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-sacubitril-valsartan-on-serum-uric-acid-and-blood-pressure-in-patients-6378ddefd7cd8a1e 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-calcium-chloride-and-polyethylene-glycol-400-on-drug-l-bbf22ecfb9b45a09 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-conventional-molecular-graphs-multigraph-based-topological-descriptors-fo-48432f2f93b11c08 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transnasal-administration-of-surfactant-aerosol-to-the-lungs-of-infants-using-di-15e0d98bf43c71fa 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/semaglutide-bioavailability-limitations-formulation-innovation-and-future-opport-86ea1f2e2c2800f6 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-orthogonal-framework-for-higher-order-structural-and-in-vitro-functional-comp-0010ab880b5503ac 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sodium-glucose-cotransporter-2-inhibitors-and-gastrointestinal-neoplasm-risk-in-6adf5f6a47736c62 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-psychiatric-drug-initiation-after-craniectomy-a-retrospective-cohort-26f3d11ac448941a 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-health-and-functioning-in-older-adults-in-switzerland-from-1970-to-2025-a-s-16c8b53579418da3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vascular-and-autonomic-recovery-after-resistance-training-with-and-without-post-8066e974c23d4808 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/volumetric-and-functional-connectivity-alterations-of-the-thalamus-and-thalamic-eb2eea0aa27ca4a0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07803549-the-effect-of-self-management-interventions-among-patients-with-brea-3ca15db906d2ebc5 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07803120-effects-of-external-upper-limb-loading-on-gait-and-trunk-muscle-acti-4feef7e864160149 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07802834-adjuvant-ctdna-adapted-treatment-with-zipalertinib-in-early-stage-at-c2d7d080dba11bf8 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07802132-a-prospective-observational-single-arm-multicenter-real-world-study-fd91cda2be97b0e7 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07801417-clinical-biochemical-evaluation-of-antioxidant-vs-chlorhexidine-as-a-c93a6c9e605280c4 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07801339-clinical-evaluation-of-immediate-dental-implants-in-very-elderly-pat-6b66b3ce91e03bca 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07786701-treatment-of-camptodactyly-with-radial-longitudinal-flap-versus-full-ab0801914f16114b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07719725-effects-of-visual-feedback-induced-therapy-and-active-release-techni-3f43b35d6a434bf8 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07684235-extension-trial-to-evaluate-the-long-term-efficacy-safety-and-tolera-f33b5bffb01a2fc3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07678931-study-on-the-treatment-of-adolescent-patients-with-seasonal-allergic-fc4b86a86c347df7 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07661108-a-clinical-study-of-mk-8527-in-healthy-participants-mk-8527-021-18f74983ac589a48 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07630831-patient-navigation-for-improving-transition-success-among-multiply-d-f711752150395a13 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07620561-efficacy-and-speed-of-response-of-lebrikizumab-in-high-burden-prurig-54feb83b5d470419 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07606144-pecha-kucha-based-eras-education-in-cardiovascular-surgery-effects-o-e856b226ac56abb1 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07600749-clinical-study-of-mk-4884-in-participants-with-advanced-or-metastati-2d41f3a6b028aa9b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07594730-brief-intervention-addressing-stigma-among-parents-of-children-with-bbf85563aa96deac 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07545811-study-of-janx014-in-subjects-with-metastatic-castration-resistant-pr-6aa1e42bc6852e37 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07545265-skb565-for-injection-in-advanced-solid-tumors-0cc1c6106d9c46c0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07538518-pet-imaging-study-using-evuzamitide-to-detect-cardiac-amyloidosis-in-0dea7794766b509d 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07489495-a-clinical-study-of-belzutifan-mk-6482-and-zanzalintinib-in-people-w-a3e0d6fe17ba3f25 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07484620-physical-activity-and-fitness-in-pediatric-inflammatory-bowel-diseas-bc58426f4ec17f87 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07414992-a-study-of-radiation-therapy-and-cemiplimab-with-or-without-fianlima-ff8eb97481943626 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07326566-study-of-silevertinib-with-temozolomide-for-the-treatment-of-newly-d-c79f0cf666642e01 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07280468-endotype-directed-treatment-for-osa-in-down-syndrome-8211218c37c40f9f 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07156227-testing-the-addition-of-an-anti-cancer-drug-camonsertib-to-radiation-9e32cb0460922608 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07047079-patient-navigation-based-preoperative-rehabilitation-exercise-progra-fac1c36c1193f8d5 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07026331-effect-of-balloon-angioplasty-vs-stenting-following-residual-stenosi-c505d4bff28bb9fb 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06989359-phase-2-study-of-adx-038-in-complement-mediated-kidney-disease-e19805be6982b1bf 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06975176-combating-hiv-stigma-in-healthcare-settings-a-standardized-patient-a-62493b8d11a4810f 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06959979-novel-molecular-targets-and-innovative-therapeutic-perspective-in-me-74e9efac56b00105 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06905834-evaluation-of-allogenic-mesenchymal-stem-cell-msc-injection-therapy-f1544c84fa352983 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06868914-phase-i-trial-of-high-density-theta-burst-stimulation-hdtbs-50974328c917c8e9 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06851767-base-edited-hematopoietic-stem-progenitor-cell-x-linked-severe-combi-7e80bdcae407fc6b 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06790693-a-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-cdk4-6-6f1e9caf08c3d834 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06750484-trial-of-trastuzumab-deruxtecan-in-previously-treated-her2-03b4259de70d475c 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06727565-study-of-novel-treatment-combination-therapies-in-participants-with-a2f6e6c632fa60cd 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06703489-safety-and-performance-assessment-of-the-sphere-9tm-catheter-and-aff-1cc56312f9c981ee 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06514937-efficacy-of-the-e-motional-training-program-for-improving-social-cog-9535cd8a7afffeb3 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06470750-feasibility-of-patient-centered-home-care-pchc-to-reduce-disparities-69e48f5038e920ae 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06445972-substudy-06d-combination-therapies-in-second-line-2l-gastroesophagea-6f0d2f1c8dfd9ede 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06245889-pet-dynamics-to-response-adapted-neoadjuvant-therapy-in-tnbc-24e00a5a88014a96 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06227611-evaluation-of-different-perimetric-grids-to-detect-central-visual-fi-392c69ea0a8d73af 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06203600-adding-nivolumab-to-usual-treatment-for-people-with-advanced-stomach-520cb5d107702f36 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06064097-a-study-using-nivolumab-in-combination-with-chemotherapy-drugs-to-tr-f27a51555e8948ac 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05691478-a-study-to-test-the-addition-of-the-drug-cabozantinib-to-chemotherap-faed8be82b31b368 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05491980-florida-cerebrovascular-disease-biorepository-and-genomics-center-3202d9d4647f154a 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05282732-retrospective-analysis-of-performance-and-treatment-data-collected-f-f7ad16b33e06ba05 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05009459-evisualisation-of-physical-activity-and-pain-evis-for-patients-with-92f624b0141e3d20 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04873362-a-study-evaluating-the-efficacy-and-safety-of-adjuvant-atezolizumab-b9c89b5d7939fa46 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04677049-study-of-niacin-in-glioblastoma-6e89a79f7981eabb 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04657991-a-clinical-trial-of-three-study-medicines-encorafenib-binimetinib-an-29a145dafe104c25 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01343342-genes-omega-3-fatty-acids-and-cardiovascular-disease-risk-factors-cbf4d01a13c14f7d 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01011712-the-natural-history-of-severe-viral-infections-and-characterization-273f119f11e3c127 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00040352-clinical-laboratory-and-epidemiologic-characterization-of-individual-0698a34f21953ae4 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-holdings-publishes-integrated-report-2026-a4b1fbb930580ca0 2026-09-03T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-invest-in-bc-2026-a7532d218c233bf0 2026-09-02T23:50:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-bix-2026-in-seoul-5befa78f80a6e83e 2026-09-02T23:44:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/handol-kim-to-deliver-keynote-at-bioalberta-s-health-and-life-sciences-showcase-feac2bb0a1c746b0 2026-09-02T23:35:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-ms-drug-bests-approved-therapy-in-cutting-relapses-in-2-trials-4a2babdd479fc2bf 2026-09-02T23:21:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-bionation-2026-791e27bcef603493 2026-09-02T23:19:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/mark-your-calendar-the-wbur-breakfast-club-brings-together-founders-and-ceos-res-ef50ee167c3fc9e1 2026-09-02T23:13:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptive-biotechnologies-nasdaq-adpt-director-reports-stock-gift-still-holds-66-caea8e5333f28d79 2026-09-02T23:12:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/variational-ai-at-all-in-2026-db920fed1f47e61b 2026-09-02T23:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-properly-leverage-fda-flexibility-canva-573eb6ab91a45304 2026-09-02T23:01:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-and-langara-college-formalize-partnership-to-strengthen-student-pathways-and-72e5b375985c7dfa 2026-09-02T22:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shaanxi-micot-pharmaceutical-technology-co-ltd-bec6d3a26c697399 2026-09-02T22:40:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-s-rinvoq-restores-80-hair-growth-in-severe-alopecia-areata-phase-3-trial-ab5af11c40880b9f 2026-09-02T22:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/el-proyecto-troposplice-coordinado-por-el-investigador-william-joyce-en-el-cnic-8a5c2e744e3f7d67 2026-09-02T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/revolution-medicines-announces-nejm-publication-of-phase-1-2-rasonque-data-suppo-66b7850ad6e76c80 2026-09-02T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rassegnastampa-l-archivio-storico-del-policlinico-protagonista-su-tgr-lombardia-64f2a42313c47b9b 2026-09-02T21:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-experimental-lung-cancer-drug-held-disease-in-check-for-89-of-patients-in-one-525bfa9850259641 2026-09-02T21:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-up-on-biotech-momentum-health-care-roundup-17dff033cce682bd 2026-09-02T21:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-drug-rises-to-the-gluten-challenge-stopping-intestinal-damage-in-celiac-dis-39a3798b54f80a27 2026-09-02T21:41:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-finds-less-intensive-drug-combination-is-more-effective-than-stan-6e4bc03a4ce4e1e3 2026-09-02T21:20:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/hygen-promotes-omid-ghobadi-to-coo-as-pharmaceutical-distributor-expands-0075dc505745381e 2026-09-02T21:06:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-drug-to-treat-angelman-syndrome-a-rare-disease-fails-late-stage-trial-08b478046478cf85 2026-09-02T20:51:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-971303b30f546b58 2026-09-02T20:43:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-buys-former-merrimack-anheuser-busch-brewery-for-47-million-d712ff1c239730fc 2026-09-02T20:40:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/plant-based-eczema-drug-firm-devonian-dvhgf-lines-up-u-s-ipo-but-only-if-one-con-eb9126b5333852eb 2026-09-02T20:35:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/insula-deep-rtms-and-varenicline-for-smoking-cessation-a-randomized-control-tria-d1bdd232cdecd326 2026-09-02T20:33:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-differences-in-bowel-cancer-before-50-91af7ddc367416c6 2026-09-02T20:30:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/repetitive-transcranial-magnetic-stimulation-a-potential-treatment-for-obesity-i-4f5fa23ae489d420 2026-09-02T20:24:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-regulatory-labyrinth-how-biotech-leaders-are-rethinking-strategy-872ead8b5d215f44 2026-09-02T20:23:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/consun-pharmaceutical-group-sehk-1681-lifts-earnings-and-dividend-on-a-valuation-56bea6a410da2ca9 2026-09-02T20:19:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-orders-recall-of-arcan-bitters-over-undeclared-drug-substance-f758533ae9392abb 2026-09-02T20:14:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/senators-demand-federal-probe-linking-foreign-drug-makers-to-u-s-recalls-a3a5e1078c7ea4cb 2026-09-02T20:11:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-e21fa8c6e9fdd810 2026-09-02T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-announces-last-patient-visit-in-nativ3-phase-3-clinical-trial-of-lanif-56ef0aa40f3df5b5 2026-09-02T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc1-stock-price-and-chart-ham-uc1-0bea85fdbbc1cbeb 2026-09-02T19:45:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-west-pharmaceutical-services-wst-undervalued-or-already-fully-valued-540404a08e815f7b 2026-09-02T19:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/st-louis-biotech-raises-10m-and-names-new-ceo-as-cancer-treatment-advances-862f21ae68cce7f9 2026-09-02T19:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/add-on-high-frequency-deep-transcranial-magnetic-stimulation-dtms-to-bilateral-p-3190916a3c60c88d 2026-09-02T19:36:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-orders-recall-of-arcan-bitters-over-undeclared-sildenafil-content-c038136e31f6e5f8 2026-09-02T19:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-adds-its-strongest-warning-to-a-common-iv-iron-drug-over-dangerously-low-pho-c0aea84dea9eedf6 2026-09-02T19:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-bristol-myers-pause-autoimmune-car-t-trials-over-safety-concerns-report-b6b580d2f9bcfeb8 2026-09-02T19:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-transcranial-magnetic-stimulation-for-posttraumatic-stress-diso-dbee0226d83cd52a 2026-09-02T19:08:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/solving-batch-variability-issues-6e881b9d0e00e02a 2026-09-02T19:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifarma-w-a-i-t-indicator-2026-do-tempo-de-espera-a-oportunidade-de-avancar-152ce3927b5a7dce 2026-09-02T19:06:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortrea-boosts-early-phase-cro-platform-with-45m-acquisition-of-worldwide-divisi-3eb5e65911852c58 2026-09-02T19:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intermountain-health-unveils-plans-for-new-intermountain-lds-hospital-in-downtow-ab67e04d4343086e 2026-09-02T18:53:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/3d-retina-model-reveals-cause-of-vision-loss-in-batten-disease-0f84fd8767187d93 2026-09-02T18:50:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/mccloud-remedy-project-recovery-plan-review-update-e3e3ac54e8fa5ec4 2026-09-02T18:44:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifarma-w-a-i-t-indicator-2026-from-waiting-time-to-an-opportunity-to-move-forwa-b4b85f1600f314ee 2026-09-02T18:25:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pirbright-expertise-helps-uncover-3-800-year-history-of-sheeppox-96fb5839443c2dd9 2026-09-02T18:17:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-chronic-pain-before-it-starts-52cfe5eb2495aa8e 2026-09-02T18:13:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-cancer-accelerated-approvals-9d91fd407d4e65c0 2026-09-02T17:55:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/american-shoppers-are-so-rattled-by-surging-fda-recalls-that-67-now-avoid-a-whol-3c9c865918c153c5 2026-09-02T17:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-expansion-at-levit-green-f9fef5498336c65b 2026-09-02T17:40:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-invasive-brain-stimulation-for-suicidal-ideation-a-systematic-review-and-met-6664dc39464c2315 2026-09-02T17:32:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tscan-therapeutics-sheds-majority-of-staff-pauses-phase-3-trial-amid-funding-sho-37cc678d9a4fa9e5 2026-09-02T17:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-exploratory-randomized-double-blind-trial-of-accelerated-deep-tms-for-patient-fedab9ef1c8834a6 2026-09-02T17:21:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/marked-reduction-in-suicidality-and-depression-in-a-transcranial-magnetic-stimul-b0d8bf883651a0f8 2026-09-02T17:16:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-etf-comparison-fidelity-s-fhlc-vs-invesco-s-biotech-focused-ibbq-7d011210e82c16e0 2026-09-02T17:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-fda-suspends-eat-club-rani-creators-licences-over-food-safety-and-hygiene-a7895979429b94c4 2026-09-02T17:08:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-2-more-mumbai-food-establishments-over-safe-0fb98eac3fc7afa9 2026-09-02T16:52:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-spend-over-500-2026-45a3f0a33e5a8499 2026-09-02T16:44:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortrea-to-acquire-worldwide-clinical-trials-early-phase-services-division-in-45-10377a4c42ad7165 2026-09-02T16:25:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-pharmaceuticals-inc-stock-alny-moved-up-by-7-90-on-sep-2-facts-behind-th-4546a421d9c36465 2026-09-02T16:15:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-novartis-s-3-2-billion-enzyme-licensing-deal-means-for-formulation-04244c3b0098bf90 2026-09-02T16:07:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/if-there-s-a-will-there-s-a-way-says-fssai-chief-backing-tukaram-mundhe-s-crackd-7266a78d7b18663b 2026-09-02T16:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kidney-health-guidance-on-cardiovascular-kidney-metabolic-ckm-syndrome-c2113d23ffa6081d 2026-09-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asian-data-face-global-test-in-biotech-deals-5fcf53e3b2b9ef51 2026-09-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-red-alert-for-us-heart-pump-system-31590cc1e9ac1c6a 2026-09-02T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-erhalt-vor-berliner-arbeitsgericht-wegen-notdienstvereinbarung-recht-9da0a5b1027c3c06 2026-09-02T15:50:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-biopharma-evaluates-earlier-interim-analysis-for-key-liver-cancer-study-11862df3d3b21800 2026-09-02T15:48:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-is-vertex-pharmaceuticals-stock-performance-compared-to-other-biotech-stocks-648698b03644f66c 2026-09-02T15:44:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-payers-know-the-price-of-everything-25e1afbc7a228dd2 2026-09-02T15:38:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/septembre-en-or-au-chu-de-toulouse-6e9c71a62c8a8c32 2026-09-02T15:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-up-12-since-last-earnings-report-can-it-continue-7f45c9881d5ac2fc 2026-09-02T15:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/hsv-1-keratitis-clinical-trial-pipeline-analysis-3-key-61209467016d98c1 2026-09-02T15:26:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-busts-firm-faking-expiry-dates-nutrition-labels-on-pepsico-nestle-food-exp-4d92a4d8328572a0 2026-09-02T15:16:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/workwell-1415ead5314a3eea 2026-09-02T15:15:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/auchincloss-us-biotech-s-biggest-threat-isn-t-beijing-it-s-washington-5142e4ec999f4781 2026-09-02T15:14:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-the-independent-pharmacy-cooperative-acquisition-of-usave-pharmacy-group-si-f3321d130021642f 2026-09-02T15:03:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/r-ccs-adopts-quantum-software-development-kit-from-qunasys-93a580721b1920af 2026-09-02T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-merida-deal-shows-the-glp-1-king-is-already-thinking-beyond-obesity-63fbcf2c512b2db6 2026-09-02T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifarma-w-a-i-t-indicator-2026-del-tiempo-de-espera-a-la-oportunidad-de-avanzar-d1bab7a311ee97b3 2026-09-02T14:54:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-steps-up-mumbai-inspections-goregaon-kurla-eateries-and-chembur-d72689334c5b0cb4 2026-09-02T14:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-autoimmune-antibody-notches-ph-2-win-in-celiac-disease-0e151d573c0d6b4d 2026-09-02T14:52:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-s-immune-disorder-drug-meets-main-goal-in-mid-stage-trial-6245ea409f91eecb 2026-09-02T14:49:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/purple-biotech-jumps-after-new-u-s-patent-allowance-for-captn-3-platform-b8cdddba32e0fa76 2026-09-02T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tscan-axes-75-of-staff-to-make-room-for-solid-tumor-programs-cabef5148cc9e92d 2026-09-02T14:46:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-claims-success-in-celiac-study-biomarin-ascendis-settle-patent-dispute-014de9a6822360af 2026-09-02T14:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-challenge-to-policy-permitting-mifepristone-by-mail-paused-until-after-mid-068256b2d2c75f51 2026-09-02T14:17:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-landmark-pancreatic-cancer-drug-00061c57e210ea02 2026-09-02T14:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-gesundheitskommissionen-verlangen-kurskorrektur-bei-der-kvv-rev-20e589365a6e4ca6 2026-09-02T14:13:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-next-generation-of-pharmaceutical-logistics-personalization-cold-chain-expan-8f5c34cab250a72a 2026-09-02T14:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/farewell-black-spruce-how-climate-change-and-pests-are-reshaping-north-america-s-8b4df59771b69a90 2026-09-02T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-evidence-for-modulation-of-the-readiness-potential-by-respiratory-phase-durin-cf004544b118b753 2026-09-02T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-the-brain-dances-across-critical-boundaries-c88b2a7337be3315 2026-09-02T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roundup-alteogen-enters-option-license-agreement-with-novartis-newbiologix-synas-f543c5682ab79a48 2026-09-02T13:53:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-sets-target-to-reduce-greenhouse-gas-emissions-35-by-2035-45cccf8ed9419f04 2026-09-02T13:51:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacist-training-sites-to-receive-backdated-funding-uplift-ff2c8536276d59f7 2026-09-02T13:47:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/arpa-h-funds-biotechs-working-on-custom-rna-therapies-baa9ec294e130b13 2026-09-02T13:41:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-investors-undervaluing-takeda-pharmaceutical-co-tak-right-now-0f84fdff37ff659d 2026-09-02T13:40:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/protocol-amendment-checklist-for-sponsors-a5a7c2efdc9c1c93 2026-09-02T13:30:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-protocol-amendment-execution-through-site-sponsor-alignment-ecd7763cadd47384 2026-09-02T13:27:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-purple-biotech-stock-gaining-wednesday-96fbd407dfa80821 2026-09-02T13:24:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pesticide-found-in-supplement-brain-eating-amoeba-kills-teen-b12-and-birth-defec-a152bfa020a84766 2026-09-02T13:23:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansa-ceo-aguiar-lucander-u-s-listing-is-not-optional-for-european-biotech-79b4c33dd2848b1f 2026-09-02T13:14:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-announces-exercise-of-warrants-for-approximately-4-0-million-in-gross-p-8b4b55ad8fa8957a 2026-09-02T13:12:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/relevate-health-and-flora-health-launch-formulary-capability-for-pharmaceutical-6cf235ab28fdddc1 2026-09-02T13:08:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-bi-weekly-designing-preclinical-oncology-programs-mass-spectrometers-442cc7e29f30c452 2026-09-02T13:08:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-biopharma-canf-halves-warrant-price-in-cash-for-warrants-deal-f98cf174b9ca02c3 2026-09-02T13:06:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-case-on-abortion-pill-access-until-after-midterm-elections-bf0e5c866dc4f1b2 2026-09-02T13:04:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/biocytogen-enters-into-non-exclusive-licensing-agreement-with-qilu-pharmaceutica-564bc72a0fa0af82 2026-09-02T13:04:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-announces-exercise-of-warrants-for-approximately-4-0-million-in-gross-p-20195683e046d74a 2026-09-02T13:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-to-participate-in-upcoming-investor-conferences-f5091941aaf6ad32 2026-09-02T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/purple-biotech-ppbt-secures-key-patent-allowance-for-tri-specific-antibody-platf-22490c6129990c1f 2026-09-02T12:59:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-pandemic-prevention-to-pharmaceutical-resilience-why-health-security-should-0cee4213be3006a0 2026-09-02T12:55:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/veru-to-participate-in-fireside-chat-at-the-2026-cantor-global-healthcare-confer-d037618e57230bda 2026-09-02T12:51:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-hikma-pharmaceutical-holding-s-in-company-75b5f343b5d6613b 2026-09-02T12:45:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-makes-big-call-on-major-abortion-medication-case-amid-fda-review-1ff7a40a4171f2a4 2026-09-02T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunic-to-host-virtual-relapsing-multiple-sclerosis-r-d-day-on-september-9-2026-2ccde2d993db2306 2026-09-02T12:43:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-has-put-its-strongest-warning-on-a-common-iron-infusion-over-dangerously-8572ac4f94a3549e 2026-09-02T12:40:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-k-report-of-unscheduled-material-events-or-corporate-event-c9c36c3a6c93075b 2026-09-02T12:36:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/purple-biotech-ppbt-slides-as-cash-crunch-shadows-preclinical-progress-703e165828e8272e 2026-09-02T12:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veru-to-participate-in-fireside-chat-at-the-2026-cantor-global-healthcare-confer-240bd0e9610780d6 2026-09-02T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-announces-retirement-of-chief-financial-officer-geoffrey-p-3d3adf8d9810c3c7 2026-09-02T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/german-biotech-days-2026-biotechnology-as-the-key-to-industrial-competitiveness-d98d35f124055096 2026-09-02T12:28:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/aaps-pharmsci-360-microstructure-intelligence-in-predictive-drug-development-par-923856ea1824b374 2026-09-02T12:25:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-pancreatic-cancer-drug-could-buy-patients-more-time-5a5ce07e7e4b7611 2026-09-02T12:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-human-clinical-trial-to-test-precision-form-of-flash-proton-therapy-b95f64c4a6f05e11 2026-09-02T12:20:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortrea-to-acquire-worldwide-clinical-trials-early-phase-business-for-45m-d84e590e7a3054ee 2026-09-02T12:15:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/ondine-biomedical-s-nasal-photodisinfection-reduced-surgical-site-infections-by-145772489337f9f1 2026-09-02T12:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-adoption-of-biomarker-informed-trial-enrollment-beyond-oncology-63a364577cf4760a 2026-09-02T12:13:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/asus-partners-with-qualcomm-to-launch-pharmaceutical-ai-assistant-targeting-10-0-42ed7551651fbd8c 2026-09-02T12:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-pharma-awards-2026-finalists-announced-8b43cf76b1312d8b 2026-09-02T12:08:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-risk-assessment-shift-the-calculus-of-early-intervention-trials-for-47f32ba043209cf1 2026-09-02T12:01:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-highland-names-chris-kido-global-head-of-life-sciences-b56e458db3c41da0 2026-09-02T12:01:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/biocytogen-enters-into-non-exclusive-licensing-agreement-with-qilu-pharmaceutica-5dfb1a21c5e5992c 2026-09-02T12:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/information-about-the-criminal-offence-committed-by-a-former-employee-of-the-uni-81045ee3813f9a39 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantum-pureflow-standard-heat-exchanger-high-flow-bfa4d36b4d9c5162 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lifepak-35-monitor-defibrillator-016813b99e354aa9 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leo-intracranial-self-expandable-stent-and-delivery-system-56f7825c859b46a4 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bicoag-hemostasis-probe-cc392534b3fde809 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-highland-names-chris-kido-global-head-of-life-sciences-bcd029711fa74027 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biocytogen-enters-into-non-exclusive-licensing-agreement-with-qilu-pharmaceutica-ff27299ad4b8aa0d 2026-09-02T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kane-biotech-expands-canadian-commercial-reach-with-ontario-medical-supply-inc-1be2643cd66b5fc6 2026-09-02T11:52:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-inks-3-2b-subcutaneous-drug-delivery-deal-with-alteogen-98edddac224b9882 2026-09-02T11:51:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/ppbt-stock-squeezed-between-biotech-promise-and-cash-crunch-b8b36740f2e56456 2026-09-02T11:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/purple-biotech-receives-u-s-patent-allowance-for-tri-specific-antibody-construct-a9d3c7b45527b248 2026-09-02T11:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-patent-backs-purple-biotech-nasdaq-ppbt-cancer-antibody-platform-898e9a4d8db913aa 2026-09-02T11:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-extra-officers-tougher-enforcement-what-fssai-praised-in-tukaram-mundhe-s-fda-1f62992a237c1097 2026-09-02T11:34:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-rhapsido-cuts-ms-progression-in-phase-3-trial-teeing-up-roche-battle-8668e6a20568a204 2026-09-02T11:30:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-participation-in-upcoming-investor-conferences-7080195dcc16fbb5 2026-09-02T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-is-a-threat-to-biotech-s-massive-bull-run-7cc353eba49c1c00 2026-09-02T11:26:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-daily-drug-may-offer-alternative-for-those-who-cannot-use-cpap-machines-08b76e6c14c18147 2026-09-02T11:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/explained-why-sun-pharma-is-offering-cheaper-drugs-to-trump-administration-f3aed331089aa227 2026-09-02T11:19:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-reports-longer-than-anticipated-overall-survival-in-ongoing-pivotal-pha-6b7292d8b754138f 2026-09-02T11:12:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-fite-biopharma-to-evaluate-earlier-interim-analysis-timing-in-phase-iii-namo-fde4b672e9c43070 2026-09-02T11:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newron-announces-completion-of-screening-for-enrollment-in-pivotal-phase-3-enigm-83b81d778ea5abac 2026-09-02T11:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptide-innovator-says-the-drug-class-is-due-for-a-rethink-88a38b02cdd0b0ab 2026-09-02T11:06:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-marketed-injectable-drug-is-expected-to-bring-lifecore-revenue-in-2028-26cd668cc8f2496b 2026-09-02T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-ltd-e982dd3db21dd0a0 2026-09-02T11:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/people-in-a-liver-cancer-study-may-be-living-longer-than-expected-can-fite-may-a-b15d2f61d422b9bd 2026-09-02T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newron-announces-completion-of-screening-for-enrollment-in-dcc0883ae104bde1 2026-09-02T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-rad-expands-chromatography-columns-with-nuvia-ion-exchange-d483e40ca1f5e799 2026-09-02T10:56:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-plc-sec-filing-sep-2-2026-d0550ffa8f07d274 2026-09-02T10:48:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fy2026-annual-results-short-form-announcement-7b13871a2772b542 2026-09-02T10:48:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/fy2026-annual-results-booklet-7b9b4c3719dbfa91 2026-09-02T10:47:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fy2026-annual-results-presentation-d7b7765be2e8d371 2026-09-02T10:46:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-to-participate-in-the-wells-fargo-21st-annual-healthcare-conference-f0d6609a9a8ddb7f 2026-09-02T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mhra-and-manchester-nhs-partner-to-bring-safe-healthcare-innovations-to-patients-4cd194f696da6300 2026-09-02T10:44:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/getting-back-into-the-lab-it-s-not-out-of-reach-eeeffdb547843f59 2026-09-02T10:37:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/care-quality-commission-cqc-adult-inpatient-survey-results-b294612f5acfe611 2026-09-02T10:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-pharmaceutical-joins-forces-with-aitia-for-drug-discovery-in-neurology-baeb8ed93ef5afea 2026-09-02T10:12:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-pill-case-is-frozen-until-december-while-a-federal-judge-waits-for-the-429b9647de35cde8 2026-09-02T10:10:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-regulators-add-their-strongest-warning-to-a-common-iron-infusion-over-da-40080681b38f4178 2026-09-02T10:00:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-and-bms-paused-car-t-trials-revmed-s-pancreatic-cancer-approval-more-mf-f9169315e2153c74 2026-09-02T09:55:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/gustave-roussy-fait-evoluer-sa-gouvernance-avec-la-nomination-de-juliette-le-gel-aa402f107e80d52d 2026-09-02T09:45:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-remibrutinib-a-high-efficacy-oral-btk-inhibitor-significantly-reduces-r-ac21ec08286fe1df 2026-09-02T09:36:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-btk-inhibitor-clears-phase-iii-hurdle-in-relapsing-ms-0148f1262711c2fc 2026-09-02T09:25:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-2-september-2026-a42e8bef3b31fe3e 2026-09-02T09:25:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-online-pharmacy-advertisements-for-non-fda-approved-treatments-95af123c936c88af 2026-09-02T09:17:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-pharmaceutical-joins-forces-with-aitia-for-drug-discovery-in-neurology-fae2deb9bb6dfae6 2026-09-02T09:12:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/qualcomm-asus-launch-pharmacy-ai-agent-for-drug-safety-5b9521aae5f7bde1 2026-09-02T09:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-warning-prompts-taiwan-red-alert-over-heart-pump-device-cf873f10a3be8794 2026-09-02T09:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenx-has-delivered-18-consecutive-quarters-of-sales-growth-but-is-the-biotech-45c417e002be6760 2026-09-02T09:07:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/royal-bank-of-canada-reduces-stock-position-in-ultragenyx-pharmaceutical-inc-rar-a400d3fcb76b4f2b 2026-09-02T09:02:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidelberg-geoinformation-scientists-classify-global-road-networks-18623cb835f0f1a1 2026-09-02T08:52:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-retira-varios-productos-adelgazantes-por-contener-sibutramina-un-princi-5c5c0626c1f29d3e 2026-09-02T08:37:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-biomarin-s-navepegritide-settlement-and-royalty-deal-with-ascendis-could-sha-0ad2aa7bf4ed938b 2026-09-02T08:31:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/incyte-shifts-to-multi-franchise-biotech-with-1-47cdbe22b572d525 2026-09-02T08:24:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-breaks-btk-losing-streak-in-multiple-sclerosis-141b965e75a3954e 2026-09-02T08:07:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-simcere-pharmaceutical-stock-surging-today-by-investing-com-b55165890756e263 2026-09-02T08:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biggest-biotech-funding-rounds-in-august-2026-2b0a1a542b960efb 2026-09-02T08:02:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-simcere-pharmaceutical-stock-surging-today-7b5163c2f795425a 2026-09-02T07:47:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/50-ans-de-pharmacovigilance-en-belgique-save-the-date-7a406ddc1e6ec0a0 2026-09-02T07:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-companies-warn-greek-prime-minister-medicine-financing-model-has-reached-618ae4c26f614680 2026-09-02T07:42:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/seamless-pharma-solutions-at-cphi-milan-e2ef6c79ccee49a3 2026-09-02T07:39:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-simcere-pharmaceutical-stock-surging-today-3c339d20a1e6216c 2026-09-02T07:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medipost-recruits-samsung-biologics-veteran-min-ho-sung-as-president-to-accelera-7ca34cc34241944c 2026-09-02T07:33:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/heparegenix-wins-orphan-drug-status-for-darizmetinib-026a3717f3bd3012 2026-09-02T07:31:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fssai-chief-roots-for-tukaram-mundhe-says-food-safety-is-not-punishment-posting-9734826a58e13b01 2026-09-02T07:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/ono-pharmaceutical-partners-with-aitia-to-hunt-new-brain-disease-drug-targets-us-f0c51bf051de7529 2026-09-02T07:12:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-his-parents-basement-to-your-medicine-cabinet-absci-ceo-endeavors-to-create-f88a2388e429988b 2026-09-02T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/warning-for-mychart-users-new-scam-impersonates-the-patient-portal-4e078e8327b21202 2026-09-02T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-mobile-clinic-provides-free-vision-screenings-and-evaluations-for-fols-82b2083c9b775bdb 2026-09-02T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-the-biotech-act-deliver-for-europe-3aaea1aafe6c4620 2026-09-02T06:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korea-creates-quasi-innovative-tier-to-boost-r-d-driven-drugmakers-chosunb-69ff0ef909508ae8 2026-09-02T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-public-private-consultative-body-launched-stepwise-promo-e3fc00933496e32a 2026-09-02T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-rare-wins-fda-approval-is-the-stock-fully-priced-bc75c563f16ff02f 2026-09-02T06:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-legn-heads-to-morgan-stanley-conference-is-the-57-valuation-gap-j-f7dff0f5f79a6a5b 2026-09-02T06:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-btk-pill-cuts-ms-relapses-without-liver-risk-lifts-shares-6-chosunbiz-62c42679cdabfa29 2026-09-02T06:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-rare-after-fda-approval-is-the-gene-therapy-win-alread-6a83829dad1e094d 2026-09-02T05:40:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/iba-joins-pfaros-european-initiative-to-advance-pfas-destruction-for-healthcare-592de0ecf07d41ce 2026-09-02T05:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tectonic-therapeutic-competitor-data-strengthens-the-tx45-bull-case-239ef46e29c93665 2026-09-02T04:58:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/stripped-of-astrazeneca-safety-net-bms-could-face-carnage-if-high-risk-clinical-b5442e9e5c45e5c2 2026-09-02T04:25:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-fda-approval-of-mimrylo-reshape-how-investors-view-takeda-pharmaceutical-0f905927091c2d04 2026-09-02T04:18:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-is-popping-no-one-seems-to-care-e383d46a878c2867 2026-09-02T04:03:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-new-treatment-for-lung-cancer-daraxonrasib-aimed-at-ras-mutations-46162555f6093ac9 2026-09-02T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-convenience-kit-issue-from-avid-medical-df95e32d4399a3f1 2026-09-02T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenience-kit-correction-medline-issues-correction-for-convenience-kits-contai-fcd9b51b06dfff68 2026-09-02T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/catheter-recall-expansion-medline-industries-removes-reprocessed-electrophysiolo-422afa4345e04602 2026-09-02T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eib-approves-10b-renewable-infrastructure-biotech-funding-284fad55668d41af 2026-09-02T03:45:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-teva-pharmaceutical-industries-teva-undervalued-on-its-fda-filing-news-or-alr-49b0d035fcc40149 2026-09-02T03:25:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/recce-pharmaceuticals-advances-r327-as-diabetes-and-antibiotic-resistance-burden-71af97087cbe928f 2026-09-02T02:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/millions-take-zyrtec-daily-and-stopping-after-months-of-use-can-trigger-severe-i-8956616fce13f096 2026-09-02T02:50:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/c-diff-prevention-vaccine-enters-vermont-clinical-trials-5fdc7e710bc10828 2026-09-02T02:20:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/battelle-researchers-demonstrate-biotech-breakthrough-for-rare-earth-element-sep-7eb1486f3cb31902 2026-09-02T02:16:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/simcere-pharmaceutical-partners-with-roche-in-trispecific-antibody-licensing-dea-146547d1a6d92212 2026-09-02T01:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/haier-biomedical-highlights-automated-biostorage-and-connected-pharma-solutions-57ebdaa43dd9c576 2026-09-02T01:39:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-and-medtech-stocks-sold-off-on-bad-news-4d8fef168b5c61ef 2026-09-02T01:33:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-completes-enrollment-in-phase-3-bipass-study-aligns-with-fda-on-nda-pathwa-f298b81f3968cf9f 2026-09-02T01:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-biotech-ena-respiratory-secures-a-2-98-million-to-advance-inna-051-asthma-f3ea7faaec5d8c32 2026-09-02T01:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-states-lawsuit-seeking-to-curb-abortion-drug-access-paused-for-now-e434f3ab8166c316 2026-09-02T01:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-announces-personnel-changes-a009e8110c3f6afa 2026-09-02T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stonepine-capital-management-llc-expands-edesa-biotech-inc-edsa-stake-with-strat-4a56e1ef7fb96a8e 2026-09-02T00:52:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/opdp-s-latest-reminder-on-preapproval-promotion-213f8268fdfa4001 2026-09-02T00:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/recce-pharmaceuticals-holds-general-meeting-ahead-of-september-2026-phase-3-tria-f2f6882e824d4885 2026-09-02T00:11:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/optogenetic-vision-restoration-translational-barriers-and-emerging-therapeutic-s-2f5b288a68dbf60f 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-grant-of-an-exclusive-patent-license-development-and-commercializati-64adfe420f2a8c6a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/submission-for-office-of-management-and-budget-review-tanf-contingency-fund-appl-d1f52435830c26aa 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-omb-review-comment-reque-459d999e27af8177 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-that-carafate-sucralfate-oral-suspension-1-gram-10-milliliters-was-0bca3474b5ce4528 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-an-f3be2a856a2f6ffe 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/announcement-of-the-intent-to-award-a-single-source-cooperative-agreement-to-spa-73ef19603f02fdd8 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dental-composite-resin-devices-and-dental-curing-lights-premarket-notification-5-8c795b8b464037e5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/issuance-of-priority-review-voucher-rare-pediatric-disease-product-genglycos-par-6beb3602a6cc1fec 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-cooperation-on-harmonisation-of-technical-requirements-for-registr-a6e490930bc8ee48 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-cooperation-on-harmonisation-of-technical-requirements-for-registr-01c2d015bba26aa5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/privacy-act-of-1974-matching-program-a85995ee390c823a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-collection-60-day-comment-request-assurance-interinstitutional-foreign-37add9c60ae61a0c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-db2cd99178883369 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-opens-two-new-research-buildings-10ca0cb97b8e6f33 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-fda-acceptance-of-supplemental-new-dru-f5d05ebbb138ea52 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-3-randomized-double-blind-placebo-controlled-multicenter-study-to-evalua-29dfe606544b704c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidisciplinary-rehabilitation-following-upper-gastrointestinal-cancer-surgery-002df31e804840fd 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-update-on-xanomeline-trospium-cobenfy-for-schizophrenia-emerging-evidence-and-fdc08dc068cfe5e1 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-probiotics-for-human-health-a-critical-narrative-review-of-mecha-a9683e6d2dc0da57 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-computational-approaches-for-natural-product-based-drug-discovery-tar-3db7edbf4d54798c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/75-years-of-adventure-in-turkish-scientific-medical-publishing-from-istanbul-con-3d7148e260ae3d88 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-diabetes-mellitus-on-drug-induced-liver-injury-during-antituberculosis-a72c8c383c9b11c9 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asf1a-a-versatile-histone-chaperone-bridging-chromatin-dynamics-disease-mechanis-7247748967056d13 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acute-caffeine-administered-in-chewing-gum-may-improve-functional-firefighting-b-2361682e1c41e9d6 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/absorbable-synthetic-meshes-in-implant-based-breast-reconstruction-after-subcuta-f964d8d8a4f3bf88 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/voice-based-screening-of-depression-and-anxiety-using-machine-learning-and-deep-014fc6916ad2a5f2 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preoperative-sglt2-inhibitor-use-and-outcomes-after-major-cardiac-procedures-a-p-1ff74fb030035e63 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-of-abnormal-uterine-bleeding-in-women-with-chronic-spontaneous-urticaria-ko-8cfa4878db58bef5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-prognostic-value-of-the-advanced-lung-cancer-inflammation-index-on-disease-f-cb3d6a69f5c59b79 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hepatic-steatosis-in-pulsed-field-ablation-for-atrial-fibrillation-prevalence-li-22ca0788375f9142 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/excessively-high-maternal-total-cell-free-dna-concentration-and-fetal-growth-res-b876c3baa129a334 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/knowledge-and-self-reported-clinical-approaches-regarding-medication-related-ost-ab40d7c2e30b16a5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-d-supplementation-in-infertile-men-beyond-pooled-effects-a-critical-meta-5296c55a41ba41c2 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-application-of-sugammadex-in-renal-impairment-pharmacokinetics-and-phar-6252d52c2eeb0d73 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-comparative-assessment-of-the-activity-of-racemic-and-dextrorotatory-6748c5518ba4b2de 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/repeated-voriconazole-therapeutic-drug-monitoring-in-hospitalised-patients-a-rea-8b05476906f8b686 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-from-black-box-to-clarity-in-lesion-diagnostics-clinical-causal-cognit-959db905c2b6d69a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gut-microbiota-dysbiosis-and-the-gut-lung-axis-in-copd-mechanisms-clinical-relev-d674c1e798b6f073 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/review-of-integrity-of-clinical-rcts-safeguarding-trust-evidence-and-patient-wel-993755aedb59b25e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-strengths-in-individuals-with-adhd-exploring-experiences-and-applica-3a02cb6a1d6e3fa0 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-intraoperative-epiaortic-scanning-of-the-ascending-aorta-on-the-ta-8d815d25e1395e99 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identifying-key-prognostic-indicators-for-extended-hemodialysis-survival-a-compr-e317faa4dde176e6 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-natural-and-synthetic-photosensitizers-in-visible-light-mediated-a-320bfbfd4ca4b522 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-outcomes-in-low-and-middle-income-countries-the-role-of-clinical-sociodem-ca4169a0d35fcda9 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prediction-of-non-surgical-spinal-decompression-efficacy-in-lumbar-disc-herniati-f47cfc2b4cb521b9 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimizing-physiological-image-compression-via-discrete-wavelet-transform-withou-c22e87aac4da5cf7 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-inflammatory-benefits-of-nebulized-furosemide-with-salbutamol-iprat-bb3daf6b39d403a9 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-of-the-clinical-presentation-and-antibiotic-susceptibility-pattern-of-burk-7d2d2a6ab875711d 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/approach-to-the-patient-theranostics-as-precision-medicine-for-neuroendocrine-tu-e794c311f5543c5f 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-admission-ldl-cholesterol-with-clinical-profile-and-3-months-outc-a561d9aa08b5ad86 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/knowledge-tdm-related-practices-and-training-needs-regarding-the-clinical-use-of-727fd9e7306c464a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mistreatment-gender-differences-and-reporting-behaviors-among-medical-students-i-0eeb66d4ff9a98d7 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-rationale-and-indications-for-the-use-of-cone-beam-computed-tomography-568225ffb6efcb2c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-a-sexual-violence-primary-prevention-program-at-an-australian-univers-90bf15741eb457c8 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/automated-whole-brain-mri-segmentation-combined-with-clinical-scores-for-the-dia-51474317c8bf1121 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wellbeing-mastery-and-work-participation-effects-of-the-five-ways-to-wellbeing-c-fdaed6098dfad7b3 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intravascular-hemolysis-and-clinical-outcomes-in-continuous-flow-lvad-patients-a-0cde3992c370481d 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/data-from-antibody-drug-conjugates-prepared-with-peptide-asparaginyl-ligases-ach-ecbb80033c64998a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s2-from-amanitin-based-fc-small-molecule-drug-conjugates-wi-35ffe487013eea13 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s3-from-amanitin-based-fc-small-molecule-drug-conjugates-wi-188123615f08bac9 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s5-from-amanitin-based-fc-small-molecule-drug-conjugates-wi-cccc8ef11745a471 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s7-from-amanitin-based-fc-small-molecule-drug-conjugates-wi-eb994e7258f3de98 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-4-from-antibody-drug-conjugates-prepared-with-peptide-aspar-7c386a52487f1afb 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-6-from-antibody-drug-conjugates-prepared-with-peptide-aspar-f69c9de764891828 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-7-from-antibody-drug-conjugates-prepared-with-peptide-aspar-4489d29c3dcd6999 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/varying-cancer-drug-doses-to-balance-tumor-control-and-resistance-evolution-b06a16c56db6e9a5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-information-from-evolutionary-antifragile-therapy-is-a-treatment-s-eec8fb3f84871c49 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-2-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-i-709a122789989291 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-5-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-i-f41c1b2f2a557aa6 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-s11-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-d216f764fc536219 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-s4-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-e975b7df66c9709e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-s5-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-1cdf93671c6cc044 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/table-s3-from-kras-inhibitor-induced-cancer-cell-death-enhances-sensitivity-to-i-9153809f1fecfcec 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secondary-use-and-scholarly-impact-of-a-portfolio-of-clinical-trials-with-shared-e30b75693112b369 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/professional-identity-formation-in-the-transition-from-undergraduate-to-postgrad-c9b6460b94cbcf73 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-targets-for-periodontitis-a-systematic-review-of-drug-target-men-5637bce0afa12d6a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-to-efficacy-and-safety-of-tegoprazan-amoxicillin-dual-therapy-for-scp-i-e376ea6e9aae83db 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-escalation-patterns-infection-risk-and-clinical-outcomes-in-refractory-24a82b1ee6ad07ee 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceptions-of-doctors-disclosing-ai-use-in-their-online-biographies-evidence-fr-b6b7c20f2f3a5b8e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-based-analytic-hierarchy-process-decision-making-trial-and-evaluation-la-34aee6630c6add1a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phosphodiesterase-5-inhibitor-use-and-clinical-outcomes-in-left-ventricular-assi-d4dbbb1f99f46a72 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iron-deficiency-during-pregnancy-and-lactation-438efd2dfe9dd59a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-upper-extremity-strength-exercises-in-subacromial-impingement-syndrom-4ae313ad49574c00 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-adjuvanted-hiv-vaccines-tailored-for-early-life-immunologic-ratio-1d9b2a2456e5d74a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/complete-revascularization-according-to-age-in-patients-with-st-segment-elevatio-8f1cdfbba3e8c632 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modeling-uncertainty-in-performance-validity-testing-with-bayesian-logistic-regr-44e368fe13614d3a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lived-experience-in-layers-personal-professional-and-partnership-an-autoethnogra-d64ece2f21eb3bcb 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/discovery-and-preclinical-validation-of-a-translationally-optimized-mitochondria-d0ba876413f9eeed 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-umbrella-review-of-ethical-challenges-in-clinical-trials-conducted-in-low-and-c558d5644faeacf3 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-drug-discovery-and-personalized-medicine-integrating-quantum-computing-64489d897ee68a0e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prognostic-markers-in-ckd-patients-stratified-by-co-morbid-conditions-and-on-dia-60401a4ad44bc14e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/socioeconomic-inequalities-in-dietary-diversity-and-nutritional-status-among-ear-d7a87e7fdf0aadbf 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optic-nerve-sheath-diameter-by-ocular-ultrasonography-rapidly-detects-high-intra-7c41208e39864979 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/screening-of-sarcopenia-in-long-term-care-facilities-using-wireless-surface-elec-2999423a72fb7972 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/isop-mena-chapter-strategic-development-and-future-directions-following-a-decade-76b8243ff40fe9bd 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivery-of-liothyronine-by-microneedle-patch-for-the-treatment-of-hypothyroidis-d2f7872df85c6e4c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-protamine-to-heparin-ratio-concept-and-clinical-application-3be243686f0436e8 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-stereotactic-body-radiotherapy-in-oligometastatic-disease-a-90b09beec54f8a29 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidemic-thunderstorm-asthma-in-china-a-systematic-review-of-an-artemisia-associ-2900e3ab6cad59cb 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiomics-and-artificial-intelligence-in-pituitary-adenomas-pitnets-from-imaging-02f3ee72da126035 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-janus-kinase-inhibitors-in-patients-with-rheumatoid-1e4ce9516dedbba4 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-physicochemical-properties-and-adhesive-interface-quality-of-b-433fb5fbc4439569 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-derived-tetrahydropyrazines-for-late-stage-i-i-and-i-i-functionalization-of-b334813205469577 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07799909-behavioral-activation-for-cancer-related-fatigue-after-breast-cancer-9bdf2b351643352c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07799467-implementing-a-digital-alcohol-intervention-to-raise-women-s-awarene-df3f2cca19a0c029 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07799012-sexual-quality-of-life-in-female-patients-with-lipodystrophy-syndrom-3b810868fe4300c8 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07798999-anodic-stimulation-in-parkinson-s-disease-97eaaf97c681a3e4 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07798986-acupuncture-for-generalized-anxiety-disorder-db92448e0b86d9bf 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07798310-protocol-for-rapid-onset-of-mobilization-in-patients-with-traumatic-180df6c42b1c758a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07795528-postoperative-circulating-tumor-dna-monitoring-in-stage-i-iii-driver-f2fe9415ed027581 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07738224-using-the-babble-boot-camp-speech-therapy-approach-with-babies-born-53c7ce26d71c8816 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07681505-analysis-of-the-role-of-the-microbiota-in-diverticular-disease-82fdabbef0b6453e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07679958-immersive-virtual-reality-applied-to-therapeutic-physical-exercise-i-d8ebd5bbfaef150d 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07673887-a-study-of-asp2138-together-with-chemotherapy-and-pembrolizumab-in-a-e0a3858bcce381cb 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07622186-a-study-of-skb571-combination-therapy-in-participants-with-non-small-00056c7831ccbce1 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07613099-fibrotic-disease-activity-in-cardiopulmonary-disorders-using-18f-fib-d3d2836ef9a19c9f 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07607730-regulating-together-for-prader-willi-syndrome-a-group-behavioral-the-2aad7612ebccd74b 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07570862-a-phase-2-open-label-single-arm-trial-of-ft819-in-participants-with-955ceb162ed74ab6 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07565974-thc-versus-thc-cbd-versus-placebo-to-improve-sleep-quality-for-patie-5b47bb773629147a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07563998-prehospital-point-of-care-hs-troponin-i-for-rule-out-of-acute-myocar-a4fd5a2c6454848a 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07501039-a-phase-1-study-of-blkr201-in-healthy-adult-participants-7e47c13cd992bdd4 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07369024-sub-dissociative-dose-ketamine-in-treatment-of-vaso-occlusive-pain-e-aa79a623ed66ee25 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07363408-ivonescimab-and-adg126-alone-and-in-combination-with-leucovorin-and-597d0cc8b8c450ab 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07292298-phase-2-single-arm-rectal-cancer-brachytherapy-for-patients-with-low-3df3ee2c6b3c1826 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07235514-anesthesia-management-in-endovascular-therapy-for-ischemic-stroke-2-fc5b6e049d659fe4 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07221851-trial-investigating-the-efficacy-and-safety-of-weekly-lonapegsomatro-d2c3cef8323ec8ac 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07131033-esketamine-combined-with-magnesium-sulfate-for-postoperative-fatigue-1e94393ad1fd9f70 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07126704-a-phase-1-sad-and-mad-to-evaluate-the-safety-tolerability-pharmacoki-13b4adf65890f767 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07025785-molecular-residual-disease-assessment-in-a-representative-diverse-po-32d76c3817f0f143 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07022314-urine-output-response-to-fluid-and-diuretic-therapy-in-cardiac-icu-p-2d814e5e6b1a332e 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06888310-optimizing-noninvasive-assessment-of-dysmetabolic-compensated-advanc-0b53e7cc0750ce09 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06873789-a-study-to-evaluate-incb177054-in-participants-with-select-advanced-ff8510e559938ca3 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06865482-clinical-course-of-disease-in-participants-with-fa-cm-4e8b82c995e54e26 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06710210-hybrid-percutaneous-coronary-intervention-combining-a-bioresorbable-5093e227b0f47fe0 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06694454-neoadjuvant-inhaled-azacytidine-with-platinum-based-chemotherapy-and-0c2ce5ad67f1e6f8 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06524024-clinical-study-of-tumor-polypeptide-dc-ctl-in-the-treatment-of-solid-34f4b80b785d242c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06441006-program-for-rifampicin-resistant-disease-with-stratified-medicine-fo-f183ca5601f3dcc7 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06076629-acute-health-effects-of-low-temperature-exposure-3c13ffaeb4d35629 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06072612-study-of-the-bria-imt-regimen-and-cpi-vs-physicians-choice-in-advanc-8a4b8f9afe8bef03 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06058702-genetic-basis-of-the-risk-and-consequences-of-cannabis-exposure-in-h-507306101345e5b7 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05548127-tactive-u-a-study-to-learn-about-the-study-medicine-vepdegestrant-wh-2634e52536d72c02 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05470777-cd22-cd19-car-t-and-auto-hsct-sandwich-strategy-as-consolidation-the-053e468259e4c823 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05350761-rare-tumors-and-cancer-predisposition-in-individuals-and-families-b312aaaa93eceb32 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05319730-a-study-to-evaluate-investigational-agents-with-or-without-pembroliz-8bbb40e614927ea5 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05286814-pds01adc-in-combination-with-hepatic-artery-infusion-pump-haip-and-s-39fc262ac6c6001f 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04953780-phase-1-of-calaspargase-pegol-mknl-w-cytarabine-and-idarubicin-in-ne-87f0916374c9a2e1 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04910867-apol1-genetic-testing-program-for-living-donors-1491f22584a65c8b 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04340141-testing-the-use-of-the-usual-chemotherapy-before-and-after-surgery-f-36bd30f07b88a494 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04267848-testing-the-addition-of-a-type-of-drug-called-immunotherapy-to-the-u-845ef48f3d5607d0 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04041713-a-pilot-study-of-an-antioxidant-cocktail-vs-placebo-in-the-treatment-94425ef59a6d160c 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03781700-evaluation-of-cortisone-treatment-in-children-with-acute-facial-nerv-5adabb39313a6db3 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03739814-inotuzumab-ozogamicin-and-blinatumomab-with-or-without-ponatinib-in-50ecb5ccc6c1fbea 2026-09-02T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flexible-tablet-coaters-syntegon-s-sepion-75-scales-pharmaceutical-batch-process-1b260c082692e0a5 2026-09-01T23:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/employees-rise-with-yeast-biotech-giant-e595b459f084c375 2026-09-01T23:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-buys-former-merrimack-anheuser-busch-brewery-for-47-million-3daf42ad961cfe7e 2026-09-01T23:15:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-buys-former-merrimack-anheuser-busch-brewery-for-47-million-d0c8b52be1673d26 2026-09-01T23:13:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/citizens-upgrades-ideaya-biosciences-stock-rating-on-ide849-progress-by-investin-43bfc3a851c14ac2 2026-09-01T22:55:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-bull-case-for-legend-biotech-legn-could-change-following-its-car-t-scale-up-cd68073f8d7a8897 2026-09-01T22:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/perspective-therapeutics-strong-buy-on-bamzireotide-navoxetan-reinforced-data-an-363de8997a60447d 2026-09-01T22:23:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/up-to-75-of-prostate-biopsies-are-negative-telix-enrolled-350-patients-7815a2760f48b4a3 2026-09-01T22:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-delays-mifepristone-lawsuit-until-after-midterms-4967c412d01af3f9 2026-09-01T22:17:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/passive-stake-disclosed-in-fortress-biotech-nasdaq-fbio-by-millennium-group-bc422e7e8c056a13 2026-09-01T22:14:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/state-challenge-to-policy-permitting-mifepristone-by-mail-paused-until-after-mid-f83f7ecd6c305af2 2026-09-01T22:13:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/european-journal-of-heart-failure-un-medicamento-para-la-diabetes-reduce-las-com-3a53f9083dc91eef 2026-09-01T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chattanooga-company-turns-amniotic-membranes-into-powerful-grafts-7a3ed16629422d2a 2026-09-01T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-mifepristone-lawsuit-amid-fda-safety-review-afce06dfe429f37a 2026-09-01T21:52:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/intelligent-bio-solutions-advances-fingerprint-drug-test-toward-fda-d11ad6ae84e6deef 2026-09-01T21:51:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/lineage-cell-therapeutics-balancing-an-out-licensed-pipeline-against-clinical-ri-fac8ea46338214eb 2026-09-01T21:50:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-guardrails-are-abortion-pill-companies-putting-profit-over-safety-rules-ec52173d9d152080 2026-09-01T21:50:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/traceiq-launched-to-maximize-pharmaceutical-traceability-47d903ace6098041 2026-09-01T21:36:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-drafts-guidance-on-assessing-impact-of-hepatic-impairment-on-drug-pk-pd-e612fd90dd9011a3 2026-09-01T21:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-pipeline-narrative-keeps-valuation-in-focus-after-recent-ru-4a610d1f7d6c3e2c 2026-09-01T21:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spring-is-the-time-for-footy-finals-swooping-magpies-and-clinical-trial-results-60412a15b56150bb 2026-09-01T21:00:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/verrica-advances-wart-drug-expansion-as-phase-3-trial-fills-653d44c09d492f67 2026-09-01T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-states-lawsuit-seeking-to-curb-abortion-drug-access-paused-for-now-3955213c860f75ad 2026-09-01T20:48:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/heart-drug-breakthroughs-can-t-stop-biotech-stocks-from-sliding-accd1ddf613433fa 2026-09-01T20:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atyr-pharma-provides-update-on-timing-of-regulatory-response-for-planned-phase-3-8b67ba554da10f22 2026-09-01T20:39:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/repetitive-transcranial-magnetic-stimulation-in-stroke-rehabilitation-review-of-0e431710c6b39016 2026-09-01T20:38:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-response-expected-by-mid-september-for-atyr-s-lung-disease-trial-48900dfcf52e3b86 2026-09-01T20:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shoulder-innovations-to-participate-in-the-morgan-stanley-24th-annual-healthcare-2355228037eab73f 2026-09-01T20:33:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/repetitive-transcranial-magnetic-stimulation-of-the-primary-motor-cortex-in-stro-7472bffb508640e8 2026-09-01T20:32:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/mounjaro-tirzepatide-side-effects-risks-fda-warnings-1ecd95363510192b 2026-09-01T20:27:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-pill-lawsuit-delayed-again-until-as-late-as-december-51856dd49fa0d920 2026-09-01T20:15:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/gp-led-walk-in-pilot-could-duplicate-existing-services-says-royal-college-of-pha-15e05f00126b1f7c 2026-09-01T20:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-intends-to-explore-expanding-advance-payments-to-pharmacy-students-4a3d17798c0bea2d 2026-09-01T20:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-practice-for-clopidogrel-prescribing-4c100053002f856c 2026-09-01T20:13:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/pediatric-plating-platformtm-hip-trauma-96e082fa1063f50b 2026-09-01T20:04:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/lavoraconnoi-cercasi-research-assistant-per-progetto-di-ricerca-multi-omica-ulti-ce8784690a44a4f3 2026-09-01T19:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oculis-doses-first-patient-in-phase-3-privosegtor-trial-for-on-24aaec2a42d5761e 2026-09-01T19:40:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/pacientes-de-trasplante-medicos-y-empleados-de-cuatro-hospitales-celebran-el-40-156b621ae675aa29 2026-09-01T19:21:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-glp-1-trends-to-expect-in-2026-expanded-uses-oral-options-and-more-a72fa01a22fd1a9b 2026-09-01T19:02:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-2026-tirzepatide-5mg-sustains-cardiometabolic-benefit-with-weight-maintenanc-bc61ccd762a88ad6 2026-09-01T18:55:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/byuh-intern-represents-an-international-agency-at-asia-s-premier-biotech-confere-e2a40b983bea8c84 2026-09-01T18:37:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-alnylam-s-next-gen-silencer-sees-silver-linings-after-fallout-of-az-ionis-tr-973bc8da6a89409d 2026-09-01T17:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-your-dna-predict-a-dangerous-drug-reaction-2dd2cc2354aaaebd 2026-09-01T17:44:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-sickle-cell-pain-trials-asking-the-wrong-question-start-investigator-examine-eab47a88e8b04421 2026-09-01T17:39:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-lupus-drug-was-a-failure-and-this-biotech-stock-is-down-58-because-of-it-e84cd542fa214f55 2026-09-01T17:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-to-buy-immunology-biotech-merida-biosciences-in-2-9b-deal-67dfbb7f895a9a0d 2026-09-01T17:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-novartis-stock-soaring-tuesday-novartis-nyse-nvs-661bf5530bc9ef4a 2026-09-01T17:07:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biotech-stocks-worth-watching-september-1st-10c655bb7043afee 2026-09-01T17:05:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/depassements-de-quotas-l-afmps-poursuit-ses-travaux-et-renforce-la-transparence-81b51bd89e4ada6e 2026-09-01T16:40:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-mifepristone-lawsuit-amid-fda-safety-review-e77f787ad0df1242 2026-09-01T16:38:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/myriad-genetics-stock-gets-double-downgrade-as-profitability-concerns-grow-9b7345efff29b39c 2026-09-01T16:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thx-pharma-files-phase-3-trial-applications-for-batten-1-in-the-united-states-un-b6e17275e571e882 2026-09-01T16:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-next-biotech-boom-may-be-cancer-vaccines-watch-these-etfs-moderna-nasdaq-mrn-e50b681e6dfa5da5 2026-09-01T16:25:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cmc-readiness-is-becoming-central-to-biopharma-licensing-deals-5c29797ab74a11bb 2026-09-01T16:22:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cmc-readiness-is-becoming-central-to-biopharma-licensing-deals-5b39a1a3e3045748 2026-09-01T16:20:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/thx-pharma-bbdf-and-biocodex-announce-regulatory-submissions-for-the-phase-3-cli-9d36eeb70fb3d4ae 2026-09-01T16:07:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/thx-pharma-bbdf-and-biocodex-announce-regulatory-submissions-for-the-phase-3-cli-47847447b81d9a4f 2026-09-01T16:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/thx-pharma-bbdf-and-biocodex-announce-regulatory-submissions-for-the-phase-3-cli-3758b62a22a201b9 2026-09-01T16:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-mifepristone-lawsuit-amid-fda-safety-review-9783087ee585f214 2026-09-01T15:57:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-mifepristone-lawsuit-amid-fda-safety-review-03433f830cac22fe 2026-09-01T15:56:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-mifepristone-lawsuit-amid-fda-safety-review-24bb9be3f82755ba 2026-09-01T15:55:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/exoskeleton-aims-to-make-daily-life-easier-for-people-with-traumatic-brachial-pl-73db337c65c30ee8 2026-09-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/animal-free-chemical-testing-8785000fd06c9474 2026-09-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-sustainable-flame-retardant-derived-from-corn-steep-liquor-2fcc69134f328646 2026-09-01T15:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/president-trump-announces-new-pharmaceutical-deals-knoe8-streaming-news-9-1-2026-72584c59e9868b12 2026-09-01T15:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/representative-lauren-boebert-introduces-h-r-10150-advancing-botanical-drug-deve-dd3fea9eec629875 2026-09-01T15:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-clinical-biopharmaceutical-company-07dcf490eaf9ed67 2026-09-01T15:39:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-patent-cliff-why-generics-and-biosimilars-demand-different-playbooks-5ac9792351d3830c 2026-09-01T15:37:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-cap-wrap-tnr-gold-first-phosphate-374water-blockmate-ventures-753ed2a401d2fce3 2026-09-01T15:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocugen-s-quiet-transformation-new-medical-leadership-and-a-dosed-trial-signal-a-9674907b1a2dcfcf 2026-09-01T15:33:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/starting-kindergarten-expert-tips-for-a-smooth-school-transition-81c095bc7ad903e5 2026-09-01T15:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/select-health-recognizes-30-organizations-addressing-community-health-needs-acro-768414f20395006e 2026-09-01T15:14:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-led-analysis-behind-intriguing-dark-matter-results-a3c834b162b1b171 2026-09-01T15:12:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-legn-stock-may-be-undervalued-despite-a-70-3-year-fall-305257f0e09ed1f8 2026-09-01T15:10:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-claims-ms-win-as-rhapsido-clears-phase-3-with-no-liver-safety-signal-ce3700bd6685a9cb 2026-09-01T15:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serbia-launches-pharmaceutical-waste-management-project-c76d9d91a9c8c1f8 2026-09-01T15:03:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cphi-milan-names-2026-pharma-awards-finalists-df99db5518437d1e 2026-09-01T15:01:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-dealmaking-spreads-the-wealth-among-a-broad-set-of-biotech-venture-inves-7a9a2ce3471f207a 2026-09-01T15:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-lands-8m-nasa-grant-to-make-medicine-in-space-99186348954db30a 2026-09-01T15:00:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/atlas-of-the-brain-s-striatum-could-guide-researchers-to-new-drug-treatments-88f129baa1e586b9 2026-09-01T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-and-expired-guidances-drugs-1057bbfe24e27904 2026-09-01T14:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-blinkit-facility-citing-safety-lapses-13cb2d1a60b6fbdd 2026-09-01T14:55:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-inks-1-53b-deal-for-simcere-s-b-cell-targeting-antibody-575b210408d58715 2026-09-01T14:41:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-reported-encouraging-trial-data-for-a-multiple-sclerosis-drug-the-stock-6d3f922a4de210b3 2026-09-01T14:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-oral-medication-ad109-shows-promise-in-treating-obstructive-sleep-apnea-in-p-77e7ae09de0d53a8 2026-09-01T14:33:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/seqens-announces-the-completion-of-the-transfer-of-wavelength-activities-48c6e14da6ae491b 2026-09-01T14:30:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-s-biotech-strategy-must-catch-up-to-avoid-discovery-without-scale-a5c9984b185c7b29 2026-09-01T14:27:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-way-forward-must-be-the-european-way-550d0c8456153ccf 2026-09-01T14:26:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approved-sunscreen-filter-bemotrizinol-debuts-in-new-us-products-cc1e7c3f025d5bd6 2026-09-01T14:25:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-cmc-readiness-is-becoming-central-to-biopharma-licensing-deals-0a1bf39436695936 2026-09-01T14:17:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/malaria-rl-reference-diagnostic-and-advisory-services-139f9fabb284e7b4 2026-09-01T14:16:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/aaps-pharmsci-360-microstructure-intelligence-in-predictive-drug-development-par-eda55d7d05a0169a 2026-09-01T14:13:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/krebskachexie-wie-ein-tumorprotein-den-korper-auszehren-lasst-e85bdca556a9a879 2026-09-01T14:06:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimising-microbiology-practices-ensuring-product-safety-and-regulatory-complia-f295045246416755 2026-09-01T14:04:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/learn-french-as-a-foreign-language-with-decalages-culturels-the-podcast-from-rfi-39bec7ff76067907 2026-09-01T14:01:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-carbohydrate-utilization-regulator-cbr1-coordinates-nutrient-specific-gene-a-09ad8f3c94176061 2026-09-01T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rencontre-chercheurs-associations-grand-public-a-lyon-la-recherche-participative-bedb28414f5a737f 2026-09-01T13:59:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-adds-boxed-warning-to-labeling-for-ferric-carboxymaltose-injection-injectafe-2aae1c61eed53f09 2026-09-01T13:59:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/arsenalbio-sheds-most-of-staff-in-pivot-to-in-vivo-car-t-2fb8908a7d171de9 2026-09-01T13:59:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/nine-more-pharmaceutical-manufacturers-join-trump-s-most-favored-nation-initiati-13079b6bdecf12a7 2026-09-01T13:44:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/cormedix-therapeutics-to-participate-in-the-wells-fargo-healthcare-conference-1911413c9d615893 2026-09-01T13:39:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-gets-multiple-sclerosis-win-with-btk-inhibitor-e50070102afe595c 2026-09-01T13:38:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-pre-market-movers-biaf-labt-alms-pasw-swing-big-4981226f4a2cd4bd 2026-09-01T13:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alumis-crushed-by-midstage-lupus-flop-but-plots-path-to-phase-3-for-tyk2-inhibit-3824ac8e70c1a588 2026-09-01T13:27:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/fassier-duval-telescopic-intra-medullary-system-c6cf3a53434424dd 2026-09-01T13:19:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/novocure-hit-by-cyberattack-exposing-patient-data-eb1d852f4440a291 2026-09-01T13:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cook-medical-launches-prepped-and-draped-a-new-podcast-bringing-the-clinician-s-adb1e6fe73db9f82 2026-09-01T13:12:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-difference-between-meeting-dscsa-and-mastering-it-3db31c9b6a6ea424 2026-09-01T13:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/german-biotech-revier-therapeutics-launches-with-6-million-48931909d839c378 2026-09-01T13:02:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-going-on-with-pmv-pharmaceuticals-stock-tuesday-pmv-pharmaceuticals-nasda-c21744e56ceb5aa7 2026-09-01T13:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-into-pharmaceutical-cannabis-with-a-gmp1-licence-7f08635b7c75b904 2026-09-01T12:53:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-biotech-growth-trust-plc-net-asset-value-s-bd1c677272f3136a 2026-09-01T12:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-eu-biotech-act-must-turn-competitiveness-ambition-into-reality-5c24887f6d0e2900 2026-09-01T12:51:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/celcuity-to-participate-in-upcoming-investor-conferences-6f93731d5480ab64 2026-09-01T12:47:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cannara-biotech-names-nicholas-fozard-as-chief-financial-officer-086a821844087018 2026-09-01T12:29:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/signant-health-unveils-patient-centered-redesign-of-trialmax-ecoa-b04f270e6d765f0d 2026-09-01T12:28:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-trump-s-most-favored-nation-deal-means-for-drug-prices-fff2badb7858d28b 2026-09-01T12:09:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/redefining-the-standard-for-recessed-lighting-in-the-pharmaceutical-industry-2f02a9f1cadd2172 2026-09-01T12:03:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/applied-biologics-activates-first-clinical-site-in-phase-3-bioxhealtm-trial-6d3db1d886d04436 2026-09-01T12:02:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference-5f06e96dc9cc99a3 2026-09-01T12:01:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/convegno-29-10-umano-troppo-umano-transumano-fino-a-dove-puo-spingersi-la-medici-8b96e953be60a327 2026-09-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-classes-on-20-and-24-november-due-to-2026-november-festival-0edb746fb1a1c6e7 2026-09-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deadline-extended-ku-star-program-for-australia-2027-85569d61d594d826 2026-09-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/designing-clinical-trials-around-the-patient-journey-a1344d125b12dabf 2026-09-01T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/applied-biologics-activates-first-clinical-site-in-phase-3-bioxhealtm-trial-c3311c3e714e9a78 2026-09-01T11:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listin-c212808ddbea89e0 2026-09-01T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-nvs-stock-surges-5-following-positive-multiple-sclerosis-drug-trial-res-2938f2aa5d69d190 2026-09-01T11:23:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-s-ddc3ab991594c1e1 2026-09-01T11:21:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/invivyd-names-marc-elia-ceo-adds-new-independent-director-as-vyd2311-phase-3-stu-da2ce8923e44b39b 2026-09-01T11:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocugen-announces-first-patient-dosed-in-phase-3-registrational-trial-of-ocu410-m-d1f819233c053456 2026-09-01T11:02:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/ocugen-doses-first-patient-in-ocu410-phase-3-trial-ocgn-stock-news-cf3fa3f79de6eb21 2026-09-01T11:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-naloxone-and-drug-labels-medication-safety-pearls-from-ashp-meeting-4b98f0e0a91b0614 2026-09-01T11:01:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/harmonizing-data-collection-for-precision-oncology-aacr-project-genie-data-model-362eed6344164164 2026-09-01T11:01:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/netramark-strengthens-board-of-directors-with-appointment-of-veteran-pharmaceuti-43635865e7efcc49 2026-09-01T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-s-f8026af63f8654ed 2026-09-01T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-loss-supplement-recalled-over-toxic-substance-other-undeclared-ingredient-7b7d383f21b1806f 2026-09-01T10:53:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-reports-first-quarter-fiscal-2027-results-delivers-broad-based-portfol-e62a4a1e565d2a0d 2026-09-01T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-announces-strategic-partnership-with-cornerstone-robotics-to-further-e-ac43bbf02fb74ead 2026-09-01T10:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unaids-sadc-and-china-partner-to-advance-local-pharmaceutical-manufacturing-and-14b57cb3c6125d4c 2026-09-01T10:35:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/briacell-therapeutics-corp-tsx-bct-falls-4-24-as-clinical-stage-risk-and-volatil-7354861d3b3b1799 2026-09-01T10:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atezolizumab-in-early-triple-negative-breast-cancer-the-randomized-phase-3-nsabp-4d2de4700021fc91 2026-09-01T10:15:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/simcere-pharmaceutical-enters-exclusive-global-licensing-agreement-with-roche-fo-b88c54b5bb092ac6 2026-09-01T10:10:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-signs-mfn-agreements-with-nine-new-companies-538216cab3227725 2026-09-01T10:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-in-global-clinical-development-why-early-inclusion-matters-e5d141a536ec9cef 2026-09-01T10:00:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-loss-supplement-recalled-nationwide-after-fda-finds-undisclosed-drug-toxi-b4eaf10555ed4c93 2026-09-01T09:55:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/wall-street-s-momentum-trade-is-unraveling-as-chip-stocks-slide-and-biotech-make-d574b99be9864874 2026-09-01T09:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-catches-phase-3-fever-after-mrna-flu-vaccine-beats-standard-shots-304db1220ba2ce8a 2026-09-01T09:43:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/ondine-biomedical-share-price-rallies-following-40-drop-in-surgical-infections-60f579e19e553471 2026-09-01T09:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/russia-experiencing-shortage-of-hemophilia-b-drugs-475eed08f1ab4abf 2026-09-01T09:26:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/kuwait-cuts-prices-of-517-medicines-pharmaceutical-products-cf04f71c801de452 2026-09-01T09:15:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/lung-cancer-combo-succeeds-in-first-line-china-trial-5d3b8b7f2767ece0 2026-09-01T09:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-political-scientist-s-view-on-the-election-in-saxony-anhalt-we-need-to-rethink-589839368ba1f769 2026-09-01T09:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/election-researcher-on-the-saxony-anhalt-election-where-emotions-dominate-facts-a0d01fe6ff64c185 2026-09-01T08:59:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiro-and-differentia-biotech-collaborate-on-clinical-trial-simulation-9087e113d5806752 2026-09-01T08:56:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-learning-and-development-support-scheme-a-guide-for-employers-174a5fc9cb0f0949 2026-09-01T08:42:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-inc-nasdaq-rare-receives-average-rating-of-moderate-bu-44d13e62530b90f4 2026-09-01T08:34:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/corient-private-wealth-lp-acquires-new-shares-in-ultragenyx-pharmaceutical-inc-r-32be5efffaa9f199 2026-09-01T08:34:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/ondine-biomedical-share-price-rallies-following-40-drop-in-surgical-infections-89bbffd178c9f809 2026-09-01T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adult-social-care-provider-statistics-england-quarterly-update-to-august-2026-79e3735780ca7568 2026-09-01T08:26:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/daiichi-sankyo-advances-aax-biotech-s-opti-mab-into-antibody-program-cd81e10a445bcbb3 2026-09-01T07:49:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/hsbc-holdings-plc-takes-1-53-million-position-in-ultragenyx-pharmaceutical-inc-r-0864fbe07ece0b78 2026-09-01T07:48:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-rnxt-15-eols-crnx-apge-dfb124ab796845d2 2026-09-01T07:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bank-of-new-york-mellon-corp-makes-new-investment-in-ultragenyx-pharmaceutical-i-25bc4284f12c2c15 2026-09-01T07:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/nature-medicine-s-38-753-patient-hf-synthesis-signals-a-replicable-model-for-rwe-75ad51f729b679db 2026-09-01T07:31:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-touts-latest-drug-discount-deals-2f5ba2d6f94c3531 2026-09-01T07:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-oral-weight-loss-pill-delivers-12-body-loss-without-injections-or-fasting-670c11b320c7ceab 2026-09-01T07:21:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-partir-du-1e-septembre-2026-nouvelle-version-du-formulaire-de-demande-d-autori-8074758a096207b7 2026-09-01T07:18:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/gratis-pneumokockvaccin-till-alla-65-ar-eller-aldre-i-vastra-gotaland-b4c376a651e473a5 2026-09-01T07:17:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-gets-fda-nod-on-phase-3-design-for-lung-cancer-drug-ide849-0ac74250aeaf0a51 2026-09-01T07:09:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/cadrenal-aligns-with-fda-on-phase-3-design-for-blood-clotting-drug-cad-1005-a218378b002686c3 2026-09-01T07:09:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-to-advance-mrna-seasonal-flu-vaccine-candidate-to-phase-iii-following-positi-424dc5368caa3e3d 2026-09-01T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-davis-health-launches-fellowship-programs-in-pediatric-cardiology-and-pediatr-059c06300b947e52 2026-09-01T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-second-chance-at-life-started-with-an-unexpected-gift-890685ca391a7b3a 2026-09-01T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-europe-must-seize-the-biotechnology-opportunity-2c6640a9d588d89c 2026-09-01T06:55:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/jiangxi-bio-announced-2026-interim-results-3ce768a1fc16bbd5 2026-09-01T06:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/canada-s-drug-agency-issues-positive-reimbursement-recommendation-for-lecanemab-f1e7ac4c2e07b234 2026-09-01T06:35:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/xyra-doses-first-european-patient-in-phase-2-3-trial-of-af-drug-budiodarone-1b55c9e5e202806b 2026-09-01T06:15:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-ibrx-stocks-post-august-gains-eli-lilly-s-latest-2-9b-deal-has-retail-trader-52d054f0890ad081 2026-09-01T06:09:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-ibrx-stocks-post-august-gains-eli-lilly-s-latest-2-9b-deal-has-retail-trader-bd69cb01c6dac5b4 2026-09-01T06:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-wins-7-96-million-nasa-award-to-advance-space-based-medicine-manu-a240a39b3388fac4 2026-09-01T06:08:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-welcomes-federico-sebastiani-as-chief-commercial-officer-e95a664a12699565 2026-09-01T06:06:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/share-option-awards-to-management-team-at-avacta-ceedb377a126682f 2026-09-01T06:01:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/csafe-expands-reusable-thermal-cover-portfolio-with-the-launch-of-silverskin-re-816fa9ef85e5681b 2026-09-01T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisory-no-2026-0995-public-health-warning-against-the-purchase-and-use-of-47d56fb495a7fd96 2026-09-01T05:32:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-has-found-that-upadacitinib-a-drug-used-to-treat-inflammatory-diseases-s-b50228adece96226 2026-09-01T05:19:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/senate-report-exposes-complicity-of-mifepristone-companies-in-america-s-abortion-1a335192b4ea34f7 2026-09-01T05:06:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-s-bold-new-mandate-breakthroughs-beyond-the-lab-131bb0804ca9bc5e 2026-09-01T04:57:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/goodbye-cpap-new-sleep-apnea-pill-cuts-breathing-events-by-44-61a5553cf5295c41 2026-09-01T04:52:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/goodbye-cpap-new-sleep-apnea-pill-cuts-breathing-events-by-44-d2df350882decec2 2026-09-01T04:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/fort-myers-innovator-turns-blood-into-healing-technology-c2dbee9d13758579 2026-09-01T04:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-unveils-new-drug-pricing-accords-with-csl-astellas-and-other-biotech-drugm-cdce7b24630833c2 2026-09-01T04:10:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-recall-prompts-fda-safety-alert-after-184-serious-injuries-a15696d1b8f65ae1 2026-09-01T04:08:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/breathing-circuit-recall-medline-removes-neonatal-and-infant-heated-wire-breathi-cf71e01a88e25210 2026-09-01T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-1890-and-1891-new-york-pharmaceutical-manufacturer-eugene-schieffelin-release-641bc2238534ff00 2026-09-01T03:34:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-touts-new-drug-price-deals-seeking-a-midterm-edge-17df0cf21f87b80d 2026-09-01T03:18:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/percheron-therapeutics-raises-2-3-million-to-fully-fund-vanderbilt-aml-clinical-840a748c48a966be 2026-09-01T03:11:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/kokusai-pmda-atc-training-materials-have-been-updated-e63a6ee2d2de61f2 2026-09-01T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisory-no-2026-0920-public-health-warning-against-the-purchase-and-use-of-fa13d34c5fc3a4dd 2026-09-01T02:46:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/sls-stock-looks-like-a-3-billion-biotech-winner-this-short-seller-says-the-marke-27bfd0ba2087028e 2026-09-01T02:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-stock-chart-and-price-history-2026-34f0dc7a0c6bac82 2026-09-01T02:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-biotech-sector-must-boost-original-research-to-drive-innovation-9f0ccf6220de94da 2026-09-01T01:50:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/oligomerix-appoints-biopharmaceutical-industry-veteran-cara-cassino-m-d-as-inter-81019999db04f2a1 2026-09-01T01:49:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/prasco-increases-pharmaceutical-footprint-in-ohio-60296795c1d9f666 2026-09-01T01:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/velan-capital-investment-management-lp-expands-edesa-biotech-inc-edsa-stake-aae406dfa037d6b8 2026-09-01T01:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/percheron-therapeutics-raises-2-3-million-to-fully-fund-vanderbilt-aml-clinical-490dd5c948cf3a00 2026-09-01T00:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-asx-dxb-could-the-next-clinical-or-commercial-catalyst-spark-a-major-re-17809651a4a9e016 2026-09-01T00:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-solid-dosage-pharmaceutical-formulation-market-forecast-to-reach-us-949-8-b-41825a9dec762674 2026-09-01T00:40:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-inc-vktx-stock-price-news-quote-history-2933dfa458a78da1 2026-09-01T00:38:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-line-anlotinib-versus-bevacizumab-plus-capeox-in-ras-braf-wild-type-unrese-96943f91fd8dc142 2026-09-01T00:20:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-1e540ef5747aa2b6 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-pharmaceuticals-filed-form-8-k-1b281d7ff4ac56af 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-filed-form-8-k-e221b2e303f0d44e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-557360222275bd8a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novartis-filed-form-6-k-e1560aaba7c9d4fa 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/9a14149a97e7e4ef 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-154cf4e8e16ef53a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-29372f7cd2415f16 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sns-796fb09f9bc9dc2d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-dee0ece8d9cdecfb 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/s-p-global-sustainability-yearbook-member-2026-2650a657657c3450 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stn1012700-0-025-e7b4fde19b11ee3f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-02-d1fa929e7bfd6020 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-summit-for-eye-health-high-impact-partner-d7b8b754db9aaaac 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-5-ed0a806367b68b1d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stn1012700-ryjusea-0-25mg-ml-698993191fe26505 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-02-909dba3a01fbbcb9 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/9a972751d1968bd3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/santen-5-121ff622ee60b4e8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/0-1-a0887de2a01028a5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbb39745e28a4e60 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/8-60471d618cebb8e6 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/40-mg-ml-05ce165adf0e4a14 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/l-glutamine-s-potential-to-enhance-chemotherapy-efficacy-in-advanced-pancreatic-d3773b8e06e0083a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/more-sustainable-microchip-production-51c255c40b1d2581 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-alcohol-abuse-and-alcoholism-notice-of-closed-meeting-4d8c50c63abd6e09 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-762bc12534a6162b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-on-drug-abuse-notice-of-meeting-6c6bd97fbb3638be 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-4cafe02e9b44f28d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergency-office-of-management-and-budget-review-and-public-comment-questionnair-2366da323d834c60 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-list-of-hhs-certified-laboratories-and-instrumented-initial-testing-faci-235d10491ebe7628 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-7f05865fc95c60cf 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-allergy-and-infectious-diseases-amended-notice-of-meeting-fec56633351a2952 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-that-namenda-memantine-hydrochloride-tablets-5-milligrams-and-10-m-7f35cc0c0117f296 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meeting-of-the-microbiome-subcommittee-of-the-presidential-advisory-council-on-c-fe06d814dcd1dd5f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ars-pharmaceuticals-to-participate-in-upcoming-investor-conferences-cfcd31b7c40cd01b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bio-spectra-attitude-c9633d501693c08d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-pomalidomide-dc0fb2182079b266 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-raldesy-tm-b58af214ced86bb2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unpaste-960ca6c903ac8111 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cyclobenzaprine-hydrochloride-db48fe93db897efa 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-la-vaquita-new-extra-08d39f3a67ebffc3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sun-wave-anti-aging-insta-dry-spf-30-2b41ac44a91d5278 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-haloperidol-decanoate-630840e8764cdb73 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-fluconazole-18b5820ac272219a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-kroger-digestive-relief-5df9bdaab8ebaa7e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-movantik-580e3c8dc60bc3f5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-onelax-senna-96c034f99a9bd755 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-rifabutin-8c92e0a18eb787ea 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-tofacitinib-7eb7ea98aa256a2c 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-meclizine-hydrochloride-3a4b59939aa94df5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-kroger-extra-strength-af522862d39d2439 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-zolpidem-tartrate-63092e362597afe1 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-primidone-11d61cf7f7609905 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sun-wave-cross-sport-insta-dry-spf-50-3d574c766ca0c1d2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gabapentin-d29c3d394745b2e6 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-potassium-phosphates-09af05beff5b26e3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gentle-lax-5efa391b116d7a4c 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-terramed-just-think-comfort-hydrocortisone-1-cream-7010fdc2664c799b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-topiramate-e2426c119556a738 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-prednisone-803c198967935b2c 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-168ca8d082a7f209 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sunski-hot-block-mineral-sunscreen-stick-spf-50-9498e0fb824fd21d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibuprofen-b0febfbfd8ba0a45 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gas-relief-12dec279f995013e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-memantine-hydrochloride-ac72c55112067a9a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/2026-5252dd6a9502ec2f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-participation-at-upcoming-investor-con-c4e589c9da54f35f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-availability-of-solta-medical-s-fraxel-ftx-in-australia-492455470437b681 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-of-human-effective-dose-via-translational-ocular-modeling-clinical-8f6379bcce64dcb4 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regional-variation-in-bladder-cancer-clinical-trial-availability-in-the-us-89cfae19ab7f128f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-oral-hiv-pre-exposure-prophylaxis-efficacy-in-cisgender-women-across-037bb7a8d4ca3d26 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/angiography-based-index-of-microcirculatory-resistance-in-assessing-the-mvo-and-5bc1d79147921b08 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xy0206-targets-flt3-dependent-resistance-states-in-acute-myeloid-leukemia-9004a1d96a69ccab 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-supportive-galenic-compounding-to-advanced-clinical-pharmacy-a-decade-of-ex-7213861ced44d953 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-selection-for-ceftibuten-combined-with-avibactam-tomilopil-a-potential-oral-b4d254774cf1fe22 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-randomized-trial-results-of-dtx401-aav-gene-therapy-for-the-treatment-of-56f10070b988fc31 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natural-compounds-targeting-oncogenic-signaling-networks-in-glioblastoma-molecul-bb67bf70c275a284 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alg-020572-an-antisense-oligonucleotide-for-the-treatment-of-chronic-hepatitis-b-e1a1f17c4d616a96 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-dermatological-safety-of-chlorhexidine-impregnated-dressings-in-paedi-4ff098edd94efe7e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seamless-phase-i-ii-cancer-clinical-trials-using-kernel-based-covariate-similari-db580f0b729f6afa 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-cautionary-note-on-regional-consistency-evaluation-with-multiple-primary-endpo-e7e17787dd5a3d0b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dose-optimization-design-for-randomized-phase-ii-trials-with-toxicity-and-effica-bc82de0d12c409a7 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/redefining-regulatory-proof-the-end-of-the-two-trial-paradigm-f8982c35b3f405e3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-the-concurrent-validity-of-the-australian-treatment-outcomes-profile-i-b167fb52bf5bf9c1 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-fast-flexible-simulation-framework-for-bayesian-adaptive-designs-the-r-package-ebc4d7cfccaa7ad8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-resistance-assessment-of-commonly-used-anthelmintics-and-their-combination-579f73de3177c082 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-development-of-therapies-for-charcot-marie-tooth-disease-recommendation-be178a5f6cdd6254 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-acting-injectable-buprenorphine-in-prison-insights-from-a-short-answer-surv-8d449b5a7ca842e8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/home-phototherapy-for-psoriasis-evidence-and-implementation-8d42a9d6f7869cff 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sample-size-reduction-by-applying-ml-based-causal-inference-methods-a867d99b40e1e9a7 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tirzepatide-and-sglt2-inhibitors-for-heart-failure-with-preserved-ejection-fract-e75ca63809f1f808 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quitline-counsellors-experiences-with-vaping-and-nicotine-replacement-therapy-fo-1d2cea8f10bc8f0e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analytical-quality-by-design-based-reverse-phase-high-performance-liquid-chromat-25d4968cdda8f531 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-evaluation-frameworks-in-autism-spectrum-disorder-methodological-6c9b8707ae2d4d2d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioactive-phytochemicals-of-jasmine-oil-and-their-role-in-managing-hypertension-aec862d865c3c192 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-short-versus-standard-course-ceftriaxone-therapy-in-child-6f6a699b12989428 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-pharmacist-led-intervention-improves-anxiety-depression-and-inhaler-tec-5d5dcd41768c8a1a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-the-path-to-attrition-multidomain-risk-assessment-in-diabetic-foot-ul-469e0f569f644e75 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-an-observational-study-of-the-effectiveness-and-safety-of-nivolumab-p-d99c59fe532c0dcd 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-and-bioequivalence-study-of-apremilast-tablets-in-healthy-chines-223acc39086768da 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tqb2618-plus-penpulimab-alone-or-in-combination-with-chemotherapy-for-recurrent-ea5d36e634a09ca2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/swab-testing-to-optimize-pneumonia-treatment-with-empiric-vancomycin-a-randomize-daf4082344a47207 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-evaluation-of-two-oral-formulations-of-chlorpromazine-in-healthy-72516ced0fb475f1 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellular-neighborhoods-govern-antitumor-t-cell-infiltration-following-anti-ctla-2ee5f474d668fbca 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dexamethasone-implant-and-aflibercept-combination-therapy-versus-aflibercept-mon-a683dadfd0a4c4f8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-genomic-analysis-of-her2-mutant-metastatic-triple-negative-breast-c-a6e01e4718ec254f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-it-time-to-eliminate-time-to-elimination-of-symptoms-as-a-primary-trial-end-p-c32512b26951c26f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/m6-metabolite-contributes-to-the-efficacy-of-the-rac-cdc42-inhibitor-mbq-167-in-397bafa4f106dd7e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pure-red-cell-aplasia-with-triple-pulmonary-co-infection-and-shock-induced-organ-f789478f0d9edffb 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetic-and-bioequivalence-study-of-apremilast-tablets-in-healthy-chines-bb354bc8e23344f2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tuberculosis-recurrence-rates-in-various-world-health-organization-regions-from-b6429f05b67cc87e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-mindfulness-based-cognitive-therapy-on-fatigue-and-the-quality-of-life-175f97d863f9360b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exercise-as-an-adjunctive-therapy-for-patients-on-maintenance-hemodiafiltration-ed13017c921105d8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/target-trial-emulation-for-drug-repurposing-in-neurodegenerative-diseases-dea9cdb159c2633a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imaging-review-and-clinical-manifestations-of-lacunar-stroke-syndromes-fc5d8d20a4d6f0fc 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/principles-of-drug-use-in-palliative-care-2b3403664e13f9d8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-wrong-with-nonmaleficence-updating-an-ancient-injunction-a5e6a817cc908269 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extracorporeal-membrane-oxygenation-during-aeromedical-transport-of-cardiovascul-4061b8f3d8b98aff 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secukinumab-biosimilar-bat2306-versus-reference-secukinumab-in-patients-with-mod-c3059f0d7fb8b3e1 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-intraoperative-analgesic-effects-of-perioperative-electroacupu-866b9f08b54adbe2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-icg-use-during-r-veil-provide-relevant-clinical-advantages-technical-aspect-eeb725fe52a3f48b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-multiple-micronutrient-supplements-during-pregnancy-on-zinc-status-a-930014f4f7f714e3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characterization-of-beo-oslds-high-dose-response-and-extended-energy-de-1a47de0ca99de72d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modulation-of-neuroendocrine-and-autonomic-responses-to-competitive-stress-by-sl-d12db5c78ab1b852 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-chatbot-tool-on-a-smart-mobile-device-to-promote-adherence-to-home-rehabilitat-d9505e14ffef4f26 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-functional-severity-of-cerebral-palsy-in-a-tertiary-referral-cohort-f715e79f416ce55a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-statin-treatment-and-outcomes-after-acute-intracerebral-hemo-2300a3c72e7b9fc7 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/candida-candidozyma-auris-in-pediatric-population-risk-factors-clinical-presenta-d8b317eb13af59ea 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-revolution-of-deep-eutectic-solvents-and-natural-deep-eutectic-solvents-in-p-6959c49d7b46b485 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/closed-incisional-negative-pressure-wound-therapy-vs-standard-surgical-dressing-8a646cb719172fa2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/validation-of-the-ninth-edition-tnm-classification-for-thymic-carcinoma-after-co-7db7429323e5707f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-application-of-serum-zinc-to-copper-ratio-in-covid-19-severity-and-mort-b951039aed4e49c7 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nat10-aggravates-psoriasis-by-promoting-keratinocytes-fatty-acid-synthesis-via-s-9ab0d56628942c1c 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differences-in-postoperative-clinical-outcome-and-quality-of-life-up-to-2-years-d97ae8ad63e4d49a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-bipolar-hemiarthroplasty-for-femoral-neck-fracture-a-nation-9254d15eeae2d511 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gastro-stable-liposomal-bee-s-propolis-extract-protects-against-cisplatin-induce-df1002ae91156859 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-time-to-event-clinical-outcomes-with-multivariate-repeated-measuremen-2ee0551e9221cd1f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-between-complementary-feeding-approach-dietary-intake-and-growth-a-0093ec91eb170994 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/engineered-plga-nanocarriers-advance-precision-drug-delivery-in-ovarian-cancer-1b442907a9f336d6 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seasonality-and-clinical-characteristics-of-influenza-like-illness-and-severe-ac-f11fefdc7506d79a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlation-of-pelvic-magnetic-resonance-imaging-with-diagnostic-loop-electrosur-e95412a597f1b482 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-childhood-trauma-and-dissociation-among-alcohol-dependent-inpatients-c-199e78f76e5b285f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-preparedness-for-resuscitative-hysterotomy-a-novel-low-cost-task-train-2a9532f174858b2e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/student-perceptions-of-high-authenticity-moulage-in-obstetric-paramedicine-simul-08b61d86414a6792 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/toward-sustainable-therapeutics-integrating-regenerative-medicine-into-pharmacol-bd360e62d1d642af 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/universal-care-under-strain-navigating-population-ageing-in-europe-1230c70c065d165f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turning-animal-study-administration-signals-into-drug-development-intelligence-f2d801f92b3f4e23 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/if-glp-1s-are-longevity-drugs-the-evidence-bar-must-change-carefully-61e2a43e1678618b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapid-and-comprehensive-identification-of-the-metabolic-soft-spots-of-peptide-dr-5fc1d1be8176041b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-overlooked-opportunity-sbrt-adt-for-aggressive-prostate-cancer-in-the-elderly-755ff2009d753e50 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-implementation-of-a-pre-consultation-patient-educational-tool-for-int-61e96074b04feecf 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pneumonitis-after-chemoradiotherapy-and-or-immunotherapy-for-stage-iii-and-iv-no-de3bd1af49570e85 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-surveillance-to-participation-redefining-respiratory-virus-epidemiology-in-7e2366410288a9ce 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotic-prophylaxis-a-sharp-tool-that-could-be-blunted-easily-11658ad4c9f18d50 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-protocol-for-cns-gcts-0ba3919ed1dc9a9e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-d-containing-supplementation-and-depressive-symptom-severity-in-adults-a-5fd685214d8e0c44 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-safety-of-icotinib-as-adjuvant-therapy-for-resected-stage-b0f5cc0c02b06298 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regional-in-consistency-and-comparability-of-cannabis-laboratory-testing-a-stati-26363e35294e57db 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraoperative-study-of-afferent-and-efferent-connections-in-the-upper-lumbar-sp-e06e91c9e90d2338 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraoperative-study-of-afferent-and-efferent-connections-in-the-upper-lumbar-sp-1916f7a86a9d07ed 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbe-snapshots-lomentospora-prolificans-8eaed4a20c75cccd 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-of-body-perceptions-and-preferences-for-breast-reconstruction-in-m-3dda7f2f1b144f9e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-trauma-informed-sports-based-intervention-on-emotion-regulation-se-511f895f45749538 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-expert-delphi-consensus-on-endoscopic-ultrasound-guided-portosyste-d6ded3caf20d1910 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-influence-of-dietary-emulsifiers-on-the-gastrointestinal-tract-the-jury-is-s-1fb11e3f3e15a810 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/visualization-and-detection-of-ciliary-beating-frequency-in-human-airway-organoi-0cd9bf27ae1113f0 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/based-on-ct-radiomics-and-clinical-features-to-distinguish-pathological-subtypes-9215a58c5124f148 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microphysiological-organ-on-a-chip-models-of-pulmonary-infections-for-developing-499c22da84345eb5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07798323-noninvasive-imaging-biomarkers-of-treatable-macrovascular-disease-in-97c6f6d5e19ec977 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07797556-use-of-apple-vision-pro-as-virtual-monitor-for-diagnostic-and-therap-dc14911b82806e95 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07797335-ambition-7-a-research-study-investigating-how-well-zenagamtide-lower-80555b2cfb06c936 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07796347-dyadic-life-review-intervention-for-older-patients-with-advanced-can-eee39ef1a8316739 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07796191-drug-drug-interactions-studies-of-vc005-tablets-in-healthy-adult-sub-1bb19dc949553928 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07795502-dynamic-infection-kinetics-for-early-diagnosis-monitoring-and-progno-89ac7e35ebd7e4d3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07776327-analyzing-positional-release-therapy-and-dry-needling-c52ccd4260556a6f 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07726069-haloperidol-for-outpatient-symptom-management-in-patients-diagnosed-c99b5e5a816fddb3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07701772-laser-versus-crystallized-phenol-in-pilonidal-sinus-disease-f4577c401aa72849 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07693868-a-study-to-see-how-safe-a-new-medicine-nnc6022-0004-is-in-healthy-pe-47a69da0b879519d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07690839-pre-clinic-visit-online-education-for-thyroid-cancer-f64144239f80a29a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07392372-a-clinical-trial-investigating-the-safety-and-biological-activity-of-273aeb34458003e8 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07294664-pdl1-tgf-in-combination-with-shr2554-or-apatinib-and-chemotherapy-fo-786bf2c40a29bb51 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07222917-a-phase-iib-study-to-evaluate-the-effect-of-dapagliflozin-in-combina-69449a2e157d8d33 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07160530-healthy-children-healthy-communities-effectiveness-of-a-multilevel-r-5dbb38248521edaf 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07105735-rn1201-injection-for-autoimmune-diseases-refractory-to-standard-ther-885f8bf188c662bc 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07027826-the-esophageal-string-test-as-a-diagnostic-screening-tool-for-eosino-dc90d2edb4b0417d 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06938178-high-density-eeg-meg-wearable-eeg-comparison-of-quantitative-electro-0e6c20521e71bf3e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06890338-a-study-to-assess-anti-tumor-activity-of-intravenously-iv-infused-ca-fdd64de7fa91e0d3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06743529-immediate-versus-substantiated-antibiotic-therapy-in-suspected-non-s-32dda36ff2a78281 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06481319-implementing-a-pilot-patient-navigator-program-to-improve-access-to-b7ff837e61dd41c5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06340568-a-clinical-study-of-the-anti-cancer-effects-of-an-investigational-th-c1ebce34a542cd29 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06325683-anti-lag-3-relatlimab-and-anti-pd-1-blockade-nivolumab-versus-standa-b2fbdcd7c5ae634b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06222203-surveillance-for-malignant-transformation-of-neurofibromatosis-type-e2e2088d4c1c3008 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05656378-a-repository-to-study-host-microbiome-interactions-in-health-and-dis-3d8064f7f07e15b0 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05653037-a-single-ascending-doses-phase-i-study-to-evaluate-the-safety-and-ph-e0d618537f26379a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05276973-testing-the-addition-of-ipatasertib-to-the-usual-chemotherapy-treatm-1e8fc5d1723fc191 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05152147-a-study-of-zanidatamab-in-combination-with-chemotherapy-plus-or-minu-46be30b705f84cc5 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05026723-food-as-medicine-for-hiv-and-diabetes-9031943f7da1373e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04977986-clinical-study-of-cannabidiol-in-children-adolescents-and-young-adul-834de854bc5acafa 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04933539-subcutaneous-daratumumab-once-weekly-carfilzomib-and-dexamethasone-d-ec64df78a0f720a1 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04609046-testing-the-addition-of-lenalidomide-and-nivolumab-to-the-usual-trea-7f50f948c51ec8ed 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04484272-a-stress-and-pain-self-management-m-health-app-for-adult-outpatients-3f43632a83841f98 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04269239-effectiveness-of-healthy-habits-for-hospitalized-older-adults-to-opt-f1354a9b15e0f02b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04266093-gene-therapy-follow-up-protocol-for-subjects-previously-enrolled-in-d982d3555f77b2d3 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04124341-pcs-in-severe-treatment-resistant-depression-eccdb4c1666647bf 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03910452-haploidentical-transplant-for-people-with-chronic-granulomatous-dise-481ba3f7cd232cb2 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03604991-nivolumab-and-ipilimumab-in-treating-patients-with-esophageal-and-ga-9f0403cd92796f35 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03581318-technical-and-translational-development-of-cardiovascular-magnetic-r-df7a43561481ea99 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03538600-sample-collection-from-healthy-volunteers-for-assay-optimization-042ce20d59f4cf1b 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03510442-natural-history-genetics-and-pathophysiology-of-systemic-juvenile-id-a5135e503470d567 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03401385-first-in-human-study-of-ds-1062a-for-advanced-solid-tumors-tropion-p-f8c8437e42b9378e 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03269578-sample-collection-and-tracking-for-the-developmental-therapeutics-cl-7c1598eb35a25730 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02669225-brain-amyloid-retention-during-wakefulness-and-following-emergence-f-4615d8f94976ae54 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02544022-development-and-validation-of-patient-reported-outcome-pro-measures-f3860962c5055e29 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01778543-pathogenesis-and-genetics-of-microphthalmia-anophthalmia-and-uveal-c-2506eb32541eec12 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00794352-comprehensive-multimodal-analysis-of-neuroimmunological-diseases-of-d726be7bab25aaab 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00598351-natural-history-study-of-patients-with-neurofibromatosis-type-2-054fcc8a1d804bcd 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00007150-treatment-of-hemochromatosis-39e19b89607dd77c 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001471-tissue-biopsy-and-imaging-studies-in-hiv-infected-patients-4bb4fa848a4a0465 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001467-genetic-analysis-of-immune-disorders-64d622071b2f208a 2026-09-01T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-expands-his-plan-to-lower-drug-prices-26-pharmaceutical-companies-have-now-741117046752defe 2026-08-31T23:07:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/upfront-help-cuts-placement-costs-for-healthcare-students-027559558240a35a 2026-08-31T23:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-touts-deals-with-nine-more-pharmaceutical-companies-c7892da2b76f4605 2026-08-31T22:59:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-enters-voluntary-agreement-with-u-s-government-supporting-affordable-ac-4210ba098e68da92 2026-08-31T22:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/updated-novartis-halts-autoimmune-car-t-trials-after-3-deaths-as-bms-also-pauses-ca12eff90a993feb 2026-08-31T22:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/column-drug-compounding-has-changed-oversight-should-too-2812efa32088ff5b 2026-08-31T22:06:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/column-drug-compounding-has-changed-oversight-should-too-97d19464ed91d9c8 2026-08-31T22:05:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/resultados-financieros-de-los-nueve-primeros-meses-de-2026-42fb634480ce7bce 2026-08-31T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-guardrails-report-shows-most-physicians-don-t-prescribe-abortion-pills-21c4c6fafdf2e5cf 2026-08-31T21:50:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-2026-aficamten-breaks-new-ground-in-nonobstructive-hcm-103c9f78ed078ac0 2026-08-31T21:32:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-announces-nine-new-drug-pricing-deals-with-pharmaceutical-companies-d9db2d80d0fde57c 2026-08-31T21:30:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/tackling-the-lingering-questions-surrounding-ai-adoption-in-clinical-trial-setti-2f4f470b9afd90bf 2026-08-31T21:29:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-announces-drug-pricing-deals-with-nine-pharmaceutical-firms-d10d187aee61b92b 2026-08-31T21:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-announces-new-drug-pricing-deals-with-9-pharma-companies-4cfa1a2d2a0349d1 2026-08-31T21:27:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-delays-a-mifepristone-lawsuit-until-after-midterms-255fd6759fd414c4 2026-08-31T21:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/florida-texas-abortion-pill-suit-paused-for-fda-s-safety-review-e6218d56b6644117 2026-08-31T21:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-unveils-next-round-of-mfn-pricing-deals-with-9-midsized-drugmakers-f196662e2998f9d8 2026-08-31T21:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-trump-says-more-pharmaceutical-companies-will-lower-drug-prices-a61999f0623a690b 2026-08-31T21:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-strikes-new-drug-pricing-deals-d7f355032b33d910 2026-08-31T21:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/court-lets-us-abortion-pill-access-continue-until-trump-fda-finishes-review-cond-a79c0687679a32e6 2026-08-31T20:58:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-defoamers-market-outlook-to-2035-d7745d8246159bb7 2026-08-31T20:56:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-announces-new-nih-funding-award-for-approximately-e532e7f9235d8bab 2026-08-31T20:20:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-announces-deal-with-9-new-pharmaceutical-firms-in-move-to-ease-drug-costs-f80632ff555ad993 2026-08-31T20:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-a-whitehead-alum-alicia-zhou-ceo-of-the-cancer-research-institute-6294bcd983605cbc 2026-08-31T20:15:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-adds-nine-drugmakers-to-most-favored-nation-program-report-216b38da1b15733e 2026-08-31T20:13:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-appoints-chris-benecchi-as-chief-operating-officer-02889504bb9b6ed9 2026-08-31T20:12:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-ceo-now-holds-5-000-ordinary-shares-7865d21f1f04226f 2026-08-31T20:10:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/inventiva-1121d4d7d54c6683 2026-08-31T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-other-biotech-firms-to-announce-new-drug-pricing-deals-with-white-house-eb93ec8023e0f32e 2026-08-31T20:03:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-announces-deal-with-pharmaceutical-companies-to-lower-drug-prices-e2af0c8e2de6653d 2026-08-31T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-cannot-inspect-its-way-to-a-safe-global-food-supply-3947c3b0304c80d0 2026-08-31T19:52:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-strikes-nine-more-deals-with-drugmakers-to-lower-prices-dc05b5d35c6b795a 2026-08-31T19:52:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-dings-alar-over-extremely-concerning-ketamine-claims-bebd495ec608c1b0 2026-08-31T19:46:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/donald-trump-announces-pharma-deal-list-of-drugs-getting-prices-reduced-11a0d88dc5478146 2026-08-31T19:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ufrj-aprova-criacao-da-medalha-minerva-de-merito-administrativo-para-valorizar-s-de178b78d23441f7 2026-08-31T19:34:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-shortages-threaten-lives-as-efforts-to-prevent-them-hit-regulatory-r-6aeb26f6cd31f8b1 2026-08-31T19:32:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/mit-quantum-initiative-launches-postdoctoral-fellowship-program-217c8a52344ba3d3 2026-08-31T19:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-is-vivek-ramaswamy-not-in-prison-ohio-governor-candidate-accused-of-multibil-4d9d6872b66afc1e 2026-08-31T19:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-judge-pauses-case-on-mifepristone-access-until-after-midterm-elections-de73543677cc61b3 2026-08-31T19:17:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-peptides-can-form-well-defined-structures-in-harsh-venus-like-conditions-930933dfb758bf75 2026-08-31T19:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-enters-2-8-billion-agreement-to-acquire-merida-biosciences-pharmexec-a8aed674cbf5acf7 2026-08-31T18:58:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-clears-first-targeted-dermatomyositis-treatment-from-roivant-000c5f45f7bdf5cc 2026-08-31T18:37:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-global-diagnostic-equity-gap-an-interview-with-dr-philip-angelides-90ebbe02793bf69f 2026-08-31T18:35:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-roundup-august-2026-4c07ca9711560bd5 2026-08-31T18:27:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-to-acquire-biotech-firm-merida-in-2-87bn-deal-d0a56495033f4ce1 2026-08-31T18:21:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/managing-risk-across-clinical-development-25d2278635fbbfca 2026-08-31T18:17:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/yokogawa-ss2000-high-content-imager-0b00440dcd53763b 2026-08-31T18:15:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-stelara-for-pediatric-ulcerative-colitis-ab7105e4b3fa7e42 2026-08-31T18:13:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/medtronic-recall-prompts-fda-safety-alert-after-184-serious-injuries-21201f6ba192b10a 2026-08-31T18:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/idexx-laboratories-to-participate-in-morgan-stanley-24th-annual-global-healthcar-80e5cd42d216b3c9 2026-08-31T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fulcrum-therapeutics-faces-securities-probe-aft-d9361e8df153c382 2026-08-31T17:51:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-going-on-with-cytokinetics-stock-today-cytokinetics-nasdaq-cytk-eda4637cf35f06b7 2026-08-31T17:43:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-gilead-s-new-single-tablet-hiv-regimen-9d3aa392fa2af1b8 2026-08-31T17:38:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-additives-are-in-your-food-the-fda-doesn-t-always-know-but-seeks-to-change-0a91093b1d2162d8 2026-08-31T17:23:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-pharmaceutical-company-limited-tak-stock-price-news-quote-and-history-09594fd8434774bd 2026-08-31T17:21:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-strikes-new-drug-pricing-deals-with-nine-midsized-drugmakers-fde6c4e5562afd94 2026-08-31T17:20:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/seattle-area-biotech-led-by-ex-athira-ceo-leen-kawas-raises-35m-for-hepatitis-d-5f8f251735b13d10 2026-08-31T17:14:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-25-years-without-a-new-ptsd-drug-here-s-what-s-in-the-pipeline-7d0d1bbeacc37340 2026-08-31T17:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/craig-lipset-on-decentralized-clinical-trials-and-the-birth-of-dtra-839f009ae0f26fca 2026-08-31T16:34:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-governance-what-it-is-and-why-it-matters-c47550c9a248afda 2026-08-31T16:28:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-calls-out-alar-pharmaceuticals-for-promoting-unapproved-ketamine-drug-at-apa-7c48ef5c8d63e959 2026-08-31T16:04:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/prasco-acquires-130-000-square-foot-ohio-facility-to-expand-pharmaceutical-distr-cc7a2e2c09c39fa7 2026-08-31T16:03:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cvkd-advancing-partnering-process-for-cardiac-acute-critical-care-franchise-8cba4020bd163350 2026-08-31T15:48:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cybin-shares-slide-4-12-as-investors-weigh-phase-3-progress-cash-burn-and-ceo-tr-d885c74f6ab33811 2026-08-31T15:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novavax-stock-climbs-monday-what-s-going-on-f69db783f377129b 2026-08-31T15:38:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-read-a-biotech-clinical-trial-result-p-values-endpoints-and-investor-impl-373d008ca8bd9acf 2026-08-31T15:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electra-aims-to-light-up-nasdaq-with-ipo-for-phase-2-3-i-i-push-7f6a089124b00c2e 2026-08-31T15:27:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/prof-milos-a-lucic-obituary-0ccf576c29750b13 2026-08-31T15:14:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/esr-mourns-the-passing-of-prof-milos-a-lucic-3ee12fbfb3933daf 2026-08-31T15:13:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc26-astrazeneca-s-heart-failure-drug-shows-promise-in-ph-2-trial-0d07b098d535d80e 2026-08-31T15:13:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-giant-mckesson-warns-of-service-degradation-following-cyberattack-dd73486705b625e7 2026-08-31T15:09:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/outbreak-investigation-of-shiga-toxin-producing-e-coli-salmonella-sprouts-august-5f60f01cfb5d643b 2026-08-31T15:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cencora-s-ameer-ali-on-readying-systems-for-ndc-12-6f799622f06991b8 2026-08-31T15:06:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/snakes-in-an-egg-all-coil-in-the-same-direction-scientists-think-they-ve-learned-168f0c6111d4fed6 2026-08-31T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-why-rule-breakers-fear-him-179f1d737378a31b 2026-08-31T14:56:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/core-biogenesis-and-faravelli-showcase-biotech-powered-longevity-body-care-7a9ec031ce04c4e6 2026-08-31T14:54:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-26-cytokinetics-sell-off-arrowhead-s-edge-and-a-heart-drug-autopsy-a8643b00af9a2aec 2026-08-31T14:51:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotecanada-announces-2026-gold-leaf-award-winners-recognizing-excellence-across-d0f2e14cc02525d7 2026-08-31T14:51:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/worcester-startup-gets-8m-nasa-grant-to-make-medicine-in-space-19a28bac37cfe691 2026-08-31T14:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innocan-pharma-cn-inno-jumps-9-22-today-as-biotech-catalysts-and-consumer-wellne-a2001be0d9831c69 2026-08-31T14:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-70-of-new-drugs-now-win-fda-approval-with-just-one-study-05c34b1a8afd5add 2026-08-31T14:25:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/co-creation-for-glp-1-rtu-cartridges-7069e9a93b8770c5 2026-08-31T14:23:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-prepares-phase-3-ide849-lung-cancer-trial-c2f57617ec125f6b 2026-08-31T14:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moving-beyond-single-targets-in-neurological-repair-ced76b09afa5b5b7 2026-08-31T14:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/kiora-licenses-south-korean-rights-to-kio-301-for-rp-to-chong-kun-dang-f2beaa6c6490f84b 2026-08-31T14:11:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/traffic-and-travel-advisories-for-visitors-91e386fca94d9f59 2026-08-31T14:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-besremi-for-adults-with-essential-thrombocythemia-c5eefbd7484c4ac3 2026-08-31T14:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/prasco-increases-pharmaceutical-footprint-in-ohio-8cdddc84571d9ded 2026-08-31T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-stock-maintained-at-buy-by-truist-on-mixed-trial-data-ec684ebb8e16f4dd 2026-08-31T13:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-patient-dosed-in-phase-3-summit-trial-of-axs-05-for-smoking-cessation-5eb8545cb2fe51d2 2026-08-31T13:47:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-authorizes-generic-ivermectin-shot-to-help-prevent-screwworm-in-cattle-0c201aa503a5d8ef 2026-08-31T13:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-national-licensure-means-for-wholesalers-and-3pls-853ff04939f3d594 2026-08-31T13:21:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-2026-evolocumab-explores-new-frontiers-in-cv-disease-prevention-a265e71181f4ae86 2026-08-31T13:19:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-inks-2-88b-merida-buyout-for-autoimmune-drugs-against-rogue-antibodies-0767a5d24ef1e486 2026-08-31T13:18:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/wall-street-analysts-bullish-on-attovia-as-itch-drug-data-fuel-biotech-optimism-3f1bc0fdb1a13a15 2026-08-31T13:15:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-packaging-market-report-2026-2036-now-available-forecasts-market-b444bf5db36ef7e6 2026-08-31T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jds-consulting-group-launches-in-the-uae-to-deliver-engineering-pharmaceutical-a-fa5ff95a014bba60 2026-08-31T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-a-pregnancy-hormone-steer-a-cardiovascular-treatment-e962baa00756a8c4 2026-08-31T12:51:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-als-drug-plan-replaces-a-single-large-trial-with-three-focused-studies-a570e3bed3d28e4a 2026-08-31T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurosense-unveils-accelerated-capital-efficient-strategy-to-advance-primec-towa-e4799542cc609ae8 2026-08-31T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cadrenal-therapeutics-cvkd-advances-phase-3-trial-protocol-fa-3aaec9076de0c22f 2026-08-31T12:43:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/bmf-capital-shorts-sellas-life-sciences-sees-76-downside-sellas-life-sciences-gr-19ade47a33eb5f22 2026-08-31T12:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rhelion-life-sciences-reports-first-quarter-2027-results-ba7ffe1531026bf1 2026-08-31T12:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rdhl-stock-volatility-draws-trader-focus-as-biotech-reprices-68056963ed1a75bb 2026-08-31T12:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-opioid-study-from-ensysce-is-fully-enrolled-to-test-overdose-protection-221666bc8847d71d 2026-08-31T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/allogene-therapeutics-announces-participation-in-september-investor-conference-ba99cac2eb75a2b8 2026-08-31T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cadrenal-therapeutics-announces-positive-outcome-from-fda-type-d-meeting-for-pha-3d5e9bbb4c27d9fd 2026-08-31T12:21:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/80-year-old-pharma-veteran-returns-to-hong-kong-stock-exchange-bangshun-pharmace-401cbc4f2a5699fe 2026-08-31T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ceremony-and-reception-commemorating-the-new-institute-for-the-evolutionary-orig-d50247e92da9e01f 2026-08-31T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jamp-temozolomide-out-of-specification-assay-4e0b8577256f8b42 2026-08-31T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-agrees-to-a-placebo-trial-for-a-drug-aimed-at-a-blood-reaction-affecting-50-e8ee488b1935e347 2026-08-31T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seizure-related-phenomena-associated-with-propofol-insights-from-the-fda-adverse-fa5334be2be73980 2026-08-31T11:59:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/canaccord-reiterates-alnylam-stock-buy-rating-after-cardiology-data-f4affa7524e5a7c7 2026-08-31T11:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-buying-merida-biosciences-for-up-to-2-875-billion-6c8e1e93e7a6b0ce 2026-08-31T11:55:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-boosts-lipid-based-drug-manufacturing-in-canada-59dd46e4acab0f3a 2026-08-31T11:54:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-repatha-trial-shows-20-lower-death-risk-0a6a91bc32eb580e 2026-08-31T11:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/verastem-shifts-from-speculative-biotech-to-com-78d755f3aa7d7b2e 2026-08-31T11:53:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/chula-wins-at-ipsf-asia-pacific-pharmaceutical-symposium-chulalongkorn-universit-868ecbdc504b0faf 2026-08-31T11:50:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/karyopharm-submits-supplemental-new-drug-application-to-the-fda-for-xpovio-selin-a062fbc582a1d281 2026-08-31T11:31:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-steps-up-festive-food-safety-checks-puts-focus-on-licensed-opera-25b532a42cef62c3 2026-08-31T11:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/karyopharm-submits-supplemental-new-drug-application-to-the-fda-for-xpovio-selin-8ed044cfee476323 2026-08-31T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/origin-agritech-opens-biotech-research-center-in-guizhou-by-investing-com-ea1efd0b611b4684 2026-08-31T11:27:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/hair-loss-drugs-are-the-next-ozempic-biotech-stocks-are-climbing-24f8e66717eff2b9 2026-08-31T11:24:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/silicone-tubing-for-pharmaceutical-use-market-outlook-to-2035-f47edd36ffd95cd7 2026-08-31T11:21:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-inks-licensing-deal-for-her2-cancer-drug-tqb2102-abf11ea1e9f45009 2026-08-31T11:20:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/axsome-therapeutics-initiates-summit-phase-3-trial-of-axs-05-in-smoking-cessatio-fd092e93786ee3ba 2026-08-31T11:19:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-eli-lilly-nyse-lly-the-pharmaceutical-bellwether-as-approvals-sweep-healthcar-3babc8cd2db01ab6 2026-08-31T11:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unboxing-cancer-news-august-2026-fishy-cancer-federal-vs-industry-funded-trials-4a13fe2a87e88c8a 2026-08-31T11:03:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-platelet-transfusions-in-newborns-a5788225f7b979ec 2026-08-31T11:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-startup-investment-held-steady-even-as-ai-funding-surged-e39ea496f926ef92 2026-08-31T11:00:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/origin-agritech-tests-10-000-corn-samples-as-300-distributors-cover-guizhou-1bcb6efc09440502 2026-08-31T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/origin-agritech-establishes-r-d-center-in-guizhou-with-biotech-unit-and-state-ba-07a707f97563c751 2026-08-31T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alterity-therapeutics-nasdaq-athe-lines-up-pivotal-phase-3-trial-in-rare-msa-1d28c2e1251edbab 2026-08-31T10:58:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/panda-therapeutics-secures-160k-to-advance-multi-target-alzheimer-s-therapy-e93dbce2c8f7070f 2026-08-31T10:49:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-invests-93-million-in-vancouver-gmp-plant-to-triple-lnp-capacity-a8c1fee7571142e6 2026-08-31T10:49:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/25-years-of-expanding-access-to-cancer-care-5b0e277569e5709f 2026-08-31T10:45:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/760-yuan-per-pill-pianzihuang-loses-market-popularity-does-the-pharmaceutical-in-5432cef937811608 2026-08-31T10:31:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/beone-s-cancer-regimen-gets-fda-approval-after-median-survival-exceeded-two-year-eac4c99ef0ee7c43 2026-08-31T10:07:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ziihera-zanidatamab-hrii-plus-chemotherapy-demonstrates-statistically-significan-33c9865bfe713278 2026-08-31T10:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-s-lee-s-pharmaceutical-h1-profit-jumps-on-higher-margin-product-sales-b9697e34f01f5f48 2026-08-31T10:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/veranex-appoints-manasi-ramanna-as-chief-financial-officer-78e05ac2cccfcc18 2026-08-31T10:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/beone-medicines-announces-new-phase-3-survival-data-reinforcing-benefit-of-ziihe-6e9b6100cb9753a3 2026-08-31T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ideaya-biosciences-announces-successful-fda-type-c-meeting-for-ide849-dll3-top1-be37d5cb295e03f7 2026-08-31T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wellington-management-group-llp-raises-stock-position-in-teva-pharmaceutical-ind-8b5ba805b862320d 2026-08-31T09:53:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/conference-de-presse-presentation-de-la-plateforme-presidentielle-du-leem-c35259f6342ad81b 2026-08-31T09:45:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/tempus-ai-bid-to-derail-dna-patent-case-hits-snag-9ec6189671d717c5 2026-08-31T09:45:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/kangwon-national-university-to-train-205-biotech-graduate-students-with-state-fu-37db22d4cda82be7 2026-08-31T09:28:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/argentina-to-ease-pharma-barriers-as-india-trade-tops-6-5-bn-fb195fc7074cd74a 2026-08-31T09:24:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/onroute-acquires-joanca-logistica-y-transporte-to-strengthen-its-position-in-the-973d4e2bf9d1e250 2026-08-31T09:19:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-are-bullish-on-top-healthcare-stocks-sichuan-kelun-biotech-biopharmaceu-398d53b2e040805a 2026-08-31T09:08:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/consun-pharmaceutical-group-ltd-c1p-receives-a-buy-from-guoyuan-securities-hk-d463833553cd7d7d 2026-08-31T09:08:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/zydus-saroglitazar-posts-positive-results-in-phase-2b-fatty-liver-trials-886d31407943598f 2026-08-31T09:04:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/livingston-residents-reminded-of-safe-drug-disposal-boxes-on-international-overd-2d117c320b5aed2b 2026-08-31T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-pharmaceuticals-limited-asx-tlx-swings-to-a-us-38-million-profit-is-the-as-a6b7cc04bb1a1337 2026-08-31T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiol-therapeutics-tsx-crdl-falls-5-92-as-clinical-trial-uncertainty-and-biote-6c12ce89fb3e80a0 2026-08-31T08:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/harid-anad-explains-what-sets-africure-pharmaceuticals-apart-in-cote-d-ivoire-s-2ecd09a962895970 2026-08-31T08:54:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/foreign-selling-and-thinnest-turnover-of-year-hit-biotech-brokerage-stocks-1670446f5238e5e7 2026-08-31T08:54:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-darling-palvella-suddenly-slumps-as-optimism-fades-02deab538edbaea8 2026-08-31T08:53:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-accelerates-multi-billion-dollar-radiopharmaceutical-can-2482e51a6da96eb4 2026-08-31T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eupraxia-pharmaceuticals-inc-tsx-eprx-faces-downside-pressure-as-biotech-volatil-9d8f2bc684e2187d 2026-08-31T08:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/satellos-bioscience-inc-tsx-mscl-falls-7-42-as-biotech-volatility-and-clinical-d-284277981b96ed3e 2026-08-31T08:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/devonian-health-group-tsxv-gsd-faces-renewed-selling-pressure-as-investor-confid-504073d3c1c007c2 2026-08-31T08:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-lab-to-global-scale-building-osd-success-together-2d3c92e147ac9891 2026-08-31T08:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/utoledo-college-of-pharmacy-and-pharmaceutical-sciences-welcomes-largest-pharm-d-a5673f9e1e25cee0 2026-08-31T07:52:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/africure-pharmaceuticals-targets-10-of-cote-d-ivoire-s-pharmaceutical-demand-thr-ade7c4737845f656 2026-08-31T07:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/chong-kun-dang-signs-deal-with-u-s-based-kiora-to-develop-commercialize-retinal-b967eb56eae779e8 2026-08-31T07:35:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-presses-brazil-for-regulatory-stability-to-boost-pharmaceutical-exports-ee8f816b99688a80 2026-08-31T07:32:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-a-failed-primary-endpoint-teaches-more-than-a-win-what-cardiottransform-s-s-468fd1ced628eb8b 2026-08-31T07:30:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-tiny-biotech-wants-to-mine-dogecoin-and-traders-are-loving-it-6c4c47e11e9e4fa3 2026-08-31T07:28:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-cancer-vaccine-trial-halted-after-survival-imbalance-2b83d68b4cc2a28a 2026-08-31T07:16:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-under-the-radar-cancer-stock-lighting-up-the-forums-is-racura-the-next-biote-ec9c685308f235ae 2026-08-31T07:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secret-novo-lundbeck-collaboration-helped-seal-swedish-cns-deal-you-have-to-move-4c2502a17dafac21 2026-08-31T07:05:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/emzor-raises-n26-7bn-bond-to-boost-local-drug-manufacturing-79d202e8df7d7ed3 2026-08-31T06:53:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-beam-therapeutics-uses-openblue-to-keep-biotech-research-moving-78c52cc4d89fe588 2026-08-31T06:47:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/flexible-on-edge-packaging-for-cookies-and-crackers-f199071025ef924c 2026-08-31T06:41:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/flexible-flat-and-on-pile-packaging-for-cookies-and-crackers-e1f3f233ad99f27b 2026-08-31T06:40:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/flexible-vertical-packaging-for-cookies-and-crackers-075bcdd5c98831a1 2026-08-31T06:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-the-eu-biotech-act-must-turn-competitiveness-ambition-into-reality-bd5b037397413047 2026-08-31T06:33:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/neues-lungenzentrum-charite-und-evangelische-lungenklinik-bundeln-kompetenzen-d538123ea9bdee2a 2026-08-31T06:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-senior-research-fellow-at-icar-iari-new-delhi-walk-in-interview-5937f57bec65143e 2026-08-31T06:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/zymeworks-stock-holds-steady-as-investors-look-to-next-data-and-licensing-milest-12fea554a794e5d4 2026-08-31T06:13:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/unga-demokratiambassadorer-vill-fa-fler-att-rosta-5469b618595455e0 2026-08-31T06:10:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/exposition-au-cadmium-pourquoi-il-faut-s-inquieter-e5fb21c53c1ca1a5 2026-08-31T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-seeks-easier-pharma-access-in-brazil-pushes-to-expand-mercosur-trade-pact-bb2f65329d5cfb5c 2026-08-31T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-paradigm-shift-in-medtech-m-a-and-life-sciences-dealmaking-licensing-collabo-5044882b264e0d4d 2026-08-31T05:53:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/volumes-spurt-at-concord-biotech-ltd-counter-fd758e03bd3df842 2026-08-31T05:46:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/aax-biotech-enters-next-phase-of-collaboration-with-daiichi-sankyo-following-ini-cac4192c83917565 2026-08-31T05:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-national-growth-fund-a-government-policy-finance-will-also-invest-funds-to-b-869be68d807c42ea 2026-08-31T05:12:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/andera-partners-olivier-litzka-biotech-investors-must-pick-winners-beyond-the-hy-9cfbc375e23841ac 2026-08-31T05:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/picking-biotech-winners-beyond-the-hype-cycle-with-andera-partners-olivier-litzk-dd9ffdc3becb4b59 2026-08-31T04:53:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-high-court-pulls-up-maharashtra-fda-over-cipla-licence-cancellation-order-320bbb84ba73d43d 2026-08-31T04:52:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/donga-pharmaceutical-s-fation-enters-us-offline-market-37518a6923df7e18 2026-08-31T04:39:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/swiss-biotech-nerai-bioscience-develops-ai-powered-high-throughput-protein-engin-2922bf844881ff60 2026-08-31T04:34:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/consun-pharmaceutical-group-and-2-other-undiscovered-gems-in-asia-fea6083b4dd4f005 2026-08-31T04:17:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-warns-three-importers-about-missing-foreign-supplier-documents-10b90d36a7af2c57 2026-08-31T04:11:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-america-can-reduce-its-dependence-on-chinese-active-pharmaceutical-ingredien-6b43ad58e821200f 2026-08-31T04:07:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-poses-increasing-security-risk-as-us-biotech-innovation-edge-erodes-33e79ce3730466e6 2026-08-31T04:04:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ana-salazar-modela-tu-cuerpo-inc-issues-nationwide-voluntary-recall-of-lipofit-e-080da6cdd1ec58c0 2026-08-31T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/avecho-resumes-pivotal-insomnia-trial-recruitment-after-positive-interim-review-3c623a637696c0b2 2026-08-31T03:49:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/alterity-secures-option-underwriting-as-it-prepares-for-pivotal-msa-trial-a62343240e7f97e1 2026-08-31T03:49:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/tetratherix-sends-first-commercial-polymer-shipment-to-united-states-5ce05f4172eb64c2 2026-08-31T03:49:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/upadacitinib-alopecia-areata-arthritis-drug-restores-100-hair-growth-133c1ec0e08395f6 2026-08-31T03:10:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/japan-pharmaceutical-distribution-service-market-to-reach-76e83dfb2f6bd151 2026-08-31T03:03:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibento-ibento-report-of-pmda-atc-u-s-fda-pediatric-review-seminar-2026-c2b9d7c8d9196113 2026-08-31T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dgist-yuhan-partner-to-accelerate-drug-development-with-ai-71b63536fe61465a 2026-08-31T02:54:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-science-partners-with-megazone-to-accelerate-ai-transformation-in-pharmace-8f7f54d7b1bfcccb 2026-08-31T02:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-well-does-india-s-food-safety-rulebook-protect-what-actually-lands-on-your-p-a01e3e0f32c83a98 2026-08-31T02:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-ceo-lee-dong-hoon-buys-180-million-in-company-shares-day-a-b9a8d362af1ed6c5 2026-08-31T02:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-presents-new-data-at-esc-congress-2026-reinforcing-strength-in-rnai-powe-b17067b106735923 2026-08-31T02:23:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-opens-boston-sci-tech-hub-to-sell-homegrown-biotech-6b8e03988d24c35d 2026-08-31T02:18:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/leios-therapeutics-announces-exclusive-licensing-agreement-and-strategic-investm-722eef748bc01c1a 2026-08-31T02:15:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-pharma-license-cancellation-fda-withdraws-order-after-hc-raps-it-for-going-3b46c3ac4b0ef196 2026-08-31T02:15:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/leios-therapeutics-announces-exclusive-licensing-agreement-ef02a7d4fe6698ae 2026-08-31T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-shows-way-in-new-pharma-race-own-meds-don-t-just-make-em-be6b3484b7c3479e 2026-08-31T01:51:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-expands-eye-care-brand-with-chewable-candy-2bf6d1586dd5f2c2 2026-08-31T01:16:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/lee-dong-hoon-boosts-sk-biopharm-with-share-buy-as-korea-bets-on-opacalim-trials-c1837186855a5ba9 2026-08-31T01:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-selected-as-a-constituent-of-five-gpif-adopted-esg-indexes-3b702bfb232459bd 2026-08-31T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-loss-drug-fda-approval-what-it-means-for-your-health-journey-in-2026-0uzh-d2204fde5cc3e14d 2026-08-31T00:50:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-growth-fund-fuels-korea-adc-ecosystem-with-kyongbo-loan-chosunbiz-55dc8184b6d6a91c 2026-08-31T00:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-e68e1d46c37edc4f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-interest-rate-on-overdue-debts-0f37c64e7e17c7f2 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/submission-for-office-of-management-and-budget-review-head-start-state-collabora-b04347f674d30715 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/authorization-of-emergency-use-for-three-animal-drugs-for-the-prevention-and-tre-5c05669e36b09afc 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-40c655e1f52c598f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-center-for-advancing-translational-sciences-amended-notice-of-meeting-d31c2de3c2b51baf 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-public-hearing-niaid-proposed-reorganization-5423a46c075efc3b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-63a971c47d578fae 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-reg-fb4da7278e778c4b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-med-7e3ab0780d0c8cc4 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rahim-shafa-denial-of-hearing-final-debarment-order-be591d36521d0929 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sohonos-6542bf143167dbc7 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-levonorgestrel-and-ethinyl-estradiol-402f80ead3048ff3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-announces-availability-of-solta-medical-s-fraxel-ftx-in-australia-6ea14650062cb58c 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-in-silico-simulation-of-the-vesalius-cv-trial-using-biomedical-knowl-cd17e8a2be7ab332 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bayesian-borrowing-of-external-information-in-clinical-trials-a-comparison-of-ma-e4c56a10236c407d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-operational-roadmap-for-drug-repurposing-of-registered-pharmaceuticals-a-four-1ac7fe497c66c161 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-landscape-of-clinical-trials-for-antibody-drug-conjugates-in-the-treatment-o-403b8a299598f9d3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extensive-subcutaneous-hematoma-in-a-patient-receiving-lt-i-gt-nigella-sativa-lt-375c9904b877ff1f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-ferric-citrate-tablets-in-chinese-patients-with-hyperphos-0a7b7adb2a426492 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-placebo-effect-in-psoriatic-arthritis-4fdf79a486432578 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-framework-for-quantifying-the-clinical-impact-of-substandard-and-falsifi-10b4f705b316b719 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-kidney-function-on-drug-concentrations-of-first-line-anti-tubercular-t-12d34f95ebe32096 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trials-and-tribulations-of-spironolactone-in-heart-failure-with-preserved-ejecti-7aba2973068b5902 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-read-sequencing-reveals-putatively-mobilizable-resistance-genes-and-multi-d-5c11c66f3206ee41 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-for-medical-imaging-diagnosis-from-accuracy-to-clinical-c7f86ec4b65efcee 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/end-to-end-drug-development-workflow-7a14f1a4979c9740 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cd44-targeted-hyaluronic-acid-nanoparticles-for-triple-negative-breast-cancer-re-c268c263e64c98cd 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidence-and-impact-of-drug-related-problems-on-asthma-control-and-effectivenes-bf7f0c4eaf697059 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/renal-tubular-acidosis-57e319ddde6937ec 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breaking-lab-barriers-artificial-intelligence-for-clinical-translation-of-optica-c34d03c83322f832 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-medicolegal-evidence-patterns-in-granted-and-rejected-medical-malpr-b2e781c6b4cadcc6 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/growth-inhibitory-properties-of-pseudomonas-fluorescens-against-wheat-pathogen-f-3a89e1e2c1ae76cc 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrative-analysis-of-bioinformatics-databases-to-identify-thyroid-cancer-drug-ea282d418bbebd2b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantitative-analysis-of-active-compounds-in-a-three-component-pharmaceutical-fo-abe358573bfde822 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-antimicrobial-and-biofilm-inhibitory-activities-of-flower-leaf-see-2b27fe1d0d0ea46a 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/innovative-approaches-to-combating-antibiotic-resistance-the-role-of-metal-oxide-81575ab828089dc5 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-docking-guided-coformer-selection-and-cocrystallization-for-enhanced-b-ce27c1a749310c5e 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-practices-among-turkish-physiotherapists-a-cross-sectional-study-of-t-0ab70a7e969da0e3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypercellular-mucinous-carcinoma-resembling-invasive-cribriform-carcinoma-and-hy-9d1803bbced4210e 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-clues-for-diagnosis-in-painful-ophthalmoplegia-fd0c1b08a8e329c3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suicidality-current-trends-in-research-and-insights-into-clinical-and-systemic-p-f89d4482ef68e63e 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-treatment-strategies-and-amputation-outcomes-in-electri-604e9b6ae6d6b417 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanisms-clinical-translation-and-future-perspectives-of-liver-mediated-immuno-b82e8ee537328e0f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-nurses-situation-awareness-scale-for-clinical-deterioration-a-m-d97c739883f70232 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-preliminary-clinical-application-of-an-imu-based-lightweight-fun-fef31de6eb22e93f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/madecassic-acid-attenuates-sepsis-associated-acute-lung-injury-by-regulating-the-4e1fee56dcb4d55b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dry-needling-in-myogenous-temporomandibular-disorders-current-evidence-and-clini-8d3fb25e47a4918d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-reference-values-for-dynamic-plantar-pressure-assessment-in-healthy-you-4a9e539ea2642a7f 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adc-based-radiomics-for-risk-stratification-in-prostate-cancer-a-clinical-decisi-6b2fba5b9b326f95 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-of-an-antitumor-drug-based-on-the-recombinant-vaccinia-virus-strain-vv-gm-fecc488d8b285135 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-of-bettina-hufschmidt-et-al-2026-adaptive-and-maladaptive-networks-us-96d463b1f9fa4730 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-cognitive-scarring-over-20-years-in-recurrent-depression-bidirectionality-of-27279592a741afc9 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sleep-quality-relationship-functioning-and-health-related-quality-of-life-in-par-4ab82fb14f38866b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trusting-the-psychotherapist-trusting-the-governmental-system-and-perhaps-trusti-e035d3e8fa96c858 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-parenteral-nutrition-based-on-the-non-protein-calorie-to-ni-03f118532c3ac3cc 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-evaluation-of-a-web-based-integrated-clinical-evidence-search-sy-21b989469f742267 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/c276a5c43decd603 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethnogastronomy-of-traditional-food-in-gunungkidul-s-traditional-markets-and-pro-f626789a34b777d0 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/environmental-pollutants-and-thyroid-disorders-a-review-fa64cbe23ede987c 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spectrophotometric-indirect-determination-of-spiramycin-through-redox-reaction-w-2bc2555929784990 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-inspiratory-phonation-during-laryngeal-stroboscopy-for-diffe-76c4ff41dc2f8e32 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-drug-development-applications-and-challenges-627d99dcab701c29 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-feasibility-of-claudin18-2-cldn18-2-specific-car-nk-cells-in-advanced-a1a261b878757b00 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-the-efficacy-of-intranasal-insulin-in-the-treatment-of-post-7b2ff7a89d2ed4cc 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/airway-anatomy-and-surgical-management-in-obstructive-sleep-apnea-1c7fc87166b76df6 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/st6gal1-promotes-cancer-stem-like-cell-associated-paclitaxel-resistance-through-4c38d58ec7cb0f0d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pseudoaneurysm-of-the-pancreaticoduodenal-artery-complicated-by-obstructive-jaun-7f2df57ff5112f99 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantifying-m-proteins-an-analytical-challenge-beyond-interference-5e9d16a7d892b2f5 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nipple-adenoma-mimicking-paget-s-disease-a-case-report-9d3d96b27432133c 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-review-of-osteosarcoma-derived-exosomes-in-tumor-progression-chemoresistance-a-708a84287ff699b7 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-genetic-profiles-of-postnatal-patients-with-skeletal-dysplasia-in-g-c666347651300fec 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-self-nanoemulsifying-drug-delivery-system-for-the-treatment-of-theileria-annul-7dbd512e3f1801e3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medical-assistance-in-dying-in-canada-a-multidisciplinary-pan-canadian-delphi-st-a118f7526879c097 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exercise-and-cardiorespiratory-fitness-improvement-through-supervised-training-i-eb66d3214d85c1f7 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-ultrasound-by-general-practitioners-a-systematic-review-b8637fb9129f7d41 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-a-supplement-containing-bergamot-and-plant-sterols-with-or-without-6205f5dc083ee960 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-ethnography-sees-that-diagnosis-misses-a-clinical-commentary-on-borderline-48ab52b4f73ce50e 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-financial-outcomes-with-minimally-invasive-excision-with-epidermal-3ac58cb69f4c1aef 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subcutaneous-allergen-immunotherapy-with-thermosensitive-hydrogel-and-recombinan-b1d67d65a693b790 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/journal-writing-for-enhancing-career-adaptability-in-vocational-students-a-clini-a6749e719ea71473 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidisciplinary-intervention-in-frail-elderly-patients-with-cardiovascular-dis-004f31bddc4e95fd 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neoadjuvant-anti-her2-antibody-drug-conjugate-shr-a1811-in-hormone-receptor-posi-6e50f81f43e4190d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bibliography-29b7323897ab024a 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/conclusion-5b0892e471a9ee7a 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moral-authority-societal-cleavages-and-barriers-to-intervention-in-brazil-and-th-c9461d07feceb5e3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-boundaries-of-protection-6f610e303353c4ed 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interventions-and-their-audiences-c461da0885566715 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organizational-capacity-trusted-networks-and-local-access-58025bbf37f104cb 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commitment-capacity-and-parish-response-d3a278addc3b86ac 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introduction-867b95ed16d75722 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroprotective-potential-of-diacerein-against-cerebral-ischemia-reperfusion-inj-ee5f9958138329d1 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spine-hip-bone-mineral-density-discordance-and-fracture-risk-misclassification-c-2192bb4235f773e2 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novel-blood-biomarkers-distinguish-active-pulmonary-tuberculosis-from-non-pulmon-62ee6cfe73b97bee 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implementation-and-preliminary-clinical-application-of-a-robotic-thoracic-telesu-b936ff7ea78b83e4 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-audit-apply-a-framework-for-clinical-reasoning-with-artificial-intelligence-1e5049caddfef8be 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-of-acceptance-and-commitment-therapy-for-parents-in-the-nicu-99d662517f08979d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-dominant-negative-card11-variant-causes-atopy-and-immunodeficiency-syndr-e223ab994fdeb43d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-market-individual-report-phenotypes-after-pulsed-field-ablation-for-atrial-9ca26caa4ec78e52 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-and-delayed-acute-kidney-injury-after-contrast-enhanced-ct-in-critically-i-e78808fa010c0ed8 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whole-exome-sequencing-in-pediatric-drug-resistant-epilepsy-diagnostic-yield-and-5d4d03f62247c1d2 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-regarding-development-and-internal-validation-of-a-clinical-a3225fcb4da99eb3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reconstructive-options-for-myelomeningocele-defects-clinical-experience-and-anal-d4e9f5d82982eeeb 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blackwell-an-explainable-anamnesis-based-multi-agent-framework-for-remote-clinic-c9153f18a97cf7d2 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/black-race-predicts-poor-compliance-and-higher-prostate-cancer-risk-in-a-multina-6ffba421ad9ab40b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-oncologic-outcomes-of-neoadjuvant-tumor-directed-immunotherapy-prostva-3b0cf114c2278b6b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shortening-protein-total-residence-time-to-improve-high-cycle-purification-effic-c4a5cee43e88c2c5 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-minds-ae3803194dce2f3b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07795892-circulating-rna-markers-of-ventricular-arrhythmias-in-remotely-monit-5e7edabddbe63c81 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07795411-prospective-multiomic-analysis-in-small-cell-lung-cancer-860417e1e1af8f68 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794774-a-study-to-learn-about-safety-and-effects-of-once-monthly-treatment-b7d053926d610f2e 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794735-a-study-of-tak-664-in-people-with-primary-immunodeficiency-diseases-3c40deb2c5154f5b 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07794657-brief-training-program-for-general-practitioners-on-malnutrition-and-0b7fb814110468e0 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07791251-efficacy-and-safety-of-inhaled-peramivir-solution-for-the-treatment-8554a2adcc5dffc7 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07789600-trial-evaluating-the-analgesic-efficacy-of-magnesium-sulfate-as-an-a-93e13de6d682ad75 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07789236-mandala-coloring-and-music-for-cancer-fear-and-screening-anxiety-673aaff8cf7126ac 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07776691-a-study-of-raludotatug-deruxtecan-with-or-without-bevacizumab-as-fir-3300451ece549780 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07485569-drug-repurposing-in-thyroid-carcinoma-a-feasibility-trial-20d7f03f31bf4923 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07466498-estrogen-to-improve-quality-of-life-for-men-with-newly-diagnosed-or-bca97165eff52661 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07365241-a-study-to-evaluate-adverse-events-and-change-in-disease-activity-of-f4d9bb3a395518de 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07269847-comparing-a-healthy-beef-centric-diet-to-a-healthy-u-s-style-diet-on-9dd69d397b943b26 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07172698-effects-of-a-multicomponent-protocol-with-emphasis-on-muscle-power-t-6f106c4b5339c853 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07061964-combining-immunotherapy-and-radiation-therapy-to-help-patients-avoid-ad1818cfbf369e2c 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07054190-a-study-to-test-inavolisib-treatments-in-participants-with-early-sta-182f02ccf616bfab 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07053514-same-day-antiretroviral-therapy-as-a-behavioral-design-intervention-fc4853a1853d3c10 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06800313-study-of-hld-0915-jnj-101556143-in-patients-with-metastatic-prostate-40d4211f52bc0400 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06747117-a-study-of-patients-with-lower-extremity-acute-limb-ischemia-to-remo-d3282bf77400b652 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06701903-study-of-iti-1284-as-monotherapy-treatment-in-patients-with-generali-fe93a9a8e3b95508 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06664619-a-randomized-double-blind-placebo-controlled-trial-on-efficacy-and-s-670d3c6b7587517c 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06664034-intervening-on-women-s-health-for-rural-young-cancer-survivors-0a00b6fd4aa1ca17 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06470828-a-study-of-tak-861-for-the-treatment-of-narcolepsy-type-1-edecb2e625991efb 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06398418-r-5780-01-in-combination-with-pd-1-checkpoint-inhibitors-checkpoint-2795ea39178a5fec 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06362928-safety-and-effectiveness-of-the-akura-thrombectomy-system-in-the-tre-a63ed935092040ea 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06313398-determination-of-red-cell-survival-in-sickle-cell-disease-and-other-015646dc33e24adf 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06181344-implementation-and-evaluation-of-a-fear-of-cancer-recurrence-screeni-7b354065e43a6b6d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06075810-a-study-of-oral-mbq-167-in-participants-with-advanced-breast-cancer-72e7586b7559c7da 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06023199-assessing-physical-function-in-sickle-cell-patients-taking-voxelotor-20d09769855fe579 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06019000-study-of-cyr-064-versus-placebo-in-patients-d1fb70ab69bc817a 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05896839-immunotherapy-in-combination-with-prednisone-and-sirolimus-for-kidne-8cf2bc4d3bcb60be 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05391321-identification-of-the-most-suitable-questionnaire-to-assess-the-sexu-62bacb230394a2a0 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05226494-safety-and-tolerability-of-fb-pmt-in-recurrent-glioblastoma-65da94b8ebcb1b5a 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04633252-a-phase-i-ii-study-of-pds01adc-with-docetaxel-and-abiraterone-in-adu-eb7722f7e9f62c16 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04538664-a-study-of-combination-amivantamab-and-carboplatin-pemetrexed-therap-6ddd5c73dd25fd10 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04201873-pembrolizumab-and-a-vaccine-atl-dc-for-the-treatment-of-surgically-a-41ec57bab1a9cbf1 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04172532-testing-the-addition-of-a-new-anti-cancer-drug-m3814-peposertib-to-t-3bd2b31f16ad7655 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04086485-lu-177-dotatate-lutathera-in-combination-with-olaparib-in-inoperable-37b1005ad47673ed 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03480633-biomechanical-precision-medicine-registry-for-patients-with-and-with-ac7c1adace68708d 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02769949-pediatric-patients-with-metabolic-or-other-genetic-disorders-6bdef6f88c334fe7 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02257736-an-efficacy-and-safety-study-of-apalutamide-jnj-56021927-in-combinat-58e41bc11d299aed 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01834001-imaging-studies-to-check-the-local-response-of-prostate-cancer-to-ra-dda98e476fdb8311 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01678222-the-cox-2-gene-and-the-immune-system-48082553255ab847 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01143454-characterization-of-patients-with-uncommon-presentations-and-or-unco-03fef2deaf7fef03 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01087294-administration-of-anti-cd19-chimeric-antigen-receptor-transduced-t-c-acca4493febcab98 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00923065-data-collection-clinical-care-and-interventions-in-ccr-nci-1ee2f0b3238458f3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00895271-establishing-fibroblast-derived-cell-lines-from-skin-biopsies-of-pat-e8722c34f1e3ca58 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00837122-genetics-of-type-2-diabetes-in-west-africans-936ebb282843b8a9 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00339495-prostate-lung-colorectal-and-ovarian-plco-cancer-screening-trial-a488121db749d0a0 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00026650-evaluation-of-late-effects-and-natural-history-of-disease-in-patient-9b432764a776c4e3 2026-08-31T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-jungwoo-pharmaceutical-launches-first-expansion-product-ice-crunch-under-fren-4f2e424b67c98e87 2026-08-30T23:59:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-bmrn-stock-looks-to-trade-at-a-discount-to-fair-value-562ec6e4bdc6f9d4 2026-08-30T23:39:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/jose-javier-fuster-recibe-el-esc-outstanding-achievement-award-2026-b6dbca479920e165 2026-08-30T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-kill-a-mosquito-with-a-sword-court-warns-of-stinging-orders-contempt-actio-6b6ef562a5ce6dda 2026-08-30T21:30:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-new-use-of-popular-diabetes-drug-48ad6f0dfafbb081 2026-08-30T21:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pain-in-nyc-s-biotech-market-is-hitting-harlem-hardest-e7de3a125366dbf1 2026-08-30T21:04:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/bukwang-boosts-h1-revenue-past-100b-won-as-latuda-targets-korea-depression-marke-f5b476475fbce087 2026-08-30T21:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-brenipatide-steps-into-phase-3-a-new-long-term-play-in-depression-care-d0add310b93ece0b 2026-08-30T20:10:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-tenx-reports-promising-phase-3-trial-data-a-da6d06bcc8e0aeaf 2026-08-30T20:07:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-2c8e9d230c5b388f 2026-08-30T19:47:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-seizes-fdc-enerzal-stock-over-misbranding-allegations-ca1ef6ab2eceebaa 2026-08-30T19:40:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-protagonist-and-takeda-s-drug-for-rare-blood-cancer-51dd368384dc6c76 2026-08-30T19:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-it-too-late-to-buy-moderna-stock-after-its-127-surge-6fb4dc24eaa19858 2026-08-30T17:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncy-stock-crashed-45-today-why-did-fda-reject-its-kidney-disease-nda-for-a-seco-b446b6e1b7727f09 2026-08-30T17:05:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-keep-an-eye-on-august-30th-b1c32545e2d4fee6 2026-08-30T17:04:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-hc-pulls-up-maharashtra-fda-over-enforcement-actions-what-businesses-need-5032f3b9af67542a 2026-08-30T16:21:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/pdt-partners-takes-3-35m-stake-in-west-pharmaceutical-as-earnings-beat-estimates-3faebd1b8f20758a 2026-08-30T16:07:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-s-drug-license-cancelled-over-reactin-plus-then-restored-why-did-bombay-hc-3ef017f99542c609 2026-08-30T15:35:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/arrowhead-pharmaceuticals-presents-phase-3-shasta-3-and-shasta-4-data-demonstrat-419a492b2337ad38 2026-08-30T15:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-bio-broadens-u-s-prospects-licensing-late-stage-epilepsy-drug-from-biohaven-f1369df381e3aa21 2026-08-30T14:52:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/don-t-kill-a-mosquito-with-a-sword-court-warns-of-stinging-orders-contempt-actio-2f59ef9160d316f2 2026-08-30T14:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evotec-stock-holds-at-1-91-as-analysts-stick-to-a-hold-view-4d57bdecc688be64 2026-08-30T14:24:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-must-move-from-pharmacy-to-laboratory-of-the-world-anupriya-patel-e63c5a3be813e73c 2026-08-30T14:21:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-australia-needs-better-pbs-transparency-frameworks-6ed7917dd366d690 2026-08-30T14:07:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-pharmaceutical-drying-equipment-market-size-share-trends-growth-analysis-f8ff2a98c00b3ce8 2026-08-30T13:28:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-hc-pulls-up-maharashtra-fda-over-cipla-licence-cancellation-says-you-are-30afede5167c9dc6 2026-08-30T13:18:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-hc-pulls-up-maharashtra-fda-over-enforcement-actions-what-businesses-need-d44143cad3d06ec9 2026-08-30T13:05:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/cna938-rewind-impact-of-planned-trump-tariffs-on-pharmaceutical-imports-d2b2ac2c90ac036b 2026-08-30T12:38:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-presents-new-data-at-esc-congress-2026-reinforcing-strength-in-rnai-powe-69c60b95e803eb32 2026-08-30T12:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aci-s-6th-annual-passport-to-proficiency-on-the-essentials-of-hatch-waxman-and-b-9893dc51ccdeb950 2026-08-30T12:20:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/induction-prog-held-at-mgm-s-dept-of-pharmaceutical-sciences-4f72e3499fabdf85 2026-08-30T12:18:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-teva-pharmaceutical-industries-teva-gaining-from-this-bankruptcy-drug-de-efee6537399ecef7 2026-08-30T12:15:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-feel-you-are-a-lord-bombay-hc-pulls-up-tukaram-mundhe-led-fda-122344b16f9f2977 2026-08-30T12:06:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/september-rebalancing-predictions-for-yuanta-taiwan-top-50-etf-pharmaessentia-po-22c3d7836fc905b1 2026-08-30T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-falls-as-new-data-cloud-heart-drug-class-288e4c70bd9e1ae3 2026-08-30T11:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-feel-you-are-a-lord-bombay-hc-pulls-up-tukaram-mundhe-led-fda-in-cipla-mc-d57cb81522060f7d 2026-08-30T11:15:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/gv1001-for-progressive-supranuclear-palsy-fda-fast-track-and-korean-therapeutic-09c14aafb17f47b7 2026-08-30T10:50:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-crackdown-what-bombay-hc-scrutiny-means-for-businesses-7c8b479dd13ea1f1 2026-08-30T10:27:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-pharmaceutical-stocks-extend-rally-as-pricing-deals-and-trial-data-lift-sect-feb618dfd39cd5cc 2026-08-30T10:25:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/argentina-to-reduce-entry-barriers-for-indian-pharmaceutical-firms-bilateral-tra-16043d407f68a77a 2026-08-30T10:05:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/argentina-to-reduce-entry-barriers-for-indian-pharmaceutical-firms-bilateral-tra-d7276cf90240ef58 2026-08-30T09:58:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-commissioner-tukaram-mundhe-defends-crackdown-cites-strict-safet-b5be2f4271f9f55a 2026-08-30T09:47:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/man-group-plc-makes-new-6-51-million-investment-in-ultragenyx-pharmaceutical-inc-f998b09a5c74ea3f 2026-08-30T09:14:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/legal-general-group-plc-makes-new-19-58-million-investment-in-ultragenyx-pharmac-2fdf8fbfaabbb62c 2026-08-30T09:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/high-blood-pressure-and-diabetes-how-artificial-intelligence-detects-them-using-2352aacf47d468b2 2026-08-30T08:59:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/japanese-cash-flow-stocks-trading-below-fair-value-5c59a0d288f10111 2026-08-30T08:42:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ministry-of-pharmaceutical-industry-announces-emergency-aid-measures-3c6c07b230058275 2026-08-30T08:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-matcha-masks-to-viral-gloss-5-beauty-trends-that-might-take-over-2027-e75b014d135400ab 2026-08-30T07:42:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-uthr-will-present-phase-3-data-at-european-congresses-70167ff411d064d1 2026-08-30T07:37:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-you-a-lord-bombay-hc-pulls-up-tukaram-mundhe-over-fda-action-against-mca-eat-db6385eff2772fe1 2026-08-30T07:35:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ipo-databook-dizal-pharmaceutical-hk-aug-2026-cf676fedd7ad5f72 2026-08-30T07:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/lecanemab-s-at-home-start-dose-just-rewrote-the-rules-for-alzheimer-s-trial-desi-9724cc3cc82ece2e 2026-08-30T07:27:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-teva-could-be-11-undervalued-as-fda-accepts-ecopi-451d7c5455c4d4ec 2026-08-30T07:06:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiometabolic-biotech-secures-6-million-seed-round-02f02aa599036f0c 2026-08-30T07:05:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-177-then-20-cancer-vaccine-breakthrough-explained-personal-injury-f2d2e20a339240bd 2026-08-30T06:20:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-hc-slams-maharashtra-fda-over-restaurant-suspensions-warns-of-contempt-ac-ee11086679e9e330 2026-08-30T06:18:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-seeks-phase-3-trial-for-diabetes-drug-after-obesity-bid-cf32a92d1b4f949f 2026-08-30T06:15:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/entera-bio-ceo-miranda-toledano-to-speak-at-canaccord-genuity-conference-1aa9cda10eedf1ad 2026-08-30T06:01:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/wedbush-raises-replimune-price-target-to-9-maintains-neutral-99dadd59a349915e 2026-08-30T06:00:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/busy-fda-week-framework-to-guide-cmt-clinical-trials-mentorship-and-the-future-o-99be84ce021c6938 2026-08-30T05:47:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-group-company-limited-3692-receives-a-buy-from-cmb-interna-a0cae9c21e3945d2 2026-08-30T05:46:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-feel-you-are-a-lord-bombay-hc-pulls-up-tukaram-mundhe-led-fda-242e4a62924a3167 2026-08-30T05:17:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/dizal-pharmaceutical-dizal-hk-synthetic-expert-call-transcript-30-aug-2026-8155594cc15c0c6d 2026-08-30T05:15:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-therapeutics-crsp-stock-may-look-rich-following-fresh-ctx310-data-5635dcba09811fc9 2026-08-30T04:17:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-feel-you-are-a-lord-bombay-high-court-raps-tukaram-mundhe-s-food-safety-b-97a5a60cc7abea4b 2026-08-30T04:08:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/crossing-your-limits-bombay-hc-pulls-up-fda-cipla-licence-cancellation-order-wit-ac90116a2f0d5561 2026-08-30T04:01:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-you-feel-you-are-a-lord-high-court-pulls-up-tukaram-mundhe-s-food-safety-body-b9af25cc68e97533 2026-08-30T03:48:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-has-more-women-leaders-old-double-standards-persist-executive-says-c90e9f16cf56d28c 2026-08-30T03:43:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/building-africa-s-pharmaceutical-future-starts-with-regulation-40b31c6fdf3b975f 2026-08-30T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-strikes-5-trillion-in-tech-export-deals-in-three-months-wit-b6903159eff7ee85 2026-08-30T02:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-teva-stock-looks-below-fair-value-while-earnings-sit-above-fair-value-c412992a1c46e59b 2026-08-30T02:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/standards-to-become-a-senior-doctor-and-pharmacist-in-the-army-87f48b18db5bdbf7 2026-08-30T01:59:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-bombay-high-court-pulls-up-maharashtra-fda-over-cipla-licence-cancellation-31bb03c27df2820d 2026-08-30T01:48:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/you-re-going-overboard-bombay-high-court-to-fda-restores-cipla-s-licence-e83ad3bbcbd7b0fd 2026-08-30T01:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-coercive-world-of-retail-pharmacy-39401de6ab33489a 2026-08-30T01:26:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-lands-3-5-billion-in-licensing-deals-in-three-months-2de6fd182aa7a759 2026-08-30T01:20:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/duopharma-biotech-berhad-klse-dpharma-looks-interesting-and-it-s-about-to-pay-a-b4b7fa908b3a5c85 2026-08-30T00:57:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-teva-teva-buying-a-neuroscience-asset-through-bankruptcy-court-e40598a60309a29b 2026-08-30T00:44:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/bombay-high-court-pulls-up-fda-over-revocation-of-pune-drug-firm-s-licence-29fc291448f58b6e 2026-08-30T00:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/m4-drug-discovery-human-drug-predictions-from-integrated-preclinical-insights-ex-6f1b23144aed0a26 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-implementation-of-pharmacogenetics-based-machine-learning-clinical-deci-05c5169b90d4f328 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-diffuse-large-b-cell-lymphoma-of-the-urinary-bladder-a-case-report-and-n-3fb0db4b2edb73e6 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertebral-mass-mimicking-thoracic-outlet-syndrome-a-case-report-with-literature-c0d0ec675a3b7a5e 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-explains-the-survival-gap-decomposing-cross-national-inequality-in-breast-c-844e0f20c156b774 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-associated-with-platelet-recovery-in-dengue-patients-on-fever-day-7-77f95817af5dc5ee 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-preoperative-lactobacillus-acidophilus-supplementation-on-postoperativ-7f6bb133c8b48398 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-subcutaneous-bupivacaine-ketamine-wound-infiltration-in-reducin-703c13175b4f77ea 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/occurrence-and-severity-of-chemotherapy-induced-peripheral-neuropathy-and-its-as-6d4172afe1c2dba4 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/traditional-knowledge-and-molecular-evidence-of-medicinal-plants-for-multi-targe-e5cb594d22ba42b1 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-helicobacter-pylori-stool-antigen-test-results-according-to-demogr-4182beb5c0d16d05 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comorbidity-patterns-associated-with-renal-dysfunction-across-copd-severity-stag-ac9c525b7c64a9f8 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/navigating-the-gap-a-review-of-time-to-treatment-intervals-and-cervical-cancer-s-63a61ce88da2b1c5 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cognition-enhancing-effect-of-artemisia-pallens-leaf-extract-against-scopolamine-9f4da29086f083ce 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-and-evaluation-of-biodegradable-microsphere-hydrogel-for-ocular-deli-15e2e0e74eefacee 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-comparative-study-of-propofol-based-total-intravenous-anaesthesia-and-isoflura-c395bb68b5477e5b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veterinary-faculty-students-career-perceptions-regarding-the-human-pharmaceutica-3ef23bac977fac92 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-complementary-nutritional-and-herbal-interventions-on-peripheral-inf-0350be5f3f70f01b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/burning-mouth-syndrome-pathophysiology-clinical-characteristics-and-management-7516ccbc13d31063 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/acupuncture-management-of-post-term-pregnancy-with-spleen-qi-deficiency-to-promo-1c76c3840b69e77b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/management-of-arthritis-associated-with-inflammatory-bowel-disease-ibd-a-systema-e50ec7cddff9dd6d 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-completeness-of-electronic-medical-records-in-supporting-repor-f1ad3691cb0e3a09 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/congenital-anterior-staphyloma-in-a-paediatric-patient-clinical-presentation-and-62b15fb5d04a9eb5 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recent-advances-in-mouth-dissolving-films-formulation-strategies-evaluation-and-678b70942766fa96 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-by-design-development-of-the-quality-target-product-profile-qtpp-critica-d4017a515424ff12 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/detection-of-danger-signs-of-acute-respiratory-infections-among-under-fives-amp-98035c56d564999b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/20-5e0b3603b3bc6463 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/15be84bfc2a17647 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-affecting-the-stability-of-probiotics-in-pharmaceutical-products-a-compr-0233d4a76d09ccc1 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frailty-in-older-patients-in-the-emergency-department-assessment-prognostication-50de219e01f2ec82 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-checking-results-participant-characteristics-and-service-retention-from-a-l-728a9a13f053b57e 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-light-triggered-hydrogel-depot-of-homotypic-muller-membrane-vesicles-enables-c-775cd544615dd2ae 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seasonal-variations-and-clinical-influencing-factors-in-the-volume-of-emergency-2be87618ff9df0eb 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lipid-based-nanomedicine-for-hepatocellular-carcinoma-flavonoid-enhanced-pathway-f1c4af0a5792c00d 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-anselamimab-on-cardiac-structure-and-function-in-patients-with-light-c-8769eb257145d3cf 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-relaxin-receptor-agonist-azd5462-in-participants-with-chronic-heart-failure-4537e45771e2180b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relation-of-lipoprotein-a-levels-with-risk-of-serious-bleeding-in-the-odyssey-ou-9ba0dc80e80e990f 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-of-withdrawal-of-pharmacological-treatment-after-recovery-from-her2-thera-6293343bfef5ce7d 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/increasing-plasma-potassium-and-risk-of-atrial-fibrillation-the-potcast-trial-c4342ffb67a2f2fd 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-19-vaccination-and-risk-of-post-covid-19-cardiovascular-disease-a-populati-602357ec6f9d338d 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-valve-leaflet-thickening-be-considered-a-characteristic-lesion-of-infecti-0b17c1c8ef73e1ea 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-synthesis-of-the-antifungal-clinical-candidate-asp2397-cyclohexapeptide-fa-ab4940dd11512296 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lpb-plantarum-inhalation-powders-for-the-reduction-of-lung-inflammation-and-s-au-fa4e015e4c77b438 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-the-quarter-of-an-hour-rule-single-instruction-derived-from-stimulus-615e5cbd012e4330 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-steps-quick-wins-optimizing-clinical-diagnostic-stewardship-in-the-era-of-20e41a09c709b8cf 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heritability-pregnancy-determination-and-clinical-follow-up-in-fetal-copy-number-233b114d4ce96199 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-value-of-the-endoscopic-scratch-sign-in-diagnosing-helicobacter-pylori-d6c5afc999f5bc53 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antidiabetic-and-cytotoxic-effects-of-solid-lipid-nanoparticles-loaded-with-olea-f472b6345c30006f 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-stage-many-stories-unravelling-the-clinical-heterogeneity-of-stage-iiic1-cer-0742bd0c86a41077 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prognostic-performance-of-the-ehmrg-score-and-the-ehmrg-bi-model-in-geriatric-ac-829f1d23a1c005c2 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-antiviral-drug-design-gap-a-combined-machine-learning-and-qsar-appr-9dcae9ccff7ee28e 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rifampicin-exposures-and-clinical-outcomes-an-exploratory-analysis-for-the-deter-734fbefe22723996 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sanguinarine-chloride-exerts-its-antitumor-effects-on-enzalutamide-resistant-pro-c3b0a5d43b598039 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imrt-planning-quality-under-a-single-full-time-radiation-oncologist-supported-by-bb3bc8fef6911b05 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-of-uveitis-in-leprosy-in-a-cohort-of-patients-in-egypt-5717a04fcc1becf9 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cx3cl1-cx3cr1-signaling-in-spinal-metastasis-mechanisms-and-translational-opport-56d7c59be5b97888 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-validation-and-clinical-utility-of-an-artificial-intelligence-based-16eb718e69194de4 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-genome-alternative-splicing-as-a-key-driver-of-cellular-plasticity-an-3f3629516932102c 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-basic-body-awareness-therapy-with-scoliosis-specific-exercise-for-tr-aa43edbf75896304 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quality-improvement-in-the-management-of-degenerative-spinal-disorders-a-systema-7124914e6b5f43f4 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cognitive-disengagement-and-emotional-behavioral-profiles-in-children-with-voidi-c0db89913aaadb55 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/untargeted-plasma-metabolomics-identifies-metabolite-signatures-associated-with-53230701fa1fba7b 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/locking-plate-fixation-for-proximal-humerus-fractures-are-four-proximal-screws-a-8af963b2a5ccdc80 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unveiling-i-s-i-adenosylmethionine-decarboxylase-natural-antagonist-to-block-pol-04bef841f1ace606 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dengue-virus-molecular-targets-and-antiviral-drug-development-advances-challenge-cc6359493524a4aa 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-adult-blood-donors-what-are-the-benefits-and-harms-of-oral-iron-supplementati-191cfaf1a430b362 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-pregnant-women-with-hypertensive-disorders-between-34-weeks-gestation-and-ter-2b156afb943e1d5a 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydro-and-lipophilicity-of-molecular-size-controlled-hydrogel-drug-carriers-b65b717e30f88319 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/specialist-referral-for-cardiovascular-risk-in-patients-with-prostate-cancer-01bdc6df748588a9 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sup-124-sup-i-evuzamitide-positron-emission-tomography-computed-tomography-for-d-b75ba2b6e303816c 2026-08-30T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expansion-of-immunotherapy-pbs-listing-to-treat-multiple-new-cancers-d0bbd0ead4d27a15 2026-08-29T23:39:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/gameto-builds-momentum-with-expanded-phase-3-fertilo-trial-and-ipsc-fertility-fo-4b19d4906a45e0a3 2026-08-29T23:04:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/k-bio-emerges-as-global-rule-setter-shedding-passive-role-in-technology-exports-cea16b479537271d 2026-08-29T22:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-drug-sale-licence-of-cipla-s-pune-c-f-unit-over-complian-9100fb09a612a069 2026-08-29T21:43:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-supply-chain-disruption-ai-in-pharmaceutical-industry-in-depth-analysis-2-9f241889fa8404a3 2026-08-29T21:13:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-withdraws-cipla-drug-licence-cancellation-to-issue-fresh-notice-75fd11a2cecf4086 2026-08-29T20:55:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/dawnrays-pharmaceutical-sehk-2348-stock-looks-cheap-as-margins-improve-e93f50f71e5faee8 2026-08-29T20:55:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pyc-therapeutics-asx-pyc-shares-chase-revenue-growth-despite-deep-losses-695de0baff0ad66a 2026-08-29T20:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/karuna-therapeutics-stock-steady-with-abbvie-deal-and-schizophrenia-drug-progres-1ea2d72b1c723476 2026-08-29T20:03:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/selecta-biosciences-stock-update-with-limited-data-context-67b474e10974c233 2026-08-29T19:01:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-backs-down-after-high-court-rebuke-over-licence-cancellations-f851e48619829435 2026-08-29T18:47:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-to-invest-c-150-million-in-new-vancouver-drug-manufacturing-facility-5130f2af487d3131 2026-08-29T18:23:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pune-unit-s-drug-licence-over-reactin-plus-lapses-42835a6089ef603f 2026-08-29T18:15:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-eplontersen-trial-results-disappoint-0789faf84b1ae41e 2026-08-29T18:04:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cidg-busts-alleged-unregistered-cooking-oil-in-camarines-sur-6bdb34379a8e4cb4 2026-08-29T17:17:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-leaders-association-adds-lisa-reilly-as-boston-coaching-partner-bringing-2-d3cd3e59853075df 2026-08-29T17:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/missed-ai-memory-bull-run-biotech-may-be-the-next-breakout-trade-but-retail-sent-671bce17695a553a 2026-08-29T17:15:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-biotech-stocks-to-research-august-29th-3959994f25a5d09a 2026-08-29T16:07:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-medicine-factories-stop-patients-pay-the-price-fc6b564dd4b3a5e4 2026-08-29T15:54:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-food-you-eat-has-to-be-safe-if-there-are-violations-we-will-come-down-heavil-6ab98acdfa30b9d3 2026-08-29T15:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-chief-tukaram-mundhe-shares-essential-food-safety-tips-for-diner-9de1d6eb7b60ff0b 2026-08-29T15:31:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-bombay-hc-rap-fda-withdraws-orders-against-cipla-mca-eateries-bd9ae67189661d88 2026-08-29T15:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chugai-pharmaceutical-co-ltd-unsponsored-adr-otcmkts-chgcy-short-interest-update-387643d03fe81b80 2026-08-29T15:04:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/bristol-myers-squibb-presents-data-up-to-five-years-reinforcing-the-long-term-ef-e33893dd15b6919e 2026-08-29T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-announces-presentation-of-phase-3-level-results-in-late-break-e2ee7d559854f962 2026-08-29T14:56:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokinetics-announces-additional-results-from-acacia-hcm-and-maple-hcm-presente-dc2f9a5cf91d4a96 2026-08-29T14:51:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firms-eye-hair-loss-market-as-potential-cash-pay-frontier-985268d946b64b1f 2026-08-29T14:47:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/evonik-to-invest-c-150-million-in-new-vancouver-drug-manufacturing-facility-79a23dcf7e28d13d 2026-08-29T14:41:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokinetics-announces-additional-results-from-acacia-hcm-and-maple-hcm-presente-11a25031c584dd67 2026-08-29T14:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/market-intelligence-focus-shifts-to-licensed-content-in-pharma-and-biotech-53f1a5ed53ac3da9 2026-08-29T14:23:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/nppa-fixes-retail-price-of-windlas-biotech-biological-e-paracetamol-combination-0ec5bdd4e14de061 2026-08-29T14:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridgebio-propel-3-data-in-nejm-shows-significant-growth-velocity-3e0e3e54bcec5055 2026-08-29T13:39:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/venture-into-high-volatility-corners-of-the-market-with-these-3-etfs-4499040f6e1c1e8a 2026-08-29T13:31:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/acg-co-founder-jasjit-singh-dies-at-83-after-six-decades-of-contribution-to-phar-5650bdc6f342e294 2026-08-29T13:30:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/my-wife-fed-me-stale-rice-tukaram-mundhe-s-fda-portal-gets-7-005-complaints-in-t-93e52bf386656505 2026-08-29T13:03:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-cipla-order-after-hc-says-it-went-overboard-7115da24e2e8d09d 2026-08-29T12:59:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cbn-seizes-66-80-lakh-psychotropic-tablets-in-major-inter-state-pharmaceutical-d-2e39c645b707ba3b 2026-08-29T12:45:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-presents-additional-phase-3-trial-data-for-tnx-103-d7c3ea2785748d7c 2026-08-29T12:37:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-presents-additional-phase-3-level-data-showing-tnx-103-benefi-79bbfa927af8d37d 2026-08-29T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gameto-expands-u-s-clinical-site-network-for-phase-3-fertility-study-ead264d4c1b1665d 2026-08-29T12:28:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/educacao-clinica-f25c659a2ede8c13 2026-08-29T12:26:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/formacion-clinica-56bd7e38afc63dab 2026-08-29T12:24:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/tenax-therapeutics-announces-presentation-of-phase-3-level-80eef44b2cf378f2 2026-08-29T12:21:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-post-hoc-phase-3-subgroup-analysis-found-tenax-s-drug-cut-a-heart-stress-marke-94b6cad89b899d80 2026-08-29T12:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-drug-to-reduce-heart-attack-risk-in-people-with-type-2-diabetes-53e7862fed0f7059 2026-08-29T12:15:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/tarsus-450m-alkeus-deal-puts-phase-3-retina-programs-on-the-same-integration-pla-869f13d80d40acdf 2026-08-29T11:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/goldline-pharmaceutical-promoter-swapan-khandelwal-acquires-78-000-shares-e3c7e405c689948a 2026-08-29T11:43:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-compounded-glp-1s-mean-for-patient-safety-ac6f33ea80c8a094 2026-08-29T11:39:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-daraxonrasib-for-metastatic-pancreatic-cancer-following-landmark-cl-158b8626189ffbd9 2026-08-29T11:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fpj-quick-take-at-5-pm-maharashtra-fda-withdraws-cipla-drug-licence-cancellation-9864e818cc8e043a 2026-08-29T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-drug-licence-row-maharashtra-fda-withdraws-cancellation-order-after-bombay-a97150af0a58fc24 2026-08-29T11:11:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-alvotech-alvo-is-up-11-7-after-expanding-biosimilar-deal-with-lotus-pharmace-45d096685965d8b7 2026-08-29T11:07:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-by-cnbc-tv18-on-tradingview-2026-08-29-cnbctv-9ff88bb79094b-0-e8060a7bc954a451 2026-08-29T11:06:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-now-on-demand-conference-spotlights-nine-emerging-biotech-and-healthcare-sto-8f450373df213482 2026-08-29T10:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viral-video-angry-crowd-corners-maharashtra-fda-officer-forces-him-to-eat-expire-76e9f9411a33a03c 2026-08-29T10:29:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-withdraws-cipla-drug-licence-cancellation-to-issue-fresh-notice-2ae9fcc7a6d376c3 2026-08-29T10:21:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-shares-slip-5-26-to-12-79-as-price-tests-16-resistance-e59ac8fc7b5bb46a 2026-08-29T10:11:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-manufacturers-life-insurance-company-invests-12-74-million-in-ultragenyx-pha-3e88d951afc41680 2026-08-29T10:02:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/bis-seizes-pharmaceutical-aluminium-foil-worth-1-4m-from-rohtak-firm-ce23284ccbafdef3 2026-08-29T09:28:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/virios-therapeutics-stock-trades-quietly-as-small-cap-biotech-story-remains-spec-28834f6fddb41d0d 2026-08-29T09:19:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptides-til-covers-emerging-retatrutide-data-from-landmark-phase-3-trials-49d4e1e0b5d9c36d 2026-08-29T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-withdraws-cipla-drug-licence-cancellation-after-bombay-hc-rebuke-fb40730da3c40b0d 2026-08-29T09:12:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-withdraws-cipla-pune-licence-order-after-bombay-high-court-criti-17b6e2846ad83994 2026-08-29T09:03:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/schall-law-investigates-elicio-after-phase-2-trial-failure-c87d7f2677ff5bc0 2026-08-29T08:32:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-supply-chain-disruption-pharmaceutical-and-life-sciences-sector-synthesis-8913645ff5fb9159 2026-08-29T07:45:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-choose-between-two-major-pharmaceutical-themed-etfs-833f6fb23ac6b0d7 2026-08-29T06:56:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-facility-s-drug-licences-in-pune-over-packaging-st-784beec30f78f6f7 2026-08-29T06:18:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pune-drug-sale-licences-over-regulatory-violations-60e8b052905ceb07 2026-08-29T05:27:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-merck-cancer-vaccine-succeeds-in-phase-3-trial-08eddeec300bc054 2026-08-29T05:25:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/upadacitinib-restored-substantial-scalp-hair-in-severe-alopecia-areata-but-long-44248b512468b14c 2026-08-29T05:11:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-drug-sale-licence-of-cipla-pharma-life-sciences-s-pune-carry-and-for-67b20e65d35a699c 2026-08-29T05:09:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-next-big-moves-for-a-pharmaceutical-giant-time-magazine-news-f12c9cb53e766d55 2026-08-29T04:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-drug-sale-licence-of-cipla-pharma-cancelled-over-fda-violations-50cc9695010d3156 2026-08-29T04:37:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-drug-sale-licence-of-cipla-s-pune-c-f-unit-over-complian-241fa94c081bb618 2026-08-29T04:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-cancels-cipla-c-f-drug-sale-licence-seizes-reactin-plus-stock-worth-rs-1602d1a2e9745719 2026-08-29T04:23:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-crackdown-on-cipla-pune-unit-s-drug-sale-licence-cancelled-over-violations-7b5580718446516b 2026-08-29T04:12:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/review-examines-pharmaceutical-contamination-in-edible-plants-grown-on-waste-ame-2b711d620d9af120 2026-08-29T03:53:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pune-unit-s-drug-sale-licences-over-reactin-plus-i-209c1b5deb5ab57c 2026-08-29T03:25:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sls-falls-13-as-firm-still-mum-on-alm-drug-candidate-1ec72a164fceaddc 2026-08-29T03:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptide-party-in-bengaluru-cancelled-after-fda-raises-regulatory-safety-concerns-dfed8bf7b259d0e1 2026-08-29T02:58:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-chugai-pharmaceutical-tse-4519-s-agentic-ai-partnership-with-phylo-means-fo-510a5247ed80336a 2026-08-29T02:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/pleopharma-wins-6-5-million-nih-grant-for-phase-3-trial-7020d8dbe899a4ca 2026-08-29T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-cipla-s-drug-sales-licence-cancelled-over-violations-and-irregularities-7a51b52c94ff0d74 2026-08-29T01:48:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-concocted-cancer-drug-ip-claims-biotech-firm-says-f8b0ca2e5e75a030 2026-08-29T01:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-raises-target-price-despite-spending-1-1-trillion-won-on-n-0f91534aa5264c57 2026-08-29T01:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubs-keeps-their-buy-rating-on-hansoh-pharmaceutical-group-company-limited-3692-47007889c7112ec5 2026-08-29T00:53:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-randomized-crossover-trial-comparing-the-acute-physiological-and-psychological-335e726c81a1942a 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-complement-system-in-the-pathophysiology-and-treatment-of-depression-from-sy-09b00d072202e3dc 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-failure-in-diabetic-kidney-disease-translational-barriers-target-validation-e3ec27878cd06572 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prothrombin-complex-concentrate-pcc-vs-non-pcc-strategies-for-warfarin-reversal-09dd5fbb1687020e 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-rivoceranib-200-mg-once-daily-on-the-pharmacokinetics-of-a-cocktail-pr-fca147dab222c7e8 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lack-of-efficacy-of-low-dose-cyclobenzaprine-on-electromyographic-activity-relat-2d6c536e7ebcb590 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-the-analysis-of-the-fetal-genome-in-utero-a-critical-1db16bed7a8a0cda 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-treatment-courses-of-exceptional-long-term-survivor-c34be4825ce45ed3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-of-monopolar-versus-bipolar-transurethral-resection-of-the-pro-44d5ba2633dd1183 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/collaborating-for-excellence-strengthening-clinical-trials-in-pakistan-editorial-e35eac2927752af3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-concept-to-practice-establishing-clinical-trials-unit-at-pkli-amp-rc-in-a-r-52fb4b00c87a16a5 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/telesalud-y-formacion-de-psicologos-clinicos-en-mexico-post-covid-19-8d24cd46392dc0c1 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/awake-tracheal-intubation-practice-and-clinical-decision-making-in-brief-airway-72e1eefd2c98bef1 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trends-manifestations-issues-and-prospects-of-chloroquine-resistance-in-nigeria-51e455ca2bc0a25f 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/screening-of-tomato-germplasm-for-resistance-to-fusarium-wilt-caused-by-fusarium-e664ea87b49283e8 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-difference-in-the-effect-of-ankle-strategy-exercise-and-tandem-strategy-exer-f19793567e8ce41a 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-based-therapies-beyond-diabetes-emerging-clinical-applications-and-future-526f6b330c1f1cee 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-clinical-characteristics-and-outcomes-of-acute-pulmonary-embolism-in-olde-c04ff648568ab220 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-open-weight-large-language-models-for-structured-depression-assessmen-e6fee55cc952cbc2 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-the-multi-attributive-border-approximation-area-comparison-mabac-4eddc8f1898f4d78 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-face-of-pediatric-and-adult-brain-abscesses-differences-and-clinical-charact-5ff5b1672ef566c4 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-management-of-contamination-subtype-obsessive-compulsive-disorder-throu-91fca2b35ce191b3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/simulation-based-training-in-optometry-education-current-evidence-clinical-appli-870d11da7c861773 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bilateral-undescended-testes-with-intraabdominal-non-seminomatous-germ-cell-tumo-0cc92b8fe12f9e95 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-pretreatment-hepatic-function-markers-with-clazosentan-associated-0bc65a84a6ce8ace 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-napsflex-and-standard-nasal-cannula-during-sedation-for-gastrointe-e3dc646edf6bc089 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/18f-fdg-pet-ct-as-an-endpoint-marker-in-drug-interventional-studies-in-atheroscl-6c357dec8349514b 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nocardia-gipuzkoensis-clinical-characterization-identification-and-antimicrobial-984a6563f8038e51 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bladder-cancer-precision-cut-tumor-slices-pcts-preserve-functional-immune-microe-df2298b58b48b621 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-remote-ischemic-conditioning-on-cerebral-blood-flow-regulation-in-pati-825e775ae8abcb46 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eco-friendly-dentistry-in-clinical-practice-awareness-implementation-and-factors-156d797ba559f666 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-accuracy-and-clinical-utility-of-simple-screening-strategies-for-sarc-471071a7317bdf45 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-knowledge-of-plastic-related-chemical-risks-and-intention-to-reduce-expos-c74b5395730ef6b6 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-distribution-of-high-risk-human-papillomavirus-genotypes-among-as-c077798d870b397c 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/changing-clinical-spectrum-and-hospital-burden-of-pulmonary-aspergillosis-before-e7d1daa722871b75 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commentary-beyond-failing-to-fail-reframing-clinical-competence-assessment-as-sh-dffb5e7e8da94f96 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-academic-careers-need-structural-integration-not-individual-endurance-2c1dd353da5027dc 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brain-network-convergence-of-abnormal-gray-matter-and-functional-activity-of-pat-44eecc97b9e17150 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cultural-complexities-in-conducting-research-with-patients-with-cancer-a-qualita-0dcb480652961afc 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effects-of-continuous-venovenous-hemofiltration-on-immunosuppressive-drug-co-b075ca86ffe99fa6 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunistic-coronary-artery-calcium-reporting-on-non-gated-chest-scp-ct-scp-fr-188d3bb611a9d5e9 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/time-to-antibiotics-and-clinical-outcomes-in-pediatric-cancer-patients-with-feve-49ce1e70177978a8 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-outcomes-of-respiratory-viral-infections-in-pediatr-f241de02cae869ea 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/candidemia-among-pediatric-cancer-patients-clinical-features-resistance-pattern-8f141f3fad1ea448 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/profile-and-outcome-of-children-treated-for-multi-drug-resistant-gram-negative-b-0364b13c600389b1 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-ten-year-retrospective-study-on-the-clinical-and-microbiological-characteristi-b5ecc7663c1fc6d0 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-antimicrobial-resistance-and-the-clinical-evolution-of-patie-7844bf7059cd1398 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimizing-empirical-antibiotic-therapy-in-febrile-pediatric-oncology-patients-t-8a7d3bc39e6e591d 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-practice-changes-in-the-diagnosis-and-management-of-bacterial-tracheiti-0f43b17edf85e809 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/narrative-review-of-the-clinical-safety-of-menacyw-tt-a-quadrivalent-meningococc-1ba3c88ff37553b4 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/light-source-dependent-photooxidation-of-therapeutic-monoclonal-antibodies-a-com-f4c289199e1ef963 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/progress-and-challenges-in-expanding-access-to-clinical-trials-in-pancreatic-can-bca4a88543e1cdf7 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dual-antithrombotic-therapy-using-potent-antiplatelet-inhibitors-in-atrial-fibri-de3a2fdcda67d19d 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinct-multi-omics-signatures-of-clinical-subgroups-of-type-2-diabetes-define-2a02f51467d00269 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/validity-and-reliability-of-the-turkish-version-of-the-barriers-to-physical-acti-008816a39d884a47 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parathyroid-camouflage-an-illusion-or-unsettled-mystery-an-interesting-case-repo-f59284b612e047d3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rickettsial-diseases-in-the-mediterranean-basin-an-evolving-clinical-and-epidemi-152348487473054e 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-rivoceranib-200-mg-once-daily-on-the-pharmacokinetics-of-a-cocktail-pr-85181d976b29e851 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-low-concentration-atropine-for-myopia-management-recent-evidence-and-f62544ec77091728 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-quercetin-ameliorates-oxidative-stress-inflammation-and-metabolic-dys-e342c4823627671c 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/qsrr-based-rp-hplc-method-development-for-antiviral-drug-analysis-machine-learni-080f963340e3c2a7 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-wogonin-nanoliposomes-using-box-behnken-design-optimization-in-vi-05847b09a7f3026b 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-evaluation-of-pyrazinamide-loaded-immediate-release-3d-printed-t-a1ec61bf4c0115c3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biopolymer-based-membrane-incorporating-capsaicin-silver-nanoparticles-for-enhan-3855bb36ec3600e6 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-the-pi3k-akt-mtor-pathway-in-gastrointestinal-cancers-a-comprehensive-f79e54ad3f3d5110 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impacts-of-environmental-pollutants-on-innate-immunity-the-role-of-group-2-innat-c8af35d8d1439524 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-agents-in-clinical-medicine-delegation-supervision-and-the-problem-of-correla-9c10ffe708d1ece3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/differentiating-pulmonary-sarcoidosis-from-pulmonary-tuberculosis-in-clinical-pr-275a24d30d696a2a 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-clinical-frailty-and-multidrug-resistant-positive-cultures-i-a3792e430864fd36 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cope-trial-comparison-of-yoga-therapy-versus-medical-therapy-in-men-with-chronic-a9d18480ff8cc908 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deciding-on-thresholds-for-clinical-relevance-of-promis-upper-extremity-v2-0-in-1fb62d249758f1ae 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-asymptotic-model-for-drug-dissolution-in-a-standardized-flow-through-apparatu-76313dac6326cddb 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-embodied-cognition-and-artificial-intelligence-in-university-physica-400f79423ce190a3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-clinical-relevancies-of-sarcopenic-obesity-in-patients-with-metabolic-c03a1bf1245d559d 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/family-accommodation-in-pediatric-anxiety-disorders-a-critical-review-of-current-e1d4023d7fc4d8e5 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-660-nm-amp-808-nm-photo-biomodulation-on-s100a8-a9-in-symptomatic-pul-e181a9b11695a5bc 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-changes-in-renal-function-in-rheumatoid-arthritis-patients-treated-55b49c65890c4faf 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temporality-before-complexity-in-jak-inhibitor-cardiovascular-safety-analyses-8cd629443a8fd02e 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-to-temporality-before-complexity-in-jak-inhibitor-cardiovascular-safety-a4b68fe49307d410 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-different-onlay-materials-and-resin-core-thickness-on-stress-distribut-62a4c2e2cc32cb7b 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hematological-and-serum-biochemical-alterations-in-labeo-rohita-following-sublet-38511fb8b7140596 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-conundrum-chest-discomfort-on-swallowing-in-a-patient-with-stiff-person-43f59719018ca173 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-targeted-scn1a-analysis-to-whole-exome-sequencing-clinical-utility-and-nove-a98b050c46be787a 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bilateral-choroidal-thinning-during-unilateral-aflibercept-for-neovascular-age-r-7bf2f4b05b6a8208 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/esketamine-based-treatment-depression-specific-metacognitive-training-and-their-b35a73cc2642200e 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/der-muskeltonustest-als-klinisches-orientierungs-therapie-und-kontrollinstrument-37661f4519eb5fc7 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-organ-damage-and-survival-in-idiopathic-inflammatory-my-39f15be7bb8cc9a9 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-meg3-mir-133b-regulatory-axis-in-exosomes-influences-macrophage-responses-to-e6cb3c87609de19a 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-of-heart-failure-hospitalization-associated-with-hypoxia-inducible-factor-p-f8a2e419ffc1cec3 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-between-chemiluminescence-immunoassay-and-liquid-chromatography-effeb32d5fa7658b 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ldl-cholesterol-lowering-with-evolocumab-before-percutaneous-coronary-interventi-9cf4e093fd29127c 2026-08-29T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-grade-gas-filters-market-outlook-to-2035-c5aceebb87754093 2026-08-28T23:16:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/eypt-alert-investigation-launched-into-eyepoint-inc-investors-are-encouraged-to-57b9f11909639cbc 2026-08-28T23:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/takeda-receives-u-s-fda-approval-of-mimrylotm-rusfertide-marking-a-potential-shi-b5efa55a00faeb82 2026-08-28T22:40:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/ma-takeda-pharmaceutical-6d67c757394e1f3f 2026-08-28T22:40:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/here-s-what-analysts-are-forecasting-for-hansoh-pharmaceutical-group-company-lim-0bd620d48844acb1 2026-08-28T22:33:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-approves-takeda-protagonist-s-drug-for-rare-blood-cancer-47a27c405f116bd9 2026-08-28T22:16:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/over-200-000-units-of-retatrutide-may-june-2026-freight-fraud-report-07c07a2fd9904383 2026-08-28T22:12:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-ionis-pharmaceuticals-ions-stock-become-a-biotech-powerhouse-as-its-commer-702a2bda330ae4ee 2026-08-28T22:05:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bofa-makes-bullish-call-on-newly-public-biotech-stock-8ea801b6496c247f 2026-08-28T22:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/robbins-llp-urges-aard-stockholders-who-lost-money-investing-in-aardvark-therape-456d4582cc098c82 2026-08-28T22:02:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-ltd-teva-shares-fall-3-1-what-gf-score-of-47-tell-fa1b867b643644ad 2026-08-28T22:02:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/nejm-react-revela-que-la-aterosclerosis-silenciosa-afecta-ya-a-1-de-cada-13-jove-13bf80231484affa 2026-08-28T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/without-guardrails-abortion-pill-report-exposes-stunning-lack-of-accountability-06d9fcafdfc23964 2026-08-28T21:50:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/inebilizumab-reduces-exacerbations-in-gmg-mint-trial-analysis-d4b435587aa18238 2026-08-28T21:48:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/melanoma-vaccine-data-breakthrough-moderna-receives-fifth-analyst-upgrade-in-fiv-04f36f1aa9820272 2026-08-28T21:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-expands-prepsia-patent-portfolio-to-nine-patents-0bd023435230ecd3 2026-08-28T21:33:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-revenue-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-0-fa1540b182448e83 2026-08-28T21:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-nasdaq-trib-moves-to-keep-nasdaq-listing-78aaf5f4e4806fb7 2026-08-28T21:24:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-updates-on-commercial-progress-manufacturing-transformation-prep-e2df816409676e33 2026-08-28T21:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-kingdom-silicone-tubing-for-pharmaceutical-transfer-market-analysis-forec-9275a7c99b6017d1 2026-08-28T21:16:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-provides-diagnostics-business-transformation-and-corporate-updat-c32c11c22f7d1725 2026-08-28T21:16:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-provides-diagnostics-business-transformation-and-corporate-updat-38a94276a5a436b0 2026-08-28T21:15:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/kff-survey-methodology-data-collection-standards-f590133b100731cd 2026-08-28T21:11:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/incyte-corporation-incy-vs-revolution-medicines-rvmd-which-biotech-stock-offers-8103d9a22d370ab6 2026-08-28T21:11:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-inc-stock-underperforms-friday-when-compared-to-com-97178b934fc7af39 2026-08-28T21:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dilution-adjustment-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-3a7f9d1d5f476394 2026-08-28T20:46:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-margin-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-0479-df19015c417ba7d9 2026-08-28T20:43:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/return-on-invested-capital-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-ba2cf4bee0a72e7b 2026-08-28T20:41:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-operating-income-total-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-6e8fcac8ec3089ce 2026-08-28T20:40:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-37222e5e49e51c72 2026-08-28T20:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-11c914f54ee3ae75 2026-08-28T20:35:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/gross-margin-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-04-7ee8d1d5b43cd92f 2026-08-28T20:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-trib-pulls-675m-unsold-shares-from-25m-standby-deal-197466dbe53f1512 2026-08-28T20:21:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-untitled-letter-to-alar-for-false-advertising-of-investigational-drug-3872eb77c0e4d8f8 2026-08-28T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tribute-to-senator-kassebaum-baker-2468486a4c80202b 2026-08-28T19:49:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/coronavirus-german-us-vaccine-candidate-cleared-for-phase-2-and-3-clinical-trial-c07a7fa18401d3d6 2026-08-28T19:44:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-companies-prescribers-endanger-patients-by-routinely-flouting-fda-rules-sen-a345dc13167ae317 2026-08-28T19:41:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/sapablursen-lowers-need-for-blood-draws-in-polycythemia-vera-6f7dcef8a25b4e18 2026-08-28T19:17:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-6908e5cfeb7ec47f 2026-08-28T19:14:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/net-income-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-0479-400000f575cc4cb2 2026-08-28T19:12:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/discontinued-operations-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-sh-ba6c4eb17654c804 2026-08-28T19:10:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohacking-party-grounded-in-koramangala-karnataka-fda-scuttles-india-s-first-pe-146b08379482821e 2026-08-28T19:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-assets-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-04-fda2c1573f259b03 2026-08-28T19:08:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-debt-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-0479-6108e2a9154a2fd4 2026-08-28T19:06:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-569a16cfdba2f2c1 2026-08-28T19:06:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-secarna-partnership-milestone-opens-new-potential-market-for-fb796448989b64ed 2026-08-28T19:06:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/tech-bills-of-the-week-identifying-sponsored-content-in-ai-tools-reshoring-biote-bda014ac55c354d8 2026-08-28T18:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dolly-s-cancer-death-mammogram-safety-alert-chemo-drug-shortage-worsens-9ba8a3cc7c0f17e5 2026-08-28T18:50:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-s-mounjaro-wins-us-label-expansion-for-cardiovascular-risk-reduction-1ef7fc529dd178b8 2026-08-28T18:47:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-pune-unit-s-drug-sale-licence-cancelled-over-irregularities-81a2b415536b4f33 2026-08-28T18:39:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-d7a6839daac6ef07 2026-08-28T18:32:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengaluru-peptide-party-called-off-after-food-safety-and-drug-administration-not-80f33ddfa44301f0 2026-08-28T18:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengaluru-peptide-party-called-off-as-fda-inspects-company-7c1f8d16ea8b05ad 2026-08-28T18:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-to-announce-new-drug-pricing-deals-with-biotechs-prices-drop-at-reco-baa7f51827e07c56 2026-08-28T18:29:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/total-debt-per-share-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-share-841bba7db5c17db1 2026-08-28T18:29:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/pretax-income-of-hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-krx-0-7d532cb91c76ea1b 2026-08-28T18:27:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-pharmaceutical-co-ltd-rights-2026-11-08-26-for-shares-2224218ed7cc9acb 2026-08-28T18:20:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-drug-sale-licence-of-cipla-s-pune-unit-fa3d45d9285a1ab2 2026-08-28T18:15:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-drug-sale-licence-of-cipla-pharma-life-sciences-s-pune-carry-and-for-5b23b7535130f1ca 2026-08-28T18:14:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/dualitybio-and-teva-strike-major-biopharma-deals-pharmexec-f73d2affe728490e 2026-08-28T18:09:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-licence-of-prominent-pharma-company-in-pune-ae58f732a433c1e7 2026-08-28T17:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-s-pune-unit-s-drug-sale-licence-92468db53c632af7 2026-08-28T17:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/myasthenia-gravis-market-to-reach-13-0bn-across-7mm-by-2034-97b98c6bff0c9e1e 2026-08-28T17:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/msd-s-lipfendra-takes-on-injectable-rivals-for-cholesterol-lowering-market-supre-3b466903abc5fcfe 2026-08-28T17:50:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-commissioner-tukaram-mundhe-drug-safety-public-health-462163fbc1f94fe6 2026-08-28T17:34:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-book-forward-of-eastgate-biotech-corp-otc-etbi-726b07af9baaaeb7 2026-08-28T17:24:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/wells-fargo-company-forecasts-strong-price-appreciation-for-ultragenyx-pharmaceu-18b6c4684ef3b409 2026-08-28T17:23:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-biotech-ceo-is-creating-a-cure-for-type-1-diabetes-meet-the-ceo-of-eledon-p-7c5dc9e10964b8f6 2026-08-28T17:10:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-rejection-in-kidney-transplant-d62896bd46677f3b 2026-08-28T17:10:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/northwestern-medicine-marianjoy-rehabilitation-hospital-helps-patients-with-mult-b04b958264d898bb 2026-08-28T16:55:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/terminally-ill-adults-end-of-life-bill-2026-13e3af1a53eceeba 2026-08-28T16:50:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/terminally-ill-adults-end-of-life-bill-2026-echr-memorandum-4a97a4447e7cc172 2026-08-28T16:50:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/terminally-ill-adults-end-of-life-bill-2026-equality-impact-assessment-3255751a00c2709b 2026-08-28T16:49:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/terminally-ill-adults-end-of-life-bill-2026-impact-assessment-b4e4927e25057061 2026-08-28T16:49:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cipla-pune-unit-loses-drug-sale-licences-what-triggered-fda-action-14e05fb887e80e7e 2026-08-28T16:44:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan-dde8d733db7dc8dd 2026-08-28T16:43:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/fenwick-partners-see-biotech-ipo-demand-building-9c7e2aa10ca03976 2026-08-28T16:36:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/bengaluru-s-peptide-party-cancelled-after-karnataka-food-safety-and-drug-adminis-9befc3bcd3f57da9 2026-08-28T16:36:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-led-maharashtra-fda-cancels-cipla-unit-s-drug-licence-over-reacti-b190a7a830f23266 2026-08-28T16:31:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-biotech-stocks-to-research-august-28th-99485bc96bf0a320 2026-08-28T16:16:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/here-s-why-maharashtra-fda-cancelled-drug-sale-licence-of-cipla-s-pune-unit-47b21f49c125c951 2026-08-28T16:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-facility-drug-licences-over-reactin-plus-irregular-21628f33b97d1dc2 2026-08-28T16:12:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-companies-bring-on-new-hr-talent-in-august-c2451b920b09563f 2026-08-28T15:56:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-and-merck-s-positive-preliminary-cancer-vaccine-results-could-signal-a-n-dc59cccbe9d53f26 2026-08-28T15:56:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-led-maharashtra-fda-cancels-cipla-unit-s-drug-licence-over-reacti-1725f8da1d3f5ed1 2026-08-28T15:51:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-healthcare-etf-offers-the-better-growth-outlook-vaneck-biotech-or-invesco-9511ed22b1233ab4 2026-08-28T15:51:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-healthcare-etf-offers-the-better-growth-outlook-vaneck-biotech-or-invesco-6882a9d802f0841d 2026-08-28T15:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pune-unit-s-drug-sale-licence-over-violations-9bc2b905c724e839 2026-08-28T15:40:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/show-me-the-money-cadl-delivers-190-gain-in-less-than-six-months-as-bla-filing-n-85c2633fa7e77228 2026-08-28T15:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bank-of-america-sees-major-upside-in-this-biotech-stock-ecf265dbcb7366b6 2026-08-28T15:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokinetics-shares-drop-5-even-as-company-delivers-first-positive-phase-3-resul-425bf6a4c104eb33 2026-08-28T15:29:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-disease-caused-by-bundibugyo-virus-democratic-republic-of-the-congo-75058bc9fbebf19a 2026-08-28T15:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-autopsy-of-failed-heart-disease-study-astrazeneca-raises-broader-questions-ab-5e80d5c9ad949c47 2026-08-28T15:27:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-fda-aprueba-mounjaro-tirzepatida-de-lilly-para-reducir-el-riesgo-cardiovascul-66360e30b7da2982 2026-08-28T15:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-week-in-charts-biotech-s-rebound-is-undeniable-62373326a28e09c6 2026-08-28T15:25:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-cipla-pharma-s-cfa-drug-sale-licence-in-pune-4147e8e06fc6da00 2026-08-28T15:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-s-updated-ind-safety-reporting-guidance-what-changed-what-didn-t-and-what-to-2c975ca6133f099a 2026-08-28T15:15:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-news-maharashtra-fda-cancels-licence-of-prominent-pharma-company-in-pune-82465751840aac81 2026-08-28T15:10:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-trial-shows-no-sign-of-tumors-here-s-what-happens-next-e7a30e07f1a7bca4 2026-08-28T15:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-pune-pharma-firm-s-drug-sale-licences-9ae66b69a26cf34b 2026-08-28T15:02:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/self-blinking-fairy-lights-allow-dna-to-be-imaged-at-double-helix-width-resoluti-421e4558c535d2dc 2026-08-28T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-licence-of-prominent-pharma-company-in-pune-6bdb9c7bef240fff 2026-08-28T14:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/annex-1-turns-three-spotlight-on-sterile-manufacturing-10341808edb553af 2026-08-28T14:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pune-unit-s-drug-licence-over-reactin-plus-lapses-20a1e41540da7c72 2026-08-28T14:45:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-gild-roiv-win-fda-nod-bhvn-lly-strike-deal-syre-misses-monotherapy-g-8a3fe8598292712a 2026-08-28T14:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-ultragenyx-pharmaceutical-rare-fallen-far-enough-after-gene-therapy-approval-e99a6c5bcf6280c6 2026-08-28T14:36:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-unit-s-drug-licences-in-pune-over-reactin-plus-rec-81d247017d8d5147 2026-08-28T14:35:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/miami-biotech-collective-rings-the-nasdaq-stock-market-opening-bell-c6160c2172824602 2026-08-28T14:35:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-trial-tests-new-way-to-treat-common-inherited-heart-disease-7f29b657350574be 2026-08-28T14:23:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-drug-sale-licences-of-cipla-pharma-life-sciences-pune-c-d5fe13d3bc83bbc6 2026-08-28T14:07:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-cipla-pune-unit-s-licence-over-reactin-plus-violations-firm-contests-b576ac715759d27e 2026-08-28T14:06:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/viking-therapeutics-stock-vktx-opinions-on-phase-3-obesity-drug-data-timing-0ae5722d9fb9cb09 2026-08-28T14:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pharma-s-pune-drug-licences-seizes-11-19-lakh-stoc-7a18d26a0a79ab97 2026-08-28T14:04:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cancels-cipla-pharma-s-pune-unit-drug-sale-licence-d8e751db3daf8fe4 2026-08-28T14:04:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-drug-sale-licences-of-cipla-pharma-life-sciences-s-pune-carry-and-fo-11b439ac9969ba6a 2026-08-28T13:55:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-cracks-down-maharashtra-fda-cancels-licence-of-cipla-s-pune-unit-fb428238d3f4ac91 2026-08-28T13:43:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-and-ionis-detail-surprise-failure-of-heart-disease-drug-with-alnylam-a4e6ee1a8cf67fcf 2026-08-28T13:43:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-standardized-patient-friendly-computational-language-mapping-to-g-52074ee06abdcb49 2026-08-28T13:36:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cancels-drug-sale-licences-of-cipla-pharma-life-sciences-pune-carry-and-forw-ec3c5f057408fa05 2026-08-28T13:30:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/misbranding-storage-lapses-fda-cancels-cipla-pune-unit-s-drug-licence-over-react-0ccf9ec1ae6626e6 2026-08-28T13:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-pick-for-fda-faces-scrutiny-after-cyclospora-outbreak-2fb6098750a64867 2026-08-28T13:29:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firms-point-to-sustainability-benefits-of-ngts-7783f2c9039d136b 2026-08-28T13:20:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-haven-biotech-bioxcel-files-for-bankruptcy-agrees-to-potential-145m-sale-7b3c798fc516197d 2026-08-28T13:18:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-saddles-up-as-stalking-horse-bidder-for-bankrupt-bioxcel-s-neuroscience-por-fdc367fa9d83648a 2026-08-28T13:17:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/live-miami-biotech-collective-rings-the-opening-bell-de39751e0e7ba42a 2026-08-28T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-cancer-vaccine-met-endpoints-in-adjuvant-melanoma-16bab30bddd1160a 2026-08-28T13:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/fierce-pharma-asia-roche-s-2-5b-obesity-deal-akeso-ceo-s-defense-lawmaker-s-refl-6ca91bbf3802a665 2026-08-28T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/symbiosis-pharmaceutical-services-appoints-jay-chima-as-vp-business-development-c10ccd77f93c152f 2026-08-28T12:30:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/withdrawn-cder-product-specific-guidances-7184a0c973b6bb81 2026-08-28T12:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/quadram-institute-announces-dr-perry-bateman-as-new-director-of-operations-c618ea6d9fca1d58 2026-08-28T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chutes-ladders-vivace-revs-up-c-suite-ahead-of-pivotal-push-79e5aec23dd76334 2026-08-28T12:29:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/florida-to-sue-two-big-pharmaceutical-companies-f53ad3b2c069c824 2026-08-28T12:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-income-investors-look-at-middle-east-pharmaceutical-industries-company-ta-53e4e88c8ef6fdd0 2026-08-28T12:22:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-s-touyun-biotech-profit-surges-on-fair-value-gains-6fb7a91ad0d77485 2026-08-28T12:19:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-giants-hide-early-projects-from-competitors-9462b101d176c863 2026-08-28T12:16:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-s-secret-biotech-startup-just-raised-23m-what-we-know-about-outer-bio-1b2dd4706c89c53c 2026-08-28T12:06:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/carestation-850-ac9c2c1a969cc990 2026-08-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blanketrol-ii-115v-and-blanketrol-iii-115v-2f679ac48ef11dd0 2026-08-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiro-and-differentia-biotech-forge-strategic-alliance-to-redefine-clinical-trial-b20bf0b6f1d96c2b 2026-08-28T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multiple-food-recalls-and-outbreaks-are-raising-food-safety-questions-in-us-fb54904d83d7f2ae 2026-08-28T11:50:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/traditional-chinese-medicines-plus-metformin-improve-a1c-6bdd402540f0eb2c 2026-08-28T11:50:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-pharmaceuticals-stock-falls-on-silencer-drug-concerns-7abcb4ab480ea2db 2026-08-28T11:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-generic-ivermectin-drug-for-screwworm-prevention-917e17c2ed7e8a4d 2026-08-28T11:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-lilly-s-mounjaro-tirzepatide-to-reduce-cardiovascular-risk-in-adult-650bdd7eb2fb56dd 2026-08-28T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/freedom-to-innovate-as-a-driver-of-industrial-growth-technology-transfer-needs-s-597d0522d7448752 2026-08-28T10:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/act-brief-site-relationships-and-payment-reliability-ai-adoption-without-governa-68bd2e34addfc860 2026-08-28T10:49:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/revolution-medicines-advances-rasolve-308-lung-cancer-trial-raising-long-term-up-db18ef30a906be36 2026-08-28T10:49:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokinetics-announces-positive-results-from-acacia-hcm-presented-in-hot-line-se-18bbb0c90c7f4680 2026-08-28T10:47:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-priovant-s-rare-autoimmune-therapy-lisraya-in-indication-first-a99d2abe10201523 2026-08-28T10:44:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/palo-alto-investors-lp-takes-19-92-billion-position-in-ultragenyx-pharmaceutical-3efea88ca26e686d 2026-08-28T10:35:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/sun-pharmaceutical-industries-climbs-friday-outperforms-competitors-b6983a2609f6cae5 2026-08-28T10:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-shineway-pharmaceutical-group-sehk-2877-stock-cheapness-meets-revenue-pres-a5fbdce1f13fcd9b 2026-08-28T10:31:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/jefferies-financial-group-inc-makes-new-31-04-million-investment-in-ultragenyx-p-ad43888e2db4e474 2026-08-28T10:31:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-immunity-under-pressure-mapping-compression-driven-tumor-immune-r-40c5dd163911cb3d 2026-08-28T10:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-creating-a-bilingual-organism-with-two-mutually-orthogonal-geneti-fe658d451f1febd6 2026-08-28T10:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-revolutionizing-mrna-cancer-vaccines-with-nanosized-bacterial-out-2b85e676e41bb4ae 2026-08-28T10:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/fluoropolymer-barrier-films-pharmaceutical-packaging-market-to-reach-usd-12-215-67dfbcb69b97968c 2026-08-28T10:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extrawell-pharmaceutical-holdings-limited-announces-retirement-of-dr-lou-yi-as-a-eae6c0187a229b98 2026-08-28T10:20:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-to-bid-on-bioxcel-therapeutics-bxcl501-dexmedetom-a404137850c5439f 2026-08-28T10:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-authorship-study-purpose-and-journals-when-evaluating-clinical-studies-093c97637593a528 2026-08-28T10:19:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-biotech-bicara-signs-sublease-for-wayfair-space-c7e11c1fc6ac874c 2026-08-28T10:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-concerning-gain-on-return-of-retirement-benefit-trust-extraordinary-incom-172193966f49beb0 2026-08-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lgbtq-1b5d62bda8af792b 2026-08-28T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-neo-blsm-rvmd-ormp-cadl-645374b46c95764a 2026-08-28T09:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-neurobiology-of-how-mice-play-follow-the-leader-845ce81483559499 2026-08-28T09:54:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cytokinetics-announces-positive-phase-3-acacia-hcm-results-for-aficamten-in-non-d8779ac8ed2c4c40 2026-08-28T09:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zhangzhou-pientzehuang-pharmaceutical-revenue-and-profit-fell-sharply-year-over-d4e0222250cbd860 2026-08-28T09:21:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-swissmedic-inspection-of-the-new-adc-suite-0c70d4877f50d2b4 2026-08-28T09:12:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-announced-on-the-28th-that-it-has-applied-to-the-ministry-of-f-70070aa9e66daa36 2026-08-28T09:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-seeks-korea-phase-3-trial-for-biweekly-glp-1-in-diabetes-chosu-ce9dd0b94161d4c9 2026-08-28T08:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-to-evaluate-qualifications-for-pharmaceutical-and-medical-translation-cb50f1bea4542a42 2026-08-28T08:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-update-issue-374-august-2026-d476a563c22f741e 2026-08-28T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genentech-doubles-down-on-adc-resistant-cancers-with-1b-dualitybio-pact-d19dcafb82d9a3ac 2026-08-28T08:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/find-out-who-is-approved-to-access-ukhsa-data-for-research-and-other-secondary-u-128dfd5e8b3b6319 2026-08-28T08:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/nice-has-updated-how-it-values-quality-of-life-the-move-from-3l-to-5l-8612be4622116e6b 2026-08-28T07:49:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/fran-praktikant-till-sveriges-framsta-snigelexpert-nu-gar-ted-von-proschwitz-i-p-e93ad25210b9c9a8 2026-08-28T07:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/marquis-who-s-who-honors-dr-wafick-mohamed-d-sc-m-sc-cqa-chrc-clssbb-pmp-for-lea-590519b88f4cfd56 2026-08-28T07:22:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/marquis-who-s-who-honors-randolph-greasham-for-expertise-in-the-pharmaceutical-s-6bdb155543cfa37e 2026-08-28T07:22:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/stuart-medina-says-spain-s-biotech-industry-is-ready-for-an-annual-stage-ef02c18fe399133e 2026-08-28T07:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-s-vabysmo-demonstrates-sustained-two-year-results-in-a-difficult-to-treat-18b526e0eca146da 2026-08-28T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/do-no-harm-how-hospitals-can-better-track-and-manage-their-environmental-impact-049fd9463e8dad5b 2026-08-28T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ausperbio-closes-120m-series-c-for-ahb-137-hepatitis-b-program-e52e760d55ba3137 2026-08-28T06:45:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/genentech-dualitybio-partner-on-next-generation-adc-payloads-272482a5f3cc4c66 2026-08-28T06:45:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/mbx-biosciences-doses-first-patient-in-phase-3-canvuparatide-trial-for-hypoparat-b5545ecc5fc6cca8 2026-08-28T06:40:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-revolution-ary-new-drug-for-pancreatic-cancer-05bf28838fa020f0 2026-08-28T06:39:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-life-s-revenue-surges-as-insurer-plans-deeper-push-into-ai-and-biotech-2915fada45806841 2026-08-28T06:00:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-fosun-pharmaceutical-s-gr1803-injection-gets-conditional-approval-in-ch-9d0d1c975045fa23 2026-08-28T05:21:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-group-sehk-3692-stock-draws-attention-with-42-margin-stren-d78e3fa0b9fb84e5 2026-08-28T05:06:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunological-toolbox-supports-fight-against-global-animal-viruses-9db33749cf95b2c3 2026-08-28T05:02:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-small-cap-biotech-stocks-trading-at-a-discount-with-late-stage-clinical-cataly-afbc766c310b422d 2026-08-28T04:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abortion-drug-companies-exposed-for-endangering-mothers-in-new-report-6e48817199502bf3 2026-08-28T04:22:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-venture-capital-investment-rebounds-as-software-and-biotech-attract-funding-8d36abdbd26d1f4a 2026-08-28T04:02:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-iv-start-kit-issue-from-avid-medical-d92ff2979cfede60 2026-08-28T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-angiographic-catheter-issue-from-boston-scientific-d57194fd8e2f82eb 2026-08-28T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-reports-widened-loss-amidst-major-clinical-trial-adv-749b44db343b62f9 2026-08-28T03:46:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/kazakhstan-s-pharmaceutical-production-rises-37-in-3years-641270cd87fd3713 2026-08-28T03:39:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/monod-bio-signalchem-biotech-ink-licensing-deal-to-advance-ai-designed-protein-t-5b9fea23e67887d6 2026-08-28T03:39:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-dominates-oral-obesity-drug-market-pressuring-eli-lilly-with-phase-e2371468327325d4 2026-08-28T03:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/science-blog-called-an-early-trial-a-magic-wand-in-2024-two-years-on-a-placebo-c-87984a0a023d131f 2026-08-28T03:03:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/anzen-mhlw-pharmaceuticals-and-medical-devices-safety-information-no-430-posted-5f0789370ac962d4 2026-08-28T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iaso-bio-acquires-medisix-therapeutics-48f33809e53b7447 2026-08-28T02:42:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/i-am-no-celebrity-maharashtra-fda-chief-tukaram-mundhe-on-food-safety-public-ser-668ffb5cebdf8760 2026-08-28T02:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/interview-renew-lawmaker-wants-novel-foods-inside-eu-biotech-act-deaa440c2e86c159 2026-08-28T02:07:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/huawei-plans-for-more-ai-pharma-tie-ups-says-healthcare-president-9ef15ccf81c70276 2026-08-28T01:54:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivozon-signs-deal-to-supply-unafra-painkiller-to-china-s-hainan-medical-zone-87a57f3ecaf83ca4 2026-08-28T01:48:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-roivant-therapy-for-rare-autoimmune-disease-6b8d4d06e09860b1 2026-08-28T01:27:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/abl-bio-s-adc-candidate-achieves-100-complete-response-rate-in-phase-1b-dlbcl-co-c3f5da6b6ed089f8 2026-08-28T01:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/value-of-innovation-in-vietnam-4ac234c5e7f43f8b 2026-08-28T01:19:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-releases-new-guidance-documents-on-when-to-submit-an-anda-or-505-b-2-applica-8aa53fa5e0bb4da1 2026-08-28T01:16:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-once-yearly-salanersen-across-the-spinal-muscular-atrophy-spectrum-a-fa7f6a314f81b35f 2026-08-28T00:48:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-look-at-collegium-pharmaceutical-inc-coll-after-3-9-decline-gf-value-47-17-vs-744ddf9b89221ca1 2026-08-28T00:37:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-look-at-collegium-pharmaceutical-inc-coll-after-3-9-decline-gf-value-47-17-vs-11257d3406b64f2d 2026-08-28T00:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiwan-s-next-biotech-prescription-ai-drug-discovery-smart-devices-biomedical-ch-133f4edd1ed3d6c6 2026-08-28T00:30:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-lipids-market-set-for-5-4-cagr-growth-during-2025-2034-abdaab98c42c33c8 2026-08-28T00:27:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/rx-to-otc-switches-market-to-reach-us-62-71-billion-by-2034-expanding-at-4-8-cag-c664d350f0b857fe 2026-08-28T00:27:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-the-dream-of-the-autonomous-clinical-trial-dawns-agent-supervision-is-today-s-886aa4dd147e0ad2 2026-08-28T00:01:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/dizal-pharmaceutical-resubmits-listing-application-to-hong-kong-stock-exchange-3d42ebf56dd8b146 2026-08-28T00:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-e9d36ef612b511d8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/menu-petros-love-at-first-bite-petros-love-at-first-bite-4a3374ea11e1dc4c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-public-comment-requ-2dc800e761357bb6 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-data-collection-submitted-for-public-comment-and-recommendations-6775d0354090e187 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-498ff3b5248727f3 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-independent-dispute-resolution-operations-correction-633c02829d0d1c49 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-qua-c92250eaca514f16 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-182d2fe0a720f6eb 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-for-office-of-management-and-9ade0e3f314358fc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-foo-23f080931f797d8d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-foc-7ba93c8ae1658c53 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atlantic-treatment-center-llc-decision-and-order-5979c61a596182cb 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thomas-earley-d-d-s-decision-and-order-1b5dd40bc26ff62d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/leila-kump-m-d-decision-and-order-fd4388a9b8ed25c4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/compounding-animal-drugs-from-bulk-drug-substances-compounding-under-cgmp-in-fed-52b4521e9d42c602 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/submission-for-office-of-management-and-budget-review-national-and-state-survey-fff08cee2e605c45 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-core-5cfbc3f040f0da40 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-duke-population-research-center-7a1aa4ffa650703b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-definitive-evaluation-of-gastric-dysrhythmia-as-a-disease-mechanism-by-4d25a59b754cb885 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-role-of-chemical-exposures-in-alzheimer-s-disease-ad-and-its-traje-8aac58c5f7632aac 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-virology-core-be39687e678bb9d9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-shared-resources-core-334888538f91756f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-innovative-network-on-the-science-and-practice-of-implementation-resea-19bcf483f1ed3aed 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-knowledge-base-and-portal-eb98746cf217464f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-international-maternal-adolescent-and-pediatric-therapeutics-clinical-7b1fd3b9699adcf7 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-attract-assessment-of-temporomandibular-joint-morphology-mechanics-and-0647a4f4cc70099d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-person-centered-research-on-culture-as-health-perch-an-indigenous-mode-1916676b31ae3577 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-indiana-university-ohio-state-university-maternal-and-pediatric-pr-aef5a4bf18e269c8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-effect-of-gestational-arsenic-exposure-on-maternal-cardiovascular-heal-b70cd02357d7bcf3 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigating-lipid-droplet-regulation-and-function-in-the-developing-2de10b626f788b28 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-spatial-dissection-of-pathogenic-endotypes-and-therapeutic-mechanisms-a819403c9b53139b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-first-taste-lasting-impact-early-life-exposure-to-added-sugars-from-in-226c0f023384241b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-evaluating-impacts-of-a-food-prescription-program-embedded-into-a-heal-3db64545c28301c9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-d-animal-models-of-bone-and-joint-injury-disease-bc899441f637ce6b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-c-musculoskeletal-histology-and-morphometry-core-318b0696b0ea151b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-b-musculoskeletal-structure-and-strength-core-66db128335729558 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-resource-based-center-for-musculoskeletal-biology-and-medicine-ec0196183e64aeeb 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-single-maintenance-and-reliever-therapy-strategies-for-implementation-741525641f6f43b6 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mount-sinai-clinician-scientist-training-program-in-emergency-care-res-e92768dcd99db9e1 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-communityrx-chronic-kidney-disease-crx-ckd-in-rural-north-carolina-1e5bb30a0db3777e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-type-1-diabetes-trialnet-clinical-network-hub-0a6c308f5dcfd5bc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-epicardial-high-definition-electrotherapy-of-afib-30318028158f0cc4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-transactivation-of-human-endogenous-retrovirus-herv-k-by-oncogenic-9454071c743497df 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-predictive-modeling-of-viral-rna-cellular-behavior-f328120b83ff07ec 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-validation-of-nad-measurements-for-human-clinical-studies-multi-method-d9f6df58b4828742 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-human-pulmonary-neuroendocrine-progenitors-in-lung-injury-and-disease-f831be543d8d8dfd 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-project-1-overcoming-immune-exclusion-in-microsatellite-stable-colorec-4a0efecba6eaad7d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-b-preclinical-models-core-8686009c462a876e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-a-tissue-pathology-and-cellular-analysis-17daf285b188da00 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-vanderbilt-ingram-cancer-center-spore-in-gastrointestinal-cancer-5d1e5414cade1595 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-rbc-effects-on-neutrophil-activation-and-phenotypes-in-sickle-cell-dis-9e40812d6aff3114 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-use-of-registries-claims-and-health-system-data-to-enhance-the-evaluat-fca605269ef4c9df 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sequential-strategies-to-reach-and-reengage-individuals-after-lapses-f-869f6d96bf620443 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-unified-probabilistic-model-and-software-implementation-for-analysis-2b0a84e6550316f5 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-factors-impacting-global-health-the-importance-of-individualized-treat-7822a86b614b7102 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-core-a-administrative-core-a31f7b78ecc88692 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-vermont-center-on-behavior-and-health-b7b555c1da5a0b00 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-adding-bright-light-treatment-to-cognitive-behavioral-therapy-for-inso-188e0c4d148591b1 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-uab-regional-consultation-hub-for-precision-hiv-implementation-science-a3282e56ec84d9ed 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-dissemination-core-the-center-for-innovation-in-point-of-care-technolo-2f9ad40a25730b6a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-technology-core-the-center-for-innovation-in-point-of-care-technologie-52f40c93bdd5025c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-precision-imaging-of-electromechanical-coupling-for-non-invasive-cardi-807e8fb3639c70af 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-cognitive-training-for-emotion-regulation-in-psychotic-disorders-1e69bb8dd35c05f0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-building-capacity-for-global-infectious-disease-research-training-in-s-6e91ebd1c1c6f7e1 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-examining-the-impact-of-state-laws-on-intimate-partner-violence-3821b5327ec7095e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-gpr68-as-a-novel-modulator-of-septic-lung-injury-4331f49bdb89b6c9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigating-the-role-of-macrophages-in-heart-failure-with-preserved-1347c65b8a3b2bb0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-large-animal-core-db77b12c1051a99d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-small-animal-ocular-imaging-core-779338899ebdf229 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-molecular-construct-and-packaging-core-afb7ad7ae5efa86d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-vision-research-core-grant-49678d954c0b02d2 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-using-mirna-to-identify-new-therapeutic-pathways-for-dilated-cardiomyo-c6346c52f7d9d1ee 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-introducing-young-children-to-biomedical-science-with-a-screenless-int-92d0bbf31fe20028 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-tesamorelin-as-an-adjunct-to-exercise-for-improving-physical-function-6603892f25c027a9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-deciphering-neuronal-control-of-behavioral-initiation-and-suppression-dcb4b8aa8d04d2e8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-gene-therapy-for-alpha-1-antitrypsin-deficiency-796d04f34479352d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-measure-s-of-financial-hardship-and-health-disparities-5800c1e1ff6d145a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sglt2i-as-novel-gout-care-save-care-a-randomized-controlled-trial-5b2954f640db89e5 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-georgia-cystic-fibrosis-data-warehouse-967b212599b9dd5f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-economic-precarity-costs-and-continuity-of-mental-health-care-50a8dc760dc79621 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-low-cardiorespiratory-fitness-and-chronotropic-incompetence-in-hiv-ris-4ea3ac01bbd0126d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-molecular-regulation-of-cardiovascular-7-tm-receptors-6fe6593583914cef 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-musiquest-steam-interactive-digital-media-for-k-5-stem-education-integ-6d631e8efef46c4e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-deep-learning-to-assess-cardiovascular-disease-risk-from-chest-imaging-7a93965dea8e0b88 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-ind-enabling-studies-of-a-usp30-inhibitor-for-acute-kidney-injury-18b79b6ea273ea95 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-crispr-cas9-based-exon-skipping-strategies-for-the-trea-823d1121c3b081e0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lisdexamfetamine-dimesylate-749fdeabbd3b2c16 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cleveland-clinic-first-in-human-trial-of-crispr-gene-editing-therapy-shown-to-sa-edf687c4e62deb6f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-presents-data-at-the-european-society-of-cardiology-congress-16c8782a34d46528 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/llm-assisted-large-scale-curation-of-peptide-clinical-trials-maps-trends-in-ther-1c4eee80ed26fac0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-sub-anesthetic-dose-esketamine-on-oculocardiac-reflex-in-children-unde-e5374d29b3c61c71 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-sp16-in-preventing-acute-kidney-injury-in-at-risk-subject-0ccd0e18d9145909 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novel-agents-and-evolving-strategies-in-waldenstrom-macroglobulinemia-clinical-t-91d5b33d3cd8b475 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/universal-pipeline-for-high-resolution-gpcr-structure-determination-6ea22fdebcfe602f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lyophilised-faecal-microbiota-transplantation-capsules-for-intestinal-multidrug-c1eed64d41453095 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/delivery-strategies-for-malaria-chemoprevention-in-the-post-discharge-management-c3a366a189f5c4a0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nicotine-pouches-harm-reduction-or-initiation-pathway-a-pharmacy-focused-review-62b0747f0f665915 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-lipoprotein-a-lowering-effects-of-kylo-11-a-non-canonical-long-durati-e84f903e1ae14686 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/variation-in-meningioma-recurrence-risk-estimates-across-observational-cohorts-t-57365a1d1fa4976f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treating-through-in-pediatric-patients-a-single-center-experience-bfeebd159f7a056f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-year-adjuvant-treatment-of-icotinib-in-stage-ii-iiia-egfr-mutated-lung-ade-f930a02dc21e435f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-high-intensity-interval-trx-training-on-body-composition-muscular-pow-0e285f69012d4303 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amyloid-pet-guided-anti-amyloid-therapy-in-corticobasal-syndrome-associated-with-43bd252871bc6481 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/selecting-the-right-probiotic-from-strain-specificity-to-rational-clinical-appli-972649fa5b07a586 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-outcomes-of-enhanced-recovery-after-surgery-for-laparoscop-524f67bb508e0521 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autonomic-dysfunction-in-pulmonary-arterial-hypertension-neurocardiological-mech-57fe093650ea8f82 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-efficacy-of-naloxone-hydrochloride-combined-with-hemoperfusion-in-to-665ddb16b84abbf0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transforming-liver-transplant-oncology-a-comprehensive-framework-for-clinical-tr-71680611426dbe03 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/animal-assisted-therapy-in-dementia-a-systematic-review-and-meta-analysis-of-cog-bb6622339e3eb6f2 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/results-of-the-carillon-procedure-in-proportionate-and-disproportionate-fmr-effe-5730fc8123d29f26 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-transplant-whole-blood-transcriptomic-profiling-identifies-mrnas-linked-to-c-8232f53c5f3d4a6f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-perspectives-on-pain-care-pathways-informing-implementation-with-insight-177d46724e4cc83a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prediction-of-risk-factors-for-respiratory-failure-in-children-with-mycoplasma-p-abf9b1dd8698434e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-early-infantile-drug-resistant-epilepsy-and-gastrointestinal-dysmoti-39c646a0382450a6 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-temporal-validation-of-a-postoperative-nomogram-based-on-clinica-2e7bd96d0b6658f2 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whole-wheat-bread-improves-postprandial-glucose-tolerance-in-adults-with-prediab-b5872ae2bb60aafc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-benefit-without-sweat-chloride-response-after-eti-therapy-in-an-adult-w-ac5bd3f07bded51b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-of-masquelet-technique-in-the-treatment-of-tibial-and-fibular-5f5299dd0feb923f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/streptococcus-suis-meningitis-complicated-with-communicating-hydrocephalus-compl-726e217ed6688e35 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feasibility-and-acceptability-of-two-remote-physical-activity-programs-for-older-203245df6eb3c78e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhibitory-immune-checkpoints-in-preeclampsia-current-landscape-mechanisms-and-c-f517bc39731f0a5c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oral-absorption-of-high-molecular-weight-polyethylene-glycols-mechanistic-safety-586121ba8fb385c1 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/df25d2161f91b84d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integration-of-artificial-intelligence-into-health-technology-assessment-optimiz-b46b59b4dbe768a7 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/addressing-drug-abuse-among-youth-with-disabilities-in-zimbabwe-737214337f32b61c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/setaria-digitata-novel-findings-of-antigen-protein-nucleotide-and-sequential-ant-28cd0edab6190fb1 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translating-nanoparticle-based-drug-delivery-systems-for-natural-products-into-c-7fb2873f04f9351d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-gc-ms-metabolite-profiling-and-antibacterial-activity-against-staphy-4920ff5ce4b85624 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/status-of-patients-satisfaction-with-hospital-food-services-among-patients-admit-4f043a2a1b8547e7 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nintedanib-treatment-of-patients-with-interstitial-lung-diseases-a-retrospective-4474a2b1a7b30714 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-radiographic-union-matter-clinical-outcomes-after-anterior-odontoid-screw-f-573bb5a742989a31 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-the-c-reactive-protein-albumin-lymphocyte-index-as-a-prognost-7946d7434dff1274 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cervical-cancer-screening-and-traditional-medicine-use-among-indigenous-women-in-d362d09f5966f18a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidemiological-study-of-covid-19-coronavirus-2-in-fct-abuja-nigeria-7beaf0c52dbba434 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/perceived-susceptibility-of-glaucoma-among-healthcare-workers-in-a-tertiary-hosp-46bb3c513ab2ba16 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multilevel-mechanistic-platform-for-antidepressant-response-prediction-integra-22096dcde0a4f956 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/llm-assisted-large-scale-curation-of-peptide-clinical-trials-maps-trends-in-ther-3328bc14b3242f86 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-external-validation-of-a-metabolic-clinical-xgboost-model-for-mo-27ffa075c4c45503 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-support-and-mobile-phone-based-diabetes-self-management-education-in-a-rura-c0b9c74290c83c94 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modern-approaches-to-the-treatment-of-ncmt-sexually-transmitted-infections-n-gon-a1d6af150c02626c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-system-of-interdepartmental-interaction-between-dermatovenereological-and-obst-948d638105d431c8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extensive-multiple-calcinosis-cutis-in-seronegative-limited-cutaneous-scleroderm-63a558d0fe8ba459 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-case-study-of-a-difficult-to-manage-patient-with-psoriatic-arthritis-ebdbb923ebbd94ea 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/focal-changes-in-the-mammary-gland-after-sectoral-resection-for-benign-tumors-li-30d6f18e443f8e92 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-case-of-pernicious-anemia-e1f54195cb2b6449 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chemoradiation-and-anti-pd-1-therapy-for-rectal-cancer-in-a-patient-with-multipl-b8215a6cbe9b38dc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bidirectional-regulation-of-c-myc-and-trb1-establishes-oncogenic-reciprocal-regu-b7ed4581402e51e8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-integration-of-trabecular-bone-score-in-precision-osteoporosis-care-a-p-f04ab15566d4b577 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-interactional-work-of-translating-clinical-practice-guidelines-in-primary-ca-3f262e131f923c51 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-balloon-guide-catheter-versus-conventional-guide-catheter-on-technical-2665a6a4af47cf93 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-global-clinical-trials-and-development-trends-of-antibody-drug-conjug-dbe7ffcab6b527cd 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-sp16-in-preventing-acute-kidney-injury-in-at-risk-subject-23d75e8a1dbdd0ad 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhanced-cognitive-behavioural-therapy-for-suicidality-among-people-with-comorbi-174618178621533c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metacognitive-training-for-negative-symptoms-mct-minus-in-schizophrenia-study-pr-ba1dd89163336e0d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/death-determination-at-the-bedside-clinical-judgement-beyond-criteria-02ba0dba2b7350f8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characterization-and-baseline-immune-correlates-of-immune-checkpoint-in-60bf6f09ad4a7391 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-an-improved-problem-based-learning-method-in-clinical-endodontic-4492fe1303e65153 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epidemiological-characteristics-and-clinical-outcomes-of-primary-congenital-glau-08e4d58869254ad4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-for-a-target-trial-emulation-choosing-the-right-dialysis-modality-948009fccb8bf9b0 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-better-plastic-to-better-pharmaceutical-packaging-systems-a-philippine-pers-86b9d2a002e80dd8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emergent-eeg-in-status-epilepticus-off-hours-delays-limit-clinical-utility-d8e3ea478f33a26e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitamin-k-sub-2-sub-and-d-sub-3-sub-supplementation-in-patients-with-severe-coro-271a896b5c92407c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaginal-oestrogen-therapy-for-postmenopausal-women-undergoing-prolapse-surgery-a-8a13db998a3658b2 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-corticosteroid-therapy-in-kawasaki-disease-a-meta-analysis-and-trial-beb2fecb8ed49a7e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-linear-associations-between-blood-pressure-and-clinical-outcomes-in-atrial-f-461c1594a7a92ff5 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/general-dermatology-and-dermatology-in-primary-healthcare-5ee386ff9f61fbc9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-public-health-economic-impact-of-rapid-strain-matched-vaccination-i-2f73c48054964369 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/misdiagnosis-of-soft-tissue-infections-clinical-pitfalls-and-management-implicat-f2ee2aa048279ba6 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/profiling-of-euphane-and-tirucallane-triterpenes-from-i-euphorbia-systyloides-i-67c5c57edf2258d4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-and-evaluation-of-a-novel-peptide-ev-complex-for-targeted-alzheimer-s-dis-656ae8d363c4e88f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-phonetics-and-phonology-in-speech-and-language-therapy-training-e2cbe1770130da2e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interpreting-oral-microbiome-research-in-clinical-dentistry-terminology-limitati-939b0e8ddd2f3608 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-year-adjuvant-treatment-of-icotinib-in-stage-ii-iiia-egfr-mutated-lung-ade-4c4970a9a6229e91 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serotonin-receptor-agonist-suppresses-colorectal-cancer-d098aa9788b5aca9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-metabolically-activated-molecular-glue-fcd0d3d57084c9f5 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viral-protease-initiated-pyroptosis-1440c82f485c64f8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-landscape-for-in-vivo-car-t-cell-therapies-27bfb3b21a91520f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-clinical-practice-to-the-compete-trial-prrt-confirms-superiority-over-evero-27442c220c002e13 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-study-coordinator-in-italian-nuclear-medicine-departments-a-national-cross-s-82fe0eb2b41e58a9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-a-relative-bioavailability-study-of-vepdegestrant-tablets-in-healthy-9698fcd39a3614bf 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-validation-of-a-novel-and-eco-friendly-rp-hplc-method-for-the-si-e3590e68c60ab928 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidence-mortality-and-survival-of-testicular-germ-cell-cancer-in-the-province-e0b98adffb3a1125 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/contemporary-epidemiology-and-real-world-management-of-hepatocellular-carcinoma-61d7b51dc11194c4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-port-robotic-areolar-thyroidectomy-technical-feasibility-and-clinical-out-e16eb9d3b356368e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/broad-spectrum-lc-ms-ms-hair-analysis-for-monitoring-recreational-drug-use-in-el-3b71cbeefbd8b2cb 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preferential-retention-of-the-lmp-1-promoter-at-ebv-integration-sites-in-lymphom-e6615bee27f956ec 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/timely-access-to-computed-tomography-and-magnetic-resonance-imaging-in-acute-cri-0ea7c42cbe53c697 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/risk-factors-for-polymicrobial-klebsiella-pneumoniae-bloodstream-infection-a-ret-25b69f2c45d9480b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-invasive-detection-and-monitoring-of-oral-squamous-cell-carcinoma-and-oral-p-d6d1829cce1deb82 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/methodology-of-analysis-of-cognitive-impairment-in-longitudinal-randomized-clini-15c31d0aa8d396bd 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07793695-a-randomized-controlled-trial-evaluating-different-doses-of-oral-zin-4b822ffe5f5d648b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07793461-gastrointestinal-dopamine-decarboxylase-and-levodopa-pharmacokinetic-436533ebf3b69e8b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07793149-comparison-of-kira-hydrating-treatment-and-jet-peel-for-facial-skin-bf4a43a40abe328d 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792902-microbiological-modulation-of-the-oral-gut-axis-after-treatment-with-3b8f627d029550fd 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792408-effects-of-vx-407-on-the-pharmacokinetics-of-combined-oral-contracep-687a5fe2ede6db19 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792395-ginger-s-therapeutic-potential-in-asthma-465e1f14fe0d1f39 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07792122-women-who-are-victims-of-violence-treatment-of-ptsd-through-reactiva-b94d31a09639efe2 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07791966-effects-of-non-invasive-brain-stimulation-on-pain-avoidance-behavior-dded1032831dbb80 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07791927-effect-of-non-surgical-periodontal-therapy-on-inflammation-in-heart-39c4672c7a41d961 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07782450-a-study-to-learn-about-a-medicine-called-pf-08154225-in-participants-e910108a8c416fc8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07777341-study-evaluating-the-effects-of-red-grape-juice-consumption-on-metab-02f4c47826b1c202 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07756853-visual-attention-object-recognition-and-eye-movements-in-healthy-vol-2779eef436dba5c6 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07716098-a-study-of-esketamine-nasal-spray-versus-placebo-spray-in-adult-part-7bfd0d02b87ee20a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07612176-a-study-of-neok001-a-b7-h3-and-ror1-targeting-bispecific-adc-in-part-bb349d5ee164efdf 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07594041-pulse-patient-understanding-and-learning-through-structured-educatio-58f8ae22e3a4b06a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07570173-a-clinical-trial-of-mk-1045-in-people-with-b-cell-acute-lymphoblasti-b5cab948918b604c 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07293650-precision-medicine-in-achalasia-premedia-251db7005626583e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07214272-a-phase-4-clinical-study-to-investigate-the-effectiveness-and-safety-0ba5d14b641ddcea 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07211958-study-of-revumenib-in-combination-with-intensive-chemotherapy-in-new-7b4a2873e7f11ef8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07196722-a-study-of-icotrokinra-in-participants-with-moderately-to-severely-a-af2ae903a6db9ef5 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07110376-deep-brain-stimulation-neural-recordings-of-varied-stimulation-durin-22d1cde4a83c3952 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06852222-a-study-of-bleximenib-venetoclax-and-azacitidine-for-treatment-of-pa-57f7594282957463 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06801210-the-weight-of-victory-exploring-short-and-long-term-health-outcomes-938c61da717ee19b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06741969-nipocalimab-in-moderate-to-severe-sjogren-s-disease-b222763cc3ba834a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06683755-phase-i-iia-dose-finding-study-of-triplet-regimen-of-relatlimab-ipil-231a83d2cddf3b6b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06585306-high-flow-nasal-oxygen-therapy-in-obese-patients-undergoing-sedative-9f4d4d2771d3543e 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06529718-testing-ivonescimab-versus-folfox-in-advanced-biliary-tract-cancer-p-c6ba8b358c237dfc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06528496-n10-a-study-of-reduced-chemotherapy-and-monoclonal-antibody-mab-base-b055b5586ee10a3a 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06500884-a-study-to-evaluate-preventive-treatments-for-gprc5d-related-oral-ev-61f78c788f314f61 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06385080-a-study-of-amivantamab-alone-or-in-addition-to-other-treatment-agent-d276bef86e3d0e43 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06319820-a-study-to-evaluate-tar-210-versus-single-agent-intravesical-cancer-f0d7e4b97a811928 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06152042-phase-2-trial-of-bmf-219-in-participants-with-type-1-diabetes-mellit-134de639456bf969 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06132958-sacituzumab-tirumotecan-mk-2870-in-post-platinum-and-post-immunother-8ab01b717ce9d5bf 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05926583-a-study-of-aav5-hrkp-rpgr-for-the-treatment-of-japanese-participants-13f6a436fe1e6978 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05344833-post-autologous-transplant-maintenance-with-isatuximab-and-lenalidom-335cc0af97788128 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05049798-a-study-of-guselkumab-and-interleukin-17-il-17-inhibitor-therapies-i-15bcf655708f3896 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04658862-a-study-of-tar-200-in-combination-with-cetrelimab-versus-concurrent-eb7a4002c8c668a4 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04644770-a-study-of-jnj-69086420-an-actinium-225-labeled-antibody-targeting-h-36bfba132500f121 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04444921-ea2176-phase-3-clinical-trial-of-carboplatin-and-paclitaxel-nivoluma-231a8bc4ebb524b3 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04357821-combinatorial-therapy-to-induce-an-hiv-remission-e85def91e81722f8 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04023552-assessing-the-impact-of-lipoprotein-a-lowering-with-pelacarsen-tqj23-3f1ddd5f10ff119b 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03762733-tissue-acquisition-and-genomics-analysis-of-breast-cancer-and-other-c9d8517b83477a8f 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03076554-a-pilot-study-to-investigate-the-safety-and-clinical-activity-of-ave-75f53eb78ecb7641 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02851706-natural-history-of-and-specimen-banking-for-people-with-tumors-of-th-7814b89c7e4b4197 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02194738-genetic-testing-in-screening-patients-with-stage-ib-iiia-non-small-c-9a3f887a3cdadad9 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02055209-genomics-environmental-factors-and-social-determinants-of-cardiovasc-34a05e8c24b14038 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01878045-mechanisms-of-diabetic-kidney-disease-in-american-indians-b8295f6f15ff9e99 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01386424-screening-for-lid-clinical-studies-unit-healthy-volunteer-protocols-c2fb2775f0963ede 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01117870-assess-the-effectiveness-of-pulse-radiofrequency-in-patients-with-ch-7411db205cf5c694 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01087307-sample-collection-registry-for-quality-control-of-biological-and-env-f5b88858ceefe450 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01081262-carboplatin-and-paclitaxel-or-oxaliplatin-and-capecitabine-with-or-w-77cbc26fc36a6ecf 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00070564-s0221-adjuvant-doxorubicin-cyclophosphamide-and-paclitaxel-in-treati-62a0a39af9749dca 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00005927-study-of-adrenal-gland-tumors-31c649e5eb3fb298 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001208-botulinum-toxin-for-the-treatment-of-involuntary-movement-disorders-2fbc72915383c9fc 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001205-natural-history-of-treated-neurocysticercosis-and-long-term-outcomes-e8ab7ef6ad0c4ea7 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/otsuka-holdings-enters-into-virtual-ppa-with-special-purpose-company-established-4a10c8e8e4c15635 2026-08-28T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-starts-korea-phase-3-for-dual-action-obesity-drug-cagrisema-chosunb-fc83d8dd58d24f7e 2026-08-27T23:39:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-biotech-files-world-s-first-approval-application-for-4-1bb-bispecific-an-74cf295930a2b9fc 2026-08-27T23:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cmp-plot-thickens-solicitor-general-letter-casts-fda-s-tobacco-civil-money-p-ef46a7eab44f91e1 2026-08-27T23:22:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/prescient-therapeutics-first-in-class-cancer-drug-approaching-a-pivotal-moment-d428ac967149648e 2026-08-27T23:02:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-u-s-china-biotech-race-heats-up-seattle-makes-its-case-to-d-c-c8b301f2f6bdfc8f 2026-08-27T22:39:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/prescient-therapeutics-first-in-class-cancer-drug-approaching-a-pivotal-moment-fe799ed68e9a8dc7 2026-08-27T22:34:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ganeshotsav-2026-cm-devendra-fadnavis-directs-mandals-to-ensure-hygienic-prasad-5cbb951d4a65855f 2026-08-27T22:03:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/florida-sues-two-pharmaceutical-companies-for-fixing-drug-prices-6b65bbcb04ce6ef7 2026-08-27T21:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/florida-sues-two-pharmaceutical-companies-for-fixing-drug-prices-dadee2d4ec0023ab 2026-08-27T21:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncologist-explains-what-the-rasonque-approval-means-for-patients-with-metastati-6baa3ab7ba78c903 2026-08-27T21:06:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/kane-biotech-announces-second-quarter-2026-financial-results-014156f082af9def 2026-08-27T21:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-inc-stock-outperforms-competitors-despite-losses-on-2c3ea34c296dc423 2026-08-27T21:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fast-growing-california-biotech-company-cg-oncology-relocates-its-hq-to-texas-77cf9b41bdde7c8f 2026-08-27T20:54:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/senator-young-attends-sk-hynix-groundbreaking-ceremony-in-west-lafayette-7970191236dac580 2026-08-27T20:53:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/small-kids-big-germs-tips-on-keeping-children-in-daycare-healthy-fcfae14be1ccd4bf 2026-08-27T20:37:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenx-nasdaq-argx-seals-forte-deal-for-first-in-class-autoimmune-antibody-306ceeea0bce8015 2026-08-27T20:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/making-space-for-jacob-s-big-dreams-rooted-in-family-support-7da8e15ded779ace 2026-08-27T20:18:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-ceo-sabrina-martucci-johnson-participates-in-the-v-5a4553ddb5f6f8d3 2026-08-27T20:10:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-pill-provides-a-meaningful-step-forward-for-those-fighting-a-rare-and-debili-36b3804389d2951f 2026-08-27T20:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/president-trump-planning-new-medicaid-drug-pricing-deals-pharmexec-1d716d6b9c2b8905 2026-08-27T19:58:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/recon-fda-weighs-new-deputy-commissioner-posts-trump-set-to-reveal-more-mfn-drug-6cde58b190a0a9fc 2026-08-27T19:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approval-opens-new-chapter-in-pancreatic-cancer-treatment-ac10e256c6148a1b 2026-08-27T19:53:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-brepocitinib-for-dermatomyositis-3db3e5307fe79508 2026-08-27T19:52:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/cassidy-faults-abortion-drug-makers-on-online-oversight-10c299bb548a03ff 2026-08-27T19:43:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-lomb-dry-eye-combo-drop-advances-to-phase-3-evaluation-0f13cba890e5f429 2026-08-27T19:38:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ai-and-rfid-boosts-supply-chain-visibility-edb82c513ecc08fa 2026-08-27T19:35:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/constantia-flexibles-brings-system-thinking-approach-to-pharmaceutical-packaging-bc408a4b574a2ae1 2026-08-27T19:27:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-biotech-kura-oncology-rallies-to-new-high-after-ceo-s-stock-purchase-70c5c166d956f75c 2026-08-27T19:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/looking-beyond-natural-sequences-f9628d0f6744ee51 2026-08-27T19:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-inc-stock-mrna-moved-down-by-5-69-on-aug-27-key-drivers-unveiled-0183c558544cee94 2026-08-27T19:15:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-puts-experimental-therapy-that-blocks-hae-swelling-on-fast-track-d0f334667a807a70 2026-08-27T19:07:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-advances-key-drug-trials-and-secures-350m-deal-with-sk-biopharmaceutica-24292b448a7414d6 2026-08-27T19:04:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-court-rejects-phrma-challenge-to-medicare-drug-price-negotiation-1f4b56615dea356c 2026-08-27T18:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-doesn-t-have-an-ai-problem-it-has-an-information-problem-6a51af078fbf9e30 2026-08-27T18:21:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohaven-buy-reiterated-on-opakalim-license-agreement-for-epilepsy-and-more-nyse-ea618fcaaa1a3ce6 2026-08-27T18:21:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-lauren-boebert-introduces-botanical-drug-development-act-of-2026-906e4ac541af89b9 2026-08-27T18:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-data-infrastructure-award-to-help-scientific-communities-build-domain-specif-5f724df333231d6b 2026-08-27T18:12:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/uc-irvine-school-of-education-to-lead-10-million-national-center-on-ai-and-posts-a229912f645f640c 2026-08-27T18:00:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-firm-plans-expansion-at-former-hauppauge-hotel-site-7c2a160975989f63 2026-08-27T17:56:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-emergency-use-authorization-for-generic-drug-to-prevent-new-world-scr-e0c02905bb1f95ff 2026-08-27T17:52:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/help-committee-report-shows-how-abortion-drug-companies-endanger-women-9d567fc78ee00d2a 2026-08-27T17:50:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-the-pdufa-viii-framework-means-for-clinical-research-organizations-01b3fe20d8b3e8aa 2026-08-27T17:42:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-in-utah-intermountain-health-brings-innovative-mri-technology-to-intermoun-ee502eb94ed35c8d 2026-08-27T17:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/sangrail-debuts-as-new-biotech-picks-up-dropped-gene-therapy-for-sanfilippo-synd-4b3e02ec443fc394 2026-08-27T17:32:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-chapter-for-families-living-with-gsdia-from-pioneering-research-to-fda-app-8dde84ef8e21da5a 2026-08-27T16:52:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/michael-polansky-has-a-new-skin-focused-biotech-don-t-call-it-a-drug-company-6305bc5018b3ab87 2026-08-27T16:48:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/rep-boebert-introduces-advancing-botanical-drug-development-act-of-2026-8105594c1b54dd75 2026-08-27T16:42:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubc-welcomes-nine-world-leading-researchers-through-eddie-goldenberg-research-ch-41a469b1f89fbc80 2026-08-27T16:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lilly-targets-china-s-obesity-market-with-new-phase-3-oral-orforglipron-trial-6b71bf0feaf1a064 2026-08-27T16:35:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/has-ai-forever-changed-governance-around-pv-technology-use-ba4517dfe71692bf 2026-08-27T16:15:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-names-former-abbvie-exec-as-cso-d4552b258eee8845 2026-08-27T16:11:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-canada-launches-clinical-trial-search-portal-and-registration-and-results-15d5caf102b70cfd 2026-08-27T15:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-origin-biotech-assets-and-the-hidden-question-of-ip-ownership-44a28c9af781e255 2026-08-27T15:20:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/mbx-biosciences-doses-first-patient-in-pivotal-phase-3-trial-of-once-weekly-canv-b2ed3f1d37963bc1 2026-08-27T15:17:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-offers-2b-in-notes-to-fund-cancer-business-repay-debt-2a9cc5b33d4129d9 2026-08-27T15:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-frontier-crystallising-the-future-of-medicines-1722ee6cc40f0e15 2026-08-27T15:11:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-frontier-crystallising-the-future-of-medicines-6b964b5e57a51464 2026-08-27T15:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-in-merck-and-moderna-s-cancer-vaccine-algorithm-070d5e725bd6e3b2 2026-08-27T14:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-fundamentals-hold-times-in-biopharmaceuticals-risks-and-regulations-2329b9dd72785235 2026-08-27T14:52:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/general-medical-services-statement-of-financial-entitlements-directions-4a85d169127d6c46 2026-08-27T14:51:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-directs-ban-on-sale-of-junk-food-within-50-metres-in-j-k-schools-227ee1ad3a91734b 2026-08-27T14:41:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-funding-has-returned-the-bar-has-moved-with-it-0ea906b496fa34a8 2026-08-27T14:41:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-trials-for-common-cold-vaccine-offer-encouraging-signs-3b9edaaf917581fd 2026-08-27T14:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/verrica-completes-enrollment-in-phase-3-ycanth-common-warts-trial-8c7f216684ecd8e5 2026-08-27T14:36:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/social-media-reading-between-the-lines-f56f0c3cc1a7e5de 2026-08-27T14:35:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-30-august-2026-9d92219e4189fce0 2026-08-27T14:31:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-nods-lilly-roche-s-alzheimer-s-blood-test-healthcare-etfs-to-track-now-46d738894293e4cc 2026-08-27T14:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/architecting-high-velocity-healthcare-intelligence-moving-from-clinical-support-03253a6f48b062b0 2026-08-27T14:22:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/experiments-reveal-critical-behavior-of-light-71ae499af5a22e71 2026-08-27T14:21:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-pulse-medicaid-deals-glp-1-pullback-mckesson-s-buy-6e0a9c8481d226ed 2026-08-27T14:14:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cepi-backs-push-to-bring-egyptian-biotech-s-ebola-vaccine-into-clinic-to-curb-fa-a00f25ce4dba5bd9 2026-08-27T14:10:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-targeted-drug-offers-hope-in-pancreatic-cancer-treatment-5722af05858fab39 2026-08-27T14:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/grand-pharmaceutical-group-sehk-512-stock-grapples-with-profitability-reset-ecd9ebeda9b2a563 2026-08-27T14:09:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/osivax-bags-flu-vaccine-rights-to-pursue-combination-shot-vision-b8120318cdfc5dc3 2026-08-27T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wall-street-moves-on-maa-rivian-and-design-therapeutics-one-upgrade-one-target-t-30dc3e4699cd7821 2026-08-27T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exciting-updates-for-sneaky-sasquatch-come-to-apple-arcade-5b7ed20d30e2d34e 2026-08-27T13:59:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-wall-street-analysts-predicting-west-pharmaceutical-stock-will-climb-or-sink-0acab186773b0e69 2026-08-27T13:58:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-mrna-cancer-vaccine-trial-delivers-positive-initial-results-680f6308a94507a3 2026-08-27T13:55:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-some-tough-years-frontier-s-ceo-is-ramping-up-ambitions-for-precision-med-5cf9a4b0acd220fe 2026-08-27T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-workforce-management-information-july-2026-b0508124761b606e 2026-08-27T13:48:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-lab-advancing-clinical-laboratory-science-through-collaboration-q-a-w-6f2f99973b85e907 2026-08-27T13:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-takeda-pharmaceutical-tse-4502-is-getting-attention-today-1a8062ff0b9ca4ff 2026-08-27T13:28:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/cassidy-exposes-lack-of-action-by-chemical-abortion-drug-companies-d321ccdff34ed0a2 2026-08-27T13:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmalittle-we-re-reading-about-a-pancreatic-cancer-drug-approval-a-trump-deal-0aaca3eb31f1237c 2026-08-27T13:22:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/irt-case-study-three-randomization-decisions-preserving-the-blind-9c8fe17695d35eae 2026-08-27T13:17:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-smart-pathology-slide-scanner-for-diagnosis-and-patient-specific-9bb5ba421ea7fa03 2026-08-27T13:17:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-verification-and-validation-of-a-biomarker-panel-that-identifies-ed188b208248b1d7 2026-08-27T13:16:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-devising-a-personalized-risk-stratification-and-holistic-manageme-8dfb5d75d20f20f9 2026-08-27T13:16:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-egyptian-pharmaceutical-firm-is-developing-an-ebola-vaccine-5437a06dba1f839e 2026-08-27T13:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-cassidy-exposes-abortion-drug-companies-endangering-mothers-in-new-report-9f378575220205ca 2026-08-27T13:15:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-proposes-mandatory-gras-notification-but-stops-short-of-premarket-approval-9534cab4d1f8fc0d 2026-08-27T13:15:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-fundamentals-risks-and-regulations-for-hold-times-in-biopharmaceuticals-84dd58d0f580183c 2026-08-27T13:11:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/aim-immunotech-participates-in-the-virtual-investor-why-now-on-demand-conference-03866c95e1edce26 2026-08-27T13:05:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/slack-capital-inside-exoz-strategic-shift-building-a-compounding-value-flywheel-a1db56d84023abfa 2026-08-27T13:04:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/asnc2026-to-showcase-pivotal-phase-3-trials-advancing-cardiac-amyloidosis-diagno-c736d80d86f54514 2026-08-27T13:03:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/julie-akers-named-dean-of-the-college-of-pharmacy-and-pharmaceutical-sciences-52d0ade8050c6ff0 2026-08-27T13:03:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/cassidy-says-abortion-pill-makers-turn-blind-eye-to-safety-bcbe43e6047df8b1 2026-08-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-participant-dosed-in-the-precise-hd-trial-of-pridopidine-abc8201fd7b719cc 2026-08-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/congressional-report-exposes-how-chemical-abortion-drug-companies-endanger-mothe-bc33b9b37eb492a6 2026-08-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/codexis-to-participate-in-cantor-global-healthcare-conference-2026-9f90d399bc6a01a7 2026-08-27T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cells-have-an-early-warning-system-for-stress-in-mitochondria-88ab21ebd2f43970 2026-08-27T12:51:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-s-next-ai-problem-is-authority-b83435d5cf4efe7a 2026-08-27T12:36:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/mfn-sparks-defiance-from-europe-s-larger-nations-uncertainty-among-smaller-ones-337eab0ace14506a 2026-08-27T12:35:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/egyptian-pharmaceutical-firm-developing-ebola-vaccine-7f9c0ff16e3a6bae 2026-08-27T12:27:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-awarded-7-96-million-nasa-inspa-phase-2-contract-to-advance-space-9e44ddf4c073de63 2026-08-27T12:03:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-appoints-chief-scientific-officer-to-lead-commercialization-push-b71420c94836ebcb 2026-08-27T12:03:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/verrica-pharmaceuticals-announces-completion-of-enrollment-in-first-pivotal-phas-b2c7b673d0d070e0 2026-08-27T12:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/mbx-biosciences-announces-first-patient-dosed-in-pivotal-phase-3-optimize-trial-88ba071cc48fe60c 2026-08-27T12:03:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/kyoto-summer-program-2026-concludes-8f5dd641bd837e01 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-flat-deck-wide-w-o-x-ray-8a3059c11a517489 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardinal-health-gynaecology-robotics-and-endoscopy-packs-da9a8327d401f3cd 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/automated-impella-controller-aic-788d371bcdf67039 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/apo-semaglutide-injection-incorrect-dose-display-7e5a93543545cc1f 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/about-160-adults-will-test-mbx-biosciences-once-weekly-hormone-replacement-00fdb1438f74d841 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eascra-biotech-appoints-chief-scientific-officer-to-lead-commercialization-push-5ef95f3c66743569 2026-08-27T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guggenheim-raises-amylyx-stock-price-target-on-financing-trial-data-51fbc40868923fb7 2026-08-27T11:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-tezspire-phase-3-trial-shows-eoe-improvements-16d8e59504298588 2026-08-27T11:57:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/asnc2026-to-showcase-pivotal-phase-3-trials-advancing-cardiac-amyloidosis-diagno-32fa677eff85ed2e 2026-08-27T11:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategies-for-scaling-complex-next-generation-biologics-ac30f2973643e278 2026-08-27T11:42:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/corvus-pharmaceuticals-announces-publication-in-blood-of-final-phase-1-data-from-35cdbf6204664b3d 2026-08-27T11:42:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/breaking-down-barriers-to-cervical-screening-the-evidence-for-hpv-self-sampling-aff8302ea2e2481e 2026-08-27T11:42:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/corvus-pharmaceuticals-publishes-blood-data-showing-soquelitinib-activity-in-t-c-bfecd89b7c450979 2026-08-27T11:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eyconis-initiates-first-in-human-wet-amd-trial-on-anti-vegf-therapy-6b65ee526bff72df 2026-08-27T11:35:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-sales-power-up-kelun-biotech-s-profit-engine-2696350d9f6d7379 2026-08-27T11:22:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pancreatic-cancer-pill-that-nearly-doubles-survival-time-bb3cd9f7d9eb1f72 2026-08-27T11:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-posible-fallo-en-la-fijacion-interna-de-la-bateria-en-det-4d08554902b13dff 2026-08-27T11:08:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-fda-s-trust-issue-with-china-c697abcfa52d6d3b 2026-08-27T11:07:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/countdown-to-biohk2026-world-class-biotech-convention-prepares-to-host-global-pa-8d965267ff593640 2026-08-27T10:57:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/consun-pharmaceutical-group-sehk-1681-stock-draws-focus-to-margin-strength-and-y-69556a55af84b8c1 2026-08-27T10:56:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-extends-leadership-in-advanced-tissue-regeneration-through-continued-clinical-c9242c683bd33f08 2026-08-27T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-spending-over-500-9d0eec9bf491adbd 2026-08-27T10:46:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/dhsc-spending-over-500-july-2026-9ab5615d68329e7f 2026-08-27T10:46:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/alnylam-s-heart-drug-troubles-take-center-stage-at-a-cardiology-conference-bccbccdc190fd742 2026-08-27T10:32:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/policies-can-unlock-medicinal-plant-biotech-innovation-36533abd04d95137 2026-08-27T10:20:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-full-path-of-drug-development-and-why-so-few-drugs-make-it-q-a-with-dr-ying-3049b4feb30695e2 2026-08-27T10:13:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-at-fda-two-frameworks-one-queue-08a9cc0968778de3 2026-08-27T10:07:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/inclusive-neighbourhood-health-720f4a30ebf9e404 2026-08-27T10:06:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/biovica-enters-master-services-agreement-with-biotech-co-f27e189667b10e02 2026-08-27T10:03:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-govt-office-canteens-shut-in-goa-after-fda-finds-structural-hygiene-lapses-bb644fd15d8565c3 2026-08-27T09:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parents-urged-to-vaccinate-children-at-the-right-time-to-protect-them-ef215c5d2ca4a741 2026-08-27T09:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/childhood-vaccination-coverage-provisional-monthly-data-for-england-096cd364d32970b8 2026-08-27T09:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/influenza-the-green-book-chapter-59d117b9cdf41816 2026-08-27T09:28:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/universitat-gratuliert-ausgrundung-zu-erfolgreicher-finanzierungsrunde-1e74f4bd8557af4b 2026-08-27T09:19:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-drug-approved-by-f-d-a-for-pancreatic-cancer-could-be-first-of-many-efcc0193b95088b8 2026-08-27T09:02:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccination-programme-2026-to-2027-healthcare-practitioners-5a1f0e07631d6d7e 2026-08-27T09:01:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/zelltherapie-bei-schwerer-rheumatoider-arthritis-erfolgreich-fb0051e516272bf1 2026-08-27T09:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-therapy-successful-in-treating-severe-rheumatoid-arthritis-d8785e80ba6df918 2026-08-27T09:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-glue-that-holds-the-body-together-also-helps-swallow-dead-cells-0dd5251a4320bb06 2026-08-27T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/indonesia-salicylic-acid-pharmaceutical-market-analysis-forecast-size-trends-and-4a6478989d1f5d7e 2026-08-27T08:57:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-sets-pdufa-review-for-nicox-ncx-470-8525c518abad698c 2026-08-27T08:51:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/revmed-s-pancreatic-cancer-drug-breezes-through-with-swift-approval-e03ee4031d2a3c6a 2026-08-27T08:47:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/developing-a-fit-for-purpose-release-testing-strategy-for-adcs-7195c448a56f368d 2026-08-27T08:42:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/huawei-plans-for-more-ai-pharma-tie-ups-says-healthcare-president-c0d288aa6cc4b22e 2026-08-27T08:39:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-bill-is-supposed-to-protect-u-s-biotech-from-chinese-competition-but-there-s-a-bb92c8d2113225a1 2026-08-27T08:37:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ukhsa-ad-hoc-statistical-publications-3cbe759f572dbfdc 2026-08-27T08:30:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-quality-and-methodology-i-477e4d0565e03491 2026-08-27T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pre-release-access-lists-cover-of-vaccination-evaluated-rapidly-cover-programme-ec8f4a8028f18415 2026-08-27T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cover-of-vaccination-evaluated-rapidly-cover-programme-april-2024-to-march-2025-d0e11bf449ed1b37 2026-08-27T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-prospectus-national-immunisation-programme-and-vaccine-products-0a3cfedf21999a22 2026-08-27T08:30:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-cameroon-lagging-behind-senegal-tunisia-and-morocco-4379a50c440bbb90 2026-08-27T08:22:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-anne-geert-volbeda-associate-director-drug-substance-development-and-manufa-20aa3517c84036a9 2026-08-27T08:14:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-group-sehk-1093-rallies-following-strong-h1-results-as-valua-76493e44aced1e97 2026-08-27T08:14:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/yongan-pharmaceutical-002365-sz-announced-its-semi-annual-results-with-net-profi-1a1fc8fcfdc1c346 2026-08-27T08:13:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/191-578-shares-in-ultragenyx-pharmaceutical-inc-rare-acquired-by-connor-clark-lu-88c8c3c139fdb1e4 2026-08-27T08:11:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-biopharmaceutical-contract-manufacturing-market-size-share-trends-growth-2070a9240f518a3d 2026-08-27T08:08:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/spin-out-technology-promises-to-cut-costs-of-protein-production-f046ab83b5b98bcc 2026-08-27T07:57:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-cancer-vaccine-one-shot-500-000-is-a-misreading-475-000-is-actually-a-pe-1533129447dda97f 2026-08-27T07:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/turkey-competition-authority-investigates-teva-for-alleged-drug-market-antitrust-f7a69ec35fbdcc68 2026-08-27T07:55:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/greece-poland-urge-irish-eu-presidency-to-advance-biotech-and-medicines-security-76d73c971132e50d 2026-08-27T07:37:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharmaceutical-secures-u-s-patent-approval-for-core-anti-aging-mrna-del-1993775475ee8a40 2026-08-27T07:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tezspire-hits-both-primary-endpoints-in-phase-3-eosinophilic-esophagitis-trial-1034db1966be34b6 2026-08-27T07:34:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/amgen-s-tezspire-improved-swallowing-and-esophageal-inflammation-for-52-weeks-441e00ec49461065 2026-08-27T07:13:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/marquis-who-s-who-honors-bernard-d-santarsiero-for-expertise-in-pharmaceutical-s-c9a17b24cae23418 2026-08-27T07:03:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-aemps-informa-de-un-posible-defecto-de-fabricacion-en-la-sonda-intermitente-u-acb2f441162c77e0 2026-08-27T07:00:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/spurned-lover-exposes-maharashtra-fda-drug-inspector-exam-paper-leak-5e6ff4394285a46b 2026-08-27T07:00:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/betty-irene-moore-fellows-convene-in-the-nation-s-capital-for-seventh-convocatio-432a27e7f10808d4 2026-08-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ready-to-take-control-of-your-breathing-register-for-the-ucan-bootcamp-7254d200cc3b5f03 2026-08-27T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-landmark-pancreatic-cancer-drug-that-s-shown-to-improve-survival-c8e28ed7ed364009 2026-08-27T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/asset-value-investors-raises-stake-in-wakamoto-pharmaceutical-co-ltd-to-11-64-fr-3d90a3862edc4989 2026-08-27T06:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/generate-biomedicines-gb-0895-phase-1-data-released-early-ahead-of-ers-presentat-cfa54ca27848d5fd 2026-08-27T06:39:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-japanese-ai-healthcare-stocks-with-real-world-revenue-5a1c4f4911ba830a 2026-08-27T06:29:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/xbiusd-p-charts-and-quotes-77d3d70aa07dbe4c 2026-08-27T06:28:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-jinling-pharmaceutical-co-ltd-class-a-szse-0-aea6ce70e2d3e9ab 2026-08-27T06:18:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/swedish-biotech-oncopeptides-q2-net-sales-rise-on-strong-demand-in-italy-c14b3a2de40cd1d5 2026-08-27T06:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-us-pharmapolitik-birgt-milliardenrisiken-fur-die-schweiz-szenar-d9d393e82916f2e6 2026-08-27T06:02:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-becomes-host-city-partner-for-one-young-world-2027-tokyo-summit-f44a942b4d8683a6 2026-08-27T06:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dksh-to-buy-thai-pharmaceutical-ingredients-distributor-pr-chemicals-4a1019ffc0857bc8 2026-08-27T05:49:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/brain-biotech-reports-its-9m-results-and-continues-to-target-a-break-even-adjust-62fb514d6c7466e6 2026-08-27T05:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-secures-us-patent-allowance-for-anti-aging-mrna-technology-3e65e930c340b867 2026-08-27T05:21:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-explained-tukaram-mundhe-s-role-and-powers-09dba0243e88b35a 2026-08-27T05:11:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-sales-forward-of-biotech-growth-trust-plc-lse-biog-94b0f38bc0c83816 2026-08-27T05:08:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/monod-bio-licenses-ai-designed-protein-technologies-to-signalchem-biotech-for-cu-6c04c7c267f134cc 2026-08-27T04:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/countdown-to-biohk2026-world-class-biotech-convention-prepares-to-host-global-pa-d9b0ea04325df13b 2026-08-27T04:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-esophageal-ph-monitoring-capsule-delivery-device-issue-from-medtroni-ccb87de905fe2bee 2026-08-27T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenience-kit-correction-avid-medical-issues-correction-for-kits-containing-me-00d149c39450a146 2026-08-27T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genscript-biotech-sehk-1548-on-widening-losses-and-falling-sales-still-looks-pri-fc81b80aba1967a5 2026-08-27T03:56:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-approves-drug-that-could-extend-survival-in-metastatic-pancreatic-cancer-857edbf8b423281e 2026-08-27T03:55:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/viva-biotech-announces-its-2026-interim-results-ai-sparks-new-paradigm-in-drug-r-185fd43977ec7c4b 2026-08-27T03:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dimerix-banks-us-10m-upfront-everest-payment-087ae953acdf4a84 2026-08-27T03:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supply-had-to-respond-to-live-reality-science-in-motion-series-78ab30a206da4267 2026-08-27T02:44:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenica-therapeutics-asx-agn-stroke-drug-clears-fda-requested-safety-tests-and-6df412018988511f 2026-08-27T02:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mflusiva-becomes-the-first-mrna-influenza-vaccine-approved-by-the-fda-6fba44ff1f01c8f2 2026-08-27T02:27:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-costly-180-the-d-c-circuit-flips-fda-s-forfeiture-playbook-54a5d541e5fce3f6 2026-08-27T02:09:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-akeso-says-cancer-drug-beat-astrazeneca-s-imfinzi-in-phase-3-trial-4bafcfe0a6092aed 2026-08-27T02:07:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-sales-forward-of-oxygenta-pharmaceutical-limited-bse-oxygentaph-7871038d58521e23 2026-08-27T01:54:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/julius-baer-s-jeffrey-tam-diversify-equities-with-financials-and-biotech-2099fcf5234899a3 2026-08-27T01:02:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-burning-rock-biotech-ltd-bnr-overvalued-after-6-5-rally-g-f706dc4c6fc3e097 2026-08-27T00:32:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/caliway-secures-fda-ind-clearance-for-cbl-514-tirzepatide-phase-2-trial-advances-5982964abead952c 2026-08-27T00:29:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/argent-biopharma-takes-cannepil-into-us-veterinary-regulatory-process-ffc58a54a883cb74 2026-08-27T00:14:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-drug-sales-power-up-kelun-biotech-s-profit-engine-ca7aec4c70da925a 2026-08-27T00:02:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-2ccdf4f0471425d5 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-2a54c873a2b75b29 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-regarding-advertisements-for-new-residents-issued-under-the-name-of-the-y-22852c73407e61e4 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedules-of-controlled-substances-placement-of-cipepofol-in-schedule-iv-11a37ca7b7396f89 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-c2422d2b15041fad 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedules-of-controlled-substances-temporary-placement-of-5-6-dichloro-brorphine-95ed84743fb4e4cf 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-for-human-use-drug-efficacy-study-implementation-estrogen-androgen-fixed-c-2c57c3f837fe6e09 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-4b59f57ed85d54b3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-amended-notice-of-meeting-b3b415e5622b0234 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-vietnam-administr-3602300defd86638 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/notice-of-award-of-a-single-source-cooperative-agreement-to-fund-elizabeth-glase-202c9e0ad06ce315 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-fingolimod-9e3fbc2ff48465c7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-venlafaxine-hydrochloride-c2fbbb762af3ccc8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-vertifix-4538ee67ebd1ee9f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-surface-x-cutie-pals-hand-sanitizer-surprise-db0be0c213747a55 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-levetiracetam-er-76ac644cf817e334 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-potassium-chloride-extended-release-780e0a622ed4e5f0 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cevimeline-hydrochloride-057e91d165860728 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-clopidogrel-bisulfate-0bfa75f68f33b942 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-clobetasol-propionate-cream-usp-0-05-clobetasol-propionate-cre-1a4a07b82937896d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-torsemide-6d4bc9215cf8114f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-clonazepam-0c32c672535c1889 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-methotrexate-bbf734b231ee4c8e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cytarabine-e064e1ec881822f8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-aqvesme-3c66fe9122b8651f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-olmesartan-medoxomil-1601c3f07fd1348f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ticagrelor-7c6d912c6513f331 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sertraline-hydrochloride-707dd8a0d187e39e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-allopurinol-a635c05731ba8c3b 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-xylocaine-054176961df01fd7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-rasonque-6f293d1ea64a32c8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-mucus-relief-extended-release-8e5bd81f6a692ba3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-eagle-brand-eagle-balm-53e815f71fa2aaa5 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bupropion-hydrochloride-57729552f3eee60d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-vardenafil-hydrochloride-f6523a8b269e6268 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-61f3aa478eb76b96 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-glipizide-fd1554ff08373cd5 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bausch-health-s-ortho-dermatologics-announces-the-2026-aspire-higher-scholarship-fd9c11f2e8456915 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unlocking-pharma-s-potential-the-ai-aided-nlp-revolution-14c2f62b66cd2524 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remimazolam-versus-etomidate-for-induction-of-general-anaesthesia-in-elderly-pat-bca64402ebaa9b1a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-highest-clinical-trial-failure-rate-for-any-disease-in-modern-medicine-how-b-ec70397734e83d7a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oliceridine-versus-sufentanil-for-postoperative-intravenous-analgesia-in-patient-aaa3243dffecd7a2 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-dexmedetomidine-on-respiratory-mechanics-in-elderly-patients-undergoi-a3deaf6b8dc6c424 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevention-of-postpartum-methamphetamine-use-with-micronized-progesterone-trial-b29e280812d065a7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/depression-nutritional-status-and-substance-p-nk-1r-biomarkers-in-dysmenorrhea-a-88cfe6417fef0997 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-population-heterogeneity-in-drug-research-and-early-development-a-pr-bc3629675616258e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reporting-and-representation-of-participant-race-ethnicity-and-sex-in-pediatric-3820902cee5c78db 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/management-of-liquid-pharmaceutical-residues-in-the-intensive-care-unit-an-ancil-03bc7ac2f720a553 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expedited-pathway-portfolios-trial-complexity-and-fda-approval-timelines-in-onco-89c519cad6f4558d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-care-in-patients-with-gastric-cancer-treated-with-capecitabine-a-a857cdac0f25ec01 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pilot-study-comparing-the-effects-of-high-dose-thc-to-high-dose-psilocybin-and-p-7419417349b93cd6 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statins-in-abdominal-aortic-aneurysm-a-risk-benefit-analysis-4380c7922dbccd21 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/loberamisal-for-acute-ischaemic-stroke-lais-a-multicentre-randomised-double-blin-927a43e574752a14 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/loberamisal-injection-for-the-treatment-of-acute-ischaemic-stroke-a-multicentre-c3667d108cb24028 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-research-domain-criteria-rdoc-and-the-five-aggregates-i-skandha-i-s-of-the-e-7adb10e3a88e988e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-evaluation-of-postoperative-pain-following-nonsurgical-root-canal-tr-a56f2e37b602d17d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/author-response-a-whole-animal-phenotypic-drug-screen-identifies-suppressors-of-6d4b7c1d7b6663d0 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reviewer-2-public-review-a-whole-animal-phenotypic-drug-screen-identifies-suppre-3c07d5ef2c926843 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anti-inflammatory-effects-of-cleistocalyx-nervosum-var-paniala-fruit-extract-on-ed90604f6ea646eb 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-detection-to-clinical-decision-artificial-intelligence-based-risk-stratific-98d9a098f40e9765 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microsurgical-aspects-of-middle-cerebral-artery-variations-clinical-and-anatomo-dce0e79a451967de 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-divergent-management-of-melasma-a-2026-clinical-review-comparing-traditional-df45772b9f6aa101 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-therapeutic-potential-of-phages-in-multi-drug-resistance-infections-and-futu-9b0460286f397ff5 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/verification-index-for-the-repositioning-of-a-single-implant-analog-in-the-corre-d0a051def532bbd6 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-repetitive-peripheral-magnetic-stimulation-versus-sham-stimulation-on-4286847020e08afb 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibacterial-interventions-for-orthodontic-appliances-surface-modifications-coa-b1060c25f99c295e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/late-course-lactate-albumin-ratio-and-in-hospital-mortality-in-crrt-treated-crit-f186cf0b314daa51 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-decade-of-data-from-an-ivf-center-factors-contributing-to-infertility-their-pr-0856ed3b96a11339 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-swelling-clinical-insights-into-the-diagnosis-and-management-of-hereditar-e733b239f04a7c15 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-dupilumab-on-allergen-specific-ige-levels-and-clinical-tolerance-in-pa-4614b126c0b5c42c 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypokalemic-hypochloremic-metabolic-alkalosis-in-cystic-fibrosis-a-retrospective-4b8e502b769412c3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-a-nurse-led-web-based-fall-prevention-program-on-fall-risk-and-fear-o-03b7a06a3897890a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intra-and-inter-session-reliability-of-average-and-trial-level-motor-evoked-pote-1dfbb50a739906f8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laryngeal-transplantation-from-experimental-feasibility-to-multidisciplinary-cli-529e593cccb92fbc 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-effectiveness-of-therapeutic-ultrasound-and-pharmacotherapy-in-the-m-ea5f41df2fef7457 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cost-effectiveness-of-tremelimumab-plus-durvalumab-versus-sorafenib-for-unresect-aab5a28b62e290b9 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychological-capital-perceptions-of-clinical-stressors-and-bullying-experiences-391a63675e33ac15 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-drug-monitoring-of-zonisamide-in-children-with-epilepsy-development-fea6749664f3f15d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-associations-of-cortical-connectivity-modulation-with-clinical-and-eb8a19462a92c6f3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-features-associated-with-cerebrospinal-fluid-epstein-barr-virus-positiv-2e9d5f1298439163 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-advances-in-flow-diverter-interventions-for-complex-intracranial-aneur-b366018e62ca5999 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/internal-carotid-artery-type-cervical-spondylosis-is-not-supported-as-an-indepen-f9dceddd066170d3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-2-hz-versus-100-hz-electroacupuncture-for-pain-dominant-s-7d49e858d5e34d07 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aggregate-index-of-systemic-inflammation-and-glaucoma-status-population-based-ev-6d7f39af12c59ddc 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-and-clinical-outcomes-among-stage-ii-iva-nasopharyngeal-carcinoma-pati-752234e3d4b44f5c 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/datopotamab-deruxtecan-in-breast-cancer-treatment-a-systematic-review-of-clinica-6222cb836b8d1a2e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-empowered-echocardiography-an-updated-review-of-clinical-16bb1b044016d7aa 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anti-gd1b-positive-sensory-ataxic-guillain-barre-syndrome-with-bulbar-involvemen-d7da6b7ca2f6354b 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-letrozole-versus-clomiphene-citrate-in-polyendocrine-meta-6dc0ea339d824b80 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inverse-target-trial-emulation-a-method-to-simulate-realistic-observational-data-31083ad2aebe9398 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/broadening-treatment-options-in-primary-care-behavioral-health-pcbh-a-pilot-rand-b6646b863c7da910 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-clinical-multimodality-imaging-and-electrophysiological-markers-for-i-8121ebb6bd468547 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroimaging-abnormalities-and-genotype-phenotype-correlations-in-noonan-syndrom-8a1529df2920307f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-semaglutide-versus-bariatric-surgery-on-noninvasive-markers-of-hepati-b54dcdc1947498e4 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-protect-study-prosthesis-telerehab-care-trial-home-based-telerehabilitation-8e41464719e37d49 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polymyxin-b-hemoadsorption-in-endotoxic-septic-shock-ten-questions-on-the-tigris-12f494423d646d79 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-ventricular-unloading-during-va-ecmo-for-refractory-cardiogenic-shock-a-tar-1491ee0039ecc3e7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-clinical-case-discussions-in-anatomy-on-national-exam-performance-a-10-18f3a755d2ec918e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-study-to-develop-a-computer-model-for-measuring-how-a-drug-is-distributed-in-t-d865c28dbbd3649f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correlates-and-predictors-of-metamemory-in-an-online-sample-8da49a1fb3401113 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s1-from-tumor-mutational-burden-and-clinical-outcomes-in-pa-7c081d8b1f7aa1fa 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s2-from-tumor-mutational-burden-and-clinical-outcomes-in-pat-31d79fc551070ff8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-table-s3-from-tumor-mutational-burden-and-clinical-outcomes-in-pat-3aae546da419dfdf 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/viewing-kidneytime-videos-is-more-likely-to-result-in-live-donor-inquiries-than-fa51a7e0300fe3fc 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plant-derived-heterocyclic-compounds-a-promising-review-on-natural-remedies-for-e366d27d64f11dbc 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-spasticity-education-without-borders-platform-6a0ee531ebf3e545 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effectiveness-of-ergonomic-training-and-chiropractic-treatment-in-industrial-0eaf87b5ff25eaba 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiological-and-clinical-outcomes-following-pelvic-support-osteotomy-with-limb-35a22f7753a80ed8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyanide-toxicity-following-an-amygdalin-and-coffee-parasite-cleanse-0183c5df0050aeff 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quotidian-harms-vanishing-hands-the-challenge-of-discerning-accountability-in-an-6e8782db34fccd05 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-on-quality-of-life-and-erectile-function-recovery-in-unfavorable-40ffbd6e73a6b91a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-placements-beyond-numbers-a-guide-to-understanding-and-enhancing-clinic-39ed4566c60da051 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wrongly-estimated-pretest-probability-can-be-harmful-fc8727ab1f8ebc33 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/concordance-of-surveillance-colonoscopy-recommended-intervals-with-australian-gu-3eaa8badb40d99c7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-gut-microbiota-psychotropic-drug-interactions-and-their-impact-on-offsp-b16705790ebaf790 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/belzutifan-plus-lenvatinib-delays-disease-progression-in-advanced-stage-rcc-5cbfcadf084180ed 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reply-to-bridging-predictive-algorithms-and-clinical-practice-in-dbs-contact-sel-a46b3689b5efce0e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/matters-arising-bridging-predictive-algorithms-and-clinical-practice-in-dbs-cont-7c1fe8a649b1345e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prosci-246-with-dietary-guidance-alters-gut-microbiota-and-metabolism-in-childho-7bf44b104748aba2 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodal-deep-learning-framework-with-cross-attention-mechanisms-for-automated-405affff4dc86d0f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-association-between-cumulative-average-grip-strength-and-successful-3dd30478f76c8d80 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-genomics-of-primary-and-metastatic-cutaneous-melanoma-a-systematic-re-e748863b459e1581 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nyctanthes-arbor-tristis-attenuates-hyperglycemia-an-integrated-experimental-and-2fda11869715fb78 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/klinische-kenmerken-en-chirurgische-behandeling-van-urogenitale-endometriose-een-73307134e804b12c 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ovarian-cancer-tumor-immune-microenvironment-and-its-clinical-trial-implications-4a9773e985cd77eb 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/post-infectious-cerebellitis-a-systematic-review-of-aetiology-clinical-presentat-596c285e5927991a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/antioxidant-and-neuroprotective-effects-of-copper-nanoparticles-synthesized-usin-858059a4258dd4c7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pilot-randomized-controlled-trial-of-the-emotion-detectives-in-out-a-blended-ver-7d7ead19631c17ac 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/candidate-residual-inflammatory-risk-in-hfpef-a-multiorgan-framework-for-longitu-064392d9a6c824ca 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/coordination-of-care-in-the-context-of-primary-brain-tumors-australian-healthcar-5c5cf53c4a5062ce 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-multimodal-prehabilitation-with-wearable-device-monitoring-in-lung-can-4bbb61e774f65f31 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preoperative-structural-and-electrophysiological-markers-associated-with-visual-b50bcb7704d2265a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/suicidal-ideation-and-cognitive-function-a-comparative-study-in-adolescents-with-f11e418596940f6f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-case-and-follow-up-of-i-babesia-banethi-i-infection-in-a-red-fox-4f291f8e414a100a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/metal-organic-framework-ag-sub-24-sub-trz-sub-18-sub-sup-6-sup-as-a-nanocarrier-b9d88765fb196a03 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-global-postural-re-education-in-individuals-with-text-neck-syndrome-a-d99be1f9e34976ac 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-metacognitive-beliefs-and-cognitive-flexibility-associated-with-cannabis-use-77538bc43163ba70 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-response-to-hypomethylating-agent-based-therapy-on-survival-outcomes-i-62ae33e8c3449216 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07791225-the-variable-ventilation-trial-part-a-fd05b0e99415447c 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07791108-outcomes-of-intra-articular-steroid-injection-via-ultrasound-guidanc-da6d8c453100f4cb 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07790406-surgical-outcome-of-da-vinci-single-port-surgical-system-in-lung-can-a37fb3a3afb2937a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07790315-patient-reported-outcomes-for-different-orthodontic-thermoplastics-u-ec2643ab5a9fd420 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07790289-aerobic-strength-kegel-ask-exercise-intervention-perceptions-for-pos-3fe3483469f1c74d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07789938-intraoperative-neurophysiological-monitoring-in-brain-tumor-surgery-55da570fdd8a4747 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07749716-phase-ii-clinical-study-of-vc005-tablets-in-subjects-with-severe-alo-9dcf3dfd9046e3a8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07730489-a-study-comparing-bl-m07d1-with-physician-s-choice-therapy-in-patien-2c4dd2928d440b8a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07655479-rapid-microaxial-flow-pump-support-and-escalation-in-patients-with-m-a07d71c43a31cbfd 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07637942-cabotegravir-rilpivirine-antiretroviral-therapy-in-pregnancy-a130ff2db48a9d1e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07544680-endometrial-cancer-vaginal-fluid-specimen-collection-study-e263ca73bb6fd5ce 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07506863-a-study-to-investigate-the-efficacy-pharmacokinetics-and-safety-of-m-e30415161430154a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07409584-mental-health-and-suicidality-in-glioblastoma-patients-in-germany-3436a0bc4bbd383d 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07323173-a-study-to-assess-the-safety-and-pk-pd-of-lbl-047-in-healthy-adults-9d473f83b86adee2 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07279935-osimertinib-combined-with-chemotherapy-in-patients-who-had-distant-r-162eda1c87150780 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07213674-a-study-of-xaluritamig-plus-abiraterone-versus-investigator-s-choice-381fbae183080a1a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07117214-a-phase-i-study-of-68ga-ga-dwj155-in-patients-with-breast-and-lung-c-597c2e36769af511 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06887192-a-study-to-assess-the-efficacy-and-safety-of-ml-007c-ma-for-the-trea-8beba07e1709ce8e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06494579-lamivudine-for-solid-tumors-ccb29d75d2e26ea8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06014580-molecular-and-epidemiological-characteristics-of-endometrial-cancer-d9e8e1f9e3290fb7 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05873478-correlation-of-anti-gravity-muscle-strength-with-glycemic-control-du-7ac8722d217e6e4c 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05785039-a-study-of-bl-b01d1-in-patients-with-multiple-solid-tumors-including-329b04bcce9c2cef 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05675436-investigating-the-mechanistic-effects-of-mitapivat-in-subjects-with-75bd2a8f48aa4583 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05500092-an-open-label-randomized-study-of-neoadjuvant-nivolumab-and-chemothe-f5e0302b193a558e 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05314998-adjuvant-trial-in-patients-with-resected-pdac-randomized-to-allocati-8f5c5a72298d7122 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04927416-the-role-of-68-gallium-dotatate-pet-ct-in-the-imaging-of-metastatic-85a3cad6247d32ff 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04589468-researching-the-effect-of-exercise-on-cancer-585881e41e892eb9 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04426461-approach-avoidance-computational-framework-for-predicting-behavioral-ad093d2928e6afc3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03937817-collection-of-human-biospecimens-for-basic-and-clinical-research-int-1b29411e2a9c58c3 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03854318-longitudinal-studies-of-patient-with-fpdmm-2f8eb997d00c7f0f 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03841617-the-use-of-124-i-pet-ct-whole-body-and-lesional-dosimetry-in-differe-f411f274236149c9 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02852213-a-single-stage-adaptive-open-label-dose-escalation-safety-and-effica-80798de67cbf27ba 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02821780-cadasil-disease-discovery-fb8afeba7ed2b916 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02795806-nlm-scrubber-nlm-s-software-application-to-de-identify-clinical-text-ab992629eaacba87 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02656381-uveitis-intraocular-inflammatory-disease-biobank-ibank-6ce052cdefe7a73a 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02107989-noninvasive-pre-surgical-evaluation-of-patients-with-focal-epilepsy-f5ce73a217dc6a44 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01867411-multimodal-neuroimaging-genetic-biomarkers-of-nicotine-addictionseve-74c61c6f9de990e8 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01621594-evaluating-new-radiation-techniques-for-cardiovascular-imaging-ea77bcefdb740e89 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00373841-genomic-and-proteomic-analysis-of-disease-progression-in-idiopathic-0da692d097f49f60 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00326482-liver-fibrosis-in-hiv-infected-patients-with-elevated-liver-enzymes-0645ed3803e1e7db 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00059748-studies-of-the-natural-history-pathogenesis-and-outcome-of-autoinfla-750799e7ab231100 2026-08-27T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharm-s-795m-drug-deal-signals-new-era-for-korean-biotech-1c4d96d562c7755a 2026-08-26T23:54:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-tips-for-launching-pharma-products-in-europe-3cafcc8160216db8 2026-08-26T23:16:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/umb-celebrates-america-at-250-umsop-innovators-helped-build-the-nation-s-pharmac-9fa383987c5944d0 2026-08-26T22:55:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-photos-fda-chief-tukaram-mundhe-explains-food-safety-crackdown-962e468b4757841a 2026-08-26T22:54:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-groups-raise-questions-about-fda-s-expedited-ind-pilot-5fc32957675c5f77 2026-08-26T22:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-once-daily-pill-for-deadly-cancer-after-patients-survival-rates-nea-aa226c7fabed64d2 2026-08-26T22:13:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-once-daily-pill-for-advanced-pancreatic-cancer-298acc475880d1ce 2026-08-26T22:03:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-patient-enrolled-in-the-phase-3-revera-301-pivotal-trial-for-afib-2014f437dc56a4d1 2026-08-26T21:38:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/7b-biotech-company-leaves-oc-for-texas-citing-business-advantages-report-5fd475aeaa441621 2026-08-26T21:36:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-conversations-on-what-s-driving-pennsylvania-s-edge-in-life-sciences-and-b-2756eaf98fd64638 2026-08-26T21:22:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-melanoma-vaccine-trial-succeeds-5a7b2c0e0da52005 2026-08-26T21:19:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/bipartisan-senate-bill-would-prevent-offshoring-biotech-industry-to-communist-ch-604e6974267daac4 2026-08-26T20:30:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-to-present-at-major-healthc-06345dbd937bb61a 2026-08-26T20:27:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-rasonque-for-pancreatic-cancer-when-it-s-available-and-cost-fd745bd21f0b0047 2026-08-26T20:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introducing-deep-phenotype-a-new-home-for-perspectives-on-ai-biology-and-the-fut-98b21d37e1e1120b 2026-08-26T20:17:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/bd-to-present-at-wells-fargo-21st-annual-healthcare-conference-e6ab46fbeff66c41 2026-08-26T20:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nagpur-fda-shuts-down-mayo-hospital-s-doctors-canteen-over-licence-hygiene-viola-1f378c0dee4cc34d 2026-08-26T20:13:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-3-epilepsy-study-is-among-xenon-s-six-planned-europe-presentations-789041a2a529bc0b 2026-08-26T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/xenon-to-highlight-phase-3-x-tole2-clinical-data-and-rational-polytherapy-potent-b453d17f276da1ff 2026-08-26T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bipartisan-senate-bill-would-prevent-offshoring-biotech-industry-to-communist-ch-9206b553ebd87b26 2026-08-26T19:23:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-blood-disorder-drug-gains-a-boxed-warning-regulators-overruled-the-language-ee45cd4862fd193c 2026-08-26T19:20:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/michelle-britt-why-pharmacists-need-a-seat-at-the-policy-table-f12211343006ea0e 2026-08-26T18:47:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-alliance-closing-remarks-8b7d305f5ce11677 2026-08-26T18:45:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-processing-workers-earn-significantly-higher-salaries-17a13af0b46b52b3 2026-08-26T18:44:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-administration-preparing-new-round-of-medicaid-drug-pricing-deals-report-31a0902d6105324b 2026-08-26T18:43:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/breaking-news-daraxonrasib-approved-for-pancreatic-cancer-a44bad8f2733e5dc 2026-08-26T18:20:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-s-sildenafil-cream-data-in-postmenopausal-women-pu-eeaead3a8162b3c9 2026-08-26T18:14:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/flamma-newsletter-summer-2026-edition-44aaf9bb431d58e0 2026-08-26T18:07:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/heidi-overton-and-the-overton-window-7bc5bf7336713374 2026-08-26T18:01:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/haisco-licenses-preclinical-immunology-asset-to-sentivera-pharmexec-1fc7a09f96ab4810 2026-08-26T17:58:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/revolution-drug-heralded-as-a-pancreatic-cancer-breakthrough-cleared-by-fda-dd78addcd6aee95b 2026-08-26T17:46:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/daraxonrasib-clears-fda-as-first-ras-targeted-pancreatic-cancer-drug-758d3969a5a8a68f 2026-08-26T17:39:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-commissioner-stresses-shared-responsibility-for-safe-food-f6ab112344ce4b80 2026-08-26T17:32:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-public-safety-can-influence-public-health-b40f08cb839f792e 2026-08-26T17:28:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-is-bringing-his-drug-pricing-push-to-midsize-biotech-companies-40ce14ce59033313 2026-08-26T17:26:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-safe-food-a-shared-responsibility-not-just-fda-s-job-says-tukaram-mu-ba89f221c869116a 2026-08-26T17:25:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-the-science-behind-cooling-the-body-down-on-the-cellular-level-in-94aefe494444ea18 2026-08-26T17:21:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-safe-food-a-shared-responsibility-not-just-fda-s-job-says-tukaram-mu-c5f7d4668ef573c0 2026-08-26T17:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-alliance-global-immunotherapy-platforms-in-usa-saudi-clinical-trials-10a35e70ff4fe992 2026-08-26T17:17:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/hiv-prevention-injection-cdsco-exempts-dr-reddy-s-and-mcure-pharmaceuticals-from-8cff1dca2906ee02 2026-08-26T17:09:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/faq-how-is-trumprx-performing-six-months-in-be857d34971c7d1e 2026-08-26T17:07:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-to-announce-new-drug-pricing-deals-with-biotechs-bloomberg-news-repo-ad10dbdca8092892 2026-08-26T17:06:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-jiangsu-says-it-will-support-pharmaceutical-firms-global-m-a-licensing-b4c0f760b8def7ec 2026-08-26T16:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-greenlights-viiv-s-tivicay-pd-for-hiv-positive-newborns-in-first-month-of-li-6b8d97227813b255 2026-08-26T16:30:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-takes-major-action-tukaram-mundhe-says-3-100-food-outlets-inspected-165-lice-5db5552c3a238640 2026-08-26T16:29:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-safety-crackdown-intensifies-in-india-big-facilities-under-fda-lens-d0b0d518e852a622 2026-08-26T16:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-to-announce-new-drug-pricing-deals-with-biotechs-23e166811586b0ce 2026-08-26T16:13:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/biophytis-bptsy-leans-on-asia-jv-to-fund-bio101-phase-3-push-933a74b1827ce333 2026-08-26T16:09:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-fda-updates-substantial-evidence-gene-therapy-development-and-ai-enabled-ear-058925d93a212db6 2026-08-26T16:07:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-approves-breakthrough-pancreatic-cancer-drug-heralding-a-new-era-for-an-intr-62343a5406cd4734 2026-08-26T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-landmark-pancreatic-cancer-drug-that-s-shown-to-improve-survival-a493daccdd0c9a9b 2026-08-26T15:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tackling-local-health-inequalities-c31b3e271fc17e11 2026-08-26T15:37:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/ns-035-34315f52f49445ce 2026-08-26T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-greenlights-revmed-s-pancreatic-cancer-gamechanger-32a1680223d8078b 2026-08-26T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/siv-training-is-still-too-redundant-the-data-shows-where-to-start-88347db14a1ea86c 2026-08-26T15:28:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/76th-who-regional-committee-for-africa-special-update-on-the-ongoing-ebola-virus-8e1ca0c1834628f2 2026-08-26T15:26:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-says-i-am-no-celebrity-dismisses-internet-fame-amid-food-safety-c-9fd3b032d5ded2f5 2026-08-26T15:24:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-flu-and-covid-19-surveillance-report-week-35-report-data-to-week-34-dat-cc527c5d2e539aaf 2026-08-26T15:21:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-ceo-looks-beyond-lung-cancer-with-biliary-tract-win-counters-ivonescimab-d-0a6ceba1900af24b 2026-08-26T15:11:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-facing-fda-decision-in-september-2026-0845164b847b9ef4 2026-08-26T15:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-predictive-modelling-fix-fragmented-pharma-development-data-779c37e9245312dd 2026-08-26T15:06:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-and-managing-infection-in-adult-social-care-20be10541971471a 2026-08-26T15:02:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-sustainable-4d-hydrogels-functionalised-with-plant-based-nanopart-e54aad9735e52387 2026-08-26T14:58:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-environmental-effect-on-health-care-and-wellbeing-and-active-inte-bba8b3f25c92cb04 2026-08-26T14:57:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-deciphering-alzheimer-s-disease-molecular-subtypes-to-advance-tre-740dd4faffaea612 2026-08-26T14:57:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-integrated-multi-angle-research-and-training-network-to-eradicate-42de31ecedabd1de 2026-08-26T14:57:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/viva-biotech-announces-its-2026-interim-results-ai-sparks-new-paradigm-in-drug-r-16f754deef267574 2026-08-26T14:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-next-generation-ketoamide-inhibitors-of-fibroblast-activation-pro-2172df2f1df646fa 2026-08-26T14:56:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-putting-mechanism-in-place-to-ensure-food-safety-during-festive-909f4ef3a9917a46 2026-08-26T14:48:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/libya-ministry-of-health-expands-pharmagate-digital-registration-syste-03c81445bac60816 2026-08-26T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-cracks-down-on-mid-day-meal-tightens-blood-bank-rules-check-deta-838ff44c183d2fd0 2026-08-26T14:46:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-my-vested-interest-is-237331ee6401648e 2026-08-26T14:39:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/key-data-on-a-new-class-of-cardio-drugs-are-coming-08a127915537518f 2026-08-26T14:36:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-africa-maintains-who-maturity-level-3-ml3-for-vaccine-regulation-59e520ff3a6ee9de 2026-08-26T14:28:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-approach-to-gene-therapy-helps-smooth-road-for-people-with-sickle-cell-disea-83413179d73f2651 2026-08-26T14:16:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/summit-therapeutics-inc-stock-smmt-moved-up-by-8-95-on-aug-26-drivers-behind-the-fa2008799b5bf42f 2026-08-26T14:15:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/76th-who-regional-committee-for-africa-regional-strategy-on-regulation-of-medica-97348ac95e6370ac 2026-08-26T14:12:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/gilead-sciences-has-snapped-out-of-its-slump-and-1-catalyst-is-doing-most-of-the-7237d42adfc89e19 2026-08-26T14:02:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/amata-statement-at-who-regional-committee-for-africa-regional-strategy-on-regula-2b56f2795342931e 2026-08-26T14:00:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/e66d3462472eb135 2026-08-26T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ama-calls-for-stronger-regulatory-systems-to-support-africa-s-pharmaceutical-man-a50ce7add5ba015f 2026-08-26T13:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/centrix-and-university-of-sussex-collaborate-to-drive-data-driven-pharma-develop-a30a95e5131762cb 2026-08-26T13:58:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/grand-pharmaceutical-h1-revenue-rises-on-nuclear-medicine-demand-aba73b19b2c70161 2026-08-26T13:54:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-biotech-insitro-s-daphne-koller-on-how-to-speed-up-clinical-trials-c80c27bd92fc73f7 2026-08-26T13:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/grand-pharmaceutical-group-revenue-up-3-2-to-hk-6-39b-with-strong-nuclear-medici-a1d6dcff9d65f7ae 2026-08-26T13:46:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/jatt-mastermind-launches-latest-biotech-focused-spac-in-60m-ipo-f8102753e6970645 2026-08-26T13:45:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-authorizes-first-ketone-blood-sugar-monitor-for-diabetes-88dfc4289864c7db 2026-08-26T13:42:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-groups-sound-alarm-after-fda-compounding-panel-backs-6-of-7-peptides-ed1c0f64ae3d9974 2026-08-26T13:34:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-biotech-stocks-worth-adding-to-your-portfolio-now-037f8dc5b2d78642 2026-08-26T13:31:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-putting-mechanism-in-place-to-ensure-food-safety-during-festive-season-says-461e9339fb6f0d93 2026-08-26T13:22:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmalittle-we-re-reading-about-a-gsk-shingles-shot-u-s-employers-dropping-glp-86ecf9b0a5d10e1f 2026-08-26T13:11:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-bancorp-btig-appoints-mangesh-ghogre-as-managing-director-metals-mining-cove-bc5ff9f9551d085c 2026-08-26T13:10:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-exemption-for-5-star-eateries-in-food-safety-crackdown-fda-chief-tukaram-mund-69e89e1fe6d47ec3 2026-08-26T13:05:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/eikon-therapeutics-to-participate-in-investor-conferences-in-september-2026-f712a1529a0023a3 2026-08-26T13:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/giardia-cases-in-england-reach-highest-level-since-2016-cadaa5b6ebfda355 2026-08-26T13:03:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/shenzhen-yhlo-biotech-net-profit-surged-166-97-yoy-on-9-84-revenue-growth-and-im-114fceb9d85801a6 2026-08-26T12:56:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/dare-bioscience-s-sildenafil-cream-data-in-postmenopausal-women-published-in-men-6ac5bf220f5ca1d9 2026-08-26T12:47:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-to-host-2026-r-d-day-highlighting-phase-3-ovation-3-trial-and-the-clinica-366b8802658bb6bd 2026-08-26T12:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/lundbeck-expands-eversana-tie-up-to-scale-ai-across-usa-f8465ec145173342 2026-08-26T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-plans-two-new-deputy-commissioner-roles-for-tech-and-drugs-bc8c1a0128f7ceb9 2026-08-26T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sword-health-set-to-buy-headspace-parent-orangedot-5d79c47cc8faf8f7 2026-08-26T12:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-bell-of-kyiv-s-church-of-the-tithes-rings-again-after-nearly-800-years-e48d680415903b15 2026-08-26T12:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-customs-seizes-hk-11m-of-suspected-sex-pills-cancer-drugs-at-warehouse-6c862a9383965eec 2026-08-26T12:33:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/imunon-to-host-2026-r-d-day-highlighting-phase-3-ovation-3-trial-and-the-clinica-f4d2e99b4fc04c0c 2026-08-26T12:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/haisco-licenses-drug-to-us-venture-for-1-5bn-40b20d99661e157f 2026-08-26T12:25:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/viva-biotech-holdings-reports-earnings-results-for-the-half-year-ended-june-30-2-b5f4af357bf8e13e 2026-08-26T12:06:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/monod-bio-licenses-ai-designed-protein-technologies-to-signalchem-biotech-for-cu-3bc373ae761c348e 2026-08-26T12:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/76th-who-regional-committee-for-africa-strategy-for-financing-the-future-of-heal-62e38a6c1b7ddc3b 2026-08-26T12:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/looking-into-the-eyes-of-gibbons-7f9f0f206b1cec83 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/med-rx-medication-primary-solution-administration-kit-9f202f3d05d7e7ec 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maquet-percutaneous-insertion-kit-and-dilator-sets-809f317b374cad0b 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cyanosure-dermav-laser-system-b3fcb9654d64b94d 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/carescape-central-station-79b3f23f7ade3f25 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biofire-joint-infection-panel-30-pack-bd321da8b53e5fdb 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biohorizons-releases-prolificatm-allogeneic-growth-factor-technology-for-advance-a89a3ce836da7f5a 2026-08-26T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sichuan-biokin-pharmaceutical-co-net-loss-deepened-on-surging-r-d-but-global-fir-2e7fc624df4f55df 2026-08-26T11:47:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-says-vitruvias-recalls-one-lot-of-30-mg-thyroid-tablets-baf8b91d333179d1 2026-08-26T11:38:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-biotech-is-treating-epilepsy-beyond-seizures-1f5ad94509c5bb29 2026-08-26T11:36:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimal-balance-pharmacy-issues-voluntary-nationwide-recall-of-certain-lots-of-c-fad29e32f4630ac7 2026-08-26T11:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/massachusetts-biotech-jobs-plunge-for-first-time-in-over-two-decades-c01249f9df306962 2026-08-26T11:34:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/startup-project-through-the-gate-to-the-heart-f95c447843ba6c3a 2026-08-26T11:32:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-scientific-hit-by-cyberattack-causing-disruptions-to-parts-of-its-busines-3d188ad5355b07b6 2026-08-26T11:26:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/could-the-u-s-ban-chinese-medical-data-9a9c252f30181887 2026-08-26T11:06:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/3d-printing-revolutionizing-tissue-engineering-and-regenerative-medicine-in-euro-1aa68f1f26ea1857 2026-08-26T11:05:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/akeso-summit-hail-ivonescimab-s-biliary-tract-cancer-win-in-china-only-phase-3-t-c8b0432218d22742 2026-08-26T11:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jazz-pharmaceuticals-announces-private-offering-of-1-0-billion-of-exchangeable-s-9b7ba90dc9572db7 2026-08-26T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polityka-lekowa-powinna-optymalizowac-efekt-zdrowotny-nie-tylko-budzet-a1339e3297b50c6e 2026-08-26T10:46:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/zepbound-linked-to-lower-healthcare-costs-in-adults-over-age-55-with-obesity-acc-e659fa8f64f90734 2026-08-26T10:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sichuan-kelun-pharmaceutical-net-profit-grew-12-7-to-1-13-billion-despite-a-2-7-6638cc9cbb5e94d5 2026-08-26T10:44:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/metsera-backers-establish-new-biotech-armed-with-china-licensed-immunology-asset-b51be81ae0d679a3 2026-08-26T10:42:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/esc-2026-common-pharma-excipient-linked-to-uptick-in-cardiovascular-risk-50337c8557babe9e 2026-08-26T10:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-ten-essentials-for-preventing-hospital-controlled-substance-diversion-5d841561eb77863a 2026-08-26T10:37:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-delivers-first-gene-therapy-fda-approval-for-gsdia-e3de9b5d50c7d09f 2026-08-26T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/seven-drug-regulators-including-the-eu-uk-and-canada-have-warned-since-2019-that-050b9adb7bbbf6f5 2026-08-26T10:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/abbvie-targets-pediatric-alopecia-with-new-phase-3-trial-what-investors-should-w-6bf53ced43e1362c 2026-08-26T10:01:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/touyun-biotech-group-sees-hk-180-million-hk-200-million-profit-and-total-compreh-3f8fff938dfc2b85 2026-08-26T09:47:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenx-just-landed-another-phase-3-win-and-wall-street-may-be-missing-the-bigger-6bf24b5cd46d1f61 2026-08-26T09:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inna-gruber-appointed-senior-director-global-business-development-at-lotus-pharm-92cc986a474b015b 2026-08-26T09:43:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-wst-looks-14-undervalued-is-the-premium-valuation-s-f7dbbebf76de9463 2026-08-26T09:42:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-wst-looks-14-undervalued-is-the-premium-valuation-s-c7ac4a75ca3b5fab 2026-08-26T09:42:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/qlife-receives-first-revenue-from-pharmaceutical-deal-f90c4a17ca4dd196 2026-08-26T09:35:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/argenx-just-landed-another-phase-3-win-and-wall-street-may-be-missing-the-bigger-e5a151d06e554f77 2026-08-26T09:34:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-biotech-growth-trust-plc-lse-biog-d5e531a81904344f 2026-08-26T09:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivace-therapeutics-names-new-ceo-as-it-prepares-phase-3-trial-for-mesothelioma-4740f61d749e1e6f 2026-08-26T09:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-cdmo-market-size-report-2026-2035-ef40d401fb9ef28e 2026-08-26T09:28:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/hansoh-pharmaceutical-group-net-profit-surged-35-8-on-double-digit-revenue-growt-2d2ecef354805830 2026-08-26T09:26:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-reveals-role-at-biotech-outer-bio-2c656b15bf847cad 2026-08-26T09:18:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-drug-to-treat-hiv-infection-in-newborns-445c622084a890a1 2026-08-26T09:18:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-advisers-narrowly-vote-to-add-6-peptides-to-a-drug-compounding-list-what-s-n-6f08feb36b236399 2026-08-26T09:02:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-files-for-phase-3-trial-in-korea-of-biweekly-obesity-drug-cand-12484099bbfd771d 2026-08-26T08:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/hlb-therapeutics-completes-global-phase-3-trial-of-nk-eye-drop-candidate-rgn-259-c89d951031634621 2026-08-26T08:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharma-pens-795m-deal-to-usher-biohaven-s-epilepsy-therapy-towards-hoped-f-3467c685a8eda828 2026-08-26T08:47:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/actualisering-van-de-lijst-van-essentiele-stoffen-voor-voedselproducerende-paard-7c32c2cd67dd245a 2026-08-26T08:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-genb-15-bdsx-10-cdna-6-cpix-10-crdl-7-5e0baca0a8ccb4e4 2026-08-26T08:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blackrock-inc-makes-new-investment-in-ultragenyx-pharmaceutical-inc-rare-7a74108900b77806 2026-08-26T08:30:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-the-health-of-sellafield-workers-in-the-national-registry-for-radiat-e3cbdb4881cf8a7a 2026-08-26T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/nrrw-study-information-guidance-privacy-notice-governance-group-and-publications-ababf8fe30d75b9a 2026-08-26T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/guidance-on-expedited-syphilis-testing-and-treatment-for-inclusion-health-groups-de62788a7a08cca2 2026-08-26T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/giardia-national-laboratory-data-d511dc4406364ea6 2026-08-26T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/die-schweiz-verliert-als-klinischer-forschungsstandort-zunehmend-an-bedeutung-4055fa506e1b73f5 2026-08-26T08:24:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/australia-pharmaceutical-grade-sodium-carbonate-market-analysis-forecast-size-tr-e0fad714714bb85a 2026-08-26T08:22:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-invests-1-1t-won-targets-us-with-next-gen-epilepsy-drug-ch-2e4dcb5a83113838 2026-08-26T07:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/caliway-s-cbl-514-phase-2-combination-trial-cleared-phase-3-supreme-01-enrolling-df9c1bd70d316a7d 2026-08-26T07:33:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/referring-patients-with-suspected-cardiac-emergencies-to-the-vhh-12207bb249dee8f7 2026-08-26T07:22:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/algert-global-llc-reduces-position-in-ultragenyx-pharmaceutical-inc-rare-e786ab03872173e4 2026-08-26T07:20:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approval-for-slimming-teas-weight-loss-what-it-really-means-and-how-to-use-i-8b9bf45843fbb2b2 2026-08-26T07:15:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/increased-risk-aneuploidy-screening-results-referral-changes-1a0a17f9bd81c89d 2026-08-26T07:08:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-enwei-pharmaceutical-co-ltd-class-a-szse-301-993b6bd556722bd1 2026-08-26T06:59:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/olkapaan-rakenteellisia-muutoksia-loytyy-lahes-kaikilta-yli-40-vuotiailta-bf25c1060ea4346f 2026-08-26T06:45:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/sumitomo-pharma-selected-as-a-constituent-of-the-jpx-prime-150-index-e203f182fffcb93f 2026-08-26T06:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/consun-pharmaceutical-group-revenue-and-profit-surged-gross-margin-improved-and-5d173735ef298d74 2026-08-26T06:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mpsc-cancels-drug-inspector-recruitment-over-sweeping-paper-leak-scandal-fb850bff070f2686 2026-08-26T06:08:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharm-strikes-800m-deal-for-epilepsy-drug-from-biohaven-5ec56e23893c864b 2026-08-26T06:05:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmosa-biopharm-s-partner-liquidia-ramps-up-l606-clinical-investment-second-ha-17a59883510ba854 2026-08-26T05:59:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-the-gulf-biotech-deal-model-ahead-of-rgmbs-2026-in-riyadh-afcf58d47a8b048b 2026-08-26T05:08:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/wildland-firefighters-warned-not-to-take-supplements-for-smoke-or-pfas-exposure-775c21fae8d4bd2a 2026-08-26T04:59:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-pregnancy-bleeding-clinic-now-accepting-ereferrals-only-83c049db40010c01 2026-08-26T04:58:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/tivicay-us-fda-approves-drug-to-treat-hiv-in-newborns-dc0905effd1dfba2 2026-08-26T04:53:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-zhejiang-conba-pharmaceutical-co-ltd-clas-fd1986375a29a932 2026-08-26T04:51:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-five-years-will-k-pharma-and-biotech-cross-the-fortune-500-threshold-6be995fe5f2d9114 2026-08-26T04:31:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/ayub-s-at-fort-in-mumbai-loses-food-licence-after-fda-action-d539a89bd8bd81bd 2026-08-26T04:15:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-badly-trails-china-in-lowering-barriers-to-biotech-innovation-c72e15f6fd32abbd 2026-08-26T04:08:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-biotech-stocks-rally-as-local-firms-advance-cancer-vaccines-news-and-sta-bba12ac43213e5a3 2026-08-26T04:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/baxter-issues-voluntary-nationwide-recall-for-two-lots-of-0-9-sodium-chloride-in-65e04aacda3444ef 2026-08-26T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/percutaneous-catheter-recall-boston-scientific-removes-enroute-transcarotid-neur-475c60f5e04f1278 2026-08-26T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flies-open-drains-dirty-kitchen-popular-mumbai-eatery-ayub-s-loses-licence-4ffe7e0243ac85e9 2026-08-26T03:59:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/daiko-pharmaceutical-has-applied-to-change-its-market-segment-to-the-tokyo-stock-f64e3e2234bf6efd 2026-08-26T03:34:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-biomarkers-shaping-the-next-generation-of-oncology-drug-development-9844655156f0c40f 2026-08-26T03:33:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/winners-and-losers-of-q2-illumina-nasdaq-ilmn-vs-the-rest-of-the-life-sciences-t-31baffbbab571a3b 2026-08-26T03:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-healthcare-stocks-can-rally-on-positive-clinical-trial-results-940d55e6dabc13ae 2026-08-26T03:28:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-the-fda-s-peptide-vote-actually-means-70119ae5fcb3e2fd 2026-08-26T03:06:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-ayub-s-among-4-eateries-to-lose-food-licence-in-maharashtra-fda-crackdown-fddd333a47967880 2026-08-26T03:02:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-to-infuse-14-million-in-us-biotech-egenesis-ec99676bd8be34be 2026-08-26T02:14:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-biopharmaceuticals-secures-biohaven-epilepsy-drug-rights-in-795m-deal-chosunb-e8646d783518335c 2026-08-26T02:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccine-now-funded-for-all-children-under-five-as-influenza-cases-rise-781a89ff9486398d 2026-08-26T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flu-vaccine-funded-for-children-under-five-for-2027-flu-season-aaa715bbb521de78 2026-08-26T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nearly-15-trillion-won-in-the-second-half-already-china-s-bio-ambition-accelerat-f8c9b3810ccbb31d 2026-08-26T01:24:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/caliway-s-cbl-514-combination-therapy-cleared-by-u-s-fda-for-phase-2-trial-pivot-bbcbff8fdf9bee4b 2026-08-26T01:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/entropy-neurodynamics-sets-up-us-phase-2-head-to-head-trial-of-trp-8803-against-fb20d199e52fc63a 2026-08-26T00:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiwan-maps-four-ai-led-strategies-to-expand-its-biotech-sector-3a90aca59dbf0ddf 2026-08-26T00:47:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-profit-pharmaceutical-manufacturer-delivers-drug-access-to-rural-hospitals-93a830a0b0ca76f8 2026-08-26T00:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-dea-rules-marijuana-s-medical-status-cannabis-giants-face-rico-claims-and-ins-b3eaf8233ac1503c 2026-08-26T00:38:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-2c89e57beb4bd829 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mapping-the-global-trends-and-hotspots-of-research-on-gene-therapy-and-hair-cell-ab9b74074302aa2d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amplicon-based-long-read-sequencing-for-accurate-cyp2d6-gene-deletion-and-duplic-9c184e2745be1fbd 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindo-d3641e275582f5d5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hydroxymitragynine-above-a-specified-threshold-in-schedule-i-extension-of-commen-fd3b722765dfcae7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meeting-of-the-microbiome-subcommittee-of-the-presidential-advisory-council-on-c-b5346fad8a31ad7d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determination-that-cabazitaxel-cabazitaxel-solution-injection-60-milligrams-6-mi-816cac59a85587c0 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-curia-new-york-inc-6cb285c02718ede4 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-cambrex-charles-city-2e20f37e6c05a60c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-chemtos-llc-ac41c464308365e7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-experic-llc-5e313dbd97dc4a16 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-cambrex-charles-city-a54fdedeff02161c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-drug-scheduling-single-convention-on-narcotic-drugs-convention-on-89388d86cd7bffd9 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-all-b3b959a27423a47b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-daptomycin-1467899423b73432 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-carbamazepine-3cc4d8c9ff5bfad6 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-irinotecan-hydrochloide-8f4328c652c83d87 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-oxcarbazepine-86337f046cd3714a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibandronate-sodium-1a1d8a3d57b9b5b4 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-amitriptyline-hydrochloride-ac62cd33307e0e49 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-smart-care-hand-sanitizer-4pk-with-silicone-case-cherry-blosso-5f0e22b8efed846a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hair-regrowth-foam-54a5d185bc98d995 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-drany-nail-fungus-treatment-ff2924486fe171e7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-smart-care-hand-sanitizer-with-glitter-silicone-case-2pk-vanil-01345fd007f0c799 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-melao-hydrating-lightweight-sunscreen-c897c65269043ea6 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jardiance-1a71a00648b2b6a1 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metoprolol-tartrate-d3b18fe60b3876bb 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metoprolol-succinate-1ca7c58ec88b51cd 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ticagrelor-c6cdd926a2b1f915 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-trazodone-hydrochloride-f4b8f9115298ec65 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-oxygen-bc0009b96dec304a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cetirizine-hydrochloride-42dfbf3e79d54eee 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-zicam-cold-remedy-rapidmelts-original-and-nighttime-convenienc-37d84abd33bdd6e8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cholestyramine-powder-for-suspension-8ec1bd22de67f64d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-calcium-chloride-9b68978db23b54e5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-doxycycline-20adf1dcb48d5634 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-chlorpromazine-hydrochloride-c336c72b594997f8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-leader-dual-action-pain-reliever-36cac9ec5f071eb0 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ibuprofen-5b99ee30c08bfaf1 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-prednisone-ac1e06b346d692fc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-desloratadine-cd8af5fd14e8db5a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-e2643e71089542ac 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-gabapentin-16bba50c040cef4a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ciprofloxacin-hydrochloride-bb170575772ce7b7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-hero-force-shield-superlight-sunscreen-spf-30-6d38d6fc50479a22 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-spironolactone-aec9662d1aa14b30 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-icosapent-ethyl-01f0b23682d2a172 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-benzonatate-a04a5525458fdc6b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-anti-diarrheal-and-anti-gas-f44fd627c505484d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lidocaine-pain-relief-patch-5-ct-316fd1b76473d316 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-drug-price-row-loss-56m-biotech-verdict-and-more-d31d83f3fe56d323 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peripheral-nerve-blocks-modulate-the-pain-mood-relationship-in-bariatric-surgery-d7e606023a9ee193 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/current-and-future-therapies-for-triple-negative-breast-cancer-120677fbc60e2031 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-for-a-phase-ii-clinical-trial-evaluating-the-safety-and-efficacy-55805e0ee60b9bac 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implantable-medical-devices-from-basics-to-state-of-the-art-9f2a25dd0f3054cb 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/decreased-accumbens-amygdala-connectivity-is-associated-with-sleep-improvement-i-ff72c7a536f1a152 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-phase-i-clinical-study-of-the-safety-tolerability-pharmacokinetics-and-pharmac-ad3178bf68f651fa 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-the-effect-of-pretreatment-of-the-pilosebaceous-unit-on-cutibacterium-d5b679c8e03bffb5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enhancing-hepatitis-b-case-finding-through-tech-enhanced-community-pharmacy-resu-8f1797500323df7c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amino-acid-homeostasis-by-corvet-hops-a-metabolic-and-stress-resilience-checkpoi-9152d2db3cf90c2d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-serum-magnesium-fails-a-narrative-review-of-magnesium-biochemistry-compartme-5bea13141ba22795 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/next-generation-pharmacotherapies-for-unipolar-mood-disorders-a-leading-article-0e600dc2ca21df48 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-herbal-formula-based-on-rosa-damascena-on-functional-bloating-severity-3f74f0707515c6cd 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-safety-and-effectiveness-of-nivolumab-in-patients-with-cancer-of-unkn-c4f486c751e2a8c5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/factors-affecting-acceptance-of-participating-in-clinical-trials-of-new-drugs-a-ce464a3c45b8d195 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aerobic-exercise-attenuates-peri-infarct-fibrosis-and-improves-fitness-early-aft-eec43f45ec5ee274 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-anti-drug-antibody-incidence-to-clinical-relevance-interpreting-highly-sens-0b8a91547138d155 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bruton-s-tyrosine-kinase-inhibition-for-food-induced-anaphylaxis-d1540982672f5291 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-cervical-lordosis-restoration-and-clinical-recovery-followin-814c37da4b073cd0 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/network-based-drug-response-prediction-with-multi-omics-data-drdimont-and-beyond-77ca2f38d04dd5fb 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glycemic-control-and-cognitive-function-in-dysglycemia-a-mediation-analysis-of-d-9b778cbcd92c2c8b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adhd-medication-safety-in-pregnancy-6aa593bcf41b99cc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/theoretical-psychological-and-regulatory-dimensions-of-modern-pharmaceutical-mar-513f8dd51eb1da70 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/structured-educational-program-for-healthcare-professionals-improves-outcomes-of-075257a808388ff8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-preclinical-evaluation-of-a-dual-drug-implant-for-long-acting-hi-1cc96d47a7d8161d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-trefoil-factor-3-in-endometrioid-endometrial-carcinoma-exploratory-diagnos-6806d6ad8bc2d88d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/myocardial-bridging-in-sports-and-exercise-cardiology-screening-challenges-clini-540994f5d2803d19 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/outcomes-of-physician-modified-endografts-for-juxtarenal-and-pararenal-abdominal-039b2d22934d0da2 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-rehabilitation-in-heart-failure-evidence-coverage-and-implementation-078d73f7125153c5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/added-value-of-one-month-clinical-data-in-predicting-chronic-stage-motor-functio-743103f29c1d2cad 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-assessment-of-direct-oral-factor-xa-inhibitors-dosing-appropriateness-f422f3fc1ec68e93 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-therapeutic-roles-of-icariin-in-inflammatory-diseases-from-molecular-m-f1e91b03ea9432f8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognising-and-responding-to-clinical-deterioration-in-acute-hospitals-recordin-0ccb217dbb48cba4 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transition-from-drug-lag-to-drug-loss-in-pediatric-oncology-a-comprehensive-eval-7a7a2bb46ef4d7ac 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/natural-products-for-the-management-of-diarrhea-a-systematic-review-of-clinical-cceff15b259dd5a5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-validation-of-an-interpretable-machine-learning-model-integratin-678ee08b0e236dfd 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-applications-of-invasive-spinal-cord-stimulation-in-neurological-disord-c3d5566d55683bcc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-patient-perspectives-in-the-convince-trial-in-end-stage-kidney-dis-bcf85d5e7d04a24b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-a-case-of-secondary-syphilis-with-clinical-manifestations-resembling-a010f15214a22891 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-safety-evaluation-and-mechanism-of-acetylcysteine-in-improving-bd8309bdedf7f630 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/grand-challenges-in-sex-differences-in-immunology-problems-the-field-must-solve-b5411f44c201d2ba 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-infant-post-natal-prophylaxis-regimens-and-pretreatment-hiv-c94bee7cd2cb521f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transforming-percolated-urine-into-safe-fertilizer-tracking-pharmaceutical-and-n-bd0c71b21e6259cc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/electroacupuncture-enables-semaglutide-dose-sparing-in-type-2-diabetes-by-boosti-ccceb64b3243adae 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adjunctive-empirical-superior-vena-cava-isolation-with-fourth-generation-cryobal-edd95c9d4e4ba0d7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/elucidating-adverse-drug-reactions-and-underlying-molecular-mechanisms-of-iverme-4cca88827938931c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ns2a-v89f-mutation-in-a-denv1-clinical-isolate-enhances-neurotropism-and-neuroin-07b2344baa777e90 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eprx-associates-with-concurrent-shifts-in-antimicrobial-resistance-and-virulence-cb6162f58a026ad3 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-reading-of-a-self-help-book-reduces-perceived-problem-burden-and-state-3145e9a883b7d143 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bioactive-compounds-pharmacological-activities-toxicity-profiles-and-prospects-f-df6853a4ab510d7c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-trustworthy-ai-principles-to-verifiable-system-requirements-a-multi-stakeho-de8a411c27df6e8a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/continuous-glucose-monitoring-in-hospital-care-implementation-and-clinical-use-50f8fefeece6be2c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/robotic-inspired-tri-metaheuristic-framework-with-neuromorphic-edge-intelligence-0f8245b08988a442 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safinamide-dual-molecular-mechanisms-sodium-channel-and-glutamate-modulation-as-2125122d11482e08 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-accuracy-of-dried-blood-spot-samples-for-hepatitis-b-diagnosis-a-syst-0f015a6d33b84a68 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-and-safety-of-antifibrinolytic-agents-in-the-management-of-pulmona-3885f0a108bb75e7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-impact-of-interlesion-distance-on-acute-pulmonary-vein-isolation-succes-e50d1a268fadf18b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/happy-homework-2-0-effects-on-24-hour-movement-behaviours-in-children-findings-f-caa215390600b669 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/parent-delivered-early-language-intervention-for-children-with-down-syndrome-a-f-031925488f6b5c51 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preclinical-evidence-for-supra-clinical-acute-kidney-injury-current-biomarkers-a-095a2ec3bbd653ce 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/study-protocol-efficacy-and-safety-of-limosilactobacillus-fermentum-wis32-as-an-f1761d921db58ece 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-individualized-target-transcranial-magnetic-stimulation-f-4e3eaab0f90636d9 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/secondary-prevention-of-cancer-therapy-induced-thrombocytopenia-with-hetrombopag-402348f899dde93a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-mechanisms-of-device-monitored-aerobic-exercise-for-depression-trea-6ee53887fe6b9a46 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-different-sites-or-areas-of-preoperative-lateral-compartment-bone-mar-b4a06255a9de1cf8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nkain1-predicts-poor-prognosis-and-associated-with-drug-resistance-and-immune-in-4a2a7fc21e959847 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-prognostic-factors-in-pediatric-atypical-teratoid-r-1f8093949ec5abfc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/no-specific-molecular-profile-nsmp-endometrial-cancer-from-residual-category-to-56c77c14514a7f61 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genome-sequences-of-clinical-ehec-isolates-from-germany-s-large-2025-o45-h2-outb-e245dccaf1c19504 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mini-open-versus-open-transforaminal-lumbar-interbody-fusion-in-patients-aged-75-df50f5683a3da21f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-editor-in-response-to-glp-1-ra-plus-sglt2i-versus-monotherapy-in-masld-17823c6f9075e49b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/uncovering-the-genetic-landscape-of-pediatric-hearing-loss-along-the-texas-mexic-8ee000128bca3561 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-results-of-brentuximab-vedotin-and-bendamustine-for-first-line-treatme-c57725f3e4155012 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genomic-diversity-of-pseudomonas-aeruginosa-causing-bacteremic-pneumonia-in-an-i-164cf71bed0661c8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sepiolite-reinforced-alginate-based-hydrogels-for-drug-delivery-applications-70b1ab71602cca2f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/progressive-symmetric-distal-lower-extremity-weakness-sensory-loss-and-gait-dysf-a7b0e1f105683316 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immunologic-response-and-clinical-course-after-off-label-nonavalent-hpv-vaccinat-8d69b4dd892c15e8 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implications-of-trauma-in-patients-with-cervical-ossification-of-the-posterior-l-17dbc58b4c30d572 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/difficult-diagnosis-i-c-difficile-i-without-diarrhea-e02ec3e74dadffa6 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-father-sensitive-birth-education-on-antenatal-paternal-attachment-50494e865d5b9f4e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-learning-aging-marker-from-retinal-images-unveils-sex-specific-clinical-and-57ee55324aea04fa 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recent-advances-in-the-diagnosis-of-turner-syndrome-karyotype-with-primary-ameno-5c03fc531768717c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultra-processed-foods-and-metabolic-dysfunction-mechanisms-clinical-implications-2aea06900aaa903f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-circrna-drug-sensitivity-using-integrated-hybrid-graph-and-molecular-bb7a946aeb010517 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-analysis-of-regulatory-approaches-for-artificial-intelligence-enable-1763ec5fb228a444 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-population-approaches-to-promoting-relational-health-from-early-life-29b9c3ee2ddee80f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mir-365b-5p-and-mir-3614-5p-are-elevated-in-pbmcs-of-systemic-lupus-erythematosu-f5806e06da3ea818 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-clinical-outcomes-of-proximal-splenic-artery-embolization-in-patien-104f3ff94e160171 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atrial-fibrillation-associated-with-renal-tubular-injury-in-acute-chest-pain-n-a-e8937394bf69db78 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agentic-document-reasoning-for-evidence-grounded-clinical-report-generation-604378d81a5041ac 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-course-of-sensory-processing-difficulties-in-pediatric-obsessive-co-93f71ffb9d7eccb3 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breathe-eat-talk-three-essential-ingredients-to-quality-of-life-outcomes-in-move-54f4b42553a3226a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/editorial-for-impact-of-dapagliflozin-on-scp-mri-scp-derived-epicardial-adipose-3c5a5ea1a1dc3a41 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/repetitive-transcranial-magnetic-stimulation-in-alzheimer-s-disease-cognitive-im-1ae8294fed81495e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cystic-medial-degeneration-leading-to-popliteal-artery-aneurysm-with-distal-embo-feabdedb87bae1f2 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-does-steroid-avoidance-compare-with-steroid-maintenance-after-kidney-transpl-edaf372fc3ff013a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-are-the-benefits-and-risks-of-thromboelastography-teg-or-thromboelastometry-6ce5c2537ff0daa9 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-cannabidiol-rich-cannabis-oil-on-facial-expression-recognition-and-th-a73890077514b8e0 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07788781-pain-science-education-and-therapeutic-exercise-in-adults-with-muscu-cf53cf4c4c261d46 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07788378-metformin-in-elderly-patients-with-type-2-diabetes-and-muscle-streng-dab2bcbff662422d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07788144-eaa-guided-an69-oxiris-and-pmx-hp-therapy-in-septic-patients-8d67fbbab9e7c372 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07787884-development-and-pilot-application-of-a-solution-focused-intervention-8ce5d9823d1d47c0 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07787793-effects-of-high-frequency-rtms-on-cortical-motor-mapping-in-stroke-p-e1fed5e155c9522e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07787195-low-level-laser-therapy-versus-isometric-handgrip-exercise-on-arteri-c4be06d5b5cd526c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07787182-a-study-of-ly4405094-in-healthy-participants-and-participants-with-a-ba0d33928067b2cc 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07787130-effect-of-immune-x-on-common-cold-incidence-in-healthy-adults-a685c129d5239981 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07786402-clinical-outcomes-of-prone-and-supine-lumbar-traction-matched-to-mec-8bcdd0a42889184e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785193-a-study-of-subcutaneous-fl115-monotherapy-in-participants-with-advan-6cd92d945e63b6a7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07782840-ql1706-plus-neoadjuvant-endocrine-therapy-in-hr-positive-her2-negati-eee9d846c8d9d210 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07780604-a-single-center-5-part-study-to-investigate-the-safety-tolerability-2c8db8a9057eae45 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07776665-a-clinical-trial-of-enlicitide-mk-0616-formulations-in-healthy-parti-9f8d1864b6900fc7 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07767344-impact-of-video-based-patient-education-on-physician-trust-pain-and-eaef2eda670b324f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07576036-international-multi-center-retrospective-study-of-patients-with-seru-7e445eedafaba2ee 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07528508-a-clinical-trial-in-healthy-participants-to-study-the-effect-of-a-si-d2b69da0908b3807 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07446322-folfiri-and-bevacizumab-with-or-without-pelareorep-for-second-line-t-c6648e84667dfeda 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07399717-assessing-role-of-probiotics-in-children-aged-6-36-months-treated-fo-e866b9c34f8ad6df 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07154927-evaluation-of-feasibility-of-ultrasonography-guided-pulmonary-artery-39c8f951667fee87 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07141524-optimizing-breathing-and-blood-flow-in-patients-treated-with-va-ecmo-5559418ed5bfaab6 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07109817-desloratadine-to-prevent-taxane-induced-peripheral-neuropathy-in-pat-57f0a54da27e6d52 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07081061-clinical-outcomes-of-a-digital-mental-health-intervention-for-modera-72567178b82cd459 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06976268-a-study-to-determine-if-bhv-8000-is-effective-safe-and-tolerable-as-964886e90e7deddf 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06960798-characterizing-the-genomic-landscape-of-prostate-cancer-in-native-am-877a1c1664055286 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06926660-a-study-to-test-whether-vicadrostat-in-combination-with-empagliflozi-b4b5cb295038b3be 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06895863-copenhagen-magnetic-personalized-accelerated-brain-circuit-therapy-f-fdbe3007c99dcbe5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06834932-a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-of-azd0-cf52d9d4fb74d0f5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06767124-veech-ketone-ester-to-support-brain-energy-in-mild-cognitive-impairm-f397756e291edcb4 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06365658-cognitive-functioning-in-adults-with-somatic-diseases-and-general-po-8660646988919f45 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06300320-a-clinical-trial-of-tq05105-tablets-in-the-treatment-of-chronic-graf-7e58226a390dd646 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06192758-dose-escalation-study-evaluating-safety-of-therasphere-prostate-canc-be121f2fee81880d 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06151964-a-trial-to-learn-how-safe-azd9550-monotherapy-and-combined-with-azd6-065000fbace58b4e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06123988-prolonged-overnight-fasting-and-or-exercise-on-fatigue-and-other-pat-bc3b29094467373f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06112847-lenalidomide-and-epcoritamab-for-the-treatment-of-previously-untreat-e5477478f9fb4d8b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05986318-reducing-respiratory-symptoms-of-pulmonary-irradiation-in-interstiti-491c4ec77273186a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05705414-oral-intradialytic-amino-acid-supplementation-to-vitalize-end-stage-0ea839fc2024608c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05618574-nitrite-supplementation-in-long-covid-patients-745bb210079e309a 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05367440-study-of-azd5305-when-given-in-combination-with-new-hormonal-agents-ff71eec097ae3f6b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05306600-onco-genomas-brasil-mapping-breast-and-prostate-cancer-in-the-brazil-b89083ae2c5b51a1 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05238740-comparison-of-radiographic-fusion-rate-and-clinical-outcome-of-alif-1a1279ba88d9833e 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05230459-a-study-to-evaluate-the-safety-of-ab-1003-previously-lion-101-in-sub-d343a9bde5609b4b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05044819-assessment-of-potential-for-chronic-liver-injury-in-participants-tre-964caf7f3a65f675 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04663308-a-study-to-evaluate-efficacy-and-safety-of-an-investigational-drug-n-45c469a9a36223b5 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03961243-lentiviral-fix-gene-therapy-24cb443511c68d94 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03914768-immune-modulatory-dc-vaccine-against-brain-tumor-4875cb589e22ea13 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03644186-to-reduce-the-use-of-chemotherapy-in-postmenopausal-patients-with-er-ecb767f58404d80b 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03614650-immunotherapy-treating-gi-cancer-2143c6ee1c3ee26c 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03356808-antigen-specific-t-cells-against-lung-cancer-7ffd8b6a38b3b78f 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03356782-safety-and-efficacy-evaluation-of-4th-generation-safety-engineered-c-e4b482e655803188 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03204123-psma-pet-imaging-of-recurrent-prostate-cancer-fb0c93883b6f3f76 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01959698-carfilzomib-rituximab-ifosfamide-carboplatin-and-etoposide-in-treati-110f6d15e90698d9 2026-08-26T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-bioconjugation-market-size-share-trends-growth-analysis-report-2029-f053ae971f9b2b1e 2026-08-25T23:49:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-s-fda-nominee-could-renew-scrutiny-to-abortion-drug-risk-pro-life-org-ceo-9a489ea9eeb247d4 2026-08-25T23:37:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/north-america-al-in-clinical-trials-market-2024-2029-2520de97f2b1e864 2026-08-25T23:21:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-signs-2-3b-obesity-drug-deal-with-roche-k-bio-pulse-66f8405abca21198 2026-08-25T23:17:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/here-s-how-much-you-would-have-made-owning-krystal-biotech-stock-in-the-last-5-y-1f2f0d99516ee27c 2026-08-25T23:15:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-cannabis-manufacturers-can-learn-from-the-pharmaceutical-industry-about-tra-ba9fefcc58e56884 2026-08-25T22:32:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-nasdaq-edsa-major-holder-s-multi-million-share-stake-detailed-317967de348f3681 2026-08-25T22:01:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-enwei-pharmaceutical-co-ltd-class-a-szse-a272160ca6ea784c 2026-08-25T21:59:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/xbi-forecast-174-79-tests-biotech-etf-breakout-strength-1e99aff2bba0ddf5 2026-08-25T21:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-jazz-cancer-drug-approval-could-drive-blockbuster-sales-2d340a3c97012b2f 2026-08-25T21:22:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-up-as-biotech-momentum-persists-health-care-roundup-064434a9c776330a 2026-08-25T21:20:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/pda-becomes-latest-pharmacy-body-to-publish-ai-guidance-bcfbee8c63def126 2026-08-25T21:17:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-inc-stock-underperforms-tuesday-when-compared-to-co-d3befa6af1799a80 2026-08-25T21:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-york-stock-market-highlights-pharmaceutical-stocks-bought-amd-rises-sporting-6c49cf7d8a3ef8e2 2026-08-25T20:56:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-statement-of-changes-in-beneficial-ownership-of-securities-e0f13553bb5ce77a 2026-08-25T20:46:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/la-challenge-to-mail-order-abortion-pills-headed-back-to-court-70e0adcd46697030 2026-08-25T20:40:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/cells-use-a-little-known-molecule-to-protect-themselves-from-iron-overload-4306f2fd261fd3cc 2026-08-25T20:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-grants-inducement-restricted-stock-units-to-23-new-emp-821e6df89a75ccf3 2026-08-25T20:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/velan-capital-lifts-edesa-biotech-edsa-stake-to-9-99-with-warrant-leverage-8c922f1e6e2c8630 2026-08-25T20:39:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-legend-biotech-s-legn-move-to-q2-profitability-reshape-its-investment-narra-3fdd546b7ec26f22 2026-08-25T20:38:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/lunchbox-labour-is-back-here-s-how-canada-s-new-school-food-program-can-grow-b41ee4f99377fe63 2026-08-25T20:35:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/bms-texas-investment-advances-pharma-s-modular-manufacturing-agenda-a74eb5b43d187b63 2026-08-25T20:33:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/walter-v-klemp-discloses-investment-at-moleculin-biotech-with-9-87-stake-824e7f6eb623f5ed 2026-08-25T20:26:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/adial-pharmaceuticals-announces-inducement-grant-under-nasdaq-listing-rule-5635-cf4740c33118d23c 2026-08-25T20:05:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/tracking-ripubatide-across-three-clinical-registries-a5048c66973eab4c 2026-08-25T20:04:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/bringing-science-full-circle-ben-schooler-shares-what-has-motivated-his-path-at-7c027fa6ba13087f 2026-08-25T20:03:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/transplant-patients-physicians-and-caregivers-from-four-hospitals-celebrate-utah-861540a984b757f7 2026-08-25T19:19:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-line-development-at-an-inflection-point-insights-from-bpi-west-and-esact-20-8ccd9deea13f4b1b 2026-08-25T18:54:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-imaavy-for-waiha-pharmexec-feaa7fa1235c5268 2026-08-25T18:45:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-ayub-s-fort-licence-over-serious-food-safety-violations-2cb8624ecd4ff35b 2026-08-25T18:34:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-recalls-and-warnings-levothyroxine-and-natural-thyroid-drugs-recalled-for-po-938f0e31485d9111 2026-08-25T18:21:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/once-thriving-now-threatened-d2dcc785218ebc65 2026-08-25T18:11:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-eligibility-the-real-impact-of-the-2026-nccn-genetic-testing-updates-bf4201e78c500510 2026-08-25T18:04:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/convertible-bonds-come-back-to-bite-korean-biotech-firms-as-shares-slump-a2e6b9d5ce44ae6b 2026-08-25T18:03:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/ayub-s-food-licence-suspended-by-fda-pics-show-improper-egg-storage-open-drains-8115b28cc814f9fb 2026-08-25T18:00:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/press-release-dare-bioscience-ceo-outlines-commercial-transformation-pipeline-mo-585f9ac876db965f 2026-08-25T17:59:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-isn-t-a-stand-alone-solution-let-s-stop-treating-it-like-one-bb7508b3634b77a2 2026-08-25T17:57:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/trained-but-not-prepared-the-state-of-clinical-research-site-training-98660b03fe4e1941 2026-08-25T17:57:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-better-research-site-support-improves-clinical-trial-delivery-09a151fd0b4a0aa9 2026-08-25T17:57:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-the-database-building-relationships-that-drive-patient-recruitment-bcadfc3715cd4808 2026-08-25T17:56:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/closed-ticket-open-problem-how-vendor-handoffs-keep-becoming-site-work-44186e3142f325df 2026-08-25T17:56:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/pro-life-ceo-predicts-trump-fda-nominee-could-bring-renewed-scrutiny-to-abortion-953662918aaeb760 2026-08-25T17:38:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cockroaches-filth-food-safety-crackdown-at-posh-bengaluru-clubs-c8dddb06cb4fd205 2026-08-25T17:22:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/free-fruit-toxic-shock-datura-lands-woman-in-hospital-sparks-fda-action-18273dc0ee0a9de6 2026-08-25T17:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-business-journal-biotech-jobs-dropped-for-the-first-time-in-2025-can-rebo-2e6aa33dd37370b3 2026-08-25T16:55:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-nasdaq-vivs-research-report-highlights-ai-powered-drug-toxicity-pla-54ddb05fed838c56 2026-08-25T16:48:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/where-connected-pharmacovigilance-is-headed-next-8688be4c54662085 2026-08-25T16:42:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vivosim-labs-nasdaq-vivs-research-report-highlights-ai-powered-drug-toxicity-pla-39f5db274eef7d4b 2026-08-25T16:42:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-s-fiance-michael-polansky-has-a-biotech-startup-involving-ai-living-sk-1cb32dd3df5da814 2026-08-25T16:40:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cap-1002-deramiocel-bla-pdufa-date-90b9a21080d36c96 2026-08-25T16:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/76th-who-regional-committee-for-africa-a-new-era-of-health-for-africa-united-act-8bbfb6ba1f29a54a 2026-08-25T16:05:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-ubc-tool-helps-cities-plant-trees-where-they-re-needed-most-6a227a0f20d4b9f4 2026-08-25T15:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abcellera-biologics-stock-jumps-15-to-new-52-week-high-on-hot-flash-drug-momentu-554a117a070ba18a 2026-08-25T15:52:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-mrna-stock-soars-14-on-personalized-cancer-vaccine-success-is-it-time-to-89bc3b3946f73cde 2026-08-25T15:50:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/j-j-s-imaavy-secures-expanded-us-approval-in-rare-blood-disorder-f9a06136bbf033e8 2026-08-25T15:46:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/interfarma-na-imprensa-saude-insider-publica-entrevista-exclusiva-com-renato-por-414f12a44c21b15c 2026-08-25T15:38:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-as-a-key-differentiator-in-crowded-therapeutic-areas-0dcde310a9b0efd4 2026-08-25T15:18:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/university-of-washington-and-seattle-biotech-win-245m-patent-judgment-against-gu-305d6311c54801d5 2026-08-25T15:18:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-research-matters-when-it-s-personalby-tina-mincher-2bd81440a3acc9e8 2026-08-25T15:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-approves-first-drug-that-targets-root-cause-of-narcolepsy-rather-than-its-sym-ef6ded2ffdf30c9c 2026-08-25T15:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/thyroid-tablets-recalled-nationwide-over-potential-superpotency-fda-5273dd0c74f536aa 2026-08-25T14:57:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-and-moderna-announced-on-19-august-2026-that-a-personalised-mrna-cancer-va-741bae0e5a7161f1 2026-08-25T14:49:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/beone-medicines-announces-u-s-fda-approval-for-tevimbra-based-regimen-for-first-869e0053fdfe0093 2026-08-25T14:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-pharmaceutical-group-sehk-3320-stock-trades-cheap-as-margin-reco-673af1766de975d7 2026-08-25T14:39:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-nasdaq-vrxa-advances-vxa-222-cancer-program-beyond-discovery-phas-5d6482cafa3e51c5 2026-08-25T14:36:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-s-rsv-vaccine-cleared-by-u-s-fda-to-begin-clinical-trials-in-61a94138f2ebccb9 2026-08-25T14:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-april-2-b77f11aa2e39503c 2026-08-25T14:34:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/eltp-vs-derm-which-specialty-pharmaceutical-stock-is-the-better-buy-c56ec4d025b05cfd 2026-08-25T14:31:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-jul-3f275fca66e4a4e5 2026-08-25T14:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-ipos-approach-escape-velocity-barring-yellow-flags-that-could-threaten-r-ae1db7decb4b0094 2026-08-25T14:26:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/u-s-fda-approves-ziihera-zanidatamab-hrii-with-and-without-tislelizumab-plus-che-fbd9b464bb0c8a0f 2026-08-25T14:24:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-s-ayub-s-shut-down-fda-suspends-licence-over-multiple-violations-d29707a5aa85733b 2026-08-25T14:22:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/boston-globe-massachusetts-lost-biotech-jobs-for-first-time-in-2025-new-report-s-55c8d49ffdf53311 2026-08-25T14:18:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/touyun-biotech-to-issue-123-million-new-shares-at-hk-0-122-per-share-68f2e36c2b54d129 2026-08-25T14:10:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-ai-biotech-startup-keeps-human-skin-alive-for-4-weeks-380c4fb324fd7ac0 2026-08-25T14:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-a-years-long-slump-massachusetts-biopharma-sector-has-come-roaring-back-in-1a922a396f5773bf 2026-08-25T14:00:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-jun-e044d6b817fd0b17 2026-08-25T13:58:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-may-3cff5701bc5161bb 2026-08-25T13:57:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-apr-e12124e965faaa83 2026-08-25T13:57:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-mar-87de9e1b7971d722 2026-08-25T13:56:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-feb-b260be48ef71327d 2026-08-25T13:56:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-jan-6a304472db0b5bf4 2026-08-25T13:56:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-s-haisco-forms-immunology-biotech-with-up-to-1-5b-from-american-vcs-efd4dfe18a206deb 2026-08-25T13:56:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-dec-e5f0918065a32f6f 2026-08-25T13:55:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-older-adults-vaccination-coverage-in-england-nov-952379824a474647 2026-08-25T13:55:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-march-2-1fe3d0637be0bdef 2026-08-25T13:54:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-februar-522b9113762ca8ca 2026-08-25T13:54:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-january-6a7d9eccbe74ff32 2026-08-25T13:54:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-decembe-6b57d525809a5404 2026-08-25T13:53:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-novembe-e93492b89f222d53 2026-08-25T13:53:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-october-5b84eb9f7a85000e 2026-08-25T13:52:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-septemb-83530fb241d0098a 2026-08-25T13:52:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-maternal-vaccination-coverage-in-england-august-ad8ccd3192ac2329 2026-08-25T13:51:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-s-the-reality-for-independent-pharmacies-a5f720c59643887d 2026-08-25T13:48:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-a-texas-congressman-believes-chinese-biotechs-are-beating-us-on-our-ground-g-24f99b6cef9ce825 2026-08-25T13:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sagimet-advances-phase-3-denifanstat-acne-trial-with-2026-enrollment-plan-db7ec3c4959afa1c 2026-08-25T13:34:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/orthex-large-bone-circular-fixator-552cf4871c8f8013 2026-08-25T13:32:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/childhood-schedule-changes-2025-and-2026-information-for-healthcare-practitioner-5a46460b979d205a 2026-08-25T13:31:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/founded-by-metsera-backers-sentivera-emerges-with-1-5b-inflammatory-disease-deal-41da2d326187a996 2026-08-25T13:24:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/finding-the-opportunity-in-clinical-trial-complexity-2ae9a1eb349fa8c3 2026-08-25T13:11:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/jpmorgan-chase-co-increases-ultragenyx-pharmaceutical-nasdaq-rare-price-target-t-5d741c111ea078c6 2026-08-25T13:10:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-posts-4-3-rise-in-first-half-profit-defying-biotech-headwinds-8dce64eec630586a 2026-08-25T13:03:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-incision-receives-fda-510-k-clearance-for-the-miratm-surgical-system-in-35aeafcd3db00a59 2026-08-25T13:03:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-introduces-new-mac-studio-with-m5-max-and-m5-ultra-d04c2ec8f51649e7 2026-08-25T13:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-unveils-a-more-powerful-mac-mini-featuring-the-all-new-m6-and-m5-pro-27ca33535f881884 2026-08-25T12:59:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/apple-introduces-m6-and-m5-ultra-for-a-big-leap-in-performance-and-ai-compute-83186f67a3376f34 2026-08-25T12:58:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/natco-pharma-invests-14mn-in-biotech-firm-egenesis-total-investment-at-22mn-967f55550563f69d 2026-08-25T12:55:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/kwangdong-pharmaceutical-signs-official-sponsorship-agreement-with-the-korean-pi-5fcc3a990329ed6e 2026-08-25T12:54:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-industries-teva-could-be-10-undervalued-after-fda-accepted-e-4ee3c38c379daaac 2026-08-25T12:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fosun-pharma-announces-2026-interim-results-c6423f1704483556 2026-08-25T12:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/geovax-advances-geo-mva-toward-pivotal-phase-3-study-implementation-d13bec63ad773df0 2026-08-25T12:41:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-plus-chemotherapy-global-phase-iii-harmoni-primary-analysis-results-080a2cab262ac0cf 2026-08-25T12:38:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-based-learning-optimising-falls-prevention-through-a-multidisciplinary-appr-225f852fdb1ce186 2026-08-25T12:26:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/kane-biotech-s-revyve-research-presented-at-military-health-system-research-symp-419ff42f40984cca 2026-08-25T12:17:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/sagimet-biosciences-advances-aurora-clinical-trial-4979136ba7f4eddd 2026-08-25T12:15:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/wtr-exoz-2q26-update-from-platform-validation-to-commercial-execution-441bb5f7b826a896 2026-08-25T12:14:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-partnership-for-european-research-in-radiation-protection-and-det-3ef34c67e0b51b41 2026-08-25T12:00:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/13th-kyoto-university-inamori-foundation-joint-kyoto-prize-symposium-held-in-tok-34c068e0c5d0b178 2026-08-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/twins-herbal-products-undeclared-prescription-drug-sildenafil-c765742856eda66b 2026-08-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drager-ventstar-resus-neo-and-ventstar-resuscitaire-3fcc7394111610d5 2026-08-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-s-quest-to-eliminate-food-allergies-aa85e1515beb70f9 2026-08-25T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/two-killed-and-nine-injured-in-reactor-blast-at-telangana-pharmaceutical-unit-7680b312ca342dc2 2026-08-25T11:40:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-snags-japanese-approval-for-first-hepatitis-b-functional-cure-hibsago-909d6712167fd8e4 2026-08-25T11:37:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/brazil-pharmaceutical-industry-market-to-reach-usd-42-21-billion-by-2035-at-2-09-b228048107dc16bf 2026-08-25T11:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subgroup-analyses-of-us-eap-participants-with-niemann-pick-disease-type-c-treate-02ccdd59542d400a 2026-08-25T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/real-world-use-of-arimoclomol-in-niemann-pick-type-c-findings-from-a-german-comp-56631a5be8d0a1fb 2026-08-25T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-track-and-trace-systems-market-poised-for-strong-growth-at-12-2-c-c5050b11b3fb6325 2026-08-25T11:16:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-vaccine-breakthrough-lifts-5-biotech-names-here-s-who-s-best-positioned-66ce825c336a0a83 2026-08-25T11:15:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-identification-and-development-of-novel-colorectal-cancer-biomark-982418f8674d18da 2026-08-25T11:14:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-a-holistic-approach-to-training-a-new-generation-of-scientists-in-a0f1ac3c504104fd 2026-08-25T11:14:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-next-generation-aav-vectors-for-liver-directed-gene-therapy-781fb2a308a1791b 2026-08-25T11:14:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/sagimet-biosciences-announces-aurora-phase-3-acne-trial-on-track-to-begin-enroll-4d44e0d5ec31c51e 2026-08-25T11:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brm424-phase-2-enrollment-complete-with-safety-profile-superior-to-existing-ther-08cff65befeb88a7 2026-08-25T11:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sagimet-biosciences-advances-aurora-u-s-phase-3-trial-of-denifanstat-in-acne-tow-071f5c4e1d39ee9a 2026-08-25T11:04:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-end-of-us-biotech-dominance-14af5ed3cfe4665f 2026-08-25T11:04:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/13-2-millionen-euro-fur-neue-immuntherapien-gegen-ewing-sarkome-bei-kindern-und-772f575384deb5e3 2026-08-25T11:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/driving-car-t-cell-therapy-in-new-directions-e0a1b9bfc103df56 2026-08-25T11:00:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/sagimet-s-acne-pill-trial-plans-to-enroll-about-800-u-s-patients-including-450-t-1707c972de779682 2026-08-25T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celea-therapeutics-will-present-phase-3-trial-design-for-idiopathic-pulmonary-fi-b42e75526d008a79 2026-08-25T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ivonescimab-plus-chemotherapy-global-phase-iii-harmoni-primary-analysis-results-55f8d6ece0487f14 2026-08-25T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/act-brief-payment-performance-as-operational-brand-speed-and-discipline-in-biote-57ace848a078fd46 2026-08-25T10:57:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-amylyx-pharmaceuticals-blasted-nearly-79-higher-this-week-c32e649511e333d6 2026-08-25T10:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-fosun-pharmaceutical-revenue-up-4-75-yoy-adjusted-net-profit-up-19-09-i-ddf17068b0ed1884 2026-08-25T10:49:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/young-startups-miss-out-on-biotech-venture-funding-rebound-massbio-says-8cd760f17ea06e28 2026-08-25T10:35:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-carles-researcher-f22b7da41c562cd6 2026-08-25T10:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ksi-101-completes-first-pivotal-cohort-in-phase-3-peak-trial-eye-care-network-mo-39a3f5e933251bd2 2026-08-25T10:04:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-3m-project-to-study-opioid-treatment-during-breastfeeding-8bea3c82538dad5b 2026-08-25T10:01:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-fosun-pharmaceutical-h1-net-profit-up-1-15-y-y-432db0484975401e 2026-08-25T09:49:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-cafe-cadell-fssai-licence-suspended-over-food-safety-violations-6162f6c61e7aacdf 2026-08-25T09:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mmrv-programme-information-for-healthcare-practitioners-7c74968f4d74816c 2026-08-25T09:39:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/ieq-capital-llc-takes-position-in-ultragenyx-pharmaceutical-inc-rare-14a3fc8a47c3b6cb 2026-08-25T09:32:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-health-expo-broadens-focus-on-pharma-biotech-and-longevity-a149cfa2ac5d4278 2026-08-25T09:31:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/rebuilding-america-s-pharmaceutical-backbone-through-small-batch-manufacturing-04d5f83011341996 2026-08-25T09:25:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-made-in-europe-will-mean-for-critical-medicines-328b7c0f1163d31a 2026-08-25T09:22:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/newly-approved-psoriasis-pill-expands-treatment-options-0b356abb13852a5d 2026-08-25T09:15:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-forschung-auf-der-iss-hilft-muskelstimulation-im-all-1fa69b28c5557a18 2026-08-25T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charite-research-on-the-iss-can-muscle-stimulation-help-astronauts-stay-strong-i-f6c4a6f052d600ab 2026-08-25T09:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/newly-approved-psoriasis-pill-expands-treatment-options-0f2a0378232d8bb8 2026-08-25T09:07:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/vacant-lab-space-shrinking-workforce-put-mass-in-unique-position-for-biotech-bou-06ce39a0cb8e7735 2026-08-25T09:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regenxbio-ii-rgx-121-0c9e5911c482e6cb 2026-08-25T08:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bio-works-technologies-secures-medicine-development-deal-with-us-biotech-company-9e040ec15a72dcee 2026-08-25T08:41:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/closing-the-data-integrity-gap-in-pharmaceutical-quality-control-7a07d4b32c990bd2 2026-08-25T08:38:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharma-prepares-for-indonesia-halal-rules-ahead-of-october-rollout-14b97840b448698b 2026-08-25T08:37:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/rznomics-to-join-eli-lilly-s-san-diego-biotech-incubator-a8596b86f5be5b1b 2026-08-25T08:37:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/manufacturing-survival-gianluca-costantini-and-maziyar-ghiabi-draw-iran-s-pharma-fb696a1b92f680c9 2026-08-25T08:36:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-transmission-parameters-in-outbreak-contexts-7286ca8e9b5d1106 2026-08-25T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-transmission-and-associated-behaviours-in-outbreaks-in-clo-b5948bc79164ff9e 2026-08-25T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-routes-of-transmission-1b5750596fcf7a90 2026-08-25T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-public-health-and-social-measures-to-reduce-or-prevent-tra-ba057c2775ec0f9d 2026-08-25T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/meningococcal-disease-impact-of-vaping-on-transmission-0db0160078421e3d 2026-08-25T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/michel-bellandi-est-elu-au-conseil-d-administration-du-leem-098e5d5bac93f476 2026-08-25T08:22:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-founder-expects-new-paradigm-in-cancer-treatment-a4581773ed8e83f6 2026-08-25T08:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cha-biotech-wins-2-3-mil-grant-for-lung-disease-cell-therapy-6f55ee73b555172a 2026-08-25T08:18:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-and-moderna-s-individualised-mrna-melanoma-vaccine-just-won-a-phase-3-tria-3d795a5ffe6b7da7 2026-08-25T08:08:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/glp-1-peptides-around-the-world-part-iii-eu-evolution-expanded-expectations-and-6a374fb60b259091 2026-08-25T08:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-vogx-phvs-solv-ikt-htfl-a257c768478d40b7 2026-08-25T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/164-813-shares-in-ultragenyx-pharmaceutical-inc-rare-bought-by-deutsche-bank-ag-38ff562b901a3632 2026-08-25T07:47:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-orders-suspension-of-food-licences-over-online-sale-of-datura-seed-a682655f35a82639 2026-08-25T07:09:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-pharmaceutical-bio-business-which-sk-group-has-been-investing-in-for-a-long-15d1cbf632f7c28d 2026-08-25T07:02:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/generic-lenacapavir-for-hiv-prevention-moves-closer-to-india-with-cdsco-waiver-o-89dd41b6b798c4b2 2026-08-25T06:49:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/mrna-cancer-vaccine-trial-succeeds-biotech-sector-sees-catalyst-c6e467036479d205 2026-08-25T06:40:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/atg-201-clears-australian-approval-for-phase-i-trial-in-b-cell-autoimmune-diseas-08b32f9a83cea239 2026-08-25T06:37:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/astellas-initiates-phase-3-study-of-asp2138-in-cldn18-2-positive-gastric-cancer-91fcf741c60d3238 2026-08-25T06:37:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/aiforia-and-stratipath-partner-to-expand-access-to-ai-driven-precision-diagnosti-d414ff4df7fcd812 2026-08-25T06:30:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/chinese-biotech-funding-shift-out-licensing-deals-surpass-ipos-in-h1-2026-news-a-70b8e8c57e92e294 2026-08-25T05:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-food-safety-crackdown-mca-outlets-midday-meal-center-school-eate-fc1206d6b8fec78f 2026-08-25T05:27:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/100-day-milestone-of-ebola-bundibugyo-outbreak-must-be-a-wake-up-call-for-pandem-d013c58932d9045e 2026-08-25T05:17:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-ai-and-traditional-chinese-medicine-work-together-to-develop-new-apis-0108f7ce662f529f 2026-08-25T05:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/financialcontent-the-inauguration-and-technology-cooperation-signing-ceremony-of-4162caaa193bd4b4 2026-08-25T05:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/overseas-licensing-has-helped-fuel-china-s-biotech-profits-will-it-last-ad40f64b37b2f13b 2026-08-25T05:00:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/k-bio-licensing-deals-top-12-billion-near-record-high-16d823f2195c7ffc 2026-08-25T04:57:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/daewoong-pharma-prepares-for-indonesia-halal-rules-ahead-of-october-rollout-b0dc7274e9baae29 2026-08-25T04:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/rznomics-to-join-eli-lilly-s-san-diego-biotech-incubator-b9fc0aeef6fee188 2026-08-25T04:27:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/buy-the-evidence-do-not-license-the-model-49d36ec800968df5 2026-08-25T04:12:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-jobs-dropped-for-the-first-time-in-2025-can-rebounding-vc-m-a-bring-them-13fd76eb77585d80 2026-08-25T04:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/baxter-issues-voluntary-nationwide-recall-for-one-lot-of-anticoagulant-sodium-ci-ae8f7d0a10f8337c 2026-08-25T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/baxter-issues-voluntary-nationwide-recall-for-one-lot-of-70-dextrose-injection-d-26fc4816886f56b3 2026-08-25T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/breakthrough-diabetes-biotech-immunobiota-looks-to-raise-5-million-seed-for-clin-d8c5d46467c51942 2026-08-25T03:11:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-fda-finds-hygiene-violations-at-cafe-cadell-cockroach-infestation-at-mulu-ada67f786195ecf4 2026-08-25T03:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/presentation-on-research-results-regarding-the-application-of-li-mg-based-thin-f-223e3434ce399ccd 2026-08-25T03:00:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/anzen-pmda-risk-communications-azathioprine-etc-posted-36008cab26ef61d1 2026-08-25T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-biomedical-discovery-to-medicines-how-israel-can-turn-research-into-biotech-9ca65abe11837274 2026-08-25T02:56:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/these-two-biotech-stocks-recorded-fresh-milestones-today-what-s-driving-today-s-59745e568d16decd 2026-08-25T02:52:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-food-safety-crackdown-mumbai-outlets-suspended-school-zones-chec-8000c609c4100f1e 2026-08-25T02:31:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/novelty-nobility-clears-china-trial-hurdle-for-csu-drug-nn2802-4bfe98d0c092d290 2026-08-25T02:18:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/novelty-nobility-clears-china-trial-hurdle-for-csu-drug-nn2802-b3085833edd5f3ec 2026-08-25T02:13:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/cha-biotech-wins-government-backing-to-advance-cell-and-gene-therapy-platform-e9d35b0da1226789 2026-08-25T02:04:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/agenda-for-october-2026-cancer-treatments-ctac-meeting-ba838d30ed8d89de 2026-08-25T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-signs-record-2-3-bn-obesity-drug-licensing-deal-0352921ca2159b86 2026-08-25T01:46:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/antengene-s-atg-201-autoimmune-therapy-cleared-by-australia-to-begin-phase-1-tri-46fc706dbd47f308 2026-08-25T01:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-alliance-saudi-as-a-regional-manufacturing-hub-for-us-companies-98e71e2b32e0aae8 2026-08-25T00:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-lost-jobs-for-the-first-time-in-two-decades-but-the-industry-might-be-ma-a12011d57d9de357 2026-08-25T00:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/astrazeneca-filed-form-6-k-c3ea5de706a69e37 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/request-for-information-rfi-request-for-information-on-new-and-emerging-areas-of-2afd4aee788a49d3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-kinetochem-llc-d46ccb30684d51f0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-chattem-chemicals-beef952d04e53778 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-chattem-chemicals-e314cc57623a2d5a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-prof-compounding-cts-of-ameri-5bb903e55c26c7c6 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-galephar-pharmaceutical-research-i-fdd6f1b0e511c48d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-insti-2369bab742397761 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-curia-missouri-inc-b0b06809764af951 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-vici-health-sciences-llc-9e1de995aca07977 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importer-of-controlled-substances-application-biopharmaceutical-research-company-0189565cb69c9474 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/catina-allen-n-p-decision-and-order-7b82621e5bddbe61 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-curia-new-york-inc-b4697b60699972d0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bulk-manufacturer-of-controlled-substances-application-biopharmaceutical-researc-bc194e127e95883b 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-institute-of-diabetes-and-digestive-and-kidney-diseases-amended-notice-15562cfaa9fc7333 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/office-of-the-director-national-institutes-of-health-notice-of-meeting-470dd138bbb85eee 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-heart-lung-and-blood-institute-notice-of-closed-meeting-06ee4459cb6dac98 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-heart-lung-and-blood-institute-notice-of-meeting-ba530e9b9e43acfb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-ketorolac-tromethamine-ee5b39a8eebd72d8 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cefpodoxime-proxetil-9f37f99aeee34a54 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-tizanidine-e0ccd5c33df6c0ff 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-juyasuyon-sport-ultra-sunscreen-cream-2bfa675f6b6f910a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-wart-remover-patchs-ad85f16f3516571c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sleep-aid-nighttime-06ae0a402db1115c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-d48b76f2a6312383 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-venlafaxine-hydrochloride-bd54e572a550e86c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-witch-hazel-77dcbcd524ceacd9 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-saline-0c615836e9c925a4 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lidomar-95475b0a5df7e0b1 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-alogliptin-and-metformin-hydrochloride-c3ef17525800da8a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-synjardy-84cb664e473f88ef 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lidospra-3940b50c4b65f3f5 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-potassium-iodide-saturated-a7e70c919ce00088 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-allergy-relief-e9b6625199aac5df 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-clobetasol-propionate-2da504e77472df0a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-icosapent-ethyl-92b4e27366190b15 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-triamcinolone-acetonide-8817d7e915323989 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potential-of-plant-derived-products-for-antimalarial-combination-therapy-80caecf879f7f2e2 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/individuals-with-fragile-x-syndrome-present-with-associative-learning-deficits-b56c70886ebf734d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-forest-therapy-on-depressive-symptoms-a-systematic-review-and-meta-an-986879a8233faa50 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/findings-interpretation-concerns-regarding-the-emulated-target-trial-of-sglt2-in-d508c04c1e687c3f 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-and-efficacy-of-remimazolam-combined-with-esketamine-for-anesthesia-in-el-da0c50cf64c3c362 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-regulatory-pathways-are-an-underrecognized-bottleneck-in-precision-on-fbd8c7db61cab010 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/precision-oncology-in-breast-cancer-biomarker-driven-treatment-strategies-and-th-b96a8836a8b1f26f 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimorbidity-among-patients-receiving-home-care-in-japan-prevalence-levels-and-acfa2776a05990fb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-of-a-quadrivalent-meningococcal-conjugate-vaccine-menacyw-tt-administered-4cf8b9aa6074cbfb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-molecular-pathogenesis-to-novel-therapeutic-approaches-a-review-of-recent-a-81353048f67b596b 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cutting-vs-standard-balloon-for-lesion-preparation-in-drug-coated-balloon-only-p-98eedbd9a305efa0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-equity-in-rheumatology-the-uneven-landscape-of-cellular-therapy-4b39d5733f022871 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/manufacturing-complexity-and-scale-up-hidden-contributors-to-drug-safety-risk-6efb39f83b679d47 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-accuracy-of-the-passive-mast-cell-activation-test-in-neuromuscular-bl-2fdc63232a5aa4e9 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/influence-of-plate-type-on-pbmc-based-in-vitro-cytokine-release-assays-for-pre-c-a89834fc5e5f7d58 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crizotinib-versus-observation-or-placebo-for-surgically-resected-early-stage-alk-e4643a4162421aa7 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/molecular-targets-in-proliferative-vitreoretinopathy-rethinking-prevention-treat-ba5a5523228c368f 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/device-level-comparisons-of-sensing-and-stimulation-in-implantable-closed-loop-n-b7d21fcefac4cc35 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cobrotoxin-suppresses-tlr4-nf-b-stat1-signaling-to-mitigate-glia-mediated-neuroi-290d499717a60b1c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/physiologic-mechanisms-of-response-to-hypoglossal-nerve-stimulation-0da73e95dd43c2f5 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glucagon-like-peptide-1-receptor-agonist-use-and-risks-of-hospitalization-and-mo-702a1e422d3aca9f 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ropinirole-adjunct-to-methylphenidate-versus-placebo-adjunct-to-methylphenidate-e207d0a458715a29 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statin-use-and-arterial-calcification-in-the-general-population-a-longitudinal-a-f021883a0fcbabbf 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-medicinal-chemistry-and-translational-drug-development-78acf031ab4db495 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tailored-injectable-nanocomposite-hydrogels-for-high-performance-biomedical-appl-b69ae51bd81a1092 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endoscopic-ultrasound-guided-lumen-apposing-metal-stent-placement-for-intra-abdo-2037c08e03b83042 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/commuting-dynamics-and-their-implications-for-physical-and-psychological-well-be-820bc1fa6e779bdd 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-neuropathology-4-2026-5985879f14ad09f9 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tranilast-roxithromycin-with-topical-tacrolimus-in-refractory-atopic-facial-ecze-e58d71d1da4d2f4f 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrasound-guided-suprainguinal-fascia-iliaca-block-for-postoperative-analgesia-ae79e940a478bc71 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/radiographic-evaluation-of-distal-femoral-sagittal-morphology-following-imageles-a2970d06c6db428d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-assisted-colonoscopy-for-colorectal-lesion-detection-cur-d2b62750feb407fb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relationship-between-muscle-thickness-and-hip-and-groin-function-in-elite-profes-060dcbcc06e0e995 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determinants-of-prolonged-postoperative-length-of-stay-after-carotid-revasculari-0e870a1635bbd408 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/limb-ischemia-related-interventions-and-30-day-mortality-after-femoro-femoral-va-2c297195b675c0f2 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-onechoice-ai-based-clinical-decision-support-recommendations-with-62f78d0a6471f4b4 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whole-genome-sequencing-of-the-moruga-hill-rice-oryza-glaberrima-reveals-its-afr-5fbedacb41bcd89e 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-evaluation-of-gingival-margin-modifications-during-treatment-with-c-ca3b384f555346be 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/independent-predictors-of-clinical-outcomes-after-surgical-correction-of-degener-336bd3d1faecea31 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-infection-prevention-and-control-education-toward-int-e8b6cee84c66bd94 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-air-cleaner-effectiveness-in-schools-a-comprehensive-review-and-proto-4dc2260d47b11882 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-seropositivity-to-neurosyphilis-clinical-spectrum-and-diagnostic-classifica-f37c67cc97010a08 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prediction-of-benign-paroxysmal-positional-vertigo-recurrence-in-postmenopausal-e0ce9c0bf8d1a427 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-neurophysiological-effects-of-manual-acupuncture-for-upper-limb-mot-913f971740bbc8cb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychotropic-dispensing-in-greek-adolescents-and-young-adults-national-trends-an-e0051975d46df049 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-conditions-mortality-and-associated-risk-factors-in-patients-with-flail-6b46374a29e76b44 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/determinants-of-trust-and-reliance-on-artificial-intelligence-in-clinical-settin-3d98715e16cc10ae 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/imaging-evidence-of-osseous-fusion-of-patients-undergoing-segmental-mandibular-f-87fe2c2b28fdacb3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hypertension-not-low-density-lipoprotein-cholesterol-what-a-polygenic-lens-revea-9890a414456011a7 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frontiers-in-noninvasive-diagnosis-of-kidney-transplant-rejection-from-molecular-6e923b88a9a719ac 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-feasibility-of-an-mhealth-intervention-delivered-by-an-exercise-ph-597d8df53ab606eb 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/response-to-comments-prevalence-and-clinical-predictors-of-sleep-disturbances-in-8def3ace42b11188 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/preliminary-real-world-evidence-of-clinical-and-echocardiographic-changes-after-7ea7708a791a7ead 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-relevance-of-atriogenic-tethering-in-atrial-functional-mitral-regurgita-3f020fb348b08ec5 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-adjusted-creatinine-clearance-on-carboplatin-dosing-in-endometrial-can-9a7c43df82e06e22 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-pneumonia-as-a-pathway-to-sepsis-host-response-and-clinical-heterogen-21c4af806fb23443 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recognizing-peer-support-initiatives-organized-outside-of-the-clinical-setting-i-3b772f7de1bab002 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-ib-trial-of-the-bmi-1-inhibitor-unesbulin-plus-neoadjuvant-paclitaxel-carb-0d483a7cd6adc628 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kras-and-skil-mutations-synergistically-promote-pancreatic-tumorigenesis-through-fc11cf02ddfb2a4c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparing-different-techniques-of-uterine-artery-occlusion-during-laparoscopic-m-efd4ff87c2b66fd7 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-prediction-of-clinical-deterioration-in-older-adults-with-suspected-infect-0276607a2d1461ee 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/growth-heterogeneity-of-streptococcus-suis-in-host-mimicking-conditions-is-indep-d77b2de326a17396 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-childhood-cumulative-risk-and-temperament-predict-preadolescent-appraisal-581e5c98886573e1 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/identification-of-early-temperament-profiles-in-infants-at-elevated-likelihood-f-d4d08c434213d5dc 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/childhood-temperament-types-provide-specificity-over-dimensions-in-predicting-ea-f0f8bbfcdcfabac0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/heterogeneity-in-callous-unemotional-traits-early-temperamental-and-environmenta-5c73531112dcd643 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-dlpfc-targeted-rtms-on-phantom-limb-pain-and-associated-psychological-ce554ecfef274186 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-year-outcomes-of-m-teer-with-the-pascal-system-in-atrial-and-ventricular-fmr-4bb2e1a7932c913a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-and-secondary-raynaud-a-scientific-statement-from-the-american-heart-ass-1376d145f3b2b25b 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/figure-5-from-co-clinical-evaluation-of-synthetic-vitamin-d-and-chemotherapy-in-eb1e98f6d48b22ca 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s4-from-co-clinical-evaluation-of-synthetic-vitamin-d-and-c-012d7737b2ac66c3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplementary-figure-s9-from-co-clinical-evaluation-of-synthetic-vitamin-d-and-c-4c7332dafc128bfa 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/brightline-1-when-a-negative-trial-reveals-two-active-therapies-f0ec69f95fb943dd 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-the-i-shigella-i-specific-chaperone-ipgc-in-drug-development-a03d0266a9b69b26 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-investigating-pharmaceutical-hydrates-through-solution-spectros-c77b9e228e6441d0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crystallographic-insights-into-multi-component-pharmaceutical-solids-5a1f934841b2eaf3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-first-attempt-success-rate-of-ultrasound-guided-internal-jugular-v-56ae413046c46822 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-acting-cabotegravir-rilpivirine-in-viremic-individuals-interpreting-success-d32c7a0b8e95f341 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recalcitrant-folliculitis-decalvans-treated-with-baricitinib-or-upadacitinib-a-c-8b4a26848e2987e1 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-practice-patterns-and-unmet-needs-in-the-use-of-glp-1-receptor-agonists-201ec072d94123ee 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrated-assessment-of-pesticides-inorganic-ions-and-health-risks-in-drinking-e77532e569ae22f3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epigenetic-mechanisms-and-clinical-translation-in-ovarian-cancer-from-molecular-20c5e83371b21702 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/blood-metabolomes-distinguish-malnutrition-and-reflect-treatment-response-in-adu-da3fb7af6195ea55 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-system-independent-3d-coordinate-based-planning-method-for-hexapod-deformity-c-8b4ce50bcc5cb644 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/conceptualising-heart-disease-prediction-through-a-unified-framework-combining-c-e88d58bae96547c8 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-affecting-osseointegration-in-dental-implants-clinical-evidence-biological-90a11e2c049ea772 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combined-assessment-of-estimated-glomerular-filtration-rate-and-albuminuria-amon-4299628754814b8e 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-a-smart-ring-improve-sleep-investigating-the-effect-of-a-4-week-smart-ring-t-da9a0459fb167ed4 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-fapi-pet-versus-18f-fdg-pet-in-thyroid-cancer-a-system-7060611e4b223b10 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-and-prediction-of-anti-chandipura-virus-molecules-as-drug-and-vaccine-c-c69a7824f59a4ee6 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combined-microbial-inoculation-improves-plant-growth-nutrient-acquisition-and-so-f69b1a72b94025d0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-novel-combinatorial-therapeutic-strategy-using-resveratrol-and-viral-oncolysis-72c1f9ff534fd496 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanistic-investigation-of-juglone-5-hydroxy-1-4-naphthoquinone-as-an-anti-can-4db4752c6bbb230d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unraveling-viruses-associated-with-yellowing-disease-of-cucurbitaceous-crops-in-a5da60a860d2c669 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nanoparticles-as-catalysts-of-change-toward-third-generation-seed-technology-and-4fa42dc805355315 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/introduction-to-special-issue-on-collective-and-shared-trauma-36628344793f1327 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-nnu-net-based-segmentation-for-enhanced-mrcp-maximum-inte-7f855d9dd8850530 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/resting-sympathetic-transduction-in-veterans-with-ptsd-41cc136e852b606c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/guideline-concordant-therapy-for-community-onset-pneumonia-considering-risk-fact-e6cdcedfcf5fb43d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-a-standardized-management-protocol-and-antimicrobial-stewardship-inter-f8676e07f18e5c38 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/four-year-follow-up-on-maxillary-arch-outcomes-with-presurgical-infant-orthopedi-b202df1eb77a4041 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-sex-differences-in-endocannabinoid-system-biomarkers-and-their-relatio-d36877f742a4d606 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reshaping-the-fitness-landscape-of-classification-rule-mining-for-clinical-natur-63fb76456184ec06 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/catatonia-with-prominent-psychosocial-factors-a-case-report-967c670e9b9c5718 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/second-breast-conserving-treatment-for-ipsilateral-breast-tumor-recurrence-a-rev-42bd80ec67df9500 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/plantar-angioleiomyoma-masquerading-as-a-hyperkeratotic-lesion-a-case-report-5a3c7edc76afd3c0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scp-bird-scp-regimen-followed-by-anti-scp-bcma-car-scp-t-cell-immunotherapy-as-f-0495e503032b5725 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/log-file-based-patient-specific-quality-assurance-for-mr-guided-radiation-therap-ee93e8713918af0b 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-novel-deep-learning-based-auto-segmentation-software-util-b640a288597811cd 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07786038-e-health-lifestyle-intervention-for-arthritis-a-pilot-rct-on-feasibi-597d83c5aaf2fbbd 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785791-eras-compliance-and-nutritional-outcomes-after-lung-cancer-surgery-c4fbaca490ecde18 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785739-clinical-prediction-model-for-disease-progression-in-primary-membran-21801c537f30a3a1 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785700-home-based-functional-electrical-stimulation-for-lower-limb-rehabili-fb9a6611c42690fa 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785648-mindfulness-based-cognitive-therapy-vs-the-health-enhancement-progra-27d34fb9347e3b02 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785583-effect-of-capacitive-resistive-energy-transfer-therapy-on-postmenopa-3d5839e247f64582 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07785115-full-mouth-vs-quadrant-wise-scaling-and-root-planing-clinical-effect-ff24530ffdb4a7f0 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784816-a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetic-profiles-7b987fe976441f22 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784660-molecular-imaging-of-epcam-expression-in-breast-cancer-using-99mtc-t-1f223d2dce59ce23 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784413-a-sequential-trial-of-low-dose-radiotherapy-followed-by-concurrent-i-d83283ba59752339 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784335-pharmacokinetics-of-huperzine-a-oral-solution-in-healthy-participant-be2587133e7673b7 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784283-integrating-hpv-education-into-school-health-programs-in-cambodia-an-e5f39d097e4711ce 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07784179-ultrasound-and-photoacoustic-imaging-of-hydrocephalus-in-pediatric-p-2ebec3de42585744 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07781683-clinical-evaluation-of-salivary-1-5-anhydroglucitol-in-diabetes-4a5e1da3701b571d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07766018-a-phase-2-bridging-study-of-elacestrant-monotherapy-in-advanced-or-m-d60587e613d27d23 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07756294-restoring-vascular-and-insulin-function-to-augment-anti-amyloid-ther-e9a5f28e12e3a17c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07743580-a-study-of-secutrelvir-in-participants-with-coronavirus-disease-2019-4259a4e44c26e609 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07633158-prospective-non-interventional-single-arm-study-with-tezepelumab-to-4e782d663ae284b4 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07619534-collection-of-csf-samples-from-participants-with-metastatic-triple-n-499b6b2cc3691899 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07605949-revumenib-azacitidine-and-venetoclax-in-newly-diagnosed-kmt2a-rearra-d0b83d10fec33c9d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07601074-a-study-of-the-preliminary-efficacy-of-dare-hpv-to-treat-high-risk-p-1aec7d5ce82cceab 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07599670-a-study-to-assess-the-safety-and-effects-of-abbv-1758-following-subc-1366c94fd7770f34 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07579208-a-phase1-clinical-trial-evaluating-locoregional-delivery-of-engineer-41f32fcbe37ddb4d 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07579195-consolidative-therapy-after-ev-pembrolizumab-in-muscle-invasive-blad-d1c060a8d62c68f7 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07407738-shockfast-intravascular-lithotripsy-device-for-treatment-of-calcifie-8419c0c8ecec2eda 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07378644-study-to-evaluate-the-pharmacodynamics-safety-and-efficacy-of-sky-05-89f8a1961cefc10b 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07154290-a-study-to-investigate-ubamatamab-with-and-without-marlotamig-regn70-5711fe5722a93487 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07076615-the-effect-of-dapagliflozin-on-patients-with-cardiomyopathy-dac4f4f29c36fc4e 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07013474-a-study-to-learn-about-the-study-medicine-ibuzatrelvir-in-adults-wit-4593138ac05abf63 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06820476-a-research-study-on-how-nnc0487-0111-a-new-medicine-works-in-chinese-dfb19a888dc8af75 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06807385-the-effect-of-the-reaction-training-in-parkinson-s-disease-e7dac31e76506c6c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06804499-tampere-coronary-artery-disease-and-sudden-cardiac-arrest-study-fc46b3b5bdc1f3f3 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06545682-phase-ib-study-of-alpelisib-with-pembrolizumab-in-patients-with-meta-fa292aff070dba41 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06514261-testing-the-combination-of-an-anti-cancer-drug-iadademstat-with-othe-7ba25d34683103f9 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06289556-clinical-performance-of-masimo-invsensor00048-26d61d4673bc4982 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06059638-bradycardia-pacemaker-with-av-interval-modulation-for-blood-pressure-f82f54b866ddea38 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05652504-safety-evaluation-of-pfspz-vaccine-in-pregnant-women-in-mali-malvip1-42c9082b83410242 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05348356-nirogacestat-in-ovarian-granulosa-cell-tumors-37c0373dc5a29aaa 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05099003-a-study-of-the-drug-selinexor-with-radiation-therapy-in-patients-wit-fdb8c67fe54a8079 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04626791-modified-vr-cap-and-acalabrutinib-as-first-line-therapy-for-the-trea-00d93dac0903d081 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04565743-stop-at-one-stockholm-saos-secondary-fracture-prevention-through-act-754baf393cb1f930 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04493164-cpx-351-and-ivosidenib-for-the-treatment-of-idh1-mutated-acute-myelo-003ce4f58f05cf9a 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04419870-acute-infection-in-mitochondrial-disease-metabolism-infection-and-im-727a1528bf80fe7c 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04181060-osimertinib-with-or-without-bevacizumab-as-initial-treatment-for-pat-1d873460026613bf 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04136171-cardio-ttransform-a-study-to-evaluate-the-efficacy-and-safety-of-epl-0b54567e1e558e31 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01216371-resection-of-pulmonary-metastasis-in-clear-cell-renal-cell-carcinoma-04dbde1130af0b51 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00899301-collecting-and-storing-tissue-samples-from-women-with-or-without-bre-a354d0db7623b135 2026-08-25T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adar1-capital-management-buys-1-8m-of-tenax-therapeutics-tenx-shares-a0fdc47f98811ce7 2026-08-24T23:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/competition-or-collusion-entry-decisions-in-the-swedish-pharmaceutical-market-c5812f59e90bffb3 2026-08-24T23:43:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-outlays-2-3bn-for-hanmi-s-non-glp-1-obesity-candidate-a8fce59fd1e0de06 2026-08-24T23:04:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/doj-backs-biotech-co-against-red-cross-at-1st-circ-2a07032d97947391 2026-08-24T22:46:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-biopharma-analyst-sees-biotech-m-a-market-reopening-after-a-long-freeze-7011671999359302 2026-08-24T22:17:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-allied-biotech-corp-tpex-1780-da0a748ac2b58d02 2026-08-24T22:00:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/collegium-ceo-is-moving-the-biotech-firm-to-boston-from-the-suburbs-bd3a175b7cde4608 2026-08-24T21:51:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/central-bucks-chamber-moves-from-swamp-road-to-the-biotech-campus-4dd680e7bd21ca97 2026-08-24T21:42:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/australian-study-finds-maternal-rsv-vaccination-offers-strong-protection-for-inf-7c5ef465295ddaee 2026-08-24T21:41:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-drug-ans-858-aims-to-reduce-alcohol-and-drug-cravings-ce412ec53422bccb 2026-08-24T21:41:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/3-firms-build-biotech-merger-with-150m-in-private-funding-62a86578ce237e59 2026-08-24T21:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cellares-a-cell-therapy-manufacturing-specialist-to-lay-off-100-employees-5d114fa6f121c109 2026-08-24T21:26:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-firm-nears-700k-sf-lease-at-former-google-hub-c138af191c728e17 2026-08-24T21:02:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-side-effects-update-new-allergic-reaction-warnings-for-osteoporosis-and-hypo-e22874a2b71a8212 2026-08-24T20:51:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/creative-medical-completes-olastrocel-trial-enrollment-as-it-sets-sights-on-fda-7977558f30623457 2026-08-24T20:32:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/finding-the-invisible-ai-for-rare-disease-patient-identification-8c0352a0ec46308e 2026-08-24T20:31:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/nutricion-3c86bf3278ddaf34 2026-08-24T20:23:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/xistrovin-25sc-6692156aa9634312 2026-08-24T20:17:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/xistrovin-25sc-456f15d8508496ed 2026-08-24T20:10:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/rynagen-200sc-69373744f3708957 2026-08-24T20:09:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/rynagen-200sc-7b3d50a45b7df0e8 2026-08-24T20:09:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/savara-announces-encore-presentations-of-results-from-the-phase-3-clinical-trial-7a7e4da153e619d4 2026-08-24T20:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-sciences-professor-publishes-two-books-5b07ea93ca27ccba 2026-08-24T19:12:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-lease-on-life-sciences-biotech-takes-700k-sf-at-former-google-campus-in-redw-03efa36486ec9a55 2026-08-24T19:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-licenses-hm17321-to-genentech-pharmexec-1193813384cdcd13 2026-08-24T19:09:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-pays-190m-upfront-for-hanmi-s-first-in-class-obesity-drug-e11ddb96559ee5ce 2026-08-24T18:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/icecure-partners-with-dutch-distributor-to-target-european-breast-cancer-minimal-5fa7ce0f2f845093 2026-08-24T18:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genentech-pays-190m-for-obesity-drug-built-to-preserve-muscle-glp-1-drugs-erode-cbb56c15014a6755 2026-08-24T18:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/using-pbpk-modelling-to-identify-physiological-changes-induced-by-clf065-a-glp-2-c3b73fa2742374f2 2026-08-24T18:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-see-drastic-change-for-this-particular-part-of-healthcare-052bcc3c4634aaa7 2026-08-24T18:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/model-informed-strategies-for-methocarbamol-multiparticulate-regimen-development-f2f4f9721f566786 2026-08-24T18:35:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-doctor-behind-your-diagnosis-learn-more-about-the-role-of-a-radiologist-34949daeeb16596e 2026-08-24T18:34:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-praise-intismeran-s-landmark-phase-iii-win-look-to-further-data-3441804d71811f0b 2026-08-24T18:33:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-did-ultragenyx-pharmaceutical-rare-move-today-298e8c6d9a479d81 2026-08-24T18:27:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-supply-chain-integrity-062454d9c96954dd 2026-08-24T18:16:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/500m-austin-expansion-intended-to-boost-iv-solution-manufacturing-58b03a7e542e9d06 2026-08-24T18:13:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/fifth-circuit-to-hear-louisiana-challenge-to-mail-order-abortion-pills-b7398eea121ad4e2 2026-08-24T18:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-vrxa-builds-antibody-based-cancer-pipeline-around-dual-targeting-5d1e7fd28ed0b660 2026-08-24T18:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/licenciaturas-en-el-salvador-181d14d2d60032b2 2026-08-24T17:47:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-food-safety-officer-shakes-up-mumbai-one-viral-raid-at-a-time-f3b48159fa93df43 2026-08-24T17:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-concerns-spur-fda-to-again-halt-testing-of-regenxbio-gene-therapy-88b777786978fd3d 2026-08-24T17:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-inc-stock-mrna-moved-down-by-5-13-on-aug-24-a-full-analysis-5d703d6953a3ce76 2026-08-24T17:15:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-breakout-what-s-in-focus-after-moderna-s-cancer-win-mrna-nasdaq-a8b4d0d5ecaa32e6 2026-08-24T17:12:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/peptides-are-the-latest-looksmaxxing-craze-but-are-they-safe-a-researcher-breaks-9b60e300759036ec 2026-08-24T16:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/upadacitinib-effective-for-severe-alopecia-areata-in-phase-3-trial-147ea8396320d037 2026-08-24T16:45:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-signals-a-new-era-for-pregnancy-registries-what-biopharma-needs-to-know-661dd3ae64bd2d95 2026-08-24T16:42:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-food-safety-crackdown-fda-action-against-mca-eateries-cafe-cadell-and-oth-f53b7448e49bb693 2026-08-24T16:38:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/speed-discipline-and-the-new-rules-of-biotech-development-q-a-with-stella-k-vnoo-cfef912e3dd47f4a 2026-08-24T16:36:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-safety-officer-shakes-up-mumbai-one-viral-raid-at-a-time-443f353268378328 2026-08-24T16:35:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/industry-perspective-finding-the-missing-link-between-clinical-trial-interoperab-6ffce00b79c64f41 2026-08-24T16:30:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/can-ai-replace-animal-testing-6c03354c77824753 2026-08-24T16:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/independent-pharmacy-s-evolving-role-michelle-britt-on-what-s-next-bb45eef6587c3f6f 2026-08-24T16:28:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/celltrion-joins-race-to-launch-keytruda-biosimilar-as-competition-intensifies-25d7c6bfee07a165 2026-08-24T16:27:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/central-bucks-chamber-of-commerce-relocates-to-biotech-center-b6a04d86fef0c598 2026-08-24T16:27:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-strategic-shift-for-gene-therapies-manufacturing-and-market-size-take-centre-s-3800400f2b702855 2026-08-24T16:07:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/fulcrum-therapeutics-stock-plunges-51-after-ha-bf85e19c188af21e 2026-08-24T16:05:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-commits-to-lean-mass-preservation-with-hanmi-obesity-deal-ee78a5de9eb7d005 2026-08-24T16:01:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/moleculin-biotech-mbrx-upgraded-to-buy-here-s-why-3d986190238f1809 2026-08-24T16:00:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/phoenix-biotech-firm-to-shutter-facility-lay-off-90-employees-60faf3b015cbc956 2026-08-24T15:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-mrna-cancer-vaccine-clears-phase-3-melanoma-recurrence-cut-by-half-14236c82b045d803 2026-08-24T15:46:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/ebola-and-marburg-returning-workers-scheme-rws-0b1c8da0eb5eb1f7 2026-08-24T15:40:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/maha-fda-suspends-licences-of-5-mumbai-cricket-association-eateries-680cf4787e6604ff 2026-08-24T15:34:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/eu-ppwr-minimising-medtech-packaging-without-losing-protection-2969b3a9842dd791 2026-08-24T15:32:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-syre-a-buy-now-as-clinical-catalysts-clash-with-valuation-risk-dcceeca555e5a04f 2026-08-24T15:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-finalizes-rules-for-deciding-when-generic-drugs-can-substitute-for-brand-nam-c39637440c70087e 2026-08-24T15:26:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-5-restaurants-at-mumbai-cricket-association-premises-ov-2efa92e37dfd48ce 2026-08-24T15:23:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-five-food-outlets-on-mumbai-cricket-associa-e6b37fa23d5ccb71 2026-08-24T15:12:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-are-breaking-out-how-josh-brown-is-trading-them-b8c1c6922c39c2c8 2026-08-24T15:10:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-and-her-fiance-launch-a-biotech-startup-311afbfca6c13cc2 2026-08-24T15:01:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/innocare-reports-2026-interim-results-sustained-profitability-and-key-milestones-48def6689dd4bf28 2026-08-24T14:53:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/join-us-at-the-annual-members-meeting-2026-6c6f61435c66c186 2026-08-24T14:53:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-mumbai-cricket-association-outlets-face-fda-action-over-food-safety-violations-869fc3316a7bae60 2026-08-24T14:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/tme-holds-onto-1b-dream-for-brain-cancer-drug-as-search-for-partners-nears-concl-fc5f67e682d75a8f 2026-08-24T14:13:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-moved-higher-as-the-broader-biotech-sector-hit-a-post-pandemic-peak-but-91e0b6cf45077368 2026-08-24T14:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/reg-hikma-pharmaceutical-director-pdmr-shareholding-08e9ce9c963fed2f 2026-08-24T14:03:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-gene-editing-biotech-stocks-worth-watching-for-long-term-gains-492baed0278db0b5 2026-08-24T13:59:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/international-overdose-awareness-day-2026-904b54b7cc064b72 2026-08-24T13:57:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-5-mumbai-cricket-association-restaurant-licences-action-also-taken-cb804aba2085483a 2026-08-24T13:57:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-sls-stock-rockets-255-on-phase-3-aml-trial-progress-058a0a0e1f102b98 2026-08-24T13:55:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-enters-2-3-billion-licensing-agreement-with-genentech-for-hm17321-f5f41c758a45f7d9 2026-08-24T13:54:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-sls-stock-rockets-255-on-phase-3-leukemia-trial-progress-33c7601bce7aa740 2026-08-24T13:54:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-5-mumbai-cricket-association-restaurants-fd75bfcc086d0d0c 2026-08-24T13:53:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-sls-stock-rockets-over-255-on-phase-3-aml-trial-progress-477d4d114c7ec6f9 2026-08-24T13:53:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/our-responsible-use-of-ethylene-oxide-eto-f53313bf4e722379 2026-08-24T13:45:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-uav-technologies-to-acquire-biotech-firm-nexus-peptide-sciences-in-a-3-5m-28bbb68dad497232 2026-08-24T13:41:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-biotech-s-global-breakout-innovation-deals-and-the-next-investment-cycle-6dcebd402497c4ba 2026-08-24T13:29:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/joincare-pharmaceutical-group-industry-co-ltd-reports-earnings-results-for-the-h-0f20cdf22f904c05 2026-08-24T13:23:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-tsafe-telangana-s-new-unified-food-and-drugs-authority-is-timed-well-e10398af3cec7b4b 2026-08-24T13:19:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/dr-ram-sarma-joins-virchow-biotech-as-chief-operating-officer-bb17614545bc2ac2 2026-08-24T13:14:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/amylin-analogs-in-the-clinic-a-deep-dive-a3e4d511b7b2125b 2026-08-24T13:03:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/4-gene-editing-biotech-stocks-worth-watching-for-long-term-gains-98cceb2500811a63 2026-08-24T13:03:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/boehringer-suspends-phase-i-trial-of-oral-cns-drug-after-safety-event-206fed60a4a6e43a 2026-08-24T13:00:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurothera-clearmind-collaboration-advances-mdma-n-acylethanolamines-ip-for-the-8e6d598ca0577ee3 2026-08-24T12:59:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaneck-biotech-etf-bbh-is-a-buy-with-strong-g-557b6a70467c53da 2026-08-24T12:57:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/vaccine-breakthrough-is-bittersweet-for-bankrupt-biotech-founder-part-of-our-pai-201a7ea40f1adda5 2026-08-24T12:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-guidance-includes-mdma-as-a-psychedelic-drug-scisparc-patent-application-pub-59eea01b4a6846a4 2026-08-24T12:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scisparc-neurothera-clearmind-collaboration-advances-1dad0378f69451e1 2026-08-24T12:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alkeus-pharmaceuticals-announces-japan-ministry-of-health-labour-and-welfare-mhl-132784864999ba64 2026-08-24T12:49:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbh-biotech-s-next-growth-cycle-is-just-getting-started-nasdaq-bbh-61883e8d7deaaad4 2026-08-24T12:40:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laser-photonics-secures-1-05-million-order-from-u-s-pharmaceutical-manufacturer-325a987c22ba13cf 2026-08-24T12:32:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/laser-photonics-wins-a-1-05m-order-for-a-line-that-checks-every-tablet-8566f11ff120cd74 2026-08-24T12:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/laser-photonics-secures-1-05-million-order-from-u-s-pharmaceutical-manufacturer-3aab010d3b8a72de 2026-08-24T12:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ghana-to-establish-pharmaceutical-industrial-park-43ca929bf87e7547 2026-08-24T12:13:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/humacyte-plans-november-2026-supplemental-bla-submission-for-atev-dialysis-acces-ce68dcf9e9f0260a 2026-08-24T12:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adarx-pharmaceuticals-receives-fda-fast-track-designation-for-onvuzosiran-for-th-00402ec2354307ac 2026-08-24T12:08:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-pauses-regenxbio-gene-therapy-trial-again-due-to-safety-concerns-1d9ae56b813436b4 2026-08-24T12:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-transistor-that-operates-at-600-c-c94bf863f54d26f1 2026-08-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/importation-of-south-korean-authorized-bonky-injection-1-mcg-ml-calcitriol-due-t-9a0f95afbaff56ff 2026-08-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-hidden-vulnerabilities-of-global-pharmaceutical-supply-chains-lessons-from-t-483bbd21e495a19c 2026-08-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spruce-biosciences-announces-positive-pre-bla-meetings-with-fda-and-confirms-bla-95c6d12364f68895 2026-08-24T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-mrna-stock-skyrockets-177-on-melanoma-vaccine-breakthrough-can-it-last-8f4788b557b51787 2026-08-24T11:52:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/regenxbio-gene-therapy-refiling-plan-derailed-by-fda-hold-over-spine-mri-finding-dd9b515bd4430346 2026-08-24T11:51:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-new-life-sciences-map-is-taking-shape-in-osaka-95fd4188d5a0e08a 2026-08-24T11:47:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/clare-cancer-survivor-says-vaccine-will-offer-less-fear-and-more-hope-for-patien-9f9626cd9a19ade8 2026-08-24T11:45:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-lab-data-advance-veraxa-nasdaq-vrxa-autoimmune-aoc-8e12f3f8e36d4f1c 2026-08-24T11:39:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/h-c-wainwright-raises-lb-pharmaceuticals-price-target-to-60-172dc81d324701a3 2026-08-24T11:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arrowhead-pharmaceuticals-to-present-new-clinical-data-at-the-european-society-o-7ae4b68a4011dc7e 2026-08-24T11:35:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/baiyunshan-pharmaceutical-boosts-h1-r-d-spending-over-20-to-fuel-innovation-9a43fcd20a262d49 2026-08-24T11:20:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/nomura-adjusts-cspc-pharmaceutical-group-s-price-target-to-hk-10-93-from-hk-10-3-0c031cd411e463d0 2026-08-24T11:14:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/emily-field-large-pharma-companies-are-going-to-continue-looking-at-biotech-fc60da011a791526 2026-08-24T11:12:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/editors-picks-august-2026-weight-loss-and-breast-cancer-biomarkers-predicting-ea-4ea507b7bee9a3ed 2026-08-24T11:09:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/veraxa-biotech-and-secarna-pharmaceuticals-achieve-research-milestone-in-antibod-2404b10ced77889e 2026-08-24T11:06:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/automa-2026-highlights-ai-and-data-intelligence-as-key-drivers-of-clinical-trial-88de61ffb2462072 2026-08-24T11:05:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-reports-a-cancer-vaccine-breakthrough-245948bb1a20e390 2026-08-24T11:02:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-once-daily-pill-cut-pah-worsening-risk-55-fda-review-is-underway-f10e777dc42a7055 2026-08-24T11:02:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/labcorp-to-offer-first-fda-cleared-blood-test-to-detect-alzheimer-s-disease-path-b42f0838ee0fd11b 2026-08-24T11:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-exclusive-licensing-deal-with-genentech-for-novel-obesity-ther-3cbbb5c8bf7cd9fe 2026-08-24T11:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/tiziana-life-sciences-announces-poster-presentation-on-phase-2a-banyan-clinical-c8e76a31b5f8834f 2026-08-24T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-antibody-linked-oligonucleotide-candidate-showed-greater-potency-in-early-lab-0d88fd42dc947923 2026-08-24T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gericke-introduces-gfs-gen3-a-continuous-manufacturing-platform-built-for-fast-p-a59d60065e2a5c35 2026-08-24T10:58:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-bets-up-to-2-3b-on-hanmi-s-early-stage-muscle-building-obesity-asset-bed571019c460d33 2026-08-24T10:56:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-cancer-vaccine-breakthrough-reveals-growth-potential-for-biotech-ca60cc49414906b8 2026-08-24T10:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patented-device-reinvents-solid-phase-extraction-7b8a82958a4a2a10 2026-08-24T10:53:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/improving-access-to-medicines-for-patients-with-reduced-hand-function-e90397a66aed69ca 2026-08-24T10:46:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-praise-intismeran-s-landmark-phase-iii-win-look-to-further-data-097055da0ff75326 2026-08-24T10:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/cathay-biotech-inc-s-shareholder-plans-to-unload-stake-bf5177be0e3d78be 2026-08-24T10:26:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/should-you-invest-in-the-state-street-spdr-s-p-biotech-etf-xbi-35438a3b4c6878f5 2026-08-24T10:20:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/k-bio-exports-top-11-billion-amid-deal-surge-3b7a8009e23b410b 2026-08-24T10:14:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/routine-childhood-immunisation-schedule-7888ba8ae6ebc8f2 2026-08-24T10:11:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-pharmaceutical-group-limited-reports-earnings-results-for-the-ha-f2d8853bc14ca178 2026-08-24T10:05:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinopharmtech-at-technofest-2026-in-moscow-19ca86d8452dd5c9 2026-08-24T09:59:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/annual-epidemiological-commentary-gram-negative-mrsa-mssa-bacteraemia-and-c-diff-eb098c2f1b06a9a0 2026-08-24T09:47:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-23-august-2026-928c1ec1f181cd96 2026-08-24T09:40:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/dashenlin-pharmaceutical-h1-net-profit-up-16-1-y-y-793bd9f08136938b 2026-08-24T09:38:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/hhs-consults-on-how-us-vaccine-recommendations-are-categorized-08562b7e69f3a4fe 2026-08-24T09:09:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulatory-round-up-24-august-2026-dcd0fc42fb62da0c 2026-08-24T09:09:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/training-and-events-ukhsa-knowledge-and-library-services-9a29c86c53eff3a7 2026-08-24T09:00:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-signs-record-2-3-bn-obesity-drug-licensing-deal-with-roche-097f02edefa329b4 2026-08-24T08:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ifpi-2026-programme-architecture-unveiled-61b6b9690f342a4f 2026-08-24T08:54:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-pens-2-5b-pact-for-hanmi-s-clinical-stage-obesity-drug-targeting-less-expl-50c29584306d7646 2026-08-24T08:42:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/competition-for-obesity-treatments-is-shifting-from-how-much-do-you-lose-to-how-ec5400ea6665b976 2026-08-24T08:41:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-pharmaceutical-group-revenue-up-2-0-yoy-to-rmb134-5b-net-profit-e186eb635b6922c7 2026-08-24T08:39:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-hanmi-pharmaceutical-has-achieved-the-feat-of-exporting-up-to-2-3-billion-abo-bbf070ed670acdd5 2026-08-24T08:37:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-extrawell-pharmaceutical-holdings-limited-679e92ca0c57a02b 2026-08-24T08:33:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsgp-optimism-around-personalised-melanoma-treatment-fbb5e76bedeb2c25 2026-08-24T08:11:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-to-test-zenagamtide-against-its-own-semaglutide-in-korea-08deb2d837191c58 2026-08-24T08:09:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/ct-based-biotech-teclens-aims-to-make-reading-glasses-optional-a2980152c621927c 2026-08-24T08:00:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-killed-in-suspected-sulphur-dioxide-leak-at-karnataka-pharmaceutical-plant-299917837991b27d 2026-08-24T08:00:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-s-3-2t-won-muscle-preserving-obesity-drug-tech-export-3d9609ed5b11097d 2026-08-24T08:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/re-engineering-pharmaceutical-packaging-for-ppwr-compliance-23924d7847b5315d 2026-08-24T08:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/world-health-expo-to-showcase-trillion-dollar-growth-across-pharma-biotech-longe-357164bdec6d5fbe 2026-08-24T07:57:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/growth-of-danish-pharma-industry-cannot-be-taken-for-granted-5f47dbe0554d506f 2026-08-24T07:49:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fss-to-hold-briefings-on-revised-pharma-biotech-disclosure-rules-af24debf21b72542 2026-08-24T07:45:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/intellectual-property-ip-guidance-for-the-nhs-in-england-4ad1baaaf17192b5 2026-08-24T07:44:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-sanjiu-medical-pharmaceutical-s-attributable-profit-slides-8-in-817dcd2a5e159239 2026-08-24T07:42:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/samjin-pharm-seeks-government-dementia-friendly-certification-b5d825e9358c5f11 2026-08-24T07:39:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/psilocybin-works-in-the-lab-can-it-survive-the-clinic-e2e81f9c35360422 2026-08-24T07:33:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-order-to-support-the-on-site-settlement-of-the-pharmaceutical-and-bio-disclos-05a8791a9784874b 2026-08-24T07:32:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/olix-completes-phase-1b-trial-of-hair-loss-treatment-olx104c-in-australia-phase-11ad591554bc4d61 2026-08-24T07:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-norovirus-and-rotavirus-report-week-35-report-data-to-week-34-data-up-t-1c5eb28e6ec1bfd5 2026-08-24T07:14:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/monthly-mandatory-surveillance-of-mrsa-mssa-gram-negative-bacteraemia-and-c-diff-f01e069ac174d4ea 2026-08-24T07:07:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ribomic-completes-site-network-for-phase-3-achondroplasia-trial-in-japan-7c8a7ede44f1f7a0 2026-08-24T07:03:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/jemperli-dostarlimab-accepted-for-priority-review-by-the-us-fda-for-dmmr-msi-h-l-ec4615c21efff4e4 2026-08-24T07:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/hibsago-bepirovirsen-approved-in-japan-as-first-and-only-functional-cure-for-chr-2968faa78f88c491 2026-08-24T07:00:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/series-sea-who-s-investing-in-the-region-s-biotech-startups-790a7b0802ca148c 2026-08-24T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-shares-surge-30-after-2-3-bil-genentech-obesity-drug-deal-ddf9342869b5393c 2026-08-24T06:58:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-licenses-obesity-drug-to-genentech-19cd3939ef6c225f 2026-08-24T06:57:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/orzeyful-oveporexton-approved-in-japan-as-the-first-and-only-medicine-to-treat-t-2c822531561deea6 2026-08-24T06:36:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-biotech-s-global-breakout-innovation-deals-and-the-next-investment-cycle-fdd9a4aa399a7ceb 2026-08-24T06:24:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-2-3-bil-licensing-deal-with-roche-s-genentech-for-obesity-drug-d2aefa26553e2a33 2026-08-24T06:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-group-limited-just-beat-analyst-forecasts-and-analysts-have-0fb5fc7f7edf83a6 2026-08-24T06:18:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-lucidity-trial-success-puts-avexitide-on-track-to-become-first-pbh-treat-ebba9700beac7830 2026-08-24T06:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-glp-1-stocks-that-could-double-your-money-by-2031-1c094daeadc225ce 2026-08-24T06:07:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-3-2-tln-won-licensing-deal-with-roche-s-genentech-for-obesity-5f02b7dc3f271523 2026-08-24T06:00:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/cabinet-to-focus-on-biotech-through-policy-technology-premier-news-radio-taiwan-24153bf59930f019 2026-08-24T05:58:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/nomura-raises-target-price-for-cspc-pharmaceutical-01177-hk-to-hk-8-67-maintains-2a565f67c1c5b622 2026-08-24T05:53:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-signs-obesity-drug-deal-with-genentech-worth-up-to-2-3-billion-2c7894f0cb83b6d9 2026-08-24T05:51:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/rat-in-food-allegation-rocks-nalasopara-eatery-viral-video-sparks-outrage-reside-b979d62d3c2c6792 2026-08-24T05:50:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiwan-premier-touts-biotech-growth-at-annual-policy-meeting-7de4447537a90544 2026-08-24T05:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-massive-licensing-deal-with-us-biotech-firm-for-obesity-drug-3e8b8c1fd74dc8c4 2026-08-24T05:43:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/samjin-pharm-seeks-government-dementia-friendly-certification-2aafb28f48628878 2026-08-24T05:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/director-kunal-kohli-wants-tukaram-mundhe-to-raid-home-kitchens-here-s-why-cc9acba0f50b1ba4 2026-08-24T05:41:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/as-hanmi-pharmaceutical-succeeded-in-exporting-the-largest-new-drug-technology-s-4ef92d2448812edf 2026-08-24T05:39:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/newsgp-optimism-around-personalised-melanoma-treatment-dc73e5cc0e502936 2026-08-24T05:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-ministry-revokes-astrazeneca-vietnam-s-pharmaceutical-business-certificat-b0a39a32d3fbe052 2026-08-24T05:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/jordan-fda-warns-of-severe-health-violations-in-school-canteens-threatens-judici-b0dead346ed41eb5 2026-08-24T05:28:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/with-the-obesity-treatment-craze-sweeping-the-world-the-pharmaceutical-bio-indus-6142ac30949cf8c4 2026-08-24T05:28:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-signs-record-2-3b-obesity-drug-deal-with-genentech-122360fe62dbc94b 2026-08-24T05:27:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-sets-new-milestone-with-3-2-trillion-won-technology-export-359dc65bd0003fa6 2026-08-24T05:18:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/silicone-tubing-for-pharmaceutical-transfer-market-to-reach-index-190-by-2035-on-b00745bc778fd1b9 2026-08-24T05:16:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/alvotech-signs-agreement-with-lotus-pharmaceutical-70d63432aa174e0d 2026-08-24T05:08:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-exclusive-licensing-deal-with-genentech-for-novel-obesity-ther-6697b63f7092b9df 2026-08-24T05:07:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharm-signs-exclusive-licensing-deal-with-genentech-for-novel-obesity-ther-d89d3a67886fa28f 2026-08-24T05:02:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/after-restaurant-raids-hum-tum-director-kunal-kohli-wants-fda-chief-tukaram-mund-efba2d543c6efb47 2026-08-24T04:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fss-launches-briefings-to-enforce-korea-biotech-disclosure-reforms-chosunbiz-738bffd5ea8ba62c 2026-08-24T04:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-bad-is-the-food-safety-situation-in-india-tukaram-mundhe-interview-5f4e712553347b8e 2026-08-24T04:15:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-did-tgt-mrk-schw-stocks-surge-to-52-week-highs-last-week-8d5906f01d68f3ad 2026-08-24T04:13:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/we-have-to-ensure-food-that-is-served-prepared-and-sold-is-safe-tukaram-mundhe-cf4aa691dac3d1d0 2026-08-24T04:09:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/fss-to-support-disclosure-work-for-pharma-and-biotech-companies-with-relay-brief-f792ba4e3d52c9fd 2026-08-24T04:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vitruvias-therapeutics-inc-issues-nationwide-recall-of-one-lot-of-thyroid-tablet-83f0aa6b918c34f9 2026-08-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-ventilator-issue-from-coopersurgical-44a135b84817a67c 2026-08-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-nitric-oxide-delivery-system-issue-from-noxbox-2871b9660857cbb8 2026-08-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-convenience-kit-issue-from-medline-4ef8ef5d7b99f48f 2026-08-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-convenience-kit-issue-from-avid-medical-b533fd57ac6c9fdf 2026-08-24T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/common-rheumatoid-arthritis-drug-may-support-hair-regrowth-in-alopecia-8cafd3771b2b3c6a 2026-08-24T03:51:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insight-dongkook-pharmaceutical-nears-w1-trillion-revenue-as-centellian24-drives-9a3547758800357d 2026-08-24T03:41:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-licenses-muscle-preserving-obesity-drug-candidate-to-genent-945d72da610c187e 2026-08-24T03:40:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/gamma-interpharm-enters-cambodia-expands-sri-lanka-s-pharmaceutical-export-footp-91d63f94db1c5793 2026-08-24T03:17:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/stopping-inflated-disclosures-financial-supervisory-service-to-hold-briefings-on-c59c3ea558173b09 2026-08-24T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-has-decided-to-transfer-its-technology-to-genentech-a-subsi-5b33a1448f2a95ea 2026-08-24T02:46:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/uk-first-in-europe-to-authorize-lilly-s-foundayo-b93c2572c977d108 2026-08-24T02:35:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-pharmaceutical-licenses-obesity-drug-candidate-to-genentech-in-deal-worth-76f8c697d02af4d5 2026-08-24T02:34:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-to-prioritise-process-audits-for-revised-schedule-m-compliance-f-f212bcef42497e10 2026-08-24T02:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/sun-pharma-recalls-over-1900-bottles-of-epilepsy-drug-in-us-21b08d432fba6f91 2026-08-24T02:30:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/hanmi-licenses-muscle-building-obesity-drug-to-genentech-in-2-3b-deal-chosunbiz-2860115469114d61 2026-08-24T02:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/q4-2025-teva-pharmaceutical-industries-ltd-earnings-call-transcript-2185660d563da79b 2026-08-24T02:09:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/lee-ko-biko-sign-mou-to-advance-biotech-and-medical-big-data-7b1036091f4487fc 2026-08-24T02:04:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/jw-pharmaceutical-expands-friends-eye-care-brand-across-south-korea-chosunbiz-6c55c2ea5686489e 2026-08-24T01:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-by-cnbc-tv18-on-tradingview-2026-08-24-cnbctv-f48fee6b0094b-0-6dabbec39e7fabdd 2026-08-24T01:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/samjin-pharmaceutical-trains-staff-to-lead-korea-s-dementia-response-chosunbiz-8290cfd90a3c93ff 2026-08-24T01:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/covid-resurgence-lifts-korea-biotech-and-drug-stocks-chosunbiz-1fc9874c480b36cd 2026-08-24T01:10:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/celltrion-and-samsung-bioepis-are-in-full-swing-over-the-biosimilar-biopharmaceu-804619fe1d62aa1b 2026-08-24T00:58:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinic-offers-mdma-assisted-therapy-for-the-first-time-96729c5f53887ccd 2026-08-24T00:56:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/acrux-brings-experienced-clinical-leader-aboard-to-advance-female-testosterone-p-5012bb4a8c82d14f 2026-08-24T00:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmg-pharmaceutical-co-ltd-kosdaq-a058820-dropped-from-s-p-global-bmi-index-f4e6e0310b78e468 2026-08-24T00:40:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/weight-loss-pharmaceutical-drugs-what-they-are-how-they-work-and-realistic-expec-30687373ebf16ca6 2026-08-24T00:27:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/lexicon-achieves-new-milestone-with-novo-nordisk-69760231021731cc 2026-08-24T00:23:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/holographic-tamper-evident-films-market-to-reach-2-3b-sq-meters-by-2035-on-pharm-041e552fd5bf1988 2026-08-24T00:21:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/sinopharm-interim-revenue-edges-down-on-softness-in-pharmaceutical-distribution-11228c40a6f3ce29 2026-08-24T00:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-filed-form-6-k-926bf69fdc8aa2bf 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-filed-form-6-k-00f2281ab68e9e8f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/request-for-information-categories-used-in-federal-vaccine-recommendations-and-t-499f352801b34931 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/food-and-drug-administration-modernization-act-of-1997-modifications-to-the-list-97fbff52714ed826 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availa-9547fffecbb4c053 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-therapeutic-equivalence-guidance-for-industry-availability-1199f6cad7cf55ba 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-owned-invention-available-for-license-t-cell-receptors-targeting-hpv-25cb86ece37b0e28 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-lithobid-5065388b98d168fb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/improvement-in-heart-failure-health-status-and-functional-capacity-following-man-a81220423ebfa732 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/united-therapeutics-corporation-announces-fda-filing-acceptance-of-new-drug-appl-f51ceac6631ff056 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/medicine-against-itself-toward-a-nonlinear-neuropsychopharmacology-f06122b0939d07a1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advanced-therapy-medicinal-products-in-saudi-arabia-regulation-and-development-8fa40b616b16ad0a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/amikacin-liposomal-inhalation-suspension-advances-in-application-against-refract-4df78f1802f2cf38 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/meal-replacement-provides-additional-benefits-for-weight-and-visceral-fat-reduct-1d3968f9cfda379a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/successful-translational-prediction-of-bedaquiline-s-phase-2a-clinical-trial-res-d4b366ee5cea4e20 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-sarpogrelate-versus-aspirin-on-whole-blood-viscosity-in-patients-with-5a4fac9682eb5ff6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/immuno-pet-imaging-of-mesothelin-in-ovarian-cancer-with-lt-sup-gt-68-lt-sup-gt-g-a00e21df80321234 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lariocidin-and-ribosome-targeting-lasso-peptides-as-emerging-antimicrobial-agent-6c038920d9e39297 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/towards-precision-psychiatry-initial-foundations-and-future-directions-b4545d659611b451 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/yukgunja-tang-and-pyeongwi-san-improve-functional-dyspepsia-and-modulate-ghrelin-7e95e8ed665e9cc9 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-associations-of-almond-dark-chocolate-and-cocoa-consumption-with-stoo-c89a713d9e62a15e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/safety-tolerability-and-efficacy-of-alixorexton-a-selective-orexin-2-receptor-ag-6482abd09cb69c6f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-the-gap-predicting-early-contingency-management-outcomes-52a20a54e4f98041 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-the-role-of-glp-1-receptor-agonists-and-dpp4-inhibitors-in-the-treatme-d2dc485acb82e1fe 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ethical-and-social-recognition-of-participation-in-drug-clinical-trials-french-p-b45a79f3fbcd6229 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-evaluation-of-becotatug-vedotin-for-the-treatment-of-recurrent-or-metastatic-3dc8e0444d4cc5dd 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-outcomes-of-a-phase-ii-trial-of-laparoscopic-robotic-total-gastrectomy-w-cedf89d85554d5e7 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/virtual-reality-hypnosis-during-protective-isolation-a-parallel-group-randomized-f929e050aa3d57c6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxycodone-combined-with-pulsed-radiofrequency-for-refractory-cancer-pain-from-sp-261a5460c14c5761 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-interventions-targeting-cognition-and-related-clinical-outcomes-910df7597ded5d6f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-the-safety-and-efficacy-of-sodium-pentaborate-pentahydrate-in-indi-7797a656f3520f4c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cell-based-therapies-and-drug-repurposing-in-stroke-34fe8133af49c27f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-clinical-characteristics-of-patients-with-pseudogout-and-concomit-c5d200474cc4c8a1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shear-bond-strength-to-calcium-hydroxide-does-cavity-conditioning-make-a-differe-865adab05438c866 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/knowledge-attitudes-and-clinical-intentions-of-dental-students-toward-botulinum-43d8ce6591000089 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bibliometric-analysis-of-postgraduate-theses-employing-ultrasonographic-imaging-e897990a715e0b7f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-fully-digital-workflow-for-transferring-an-emergence-profile-in-the-esthetic-z-1d60be33f603e340 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-accuracy-and-behavioral-acceptance-of-smartphone-based-teledentistry-779561e4b4a7fe11 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/volumetric-assessment-of-maxillary-sinus-and-pharyngeal-airway-in-patients-with-089936c7d957e7bc 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/financing-decisions-and-capital-structure-dynamics-in-cross-border-acquisitions-c53f59f60f8933d4 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/functional-mechanisms-and-clinical-translation-of-resveratrol-for-lung-cancer-in-709af64af064e85e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/congenital-dermatofibrosarcoma-protuberans-in-a-seven-month-old-infant-initially-d19554f1bf521383 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/segment-specific-patterns-of-regional-lymph-node-metastasis-in-primary-small-cel-9bd9b63f2645f93b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-role-of-perioperative-carcinoembryonic-antigen-in-guiding-a-72dca64ad6c28397 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-osteoimmunology-into-modern-clinical-implantology-the-immune-bluepri-58456090283ee056 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-eye-patching-on-sclerostomy-wound-architecture-in-25-gauge-suturel-b5ca412b54be3b9a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/subconjunctival-triamcinolone-acetate-versus-topical-steroid-for-control-of-infl-bec9e0122ebd5639 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/triazole-based-hybrid-molecules-in-anticancer-drug-discovery-structural-classes-1b21451b40fddcbb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exercise-and-dehydration-associated-rhabdomyolysis-pathophysiology-clinical-feat-0d43e34ab5deca72 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/polymer-enabled-additive-manufacturing-for-personalized-drug-delivery-and-diagno-5a8d3be247441a4c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/colchicine-in-patients-with-acute-ischemic-stroke-a-meta-analysis-of-randomized-2c8109f1c5d1c313 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-based-prediction-of-pancreatic-stone-clearance-in-pancre-caaf83b6b9fdba8c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/domain-specific-motor-skill-outcomes-following-a-structured-play-based-motor-int-ea3a3c3ccbaf9e00 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/left-bundle-branch-pacing-is-a-superior-pacing-strategy-compared-to-left-ventric-7dfba18355417d1e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/urothelial-lined-perineal-masses-in-hypospadias-clinical-and-pathological-insigh-4f1086523ed4af9f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-severity-anchored-patient-reported-outcome-framework-for-clinical-trials-in-po-899ac49a0c71e4c3 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-metagenomic-next-generation-sequencing-into-a-multimodal-diagnostic-976663b7a56d2ffb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-organoids-for-personalized-medicine-from-technological-development-t-a54353c197bad3a7 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/outcomes-of-the-sustainable-culturally-adapted-nutrition-program-scan-and-food-s-8f8c904f11e93365 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/narrative-review-laparoscopic-vs-open-repair-of-inguinal-hernias-in-athletes-cli-0df0a77d2c13d671 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanisms-and-clinical-assessment-of-fear-of-disease-progression-in-amyotrophic-f1b0392e2c8d6d71 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-randomized-placebo-controlled-trial-of-htd1801-monotherapy-in-participants-wit-a7a3bdbb1958ddf2 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/divozilimab-in-neuromyelitis-optica-spectrum-disorders-evidence-based-consensus-27deb4ac46a76c9e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-analysis-and-predictive-modeling-of-the-tensile-and-flexural-streng-7854456f98af5cee 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/deep-vein-thrombosis-after-arbaeen-walking-a-case-report-346ebb4773705c86 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/to-compare-and-evaluate-the-anti-plaque-and-anti-gingivitis-efficacy-of-a-salt-t-2d052e4fe45b5521 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-pulmonary-artery-catheter-derived-hemodynamic-parameters-a-p-64f3eaf974d602df 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-mis-use-of-artificial-intelligence-in-laboratory-medicine-the-good-the-bad-a-e98bb70c3061fc8b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sample-volume-management-the-role-of-the-clinical-laboratory-in-minimizing-diagn-a6db5ff83b289478 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mid-term-clinical-and-radiographic-outcomes-of-pyrodisk-interposition-arthroplas-c092dc6cc7391074 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-strategies-for-differentiating-crohn-s-disease-from-intestinal-tuberc-be09e3eb70a9156d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effects-of-affective-expectations-on-affective-experience-and-dimensions-of-0cb17dd0824f392f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/extractive-ion-pair-spectrophotometric-methods-utilizing-bromocresol-green-to-es-40efdcaf4a14c319 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-megadose-vitamin-c-in-patients-with-sepsis-the-cemvis-randomized-clini-d38014ca44a17cc1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-application-effect-of-biological-amniotic-membrane-in-minimally-invasiv-6c4ac2ecd9d16d3a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-telomere-dynamics-and-lipid-profiles-across-pregnancy-a-secondary-analy-93c99b26b3deee3d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-ai-enhanced-virtual-patients-in-clinical-reasoning-training-of-596d6f6c67a1d3c5 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implementation-of-an-ai-simulated-consultation-platform-for-undergraduate-clinic-d26c778dc98e5ecd 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychosexual-outcomes-in-hpv-positive-women-with-abnormal-cervical-cytology-a-pr-8d323ce8cc19941b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flowable-vs-conventional-composite-for-mandibular-fixed-retainers-bond-failure-c-76d86c3036bfb6f7 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparative-efficacy-and-safety-of-oral-iron-polymaltose-complex-vs-ferrous-sulp-7ebac0e4769f28de 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-and-inflammatory-endothelial-biomarkers-associated-with-7a238bbdf7f062b0 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-impact-of-e-coach-nursing-management-on-enhancing-exclusive-breastfeeding-am-773cb2701b090153 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-year-all-cause-kidney-allograft-loss-descriptive-clinical-trajectories-of-91f54813d2f4e0cb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-comparison-of-single-level-bryan-and-prodisc-c-cervical-disc-arthropla-f254be4ac7290c31 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-outcomes-with-therapeutic-cerebrospinal-fluid-drainage-for-spinal-cord-5d5ffe4cc91164ca 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-clinical-renal-remission-serological-and-obstetric-risk-stratification-in-0370dabd22df925c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-characteristics-of-patients-with-late-onset-systemic-lupus-erythematosu-0caf84e62c0b95d4 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/scaling-moud-implementation-in-correctional-settings-through-a-digital-coaching-c3a682a9c864a89f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hyperreflective-choroidal-foci-characterization-supports-the-existence-of-differ-bc95cfca49b25edb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pf-08046876-a-differentiated-integrin-beta-6-antibody-drug-conjugate-delivering-ca92e23e981c4966 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emb-01-an-anti-egfr-c-met-bispecific-antibody-in-patients-with-heavily-pretreate-aba8547ae0c4bede 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/elacestrant-in-combination-with-everolimus-for-estrogen-receptor-positive-her2-n-3a1e712100f74245 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-based-classification-of-lower-urinary-tract-symptoms-from-urofl-208b0fd275a45a9d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-impact-of-a-training-module-for-pre-professional-health-students-7bca2b971f0b4463 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-discontinuation-after-complete-response-to-braf-mek-inhibition-in-meta-3df52da41c10fb99 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/between-hypersensitivity-and-toxicity-the-complex-spectrum-of-chemotherapy-induc-46dd863c0b16e5be 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lesson-for-the-clinical-nephrologist-acute-kidney-injury-unmasks-subclinical-she-d73eb417232e06ee 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiac-rehabilitation-programme-accreditation-and-certification-comparing-inter-88392baf013796bb 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ramifications-of-biological-variability-on-tests-for-primary-aldosteronism-scree-da2b436be1981e1c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-cluster-imitation-to-first-generic-the-impact-of-market-exclusivity-incenti-1a658455c78493ad 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-qualitative-inquiry-into-the-environmental-barriers-and-facilitators-to-non-sp-ab575554af89551e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reading-sachs-i-black-hamlet-i-on-trial-5acdc170460c5583 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/appointment-adherence-weight-reduction-and-retention-at-9-months-in-australian-c-62fb4220c72dd207 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-drug-delivery-technologies-5e6d4203754566dc 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prospective-randomized-controlled-study-on-the-hybrid-teaching-model-in-urologic-033a228374ae3f81 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multigmf-a-multi-similarity-geometric-matrix-factorization-for-identifying-drug-e6318251f6fadf8a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-clinical-characteristics-of-dermatophytosis-in-rheumatoid-arthrit-f9d608227dd57624 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-longitudinal-plasma-metabolomics-dataset-of-sepsis-associated-liver-injury-acr-3a72eeb0dbe89038 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/towards-precision-psychiatry-initial-foundations-and-future-directions-247b296269a02c0e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circulating-matrix-metalloproteinase-activity-and-functional-capacity-in-individ-89f28aaf7d2681c6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-unusual-case-of-alternaria-alternata-onychomycosis-in-an-immunocompetent-pati-1811c733e92665aa 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prevalence-and-associated-factors-of-potential-drug-drug-interactions-among-olde-4b0b42f19b68e989 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-and-digital-health-in-the-diagnosis-prediction-and-treatment-of-migraine-curr-50fca6756dc67375 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-and-minimally-invasive-management-of-hypersensitivity-in-molar-incisor-hypom-e4c6fb294e5ce3b4 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-profile-surgical-approaches-and-prognosis-of-lateral-ventricular-tumors-80fbc4683aa86f9e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-and-in-vitro-characterization-of-rosuvastatin-calcium-loaded-chitosa-93ec5dc892f2b2b3 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-a-novel-isothermal-microcalorimetry-based-sterility-test-573c8da197429696 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-optimization-and-evaluation-of-gastro-retentive-floating-beads-of-ne-7d992f4e63f91333 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-ferroptosis-to-overcome-drug-resistance-in-gastrointestinal-cancers-5bae3c8207c21c89 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictors-of-treatment-success-following-pulsed-radiofrequency-of-the-lumbar-do-c0be8d10ae6b050d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/minimal-residual-disease-in-head-and-neck-cancer-molecular-surveillance-and-clin-d224939550ef5faa 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-and-safety-of-intraperitoneal-lidocaine-in-patients-undergoing-laparosc-31df4861193e0540 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cobalamin-c-deficiency-presenting-with-cvid-like-immunologic-abnormalities-a-fiv-06dc3834313ed71b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-utility-of-fas-sequencing-in-suspected-alps-insights-from-a-large-cli-cb51e1ae9ed1cfc2 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodal-graph-neural-networks-for-integrating-heterogeneous-medical-data-in-c-ea7cd45e3fb50fd7 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-outcomes-of-a-phase-ii-trial-of-laparoscopic-robotic-total-gastrectomy-w-73b00b2f9cb73120 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mechanism-informed-combination-therapy-and-dynamic-risk-stratification-in-lupus-b7b38ff0e466d6a4 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-protocol-to-improve-quality-of-life-functionality-and-exerc-6ea6a5fff21cef98 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/crispr-cas9-knockout-of-n-acetyltransferase-1-influences-mesenchymal-transition-ef66f5b965b25dcc 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/5-year-outcomes-of-istent-micro-bypass-vs-kahook-dual-blade-goniotomy-in-open-an-2a396d39aed41e65 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-systemic-conditions-and-the-development-of-glaucoma-in-a-lon-f8141b32f13c79b1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/quantifying-the-inclusion-of-cardiovascular-research-into-clinical-guidelines-14021c7689205396 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/stress-cmr-versus-spect-for-the-detection-of-coronary-artery-disease-meta-analys-2db8bc9a149c4c91 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/late-cardiac-effects-of-anthracycline-based-therapy-in-childhood-cancer-survivor-65f4827e51e241b6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-18f-alf-nota-gl01-pet-ct-in-patients-with-solid-tumors-a-c14a5ee8f6556ba8 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacological-interventions-targeting-cognition-and-related-clinical-outcomes-1701bbba0a08125c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-predicting-aneurysm-occlusion-after-flow-diversion-4f5ce4095aaec0db 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcriptional-profiling-of-growth-hormone-secreting-pituitary-adenoma-stem-lik-2ae9f2d232d45c48 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/emerging-chemical-and-biotechnological-approaches-for-sustainable-treatment-of-f-ba7578e4452609a6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multidisciplinary-oral-rehabilitation-in-osteogenesis-imperfecta-18-year-old-cas-ed3ab609675bc174 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/hepatotoxicity-of-avacopan-real-world-incidence-and-confirmed-cases-of-severe-dr-b79bd66f884e8be8 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07782723-a-comparison-of-the-effects-of-combining-eswt-with-blood-flow-restri-00cd74e4bc4271ce 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07781969-clinical-evaluation-of-discoloration-induced-by-root-canal-treatment-7a94402a995d622d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07781618-3d-foot-scanning-and-customized-3d-printed-foot-orthotics-to-reduce-918940aaff6a43b1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07781345-a-postmarketing-study-of-leqembi-in-united-kingdom-uk-participants-w-a028926099d40f6d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07780890-a-study-to-assess-brillouin-hydration-mapping-for-the-evaluation-of-9b7374b5462e6266 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778966-community-health-worker-support-to-lower-blood-pressure-after-a-preg-6ef939acf962b2ab 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778576-effects-of-12-week-combined-exercise-on-semen-quality-and-metabolic-a21b684bae2754e1 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07758608-renal-impairment-pharmacokinetics-pk-trial-of-afabicin-2961a2195c2af76c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07733765-a-study-in-young-people-and-adults-to-learn-about-the-medicine-ritle-da7219440b0ea3be 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07566494-escalating-doses-of-vas-101-in-subjects-with-stable-sickle-cell-dise-89e71199b72a100f 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07554638-incretin-therapies-in-obesity-related-hfpef-6f4a5d190da99e95 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07513233-anisodine-hydrobromide-for-patients-with-acute-ischemic-stroke-under-8250634e5bb0fc03 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07504796-ctdna-guided-addition-of-ipilimumab-to-patients-receiving-nivolumab-5593b68f99993afe 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07437950-comparing-different-treatment-lengths-for-venetoclax-in-older-people-822295ef947a528d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07403968-a-study-of-zasocitinib-tak-279-in-adults-with-active-crohn-s-disease-48f3e9ddceb9fc4c 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07311889-patient-satisfaction-and-recovery-outcomes-associated-with-periopera-1357ae3bb58d2588 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07284745-a-study-of-karxt-karx-ec-for-treatment-of-irritability-in-children-a-2f9a04a136394489 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07278518-evaluation-of-a-patient-decision-aid-for-emergency-department-initia-7c2562ff276f12b6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07237984-colorectal-omics-and-ofcs-proteoglycans-coco-in-screening-and-a-diag-8634ef98197b730a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07020663-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-b659134621f8cf36 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06980428-a-study-to-investigate-safety-tolerability-pharmacokinetics-and-phar-56596096b2346d2b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06943872-a-study-to-investigate-progression-free-survival-with-sonrotoclax-pl-b80f0058d0fc8b09 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06938412-exercise-activity-intervention-with-sensor-based-engagement-in-patie-ae428e741d7ff071 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06711146-safety-and-efficacy-of-metabolically-armed-cd19-car-t-cells-meta10-1-e20229e996ce2901 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06665555-plasma-and-intrapulmonary-pharmacokinetics-of-ceftibuten-and-ledabor-7045310160ff8ed6 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06620302-testing-the-addition-of-an-anti-cancer-drug-dt2216-to-the-usual-chem-792ea8ac8654e2d7 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06586515-moonray-01-a-study-of-ly3962673-in-participants-with-kras-g12d-mutan-220944e1163c2a1a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06382948-elacestrant-everolimus-in-patients-er-her2-esr1mut-advanced-breast-c-d7d26874f9750fe4 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06379750-using-healthcare-financing-and-digital-technology-to-improve-hyperte-416e2cfdf608ab2d 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06338514-the-effectiveness-of-dry-needling-treatment-in-patients-diagnosed-wi-cc89334a333ea0bf 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06297590-a-first-in-human-study-of-ly3954068-in-participants-with-early-sympt-85de2cee47ce3b28 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06294691-effect-of-stem-cell-infusion-time-on-agvhd-in-patients-with-nonmalig-3f6db973466ef5ca 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06255405-effects-of-dyadic-parent-child-self-compassion-program-on-children-p-a566d1c04042c685 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06152575-magnetismm-32-a-study-to-learn-about-the-study-medicine-called-elran-8ee0e3706d8486c5 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06087653-safety-efficacy-and-pharmacokinetics-of-continuous-subcutaneous-lena-ef8230bafa812d61 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05979298-efficacy-of-plasmid-elenagen-in-combination-with-gemcitabine-in-pati-4b63aa2021e58531 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05091905-patient-titrated-automated-intermittent-boluses-of-local-anesthetic-8ba9535b6d0a4778 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04692675-multiparametric-magnetic-resonance-imaging-of-the-prostate-to-assess-5f9da790b1eadb1a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04235777-bintrafusp-alfa-m7824-and-pds01adc-alone-and-in-combination-with-ste-fe8a9d6734815850 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03351868-fanca-gene-transfer-for-fanconi-anemia-using-a-high-safety-high-effi-2d394f2faa25f3ee 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02504853-natural-history-and-genetics-of-food-allergy-and-related-conditions-95976f14f336be2a 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02008656-trial-evaluating-3-year-disease-free-survival-in-patients-with-local-5c23a78f43baaa8e 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct01399385-new-heart-imaging-techniques-to-evaluate-possible-heart-disease-11d86fe3f2b68187 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00862433-vitamin-e-pharmacokinetics-and-biomarkers-in-normal-and-obese-women-ca64d3d91803f442 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00344331-evaluation-of-biochemical-markers-and-clinical-investigation-of-niem-46b02e456052464b 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00027274-cancer-in-inherited-bone-marrow-failure-syndromes-3ec97793281fdd60 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00001539-a-comprehensive-clinical-microbiological-and-immunological-assessmen-a2c54d10a7c84370 2026-08-24T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-desiccant-strips-market-to-reach-index-183-by-2035-on-biologics-a-a0ef0d0f6b1dfef8 2026-08-23T23:26:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/novotech-strengthens-presence-in-japan-with-opening-of-tokyo-office-634711ef7b48c65d 2026-08-23T23:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-there-any-male-enhancement-that-is-evaluated-by-food-and-drug-administration-0c21eb014ad9a6eb 2026-08-23T22:47:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/eli-lilly-and-novo-nordisk-can-t-treat-this-form-of-obesity-billionaire-stanley-22fe6214184c7d4f 2026-08-23T22:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cosmetics-gold-and-biotech-etfs-stand-out-amid-sluggish-kospi-df518ffb37729c4e 2026-08-23T22:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available-76752c44735575d2 2026-08-23T22:20:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/km-pharmaceutical-targets-global-oral-care-market-with-pororo-products-02e290603ee5d2a1 2026-08-23T22:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/axsome-therapeutics-stock-is-up-16-year-to-date-why-wall-street-thinks-it-has-ev-2fff6a4043817ae9 2026-08-23T21:33:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/sellas-life-sciences-draws-significant-retail-buzz-as-traders-eye-regal-phase-3-8573551db14a7498 2026-08-23T21:21:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/indian-pharma-has-little-reason-to-fear-trump-feb25730b76c92bc 2026-08-23T21:00:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/uv-visible-spectrometers-market-growth-to-2035-driven-by-pharmaceutical-quality-de01bfa0599b1eca 2026-08-23T18:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/suzhou-fengbei-biotech-stock-co-ltd-reports-earnings-results-for-the-half-year-e-b7b79f7e4ba8b930 2026-08-23T18:23:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/maker-of-clear-eyes-recalls-nearly-40-000-bottles-over-contamination-risk-9d5d3ea108e0fbb2 2026-08-23T18:12:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/rethinking-clinical-trial-design-to-include-patients-with-brain-metastases-b5a0835a1fedf8cd 2026-08-23T18:05:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial-9db1afc707a19ffc 2026-08-23T17:54:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/serenta-trial-reaches-50-recruitment-milestone-in-phase-3-study-for-familial-ade-28c2b6322467ec39 2026-08-23T17:38:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abcuro-adds-66m-to-try-again-in-rare-inflammatory-disorder-with-no-approved-drug-bb9bba1aaf6960d6 2026-08-23T17:36:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/best-biotech-stocks-to-watch-today-august-23rd-da4270069393ba06 2026-08-23T17:07:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/steven-o-day-advances-bot-bal-toward-phase-3-neoadjuvant-colon-cancer-trial-3caf6c66c8a7892c 2026-08-23T16:41:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/iovance-biotherapeutics-stock-trends-on-sector-momentum-q2-beat-d8354cdd11a43daa 2026-08-23T16:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-it-was-like-to-go-through-a-trial-that-could-revolutionize-cancer-treatment-da4841bc2e066a8b 2026-08-23T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-assures-safety-amid-chinese-cabbage-formaldehyde-scare-a23c6a2afbb1b950 2026-08-23T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/humacyte-atev-shows-superiority-in-phase-3-v012-study-6b3dffcc06fd5638 2026-08-23T15:19:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/sustainability-for-the-future-2050-riken-s-action-plan-to-create-a-future-togeth-acd3007e1d594619 2026-08-23T15:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-co-stock-hits-fresh-52-week-high-as-mrna-melanoma-data-lift-oncology-story-5d80b0ea6af05ff9 2026-08-23T14:39:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/local-drug-production-will-help-curb-counterfeit-medicines-ajah-e0680138b798589a 2026-08-23T14:38:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/assam-dhubri-police-bust-illegal-pharmaceutical-narcotics-network-two-arrested-b3f8cd8b44d91781 2026-08-23T13:12:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/sfda-slaps-17-pharmaceutical-establishments-with-sar-1-6m-fines-9103fd313c1ccfa4 2026-08-23T13:10:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-breakthrough-was-made-by-moderna-a-pivotal-moment-for-biotech-1ec3e77fdb565777 2026-08-23T12:50:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/delhi-court-permanently-bars-sainus-pharmaceutical-from-using-udaan-trademark-482b3058959da95e 2026-08-23T12:35:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/sfda-fines-17-pharmaceutical-establishments-sr1-575-million-over-violations-190e2d76a1d036ac 2026-08-23T12:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/udan-vs-udaan-delhi-court-restrains-pharmaceutical-firm-from-using-udaan-mark-38d3242265635101 2026-08-23T11:59:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/officials-warn-wildland-firefighters-about-the-risks-of-using-a-supplement-for-s-63ec1c7a96150a8a 2026-08-23T11:50:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available-e1b43963f2412cea 2026-08-23T11:37:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/ghana-to-build-major-pharmaceutical-industrial-park-under-24-hour-economy-initia-50d3832da472bc3e 2026-08-23T11:37:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/rubber-lined-metal-closures-market-demand-to-accelerate-by-2035-on-pharmaceutica-5589f8eb7082ea79 2026-08-23T11:26:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-big-pharma-merck-s-stock-price-is-soaring-revealing-its-strong-presence-i-8a24a6ec8a21724b 2026-08-23T11:23:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/slimming-tea-available-in-mercury-drug-affordable-support-for-metabolic-balance-7c1d80b384e7d57a 2026-08-23T11:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/purge-and-trap-concentrators-market-to-reach-usd-180m-by-2035-on-stringent-voc-t-99742ea3ab5f69dc 2026-08-23T11:01:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/x-square-capital-llc-makes-new-investment-in-teva-pharmaceutical-industries-ltd-67c4ee5522bca895 2026-08-23T10:42:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-flu-vaccine-moderna-s-mrna-vaccine-approved-by-fda-18404f8dfecbfca7 2026-08-23T10:04:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/rivers-port-terminal-operator-needs-equipment-upgrade-cac-atuluku-89b5036b1c441618 2026-08-23T09:48:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/ghana-to-establish-pharmaceutical-industrial-park-to-boost-local-production-0ccc857d4e53fff1 2026-08-23T09:36:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-krys-rallies-on-pipeline-hopes-but-is-the-valuation-already-pric-22924c1051040413 2026-08-23T09:20:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/inside-xeraya-khazanah-s-biotech-closet-317e4809ae8de670 2026-08-23T09:05:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/ncb-to-start-year-long-anti-drug-campaign-in-september-a3803a151c5e68c1 2026-08-23T08:55:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/netramark-signs-phase-2-neurodegeneration-trial-contract-with-cro-c1dd1388925e0125 2026-08-23T08:52:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/glenmark-advances-phase-3-trial-of-trastuzumab-rezetecan-67b0941aa5a4ccf0 2026-08-23T08:51:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/go-systematically-why-bombay-hc-praised-fda-crackdown-but-has-pulled-up-its-meth-964d9d4b5bb7696d 2026-08-23T08:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-revenue-forward-of-beijing-science-sun-pharmaceutical-co-ltd-2fdc17c6dcda0dee 2026-08-23T08:33:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/recently-a-personalized-messenger-ribonucleic-acid-mrna-cancer-vaccine-jointly-d-5f6941af5876dcd9 2026-08-23T08:30:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/filmmaker-kunal-kohli-urges-maharashtra-fda-chief-tukaram-mundhe-to-inspect-kitc-752794d91083fe54 2026-08-23T08:30:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-s-top-pharmaceutical-firms-spend-over-100-billion-won-each-in-first-half-o-9b2861fb5a48cdb2 2026-08-23T07:46:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-weight-loss-approval-view-chseemoto-fbfd13352ea2134f 2026-08-23T07:35:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/iim-ahmedabad-launches-digital-archive-documenting-125-years-of-indian-pharma-hi-860d588344b8486e 2026-08-23T07:25:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-mindset-for-success-in-biopharma-s-new-multipolar-world-ceb9db0654b38bd2 2026-08-23T06:46:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-mrna-soars-179-as-melanoma-therapy-candidate-rewrites-growth-story-ac57d0e4be28ae2c 2026-08-23T06:23:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-sales-forward-of-suzhou-highfine-biotech-co-ltd-class-a-szse-301393-243fbbef1f2fbfd2 2026-08-23T06:21:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/amid-food-safety-checks-hum-tum-director-kunal-kohli-wants-maharashtra-fda-to-ra-f5241a17cfb5ceea 2026-08-23T05:45:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/entertainment-news-ef16ab9b5b6a85d7 2026-08-23T05:38:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-is-eyepoint-pharmaceuticals-eypt-stock-down-69-today-30dd74e5e3da883f 2026-08-23T05:12:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-licences-of-two-restaurants-15b7bd3336c48808 2026-08-23T05:11:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/emirates-biotech-appoints-david-miller-as-chief-operating-officer-96a407178b8fc736 2026-08-23T04:48:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/officials-warn-wildland-firefighters-about-the-risks-of-using-a-supplement-for-s-c0800aca462ed071 2026-08-23T04:10:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-latest-news-today-on-august-23rd-2026-ganesh-idol-tragedy-fda-raids-tunne-082f191e6c12d573 2026-08-23T03:18:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/lcci-calls-for-strengthening-of-local-pharmaceutical-manufacturing-capacity-for-f011769a4bd349d6 2026-08-23T03:04:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/korea-s-top-pharmaceutical-firms-spend-over-72-13-mil-each-in-first-hald-of-the-601d619c49e6a90c 2026-08-23T03:01:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-shares-surge-150-on-positive-mrna-cancer-vaccine-results-d69efeeb9bab84f2 2026-08-23T03:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/those-who-do-not-abide-by-law-cannot-do-business-tukaram-mundhe-d2a2261431718be5 2026-08-23T02:52:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/those-who-do-not-abide-by-law-cannot-do-business-tukaram-mundhe-304da9d9b15bcaa5 2026-08-23T02:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/s-korea-s-top-pharmaceutical-firms-spend-over-100-bln-won-each-in-h1-for-r-d-dat-5fcc50741d22e425 2026-08-23T02:32:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-melanoma-vaccines-what-the-phase-3-intismeran-results-actually-show-0432f88b35015365 2026-08-23T02:29:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/iterative-development-of-an-ai-assisted-data-extraction-tool-for-literature-synt-65100720d79a562f 2026-08-23T01:49:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/bad-food-bc3c01d36688126c 2026-08-23T01:06:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-group-limited-beat-analyst-estimates-see-what-the-consensus-3e5de23bbd214b62 2026-08-23T00:59:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/orum-therapeutics-wins-fda-nod-to-start-phase-1-trial-for-aml-drug-chosunbiz-42a31b4dc93f7ab2 2026-08-23T00:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/binghamton-university-s-doctor-of-pharmacy-class-of-2030-receive-white-coats-c43c387b57ad75c3 2026-08-23T00:16:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-aibrave-8061ad3b17ec6291 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-minoxidil-hair-regrowth-treatment-370b6aed1724ed0e 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-isntree-hyaluronic-acid-watery-sunscreen-8d2a14e2e0392145 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/combination-therapy-with-baloxavir-and-oseltamivir-1-for-hospitalized-patients-w-aeffecd6699f5651 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbiota-derived-4-hpaa-alleviates-crohn-s-disease-by-stabilizing-sirt1-and-re-277c1c143696c1a5 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-clinical-staging-with-mri-findings-pre-and-post-intra-articular-s-8d05e1e1d7ac2912 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-chain-fatty-acids-in-blood-pressure-management-a-systematic-review-of-clin-1afa6a608f571580 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/damnacanthal-from-morinda-citrifolia-l-experimental-characterization-biological-66835d977cd0d0c6 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/explainable-ai-in-healthcare-a-comparative-analysis-of-interpretability-techniqu-fd7096217e511c02 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distribution-of-antibiotic-resistance-genes-in-staphylococcus-epidermidis-clinic-e37febf6a08f98b2 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-of-hydrotherapy-in-the-rehabilitation-of-patients-with-rheumat-a85d88c7adcc29bc 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mesalazine-enteric-coated-tablets-combined-with-retention-enema-for-symptom-alle-77633ab1dac56d1c 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pgr-expression-as-a-pharmacogenomic-companion-biomarker-to-gene70-derived-genomi-c5295f7c1bc667a5 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessing-clinical-activity-in-behcet-s-disease-relationship-between-bdcaf-score-72aa09f4032f2b1c 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bridging-clinical-practice-and-research-semi-automated-extraction-and-analysis-o-4eb8bc3082a33c83 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/synergism-of-triggers-for-loss-of-asthma-control-in-children-during-wartime-e0ab8c40d7bd1475 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/severe-protracted-lithium-intoxication-with-delayed-serum-surge-after-5-days-of-81b91598e203ad83 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advancing-nursing-practice-through-simulation-enhancing-competency-quality-and-p-d65c7be6208fdfbe 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/beyond-knowledge-transfer-caregivers-evolving-medication-information-needs-acros-1a07e7ed401dde79 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recent-advances-in-coated-and-dissolving-microneedle-technologies-for-clinical-t-7b00a1df798d1b3d 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-and-prediction-study-on-the-burden-of-drug-use-disorders-in-china-from-308810f117536a98 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/microbial-enzymes-comprehensive-insights-into-production-optimization-and-curren-5156b3449f5f0ca9 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/organizational-and-work-related-factors-associated-with-occupational-stress-amon-8c707a2a009bb1d9 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/circular-rnas-as-regulators-of-epithelial-mesenchymal-transition-in-gliomas-from-89e7adc84d9e5dce 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-clinical-characteristics-between-children-and-adults-with-adrenal-133e8dbb178863bf 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/experimental-evaluation-of-nilotinib-and-paclitaxel-co-delivered-via-albumin-nan-a445bf9e547bf2c0 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-impact-of-acute-pancreatitis-on-patients-quality-of-life-a-multi-cente-64fbe5c9b48f58ae 2026-08-23T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecopipam-priority-review-could-be-a-game-changer-for-teva-pharmaceutical-industr-5290437288c27203 2026-08-22T23:36:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-vaccines-are-coming-merck-moderna-clear-phase-3-hurdle-as-korean-biotech-e83a1451da325fac 2026-08-22T22:54:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/kolon-tissuegene-probes-leak-as-u-s-trial-failure-triggers-layoffs-stock-plunge-223575bdc47b5f1e 2026-08-22T22:31:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-commissioner-nominee-heidi-overton-faces-almost-disqualifying-vaccine-scruti-2b71091ab5e1d7b2 2026-08-22T22:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-notice-on-blacklisting-ayrtons-saunders-ltd-uk-672535ba38053e76 2026-08-22T21:19:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-sehk-2696-stock-sees-revenue-growth-amid-margin-compres-d93c015fdbd0e650 2026-08-22T21:11:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-games-dea-attorneys-play-what-marijuana-rescheduling-closing-brief-didn-t-te-0fe6ced3528fd060 2026-08-22T20:14:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/irresponsible-unregistered-sa-man-banned-from-supplying-drugs-2e926a4bd0ffc9a9 2026-08-22T19:43:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/jubilant-pharmova-receives-usfda-approval-for-spokane-facility-s-line-3-ea40398122d2fb6d 2026-08-22T19:35:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/working-together-on-new-course-descriptors-for-ms-ed56feffdc5c9717 2026-08-22T18:50:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-heilongjiang-zbd-pharmaceutical-co-ltd-class-a-stocks-f46c3a614e1cb6a4 2026-08-22T18:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ghana-receives-eur-two-million-for-vaccine-pharmaceutical-innovation-1fd11c4b64953fba 2026-08-22T18:23:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-etf-showdown-why-a-251-stock-basket-is-beating-concentrated-rivals-ece42b35455be30e 2026-08-22T18:07:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-vaccine-breakthrough-raises-new-hope-as-portugal-advances-research-f2f76e98b81694b5 2026-08-22T17:58:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/zeon-lifesciences-secures-us-fda-approval-strengthening-export-readiness-for-the-ea2bd2632a94c6a6 2026-08-22T17:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcdonald-s-india-responds-after-fda-suspends-colaba-outlet-licence-over-food-saf-b89799a7a9667984 2026-08-22T17:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-add-to-your-watchlist-august-22nd-2af464ee6fbf44cf 2026-08-22T17:05:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-novak-djokovic-built-a-240-million-fortune-from-grand-slams-biotech-stakes-a-2dbc20a868cee823 2026-08-22T17:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/union-mos-anupriya-patel-calls-for-domestic-innovation-as-centres-of-excellence-bfb163c3731aef3b 2026-08-22T16:50:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-pharmaceuticals-rally-has-a-new-engine-and-wall-street-thinks-the-best-is-38025c5e89f7e2ee 2026-08-22T16:44:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/lady-gaga-s-partner-launches-ai-biotech-to-develop-new-cosmetic-ingredients-847f4011dbe4f4f3 2026-08-22T16:34:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/scholar-rock-nasdaq-srrk-stock-rises-as-company-removes-novo-nordisk-facility-fr-4ba298cb4c3b4b59 2026-08-22T16:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iim-ahmedabad-launches-digital-archive-tracing-125-years-of-indian-pharma-5f6463a34e5afa9b 2026-08-22T16:18:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/assessment-of-neurotoxicity-and-oxidative-stress-induced-by-environmentally-pers-ca2dfcbcc34e6414 2026-08-22T15:40:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-biotech-stocks-shaping-up-for-major-breakouts-204165866d3d73a4 2026-08-22T15:12:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/sichuan-kelun-biotech-biopharmaceutical-sehk-6990-after-profitability-and-oncolo-a6892ebadd27ba8f 2026-08-22T14:54:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-mumbai-cricket-association-s-bkc-food-licence-over-safe-458aaf363363c04c 2026-08-22T14:43:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-integrated-scientific-workflows-are-redefining-strategic-advantage-for-india-42fe716d9f49b9fa 2026-08-22T14:41:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-shock-rally-redraws-the-biotech-playbook-76f4fd84deb7838d 2026-08-22T14:24:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-radio-club-khar-gymkhana-11-others-for-viol-0d25b241f2d40efc 2026-08-22T13:56:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-integrated-scientific-workflows-are-redefining-strategic-advantage-for-india-3db23b37aa80a075 2026-08-22T13:56:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/innocan-pharma-s-slide-deepens-as-investors-weigh-a-widening-gap-between-operati-858f26df5818e636 2026-08-22T13:52:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysts-offer-insights-on-healthcare-companies-evaxion-biotech-evax-and-boston-9f16358bbfb87657 2026-08-22T13:40:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategic-roadmap-for-delivery-of-clinical-trials-in-rare-childhood-central-nerv-d5a2a8d0ff642484 2026-08-22T13:23:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/possible-turnaround-for-burning-rock-biotech-insiders-still-down-cn-1-4m-6f8c2e4b1dc4b11f 2026-08-22T13:04:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cheshire-biotech-behind-addiction-treatment-launches-fundraising-79430e60fce96e43 2026-08-22T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lepu-scientech-plans-rmb1-09-billion-connected-acquisition-in-biotech-arm-c0606b3bb0ede485 2026-08-22T12:52:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/zeon-lifesciences-secures-us-fda-approval-strengthening-export-readiness-for-the-73b45177f41e343d 2026-08-22T12:48:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/sichuan-kelun-biotech-biopharmaceutical-sehk-6990-after-profitability-and-oncolo-6cac41a738558aef 2026-08-22T12:38:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-biotech-etf-is-a-better-buy-concentrated-bet-or-broad-basket-75ae8d4fa08f5987 2026-08-22T12:05:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/anupriya-patel-launches-india-pharma-archives-at-iim-ahmedabad-to-preserve-125-y-59b65f22d5d71134 2026-08-22T11:57:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/zeon-lifesciences-secures-us-fda-approval-strengthening-export-readiness-for-the-5b73e10894493371 2026-08-22T11:45:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/krystal-biotech-nasdaq-krys-clears-minervini-trend-template-and-high-growth-mome-8aeb557abdfad11a 2026-08-22T11:42:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/cure-for-cancer-possible-stock-prices-surge-phase-3-trial-for-customized-cancer-bd17baaaf197edb1 2026-08-22T11:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/which-biotech-etf-is-a-better-buy-concentrated-bet-or-broad-basket-026b4cd370c7628d 2026-08-22T11:25:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-stock-holds-steady-as-q2-2026-beat-and-guidance-support-valu-132c9aa00847d787 2026-08-22T11:21:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/business-news-cef2874791a113d4 2026-08-22T10:52:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/counterfeit-medication-now-arrives-in-packaging-that-looks-correct-460a02c3d82dba76 2026-08-22T10:49:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-pharma-archives-launched-at-iim-ahmedabad-35f2c97597e59154 2026-08-22T10:36:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/india-must-move-from-pharmacy-of-the-world-to-laboratory-of-the-world-ai-must-co-0cb4d585265640a5 2026-08-22T10:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ipa-launches-india-pharma-archives-to-preserve-a-century-of-india-s-pharma-legac-cd00c4b23cfdabf9 2026-08-22T10:16:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebitda-forward-of-guizhou-bailing-group-pharmaceutical-co-lt-47b6b0112095db23 2026-08-22T09:39:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/drc-gets-16-520-ebola-vaccine-doses-amid-deadly-outbreak-713126dd62502914 2026-08-22T09:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-daewon-pharmaceutical-co-ltd-stocks-18c0ca26153297ff 2026-08-22T08:53:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/ghana-receives-2m-for-vaccine-pharmaceutical-innovation-6d9375112b26cd20 2026-08-22T07:41:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/feds-award-6-5m-grant-to-support-developing-cannabis-withdrawal-treatment-e677d2decf0ef2c5 2026-08-22T07:32:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/randomness-improves-modeling-of-tectonic-plate-formation-f19bded01ddfaf85 2026-08-22T07:24:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-powered-drug-discovery-gains-momentum-as-biotech-dynamo-targets-breakthrough-f45542a33542e35c 2026-08-22T06:47:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-imposes-one-year-ban-on-analogue-paneer-fda-cites-public-health-concer-0bd6a5c06021eeac 2026-08-22T06:17:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/novo-nordisk-stock-steadies-as-lower-dose-wegovy-pill-trial-advances-94f8b04a51e10b5b 2026-08-22T06:06:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-mcdonald-s-colaba-khar-gymkhana-5-others-over-hygiene-l-c9b0a2e2141f6642 2026-08-22T05:48:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-vidipha-central-pharmaceutical-jsc-hose-vdp-72a56f05ea4bc803 2026-08-22T05:48:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/xiamen-amoytop-biotech-co-ltd-688278-ch-0cc2152b90a08fe9 2026-08-22T05:18:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/only-1-in-10-consumers-trust-their-district-state-fda-department-dc11c93f2a26a06b 2026-08-22T05:04:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-update-us-agencies-tackle-e-coli-fauci-legal-fund-congo-s-ebola-crisis-am-1944fea29e6aca79 2026-08-22T05:00:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-covid-hero-is-back-moderna-shares-surge-177-on-cancer-vaccine-trial-success-a2bfa710f0c44f35 2026-08-22T05:00:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-translators-needed-how-to-integrate-ai-into-biotech-research-e9d8572030744a6f 2026-08-22T04:01:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/primer-orion-biotech-opportunities-oria-us-aug-2026-d5954803104f58ec 2026-08-22T03:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-license-of-gayatri-mewad-in-chhatrapati-sambhajinagar-over-safety-l-d91c4ff85e4aa2fd 2026-08-22T03:29:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcdonald-s-kitchen-exposed-maharashtra-fda-finds-cockroaches-stale-food-suspends-94d077d8c256b011 2026-08-22T03:28:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-cancer-vaccine-breakthrough-revives-hopes-for-biotech-turnaround-955c159d8194d5e9 2026-08-22T03:11:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/mumbai-fda-suspends-licences-of-seven-food-establishments-over-safety-lapses-1573568b70f6a693 2026-08-22T02:52:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-s-prompt-action-in-seizing-spurious-drugs-worth-rs-5-crore-shows-r-3e30f773dd9d80e0 2026-08-22T02:31:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-food-license-of-bombay-presidency-radio-club-here-s-why-2a22f3d77fe0f20d 2026-08-22T02:04:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/status-restaurant-among-7-mumbai-establishments-facing-fda-licence-suspension-mc-08098619493b6ecf 2026-08-22T02:03:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-kfc-outlet-baba-s-kitchen-in-pune-over-food-9fd2abf5bac447cc 2026-08-22T01:43:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/does-emlaid-work-for-toe-nail-fungus-view-cfzxqeowf-830a9a1ae07d6e02 2026-08-22T00:38:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/recently-a-personalized-messenger-rna-mrna-cancer-vaccine-jointly-developed-by-u-e206c7367534825b 2026-08-22T00:38:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-alzheimer-s-disease-neuroimaging-initiative-adni4-de037477c91d2402 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-1-ketoconazole-anti-dandruff-4babaf15a26e5f78 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-cold-crush-adult-79bc4a1f71023717 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-genexa-kids-pain-and-fever-8937ac788d064f58 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jelvoxa-dmso-58db212025efa82d 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jelvoxa-neck-pain-relieving-87cecd59681174ec 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-jelvoxa-antifungal-8ec944c84566b8bb 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-bee-venom-wart-corn-wart-remover-2e67cff570c4e4d0 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-anti-dandruff-48357b48c53f5aed 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-25a09fd9755e3311 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-genexa-infants-pain-and-fever-12a61e7c0698f7e6 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-norms-medicated-wipes-2463b828daca5004 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-genexa-antacid-maximum-strength-2ed95d4e5088c5d7 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cue-induced-retrieval-and-reconsolidation-with-episodic-future-thinking-for-crav-5199b3c9fa2e709b 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regulation-driven-variation-in-utilization-and-cost-of-b-cell-depleting-therapie-f7195dc9b8c72d6a 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/insights-from-a-double-blind-randomized-direct-to-participant-intervention-trial-870098833bc55c51 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intracerebroventricular-repeat-dose-cpi-601-recombinant-human-palmitoyl-protein-3c990ca70c597a20 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chloral-hydrate-outperforms-oral-midazolam-in-facilitating-venipuncture-in-child-3596bd940993bfb9 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/constructing-an-evidence-based-validity-rationale-for-a-multi-component-endpoint-f32600bcfb8fdb19 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/disease-modifying-antirheumatic-drugs-for-hand-osteoarthritis-a-systematic-revie-449e0e6f458c304e 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-site-centered-to-patient-centered-promises-and-challenges-of-decentralized-89c178052d98fc15 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacokinetics-elimination-and-dialyzability-of-hrs-9231-in-patients-with-vary-88b513e9c802ad15 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mixed-cardiogenic-and-septic-shock-in-a-postpartum-patient-coexisting-postpartum-b72d00ad94c2faf6 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/psychometric-properties-of-the-aaspire-autistic-burnout-measure-revised-aabm-r-682913df298526ac 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predicting-anxiety-trajectories-from-individual-differences-in-sleep-related-dis-eb38320fec71e858 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ecofriendly-microbial-screening-of-biopolymer-production-of-alginate-and-curdlan-5153023f9298c6df 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strengthening-infectious-disease-surveillance-in-nigeria-a-focused-scoping-revie-f1ff1f2936c120dc 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/neuroprotective-potential-of-semaglutide-in-parkinson-s-disease-mechanisms-precl-5aa4a974ebc21f09 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tele-optometry-and-mobile-eye-care-units-a-rural-vision-care-model-for-india-005ae54735edba23 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-of-coracoid-tenderness-with-shoulder-impairments-and-functional-disa-9acc6837f803ee8a 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-and-evaluation-of-optimized-nanoparticulate-gel-for-ocular-drug-deli-51c4082247e1ed8c 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ayurvedic-management-of-an-unknown-insect-bite-keeta-visha-using-dashanga-lepa-a-086392d7c3d73aa1 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-effective-deep-learning-based-ddos-attack-detection-and-classification-framew-2194c7da260b12dd 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/formulation-and-in-vitro-characterization-of-mucoadhesive-buccal-film-incorporat-f1d2177e8483e245 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/women-s-liberation-exploring-its-social-economic-political-and-cultural-dimensio-60e90911e22d6603 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/financial-performance-of-a-manufacturing-public-sector-undertakings-in-karnataka-bdd9ad2978238baa 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictors-of-decision-making-confidence-in-ai-assisted-brain-tumour-surgery-a-c-b246608e96965139 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-cinnamomum-zeylanicum-against-hydroxychloroquineinduced-toxicity-to-a-be91d4eeb8389f99 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/adaptive-multi-scale-retinal-feature-optimization-and-intelligent-hybrid-deep-le-b0ee2427c92e87fc 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-optimization-of-anticancer-drug-nanocrystals-using-a-quality-by-e81fea8596f9b4e3 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epilepsy-ketogenic-diet-and-gut-microbiota-implications-for-clinical-nutrition-a-18647f506a48ac88 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-and-molecular-spectrum-of-ago2-associated-lessel-kreienkamp-neurode-d1b91c5bd9357755 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-spectrum-of-intracellular-cobalamin-metabolism-disorders-a-single-cente-2a2f4ec110cb41d5 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endogenous-oxyntomodulin-in-metabolic-homeostasis-and-clinical-utility-as-a-prog-bbb02d77e1bf9bf2 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chest-x-ray-patterns-and-clinical-outcomes-of-covid-2019-patients-at-queen-eliza-7cccff050bcaf058 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/feasibility-and-acceptability-of-adding-peer-support-to-a-school-based-nurse-led-6ac9c28fae5b4ebc 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-community-validated-tool-for-clinical-outcome-calculation-in-multiple-sclerosi-1402ed3f54b3e1e7 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vulvar-dermatology-assessments-and-genitourinary-syndrome-of-menopause-a-clinica-817f7679cf2ec7c7 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-behaviour-and-outcome-of-pelvic-osteosarcoma-in-dogs-a-retrospective-mu-8e5d2122449588dc 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pulmonary-vein-isolation-pvi-versus-pvi-with-posterior-wall-isolation-with-pfa-f-cc250e820c1ec2f8 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tunnel-technique-with-connective-tissue-graft-versus-free-gingival-graft-for-mul-5b2079c1331d76ca 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/incidence-and-risk-factors-of-unplanned-emergency-department-transfers-from-ital-113e0e838bccb7c2 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/court-appointed-psychologists-and-the-retained-trial-advocate-in-child-custody-c-104e081c9bd031a2 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genetics-in-heterotaxy-a-case-series-and-literature-review-on-scp-i-dnah9-i-scp-5a0a54dee9d39f79 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-recognition-to-action-guideline-directed-medical-therapy-in-dystrophin-rela-8be64103ad103497 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-237-clinical-significance-of-cervical-lymph-node-dissection-for-esophageal-sq-6b4e83f72e034994 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-217-para-anastomotic-fluid-analysis-as-a-predictor-for-leak-after-transhiatal-8c35bf9edaaa5741 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-186-clinical-utility-of-robot-assisted-esophagectomy-based-on-short-and-long-2f4471107532789c 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-164-clinical-outcomes-of-esophageal-bypass-surgery-in-patients-with-advanced-cee2c1ad66581533 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-124-clinical-outcomes-of-esophageal-cancer-with-lymph-node-metastasis-invasio-758f07decc413bba 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-117-photodynamic-therapy-for-esophageal-cancer-a-single-center-experience-wit-375d3dda748db249 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p1-083-sequential-versus-concurrent-neoadjuvant-immunochemotherapy-in-locally-ad-318eb8d7974ff1c6 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pd03-03-clinical-characteristics-and-selected-treatment-in-patients-with-transie-59d46531fa07db0a 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pd01-04-neoadjuvant-chemoradiotherapy-versus-neoadjuvant-chemotherapy-for-esopha-492a9773006364f4 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa10-4-clinical-outcomes-in-patients-undergoing-transoral-incisionless-fundoplic-8bc1e788f68ccc58 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa07-1-clinical-features-and-treatment-outcomes-in-esophageal-lichen-planus-a-re-fb82d511c4df9055 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa06-lba01-5-evaluating-the-impact-of-prehabilitation-programmes-for-patients-un-69f50125de9aa377 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa04-6-clinical-efficacy-and-safety-of-dexmedetomidine-hydrochloride-sedation-du-2a7499ac35b1adc2 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa03-rf01-07-neoadjuvant-chemoimmunotherapy-versus-upfront-surgery-for-clinical-6f7d4191cd5a8efc 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oa01-1-invited-lecture-organ-preserving-therapy-for-higher-stage-esophageal-canc-ff909d0f846d5b03 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/p04-6-pcr-and-ctdna-in-science-a-phase-iii-trial-of-neoadjuvant-immunotherapy-in-78e89b70ce9e16bd 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/survival-in-haemodialysis-has-improved-considerably-in-okinawa-japan-1971-2020-ebf229c3d7d8d52e 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multifunctional-lipid-nanocarriers-advancing-topical-skin-cancer-treatment-c1b03766d831dc42 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advances-in-non-invasive-brain-stimulation-for-borderline-personality-disorder-c-f074f50288bdecad 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iontophoresis-enhanced-transdermal-delivery-of-curcumin-micelles-mechanisms-of-p-ae829830a3f6165c 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnosis-and-monitoring-of-metabolic-dysfunction-associated-steatohepatitis-dis-faffedee8707c1d4 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-mechanistic-validation-of-skin-gravitational-stretchability-as-a-ne-672d52d92956ed02 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-network-pharmacology-and-experimental-study-of-dihydroartemisinin-in-drug-resi-48be589c8dd7b9fa 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zanidatamab-in-patients-with-early-stage-her2-positive-breast-cancer-the-neozanh-a8a797ab832249b1 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategic-roadmap-for-delivery-of-clinical-trials-in-rare-childhood-central-nerv-a320dcbc04bfb2ff 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lavender-oil-aromatherapy-in-the-semen-sample-collection-process-a-randomised-co-9869a12ce9a44449 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-tim-3-and-galectin-9-as-biomarkers-and-havcr2-lgals9-gene-polymorphisms-in-afea65438be8acb6 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sildenafil-ca1f59a4abeb2714 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ketamine-77a2eafabd388693 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/age-stratified-clinical-characteristics-and-disability-outcomes-in-neuromyelitis-4fb9cd2329cda9ea 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cancer-cachexia-and-palliative-nutrition-in-resource-limited-oncology-settings-p-c795a7cbca99b5e8 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/glucose-lowering-therapies-and-cognitive-decline-from-molecular-mechanisms-to-cl-90ebb5a3e68364fd 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intraoperative-transcutaneous-electrical-acupoint-stimulation-attenuates-postope-ae7f107fa4eb5562 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-patient-centric-dual-drug-fast-dissolving-oral-thin-film-of-chlorpheniramine-m-f42bda8d5dc76367 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/melatonin-in-lung-cancer-integrating-molecular-mechanisms-tumor-microenvironment-b20a4617a124b314 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/influence-of-total-knee-arthroplasty-on-coronal-plane-phenotypes-and-associated-8ecb571b99dab210 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrating-biological-aging-into-clinical-practice-a-review-and-path-forward-fo-a781cacdda23eb29 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serial-transthoracic-echocardiography-for-hemodynamic-monitoring-and-early-warni-a141539214d6825a 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/increased-glioblastoma-risk-in-patients-with-myeloproliferative-neoplasms-and-my-6220b6da37b86b6b 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prognostic-impact-of-autoimmune-features-in-interstitial-lung-disease-a-single-c-77e9407a3c7c535b 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effectiveness-of-oxidative-therapies-in-mature-oral-biofilms-a-systematic-review-3a466457d002b8ad 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-indirect-effect-of-temporomandibular-kinesiophobia-on-the-association-betwee-e0b880b5866aebaf 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-reducing-aligners-wear-schedule-from-7-days-to-3-days-on-the-predictab-2c6ff8472c947d40 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/autogenous-bone-grafting-does-not-enhance-bone-repair-in-maxillary-sinuses-graft-ee3e6edbbc3789b2 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pancreatic-ductal-adenocarcinoma-and-its-subtypes-clinical-relevance-of-histopat-890c39d823cc91b9 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/structure-function-relationships-of-circumpapillary-choroidal-thickness-in-norma-707102d520cb5fdf 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/structured-narrative-nursing-intervention-improves-psychological-distress-and-di-cd88c4d80ea32bcb 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/epithelial-inclusion-cyst-at-de-epithelialized-gingival-graft-site-a-cautionary-c2b6957ee70c37fb 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/single-stage-regenerative-approach-for-persistent-rt3-gingival-recession-followi-d1b4b9224e993d3d 2026-08-22T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-pharmaceuticals-a-biotech-cash-cow-with-pipeline-upside-41a14e20ff6587d2 2026-08-21T23:56:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/144-filed-by-insiders-prior-intended-sale-of-restricted-stock-3d56726a4b734d4b 2026-08-21T23:28:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-era-of-mrna-cancer-vaccines-opens-with-moderna-here-are-the-domestic-benefic-61f2d36353afba6e 2026-08-21T23:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/vertex-pharmaceuticals-a-biotech-cash-cow-with-pipeline-upside-d04cc4df506e3b37 2026-08-21T23:05:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharma-etf-or-biotech-etf-which-matches-your-investing-mindset-490de55ee24b19d6 2026-08-21T22:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-biologics-to-sell-chromatography-unit-bestchrom-6df3eea0f3156c87 2026-08-21T22:42:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-amylyx-pharmaceuticals-blasted-nearly-79-higher-this-week-6635a51dc39e50cb 2026-08-21T22:00:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/srrk-stock-gains-after-company-drops-troubled-novo-nordisk-owned-plant-from-fda-d862d1b62ed1690f 2026-08-21T21:50:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/ascendis-pharma-asnd-three-new-drugs-are-turning-this-biotech-into-a-growth-mach-ed107614728f6e3e 2026-08-21T21:46:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-care-up-as-moderna-leads-biotech-higher-health-care-roundup-48a4301ee4399749 2026-08-21T21:35:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/phoenix-biotech-firm-to-shutter-facility-lay-off-90-employees-0a970c764c60f6bf 2026-08-21T21:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-mcdonald-s-12-others-after-flies-cockroache-c6fd6197237b56b8 2026-08-21T21:15:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/oncology-stocks-8-biggest-nasdaq-companies-in-2026-462a4d853749060b 2026-08-21T21:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-reverse-mergers-surge-even-as-ipos-make-a-comeback-7de090220c25e8fa 2026-08-21T21:14:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/there-are-currently-about-46-candidates-for-liver-dementia-treatment-up-to-phase-c7cb10183ad1dfe1 2026-08-21T21:10:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-drug-etfs-slide-as-korea-tracks-intensifying-wegovy-mounjaro-race-chosun-f440fb3057dd63c9 2026-08-21T21:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mizuho-names-top-small-midcap-biotech-stock-by-investing-com-b6100be7feb8e66b 2026-08-21T20:58:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/health-frontiers-innovations-outbreaks-and-legal-battles-shape-the-future-f796b728d7ff1ff4 2026-08-21T20:58:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/arkg-etf-price-forecast-arkg-47-hits-all-time-high-on-10-32-session-after-modern-d4ed9732ab2184ac 2026-08-21T20:21:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/archimedes-center-opens-biotech-lab-for-young-scientists-in-henrietta-8450c4b228d44b33 2026-08-21T20:20:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/dea-has-published-the-evidence-against-marijuana-rescheduling-a16a3fcd9c04a583 2026-08-21T20:17:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/rapport-therapeutics-a-22-day-half-life-creates-a-differentiated-epilepsy-franch-0afa67b19ddaf450 2026-08-21T20:14:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-reports-gh-70million-surplus-warns-of-laboratory-equipment-challenges-ae2f7c06961aa4a4 2026-08-21T20:12:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-agrees-490-million-deal-for-oral-rare-bone-disease-f3806bc4a961f7ea 2026-08-21T20:09:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/fast-growing-biotech-startup-cellares-plans-layoffs-after-losing-major-customer-9a893438f282a36d 2026-08-21T20:01:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-dynamo-biotech-puts-ai-fueled-breakout-in-motion-676c6538550cdc15 2026-08-21T20:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-sales-forward-of-prince-pharmaceutical-co-ltd-tpex-6935-39cd781a96e34f1e 2026-08-21T19:45:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-china-s-biotech-boom-is-bringing-patients-faster-more-affordable-drugs-9a3df6d3c5985019 2026-08-21T19:37:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/apogee-s-zumilokibart-advances-toward-phase-3-after-positive-phase-2-atopic-derm-3417a215a4ccfe80 2026-08-21T19:32:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-and-merck-say-personalized-melanoma-cancer-vaccine-worked-in-late-stage-f97e94b48c4fff68 2026-08-21T19:12:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/unique-mrna-cancer-treatment-has-investors-rushing-back-to-biotech-f2f61752596e8992 2026-08-21T19:11:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-companies-with-the-largest-global-market-share-abb72342282813a6 2026-08-21T19:11:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial-b97266f2391e604d 2026-08-21T19:05:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-mrna-cancer-vaccine-success-won-t-lift-all-mrna-stocks-5518a8d9426654f1 2026-08-21T18:55:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-led-healthcare-higher-as-deal-news-rolled-in-ee1f105e8d89cce1 2026-08-21T18:51:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/trinity-biotech-nasdaq-trib-ends-25m-standby-share-deal-052b46f128fd6bdc 2026-08-21T18:29:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacist-led-menopause-clinics-improve-women-s-knowledge-and-confidence-73d20de09b5af686 2026-08-21T18:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/survey-warns-of-lifestyle-drive-for-weight-loss-medication-ed2f1b478106118f 2026-08-21T18:15:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-scientists-say-this-personalized-cancer-vaccine-could-be-a-game-changer-78b0d7f7605a835a 2026-08-21T18:12:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/amplitude-therapeutics-partners-with-eli-lilly-pharmexec-9959b3bace1d2d5f 2026-08-21T17:58:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/what-is-the-difference-between-an-sae-ae-and-uade-in-clinical-trials-bf073b65bf7ea107 2026-08-21T17:56:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/little-known-howl-stock-skyrockets-100-on-biotech-merger-news-349cfd19a57d2e54 2026-08-21T17:51:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pasatru-for-rare-bone-forming-disorder-af8109638298ea46 2026-08-21T17:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/intismeran-autogene-a-turning-point-for-cancer-vaccines-b498632e0b521628 2026-08-21T17:38:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/before-its-recent-phase-3-lsd-win-definium-modeled-up-to-70-000-a-year-for-a-the-9fa78d3283b2047c 2026-08-21T17:35:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/uab-and-children-s-of-alabama-celebrate-five-year-anniversary-of-nicu-bookworms-2864b635873f32b4 2026-08-21T17:19:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/archimedes-center-opens-biotech-lab-for-young-scientists-in-henrietta-6319b8e611134714 2026-08-21T17:15:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-werewolf-therapeutics-stock-exploded-higher-and-what-comes-next-57061a0896c9747b 2026-08-21T17:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/this-news-style-clip-explains-the-evolution-of-mrna-technology-from-its-well-kno-5271c3a42fbae964 2026-08-21T17:09:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/weighing-the-pros-and-cons-of-participating-in-a-clinical-trial-6a7ba0c2da36c63f 2026-08-21T17:00:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/arcutis-backed-phase-3-zoryve-foam-study-targets-growth-in-seborrheic-dermatitis-834d34ff068c2449 2026-08-21T16:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/kodiak-sciences-advances-alto-phase-3-trial-in-diabetic-eye-disease-bad7aa2de7606298 2026-08-21T16:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/gsk-s-new-phase-3-asthma-trial-sets-the-stage-for-the-next-wave-in-respiratory-g-6ccfb13fb72a7fc9 2026-08-21T16:56:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-stage-hh160-cancer-trial-puts-beone-medicines-on-long-term-investors-radar-1b0c7b6879dc4f66 2026-08-21T16:56:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/strong-merck-stock-trades-close-to-its-52-week-high-as-analysts-lift-targets-aft-b73c3fb5644bff9a 2026-08-21T16:54:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/pittsburgh-biotech-firm-pivots-to-provide-ai-compute-reports-317m-in-prepayments-d86cc2a954f53fb3 2026-08-21T16:53:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-ai-designed-mrna-melanoma-vaccine-succeeds-in-phase-3-trial-eb1577f2bee172b9 2026-08-21T16:49:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/crbp-s-crb-701-phase-3-trial-sets-the-stage-for-a-key-oncology-catalyst-35cd6bd5702d948f 2026-08-21T16:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-bmrn-beat-q2-expectations-is-the-recent-re-rating-alread-68e1c98efcd04077 2026-08-21T16:35:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/larimar-s-phase-3-friedreich-s-ataxia-trial-puts-nomlabofusp-in-the-investor-spo-fb594f318d77bef0 2026-08-21T16:34:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/iova-stock-pulls-back-as-biotech-momentum-cools-51712879a345715a 2026-08-21T16:33:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/book-value-per-share-of-ono-pharmaceutical-co-ltd-ham-on4-eb3937da24dfce4f 2026-08-21T16:32:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/abus-stock-pops-as-moderna-windfall-resets-biotech-balance-sheet-81ee91016f49b052 2026-08-21T16:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-suspends-food-license-of-bombay-presidency-radio-club-due-to-severe-safety-a-1b5415520b361f6f 2026-08-21T16:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-pv-infrastructure-fails-commercial-launches-pay-the-price-75b9604111fb6284 2026-08-21T16:29:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-progress-is-real-but-profitability-is-the-real-test-rating-upgrade-0f5a038aa33bfd1b 2026-08-21T16:27:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/three-biotech-stocks-stick-out-with-their-stellar-charts-7e834d4932ea119d 2026-08-21T16:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-to-consider-august-21st-c0f469c76c3ff04e 2026-08-21T16:04:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/eyeworld-weekly-august-21-2026-812eacf17998db46 2026-08-21T16:01:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/former-athira-ceo-returns-to-seattle-biotech-scene-with-kirkland-company-4c426df5a35e78b1 2026-08-21T16:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/unhandcuff-america-s-biotech-innovators-to-beat-china-4205d452cbfa4983 2026-08-21T15:56:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/top-ai-trends-transforming-healthcare-economics-a5de8c5f1135f9b5 2026-08-21T15:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-pharmaceutical-says-h1-net-profit-attributable-for-tasly-pharmac-979caa9a7b3ded76 2026-08-21T15:45:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/rare-disease-drug-tavneos-recalled-in-republic-of-ireland-87c3fd86fe04f990 2026-08-21T15:43:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/department-of-health-and-social-care-record-of-processing-activity-ropa-0a8251143f475789 2026-08-21T15:33:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/65-000-patients-a-year-zero-approved-drugs-one-phase-3-trial-16819f55ccdbfed7 2026-08-21T15:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chronic-pain-biotech-co-founded-by-vivek-ramaswamy-joins-reverse-merger-train-c384a3645c29b18f 2026-08-21T15:24:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kratom-component-in-clinical-trial-for-opioid-use-disorder-1b47393d17fd729a 2026-08-21T15:09:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/medienmitteilung-ein-wichtiges-signal-fur-schweizer-patientinnen-und-patienten-a3c34d0321899a62 2026-08-21T15:08:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-of-3-canteens-ran-without-licences-maharashtra-fda-chief-tukaram-mundhe-on-bom-43d1ccc32f241f89 2026-08-21T15:03:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-is-just-the-start-why-ai-focused-money-might-flow-into-biotech-c605a20c548eac96 2026-08-21T14:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tempus-ai-stock-climbs-friday-what-s-driving-the-move-884535536a376912 2026-08-21T14:47:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/lawmakers-urge-fda-to-enact-new-china-policies-after-3-gene-therapy-deaths-4da3dc374dc8ecf8 2026-08-21T14:39:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/werewolf-and-ambros-to-tie-the-knot-in-150m-rare-disease-deal-a3565dce797aa533 2026-08-21T14:29:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-trump-administration-advisor-set-to-become-next-fda-lead-132f3a638d8cb941 2026-08-21T14:28:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/hello-biotech-ai-will-see-you-now-f774c9309370e512 2026-08-21T14:28:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kangmei-pharmaceutical-leadership-shakeup-lai-zhijian-steps-down-18-months-early-c9948c91e25083bf 2026-08-21T14:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licenses-of-radio-club-mcdonald-s-outlet-in-south-mumba-497b187e0f0bce83 2026-08-21T14:23:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/weekly-buzz-rare-regn-secure-fda-nod-bmrn-stikes-deal-huma-eypt-face-trial-setba-1a0fbd5279cb13be 2026-08-21T14:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/merck-co-inc-stock-mrk-moved-up-by-3-41-on-aug-21-facts-behind-the-movement-e1930272578dfcc2 2026-08-21T14:15:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cough-cold-e63ed9a72d6d4e4e 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/pain-management-3f8f22c7ef60f93e 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/neurology-760d1f1d172b7660 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/cardiometabolic-a68a7d03aa92cbe7 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/intim-health-e240772a21379c46 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/gastroenterology-09ad197665156b2e 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/skin-care-d0a0b51d554af467 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/antibiotics-and-antiseptics-69502d6af6237be3 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/drugs-for-allergy-d9a372fb0d9a2de1 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/84224d05bb31eebd 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/ae8f7859fe2443de 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/d38b8cf69256d7cd 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/976c02a5276e473f 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/f0a6289daf2f9bff 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/52d29a3cbf141f2e 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/872caa5924a17f43 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/331d5efc4c704bfe 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/cb9df2f609d6b658 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/4e6ff70cb45a5e0f 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/7987acfaf8f3474c 2026-08-21T14:13:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/air-pollution-awareness-coalition-apac-e917c85b4ebb88d0 2026-08-21T14:12:16.000Z weekly 0.7 https://www.pharmaradar360.com/article/pomerantz-law-firm-announces-the-filing-of-a-class-action-against-aardvark-thera-79c598c9d19f8b54 2026-08-21T14:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mcdonald-s-colaba-licence-suspended-by-maharashtra-fda-over-hygiene-violations-r-0f55c5f71621e0d3 2026-08-21T13:59:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licenses-of-radio-club-12-other-hotels-for-violation-of-933192102e6080e0 2026-08-21T13:55:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-new-era-of-pharma-distribution-balancing-precision-and-scale-11eec0ed16e6e3fc 2026-08-21T13:54:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/guangzhou-baiyunshan-pharmaceutical-holdings-company-revenue-up-slightly-net-pro-d86b4314f07d012f 2026-08-21T13:54:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/will-pbms-trumprx-price-pledge-reach-prescribers-c888350770a1ff94 2026-08-21T13:51:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/werewolf-transforms-into-ambros-via-reverse-merger-to-support-phase-3-push-for-r-8d93d45173af9ab7 2026-08-21T13:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alvotech-signs-licensing-deal-with-lotus-pharmaceutical-for-proposed-biosimilars-5a1e4bcfc8bd66a7 2026-08-21T13:47:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-revenue-up-27-3-and-net-profit-up-10-3-in-2026-h1-with-ce5cc24bc7cc2481 2026-08-21T13:41:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/strategist-sees-opportunity-for-health-care-and-biotech-stocks-576dc0adc224e0d8 2026-08-21T13:35:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/werewolf-therapeutics-takes-aim-at-untapped-pain-market-with-ambros-deal-af8e0b840b641215 2026-08-21T13:33:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/israel-englander-s-howl-stock-soars-on-500m-deal-werewolf-therapeutics-nasdaq-ho-f7ace9501d73be5e 2026-08-21T13:30:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-sanjiu-medical-pharmaceutical-co-net-profit-declined-7-96-despit-b2f11016cbf93b11 2026-08-21T13:29:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-suspends-licences-of-radio-club-khar-gymkhana-and-11-others-over-151b3b6e050d8c31 2026-08-21T13:27:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/are-cancer-patients-getting-too-much-drug-78f97fd47e7475c3 2026-08-21T13:24:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-cost-of-waiting-what-licensing-a-biotech-asset-early-really-saves-you-757d1840e9869a30 2026-08-21T13:23:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/alvotech-announces-licensing-and-commercialization-agreement-with-lotus-pharmace-f9559b2f2372f021 2026-08-21T13:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alvotech-enters-strategic-licensing-and-commercialization-agreement-with-lotus-p-90f564892aeac694 2026-08-21T13:11:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/milestone-pharmaceuticals-mist-launches-phase-3-trial-amidst-high-price-to-sales-5a5ba7066efc3bed 2026-08-21T13:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/morgan-stanley-issues-positive-forecast-for-ultragenyx-pharmaceutical-nasdaq-rar-775ccbb0a85214dd 2026-08-21T13:03:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/alvotech-announces-licensing-and-commercialization-agreement-with-lotus-pharmace-a2fbe4323baf9295 2026-08-21T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/henlius-reports-2026-interim-results-sustained-profitability-leap-advancing-glob-5b11c399a6e79a2b 2026-08-21T12:58:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmala-biotech-provides-corporate-update-u-s-patent-granted-covering-novel-ena-c8eae94c56e2b6fd 2026-08-21T12:45:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-prices-25-million-public-offering-284fb28d7318db0d 2026-08-21T12:42:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/jcvi-current-advice-and-recommendations-5ba5c84d3bf63928 2026-08-21T12:23:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/jordan-fda-mandates-strict-gluten-free-safety-controls-for-celiac-patients-19f9be0178fc823f 2026-08-21T12:21:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/commentary-fda-turmoil-and-political-interference-threatens-drug-safety-standard-483455c380f8a406 2026-08-21T12:17:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/moroccan-billionaire-anas-sefrioui-expands-from-property-into-pharmaceuticals-wi-9bba019e63e40291 2026-08-21T12:16:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/milestone-pharmaceuticals-enrolls-first-patient-in-phase-3-revera-301-trial-of-e-6ad368b18f6ec434 2026-08-21T12:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibbq-vs-pbe-which-biotech-etf-is-the-better-buy-bd4b874421f9db33 2026-08-21T12:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/taiwan-fda-says-recalled-us-berries-not-imported-fbcdcedc9d34014f 2026-08-21T12:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iq200-series-analyzers-and-dxu-840m-850m-iris-analyzers-50b796808581c8c1 2026-08-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/foresighttm-oximeter-cable-4d9c14800596ede9 2026-08-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/aisystm-cs2-and-carestationtm-06319319982d6cc5 2026-08-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/werewolf-therapeutics-and-ambros-therapeutics-announce-6c8821c120f18371 2026-08-21T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dea-judge-issues-order-on-marijuana-rescheduling-hearing-transcript-corrections-595f6ce1a846b688 2026-08-21T11:58:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-pheast-s-ceo-has-no-regrets-about-transparent-approach-to-r-d-despite-compet-868e0945fecfb0b9 2026-08-21T11:58:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/shanghai-henlius-biotech-revenue-up-27-3-to-rmb3-59b-profit-rises-global-expansi-46033e0a7b8860cb 2026-08-21T11:31:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/ibbq-vs-pbe-which-biotech-etf-is-the-better-buy-931b36c036bdf1b9 2026-08-21T11:30:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/genentech-invests-750m-in-oregon-fill-finish-expansion-ef9d6dbfd52fd84b 2026-08-21T11:26:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/cso-is-convinced-moderna-s-success-will-boost-evaxion-a1b40426294259cc 2026-08-21T11:25:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-investors-may-respond-to-ultragenyx-pharmaceutical-rare-first-fda-accelerate-b69f64583c96754c 2026-08-21T11:24:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/roche-commits-750m-to-double-oregon-based-us-manufacturing-capacity-42d989a80a0ea279 2026-08-21T11:18:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/opportunities-in-the-pharmaceutical-industry-in-the-united-states-and-mexico-2ee6cb5c9a4968d5 2026-08-21T11:18:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmala-biotech-provides-corporate-update-u-s-patent-granted-covering-novel-ena-9b3cd9985a81756b 2026-08-21T11:08:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/nfj-investment-group-llc-invests-7-76-million-in-west-pharmaceutical-services-in-7814a69610a2d4bc 2026-08-21T11:04:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/nfj-investment-group-llc-takes-position-in-biomarin-pharmaceutical-inc-bmrn-ec79e419010ab940 2026-08-21T11:04:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/40-919-shares-in-biomarin-pharmaceutical-inc-bmrn-bought-by-paralel-advisors-llc-c5f3ebf23e35d124 2026-08-21T11:04:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-teaming-to-drive-the-future-of-genomic-medicine-00071d9bdb525030 2026-08-21T10:56:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-looking-to-the-past-new-evidence-on-how-ancient-babylonian-drugs-6b0fe66ef6777971 2026-08-21T10:56:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-advancing-the-technology-of-prime-editing-to-broaden-the-scope-of-d1cf27ab58423f8e 2026-08-21T10:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-rethinking-drug-response-in-leishmania-identifying-the-genomic-de-d46f0f63d5fac515 2026-08-21T10:56:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-driving-sustainable-innovation-to-minimise-pfas-in-european-healt-c169b65ac0c6323e 2026-08-21T10:56:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-excellence-center-in-liquid-biopsy-in-personalized-medicine-excel-2a914cc519c80d64 2026-08-21T10:55:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-centre-of-excellence-in-integrative-one-health-ecosystem-19cd9ac508137805 2026-08-21T10:55:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-mechano-metabolic-responsive-nanoplatform-for-heterogenous-tumor-d19d0df0bc04e56a 2026-08-21T10:55:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/cordis-project-pancreatic-juice-based-early-cancer-identification-using-specific-75d7d619af9b0702 2026-08-21T10:55:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebitda-forward-of-central-pharmaceutical-jsc-no-3-hnx-dp3-4eb5b38ee155144c 2026-08-21T10:36:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/paradigm-biopharmaceuticals-asx-par-awaits-key-zilosul-phase-3-data-milestones-5388a5da081f0b8c 2026-08-21T10:17:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mexc-lists-ondo-tokenized-stock-moderna-mrnaon-expanding-access-to-u-s-biotech-e-8d9b21e0cd10a40d 2026-08-21T10:09:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/wealthfront-advisers-llc-acquires-shares-of-6-440-west-pharmaceutical-services-i-3e5653dc26c94121 2026-08-21T10:09:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-effect-84572ee60202c0fc 2026-08-21T10:06:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/mexc-lists-ondo-tokenized-stock-moderna-mrnaon-expanding-access-to-u-s-biotech-e-808df820b3dfbb88 2026-08-21T10:00:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/livzon-pharmaceutical-revenue-and-profit-fell-but-cash-flow-and-global-expansion-0a2e1efb4d1916c8 2026-08-21T09:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-do-indians-need-to-scan-pill-packaging-before-popping-one-853e92dafe965da8 2026-08-21T09:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/transcript-q2-2026-investor-update-from-exoz-ee78f26098b537fd 2026-08-21T09:50:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-drug-discovery-s-year-of-evidence-fe2d6b259ac98d2b 2026-08-21T09:33:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/wenzhou-yuyuan-pharmaceutical-updates-dailymed-labeling-for-2-miconazole-nitrate-39f65e0f4ca3fc4d 2026-08-21T09:20:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-challenge-launched-to-store-clean-energy-for-longer-9ca27a9a15a0242d 2026-08-21T09:20:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/wuxi-apptec-s-support-for-small-and-emerging-biotech-companies-three-global-exam-d3c98dada4b97ad7 2026-08-21T09:19:54.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-s-food-safety-crackdown-10-fda-raids-and-actions-in-maharashtra-t-c947de698b948593 2026-08-21T09:07:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/china-resources-boya-bio-pharmaceutical-group-revenue-and-profit-dropped-signifi-2afd6aec25ed1824 2026-08-21T09:05:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/ten-reputable-medication-identification-manufacturers-2026-advancing-pharmaceuti-3ceb757675cf14f6 2026-08-21T08:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sky-labs-targets-2028-profit-turnaround-aims-ring-type-blood-pressure-monitor-at-d07e8136ff237585 2026-08-21T08:26:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-transformation-in-the-ai-era-kimforest-chair-charts-a-vision-for-asia-s-40f66ec055d7fcc5 2026-08-21T08:21:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/gi-innovation-moderna-s-phase-3-melanoma-vaccine-success-bodes-well-for-gi-102-c-59022067942292cd 2026-08-21T08:09:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/kangmei-pharmaceutical-s-chairman-resigns-596b3a476aca08bf 2026-08-21T07:43:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-seeks-to-modernise-generally-recognized-as-safe-gras-framework-3cf8386c8dc8c82d 2026-08-21T07:38:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/182-638-shares-in-ultragenyx-pharmaceutical-inc-rare-purchased-by-blue-owl-capit-ba09d9c6dc1c9a48 2026-08-21T07:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/get-involved-in-the-first-ever-eu-screening-week-0231c2d97f64fd88 2026-08-21T07:23:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/2-043-823-shares-in-west-pharmaceutical-services-inc-wst-bought-by-bank-of-new-y-517304639efb273a 2026-08-21T07:15:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/dsm-firmenich-takes-legal-action-over-biotech-sclareol-patent-in-china-b3627af75c7485c2 2026-08-21T07:13:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-kfc-outlet-among-4-eateries-face-fda-action-over-food-safety-lapses-d51c7a0faa719ee9 2026-08-21T07:01:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/endo-205-is-investigational-and-not-yet-proven-ff7bec2a265fad17 2026-08-21T07:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/telemedicine-platform-doctornow-forced-out-of-drug-wholesaling-under-new-law-4e1ca936db7624c0 2026-08-21T06:48:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-news-ban-on-sale-of-loose-cooking-oil-in-the-state-mandatory-information-on-e273f57e1c8dd74d 2026-08-21T06:37:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/europe-has-its-own-biotech-star-as-argenx-soars-on-trial-success-54db9223b191ea10 2026-08-21T06:27:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-suspends-licences-of-baba-s-kitchen-ambrosios-and-kfc-storage-unit-food-6a10e910cfaf8d75 2026-08-21T06:21:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-cracks-down-on-kfc-outlet-food-establishments-in-pune-division-over-hygiene-f5d83f045a9d6bc8 2026-08-21T06:18:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/etfs-investing-in-sartorius-stedim-biotech-sa-stocks-3b9cb8a6dd361fbd 2026-08-21T06:01:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/adc-cdmo-selection-for-small-biotech-2ca4b8c60ec61e8a 2026-08-21T05:27:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-signs-executive-order-accelerating-research-into-psychedelic-drug-therapie-0a62623caa516ab0 2026-08-21T05:11:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/siegfried-delivers-profitable-growth-and-confirms-outlook-0de0e4f15c11daee 2026-08-21T04:21:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/denmark-and-indonesia-explore-closer-pharmaceutical-cooperation-cba7905a86f9a31d 2026-08-21T04:19:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-in-pharmaceutical-chemical-synthesis-does-current-ai-match-the-capabilities-o-6f49bf8f13d580dd 2026-08-21T04:01:42.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-portrait-core-services-software-issue-from-ge-healthcare-29add12a2565778b 2026-08-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-epidural-kit-issue-from-medical-action-industries-20396a075a380615 2026-08-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/early-alert-breathing-circuit-issue-from-medline-f4d76df96e36db44 2026-08-21T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-hisamitsu-pharmaceutical-co-ltd-otc-htsuy-ceb4dfb6451398d8 2026-08-21T02:57:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/political-interference-threatens-drug-safety-standards-gulf-today-newspaper-5f71b29adde672a0 2026-08-21T02:48:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/is-china-going-to-control-your-medicine-1b22d14265750cf7 2026-08-21T02:43:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebitda-forward-of-samsung-pharmaceutical-co-ltd-krx-001360-d20000bdb46c7bfa 2026-08-21T02:30:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-next-how-did-mrna-overcome-the-barriers-of-cancer-vaccines-018d0cd4f484f024 2026-08-21T02:00:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/rtw-investments-lp-buys-ultragenyx-pharmaceutical-inc-rare-shares-look-44-underv-96898bf4dd6ee293 2026-08-21T01:50:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/chong-kun-dang-wins-korean-rights-to-kiora-retinal-drug-6dcf91b5a4a42c87 2026-08-21T01:14:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-collides-with-fda-bureaucracy-news-article-c8c623869dd808fe 2026-08-21T00:36:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-08-21-support-student-call-for-applications-asian-future-075ccfaf7dcaa15b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-public-comment-requ-2ea04fbf8fb5d432 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-proposed-collection-comment-request-79620d5849f49d0b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/government-owned-invention-available-for-license-matched-patient-derived-3d-isoc-947f6606434432fd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-c69fa2256ff61764 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advisory-committee-oncologic-drugs-advisory-committee-renewal-e810348ccd9c2331 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-hedgehog-signaling-in-optic-fissure-morphogenesis-and-coloboma-77dae662b69594e6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-aryl-hydrocarbon-receptor-signaling-in-airway-inflammation-b71a4fe15de71ac1 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-donor-red-blood-cell-survival-in-recipients-with-sickle-cell-disease-640caa55209fe067 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-undergraduate-clinical-scholars-program-pathway-to-clinical-research-c-512f7f3df08e1fcd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-novel-protein-biomarkers-of-youth-onset-type-2-diabetes-4bf3771087c151bd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-vanderbilt-center-of-excellence-for-undiagnosed-disease-vceud-99b12c81ac5d24ea 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-protein-aggregation-in-hematopoietic-stem-cells-d89ff581523936dc 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mechanisms-of-cardioprotective-y-rna-signaling-in-macrophages-cac8c85234713eac 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sex-dependent-regulation-of-cardiac-camp-ecc-and-arrhythmia-by-phospho-70727e64a9f6fc79 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-autophagy-injury-and-plasticity-in-the-intestinal-regenerative-process-68c4e6ef96258ed5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-improving-understanding-of-sleep-apnea-pathogenesis-using-novel-imagin-7403956ef284689d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-phase-1-adaptive-dose-escalation-study-of-mycophenolate-mofetil-in-c-32286591b97f5bc8 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-a-b-cell-based-vaccine-for-the-treatment-of-newly-diagn-ca961b4a63ce7443 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-stinging-gbm-a-first-in-man-clinical-trial-in-surgical-resectable-recu-10aa9ccebfb6f704 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-clinical-histological-and-transcriptional-associations-between-the-dia-f174781d0f1d03fb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-virginia-advancing-cancer-control-engaged-research-through-transfo-ca87705925ec714a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-promoting-physical-activity-and-healthy-eating-in-latinas-via-interact-a97f4266b373d9e1 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-and-validation-of-a-promis-based-measure-to-assess-postpar-5c504bb798d9a49d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-investigation-of-the-quantitative-intracranial-aneurysm-wall-enhanceme-c7f64809b91fd56a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-understanding-early-drivers-and-therapeutic-targets-for-severe-forms-o-6edbc9eb42aaed30 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-ultra-thin-high-strength-drug-eluting-sutures-for-prevention-of-thromb-b3b733d3de109eaa 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-neurocognitive-effects-of-late-childhood-iron-deficiency-anemia-9b0923c420e416f5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-regulation-of-neonatal-lung-inflammation-by-novel-innate-immune-mechan-42155e772ac6c10e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-protracted-maturation-of-cortical-inhibitory-neurons-for-the-complexit-9645f532ec0d0063 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-platform-for-multi-modal-single-nucleus-spatial-genomics-for-molecul-f3dbcb6880a0154d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-bio-behavioral-core-441d6070cc19145a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-ultrasound-induced-artificial-hibernation-mimicking-natural-hibernatio-342f4f241e5372f6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-hypertensive-toads-investigating-the-physiological-and-evolutionary-pa-94907e5506b9604b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-unraveling-fcepsilonri-independent-regulation-of-mast-cell-functions-b-60f5b40317f37e31 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-p3-internal-brain-states-56141c34bae985fc 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-relating-structure-to-function-in-optic-neuropathies-a2492dd11b715aab 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-understanding-the-mechanistic-neurophysiological-and-antinociceptive-e-b14774f946588d1c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-stakeholder-engagement-studio-core-10c0731988dee98d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-center-for-lung-biology-and-disease-a355e08ce5376d22 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advancing-on-slide-and-optical-biopsy-tools-to-detect-high-risk-oral-p-c0bf95701792064e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mettl3-in-cardiac-benefits-of-exercise-in-diabetes-e116da5247cba36e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-complementary-pathways-of-necroptosis-in-recipient-and-donor-lung-tiss-19cebca41159de0a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-sleep-pain-and-recovery-in-kids-after-pediatric-intensive-care-spark-p-20de22f298f7c88f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-a-predictive-model-and-electronic-health-record-based-p-60503fa0bbde8b88 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-cns-demyelination-initiation-protection-and-correction-3c2cd48fd6b6147d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-reprogramming-of-mature-smcs-to-vascular-progenitor-cells-focus-on-vas-a0415087d58a0a37 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-leadership-planning-and-evaluation-7d2b24cca063af27 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-molecular-oncology-program-b432f11a1e8f4e19 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-identifying-transcriptomic-and-epigenomic-convergence-in-intellectual-938693e0c2e4a6cd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-stepped-care-approach-to-treating-dental-fear-a-sequential-multiple-76e74ebceccbf0bb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-peer-narrated-video-decision-aid-for-alcohol-treatment-after-critical-fb9048dda48685fa 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-novel-polymeric-materials-with-improved-durability-in-the-oral-environ-2483a6b5be4ec856 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-real-time-and-randomized-tests-of-social-media-and-mental-health-inter-4e9d408eb1ffdf25 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-a-novel-machine-learning-enabled-metabolic-imaging-platform-for-physio-3247fab34e91f1ac 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-genomic-medicine-research-and-implementation-training-program-04459cd5b8b0d2a0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-advancing-our-knowledge-of-idp-membrane-interactions-by-esr-cacd18a4e3fe2b9c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-pna5-an-angiotensin-1-7-glycopeptide-to-treat-dementia-in-parkinson-s-1df967729b8cffa0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-development-of-an-immunotherapeutic-agent-for-treatment-of-osteomyelit-d271f702bb8f9295 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mi-sleep-coach-app-for-cancer-related-insomnia-3fba48b01b834009 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-developing-high-throughput-free-energy-methods-for-small-molecule-pept-951ee78133d1f6aa 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-alveolar-macrophage-dysregulation-in-the-pathogenesis-of-gulf-war-resp-f1915f7e2d3a6126 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-mr-metabolic-imaging-of-multiple-sclerosis-7ff56ae0c5c790ce 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nih-award-the-role-of-endothelial-derived-leucine-rich-alpha-2-glycoprotein-1-lr-c26bface5814f8fc 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-colgate-optic-white-pro-series-express-white-6656a1ca6e4f1653 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-levetiracetam-df280726a58895c5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-stay-awake-46957a924c34fe30 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-d23cae456ad3ba3b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-capsaicin-0-035-percent-bb5990d2e8eb795e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-sodium-acetate-cfdc429fed6d5c77 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-metformin-hydrochloride-fdb6343e0509c16f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-doxycycline-hyclate-285b5c55f5d74078 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-case-i-could-not-solve-8974259ce534e53f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inpatient-initiation-of-target-dose-ace-inhibitors-and-lower-risk-of-death-or-ki-d14cd66b11b0bc9b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-independent-validation-of-a-machine-learning-based-non-invasive-83da890f6d0d6d13 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/gynecologic-bleeding-in-younger-female-patients-on-lvad-support-a-distinct-hemoc-439841647f3d03eb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/watch-india-s-biotech-queen-doubles-down-on-drug-access-d21889fe4fdeb167 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/flow-excursion-and-mixing-in-the-kneading-block-section-of-hot-melt-extrusion-in-955bacb79992d502 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dural-puncture-epidural-versus-standard-epidural-a-randomized-double-blinded-com-a2872fe2c1ac3f3a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-remimazolam-and-propofol-on-intraoperative-blood-pressure-variability-261f9fd57c47c5f3 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/persistence-to-multiple-myeloma-treatments-given-at-first-relapse-results-from-t-c3e50defcd67b975 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/trajectories-of-psychotic-symptoms-and-fronto-parietal-resting-state-functional-40f2ba62ff4d981a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translated-article-evidence-on-the-impact-of-treatment-optimization-on-the-safet-96c3df15e8739e2f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeting-braf-dimerization-in-cancer-structural-insights-and-therapeutic-strate-f5e02462ea12afe5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/erratum-2d515b0ec17b4eb5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recent-advances-in-diabetes-therapies-in-asia-9e36aa73701ff79b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/week-96-resistance-analysis-in-participants-receiving-bictegravir-lenacapavir-in-ee78065477fd8e2e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-2a-randomized-controlled-trial-of-tpn-101-a-nucleoside-reverse-transcripta-ac23f8005d172e36 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mucoadhesive-patch-versus-benzocaine-gel-for-reducing-injection-pain-a-split-mou-c3c19bd4d6861a15 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/bifidobacterium-longum-engineered-with-artificial-enzymes-alleviates-high-altitu-080a6a440a82eb4e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/physiologically-based-pharmacokinetic-modeling-for-mechanistic-analysis-of-food-e9b1a61aa3a94c7b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-presentation-and-differentiation-between-behavioral-problems-and-psycho-336e7e081f42df3a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-and-surgeon-willingness-to-participate-in-a-randomized-trial-of-surgery-4e07513762d9ab74 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ket-qua-chan-oan-nguyen-nhan-not-phoi-va-moi-lien-quan-voi-mot-so-ac-iem-lam-san-fbd73bdee171cfac 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutic-effects-of-i-nigella-sativa-i-black-seed-via-antioxidant-and-anti-in-73ef8532af4a9c7d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/from-efficiency-to-resilience-advantage-system-shift-as-a-structural-diagnostic-eacb39e7e387b784 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/project-management-for-clinical-data-managers-a3905f7982c93a70 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/reusable-equipment-in-anaesthesia-a-comprehensive-review-of-reprocessing-practic-acf3bf376dc45746 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/persistent-post-concussive-symptoms-after-mild-traumatic-brain-injury-prevalence-56f9661d5a25a4fc 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-effect-of-nurses-clinical-competence-and-therapeutic-communication-on-servic-929b333be7f93088 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-drug-trade-in-the-victorian-era-d268931c94cd6f2d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-women-0185950cfe3c69c8 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/normal-saline-versus-baby-shampoo-in-the-care-of-peristomal-skin-complications-i-12705cd92ba5dc76 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/temperament-analysis-of-children-at-risk-of-specific-learning-disorder-a-cross-s-763684484e6833f7 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-overview-of-the-technological-trends-in-lung-cancer-as-contribution-to-educat-2990de36fc8ff26c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-artificial-intelligence-in-early-warning-diagnosis-and-precise-tr-b24ae27eff1c54bd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/atrial-fibrillation-burden-assessment-clinical-significance-and-therapeutic-impl-60c7a2ed46f9dd14 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/expanding-general-practice-capacity-for-attention-deficit-hyperactivity-disorder-11975245ff2fbe40 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-high-serum-apelin-levels-within-the-first-24-h-in-predicting-28-day-cec120ac031e2203 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/associations-of-functional-movement-screen-scores-and-joint-stability-tests-with-bfff1f54313934db 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-padros-auge-et-al-effects-of-strength-training-on-neck-muscle-functio-1c2e1709a6cfb28e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/endoscopic-activity-prediction-in-ulcerative-colitis-using-hemogram-derived-infl-a81259911c017c33 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/variations-in-autophagy-related-genes-atg5-atg10-and-atg16l1-correlate-with-tumo-e1d5f52721ecd922 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluation-of-the-plaque-removal-efficacy-of-chewable-toothpaste-tablets-a-rando-b8525c4e8f992073 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploratory-prescribing-risk-profiles-and-drug-drug-interaction-burden-in-older-345a114564912fce 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/longitudinal-patient-reported-outcomes-and-predictors-of-improvement-in-chemothe-a2ac4286360b452d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/indications-findings-and-clinical-impact-of-invasive-pediatric-urodynamic-studie-c6d6ae8553775f2f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/opioid-receptor-agonist-antagonists-in-pain-management-receptor-specific-mechani-eb1e2c9f705497fd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-rare-case-of-multi-segmental-lumbar-intradural-ependymoma-clinical-presentatio-91bcdc98aceb91da 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/treatment-time-metrics-and-functional-outcomes-after-endovascular-thrombectomy-i-97f3f12447f3eae2 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/translating-blood-based-biomarkers-into-alzheimer-s-disease-clinical-practice-sc-99167e3c35b6d087 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-comorbid-depression-on-clinical-outcomes-in-patients-with-peripheral-a-f9c47e16bfd574d1 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/induced-pluripotent-stem-cell-reprogramming-methodological-evolution-and-challen-ee695cb6019deb4d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-significance-of-gross-morphological-type-beyond-tumor-burden-in-hepatoc-48a335c17b4c781e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oros-technology-as-an-engineering-approach-to-controlled-drug-release-review-437d09c619ede3a6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/application-of-fluorescence-polarization-immunoassay-for-acetochlor-determinatio-010662829f27ad88 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-effect-of-percutaneous-auricular-nerve-stimulation-on-fat-227b7c39677204d1 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/primary-hydatid-disease-of-the-axilla-an-unusual-presentation-bbeba923d5cfc77a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-the-imagine-project-impacts-of-a-cluster-non-randomized-c-89583f45988fd5ca 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/implementation-of-patient-reported-measures-in-clinical-registries-an-internatio-fa0021ec39d9463a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-recurrence-rate-and-outcomes-of-pterygium-surgery-with-inferior-ve-6481350c89ab36e7 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-evaluation-of-equalstwo-under-eye-gel-in-the-management-of-periorbital-69f44027e78bb0c0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/serum-neurofilament-light-chain-as-a-biomarker-of-inflammatory-activity-in-relap-5cdb037ca99ca698 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/diagnostic-performance-of-nanopore-sequencing-technology-for-detecting-thalassem-0a95c717061372d9 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/143contextualizing-drug-addiction-in-kola-eke-s-i-february-1976-and-other-poems-c896998bfd2c2f3a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abdominal-aortic-pseudoaneurysm-as-a-complication-of-percutaneous-vertebroplasty-718a49a194931b0d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/arytenoid-cartilage-dislocation-after-tracheal-intubation-with-the-mcgrath-mac-v-8a05872530e1448c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-multifaceted-understanding-of-the-drug-phenomenon-through-a-multi-method-resea-6e694c3d93911ec8 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/tfcpgregulon-defines-a-fibroblast-driven-epigenetic-transcriptional-subtype-asso-6d3fcc58c09f7e85 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/statistical-analysis-plan-for-the-china-workplace-cancer-prevention-comprehensiv-895b577e04adc1e2 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patients-and-specialist-physicians-perspectives-on-the-use-of-polygenic-risk-sco-cff8ee941505d034 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-outbreak-report-of-influenza-a-h3-among-residents-of-a-large-nursing-home-in-0d431d78e9790d08 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/understanding-clinical-features-predictors-of-late-presentation-and-caregiver-pe-bcd3bfa466e61cf6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/national-neonatology-forum-clinical-decision-making-for-infants-born-at-the-marg-38be315d6f5067fb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/predictors-of-cannabis-use-change-in-mexican-first-year-university-students-a-12-9f6dc19d3affb4ff 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-regulatory-first-myeloma-drug-approved-based-on-mrd-negativity-ac9af41534d4f131 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-features-and-outcomes-of-neonates-with-covid-19-associated-cerebral-whi-740b58b9cc1eff9d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/major-adverse-cardiovascular-and-cerebrovascular-events-after-retinal-artery-occ-5651d659741b59c3 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-dexmedetomidine-remifentanil-on-neurodevelopment-of-children-after-in-8c43ccc2dd268b93 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-post-partum-anaemia-and-depressive-symptoms-at-two-months-af-62f55a1bbb92920b 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-prophylactic-intravenous-calcium-gluconate-on-uterine-atony-during-int-46a8af3424703fe7 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/iuc26687-94-clinical-and-pathologic-outcomes-of-resection-of-thoracic-residual-m-323e0eb55cceb854 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-clinical-judgment-does-not-live-in-a-template-a-nurse-practitioner-student-e-3d85c94d97d4faac 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-endoscopic-features-of-checkpoint-inhibitor-induced-colitis-and-the-f4b07114e1a69fbf 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/estimated-vesalius-like-eligibility-and-projected-cardiovascular-benefit-in-us-a-3b6b9b14200f0584 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/additional-considerations-regarding-the-antibiotic-treatment-for-mycoplasma-geni-09a32d9080fd38d3 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/infective-endocarditis-in-solid-organ-and-haematopoietic-stem-cell-transplant-re-ad1f6d474411905c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lower-platelet-count-and-clinical-outcomes-in-patients-with-bclc-stage-b-hepatoc-d1c5bf60b323768a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-international-qualitative-study-to-understand-current-and-future-barriers-in-56d63aa745571d20 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/an-investigation-into-aspects-of-resin-retained-bridge-design-on-aesthetics-and-eafe037187d045c9 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/shared-decision-making-reduces-parental-decisional-conflict-in-pediatric-sleep-d-a37dca6b15bf86ee 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/short-term-cognitive-effects-of-psychosocial-reminiscence-therapy-in-dementia-a-0b9b17712ca2b13e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/isolation-characterization-and-identification-of-antibiotic-resistant-biofilm-fo-75292e7523f7358e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-case-of-rectal-mixed-neuroendocrine-non-neuroendocrine-neoplasm-diagnosed-only-07d2111e9413a956 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-utility-of-the-chromogenic-anti-factor-xa-assay-when-the-aptt-is-unreli-e4b850c1e59ff41a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/optimising-clinical-outcomes-following-r1-resection-in-soft-tissue-sarcoma-an-ev-3fb4db88a88e1906 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/physiologically-based-pharmacokinetic-modeling-for-mechanistic-analysis-of-food-3927aa91d7f4df79 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/digital-complete-dentures-clinical-performance-fabrication-methods-and-occlusal-3dc061bc1b9e13c6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/mucoadhesive-patch-versus-benzocaine-gel-for-reducing-injection-pain-a-split-mou-1ae2f02a1556a9ba 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-conceptual-evolution-of-myopia-management-from-refractive-correction-to-axia-59a3faef1388c12f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-combined-metformin-plus-progestin-therapy-versus-progestin-monothera-ed315962788eb3c9 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-workload-and-dental-treatment-trends-in-a-university-predoctoral-adult-2841a15c23817cd1 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-gaps-barriers-and-facilitators-to-implementing-comprehensive-medicati-4a4fe4dcc467c42d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/characteristics-of-severe-and-typical-agranulocytosis-induced-by-antithyroid-dru-e4f5427734920b50 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07780461-characterization-and-validation-of-the-short-physical-performance-ba-7c92031843c6b449 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07780240-axillary-web-syndrome-after-breast-cancer-surgery-incidence-risk-fac-d55e23dec6c8ee5a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07779967-alcohol-breast-cancer-and-metabolism-5d288a90f60100f9 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07779902-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-g01-ey-f0163a0a92a2a1e5 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07779577-serum-magnesium-levels-in-patients-diagnosed-with-lipedema-b61019c08bb6a641 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07779395-artificial-intelligence-supported-pressure-injury-prevention-and-car-a4bfde461db1b485 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778823-augmented-reality-cardiopulmonary-resuscitation-support-for-pediatri-d6728891ff4c156d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778784-evaluation-of-cardiovascular-risk-among-the-participants-of-the-esc-3681eea0c6bc31ad 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778563-predictable-method-for-restoring-endodontically-treated-teeth-compar-785aeb070f384742 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778498-a-phase-i-ii-first-in-human-study-to-evaluate-tj102-in-participants-75628aebb2ecb49d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778394-personalized-addiction-treatment-ehancement-e4b7d931d598137a 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778303-effect-of-left-paratracheal-pressure-on-cerebral-oxygenation-during-63ef5f301df1a0b0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778290-topical-boswellia-serrata-2-to-prevent-radiation-dermatitis-in-head-f2567aadd30c73cb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07778212-orelabrutinib-combined-with-pola-r-chp-as-first-line-treatment-for-p-b8cee28b94676529 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07776275-physical-profile-of-cervicogenic-headache-comparison-with-neck-pain-20b93ae62f3cc420 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07727512-pcos-and-brain-health-9a818de53fe703d0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07677358-a-study-to-learn-how-the-study-medicine-called-atirmociclib-is-handl-07c54747276700fe 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07553065-relieve-study-nt-201-intravesical-administration-using-vibe-system-v-7996ed412a5be54e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07545590-a-study-of-eltrekibart-ly3041658-in-healthy-participants-cef689845fe98f82 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07530965-omega-3-fatty-acids-in-children-with-sickle-cell-disease-6041f9983d753303 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07271355-pressurized-intraperitoneal-aerosolized-chemotherapy-with-mitomycin-e5c840547a8666d7 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07227597-a-clinical-study-of-gocatamig-mk-6070-and-infinatamab-deruxtecan-mk-c20d6f6cd3954180 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07225855-geriatric-assessment-and-management-for-older-adults-undergoing-chem-f914065aa14f9fdc 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07222332-a-study-of-baricitinib-ly3009104-to-preserve-beta-cell-function-in-c-a5d8b35251307955 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07216560-first-in-human-study-of-7mw4911-in-gi-cancer-8f4814f0d0b28e2e 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07198074-testing-the-addition-of-an-antiangiogenic-drug-bevacizumab-to-chemot-54effff9f06e7043 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07061574-a-randomized-phase-1-2-trial-of-low-dose-anti-thymocyte-globulin-atg-f8945ddd40c30344 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct07059845-a-study-to-assess-adverse-events-and-change-in-disease-activity-of-m-70a5acaa68872c78 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06925737-a-clinical-study-of-ifinatamab-deruxtecan-i-dxd-in-people-with-metas-5db9501848ecac62 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06890884-a-clinical-study-of-zilovertamab-vedotin-mk-2140-plus-rituximab-plus-f33ad4298ee4ecdb 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06887036-methylene-blue-treatment-of-chronic-hepatitis-b-virus-infection-5491b11cc1261424 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06745921-safety-and-immunogenicity-of-an-inactivated-west-nile-virus-vaccine-e3caaaf3202fc636 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06744283-experience-and-management-of-cancer-screening-related-anxiety-in-fan-4217b728233e0099 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06738654-application-of-single-port-robot-assisted-breast-conserving-surgery-d13f52b65cd46d82 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06645015-the-aidpro-crc-trial-c8eb05586ee06ad3 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06576713-combined-genome-and-rna-sequencing-for-genetic-diagnosis-of-parkinso-40273c703e2fd7c0 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06570798-a-phase-2-master-protocol-assessing-inebilizumab-and-blinatumomab-in-9b03f637c356a81d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06507488-daphnetin-capsule-in-the-treatment-of-vascular-cognitive-impairment-4712a07b4a277327 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06462469-study-of-efficacy-and-safety-of-ruxolitinib-in-patients-with-grade-i-38cb85c010aaf08c 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct06441890-bre-10-biomarker-optimization-of-neoadjuvant-therapy-in-breast-cance-6e9e9359a7ee8055 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05996627-belumosudil-for-the-pre-emptive-treatment-of-patients-with-chronic-g-3d9ec43add627ac6 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05893940-low-intensity-mechanical-stimulation-for-hematologic-malignancy-pati-021c707c5530ba86 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05189262-cardiopulmonary-bypass-induced-red-blood-cell-lysis-0a80cc4affca833f 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct05065216-treatment-of-acute-ischemic-stroke-remedy2-trial-484c06a1ea420b76 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04849741-a-study-to-evaluate-the-safety-and-efficacy-of-zilganersen-ion373-in-2671c16b12e2fc05 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct04696315-early-diagnosis-of-scd-based-on-radiogenomics-fe4155fd3963dd6d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03992404-study-to-compare-the-efficacy-and-safety-of-nt-201-botulinum-toxin-w-8e01a35cfcf3c492 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct03118492-combination-chemotherapy-total-body-irradiation-and-donor-blood-stem-8c810dd7ece1df2d 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct02716246-phase-i-ii-iii-gene-transfer-clinical-trial-of-scaav9-u1a-hsgsh-837187b45b62e258 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nct00068003-harvesting-cells-for-experimental-cancer-treatments-dd4ac91a48985dcd 2026-08-21T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-stocks-slipped-as-biotech-led-thursday-s-selloff-03d48cda43dffb94 2026-08-20T23:51:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/sec-won-t-lift-trading-suspension-on-chinese-biotech-firm-21cdb5a352a4dfa6 2026-08-20T23:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaxion-biotech-strong-r-d-progress-and-financial-discipline-support-a-cash-runw-356b187626d6a235 2026-08-20T23:48:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-book-forward-of-guizhou-bailing-group-pharmaceutical-co-ltd-class-a-szs-ec7834a2e95f7057 2026-08-20T23:42:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-mrna-cancer-vaccine-succeeds-in-phase-3-korean-biotech-delivery-system-22bee4005f8668d9 2026-08-20T23:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-phase-3-mrna-cancer-win-boosts-korea-s-alteogen-st-pharm-chosunbiz-43b5658202e96433 2026-08-20T22:34:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/enterprise-value-to-ebit-forward-of-nascent-biotech-inc-otc-nbio-42b937dab69bb0a2 2026-08-20T22:30:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-a-failed-trial-isn-t-a-failed-drug-0e9cd1de9439fdc1 2026-08-20T22:30:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/producers-keep-close-eye-on-pharmaceutical-shortages-66b2e278f3f38cd6 2026-08-20T22:26:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/personalized-mrna-cancer-vaccine-delays-melanoma-recurrence-6b8d96082d431e22 2026-08-20T22:14:17.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-healthcare-etfs-is-ishares-pharma-a-better-buy-than-vaneck-biotech-e60346d00dd8f405 2026-08-20T22:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/phase-3-trial-of-ebola-vaccine-begins-in-the-drc-ae69022207f8a333 2026-08-20T22:13:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/tender-no-amiu-21-08-2026-002-request-for-proposals-for-provision-of-manned-secu-be8329a6d26bcc0b 2026-08-20T21:16:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/west-pharmaceutical-services-wst-gains-momentum-on-an-undervalued-narrative-08e5db642934ca09 2026-08-20T21:09:12.000Z weekly 0.7 https://www.pharmaradar360.com/article/central-carolina-cc-opens-new-biotech-facility-7dd34732684fdcca 2026-08-20T21:01:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-issues-highest-risk-warning-for-recalled-frozen-berries-sold-at-publix-due-t-7e39880871af27f7 2026-08-20T20:54:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sahpra-reaffirms-the-safety-of-routine-childhood-vaccination-7d653e9b3be962da 2026-08-20T20:42:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-enters-underwriting-deal-with-guggenheim-for-23-1m-equity-offering-797a769a214ef18b 2026-08-20T20:23:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/exozymes-reports-second-quarter-2026-results-and-provides-business-update-at-5pm-f4733526d66585e4 2026-08-20T20:03:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/sterling-biotech-e2f02e10ec355aac 2026-08-20T20:00:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/nida-awards-pleopharma-6-5-million-grant-to-advance-phase-3-trial-of-pp-01-for-c-0d9bc83426eced69 2026-08-20T19:56:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/solid-phase-extraction-biotech-fluidics-speedy-device-eliminates-vacuum-manifold-7beb84c08511ba32 2026-08-20T19:40:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-investors-should-be-paying-attention-to-biotech-b0bc8677eaacd098 2026-08-20T19:22:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-pasatru-pharmexec-ae0deaaac0f9b6e6 2026-08-20T19:03:51.000Z weekly 0.7 https://www.pharmaradar360.com/article/california-biotech-s-at-home-urine-test-aims-to-catch-cancer-early-7f88f1ca4de7fd9c 2026-08-20T18:53:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-grown-brain-models-gain-a-sense-of-place-6aebbeb002b25964 2026-08-20T18:40:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/america-s-biotech-security-push-and-italy-s-challenge-735b38178c0faf38 2026-08-20T18:38:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-slaps-100-tariff-on-some-pharmaceutical-drugs-via-executive-order-4af25fb40b2f1154 2026-08-20T18:30:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/xbi-biotech-s-breakthrough-moment-happend-this-week-upgrade-nysearca-xbi-e1b525434dac2260 2026-08-20T18:25:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-breakthrough-sends-mrna-soaring-4-mrna-cancer-vaccine-stocks-to-buy-inst-85054338374bf0f4 2026-08-20T17:56:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/bbp-the-biotech-etf-that-filters-for-fda-approved-drugs-nysearca-bbp-0ca262ff832be83a 2026-08-20T17:54:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/tufts-new-hub-aims-to-bridge-biotech-and-food-manufacturing-0ee88711944ff44c 2026-08-20T17:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-announces-750m-expansion-in-hillsboro-7abffc20f03fc685 2026-08-20T17:29:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-ru-486-got-to-america-ab8851f76583b355 2026-08-20T17:26:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/sol-gel-reports-0-6m-q2-revenue-as-sgt-610-trial-advances-0a3bcd6b20102cbc 2026-08-20T17:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-iovance-biotherapeutics-stock-hit-52-week-high-69b797af3f8ed4ba 2026-08-20T17:14:58.000Z weekly 0.7 https://www.pharmaradar360.com/article/tempus-ai-s-biotech-deal-attracts-investor-attention-b9e9d281aaf0e3a2 2026-08-20T17:08:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ac-immune-says-early-data-from-anti-inflammatory-drug-gives-wider-clinical-momen-a163ee633b75626c 2026-08-20T16:32:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/maharashtra-fda-tightens-crackdown-on-adulterated-edible-oil-e61b176075570f56 2026-08-20T16:30:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-to-challenge-ipsen-as-fda-clears-bone-disease-drug-21e4e0c610299855 2026-08-20T16:24:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-177-surge-powers-a-broad-biotech-rally-1bdf1070feaa86f1 2026-08-20T16:14:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-biotech-companies-need-to-think-beyond-development-earlier-e5e2a43d68f4e379 2026-08-20T16:14:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/who-confirms-covid-19-vaccines-in-phase-3-clinical-trials-f80175722f802593 2026-08-20T16:04:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-is-booming-but-these-2-stocks-missed-the-memo-moderna-nasdaq-mrna-ishare-fdb179faa184cd5f 2026-08-20T16:03:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-forms-sit-to-probe-bidadi-drug-repacking-case-related-cases-across-sta-35cdacaad812cd58 2026-08-20T16:00:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/vimal-elaichi-ad-row-no-reply-yet-from-celebrities-to-fda-notices-action-after-d-5cea81df05d74002 2026-08-20T15:47:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/cmps-stock-rises-23-pre-market-as-compass-achieves-primary-endpoint-in-phase-3-t-4191aa06fc271c3e 2026-08-20T15:43:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/therapeutics-stocks-q2-results-benchmarking-biomarin-pharmaceutical-nasdaq-bmrn-89c4c10d30d7296b 2026-08-20T15:39:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/to-outcompete-china-unhandcuff-america-s-biotech-innovators-21309891cf17dc7a 2026-08-20T15:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-records-gh-70m-surplus-flags-ageing-laboratory-equipment-8b73081729ff14b2 2026-08-20T15:29:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortitude-provides-second-quarter-2026-financial-and-operating-highlights-0aedc026a2d6a269 2026-08-20T15:27:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fortitude-invests-1-0-million-in-heartsciences-at-a-22-premium-with-no-adjustmen-da5a3fe59420ef31 2026-08-20T15:24:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-personalised-cancer-vaccine-clears-phase-3-how-soon-could-patients-rec-d7391fc412b686ec 2026-08-20T15:20:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/governance-data-and-talent-what-to-plan-before-moving-to-a-mixed-fsp-fso-model-3615a1084689f8f6 2026-08-20T15:08:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/when-to-run-a-ugt-mediated-ddi-trial-and-why-it-matters-clinically-6102e17c28a774e3 2026-08-20T14:58:11.000Z weekly 0.7 https://www.pharmaradar360.com/article/chai-tees-up-bristol-myers-squibb-ai-antibody-discovery-collab-4c1de1bb64f6017b 2026-08-20T14:55:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/scribe-s-early-stage-ipo-standout-defies-biotech-s-derisking-trend-7c5900df6432d8c9 2026-08-20T14:53:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/math-and-medicine-join-forces-to-solve-a-cancer-mystery-563862271ba2d7c4 2026-08-20T14:51:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/my-own-secret-superpower-jocelyn-s-journey-with-c3-glomerulopathy-55d6c6806c51d07a 2026-08-20T14:50:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/public-health-commissioning-in-the-nhs-2026-to-2027-e83d4969f3a200ab 2026-08-20T14:49:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/healthcare-cdmo-2026-2031-growing-outsourcing-of-pharmaceutical-development-and-bf878b473a60d1e9 2026-08-20T14:47:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/b-braun-recalls-iv-solution-from-us-canada-hospitals-on-particle-contamination-c-efa5ffa365344112 2026-08-20T14:44:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/report-mail-order-pharmacy-satisfaction-climbs-as-retail-trust-slips-46a39414b898e6f4 2026-08-20T14:34:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/plans-being-developed-for-a-new-mental-health-emergency-department-at-st-george-b7c75fd5e67faa6d 2026-08-20T14:33:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultragenyx-pharmaceutical-nasdaq-rare-shares-gap-up-after-analyst-upgrade-2cd64543628d2c35 2026-08-20T14:22:43.000Z weekly 0.7 https://www.pharmaradar360.com/article/10x-genomics-dealt-major-blow-in-sequencing-fight-c098344c9191eaba 2026-08-20T14:18:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/partnership-begins-before-production-christian-kratzig-on-collaboration-as-equal-98ffda7f4761b0fb 2026-08-20T14:16:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/ihe-vs-xbi-pharma-stability-or-biotech-growth-which-healthcare-etf-is-the-better-1360de5c474c6e58 2026-08-20T14:16:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/oxford-researchers-win-prestigious-national-leadership-prizes-e83b632329f2147d 2026-08-20T14:14:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-falls-20-after-record-rally-as-valuation-concerns-emerge-5ddcfb88abbede24 2026-08-20T14:13:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmacists-look-at-the-future-of-glp-1-compounding-87ea91a896c3ff54 2026-08-20T14:09:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-driven-cancer-vaccine-passes-phase-3-trials-99a9764e9ed7d6e4 2026-08-20T14:03:45.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-operating-income-surged-238-yoy-as-clinical-pipeline-advanced-9e3b379fad4f2c49 2026-08-20T13:59:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/tukaram-mundhe-led-fda-bans-sale-of-loose-edible-oil-in-maharashtra-warns-of-act-3b588432376cfa1a 2026-08-20T13:52:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/meet-aletta-the-first-fda-approved-robotic-blood-draw-device-1f8a9b7684b94ae8 2026-08-20T13:47:08.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-approves-ultragenyx-gene-therapy-52d0cbb4b1b05211 2026-08-20T13:39:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/bet-on-these-biotech-etfs-as-innovation-drives-market-beating-growth-406545193cfd41bd 2026-08-20T13:38:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-teva-wins-fda-priority-review-for-pediatric-tourette-drug-candidate-d24f264763583d75 2026-08-20T13:37:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/sk-pharmteco-to-attend-cphi-showcasing-multimodal-cdmo-capabilities-and-global-m-e3ef5f7b51039268 2026-08-20T13:36:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-first-ever-personalized-cancer-vaccine-to-pass-a-phase-3-trial-just-beat-key-97eab96ad2be7145 2026-08-20T13:36:19.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-records-gh-70m-surplus-in-2025-despite-laboratory-equipment-illicit-product-ce7defb711952f19 2026-08-20T13:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaxion-biotech-q2-2026-earnings-call-complete-transcript-4784bad21c810ea6 2026-08-20T13:34:14.000Z weekly 0.7 https://www.pharmaradar360.com/article/pune-fda-crackdown-3-food-licences-suspended-products-worth-19-90-lakh-seized-ph-430ddba2dff8ba6b 2026-08-20T13:31:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/once-weekly-insulin-would-be-significant-change-for-diabetes-prescribers-e2b4b00aceb42a78 2026-08-20T13:27:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-disrupts-topical-drug-delivery-as-billion-dollar-224c6d96e2c88ca3 2026-08-20T13:25:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/walmart-raises-annual-targets-pharmaceutical-sales-weigh-on-us-business-fdadcb90090ce6b5 2026-08-20T13:18:36.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-joins-national-dialogue-to-advance-kenya-s-universal-health-coverage-agend-2b27e2698f227271 2026-08-20T13:18:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/creative-medical-finishes-treating-back-pain-patients-who-use-opioids-53edac381e44e69e 2026-08-20T13:15:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/michelle-britt-on-the-three-forces-reshaping-independent-pharmacy-economics-e8efd079ff5d9a0c 2026-08-20T13:04:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/subtle-medical-appoints-lawrence-n-tanenbaum-md-as-executive-medical-director-da20aebd751ee8a0 2026-08-20T13:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-pharmaceutical-companies-are-interested-in-psychedelics-d7cbc921e119510e 2026-08-20T12:49:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/cockroaches-in-kitchen-unsafe-food-storage-fda-suspends-food-licences-of-more-mu-afd9948ad7a661c6 2026-08-20T12:42:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/icon-releases-2025-icon-cares-report-813179f93e40a48c 2026-08-20T12:29:32.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-to-challenge-ipsen-as-fda-clears-bone-disease-drug-2d45edcb5aa6ae12 2026-08-20T12:21:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/money-has-spoken-why-chinese-biotech-ceos-tell-fierce-they-re-unfazed-about-risi-7202abd72c43d39e 2026-08-20T12:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/realcan-pharmaceutical-group-s-board-elects-chairman-8693a7e142464686 2026-08-20T12:16:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/insilico-medicine-announces-ardd-2026-program-bringing-global-leaders-in-longevi-b12b8de132bb98ae 2026-08-20T12:13:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/varmx-enrols-first-participant-in-global-phase-3-equilibrix-s-trial-evaluating-v-99b2143cb730df8e 2026-08-20T12:13:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/ai-bioweapons-harvard-s-elizabeth-sherwood-randall-on-navigating-the-ai-biotech-7436f09358a75262 2026-08-20T12:12:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/cantor-fitzgerald-forecasts-strong-price-appreciation-for-ultragenyx-pharmaceuti-4c9fdd1323e331ff 2026-08-20T12:09:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-picks-dr-heidi-overton-a-top-white-house-aide-to-lead-the-food-and-drug-ad-e0502baa02f7029d 2026-08-20T12:04:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ask-the-expert-complying-with-standards-08cc44bfe27fe204 2026-08-20T12:04:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/pleopharma-awarded-6-5-million-nida-grant-to-support-phase-3-trial-of-pp-01-for-cac10fd6fd5cc303 2026-08-20T12:04:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/theragun-pro-efe0d610998dfa09 2026-08-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/patient-information-centre-ix-4daff094f9953757 2026-08-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/centricitytm-enterprise-archive-and-pacs-workstation-2950a906eb6324fa 2026-08-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/charles-river-laboratories-and-medigen-vaccine-biologics-corp-collaborate-to-adv-02e9f54f856ce320 2026-08-20T12:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaxion-biotech-evax-releases-q2-2026-earnings-abb1585c76730142 2026-08-20T11:55:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dynamics-of-the-icelandic-ice-sheet-altered-the-chemistry-of-north-atlantic-seaw-f598f9903346bd50 2026-08-20T11:40:06.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaxion-biotech-q2-2026-featured-pipeline-advances-a-3-7m-net-loss-and-cash-runw-e926efc8abc7a6ce 2026-08-20T11:37:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/hammer-toe-has-no-fda-approved-nonsurgical-therapy-keenova-doses-the-first-patie-69697e4d1e62e18d 2026-08-20T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/keenova-advances-podiatry-pipeline-with-first-patient-dosed-in-phase-3-trial-of-ded1f51c2fa7d2ff 2026-08-20T11:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/silicone-tubing-for-biotech-market-growth-to-2035-driven-by-single-use-systems-n-29916d8830befe68 2026-08-20T11:21:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/biomarin-pharmaceutical-nasdaq-bmrn-raised-to-strong-buy-at-bmo-capital-markets-e4be6486157f4052 2026-08-20T11:11:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/madison-asset-management-llc-invests-9-90-million-in-west-pharmaceutical-service-de931012ca5da34a 2026-08-20T11:07:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/donald-trump-nominates-dr-heidi-overton-to-lead-the-u-s-food-and-drug-administra-8315724f9c20f7f8 2026-08-20T11:03:40.000Z weekly 0.7 https://www.pharmaradar360.com/article/techcyte-reorganizes-board-of-directors-to-support-next-phase-of-growth-89dd5edf8bfea878 2026-08-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-etf-canc-hits-new-52-week-high-73d17290af1e1123 2026-08-20T11:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dmd-biotech-delivers-early-muscle-data-as-sat-3247-advances-618e3cd4a6122fea 2026-08-20T10:52:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/sarepta-therapeutics-delivers-q2-operating-profit-as-ceo-transition-advances-pip-574f36be0ba68365 2026-08-20T10:52:30.000Z weekly 0.7 https://www.pharmaradar360.com/article/td-cowen-raises-helus-pharma-stock-price-target-to-62-on-trial-timing-b46814dd7cf11106 2026-08-20T10:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/regeneron-s-pasatru-wins-fda-approval-in-ultra-rare-stone-man-disease-78d8a09b9d8a8631 2026-08-20T10:45:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/kynexis-pockets-97m-to-advance-cognition-focused-schizophrenia-drug-b7c214af93031940 2026-08-20T10:45:56.000Z weekly 0.7 https://www.pharmaradar360.com/article/why-metadata-reuse-breaks-at-scale-in-global-study-builds-6abbf66bf78e1da6 2026-08-20T10:39:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/rector-s-annual-report-for-2025-has-been-published-5d4aa37e96910479 2026-08-20T10:37:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-industry-priorities-for-the-health-data-research-service-28e07d2f4c798e4d 2026-08-20T10:37:13.000Z weekly 0.7 https://www.pharmaradar360.com/article/one-of-the-most-consequential-years-for-cancer-treatment-ever-9a0dc7170c1b042b 2026-08-20T10:34:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/capricor-therapeutics-duchenne-treatment-is-heading-for-an-fda-rejection-e7887ca62cd37543 2026-08-20T10:34:55.000Z weekly 0.7 https://www.pharmaradar360.com/article/italy-s-10-billion-angelini-family-bets-4-1-billion-in-u-s-biotech-30698ecea68f5e28 2026-08-20T10:30:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kemri-becomes-the-first-african-institute-to-join-the-global-dengue-alliance-dbb69a951ba7cecc 2026-08-20T10:21:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/global-pharma-biotech-summit-10-11-november-2026-5eb71676e88a0657 2026-08-20T10:21:09.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-stock-sinks-after-fresh-capital-raise-8774a0c100e01105 2026-08-20T10:20:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-operational-reality-of-reshoring-pharma-manufacturing-q-a-with-rohit-tripath-9927f55d82b246a8 2026-08-20T10:03:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/lab-4-0-balance-connected-compliant-and-ready-to-integrate-d514151a605b442b 2026-08-20T10:01:38.000Z weekly 0.7 https://www.pharmaradar360.com/article/non-profit-pharmaceutical-manufacturer-delivers-drug-access-to-rural-hospitals-7f30dca21788a979 2026-08-20T10:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-proposes-mandatory-gras-notifications-in-major-overhaul-of-ingredient-framew-e3b6ffa65e1d490d 2026-08-20T09:38:21.000Z weekly 0.7 https://www.pharmaradar360.com/article/mitsubishi-ufj-asset-management-co-ltd-makes-new-67-58-million-investment-in-wes-fc77786b63180810 2026-08-20T09:34:41.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-strong-clinical-and-financial-momentum-in-q2-2026-with-es2b-c-8d726ea11b617312 2026-08-20T09:22:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/ubs-upgrades-sartorius-stedim-biotech-to-buy-74373933043b5a0a 2026-08-20T09:22:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-production-compliance-burdens-nobody-talks-about-6c8691c7094f8e64 2026-08-20T09:18:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-production-compliance-burdens-nobody-talks-about-7e01b724bdeb8753 2026-08-20T09:18:44.000Z weekly 0.7 https://www.pharmaradar360.com/article/mankind-pharma-licenses-two-chinese-insulin-analogues-for-india-cc0723749befc42d 2026-08-20T09:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/white-house-aide-nominated-for-fda-commissioner-role-479374c17d3d890e 2026-08-20T09:12:24.000Z weekly 0.7 https://www.pharmaradar360.com/article/hong-kong-stocks-rise-as-mrna-vaccine-breakthrough-sparks-biotech-frenzy-8c4e23685dca6460 2026-08-20T09:11:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/generation-investment-management-llp-invests-728-17-million-in-west-pharmaceutic-b4136b7d3eada450 2026-08-20T09:10:39.000Z weekly 0.7 https://www.pharmaradar360.com/article/sartorius-stedim-biotech-from-neutral-to-buy-by-ubs-ab1f982072762f5f 2026-08-20T09:10:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-skyrocketing-rally-puts-these-7-biotech-stocks-in-focus-828763509981311b 2026-08-20T09:08:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/eagle-health-investments-lp-acquires-shares-of-624-676-biomarin-pharmaceutical-i-58df53bf1250a876 2026-08-20T08:59:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/edmond-de-rothschild-holding-s-a-purchases-shares-of-687-030-biomarin-pharmaceut-fdb42fb33a705956 2026-08-20T08:59:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/eagle-health-investments-lp-acquires-shares-of-884-121-ultragenyx-pharmaceutical-be3835dedac41257 2026-08-20T08:58:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/pharmaceutical-companies-moderna-and-merck-have-announced-preliminary-successes-8e34bea41a09ff42 2026-08-20T08:49:18.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-es2b-c001-advances-with-strong-phase-i-data-grant-driven-inco-3f39e2cb6ea26dde 2026-08-20T08:45:46.000Z weekly 0.7 https://www.pharmaradar360.com/article/earnings-call-transcript-expres2ion-biotech-q2-2026-loss-narrows-as-trial-data-a-88ed4279bdb7145c 2026-08-20T08:45:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/human-t-cell-lymphotropic-virus-htlv-types-1-and-2-971684cf344ae5e0 2026-08-20T08:30:05.000Z weekly 0.7 https://www.pharmaradar360.com/article/mers-cov-clinical-management-and-guidance-f72ecb2875f99b98 2026-08-20T08:30:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/mers-cov-information-sheets-for-contacts-709a994f2e17557a 2026-08-20T08:30:03.000Z weekly 0.7 https://www.pharmaradar360.com/article/mers-cov-diagnosis-and-management-of-cases-and-contacts-5a19beaab032580f 2026-08-20T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/listeria-monocytogenes-incident-reports-5bf4bf577560b2f0 2026-08-20T08:30:02.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-health-data-research-service-a-once-in-a-generation-chance-to-lead-the-world-3ed8794ce53fe365 2026-08-20T08:28:35.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-s-skyrocketing-rally-puts-these-7-biotech-stocks-in-focus-f855c0c931d87427 2026-08-20T08:23:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-at-52-week-highs-mrna-surges-176-on-phase-3-data-sctv-mrvi-soph-i-1f5b4a1232541dfc 2026-08-20T08:21:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/teva-pharmaceutical-teva-insider-sell-evp-business-developme-65a42dc94c053724 2026-08-20T08:19:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-raises-usd-25m-to-fuel-vitiligo-phase-ii-dfc477a3ee3def17 2026-08-20T08:15:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/410-699-shares-in-west-pharmaceutical-services-inc-wst-acquired-by-deutsche-bank-e731622b32054f3c 2026-08-20T08:12:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/republican-chair-of-the-senate-health-panel-says-he-has-strong-concerns-about-tr-364743fc96ddeee0 2026-08-20T08:09:26.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-clinical-progress-and-a-successful-rights-issue-drove-financi-ee3b7f0dd369bb33 2026-08-20T07:43:01.000Z weekly 0.7 https://www.pharmaradar360.com/article/blackrock-inc-buys-shares-of-6-651-784-west-pharmaceutical-services-inc-wst-279b0367c57b993f 2026-08-20T07:36:10.000Z weekly 0.7 https://www.pharmaradar360.com/article/south-korean-biotech-industry-urges-inclusion-of-vaccines-in-domestic-production-ee9127f1775db4e4 2026-08-20T07:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-first-cycle-review-of-preservative-free-ketamine-anda-with-no-drug-related-m-384db86c29fe901f 2026-08-20T07:32:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/abclon-to-release-global-phase-3-topline-results-for-her2-targeted-gastric-cance-207963823c678c95 2026-08-20T07:19:47.000Z weekly 0.7 https://www.pharmaradar360.com/article/france-analyst-views-ubs-turns-positive-again-on-sartorius-stedim-biotech-fea2be777390b0e4 2026-08-20T07:02:29.000Z weekly 0.7 https://www.pharmaradar360.com/article/olympus-launches-flexible-tip-videoscope-supporting-4k-3d-and-ir-imaging-9d8b477c0e7787b9 2026-08-20T07:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-biotech-reports-q2-operating-profit-of-sek-10-2-mln-7a28ea75f7369e03 2026-08-20T06:50:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-biotech-reports-reduced-operating-loss-45bc675560e8a1fc 2026-08-20T06:48:25.000Z weekly 0.7 https://www.pharmaradar360.com/article/expres2ion-biotech-strong-clinical-and-financial-momentum-in-q2-2026-led-by-es2b-d9b86f4cf10e558c 2026-08-20T06:35:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/active-biotech-interim-report-q2-2026-1d4e469e9f8c5e96 2026-08-20T06:31:23.000Z weekly 0.7 https://www.pharmaradar360.com/article/fda-crackdown-in-pune-rs-14-lakh-banned-stock-seized-4-arrested-3-establishments-765901f3a4627286 2026-08-20T05:50:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/karnataka-fda-seizes-spurious-drugs-worth-rs-4-91-crore-in-bidadi-raid-dcc839e3a331ab7a 2026-08-20T05:36:33.000Z weekly 0.7 https://www.pharmaradar360.com/article/gubra-biotech-revenue-normalized-post-abbvie-deal-cro-rebounded-with-11-growth-a-b19b427a5e2f695f 2026-08-20T05:36:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-s-attributable-profit-more-than-doubles-in-h1-shares-jump-14-c7e3da740073ef1b 2026-08-20T05:10:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/how-investors-may-respond-to-rohto-pharmaceutical-tse-4527-upgraded-fy2027-guida-8c60dd2d576af708 2026-08-20T05:02:15.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-surging-after-personalized-mrna-cancer-vaccine-clinical-trial-succ-5459a6b6fd65a784 2026-08-20T04:59:37.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-stock-jumps-177-on-cancer-vaccine-success-5c35e34e7d0e748f 2026-08-20T04:54:52.000Z weekly 0.7 https://www.pharmaradar360.com/article/kringle-pharma-fy2026-q3-earnings-call-phase-3-additional-trial-for-spinal-cord-c3fd478b43f44bfa 2026-08-20T04:44:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/cspc-pharmaceutical-group-revenue-and-profit-soared-on-finished-drug-sales-and-l-f78b64b3c94d2da7 2026-08-20T04:22:20.000Z weekly 0.7 https://www.pharmaradar360.com/article/opinion-why-pediatric-rare-oncology-outperforms-in-a-volatile-biotech-market-51c5ca5807baf928 2026-08-20T04:08:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/first-personalized-mrna-cancer-vaccine-succeeds-in-phase-3-trial-fc5d6cd94cd4caf1 2026-08-20T04:05:59.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-merck-breakthrough-cancer-vaccine-shows-promise-in-clinical-trial-for-me-904e7a0b07bd3bc1 2026-08-20T04:01:57.000Z weekly 0.7 https://www.pharmaradar360.com/article/convenience-kit-recall-medline-issues-correction-for-convenience-kits-containing-adf3a8491567bb41 2026-08-20T04:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/donald-trump-picks-dr-heidi-overton-to-lead-fda-who-is-she-and-why-is-her-nomina-a872e34fa03bcf3f 2026-08-20T03:41:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/us-fda-approves-regeneron-s-pasatru-for-rare-bone-disorder-0a3780b0d06016d6 2026-08-20T03:35:50.000Z weekly 0.7 https://www.pharmaradar360.com/article/rats-in-oil-cakes-on-the-floor-maharashtra-fda-exposes-food-safety-horrors-worth-5d60b86ee7a999b9 2026-08-20T03:32:34.000Z weekly 0.7 https://www.pharmaradar360.com/article/aussie-led-trial-offers-melanoma-hope-535720fbd6924c53 2026-08-20T03:32:28.000Z weekly 0.7 https://www.pharmaradar360.com/article/aussie-led-trial-offers-melanoma-hope-c692f38678e7bad4 2026-08-20T03:09:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-and-msd-s-mrna-vaccine-succeeds-in-melanoma-2cf35e04064c6094 2026-08-20T02:56:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/sit-to-probe-rs-4-91-crore-fake-drug-racket-in-karnataka-7429460424df5ed6 2026-08-20T02:31:49.000Z weekly 0.7 https://www.pharmaradar360.com/article/futurechem-eyes-october-topline-for-fc705-u-s-phase-2a-anticipates-big-pharma-li-b905bcae12ad36a5 2026-08-20T02:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/edesa-biotech-announces-pricing-of-25-0-million-public-offering-9e97b0614f91a164 2026-08-20T02:20:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/new-release-soyjoy-matcha-yuzurich-and-intense-matcha-flavor-with-the-vibrant-ar-be5f1b002442c2ac 2026-08-20T02:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biotech-stocks-facing-fda-decision-in-september-2026-388b9b7fcf73c455 2026-08-20T01:49:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/fake-medicines-worth-5-cr-seized-in-bidadi-12064b7a581d55e1 2026-08-20T01:23:31.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-shares-surge-177-percent-after-success-in-phase-3-trial-for-mrna-cancer-1fe2afd24932741e 2026-08-20T01:12:53.000Z weekly 0.7 https://www.pharmaradar360.com/article/trump-picks-white-house-ally-overton-to-lead-embattled-fda-43a190d4c0672867 2026-08-20T01:11:04.000Z weekly 0.7 https://www.pharmaradar360.com/article/doctors-explain-how-moderna-s-melanoma-mrna-vaccine-could-fight-deadliest-form-o-d7eeaef18703b965 2026-08-20T01:03:07.000Z weekly 0.7 https://www.pharmaradar360.com/article/jianmin-pharmaceutical-group-co-ltd-class-a-revenue-breakdown-sse-600976-74d5c3c58919effd 2026-08-20T00:52:48.000Z weekly 0.7 https://www.pharmaradar360.com/article/expert-reaction-moderna-announce-results-of-phase-3-trial-of-personalized-mrna-c-2df1c730007665e6 2026-08-20T00:48:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-trial-success-sends-korea-s-samyang-biopharm-to-limit-up-chosunbiz-5fd26e6d3b42b2dd 2026-08-20T00:25:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nasdaq-biotechnology-index-posts-largest-gain-in-six-years-as-global-pharmaceuti-bafcd6d96caf24f0 2026-08-20T00:24:27.000Z weekly 0.7 https://www.pharmaradar360.com/article/price-to-earnings-forward-of-jiangsu-kanion-pharmaceutical-co-ltd-class-a-sse-60-de519d4592daf3e9 2026-08-20T00:20:22.000Z weekly 0.7 https://www.pharmaradar360.com/article/moderna-and-merck-announce-success-in-phase-3-trial-of-personalized-mrna-cancer-d0853e2af1982ca3 2026-08-20T00:12:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-st-f8b839e0704d5316 2026-08-20T00:02:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/zipalertinib-plus-chemotherapy-first-line-phase-3-rezilient3-trial-data-selected-40d4bf77c6b49525 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/biontech-filed-form-6-k-a9548cff6c148618 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/news-published-on-2026-08-20-global-engagement-education-international-exchange-8cc2a08b1e64039c 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-forms-undergoing-paperwork-reduction-act-review-04593cf5c8f31db0 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/proposed-data-collection-submitted-for-public-comment-and-recommendations-4b78add1f36993cb 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-for-scientific-review-notice-of-closed-meetings-9a704a8d7d9c8ea2 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/agency-information-collection-activities-submission-to-omb-for-review-and-approv-60efb8757682c3e0 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/privacy-act-of-1974-system-of-records-bffcc29f1f67cd20 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advisory-committee-cardiovascular-and-renal-drugs-advisory-committee-renewal-08d4164845a0e920 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/advisory-committee-endocrinologic-and-metabolic-drugs-advisory-committee-renewal-a8137bbd6052b942 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/potency-assessment-of-active-immunotherapy-products-draft-guidance-for-industry-f73bbfbfae6c641b 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/frequently-asked-questions-developing-potential-cellular-and-gene-therapy-produc-9e694fb5e84d53b5 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/center-or-scientific-review-notice-of-closed-meetings-2572187022b7ab67 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-3a7e2437773846d8 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-threshold-for-a-clinically-meaningful-improvement-in-cardiopulmonary-exercis-fb32166894bb4f2c 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/machine-learning-predicts-functional-decline-and-risk-phenotypes-in-older-patien-36cf0e6259c56efd 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-ciprofol-versus-propofol-on-hemodynamic-profiles-during-anesthesia-in-bb2f67b84f015854 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-the-anti-inflammatory-macrolide-glasmacinal-on-the-gut-microbiota-of-h-4540c24bc79baed2 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/exploring-possibilities-towards-personalised-medicine-in-rheumatoid-arthritis-pr-b0095bb6b4aa2003 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-renin-angiotensin-system-inhibitors-on-survival-in-glioma-patients-a-s-b2bead3d9072b83a 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/remission-outcomes-with-bupropion-versus-selective-serotonin-reuptake-inhibitor-7103b40fd9176c53 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-medium-chain-triglyceride-with-and-without-ketogenic-diet-in-the-manag-8024116f9d764773 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-single-dose-of-azithromycin-versus-placebo-for-malaria-in-infants-a-cluster-ra-11f96cbf4597f30d 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/alterations-to-the-consent-process-in-five-pragmatic-randomized-trials-of-routin-8d45461e7cdebacf 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/federal-and-industry-sponsorship-in-us-cancer-clinical-trials-c5b592b2d2558a1d 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spectacle-lenses-with-highly-aspherical-lenslets-for-myopia-control-a-randomized-979c344c1ac62319 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/interstitial-lung-disease-induced-by-monoclonal-antibodies-for-psoriatic-arthrit-7468efce5aa19970 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/low-dose-aspirin-in-pregnancy-indications-efficacy-safety-and-remaining-controve-3489415f1d59c263 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recommendations-for-generating-real-world-evidence-with-regulatory-grade-relevan-c6388cbdf069f4a3 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sulforaphane-mitigates-behavioral-deficits-in-experimental-chronic-kidney-diseas-4d915a4d029320f1 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/eleven-year-diagnostic-delay-in-episodic-cluster-headache-with-a-characteristic-5fddf51d1d79576a 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/relationship-between-nurse-leadership-and-the-nursing-practice-environment-among-322b9181a5de5c95 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/underwater-endoscopic-submucosal-dissection-in-the-stomach-where-are-we-now-bcbae3fc5f23ee44 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/efficacy-of-varied-liquid-microbial-formulations-on-the-growth-and-yield-perform-23ab12bdcd83a972 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/multimodal-analgesic-management-for-acute-postoperative-pain-drug-selection-safe-b3be5beb0a7c29a0 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sflt-1-levels-as-an-indicator-of-the-effectiveness-of-antihypertensive-agents-in-3bb3065e202f7487 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/nong-o-cystatin-c-huyet-tuong-va-moi-lien-quan-voi-mot-so-chi-so-lam-sang-can-la-157a66aa68db1e41 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/double-j-versus-single-j-stent-placement-in-kidney-transplant-recipients-a-syste-de4639bd5edb6fae 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/long-term-results-of-long-acting-somatostatin-analog-therapy-in-children-with-co-d198b58b9c6d5a6d 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/dental-occlusion-measurement-a-methodological-evaluation-to-improve-clinical-gna-d4e90993a3230015 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/in-silico-methods-applied-in-drug-and-pesticide-discovery-e6763d787534409c 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/maternal-vulnerability-indicators-derived-from-free-text-clinical-documentation-9538c6d383702912 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/association-between-initial-serum-galactomannan-level-and-radiological-and-clini-508a56e07804ee8b 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-and-internal-validation-of-a-multivariable-prediction-model-for-comp-33a771bdce88d3af 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/evaluating-the-clinical-significance-of-pre-and-postoperative-platelet-function-2b2637e951893874 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/development-of-a-simple-formula-for-identifying-reduced-fat-free-mass-in-health-d88de3849f9136b1 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/prognostic-nutritional-index-and-postoperative-complications-after-colorectal-su-841537e3d39385df 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-laboratory-profiles-time-to-presentation-and-antibacterial-therapy-b3822065c9a72161 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-in-periodontology-from-automated-diagnosis-to-prediction-2e4a3107c178bab5 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/kombucha-as-a-functional-fermented-beverage-emerging-clinical-evidence-proposed-4d2f8b10ca60e3a3 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/impact-of-diagnosis-related-group-based-bundled-payment-on-hospitalization-costs-1ca6bac83f76e3fb 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-based-developmental-screening-for-pre-school-children-ag-a780265c953d58bd 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ursodeoxycholic-acid-as-a-potential-cardioprotective-agent-molecular-mechanisms-170c360506af01df 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/spect-ct-imaging-in-thyroid-eye-disease-an-emerging-role-in-assessing-sub-clinic-d868ced81c1f9479 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effect-of-a-multicomponent-intervention-on-adherence-to-the-mediterranean-diet-i-d9edc9d390fd798e 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-scale-of-artificial-intelligence-based-nerve-segmentation-on-ultrasound-10f6cf2c71e67253 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/case-report-clinical-characteristics-and-outcomes-in-natural-killer-nk-t-cell-ly-b4a0bbc9586b9ad2 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chapter-iv-pharmacotherapy-systematic-treatment-835ade60833fda98 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chapter-iv-pharmacotherapy-topical-therapy-3cb6ec88b82f2e6a 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/a-pilot-study-assessing-the-clinical-significance-of-neurorehabilitation-a-retro-4a88c629bfaa0848 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/peer-review-report-for-efficacy-of-yoga-breath-linked-intervention-to-stop-smoki-f05947f6c243c079 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/modified-posterior-versus-standard-transperitoneal-laparoscopic-pyelolithotomy-a-75fa8e7deb55ba01 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/daytime-hypersomnolence-in-migraine-prevalence-clinical-correlates-and-independe-79aad4ac69ec24b9 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/professor-mathias-m-muller-when-science-becomes-poetry-and-music-f4718657a238edde 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/obesity-and-postoperative-opioid-utilization-after-total-knee-arthroplasty-a-pro-e3d6d627bc3284e9 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/monitored-anesthesia-care-combined-with-thoracic-paravertebral-block-for-percuta-ce7ef611527ea6a5 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/sex-differences-in-cue-evoked-drug-seeking-tendencies-among-abstinent-individual-ec7fc4fd5be30b7b 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/analysis-of-clinical-characteristics-and-risk-factors-of-liver-injury-in-treatme-4191864049762a81 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/genetic-diversity-of-drug-resistant-vibrio-cholerae-a-systematic-review-with-exp-502b0b568492592f 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/effects-of-repeated-sprint-training-on-physical-performance-and-competitive-anxi-fb5d3e925a98d771 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/lateral-internal-sphincterotomy-with-skin-grafting-for-chronic-anal-fissure-prot-4f42e0004248ca65 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/promoting-equitable-inclusion-in-a-multi-centre-randomized-controlled-trial-on-p-779237065b337746 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-and-pathological-investigations-into-cases-of-leg-diseases-in-yellow-fe-e2db8ada2ca14ed3 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-efficacy-and-safety-of-asciminib-in-chronic-myeloid-leukemia-chronic-ph-a0dfe6eb5b0d81a8 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-relief-trial-for-patients-with-upper-abdominal-pain-study-protocol-for-a-ran-bedd5fb55e6f22cb 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-heterogeneity-of-bronchiectasis-exacerbations-a-multicentre-real-world-0a7810d3a3aa7c7d 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-to-safety-and-efficacy-of-nerinetide-at-year-in-participants-enrolled-1dd4b56d39ccd505 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/clinical-presentation-and-prognosis-of-pathogenic-variants-in-young-onset-atrial-8ca99c4f2dc361f3 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comparison-of-delusional-disorder-and-schizophrenia-in-cases-lacking-criminal-re-f3c7e241b68955b3 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/whole-body-fluorine-18-fluorodeoxyglucose-parametric-pet-computed-tomography-in-2c784a5653e51a0a 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/methodological-considerations-in-the-dapa-stemi-trial-interpreting-a-promising-b-588e1a72fcc019e8 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/distinguishing-acute-myocardial-infarction-from-other-forms-of-cardiac-injury-wi-fbb3680d2f48958e 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/chalcone-indole-hybrid-scaffolds-as-promising-anticancer-drug-candidates-a-mini-77ab34a045513a9c 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/folic-acid-functionalized-plga-cystamine-nanoparticles-for-glutathione-responsiv-a9f08bfb5680b587 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/inhibition-of-protein-arginine-methyltransferase-5-attenuates-dialysis-related-p-a1446bb9af7614a9 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/results-of-a-6-month-therapeutic-programme-regarding-the-angle-of-trunk-rotation-090dab0d80eb6762 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/supplemental-material-for-threat-assessment-in-clinical-practice-a-look-at-clini-3cbdacee72fb9531 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/demographic-factors-sodium-reduction-awareness-and-practices-of-a-low-sodium-die-3e12f21ef433456b 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/catheter-related-staphylococcus-aureus-bacteremia-complicated-by-sternocleidomas-b49c7a4f4db25294 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/magnetite-silica-core-shell-nanoparticles-for-anticancer-drug-mediated-chemo-hyp-32c5572ea5f753cf 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/thermosensitive-in-situ-nanoemulsion-gel-for-sustained-drug-release-of-lidocaine-4f4b4d4530cc608a 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/puerarin-inhibits-nasopharyngeal-carcinoma-cell-growth-by-inducing-ferroptosis-w-f11ca0950d84b2fe 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/targeted-delivery-of-betulinic-acid-from-detarium-microcarpum-guill-amp-perr-ext-9b830b01fd62b484 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/design-development-and-characterization-of-carmustine-loaded-nanostructured-lipi-058e60a1024de812 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/the-role-of-platelets-in-the-hepatocellular-carcinoma-immune-microenvironment-an-9a0c4d554fe05402 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/ultrasound-guided-genicular-nerve-block-novel-clinical-role-for-postoperative-kn-9b4f348032025372 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-beyond-processed-eeg-towards-brain-informed-anaesthesia-0c6d27e014530155 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/correction-stepped-care-digital-gaming-intervention-enhanced-emotion-recognition-ad272fe1999d0957 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/integrative-immune-profiling-and-translational-validation-identify-a-myeloid-inf-6062f153d5bab3a1 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/recommendations-for-generating-real-world-evidence-with-regulatory-grade-relevan-260205e2751f94ca 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/artificial-intelligence-and-the-phantom-pneumothorax-clinical-reasoning-still-ma-4051acdb613bde03 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/comment-on-awareness-of-rheumatoid-arthritis-symptoms-and-complications-among-th-ccd5e15c15d15606 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/micronuclei-and-cytomorphometric-alterations-in-fixed-metal-ceramic-and-removabl-e65175a75af49cba 2026-08-20T00:00:00.000Z weekly 0.7 https://www.pharmaradar360.com/article/letter-to-the-editor-on-discontinuation-and-nonpublication-of-osteosarcoma-clini-8409b32921fda316 2026-08-20T00:00:00.000Z weekly 0.7